@prefix ns1: <https://1145.am/db/> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://1145.am/db/2157170/Charter_Communications> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:buyer <https://1145.am/db/2157170/Bright_House_Networks_Acquisition>,
        <https://1145.am/db/2157170/Merger_Charter_Communications_Has_Not_Happened>,
        <https://1145.am/db/2157170/Time_Warner_Cable_Merger> ;
    ns1:description "M & A" ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "Charter",
        "Charter Communications" ;
    ns1:name "Charter",
        "Charter Communications" ;
    ns1:sameAsMedium <https://1145.am/db/1028500/Charter_Communications>,
        <https://1145.am/db/1255140/Charter_Communications>,
        <https://1145.am/db/1359985/Charter_Communications>,
        <https://1145.am/db/1399482/Charter_Communications>,
        <https://1145.am/db/2156992/Charter_Communications>,
        <https://1145.am/db/2157021/Charter_Communications>,
        <https://1145.am/db/2157151/Charter_Communications>,
        <https://1145.am/db/2157471/Charter_Communications>,
        <https://1145.am/db/2158077/Charter_Communications>,
        <https://1145.am/db/2158498/Charter_Communications>,
        <https://1145.am/db/2158756/Charter_Communications>,
        <https://1145.am/db/2158794/Charter_Communications>,
        <https://1145.am/db/2159615/Charter_Communications>,
        <https://1145.am/db/2159890/Charter_Communications>,
        <https://1145.am/db/2159998/Charter_Communications>,
        <https://1145.am/db/2160003/Charter_Communications>,
        <https://1145.am/db/2160568/Charter_Communications>,
        <https://1145.am/db/2160691/Charter_Communications>,
        <https://1145.am/db/2160880/Charter_Communications>,
        <https://1145.am/db/2161405/Charter_Communications>,
        <https://1145.am/db/2162039/Charter_Communications>,
        <https://1145.am/db/2162107/Charter_Communications>,
        <https://1145.am/db/2162834/Charter_Communications>,
        <https://1145.am/db/2162864/Charter_Communications>,
        <https://1145.am/db/2163000/Charter_Communications>,
        <https://1145.am/db/2163088/Charter_Communications>,
        <https://1145.am/db/2163534/Charter_Communications>,
        <https://1145.am/db/2163553/Charter_Communications>,
        <https://1145.am/db/2163921/Charter_Communications>,
        <https://1145.am/db/2164211/Charter_Communications>,
        <https://1145.am/db/2164277/Charter_Communications>,
        <https://1145.am/db/2165021/Charter_Communications>,
        <https://1145.am/db/2165723/Charter_Communications>,
        <https://1145.am/db/2165868/Charter_Communications>,
        <https://1145.am/db/2166448/Charter_Communications>,
        <https://1145.am/db/2166465/Charter_Communications>,
        <https://1145.am/db/2167252/Charter_Communications>,
        <https://1145.am/db/2167848/Charter_Communications>,
        <https://1145.am/db/2167924/Charter_Communications>,
        <https://1145.am/db/2167942/Charter_Communications>,
        <https://1145.am/db/2168068/Charter_Communications>,
        <https://1145.am/db/2168654/Charter_Communications>,
        <https://1145.am/db/2168683/Charter_Communications>,
        <https://1145.am/db/2169480/Charter_Communications>,
        <https://1145.am/db/2169509/Charter_Communications>,
        <https://1145.am/db/2169845/Charter_Communications>,
        <https://1145.am/db/2170353/Charter_Communications>,
        <https://1145.am/db/2170410/Charter_Communications>,
        <https://1145.am/db/2170907/Charter_Communications>,
        <https://1145.am/db/2171022/Charter_Communications>,
        <https://1145.am/db/2171028/Charter_Communications>,
        <https://1145.am/db/2171082/Charter_Communications>,
        <https://1145.am/db/2171084/Charter_Communications>,
        <https://1145.am/db/2171473/Charter_Communications>,
        <https://1145.am/db/2171843/Charter_Communications>,
        <https://1145.am/db/2171884/Charter_Communications>,
        <https://1145.am/db/2171885/Charter_Communications>,
        <https://1145.am/db/2172655/Charter_Communications>,
        <https://1145.am/db/2172689/Charter_Communications>,
        <https://1145.am/db/2172802/Charter_Communications>,
        <https://1145.am/db/2172805/Charter_Communications>,
        <https://1145.am/db/2173637/Charter_Communications>,
        <https://1145.am/db/2173640/Charter_Communications>,
        <https://1145.am/db/2173644/Charter_Communications>,
        <https://1145.am/db/2174276/Charter_Communications>,
        <https://1145.am/db/2174389/Charter_Communications>,
        <https://1145.am/db/2174439/Charter_Communications>,
        <https://1145.am/db/2174445/Charter_Communications>,
        <https://1145.am/db/2175235/Charter_Communications>,
        <https://1145.am/db/2175260/Charter_Communications>,
        <https://1145.am/db/2175272/Charter_Communications>,
        <https://1145.am/db/2175879/Charter_Communications>,
        <https://1145.am/db/2175893/Charter_Communications>,
        <https://1145.am/db/2175915/Charter_Communications>,
        <https://1145.am/db/2176043/Charter_Communications>,
        <https://1145.am/db/2176080/Charter_Communications>,
        <https://1145.am/db/2176097/Charter_Communications>,
        <https://1145.am/db/2176320/Charter_Communications>,
        <https://1145.am/db/2176347/Charter_Communications>,
        <https://1145.am/db/2176801/Charter_Communications>,
        <https://1145.am/db/2176875/Charter_Communications>,
        <https://1145.am/db/2176901/Charter_Communications>,
        <https://1145.am/db/2176902/Charter_Communications>,
        <https://1145.am/db/2176918/Charter_Communications>,
        <https://1145.am/db/2177557/Charter_Communications>,
        <https://1145.am/db/2177565/Charter_Communications>,
        <https://1145.am/db/2177854/Charter_Communications>,
        <https://1145.am/db/2178417/Charter_Communications>,
        <https://1145.am/db/2179015/Charter_Communications>,
        <https://1145.am/db/2179048/Charter_Communications>,
        <https://1145.am/db/2179482/Charter_Communications>,
        <https://1145.am/db/2599209/Charter_Communications>,
        <https://1145.am/db/2599217/Charter_Communications>,
        <https://1145.am/db/2600855/Charter_Communications>,
        <https://1145.am/db/2601593/Charter_Communications>,
        <https://1145.am/db/2603004/Charter_Communications>,
        <https://1145.am/db/2604097/Charter_Communications>,
        <https://1145.am/db/2606162/Charter_Communications>,
        <https://1145.am/db/2611144/Charter_Communications>,
        <https://1145.am/db/2611393/Charter_Communications>,
        <https://1145.am/db/2612142/Charter_Communications>,
        <https://1145.am/db/2614043/Charter_Communications>,
        <https://1145.am/db/2617127/Charter_Communications>,
        <https://1145.am/db/2617142/Charter_Communications>,
        <https://1145.am/db/2618058/Charter_Communications>,
        <https://1145.am/db/2619394/Charter_Communications>,
        <https://1145.am/db/2621134/Charter_Communications>,
        <https://1145.am/db/2655042/Charter_Communications>,
        <https://1145.am/db/2656277/Charter_Communications>,
        <https://1145.am/db/2660355/Charter_Communications>,
        <https://1145.am/db/2661434/Charter_Communications>,
        <https://1145.am/db/559715/Charter_Communications>,
        <https://1145.am/db/756529/Charter_Communications>,
        <https://1145.am/db/774721/Charter_Communications> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2162866/Dick_Clark_Productions> a org:Organization ;
    ns1:basedInLowRaw "California" ;
    ns1:description "live-events producers" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "Dick Clark Productions" ;
    ns1:investor <https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> ;
    ns1:name "Dick Clark Productions" ;
    ns1:sameAsMedium <https://1145.am/db/2034848/Dick_Clark_Productions>,
        <https://1145.am/db/2168574/Dick_Clark_Productions>,
        <https://1145.am/db/2176611/Dick_Clark_Productions> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2162866/Madison_Square_Garden_Company> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "New York Knicks" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "Madison Square Garden Company" ;
    ns1:investor <https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> ;
    ns1:name "Madison Square Garden Company" ;
    ns1:sameAsMedium <https://1145.am/db/2159287/Madison_Square_Garden_Co>,
        <https://1145.am/db/2163216/Madison_Square_Garden_Co>,
        <https://1145.am/db/2165884/Madison_Square_Garden_Company>,
        <https://1145.am/db/2173632/Madison_Square_Garden_Company> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2162866/Rse_Ventures> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Miami Dolphins" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "RSE Ventures" ;
    ns1:investor <https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> ;
    ns1:name "RSE Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/866534/Rse_Ventures>,
        <https://1145.am/db/979636/Rse_Ventures>,
        <https://1145.am/db/979868/Rse_Ventures> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2162866/Time_Warner> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "venture capital arms" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "Time Warner" ;
    ns1:investor <https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> ;
    ns1:name "Time Warner" ;
    ns1:sameAsMedium <https://1145.am/db/1697885/Time_Warner>,
        <https://1145.am/db/1778517/Time_Warner>,
        <https://1145.am/db/1778753/Time_Warner>,
        <https://1145.am/db/1796420/Time_Warner>,
        <https://1145.am/db/1812607/Time_Warner>,
        <https://1145.am/db/1820889/Time_Warner>,
        <https://1145.am/db/1848570/Time_Warner>,
        <https://1145.am/db/1870590/Time_Warner>,
        <https://1145.am/db/1895611/Time_Warner>,
        <https://1145.am/db/2158868/Time_Warner_Inc>,
        <https://1145.am/db/2159075/Time_Warner_Inc>,
        <https://1145.am/db/2159096/Time_Warner_Inc>,
        <https://1145.am/db/2159599/Time_Warner>,
        <https://1145.am/db/2160821/Time_Warner_Inc>,
        <https://1145.am/db/2162871/Time_Warner_Inc>,
        <https://1145.am/db/2163888/Time_Warner_Inc>,
        <https://1145.am/db/2164870/Time_Warner>,
        <https://1145.am/db/2168552/Time_Warner>,
        <https://1145.am/db/2170216/Time_Warner_Inc>,
        <https://1145.am/db/2173075/Time_Warner>,
        <https://1145.am/db/2173890/Time_Warner>,
        <https://1145.am/db/2175146/Time_Warner>,
        <https://1145.am/db/2175520/Time_Warner>,
        <https://1145.am/db/2175571/Time_Warner>,
        <https://1145.am/db/2176832/Time_Warner>,
        <https://1145.am/db/2177450/Time_Warner_Inc>,
        <https://1145.am/db/2177451/Time_Warner_Inc>,
        <https://1145.am/db/2177458/Time_Warner_Inc>,
        <https://1145.am/db/2186280/Time_Warner>,
        <https://1145.am/db/2613122/Time_Warner_Inc>,
        <https://1145.am/db/2628482/Time_Warner>,
        <https://1145.am/db/2631785/Time_Warner>,
        <https://1145.am/db/2633585/Time_Warner>,
        <https://1145.am/db/2646277/Time_Warner>,
        <https://1145.am/db/2646315/Time_Warner>,
        <https://1145.am/db/2646928/Time_Warner>,
        <https://1145.am/db/2677962/Time_Warner>,
        <https://1145.am/db/2677977/Time_Warner>,
        <https://1145.am/db/2679160/Time_Warner>,
        <https://1145.am/db/2681869/Time_Warner>,
        <https://1145.am/db/334869/Time_Warner_Inc> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Arris> a org:Organization ;
    ns1:basedInLowRaw "Brazil" ;
    ns1:buyer <https://1145.am/db/2164273/Pace_Merger> ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Arris" ;
    ns1:name "Arris" ;
    ns1:sameAsMedium <https://1145.am/db/1829772/Arris>,
        <https://1145.am/db/1841456/Arris>,
        <https://1145.am/db/1877227/Arris>,
        <https://1145.am/db/2157029/Arris>,
        <https://1145.am/db/2157083/Arris>,
        <https://1145.am/db/2161435/Arris>,
        <https://1145.am/db/2162107/Arris>,
        <https://1145.am/db/2162833/Arris>,
        <https://1145.am/db/2163579/Arris>,
        <https://1145.am/db/2164267/Arris>,
        <https://1145.am/db/2165000/Arris>,
        <https://1145.am/db/2165042/Arris>,
        <https://1145.am/db/2166091/Arris>,
        <https://1145.am/db/2166458/Arris_Corp>,
        <https://1145.am/db/2168072/Arris>,
        <https://1145.am/db/2168559/Arris>,
        <https://1145.am/db/2168564/Arris>,
        <https://1145.am/db/2168618/Arris>,
        <https://1145.am/db/2168633/Arris>,
        <https://1145.am/db/2169419/Arris>,
        <https://1145.am/db/2171452/Arris>,
        <https://1145.am/db/2171733/Arris>,
        <https://1145.am/db/2172598/Arris>,
        <https://1145.am/db/2173392/Arris>,
        <https://1145.am/db/2173622/Arris>,
        <https://1145.am/db/2174391/Arris>,
        <https://1145.am/db/2174445/Arris>,
        <https://1145.am/db/2175120/Arris>,
        <https://1145.am/db/2175123/Arris>,
        <https://1145.am/db/2175235/Arris>,
        <https://1145.am/db/2175240/Arris>,
        <https://1145.am/db/2176043/Arris>,
        <https://1145.am/db/2176360/Arris>,
        <https://1145.am/db/2178823/Arris>,
        <https://1145.am/db/2179004/Arris>,
        <https://1145.am/db/2610118/Arris>,
        <https://1145.am/db/2614605/Arris>,
        <https://1145.am/db/2615513/Arris>,
        <https://1145.am/db/2617764/Arris>,
        <https://1145.am/db/2649027/Arris>,
        <https://1145.am/db/2664986/Arris> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Sling_Tv> a org:Organization ;
    ns1:buyer <https://1145.am/db/2164273/Sling_Tv_Completed> ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Sling TV" ;
    ns1:name "Sling TV" ;
    ns1:sameAsMedium <https://1145.am/db/2159542/Sling_Tv>,
        <https://1145.am/db/2167939/Sling_Tv>,
        <https://1145.am/db/2175555/Sling_Tv>,
        <https://1145.am/db/2177567/Sling_Tv> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Amazon> a org:Organization ;
    ns1:buyer <https://1145.am/db/2164290/Acquisition_Amazon_Has_Not_Happened>,
        <https://1145.am/db/2164290/Envivio_Acquisition> ;
    ns1:description "video infrastructure business" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Amazon" ;
    ns1:name "Amazon" ;
    ns1:sameAsMedium <https://1145.am/db/1015814/Amazon>,
        <https://1145.am/db/1044162/Amazon>,
        <https://1145.am/db/1046384/Amazon>,
        <https://1145.am/db/1093730/Amazon>,
        <https://1145.am/db/1112337/Amazon>,
        <https://1145.am/db/1113151/Amazon>,
        <https://1145.am/db/1155054/Amazon>,
        <https://1145.am/db/1157386/Amazon>,
        <https://1145.am/db/1158235/Amazon>,
        <https://1145.am/db/1186069/Amazon>,
        <https://1145.am/db/1223485/Amazon>,
        <https://1145.am/db/1225219/Amazon>,
        <https://1145.am/db/1226852/Amazon>,
        <https://1145.am/db/1234379/Amazon>,
        <https://1145.am/db/1257412/Amazon>,
        <https://1145.am/db/1258030/Amazon>,
        <https://1145.am/db/1258103/Amazon>,
        <https://1145.am/db/1259710/Amazon>,
        <https://1145.am/db/1314911/Amazon>,
        <https://1145.am/db/1315561/Amazon>,
        <https://1145.am/db/1357992/Amazon>,
        <https://1145.am/db/1483728/Amazon>,
        <https://1145.am/db/1635238/Amazon>,
        <https://1145.am/db/1677406/Amazon>,
        <https://1145.am/db/1678241/Amazon>,
        <https://1145.am/db/1678927/Amazon>,
        <https://1145.am/db/1692127/Amazon>,
        <https://1145.am/db/1693860/Amazon>,
        <https://1145.am/db/1693863/Amazon>,
        <https://1145.am/db/1695286/Amazon>,
        <https://1145.am/db/1697229/Amazon>,
        <https://1145.am/db/1698127/Amazon>,
        <https://1145.am/db/1698976/Amazon>,
        <https://1145.am/db/1702811/Amazon>,
        <https://1145.am/db/1704035/Amazon>,
        <https://1145.am/db/1707922/Amazon>,
        <https://1145.am/db/1710896/Amazon>,
        <https://1145.am/db/1711347/Amazon>,
        <https://1145.am/db/1715522/Amazon>,
        <https://1145.am/db/1717829/Amazon>,
        <https://1145.am/db/1718796/Amazon>,
        <https://1145.am/db/1719711/Amazon>,
        <https://1145.am/db/1721516/Amazon>,
        <https://1145.am/db/1721746/Amazon>,
        <https://1145.am/db/1734335/Amazon>,
        <https://1145.am/db/1736995/Amazon>,
        <https://1145.am/db/1738372/Amazon>,
        <https://1145.am/db/1738631/Amazon>,
        <https://1145.am/db/1738636/Amazon>,
        <https://1145.am/db/1739064/Amazon>,
        <https://1145.am/db/1744394/Amazon>,
        <https://1145.am/db/1744400/Amazon>,
        <https://1145.am/db/1744789/Amazon>,
        <https://1145.am/db/1748765/Amazon>,
        <https://1145.am/db/1748902/Amazon>,
        <https://1145.am/db/1748912/Amazon>,
        <https://1145.am/db/1748945/Amazon>,
        <https://1145.am/db/174914/Amazon>,
        <https://1145.am/db/1750127/Amazon>,
        <https://1145.am/db/1751204/Amazon>,
        <https://1145.am/db/1752381/Amazon>,
        <https://1145.am/db/1754131/Amazon>,
        <https://1145.am/db/1757846/Amazon>,
        <https://1145.am/db/1758416/Amazon>,
        <https://1145.am/db/1760187/Amazon>,
        <https://1145.am/db/1760857/Amazon>,
        <https://1145.am/db/1761547/Amazon>,
        <https://1145.am/db/1762920/Amazon>,
        <https://1145.am/db/1765492/Amazon>,
        <https://1145.am/db/1766627/Amazon>,
        <https://1145.am/db/1769237/Amazon>,
        <https://1145.am/db/1772226/Amazon>,
        <https://1145.am/db/1773703/Amazon>,
        <https://1145.am/db/1773718/Amazon>,
        <https://1145.am/db/1773730/Amazon>,
        <https://1145.am/db/1773737/Amazon>,
        <https://1145.am/db/1773929/Amazon>,
        <https://1145.am/db/1773941/Amazon>,
        <https://1145.am/db/1774514/Amazon>,
        <https://1145.am/db/1774648/Amazon>,
        <https://1145.am/db/1775076/Amazon>,
        <https://1145.am/db/1775170/Amazon>,
        <https://1145.am/db/1775467/Amazon>,
        <https://1145.am/db/1775603/Amazon>,
        <https://1145.am/db/1775920/Amazon>,
        <https://1145.am/db/1779811/Amazon>,
        <https://1145.am/db/1779826/Amazon>,
        <https://1145.am/db/1782534/Amazon>,
        <https://1145.am/db/1784411/Amazon>,
        <https://1145.am/db/1785334/Amazon>,
        <https://1145.am/db/1785361/Amazon>,
        <https://1145.am/db/1785842/Amazon>,
        <https://1145.am/db/1786154/Amazon>,
        <https://1145.am/db/1786393/Amazon>,
        <https://1145.am/db/1786514/Amazon>,
        <https://1145.am/db/1786726/Amazon>,
        <https://1145.am/db/1786824/Amazon>,
        <https://1145.am/db/1787578/Amazon>,
        <https://1145.am/db/1790923/Amazon>,
        <https://1145.am/db/1791838/Amazon>,
        <https://1145.am/db/1798223/Amazon>,
        <https://1145.am/db/1799124/Amazon>,
        <https://1145.am/db/1799863/Amazon>,
        <https://1145.am/db/1800770/Amazon>,
        <https://1145.am/db/1806797/Amazon>,
        <https://1145.am/db/1811030/Amazon>,
        <https://1145.am/db/1811058/Amazon>,
        <https://1145.am/db/1816044/Amazon>,
        <https://1145.am/db/1822708/Amazon>,
        <https://1145.am/db/1824361/Amazon>,
        <https://1145.am/db/1825858/Amazon>,
        <https://1145.am/db/1826314/Amazon>,
        <https://1145.am/db/1827735/Amazon>,
        <https://1145.am/db/1832851/Amazon>,
        <https://1145.am/db/1840437/Amazon>,
        <https://1145.am/db/1841162/Amazon>,
        <https://1145.am/db/1846846/Amazon>,
        <https://1145.am/db/1851279/Amazon>,
        <https://1145.am/db/1852800/Amazon>,
        <https://1145.am/db/1852930/Amazon>,
        <https://1145.am/db/1858472/Amazon>,
        <https://1145.am/db/1859741/Amazon>,
        <https://1145.am/db/1859781/Amazon>,
        <https://1145.am/db/1864451/Amazon>,
        <https://1145.am/db/1868599/Amazon>,
        <https://1145.am/db/1875998/Amazon>,
        <https://1145.am/db/1877305/Amazon>,
        <https://1145.am/db/1883056/Amazon>,
        <https://1145.am/db/1886968/Amazon>,
        <https://1145.am/db/1886971/Amazon>,
        <https://1145.am/db/1887552/Amazon>,
        <https://1145.am/db/1890268/Amazon>,
        <https://1145.am/db/1895508/Amazon>,
        <https://1145.am/db/1896616/Amazon>,
        <https://1145.am/db/1911388/Amazon>,
        <https://1145.am/db/1914716/Amazon>,
        <https://1145.am/db/1927512/Amazon>,
        <https://1145.am/db/1961649/Amazon>,
        <https://1145.am/db/1961807/Amazon>,
        <https://1145.am/db/198891/Amazon>,
        <https://1145.am/db/198893/Amazon>,
        <https://1145.am/db/2017188/Amazon>,
        <https://1145.am/db/2039253/Amazon>,
        <https://1145.am/db/2039789/Amazon>,
        <https://1145.am/db/2047078/Amazon>,
        <https://1145.am/db/2056237/Amazon>,
        <https://1145.am/db/2057381/Amazon>,
        <https://1145.am/db/2057384/Amazon>,
        <https://1145.am/db/2062489/Amazon>,
        <https://1145.am/db/2065431/Amazon>,
        <https://1145.am/db/2066172/Amazon>,
        <https://1145.am/db/2067787/Amazon>,
        <https://1145.am/db/2100038/Amazon>,
        <https://1145.am/db/2114169/Amazon>,
        <https://1145.am/db/211665/Amazon>,
        <https://1145.am/db/2117807/Amazon>,
        <https://1145.am/db/2123007/Amazon>,
        <https://1145.am/db/2124141/Amazon>,
        <https://1145.am/db/2126936/Amazon>,
        <https://1145.am/db/2149513/Amazon>,
        <https://1145.am/db/2149905/Amazon>,
        <https://1145.am/db/2157570/Amazon>,
        <https://1145.am/db/2159252/Amazon>,
        <https://1145.am/db/2160249/Amazon>,
        <https://1145.am/db/2160261/Amazon>,
        <https://1145.am/db/2164706/Amazon>,
        <https://1145.am/db/2164716/Amazon>,
        <https://1145.am/db/2165431/Amazon>,
        <https://1145.am/db/2167498/Amazon>,
        <https://1145.am/db/2168012/Amazon>,
        <https://1145.am/db/2168180/Amazon>,
        <https://1145.am/db/2168198/Amazon>,
        <https://1145.am/db/2169311/Amazon>,
        <https://1145.am/db/2170718/Amazon>,
        <https://1145.am/db/2170870/Amazon>,
        <https://1145.am/db/2171266/Amazon>,
        <https://1145.am/db/2173794/Amazon>,
        <https://1145.am/db/2179660/Amazon>,
        <https://1145.am/db/2180343/Amazon>,
        <https://1145.am/db/2180529/Amazon>,
        <https://1145.am/db/2180858/Amazon>,
        <https://1145.am/db/2180897/Amazon>,
        <https://1145.am/db/2180909/Amazon>,
        <https://1145.am/db/2181108/Amazon>,
        <https://1145.am/db/2181397/Amazon>,
        <https://1145.am/db/2181530/Amazon>,
        <https://1145.am/db/2181575/Amazon>,
        <https://1145.am/db/2181684/Amazon>,
        <https://1145.am/db/2183394/Amazon>,
        <https://1145.am/db/2190613/Amazon>,
        <https://1145.am/db/2191587/Amazon>,
        <https://1145.am/db/2196363/Amazon>,
        <https://1145.am/db/2197997/Amazon>,
        <https://1145.am/db/2424625/Amazon>,
        <https://1145.am/db/245750/Amazon>,
        <https://1145.am/db/2604024/Amazon>,
        <https://1145.am/db/2631613/Amazon>,
        <https://1145.am/db/2634262/Amazon>,
        <https://1145.am/db/2650132/Amazon>,
        <https://1145.am/db/2652871/Amazon>,
        <https://1145.am/db/2662981/Amazon>,
        <https://1145.am/db/2671100/Amazon>,
        <https://1145.am/db/2723854/Amazon>,
        <https://1145.am/db/2787235/Amazon>,
        <https://1145.am/db/2792386/Amazon>,
        <https://1145.am/db/328682/Amazon>,
        <https://1145.am/db/336590/Amazon>,
        <https://1145.am/db/361232/Amazon>,
        <https://1145.am/db/496515/Amazon>,
        <https://1145.am/db/496717/Amazon>,
        <https://1145.am/db/563740/Amazon>,
        <https://1145.am/db/567114/Amazon>,
        <https://1145.am/db/576981/Amazon>,
        <https://1145.am/db/606291/Amazon>,
        <https://1145.am/db/6500/Amazon>,
        <https://1145.am/db/799623/Amazon>,
        <https://1145.am/db/810902/Amazon>,
        <https://1145.am/db/816502/Amazon>,
        <https://1145.am/db/82697/Amazon>,
        <https://1145.am/db/83980/Amazon>,
        <https://1145.am/db/848402/Amazon>,
        <https://1145.am/db/892581/Amazon>,
        <https://1145.am/db/905684/Amazon>,
        <https://1145.am/db/905775/Amazon>,
        <https://1145.am/db/915104/Amazon>,
        <https://1145.am/db/915113/Amazon>,
        <https://1145.am/db/915913/Amazon>,
        <https://1145.am/db/98647/Amazon>,
        <https://1145.am/db/988506/Amazon>,
        <https://1145.am/db/989851/Amazon> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Ericsson> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:buyer <https://1145.am/db/2164290/Acquisition_Ericsson_Has_Not_Happened>,
        <https://1145.am/db/2164290/Envivio_Acquisition> ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Ericsson" ;
    ns1:name "Ericsson" ;
    ns1:sameAsMedium <https://1145.am/db/1010341/Ericsson>,
        <https://1145.am/db/1012103/Ericsson>,
        <https://1145.am/db/1100279/Ericsson>,
        <https://1145.am/db/1101018/Ericsson>,
        <https://1145.am/db/1165550/Ericsson>,
        <https://1145.am/db/1209219/Ericsson>,
        <https://1145.am/db/1225626/Ericsson>,
        <https://1145.am/db/1580225/Ericsson>,
        <https://1145.am/db/1709352/Ericsson>,
        <https://1145.am/db/1741086/Ericsson>,
        <https://1145.am/db/1747400/Ericsson>,
        <https://1145.am/db/1761010/Ericsson>,
        <https://1145.am/db/1772719/Ericsson>,
        <https://1145.am/db/1776068/Ericsson>,
        <https://1145.am/db/1798571/Ericsson>,
        <https://1145.am/db/1830579/Ericsson>,
        <https://1145.am/db/1832770/Ericsson>,
        <https://1145.am/db/2106385/Ericsson>,
        <https://1145.am/db/2159270/Ericsson>,
        <https://1145.am/db/2162797/Ericsson>,
        <https://1145.am/db/2165763/Ericsson>,
        <https://1145.am/db/2168661/Ericsson>,
        <https://1145.am/db/2169982/Ericsson>,
        <https://1145.am/db/2170316/Ericsson>,
        <https://1145.am/db/2170718/Ericsson>,
        <https://1145.am/db/2172604/Ericsson>,
        <https://1145.am/db/2173399/Ericsson>,
        <https://1145.am/db/2178800/Ericsson>,
        <https://1145.am/db/2178825/Ericsson>,
        <https://1145.am/db/2178851/Ericsson>,
        <https://1145.am/db/2600138/Ericsson_Ab>,
        <https://1145.am/db/2600586/Ericsson>,
        <https://1145.am/db/2601728/Ericsson>,
        <https://1145.am/db/2601892/Ericsson>,
        <https://1145.am/db/2602033/Ericsson>,
        <https://1145.am/db/2602724/Ericsson>,
        <https://1145.am/db/2603005/Ericsson>,
        <https://1145.am/db/2603484/Ericsson>,
        <https://1145.am/db/2603533/Ericsson>,
        <https://1145.am/db/2604206/Ericsson>,
        <https://1145.am/db/2604945/Ericsson>,
        <https://1145.am/db/2604979/Ericsson>,
        <https://1145.am/db/2605221/Ericsson>,
        <https://1145.am/db/2605429/Ericsson>,
        <https://1145.am/db/2605947/Ericsson>,
        <https://1145.am/db/2606540/Ericsson>,
        <https://1145.am/db/2606695/Ericsson>,
        <https://1145.am/db/2607457/Ericsson>,
        <https://1145.am/db/2607511/Ericsson>,
        <https://1145.am/db/2609697/Ericsson>,
        <https://1145.am/db/2609893/Ericsson>,
        <https://1145.am/db/2610483/Ericsson>,
        <https://1145.am/db/2611174/Ericsson>,
        <https://1145.am/db/2611280/Ericsson>,
        <https://1145.am/db/2611585/Ericsson>,
        <https://1145.am/db/2617143/Ericsson>,
        <https://1145.am/db/2617770/Ericsson>,
        <https://1145.am/db/2617989/Ericsson>,
        <https://1145.am/db/2620232/Ericsson>,
        <https://1145.am/db/2621929/Ericsson>,
        <https://1145.am/db/2624001/Ericsson>,
        <https://1145.am/db/2624004/Ericsson>,
        <https://1145.am/db/2624011/Ericsson>,
        <https://1145.am/db/2624028/Ericsson>,
        <https://1145.am/db/2626360/Ericsson>,
        <https://1145.am/db/2627922/Ericsson>,
        <https://1145.am/db/2628880/Ericsson>,
        <https://1145.am/db/2630260/Ericsson>,
        <https://1145.am/db/2630674/Ericsson>,
        <https://1145.am/db/2631791/Ericsson>,
        <https://1145.am/db/2632729/Ericsson>,
        <https://1145.am/db/2635007/Ericsson>,
        <https://1145.am/db/2635029/Ericsson>,
        <https://1145.am/db/2637329/Ericsson>,
        <https://1145.am/db/2637441/Ericsson>,
        <https://1145.am/db/2638354/Ericsson>,
        <https://1145.am/db/2639419/Ericsson>,
        <https://1145.am/db/2639425/Ericsson>,
        <https://1145.am/db/2640397/Ericsson>,
        <https://1145.am/db/2640432/Ericsson>,
        <https://1145.am/db/2642033/Ericsson>,
        <https://1145.am/db/2642347/Ericsson>,
        <https://1145.am/db/2642382/Ericsson>,
        <https://1145.am/db/2642984/Ericsson>,
        <https://1145.am/db/2644655/Ericsson>,
        <https://1145.am/db/2645724/Ericsson>,
        <https://1145.am/db/2646076/Ericsson>,
        <https://1145.am/db/2646393/Ericsson>,
        <https://1145.am/db/2646902/Ericsson>,
        <https://1145.am/db/2647032/Ericsson>,
        <https://1145.am/db/2647659/Ericsson>,
        <https://1145.am/db/2647820/Ericsson>,
        <https://1145.am/db/2647912/Ericsson>,
        <https://1145.am/db/2648549/Ericsson>,
        <https://1145.am/db/2649754/Ericsson>,
        <https://1145.am/db/2649852/Ericsson>,
        <https://1145.am/db/2649889/Ericsson>,
        <https://1145.am/db/2650030/Ericsson>,
        <https://1145.am/db/2650307/Ericsson>,
        <https://1145.am/db/2650433/Ericsson>,
        <https://1145.am/db/2651508/Ericsson>,
        <https://1145.am/db/2651547/Ericsson>,
        <https://1145.am/db/2651635/Ericsson>,
        <https://1145.am/db/2651649/Ericsson>,
        <https://1145.am/db/2651735/Ericsson>,
        <https://1145.am/db/2651797/Ericsson>,
        <https://1145.am/db/2651962/Ericsson>,
        <https://1145.am/db/2652172/Ericsson>,
        <https://1145.am/db/2652181/Ericsson>,
        <https://1145.am/db/2652257/Ericsson>,
        <https://1145.am/db/2652364/Ericsson>,
        <https://1145.am/db/2653139/Ericsson>,
        <https://1145.am/db/2653906/Ericsson>,
        <https://1145.am/db/2653914/Ericsson>,
        <https://1145.am/db/2653992/Ericsson>,
        <https://1145.am/db/2654565/Ericsson>,
        <https://1145.am/db/2654893/Ericsson>,
        <https://1145.am/db/2656812/Ericsson>,
        <https://1145.am/db/2659489/Ericsson>,
        <https://1145.am/db/2659498/Ericsson>,
        <https://1145.am/db/2659685/Ericsson>,
        <https://1145.am/db/2659720/Ericsson>,
        <https://1145.am/db/2660897/Ericsson>,
        <https://1145.am/db/2661242/Ericsson>,
        <https://1145.am/db/2661250/Ericsson>,
        <https://1145.am/db/2661650/Ericsson>,
        <https://1145.am/db/2663328/Ericsson>,
        <https://1145.am/db/2663872/Ericsson>,
        <https://1145.am/db/2664008/Ericsson>,
        <https://1145.am/db/2665123/Ericsson>,
        <https://1145.am/db/2665272/Ericsson>,
        <https://1145.am/db/2665925/Ericsson>,
        <https://1145.am/db/2666056/Ericsson>,
        <https://1145.am/db/2666116/Ericsson>,
        <https://1145.am/db/2666215/Ericsson>,
        <https://1145.am/db/2667803/Ericsson>,
        <https://1145.am/db/2668126/Ericsson>,
        <https://1145.am/db/2668547/Ericsson>,
        <https://1145.am/db/2668564/Ericsson>,
        <https://1145.am/db/2668584/Ericsson>,
        <https://1145.am/db/2668656/Ericsson>,
        <https://1145.am/db/2668985/Ericsson>,
        <https://1145.am/db/2669162/Ericsson>,
        <https://1145.am/db/2669977/Ericsson>,
        <https://1145.am/db/2670346/Ericsson>,
        <https://1145.am/db/2670353/Ericsson>,
        <https://1145.am/db/2670399/Ericsson>,
        <https://1145.am/db/2670483/Ericsson>,
        <https://1145.am/db/2670705/Ericsson>,
        <https://1145.am/db/2670922/Ericsson>,
        <https://1145.am/db/2671039/Ericsson>,
        <https://1145.am/db/2671161/Ericsson>,
        <https://1145.am/db/2671338/Ericsson>,
        <https://1145.am/db/2671587/Ericsson>,
        <https://1145.am/db/2671793/Ericsson>,
        <https://1145.am/db/2671856/Ericsson>,
        <https://1145.am/db/2671878/Ericsson>,
        <https://1145.am/db/2672886/Ericsson>,
        <https://1145.am/db/2673124/Ericsson>,
        <https://1145.am/db/2673365/Ericsson>,
        <https://1145.am/db/2675276/Ericsson>,
        <https://1145.am/db/2675295/Ericsson>,
        <https://1145.am/db/2675455/Ericsson>,
        <https://1145.am/db/2675513/Ericsson>,
        <https://1145.am/db/2675784/Ericsson>,
        <https://1145.am/db/2676121/Ericsson>,
        <https://1145.am/db/2676132/Ericsson>,
        <https://1145.am/db/2676137/Ericsson>,
        <https://1145.am/db/2676946/Ericsson>,
        <https://1145.am/db/2677331/Ericsson>,
        <https://1145.am/db/2677353/Ericsson>,
        <https://1145.am/db/2677895/Ericsson>,
        <https://1145.am/db/2679832/Ericsson>,
        <https://1145.am/db/2679964/Ericsson>,
        <https://1145.am/db/2680056/Ericsson>,
        <https://1145.am/db/2680776/Ericsson>,
        <https://1145.am/db/2681149/Ericsson>,
        <https://1145.am/db/2681258/Ericsson>,
        <https://1145.am/db/2681296/Ericsson>,
        <https://1145.am/db/2681328/Ericsson>,
        <https://1145.am/db/2681690/Ericsson>,
        <https://1145.am/db/2683381/Ericsson>,
        <https://1145.am/db/2683789/Ericsson>,
        <https://1145.am/db/2684100/Ericsson>,
        <https://1145.am/db/2685198/Ericsson>,
        <https://1145.am/db/2685341/Ericsson>,
        <https://1145.am/db/2685807/Ericsson>,
        <https://1145.am/db/2685844/Ericsson>,
        <https://1145.am/db/2686007/Ericsson>,
        <https://1145.am/db/2686067/Ericsson>,
        <https://1145.am/db/2686285/Ericsson>,
        <https://1145.am/db/2686301/Ericsson>,
        <https://1145.am/db/2686449/Ericsson>,
        <https://1145.am/db/275232/Ericsson>,
        <https://1145.am/db/638249/Ericsson>,
        <https://1145.am/db/641498/Ericsson>,
        <https://1145.am/db/642266/Ericsson>,
        <https://1145.am/db/642921/Ericsson>,
        <https://1145.am/db/643839/Ericsson>,
        <https://1145.am/db/643867/Ericsson>,
        <https://1145.am/db/721139/Ericsson>,
        <https://1145.am/db/910501/Ericsson> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Harmonic> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:buyer <https://1145.am/db/2164290/Merger_Harmonic_Completed>,
        <https://1145.am/db/2164290/Thomson_Video_Networks_Acquisition> ;
    ns1:description "video compression and infrastructure services" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Harmonic" ;
    ns1:name "Harmonic" ;
    ns1:sameAsMedium <https://1145.am/db/1075909/Harmonic>,
        <https://1145.am/db/1907590/Harmonic>,
        <https://1145.am/db/2156880/Harmonic>,
        <https://1145.am/db/2159287/Harmonic>,
        <https://1145.am/db/2164816/Harmonic_Inc>,
        <https://1145.am/db/2169428/Harmonic>,
        <https://1145.am/db/2170718/Harmonic>,
        <https://1145.am/db/2176444/Harmonic>,
        <https://1145.am/db/2176446/Harmonic_Inc>,
        <https://1145.am/db/2177205/Harmonic>,
        <https://1145.am/db/2179446/Harmonic> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Ibm> a org:Organization ;
    ns1:buyer <https://1145.am/db/2164290/Clearleap_Acquisition> ;
    ns1:description "IBM is trying to create a robust service portfolio that lets customers acquire, store, distribute and" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "IBM" ;
    ns1:name "IBM" ;
    ns1:sameAsMedium <https://1145.am/db/1113794/Ibm>,
        <https://1145.am/db/1187106/Ibm>,
        <https://1145.am/db/1364021/Ibm>,
        <https://1145.am/db/1561961/Ibm>,
        <https://1145.am/db/1561967/Ibm>,
        <https://1145.am/db/1562363/Ibm>,
        <https://1145.am/db/156643/Ibm>,
        <https://1145.am/db/1702435/Ibm>,
        <https://1145.am/db/1708445/Ibm>,
        <https://1145.am/db/1715485/Ibm>,
        <https://1145.am/db/1717171/Ibm>,
        <https://1145.am/db/1718002/Ibm>,
        <https://1145.am/db/1718006/Ibm>,
        <https://1145.am/db/1718010/Ibm>,
        <https://1145.am/db/1718017/Ibm>,
        <https://1145.am/db/1719227/Ibm>,
        <https://1145.am/db/1719358/Ibm>,
        <https://1145.am/db/1719360/Ibm>,
        <https://1145.am/db/1719371/Ibm>,
        <https://1145.am/db/1719377/Ibm>,
        <https://1145.am/db/1720139/Ibm>,
        <https://1145.am/db/1722158/Ibm>,
        <https://1145.am/db/1722186/Ibm>,
        <https://1145.am/db/1723567/Ibm>,
        <https://1145.am/db/1729299/Ibm>,
        <https://1145.am/db/1744949/Ibm>,
        <https://1145.am/db/1745344/Ibm>,
        <https://1145.am/db/1748887/Ibm>,
        <https://1145.am/db/1750284/Ibm>,
        <https://1145.am/db/1750872/Ibm>,
        <https://1145.am/db/1754020/Ibm>,
        <https://1145.am/db/1761320/Ibm>,
        <https://1145.am/db/1790514/Ibm>,
        <https://1145.am/db/1793057/Ibm>,
        <https://1145.am/db/1794140/Ibm>,
        <https://1145.am/db/1794605/Ibm>,
        <https://1145.am/db/1795070/Ibm>,
        <https://1145.am/db/1795243/Ibm>,
        <https://1145.am/db/1796125/Ibm>,
        <https://1145.am/db/1797083/Ibm>,
        <https://1145.am/db/1799864/Ibm>,
        <https://1145.am/db/1803641/Ibm>,
        <https://1145.am/db/1804318/Ibm>,
        <https://1145.am/db/1805752/Ibm>,
        <https://1145.am/db/1806147/Ibm>,
        <https://1145.am/db/1806429/Ibm>,
        <https://1145.am/db/1813078/Ibm>,
        <https://1145.am/db/1829714/Ibm>,
        <https://1145.am/db/1830622/Ibm>,
        <https://1145.am/db/1834463/Ibm>,
        <https://1145.am/db/1841189/Ibm>,
        <https://1145.am/db/1842104/Ibm>,
        <https://1145.am/db/1844885/Ibm>,
        <https://1145.am/db/1845158/Ibm>,
        <https://1145.am/db/1849050/Ibm>,
        <https://1145.am/db/1851682/Ibm>,
        <https://1145.am/db/1853649/Ibm>,
        <https://1145.am/db/1861511/Ibm>,
        <https://1145.am/db/1864142/Ibm>,
        <https://1145.am/db/1866712/Ibm>,
        <https://1145.am/db/1866821/Ibm>,
        <https://1145.am/db/1869161/Ibm>,
        <https://1145.am/db/1872638/Ibm>,
        <https://1145.am/db/1872804/Ibm>,
        <https://1145.am/db/1882238/Ibm>,
        <https://1145.am/db/1887867/Ibm>,
        <https://1145.am/db/1902079/Ibm>,
        <https://1145.am/db/1912512/Ibm>,
        <https://1145.am/db/1912525/Ibm>,
        <https://1145.am/db/1922035/Ibm>,
        <https://1145.am/db/1922765/Ibm>,
        <https://1145.am/db/193039/Ibm_Corp>,
        <https://1145.am/db/193041/Ibm_Corp>,
        <https://1145.am/db/2008509/Ibm>,
        <https://1145.am/db/2048339/Ibm>,
        <https://1145.am/db/2048747/Ibm>,
        <https://1145.am/db/2049611/Ibm>,
        <https://1145.am/db/2053952/Ibm>,
        <https://1145.am/db/2054357/Ibm>,
        <https://1145.am/db/2093416/Ibm>,
        <https://1145.am/db/2093468/Ibm>,
        <https://1145.am/db/2094328/Ibm>,
        <https://1145.am/db/2126585/Ibm>,
        <https://1145.am/db/2155512/Ibm>,
        <https://1145.am/db/2170755/Ibm>,
        <https://1145.am/db/2173970/Ibm>,
        <https://1145.am/db/2186113/Ibm>,
        <https://1145.am/db/2205410/Ibm>,
        <https://1145.am/db/2218232/Ibm>,
        <https://1145.am/db/2223301/Ibm>,
        <https://1145.am/db/2226206/Ibm>,
        <https://1145.am/db/2227785/Ibm>,
        <https://1145.am/db/2244886/Ibm>,
        <https://1145.am/db/2266051/Ibm>,
        <https://1145.am/db/2276589/Ibm>,
        <https://1145.am/db/2320562/Ibm>,
        <https://1145.am/db/2321794/Ibm>,
        <https://1145.am/db/2326099/Ibm>,
        <https://1145.am/db/2331583/Ibm>,
        <https://1145.am/db/2334532/Ibm>,
        <https://1145.am/db/2433768/Ibm>,
        <https://1145.am/db/2434090/Ibm>,
        <https://1145.am/db/2447733/Ibm>,
        <https://1145.am/db/2448839/Ibm>,
        <https://1145.am/db/2602156/Ibm>,
        <https://1145.am/db/2602302/Ibm>,
        <https://1145.am/db/2602679/Ibm>,
        <https://1145.am/db/2603590/Ibm>,
        <https://1145.am/db/2604038/Ibm>,
        <https://1145.am/db/2604539/Ibm>,
        <https://1145.am/db/2608961/Ibm>,
        <https://1145.am/db/2612676/Ibm>,
        <https://1145.am/db/2614413/Ibm>,
        <https://1145.am/db/2615162/Ibm>,
        <https://1145.am/db/2615175/Ibm>,
        <https://1145.am/db/2616270/Ibm>,
        <https://1145.am/db/2617606/Ibm>,
        <https://1145.am/db/2621228/Ibm>,
        <https://1145.am/db/2629545/Ibm>,
        <https://1145.am/db/2652765/Ibm>,
        <https://1145.am/db/2654783/Ibm>,
        <https://1145.am/db/2658050/Ibm>,
        <https://1145.am/db/2659905/Ibm>,
        <https://1145.am/db/2668915/Ibm>,
        <https://1145.am/db/2669998/Ibm>,
        <https://1145.am/db/2673838/Ibm>,
        <https://1145.am/db/2675554/Ibm>,
        <https://1145.am/db/2677677/Ibm>,
        <https://1145.am/db/2681299/Ibm>,
        <https://1145.am/db/2682096/Ibm>,
        <https://1145.am/db/2683576/Ibm>,
        <https://1145.am/db/2684891/Ibm>,
        <https://1145.am/db/320259/Ibm>,
        <https://1145.am/db/321734/Ibm>,
        <https://1145.am/db/336264/Ibm>,
        <https://1145.am/db/339641/Ibm>,
        <https://1145.am/db/513376/Ibm>,
        <https://1145.am/db/513385/Ibm>,
        <https://1145.am/db/560340/Ibm>,
        <https://1145.am/db/658636/Ibm>,
        <https://1145.am/db/736873/Ibm>,
        <https://1145.am/db/831920/Ibm>,
        <https://1145.am/db/886594/Ibm> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2166438/John_Malone_And_Liberty_Global> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:buyer <https://1145.am/db/2166438/Telenet_Acquisition> ;
    ns1:description "Business",
        "business" ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "John Malone",
        "John Malone and Liberty Global",
        "Liberty Global" ;
    ns1:name "John Malone",
        "John Malone and Liberty Global",
        "Liberty Global" ;
    ns1:sameAsHigh <https://1145.am/db/2171752/John_Malone>,
        <https://1145.am/db/2697450/John_Malone>,
        <https://1145.am/db/87823/Liberty_Global> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2170734/Cueball_Capital> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "Cueball Capital" ;
    ns1:investor <https://1145.am/db/2170734/Series_D_Investment_Cueball_Capital_Greenspring_Associates_Greycroft_Growth_Jw_Player_Eventures_Completed> ;
    ns1:name "Cueball Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1747899/Cueball_Capital> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2170734/Eventures> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "e.ventures" ;
    ns1:investor <https://1145.am/db/2170734/Series_D_Investment_Cueball_Capital_Greenspring_Associates_Greycroft_Growth_Jw_Player_Eventures_Completed> ;
    ns1:name "e.ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/133157/Eventures>,
        <https://1145.am/db/1736790/Eventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1740071/Eventures>,
        <https://1145.am/db/1742154/Eventures>,
        <https://1145.am/db/1743085/Eventures>,
        <https://1145.am/db/1757815/Eventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1773184/Eventures>,
        <https://1145.am/db/1777338/Eventures>,
        <https://1145.am/db/1787891/Eventures>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789573/Eventures>,
        <https://1145.am/db/1790647/Eventures>,
        <https://1145.am/db/1791628/Eventures>,
        <https://1145.am/db/1794560/Eventures>,
        <https://1145.am/db/1801009/Eventures>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1825560/Eventures>,
        <https://1145.am/db/1835236/Eventures>,
        <https://1145.am/db/1839887/Eventures>,
        <https://1145.am/db/1841180/Eventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843415/Eventures>,
        <https://1145.am/db/1845590/Eventures>,
        <https://1145.am/db/1847995/Eventures>,
        <https://1145.am/db/1850251/Eventures>,
        <https://1145.am/db/1854668/Eventures>,
        <https://1145.am/db/297651/Eventures> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2170734/Greenspring_Associates> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "Greenspring Associates" ;
    ns1:investor <https://1145.am/db/2170734/Series_D_Investment_Cueball_Capital_Greenspring_Associates_Greycroft_Growth_Jw_Player_Eventures_Completed> ;
    ns1:name "Greenspring Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1744228/Greenspring_Associates>,
        <https://1145.am/db/1760399/Greenspring_Associates>,
        <https://1145.am/db/1798788/Greenspring_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1737723/Greenspring_Associates>,
        <https://1145.am/db/1751506/Greenspring_Associates>,
        <https://1145.am/db/1760148/Greenspring_Associates>,
        <https://1145.am/db/1762479/Greenspring_Associates>,
        <https://1145.am/db/1784596/Greenspring_Associates>,
        <https://1145.am/db/1788142/Greenspring_Associates>,
        <https://1145.am/db/1806644/Greenspring_Associates>,
        <https://1145.am/db/1810769/Greenspring_Associates>,
        <https://1145.am/db/1818011/Greenspring_Associates>,
        <https://1145.am/db/1823460/Greenspring_Associates>,
        <https://1145.am/db/1828087/Greenspring_Associates>,
        <https://1145.am/db/1854807/Greenspring_Associates>,
        <https://1145.am/db/1881490/Greenspring_Associates>,
        <https://1145.am/db/2188661/Greenspring_Associates>,
        <https://1145.am/db/2246652/Greenspring_Associates>,
        <https://1145.am/db/2310796/Greenspring_Associates>,
        <https://1145.am/db/2344565/Greenspring_Associates_Inc>,
        <https://1145.am/db/2345549/Greenspring_Associates_Inc>,
        <https://1145.am/db/2443170/Greenspring_Associates>,
        <https://1145.am/db/2537417/Greenspring_Associates>,
        <https://1145.am/db/2648036/Greenspring_Associates>,
        <https://1145.am/db/336270/Greenspring_Associates>,
        <https://1145.am/db/410473/Greenspring_Associates>,
        <https://1145.am/db/487425/Greenspring_Associates>,
        <https://1145.am/db/559318/Greenspring_Associates>,
        <https://1145.am/db/583208/Greenspring_Associates> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2170734/Greycroft_Growth> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "Greycroft Growth" ;
    ns1:investor <https://1145.am/db/2170734/Series_D_Investment_Cueball_Capital_Greenspring_Associates_Greycroft_Growth_Jw_Player_Eventures_Completed> ;
    ns1:name "Greycroft Growth" ;
    ns1:sameAsHigh <https://1145.am/db/1508200/Greycroft>,
        <https://1145.am/db/1743085/Greycroft>,
        <https://1145.am/db/2187105/Greycroft>,
        <https://1145.am/db/230669/Greycroft>,
        <https://1145.am/db/422889/Greycroft>,
        <https://1145.am/db/424653/Greycroft>,
        <https://1145.am/db/508115/Greycroft>,
        <https://1145.am/db/731044/Greycroft> ;
    ns1:sameAsMedium <https://1145.am/db/1792426/Greycroft_Growth> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2208603/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Boston" ;
    ns1:documentDate "2015-09-18T15:58:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kyruus raises $25M in funding; BIDMC's John Halamka on the next big challenges for CIOs;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/kyruus-raises-25m-funding-bidmc-s-john-halamka-next-big-challenges-for-cios> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2208603/Investment_Kyruus_Mckesson_Ventures_New_Leaf_Venture_Partners_Providence_Health___Services_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2208603/Providence_Health___Services> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2015-09-18T15:58:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kyruus raises $25M in funding; BIDMC's John Halamka on the next big challenges for CIOs;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/kyruus-raises-25m-funding-bidmc-s-john-halamka-next-big-challenges-for-cios> ;
    ns1:foundName "Providence Health & Services" ;
    ns1:industry "health care" ;
    ns1:investor <https://1145.am/db/2208603/Investment_Kyruus_Mckesson_Ventures_New_Leaf_Venture_Partners_Providence_Health___Services_Completed> ;
    ns1:name "Providence Health & Services" ;
    ns1:sameAsHigh <https://1145.am/db/127343/Providence_Health_And_Services>,
        <https://1145.am/db/2187044/Providence_Health>,
        <https://1145.am/db/2217636/Providence_Health___Services>,
        <https://1145.am/db/2256498/Providence_Health___Services> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2252863/Bluemountain_Capital_Management> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York" ;
    ns1:documentDate "2015-07-20T19:25:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Daughters of Charity finds another potential savior" ;
    ns1:documentURL <https://www.fiercehealthcare.com/finance/daughters-charity-finds-another-potential-savior> ;
    ns1:foundName "BlueMountain Capital Management" ;
    ns1:investor <https://1145.am/db/2252863/Investment_Daughters_Of_Charity_Has_Not_Happened> ;
    ns1:name "BlueMountain Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/2253109/Bluemountain_Capital_Management>,
        <https://1145.am/db/2255692/Bluemountain_Capital_Management> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2268481/Cleveland_Clinic> a org:Organization ;
    ns1:basedInHighGeoName "Ohio" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5165418/about.rdf> ;
    ns1:basedInHighRaw "Ohio" ;
    ns1:buyer <https://1145.am/db/2268481/Akron_General_Health_System_Stake_Acquisition> ;
    ns1:documentDate "2015-08-31T16:43:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleveland Clinic to take full ownership of Akron General Health System" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-to-take-full-ownership-akron-general-health-system> ;
    ns1:foundName "Cleveland Clinic" ;
    ns1:industry "Health care" ;
    ns1:name "Cleveland Clinic" ;
    ns1:sameAsHigh <https://1145.am/db/1165515/Cleveland_Clinic>,
        <https://1145.am/db/2181372/Cleveland_Clinic>,
        <https://1145.am/db/2188654/Cleveland_Clinic>,
        <https://1145.am/db/2188994/Cleveland_Clinic>,
        <https://1145.am/db/2192868/The_Cleveland_Clinic>,
        <https://1145.am/db/2197626/Cleveland_Clinic>,
        <https://1145.am/db/2219875/The_Cleveland_Clinic>,
        <https://1145.am/db/2221826/Cleveland_Clinic>,
        <https://1145.am/db/2235333/Cleveland_Clinic>,
        <https://1145.am/db/2249785/The_Cleveland_Clinic> ;
    ns1:sameAsMedium <https://1145.am/db/2183715/Cleveland_Clinic>,
        <https://1145.am/db/2185687/Cleveland_Clinic>,
        <https://1145.am/db/2188551/Cleveland_Clinic>,
        <https://1145.am/db/2190081/Cleveland_Clinic>,
        <https://1145.am/db/2354379/Cleveland_Clinic>,
        <https://1145.am/db/458143/Cleveland_Clinic>,
        <https://1145.am/db/462014/Cleveland_Clinic> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2304997/Gho> a org:Organization ;
    ns1:basedInLowRaw "London" ;
    ns1:buyer <https://1145.am/db/2304997/Dna_Diagnostics_Center_Acquisition>,
        <https://1145.am/db/2304997/Quotient_Acquisition> ;
    ns1:documentDate "2015-12-02T15:39:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Quotient Clinical snapped up by Gillings-founded buyout firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/quotient-clinical-snapped-up-by-gillings-founded-buyout-firm> ;
    ns1:foundName "GHO" ;
    ns1:name "GHO" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306945/French_Cdmo_Amatsigroup> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France." ;
    ns1:buyer <https://1145.am/db/2306945/Q-Biologicals_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "French CDMO Amatsigroup" ;
    ns1:name "French CDMO Amatsigroup" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2314063/Investment_Saranas_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-06-23T14:46:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Houston's Saranas raised $ 4.5 million in equity to develop and commercialize its cardiac sheath for the early detection of internal bleeding in procedures requiring a catheter to access a blood vessel." ;
    ns1:documentTitle "Saranas raises $4.5M for sensor-enabled sheath to detect internal bleeding" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/saranas-raises-4-5m-for-sensor-enabled-sheath-to-detect-internal-bleeding> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2314063/Saranas> ;
    ns1:valueRaw "$ 4.5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2315072/Investment_The_Broad_Institute_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-06-24T11:56:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "As the drug-resistant tuberculosis epidemic rages on, The Broad Institute of MIT and Harvard got a $ 20 million gift to develop new diagnostic and therapeutic approaches for the disease." ;
    ns1:documentTitle "Broad Institute bags $20M for drug-resistant TB research" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/broad-institute-bags-20m-for-drug-resistant-tb-research> ;
    ns1:foundName "gift",
        "got" ;
    ns1:name "gift",
        "got" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2315072/The_Broad_Institute> ;
    ns1:valueRaw "$ 20 million" .

<https://1145.am/db/2316161/Investment_Microchips_Biotech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "@ VarunSaxena2: ICYMI: Microchips Biotech partners with Teva on wireless drug delivery, announces new CEO, raises $ 18M in financing." ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "financing",
        "raises" ;
    ns1:name "financing",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2316161/Microchips_Biotech> ;
    ns1:valueRaw "$ 18M" ;
    ns1:whereRaw "Microchips Biotech" .

<https://1145.am/db/2316161/Joint_Venture_Microchips_Biotech_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "@ VarunSaxena2: ICYMI: Microchips Biotech partners with Teva on wireless drug delivery, announces new CEO, raises $ 18M in financing." ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "partners" ;
    ns1:name "partners" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 18M" ;
    ns1:vendor <https://1145.am/db/2316161/Microchips_Biotech> ;
    ns1:whereRaw "Microchips Biotech" .

<https://1145.am/db/2316161/Prettybrook_Partners> a org:Organization ;
    ns1:description "private placement" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "Prettybrook Partners" ;
    ns1:investor <https://1145.am/db/2316161/Investment_Dynatronics_Prettybrook_Partners_Completed> ;
    ns1:name "Prettybrook Partners" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317269/The_Merck_Global_Health_Innovation_Fund> a org:Organization ;
    ns1:buyer <https://1145.am/db/2317269/Advandx_Acquisition> ;
    ns1:description "Investing in companies" ;
    ns1:documentDate "2015-07-14T19:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck invests $6M in microbial diagnostics specialist OpGen" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/merck-invests-6m-microbial-diagnostics-specialist-opgen> ;
    ns1:foundName "The Merck Global Health Innovation Fund" ;
    ns1:investor <https://1145.am/db/2317269/Advandx_Acquisition>,
        <https://1145.am/db/2317269/Opgen_Investment> ;
    ns1:name "The Merck Global Health Innovation Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1574442/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2069495/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2299782/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/540904/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/543257/The_Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/543263/The_Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/782351/Merck_Global_Innovation_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1018050/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1232627/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1852302/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1946588/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2231362/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2299792/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2308727/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2333080/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/750997/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/784458/Merck_Global_Innovation_Fund>,
        <https://1145.am/db/874503/Merck_Global_Health_Innovation_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317270/European_Investment_Bank> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:documentDate "2015-07-15T12:08:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Swedish biotech ropes in $11M for automated HIV testing device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/swedish-biotech-ropes-11m-for-automated-hiv-testing-device> ;
    ns1:foundName "Investment Bank" ;
    ns1:investor <https://1145.am/db/2317270/Investment_Cavidi_European_Investment_Bank_Has_Not_Happened> ;
    ns1:name "European Investment Bank" ;
    ns1:sameAsMedium <https://1145.am/db/1014129/European_Investment_Bank>,
        <https://1145.am/db/1284082/European_Investment_Bank>,
        <https://1145.am/db/1331719/European_Investment_Bank>,
        <https://1145.am/db/1333469/European_Investment_Bank>,
        <https://1145.am/db/1367807/European_Investment_Bank>,
        <https://1145.am/db/1467416/European_Investment_Bank>,
        <https://1145.am/db/1472276/European_Investment_Bank>,
        <https://1145.am/db/1553855/European_Investment_Bank>,
        <https://1145.am/db/1570145/European_Investment_Bank>,
        <https://1145.am/db/1598962/European_Investment_Bank>,
        <https://1145.am/db/1608540/European_Investment_Bank>,
        <https://1145.am/db/1669525/European_Investment_Bank>,
        <https://1145.am/db/1687882/European_Investment_Bank>,
        <https://1145.am/db/1691407/European_Investment_Bank>,
        <https://1145.am/db/1735713/European_Investment_Bank>,
        <https://1145.am/db/1744691/European_Investment_Bank>,
        <https://1145.am/db/1755739/European_Investment_Bank>,
        <https://1145.am/db/1757600/European_Investment_Bank>,
        <https://1145.am/db/1775669/European_Investment_Bank>,
        <https://1145.am/db/1803520/European_Investment_Bank>,
        <https://1145.am/db/1927969/European_Investment_Bank>,
        <https://1145.am/db/2002267/European_Investment_Bank>,
        <https://1145.am/db/2155622/European_Investment_Bank>,
        <https://1145.am/db/2289496/European_Investment_Bank>,
        <https://1145.am/db/2332394/European_Investment_Bank>,
        <https://1145.am/db/2337298/European_Investment_Bank>,
        <https://1145.am/db/2353356/European_Investment_Bank>,
        <https://1145.am/db/2371459/European_Investment_Bank>,
        <https://1145.am/db/2371478/European_Investment_Bank>,
        <https://1145.am/db/240593/European_Investment_Bank>,
        <https://1145.am/db/2555209/European_Investment_Bank>,
        <https://1145.am/db/2558655/European_Investment_Bank>,
        <https://1145.am/db/2605979/European_Investment_Bank>,
        <https://1145.am/db/2643193/European_Investment_Bank>,
        <https://1145.am/db/2666167/European_Investment_Bank>,
        <https://1145.am/db/2672591/European_Investment_Bank>,
        <https://1145.am/db/2798399/European_Investment_Bank>,
        <https://1145.am/db/318473/European_Investment_Bank>,
        <https://1145.am/db/452556/European_Investment_Bank>,
        <https://1145.am/db/454784/European_Investment_Bank>,
        <https://1145.am/db/555008/European_Investment_Bank>,
        <https://1145.am/db/557077/European_Investment_Bank>,
        <https://1145.am/db/601082/European_Investment_Bank>,
        <https://1145.am/db/641046/European_Investment_Bank>,
        <https://1145.am/db/703983/European_Investment_Bank>,
        <https://1145.am/db/704489/European_Investment_Bank>,
        <https://1145.am/db/716647/European_Investment_Bank>,
        <https://1145.am/db/718505/European_Investment_Bank>,
        <https://1145.am/db/77024/European_Investment_Bank> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318396/Industry_Ventures> a org:Organization ;
    ns1:documentDate "2015-07-28T12:28:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Castle Biosciences reels in $11M for cancer Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/castle-biosciences-reels-11m-for-cancer-dx> ;
    ns1:foundName "Industry Ventures" ;
    ns1:investor <https://1145.am/db/2318396/Series_F_Investment_Castle_Biosciences_Industry_Ventures_Completed> ;
    ns1:name "Industry Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1206820/Industry_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1373707/Industry_Ventures>,
        <https://1145.am/db/1582490/Industry_Ventures>,
        <https://1145.am/db/1617253/Industry_Ventures>,
        <https://1145.am/db/1715948/Industry_Ventures>,
        <https://1145.am/db/1753294/Industry_Ventures>,
        <https://1145.am/db/1756151/Industry_Ventures>,
        <https://1145.am/db/1760197/Industry_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1792426/Industry_Ventures>,
        <https://1145.am/db/1794548/Industry_Ventures>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1826683/Industry_Ventures>,
        <https://1145.am/db/1844474/Industry_Ventures>,
        <https://1145.am/db/1845217/Industry_Ventures>,
        <https://1145.am/db/1885090/Industry_Ventures>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2191533/Industry_Ventures>,
        <https://1145.am/db/2315049/Industry_Ventures>,
        <https://1145.am/db/317115/Industry_Ventures>,
        <https://1145.am/db/556709/Industry_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2320569/Investment_Histosonics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-10T15:11:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Michigan's HistoSonics has raised $ 2.1 million in debt, options and other securities to fund development of its noninvasive image-guided tissue ablation technology to treat benign prostate hyperplasia." ;
    ns1:documentTitle "HistoSonics raises $2M to develop its ultrasound-based ablation device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/histosonics-raises-2m-to-develop-its-ultrasound-based-ablation-device> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2320569/Histosonics> ;
    ns1:valueRaw "$ 2.1 million" ;
    ns1:whereGeoName "Michigan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5001836/about.rdf> ;
    ns1:whereRaw "Michigan" .

<https://1145.am/db/2321694/Cleveland_Heartlab_And_Procter___Gamble> a org:Organization ;
    ns1:basedInLowRaw "Irish" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "Cleveland HeartLab and Procter & Gamble" ;
    ns1:name "Cleveland HeartLab and Procter & Gamble" ;
    ns1:protagonist <https://1145.am/db/2321694/Investment_Cleveland_Heartlab_And_Procter___Gamble_Hatteras_Venture_Partners_Malin_Completed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Davita_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "Colorado" ;
    ns1:buyer <https://1145.am/db/2321694/Renal_Ventures_Acquisition> ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "> DaVita Healthcare",
        "DaVita Healthcare" ;
    ns1:industry "Healthcare" ;
    ns1:name "DaVita Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/1339012/Davita_Inc>,
        <https://1145.am/db/2186308/Davita_Medical_Group>,
        <https://1145.am/db/2188811/Davita_Medical_Group>,
        <https://1145.am/db/2190847/Davita_Medical_Group>,
        <https://1145.am/db/2191396/Davita_Medical_Group>,
        <https://1145.am/db/2192253/Davita_Medical_Group>,
        <https://1145.am/db/2197483/Davita_Medical_Group>,
        <https://1145.am/db/2197606/Davita_Medical_Group>,
        <https://1145.am/db/2197622/Davita_Medical_Group>,
        <https://1145.am/db/2198175/Davita_Medical_Group>,
        <https://1145.am/db/2254172/Davita_Healthcare_Partners_Inc>,
        <https://1145.am/db/2293102/Davita_Healthcare_Partners>,
        <https://1145.am/db/2331506/Davita_Healthcare_Partners>,
        <https://1145.am/db/2331507/Davita_Healthcare_Partners>,
        <https://1145.am/db/462169/Davita_Inc>,
        <https://1145.am/db/964954/Davita_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321707/Ipo_Raindance_Technologies_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> RainDance Technologies shimmied away from an IPO, deciding to withdraw plans to go public due to \"market conditions .\"" ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "IPO" ;
    ns1:name "IPO" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "stopped" ;
    ns1:vendor <https://1145.am/db/2321707/Raindance_Technologies> ;
    ns1:whereRaw "RainDance Technologies" .

<https://1145.am/db/2321707/Opko_Health> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "Miami, FL" ;
    ns1:buyer <https://1145.am/db/2321707/Bio-Reference_Laboratories_Acquisition> ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "OPKO Health" ;
    ns1:name "OPKO Health" ;
    ns1:sameAsMedium <https://1145.am/db/1042168/Opko_Health>,
        <https://1145.am/db/1283748/Opko_Health>,
        <https://1145.am/db/2294238/Opko_Health>,
        <https://1145.am/db/2300237/Opko_Health>,
        <https://1145.am/db/2303326/Opko_Health>,
        <https://1145.am/db/2312501/Opko_Health>,
        <https://1145.am/db/2318305/Opko_Health>,
        <https://1145.am/db/2319365/Opko_Health>,
        <https://1145.am/db/2319368/Opko_Health>,
        <https://1145.am/db/2328509/Opko_Health>,
        <https://1145.am/db/2340036/Opko_Health>,
        <https://1145.am/db/2341100/Opko_Health>,
        <https://1145.am/db/2342345/Opko_Health>,
        <https://1145.am/db/2342385/Opko_Health>,
        <https://1145.am/db/2350564/Opko_Health>,
        <https://1145.am/db/2351183/Opko_Health>,
        <https://1145.am/db/2351184/Opko_Health>,
        <https://1145.am/db/2361481/Opko_Health>,
        <https://1145.am/db/2538211/Opko_Health>,
        <https://1145.am/db/2543138/Opko_Health>,
        <https://1145.am/db/2564042/Opko_Health>,
        <https://1145.am/db/2587996/Opko_Health>,
        <https://1145.am/db/2592678/Opko_Health>,
        <https://1145.am/db/611905/Opko_Health>,
        <https://1145.am/db/613011/Opko_Health>,
        <https://1145.am/db/613838/Opko_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321707/Vermillion> a org:Organization ;
    ns1:buyer <https://1145.am/db/2321707/Ipo_Vermillion_Has_Not_Happened> ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "Vermillion" ;
    ns1:name "Vermillion" ;
    ns1:sameAsMedium <https://1145.am/db/2217860/Vermillion>,
        <https://1145.am/db/2300084/Vermillion>,
        <https://1145.am/db/2300126/Vermillion>,
        <https://1145.am/db/2300664/Vermillion>,
        <https://1145.am/db/2302901/Vermillion>,
        <https://1145.am/db/2324561/Vermillion>,
        <https://1145.am/db/2326066/Vermillion_Inc>,
        <https://1145.am/db/2326069/Vermillion>,
        <https://1145.am/db/2350522/Vermillion>,
        <https://1145.am/db/2352664/Vermillion>,
        <https://1145.am/db/2352980/Vermillion>,
        <https://1145.am/db/2364266/Vermillion> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322734/Greatbatch> a org:Organization ;
    ns1:basedInHighGeoName "Frisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4692559/about.rdf> ;
    ns1:basedInHighRaw "Frisco, TX" ;
    ns1:buyer <https://1145.am/db/2322734/Lake_Region_Medical_Unit_Acquisition> ;
    ns1:description "Business" ;
    ns1:documentDate "2015-08-27T13:17:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Greatbatch grabs Lake Regional Medical for $1.7B to expand surgical offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/greatbatch-grabs-lake-regional-medical-for-1-7b-to-expand-surgical-offerings> ;
    ns1:foundName "Greatbatch" ;
    ns1:name "Greatbatch" ;
    ns1:sameAsMedium <https://1145.am/db/2288658/Greatbatch>,
        <https://1145.am/db/2305641/Greatbatch_Inc>,
        <https://1145.am/db/2308571/Greatbatch>,
        <https://1145.am/db/2319461/Greatbatch>,
        <https://1145.am/db/2446611/Greatbatch_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2323825/Arboretum_Ventures> a org:Organization ;
    ns1:documentDate "2015-09-10T14:00:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delphinus raises $39M+ to back pivotal trial of more effective dense breast tissue ultrasound imaging" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/delphinus-raises-39m-to-back-pivotal-trial-more-effective-dense-breast-tissue> ;
    ns1:foundName "Arboretum Ventures" ;
    ns1:investor <https://1145.am/db/2323825/Investment_Delphinus_Medical_Technologies_Completed> ;
    ns1:name "Arboretum Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1464210/Arboretum_Ventures>,
        <https://1145.am/db/1465033/Arboretum_Ventures>,
        <https://1145.am/db/1580071/Arboretum_Ventures>,
        <https://1145.am/db/1618952/Arboretum_Ventures>,
        <https://1145.am/db/1619685/Arboretum_Ventures>,
        <https://1145.am/db/2281033/Arboretum_Ventures>,
        <https://1145.am/db/2283394/Arboretum_Ventures>,
        <https://1145.am/db/2286665/Arboretum_Ventures>,
        <https://1145.am/db/2297479/Arboretum_Ventures>,
        <https://1145.am/db/2300316/Arboretum_Ventures>,
        <https://1145.am/db/2303767/Arboretum_Ventures>,
        <https://1145.am/db/2306790/Arboretum_Ventures>,
        <https://1145.am/db/2317222/Arboretum_Ventures>,
        <https://1145.am/db/2352167/Arboretum_Ventures>,
        <https://1145.am/db/2352170/Arboretum_Ventures>,
        <https://1145.am/db/2367381/Arboretum_Ventures>,
        <https://1145.am/db/474783/Arboretum_Ventures>,
        <https://1145.am/db/475825/Arboretum_Ventures>,
        <https://1145.am/db/580008/Arboretum_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2323825/Beringea> a org:Organization ;
    ns1:documentDate "2015-09-10T14:00:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delphinus raises $39M+ to back pivotal trial of more effective dense breast tissue ultrasound imaging" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/delphinus-raises-39m-to-back-pivotal-trial-more-effective-dense-breast-tissue> ;
    ns1:foundName "Beringea" ;
    ns1:investor <https://1145.am/db/2323825/Investment_Delphinus_Medical_Technologies_Completed> ;
    ns1:name "Beringea" ;
    ns1:sameAsMedium <https://1145.am/db/1114659/Beringea>,
        <https://1145.am/db/1168925/Beringea>,
        <https://1145.am/db/1171251/Beringea>,
        <https://1145.am/db/1230379/Beringea>,
        <https://1145.am/db/150479/Beringea>,
        <https://1145.am/db/1707620/Beringea>,
        <https://1145.am/db/1760209/Beringea>,
        <https://1145.am/db/1764054/Beringea>,
        <https://1145.am/db/1784899/Beringea>,
        <https://1145.am/db/1795461/Beringea>,
        <https://1145.am/db/1797259/Beringea>,
        <https://1145.am/db/1801532/Beringea>,
        <https://1145.am/db/1950910/Beringea_Llc>,
        <https://1145.am/db/2050229/Beringea>,
        <https://1145.am/db/2252673/Beringea>,
        <https://1145.am/db/2322429/Beringea>,
        <https://1145.am/db/2363854/Beringea>,
        <https://1145.am/db/285942/Beringea>,
        <https://1145.am/db/474764/Beringea> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2325043/Oak_Hc_Ft> a org:Organization ;
    ns1:documentDate "2015-07-08T10:34:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Core Informatics snags $17.5M to fuel lab software land grab" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/core-informatics-snags-17-5m-to-fuel-lab-software-land-grab> ;
    ns1:foundName "Oak HC/FT" ;
    ns1:investor <https://1145.am/db/2325043/Series_B_Investment_Core_Informatics_Oak_Hc_Ft_Completed> ;
    ns1:name "Oak HC/FT" ;
    ns1:sameAsMedium <https://1145.am/db/11893/Oak_Hc_Ft>,
        <https://1145.am/db/1230022/Oak_Hc_Ft>,
        <https://1145.am/db/1340354/Oak_Hc_Ft>,
        <https://1145.am/db/1545490/Oak_Hc_Ft>,
        <https://1145.am/db/1739120/Oak_Hc_Ft>,
        <https://1145.am/db/1761089/Oak_Hc_Ft>,
        <https://1145.am/db/1762041/Oak_Hc_Ft>,
        <https://1145.am/db/1762948/Oak_Hc_Ft>,
        <https://1145.am/db/1975668/Oak_Hc_Ft>,
        <https://1145.am/db/2110317/Oak_Hc_Ft>,
        <https://1145.am/db/2183086/Oak_Hc_Ft>,
        <https://1145.am/db/2183352/Oak_Hc_Ft>,
        <https://1145.am/db/2183455/Oak_Hc_Ft>,
        <https://1145.am/db/2185156/Oak_Hc_Ft>,
        <https://1145.am/db/2189653/Oak_Hc_Ft>,
        <https://1145.am/db/2193796/Oak_Hc_Ft>,
        <https://1145.am/db/2195411/Oak_Hc_Ft>,
        <https://1145.am/db/2196875/Oak_Hc_Ft>,
        <https://1145.am/db/2325044/Oak_Hc_Ft>,
        <https://1145.am/db/310888/Oak_Hc_Ft>,
        <https://1145.am/db/310947/Oak_Hc_Ft>,
        <https://1145.am/db/320614/Oak_Hc_Ft>,
        <https://1145.am/db/325080/Oak_Hc_Ft>,
        <https://1145.am/db/350275/Oak_Hc_Ft>,
        <https://1145.am/db/412847/Oak_Hc_Ft>,
        <https://1145.am/db/425951/Oak_Hc_Ft>,
        <https://1145.am/db/468816/Oak_Hc_Ft>,
        <https://1145.am/db/586235/Oak_Hc_Ft>,
        <https://1145.am/db/623261/Oak_Hc_Ft>,
        <https://1145.am/db/626470/Oak_Hc_Ft>,
        <https://1145.am/db/676953/Oak_Hc_Ft>,
        <https://1145.am/db/868933/Oak_Hc_Ft> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328257/Uk_Epilepsy_Society> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:basedInLowRaw "UK" ;
    ns1:buyer <https://1145.am/db/2328257/Revolocity_Joint_Venture> ;
    ns1:description "Epilepsy" ;
    ns1:documentDate "2015-10-06T11:46:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity Supersequencer" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/complete-genomics-announces-uk-epilepsy-society-s-acquisition-of-its-revolocity%E2%84%A2-supersequencer> ;
    ns1:foundName "Epilepsy Society",
        "UK Epilepsy Society" ;
    ns1:name "Epilepsy Society",
        "UK Epilepsy Society" ;
    ns1:sameAsHigh <https://1145.am/db/1308194/Epilepsy_Foundation>,
        <https://1145.am/db/670063/Epilepsy_Foundation_Of_Minnesota>,
        <https://1145.am/db/670119/Epilepsy_Foundation_Of_Minnesota> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Draper_Associates> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Draper Associates" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "Draper Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1208519/Draper_Associates>,
        <https://1145.am/db/1419073/Draper_Associates>,
        <https://1145.am/db/1578475/Draper_Associates>,
        <https://1145.am/db/1580426/Draper_Associates>,
        <https://1145.am/db/1696744/Draper_Associates>,
        <https://1145.am/db/1716489/Draper_Associates>,
        <https://1145.am/db/1726544/Draper_Associates>,
        <https://1145.am/db/1771060/Draper_Associates>,
        <https://1145.am/db/1774944/Draper_Associates>,
        <https://1145.am/db/1788145/Draper_Associates>,
        <https://1145.am/db/1791426/Draper___Associates>,
        <https://1145.am/db/1797910/Draper_Associates>,
        <https://1145.am/db/1810710/Draper_Associates>,
        <https://1145.am/db/1841666/Draper_Associates>,
        <https://1145.am/db/1846144/Draper_Associates>,
        <https://1145.am/db/1858229/Draper_Associates>,
        <https://1145.am/db/1879069/Draper_Associates>,
        <https://1145.am/db/1882259/Draper_Associates>,
        <https://1145.am/db/1980264/Draper_Associates>,
        <https://1145.am/db/425922/Draper_Associates>,
        <https://1145.am/db/517818/Draper_Associates>,
        <https://1145.am/db/661747/Draper_Associates>,
        <https://1145.am/db/663618/Draper_Associates>,
        <https://1145.am/db/881298/Draper_Associates>,
        <https://1145.am/db/882723/Draper_Associates>,
        <https://1145.am/db/886722/Draper_Associates>,
        <https://1145.am/db/932418/Draper_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Great_Oaks_Vc> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Great Oaks VC" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "Great Oaks VC" ;
    ns1:sameAsMedium <https://1145.am/db/1036097/Great_Oaks_Vc>,
        <https://1145.am/db/1038108/Great_Oaks_Vc>,
        <https://1145.am/db/1383818/Great_Oaks_Vc>,
        <https://1145.am/db/1697373/Great_Oaks_Vc>,
        <https://1145.am/db/1810710/Great_Oaks_Vc>,
        <https://1145.am/db/1831401/Great_Oaks_Vc>,
        <https://1145.am/db/1838824/Great_Oaks_Vc>,
        <https://1145.am/db/1839301/Great_Oaks_Vc>,
        <https://1145.am/db/1851136/Great_Oaks_Vc>,
        <https://1145.am/db/490907/Great_Oaks_Vc>,
        <https://1145.am/db/830571/Great_Oaks_Vc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Ia_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "IA Ventures" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "IA Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1208612/Ia_Ventures>,
        <https://1145.am/db/1732340/Ia_Ventures>,
        <https://1145.am/db/1753714/Ia_Ventures>,
        <https://1145.am/db/1760608/Ia_Ventures>,
        <https://1145.am/db/1761347/Ia_Ventures>,
        <https://1145.am/db/1779277/Ia_Ventures>,
        <https://1145.am/db/1787255/Ia_Ventures>,
        <https://1145.am/db/1791642/Ia_Ventures>,
        <https://1145.am/db/1799018/Ia_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1823954/Ia_Ventures>,
        <https://1145.am/db/1827884/Ia_Ventures>,
        <https://1145.am/db/1830647/Ia_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1854389/Ia_Ventures>,
        <https://1145.am/db/1866404/Ia_Ventures>,
        <https://1145.am/db/1879830/Ia_Ventures>,
        <https://1145.am/db/1885092/Ia_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/601951/Ia_Ventures>,
        <https://1145.am/db/605143/Ia_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Karlin_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Karlin Ventures" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "Karlin Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1791426/Karlin_Ventures>,
        <https://1145.am/db/1856090/Karlin_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Slow_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "seed financing" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Slow Ventures" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "Slow Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1050140/Slow_Ventures>,
        <https://1145.am/db/1287929/Slow_Ventures>,
        <https://1145.am/db/1434436/Slow_Ventures>,
        <https://1145.am/db/1559082/Slow_Ventures>,
        <https://1145.am/db/160844/Slow_Ventures>,
        <https://1145.am/db/1748348/Slow_Ventures>,
        <https://1145.am/db/1758274/Slow>,
        <https://1145.am/db/1765380/Slow_Ventures>,
        <https://1145.am/db/1775659/Slow_Ventures>,
        <https://1145.am/db/1794572/Slow_Ventures>,
        <https://1145.am/db/1797899/Slow_Ventures>,
        <https://1145.am/db/1798572/Slow_Ventures>,
        <https://1145.am/db/1810710/Slow_Ventures>,
        <https://1145.am/db/1812038/Slow_Ventures>,
        <https://1145.am/db/1828037/Slow_Ventures>,
        <https://1145.am/db/1841791/Slow_Ventures>,
        <https://1145.am/db/516560/Slow_Ventures>,
        <https://1145.am/db/517486/Slow_Ventures>,
        <https://1145.am/db/812407/Slow_Ventures>,
        <https://1145.am/db/988703/Slow_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1418508/Slow_Ventures>,
        <https://1145.am/db/1742960/Slow_Ventures>,
        <https://1145.am/db/1750467/Slow_Ventures>,
        <https://1145.am/db/1755423/Slow_Ventures>,
        <https://1145.am/db/1757845/Slow_Ventures>,
        <https://1145.am/db/1779663/Slow_Ventures>,
        <https://1145.am/db/1783348/Slow_Ventures>,
        <https://1145.am/db/1793290/Slow_Ventures>,
        <https://1145.am/db/1806447/Slow_Ventures>,
        <https://1145.am/db/1807047/Slow_Ventures>,
        <https://1145.am/db/1810141/Slow_Ventures>,
        <https://1145.am/db/1817338/Slow_Ventures>,
        <https://1145.am/db/1837155/Slow_Ventures>,
        <https://1145.am/db/1846947/Slow_Ventures>,
        <https://1145.am/db/1852556/Slow_Ventures>,
        <https://1145.am/db/1856712/Slow_Ventures>,
        <https://1145.am/db/435625/Slow_Ventures>,
        <https://1145.am/db/437724/Slow_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Two_Sigma_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Two Sigma Ventures" ;
    ns1:investor <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed>,
        <https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> ;
    ns1:name "Two Sigma Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1202633/Two_Sigma_Ventures>,
        <https://1145.am/db/1203099/Two_Sigma_Ventures>,
        <https://1145.am/db/1536915/Two_Sigma_Ventures>,
        <https://1145.am/db/1741217/Two_Sigma_Ventures>,
        <https://1145.am/db/1741456/Two_Sigma_Ventures>,
        <https://1145.am/db/1743664/Two_Sigma_Ventures>,
        <https://1145.am/db/1748455/Two_Sigma_Ventures>,
        <https://1145.am/db/1753949/Two_Sigma_Ventures>,
        <https://1145.am/db/1759900/Two_Sigma_Ventures>,
        <https://1145.am/db/1760586/Two_Sigma_Ventures>,
        <https://1145.am/db/1762722/Two_Sigma_Ventures>,
        <https://1145.am/db/1763739/Two_Sigma_Ventures>,
        <https://1145.am/db/1772539/Two_Sigma_Ventures>,
        <https://1145.am/db/1783318/Two_Sigma_Ventures>,
        <https://1145.am/db/1785223/Two_Sigma_Ventures>,
        <https://1145.am/db/1785677/Two_Sigma_Ventures>,
        <https://1145.am/db/1796675/Two_Sigma_Ventures>,
        <https://1145.am/db/1802088/Two_Sigma_Ventures>,
        <https://1145.am/db/1802227/Two_Sigma_Ventures>,
        <https://1145.am/db/1810710/Two_Sigma_Ventures>,
        <https://1145.am/db/1815701/Two_Sigma_Ventures>,
        <https://1145.am/db/1829316/Two_Sigma_Ventures>,
        <https://1145.am/db/1834214/Two_Sigma_Ventures>,
        <https://1145.am/db/1839698/Two_Sigma_Ventures>,
        <https://1145.am/db/1845164/Two_Sigma_Ventures>,
        <https://1145.am/db/2033832/Two_Sigma_Ventures>,
        <https://1145.am/db/2325015/Two_Sigma_Ventures>,
        <https://1145.am/db/490696/Two_Sigma_Ventures>,
        <https://1145.am/db/633929/Two_Sigma_Ventures>,
        <https://1145.am/db/634370/Two_Sigma_Ventures>,
        <https://1145.am/db/683648/Two_Sigma_Ventures>,
        <https://1145.am/db/849950/Two_Sigma_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2329404/Illumina> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:description "next-generation sequencing" ;
    ns1:documentDate "2015-12-11T15:16:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-receives-strategic-investment-from-illumina-to-advance-genome-editing-software> ;
    ns1:foundName "Illumina, Inc" ;
    ns1:investor <https://1145.am/db/2329404/Investment_Desktop_Genetics_Ltd_Illumina_Has_Not_Happened> ;
    ns1:name "Illumina" ;
    ns1:sameAsMedium <https://1145.am/db/1088221/Illumina>,
        <https://1145.am/db/1202370/Illumina>,
        <https://1145.am/db/1217641/Illumina>,
        <https://1145.am/db/1232202/Illumina>,
        <https://1145.am/db/1240041/Illumina>,
        <https://1145.am/db/1311389/Illumina_Inc>,
        <https://1145.am/db/1311396/Illumina_Inc>,
        <https://1145.am/db/1315507/Illumina_Inc>,
        <https://1145.am/db/1318170/Illumina>,
        <https://1145.am/db/1319284/Illumina>,
        <https://1145.am/db/1320955/Illumina_Inc>,
        <https://1145.am/db/1321949/Illumina>,
        <https://1145.am/db/1322003/Illumina>,
        <https://1145.am/db/1339613/Illumina>,
        <https://1145.am/db/1354365/Illumina>,
        <https://1145.am/db/1357046/Illumina>,
        <https://1145.am/db/1577865/Illumina_Inc>,
        <https://1145.am/db/1668177/Illumina>,
        <https://1145.am/db/1936140/Illumina>,
        <https://1145.am/db/1938875/Illumina_Inc>,
        <https://1145.am/db/1957816/Illumina>,
        <https://1145.am/db/1974886/Illumina_Inc>,
        <https://1145.am/db/2019335/Illumina_Inc>,
        <https://1145.am/db/2029590/Illumina>,
        <https://1145.am/db/2033324/Illumina_Inc>,
        <https://1145.am/db/2033519/Illumina>,
        <https://1145.am/db/2059502/Illumina>,
        <https://1145.am/db/2083048/Illumina>,
        <https://1145.am/db/2108020/Illumina>,
        <https://1145.am/db/2141011/Illumina>,
        <https://1145.am/db/2142556/Illumina>,
        <https://1145.am/db/2143979/Illumina_Inc>,
        <https://1145.am/db/2144305/Illumina>,
        <https://1145.am/db/2144771/Illumina>,
        <https://1145.am/db/2154499/Illumina>,
        <https://1145.am/db/2154543/Illumina>,
        <https://1145.am/db/2279139/Illumina>,
        <https://1145.am/db/2279826/Illumina>,
        <https://1145.am/db/2281780/Illumina>,
        <https://1145.am/db/2282604/Illumina>,
        <https://1145.am/db/2283089/Illumina>,
        <https://1145.am/db/2283331/Illumina>,
        <https://1145.am/db/2284367/Illumina>,
        <https://1145.am/db/2287956/Illumina>,
        <https://1145.am/db/2294885/Illumina>,
        <https://1145.am/db/2294891/Illumina>,
        <https://1145.am/db/2294967/Illumina>,
        <https://1145.am/db/2296025/Illumina>,
        <https://1145.am/db/2296164/Illumina>,
        <https://1145.am/db/2296171/Illumina>,
        <https://1145.am/db/2296180/Illumina>,
        <https://1145.am/db/2296600/Illumina>,
        <https://1145.am/db/2296675/Illumina>,
        <https://1145.am/db/2296788/Illumina>,
        <https://1145.am/db/2297131/Illumina>,
        <https://1145.am/db/2297472/Illumina>,
        <https://1145.am/db/2297593/Illumina>,
        <https://1145.am/db/2297619/Illumina>,
        <https://1145.am/db/2298070/Illumina>,
        <https://1145.am/db/2306511/Illumina>,
        <https://1145.am/db/2306516/Illumina>,
        <https://1145.am/db/2307596/Illumina>,
        <https://1145.am/db/2311597/Illumina_Uk_Ltd>,
        <https://1145.am/db/2319601/Illumina>,
        <https://1145.am/db/2319603/Illumina_Inc>,
        <https://1145.am/db/2319627/Illumina>,
        <https://1145.am/db/2320930/Illumina>,
        <https://1145.am/db/2321784/Illumina>,
        <https://1145.am/db/2322901/Illumina>,
        <https://1145.am/db/2323244/Illumina>,
        <https://1145.am/db/2326093/Illumina>,
        <https://1145.am/db/2326094/Illumina>,
        <https://1145.am/db/2326119/Illumina>,
        <https://1145.am/db/2328637/Illumina>,
        <https://1145.am/db/2329403/Illumina>,
        <https://1145.am/db/2330521/Illumina>,
        <https://1145.am/db/2336625/Illumina>,
        <https://1145.am/db/2336627/Illumina_Inc>,
        <https://1145.am/db/2345558/Illumina>,
        <https://1145.am/db/2353287/Illumina_Inc>,
        <https://1145.am/db/2355226/Illumina>,
        <https://1145.am/db/2357075/Illumina>,
        <https://1145.am/db/2359655/Illumina_Inc>,
        <https://1145.am/db/2360982/Illumina>,
        <https://1145.am/db/2360997/Illumina>,
        <https://1145.am/db/2360999/Illumina>,
        <https://1145.am/db/2361624/Illumina>,
        <https://1145.am/db/2361632/Illumina>,
        <https://1145.am/db/2361994/Illumina>,
        <https://1145.am/db/2361998/Illumina>,
        <https://1145.am/db/2362001/Illumina>,
        <https://1145.am/db/2362034/Illumina>,
        <https://1145.am/db/2362590/Illumina>,
        <https://1145.am/db/2367043/Illumina>,
        <https://1145.am/db/2367537/Illumina>,
        <https://1145.am/db/2367708/Illumina>,
        <https://1145.am/db/2368611/Illumina_Inc>,
        <https://1145.am/db/2370715/Illumina>,
        <https://1145.am/db/2541350/Illumina>,
        <https://1145.am/db/2541672/Illumina>,
        <https://1145.am/db/2541685/Illumina>,
        <https://1145.am/db/2568519/Illumina>,
        <https://1145.am/db/2571613/Illumina>,
        <https://1145.am/db/2572452/Illumina>,
        <https://1145.am/db/2573339/Illumina>,
        <https://1145.am/db/2574083/Illumina>,
        <https://1145.am/db/2574281/Illumina>,
        <https://1145.am/db/2575289/Illumina>,
        <https://1145.am/db/2592803/Illumina>,
        <https://1145.am/db/2593666/Illumina>,
        <https://1145.am/db/2593713/Illumina>,
        <https://1145.am/db/2597109/Illumina>,
        <https://1145.am/db/2597648/Illumina>,
        <https://1145.am/db/294376/Illumina_Inc>,
        <https://1145.am/db/310868/Illumina_Inc>,
        <https://1145.am/db/356690/Illumina_Inc>,
        <https://1145.am/db/376116/Illumina_Inc>,
        <https://1145.am/db/385241/Illumina_Inc>,
        <https://1145.am/db/422712/Illumina>,
        <https://1145.am/db/425834/Illumina_Inc>,
        <https://1145.am/db/492277/Illumina>,
        <https://1145.am/db/580608/Illumina>,
        <https://1145.am/db/625378/Illumina_Inc>,
        <https://1145.am/db/782644/Illumina>,
        <https://1145.am/db/785864/Illumina>,
        <https://1145.am/db/791066/Illumina>,
        <https://1145.am/db/791240/Illumina>,
        <https://1145.am/db/810365/Illumina>,
        <https://1145.am/db/875920/Illumina>,
        <https://1145.am/db/876576/Illumina> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331421/Dievini> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:documentDate "2015-11-18T16:02:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Molecular Health ropes in 25M for Big Data platforms" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/molecular-health-ropes-eu25m-for-big-data-platforms> ;
    ns1:foundName "dievini" ;
    ns1:investor <https://1145.am/db/2331421/Investment_Molecular_Health_Dievini_Completed> ;
    ns1:name "dievini" ;
    ns1:sameAsMedium <https://1145.am/db/2283452/Dievini>,
        <https://1145.am/db/2329372/Dievini> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331446/Biosense_Webster> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:buyer <https://1145.am/db/2331446/Coherex_Wavecrest_Left_Atrial_Appendage_Occlusion_System_Acquisition> ;
    ns1:documentDate "2015-11-20T16:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "J&J enters market for implants to prevent stroke via acquisition of Coherex Medical" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/j-j-enters-market-for-implants-to-prevent-stroke-via-acquisition-coherex-medical> ;
    ns1:foundName "Biosense Webster",
        "Johnson & Johnson'",
        "Johnson & Johnson's" ;
    ns1:industry "med tech" ;
    ns1:name "Biosense Webster" ;
    ns1:sameAsHigh <https://1145.am/db/2334508/Biosense_Webster> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331446/Coherex_Wavecrest_Left_Atrial_Appendage_Occlusion_System> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "Salt Lake City" ;
    ns1:description "a medical device" ;
    ns1:documentDate "2015-11-20T16:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "J&J enters market for implants to prevent stroke via acquisition of Coherex Medical" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/j-j-enters-market-for-implants-to-prevent-stroke-via-acquisition-coherex-medical> ;
    ns1:foundName "Coherex Medical" ;
    ns1:industry "Medical" ;
    ns1:name "Coherex WaveCrest Left Atrial Appendage Occlusion System" ;
    ns1:sameAsHigh <https://1145.am/db/2334508/Coherex_Wavecrest_Left_Atrial_Appendage_Occlusion_System> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331453/Berytech> a org:Organization ;
    ns1:basedInHighGeoName "Beirut" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/276781/about.rdf> ;
    ns1:basedInHighRaw "Beirut" ;
    ns1:documentDate "2015-11-23T15:25:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioDiagnostics gets in on patient monitoring with plans for $7M fundraise" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiodiagnostics-gets-patient-monitoring-plans-for-7m-fundraise> ;
    ns1:foundName "Berytech" ;
    ns1:investor <https://1145.am/db/2331453/Seed_Investment_Berytech_Cardiodiagnostics_Has_Not_Happened> ;
    ns1:name "Berytech" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332441/Edwards_Lifesciences> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2332441/Harpoon_Medical_Acquisition> ;
    ns1:description "M & A" ;
    ns1:documentDate "2015-12-09T16:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edwards grabs option to acquire transcatheter mitral valve repair startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/edwards-grabs-option-to-acquire-transcatheter-mitral-valve-repair-startup> ;
    ns1:foundName "Edwards Lifesciences",
        "Edwards Lifesciences ($ EW)" ;
    ns1:investor <https://1145.am/db/2332441/Harpoon_Medical_Acquisition> ;
    ns1:name "Edwards Lifesciences" ;
    ns1:sameAsMedium <https://1145.am/db/2284047/Edwards_Lifesciences>,
        <https://1145.am/db/2289534/Edwards_Lifesciences>,
        <https://1145.am/db/2289970/Edwards_Lifesciences>,
        <https://1145.am/db/2290338/Edwards_Lifesciences>,
        <https://1145.am/db/2291529/Edwards_Lifesciences>,
        <https://1145.am/db/2293080/Edwards_Lifesciences>,
        <https://1145.am/db/2294865/Edwards_Lifesciences>,
        <https://1145.am/db/2295880/Edwards_Lifesciences>,
        <https://1145.am/db/2297644/Edwards_Lifesciences>,
        <https://1145.am/db/2307418/Edwards_Lifesciences>,
        <https://1145.am/db/2316217/Edwards_Lifesciences>,
        <https://1145.am/db/2322744/Edwards_Lifesciences>,
        <https://1145.am/db/2332447/Edwards_Lifesciences>,
        <https://1145.am/db/2334481/Edwards_Lifesciences>,
        <https://1145.am/db/2338881/Edwards_Lifesciences_Corporation>,
        <https://1145.am/db/2547647/Edwards_Lifesciences_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333326/Independent_Grants_For_Learning___Change> a org:Organization ;
    ns1:documentDate "2015-12-21T17:01:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Struggling Toshiba considers selling stake in its device unit; Mount Sinai gets $500K grant for venous thromboembolism; SI-Bone secures some Medicare coverage; and more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/spotlight-struggling-toshiba-considers-selling-stake-its-device-unit-mount-sinai> ;
    ns1:foundName "Independent Grants for Learning & Change" ;
    ns1:investor <https://1145.am/db/2333326/Investment_Independent_Grants_For_Learning___Change_The_Department_Of_Medicine_At_The_Icahn_School_Of_Medicine_At_Mount_Sinai_Has_Not_Happened> ;
    ns1:name "Independent Grants for Learning & Change" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333326/Stake_Investment_Toshiba_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-21T17:01:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Japan's Toshiba is considering a stake in its medical equipment unit as part of a broader restructuring in the wake of an accounting scandal." ;
    ns1:documentTitle "Spotlight On... Struggling Toshiba considers selling stake in its device unit; Mount Sinai gets $500K grant for venous thromboembolism; SI-Bone secures some Medicare coverage; and more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/spotlight-struggling-toshiba-considers-selling-stake-its-device-unit-mount-sinai> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2333326/Toshiba> ;
    ns1:targetDetails "stake" ;
    ns1:valueRaw "$ 4.5 billion",
        "550 billion yen" ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2334507/Investment_Vertiflex_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-14T16:18:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Minimally invasive spinal startup VertiFlex has raised $ 26.8 million out of a proposed $ 45.7 million in a financing, according to an SEC filing." ;
    ns1:documentTitle "VertiFlex raises $27M on heels of PMA approval, reimbursement breakthroughs in 2015" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vertiflex-raises-27m-heels-pma-approval-reimbursement-breakthroughs-2015> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2334507/Vertiflex> ;
    ns1:valueRaw "$ 26.8 million",
        "$ 45.7 million" ;
    ns1:whereGeoName "San Clemente" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391791/about.rdf> ;
    ns1:whereRaw "San Clemente, CA" .

<https://1145.am/db/2334948/Brainlab> a org:Organization ;
    ns1:basedInHighGeoName "Munich" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2867714/about.rdf> ;
    ns1:basedInHighRaw "Munich" ;
    ns1:documentDate "2016-01-25T16:03:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "German radiosurgery player Brainlab invests $7M+ in Jan Medical for portable concussion Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/german-radiosurgery-player-brainlab-invests-7m-jan-medical-for-portable-concussion> ;
    ns1:foundName "Brainlab" ;
    ns1:industry "radiotherapy" ;
    ns1:investor <https://1145.am/db/2334948/Series_C_Investment_Brainlab_Jan_Medical_Has_Not_Happened> ;
    ns1:name "Brainlab" ;
    ns1:sameAsMedium <https://1145.am/db/1050862/Brainlab>,
        <https://1145.am/db/1052410/Brainlab>,
        <https://1145.am/db/2152147/Brainlab>,
        <https://1145.am/db/2290676/Brainlab>,
        <https://1145.am/db/2291840/Brainlab> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334981/Aptus_Endosystems_Ordinary_Preference_Shares_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Among industry bigwigs, Medtronic ($ MDT) has shown a strong interest in the endovascular stent graft market, with an eye on treating abdominal aortic aneurysms.",
        "Vascular Flow's financing consisted of a 7 million ($ 9.98 million) loan that was converted into Series A ordinary preference shares, 3 million ($ 4.28 million) , and Series B capital increase led by an undisclosed family office and institutional and angel investors." ;
    ns1:documentTitle "Vascular Flow Technologies raises $14M+ for its prosthetic vascular graft" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vascular-flow-technologies-raises-14m-for-its-prosthetic-vascular-graft> ;
    ns1:foundName "acquire",
        "financing" ;
    ns1:name "acquire",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2334981/Aptus_Endosystems>,
        <https://1145.am/db/2334981/Vascular_Flow_Technologies> ;
    ns1:targetDetails "ordinary preference shares" ;
    ns1:targetName "Aptus Endosystems" ;
    ns1:valueRaw "$ 110 million",
        "$ 4.28 million",
        "$ 9.98 million",
        "3 million",
        "7 million" ;
    ns1:vendor <https://1145.am/db/2334981/Vascular_Flow_Technologies> ;
    ns1:when "2022-10-22T01:17:47.014781"^^xsd:dateTime,
        "2022-10-22T01:17:49.179263"^^xsd:dateTime ;
    ns1:whenRaw "Last year" .

<https://1145.am/db/2334981/Aptus_Endosystems_Ordinary_Preference_Shares_Investment> ns1:activityType "investment" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dundee, U.K.'s Vascular Flow Technologies has raised 10 million ($ 14.25 million) in support of its technology to restore natural blood flow through prosthetic vascular grafts, such as hemodialysis access catheters." ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2334981/Vascular_Flow_Technologies> ;
    ns1:valueRaw "$ 14.25 million",
        "10 million" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2334981/Arsenal_Aaa_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Among industry bigwigs, Medtronic ($ MDT) has shown a strong interest in the endovascular stent graft market, with an eye on treating abdominal aortic aneurysms." ;
    ns1:documentTitle "Vascular Flow Technologies raises $14M+ for its prosthetic vascular graft" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vascular-flow-technologies-raises-14m-for-its-prosthetic-vascular-graft> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2334981/Arsenal_Aaa> ;
    ns1:targetName "Arsenal AAA" ;
    ns1:valueRaw "$ 110 million" ;
    ns1:when "2022-10-22T01:17:49.318017"^^xsd:dateTime ;
    ns1:whenRaw "Last year" .

<https://1145.am/db/2367519/Ali_Partovi> a org:Organization ;
    ns1:basedInHighGeoName "Silicon Valley" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6940309/about.rdf> ;
    ns1:basedInHighRaw "Silicon Valley" ;
    ns1:documentDate "2015-10-26T15:15:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nuritas sets Irish record with $3.2M first round financing led by New Protein Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nuritas-sets-irish-record-3-2m-first-round-financing-led-by-new-protein-capital> ;
    ns1:foundName "Ali Partovi" ;
    ns1:industry "Silicon Valley" ;
    ns1:investor <https://1145.am/db/2367519/Investment_Ali_Partovi_New_Protein_Capital_Nuritas_Completed> ;
    ns1:name "Ali Partovi" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367519/New_Protein_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "Singapore" ;
    ns1:documentDate "2015-10-26T15:15:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nuritas sets Irish record with $3.2M first round financing led by New Protein Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nuritas-sets-irish-record-3-2m-first-round-financing-led-by-new-protein-capital> ;
    ns1:foundName "New Protein Capital (NPC)" ;
    ns1:industry "food and agro-tech investment firm" ;
    ns1:investor <https://1145.am/db/2367519/Investment_Ali_Partovi_New_Protein_Capital_Nuritas_Completed> ;
    ns1:name "New Protein Capital" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367675/Correlation_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Correlation Ventures of San Diego" ;
    ns1:investor <https://1145.am/db/2367675/Series_A_Investment_Ankasa_Regenerative_Therapeutics_Avalon_Ventures_Correlation_Ventures_Heraeus_Medical_Heraeus_Of_Hanau_Completed> ;
    ns1:name "Correlation Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1164688/Correlation_Ventures>,
        <https://1145.am/db/1166356/Correlation_Ventures>,
        <https://1145.am/db/1484404/Correlation_Ventures>,
        <https://1145.am/db/1727833/Correlation_Ventures>,
        <https://1145.am/db/1737130/Correlation_Ventures>,
        <https://1145.am/db/1764096/Correlation_Ventures>,
        <https://1145.am/db/1817971/Correlation_Ventures>,
        <https://1145.am/db/1828658/Correlation_Ventures>,
        <https://1145.am/db/1830147/Correlation_Ventures>,
        <https://1145.am/db/1830149/Correlation_Ventures>,
        <https://1145.am/db/1839922/Correlation_Ventures>,
        <https://1145.am/db/1840957/Correlation_Ventures>,
        <https://1145.am/db/1842583/Correlation_Ventures>,
        <https://1145.am/db/1843211/Correlation_Ventures>,
        <https://1145.am/db/1854668/Correlation_Ventures>,
        <https://1145.am/db/1856384/Correlation_Ventures>,
        <https://1145.am/db/1959001/Correlation_Ventures>,
        <https://1145.am/db/1974032/Correlation_Ventures>,
        <https://1145.am/db/2010246/Correlation_Ventures>,
        <https://1145.am/db/2113474/Correlation_Ventures>,
        <https://1145.am/db/2298395/Correlation_Ventures>,
        <https://1145.am/db/2340888/Correlation_Ventures>,
        <https://1145.am/db/2341896/Correlation_Ventures>,
        <https://1145.am/db/2356391/Correlation_Ventures>,
        <https://1145.am/db/2356393/Correlation_Ventures>,
        <https://1145.am/db/2356395/Correlation_Ventures>,
        <https://1145.am/db/2360258/Correlation_Ventures>,
        <https://1145.am/db/2367676/Correlation_Ventures>,
        <https://1145.am/db/2368351/Correlation_Ventures>,
        <https://1145.am/db/2369785/Correlation_Ventures>,
        <https://1145.am/db/2371165/Correlation_Ventures>,
        <https://1145.am/db/2371166/Correlation_Ventures>,
        <https://1145.am/db/343358/Correlation_Ventures>,
        <https://1145.am/db/526524/Correlation_Ventures>,
        <https://1145.am/db/556709/Correlation_Ventures>,
        <https://1145.am/db/800060/Correlation_Ventures>,
        <https://1145.am/db/984927/Correlation_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367675/Heraeus_Of_Hanau> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Heraeus Medical" ;
    ns1:name "Heraeus of Hanau" ;
    ns1:sameAsMedium <https://1145.am/db/2367676/Heraeus_Of_Hanau> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Amgen_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Boulder County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5574999/about.rdf> ;
    ns1:basedInHighRaw "Boulder, Colorado" ;
    ns1:description "investing" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "Amgen Ventures" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "Amgen Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1065608/Amgen_Ventures>,
        <https://1145.am/db/1066448/Amgen_Ventures>,
        <https://1145.am/db/1168715/Amgen_Ventures>,
        <https://1145.am/db/1169697/Amgen_Ventures>,
        <https://1145.am/db/1503058/Amgen_Ventures>,
        <https://1145.am/db/2141183/Amgen_Ventures>,
        <https://1145.am/db/2197183/Amgen_Ventures>,
        <https://1145.am/db/2349717/Amgen_Ventures>,
        <https://1145.am/db/2352203/Amgen_Ventures>,
        <https://1145.am/db/2352204/Amgen_Ventures>,
        <https://1145.am/db/2352350/Amgen_Ventures>,
        <https://1145.am/db/2353439/Amgen_Ventures>,
        <https://1145.am/db/2366693/Amgen_Ventures>,
        <https://1145.am/db/2366700/Amgen_Ventures>,
        <https://1145.am/db/874503/Amgen_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1018050/Amgen_Ventures>,
        <https://1145.am/db/1115103/Amgen_Ventures>,
        <https://1145.am/db/1116076/Amgen_Ventures>,
        <https://1145.am/db/1219346/Amgen_Ventures>,
        <https://1145.am/db/1219817/Amgen_Ventures>,
        <https://1145.am/db/1422234/Amgen_Ventures>,
        <https://1145.am/db/1422725/Amgen_Ventures>,
        <https://1145.am/db/2152096/Amgen_Ventures>,
        <https://1145.am/db/2280119/Amgen_Ventures>,
        <https://1145.am/db/2280896/Amgen_Ventures>,
        <https://1145.am/db/2284256/Amgen_Ventures>,
        <https://1145.am/db/2298167/Amgen_Ventures>,
        <https://1145.am/db/2315446/Amgen_Ventures>,
        <https://1145.am/db/2318635/Amgen_Ventures>,
        <https://1145.am/db/2320476/Amgen_Ventures>,
        <https://1145.am/db/2342629/Amgen_Ventures>,
        <https://1145.am/db/2344782/Amgen_Ventures>,
        <https://1145.am/db/2344926/Amgen_Ventures>,
        <https://1145.am/db/2345223/Amgen_Ventures>,
        <https://1145.am/db/2347469/Amgen_Ventures>,
        <https://1145.am/db/2349722/Amgen_Ventures>,
        <https://1145.am/db/2352216/Amgen_Ventures>,
        <https://1145.am/db/2352349/Amgen_Ventures>,
        <https://1145.am/db/2353524/Amgen_Ventures>,
        <https://1145.am/db/2353525/Amgen_Ventures>,
        <https://1145.am/db/2355586/Amgen_Ventures>,
        <https://1145.am/db/2356048/Amgen_Ventures>,
        <https://1145.am/db/2365138/Amgen_Ventures>,
        <https://1145.am/db/2365171/Amgen_Ventures>,
        <https://1145.am/db/2569831/Amgen_Ventures>,
        <https://1145.am/db/2570481/Amgen_Ventures>,
        <https://1145.am/db/2570483/Amgen_Ventures>,
        <https://1145.am/db/770366/Amgen_Ventures>,
        <https://1145.am/db/919784/Amgen_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Boulder_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Boulder County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5574999/about.rdf> ;
    ns1:basedInHighRaw "Boulder, Colorado" ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "Boulder Ventures" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "Boulder Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1722151/Boulder_Ventures>,
        <https://1145.am/db/1762561/Boulder_Ventures>,
        <https://1145.am/db/2152752/Boulder_Ventures>,
        <https://1145.am/db/2330852/Boulder_Ventures>,
        <https://1145.am/db/405209/Boulder_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1831452/Boulder_Ventures>,
        <https://1145.am/db/2331870/Boulder_Ventures_Ltd>,
        <https://1145.am/db/2353524/Boulder_Ventures_Ltd>,
        <https://1145.am/db/2353525/Boulder_Ventures_Ltd> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Jafco_Co_Ltd> a org:Organization ;
    ns1:basedInLowRaw "Colorado" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "JAFCO Co. Ltd" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "JAFCO Co. Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2303802/Jafco_Co_Ltd>,
        <https://1145.am/db/2320914/Jafco_Co_Ltd>,
        <https://1145.am/db/2331868/Jafco_Co_Ltd>,
        <https://1145.am/db/2350721/Jafco_Co_Ltd> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Mp_Healthcare_Venture_Management> a org:Organization ;
    ns1:basedInLowRaw "Colorado" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "MP Healthcare Venture Management" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "MP Healthcare Venture Management" ;
    ns1:sameAsMedium <https://1145.am/db/2062003/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2287244/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2327441/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2327442/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2341904/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2356567/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2364468/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2364471/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2365296/Mp_Healthcare_Venture_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Mrl_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Colorado" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "MRL Ventures" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "MRL Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2370208/Mrl_Ventures>,
        <https://1145.am/db/2573068/Mrl_Ventures>,
        <https://1145.am/db/846773/Mrl_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Remeditex_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Boulder County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5574999/about.rdf> ;
    ns1:basedInHighRaw "Boulder, Colorado" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "Remeditex Ventures" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "Remeditex Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296606/Remeditex_Ventures>,
        <https://1145.am/db/2342752/Remeditex_Ventures>,
        <https://1145.am/db/2344204/Remeditex_Ventures>,
        <https://1145.am/db/2353524/Remeditex_Ventures>,
        <https://1145.am/db/2353525/Remeditex_Ventures>,
        <https://1145.am/db/2365363/Remeditex_Ventures>,
        <https://1145.am/db/2370945/Remeditex_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367782/Mydicar_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment",
        "merger" ;
    ns1:documentDate "2015-06-26T10:43:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO, June 26, 2015 - Celladon Corporation (CLDN) , today confirmed its plans to suspend further research or development of its MYDICAR (AAV1/SERCA2a) program and its other pre-clinical programs including the Stem Cell Factor (mSCF) gene therapy and SERCA2b small molecule programs." ;
    ns1:documentTitle "Celladon Corporation Provides Business Update" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-provides-business-update> ;
    ns1:foundName "merger",
        "sale" ;
    ns1:name "merger",
        "sale" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2367782/Celladon_Corporation>,
        <https://1145.am/db/2367782/Mydicar> ;
    ns1:targetName "MYDICAR" ;
    ns1:vendor <https://1145.am/db/2367782/Celladon_Corporation> ;
    ns1:when "2015-06-26T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "June 26, 2015" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2367846/Bpifrance> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:documentDate "2015-11-12T20:15:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CROSSJECT secures 6.7 million in funding for the development of three new drugs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crossject-secures-%E2%82%AC6-7-million-funding-for-development-of-three-new-drugs> ;
    ns1:foundName "Bpifrance" ;
    ns1:investor <https://1145.am/db/2367846/Investment_Bpifrance_Crossject_Industrial_Projects_Of_The_Future_Has_Not_Happened> ;
    ns1:name "Bpifrance" ;
    ns1:sameAsMedium <https://1145.am/db/1156244/Bpifrance>,
        <https://1145.am/db/1220313/Bpifrance>,
        <https://1145.am/db/1320340/Bpifrance>,
        <https://1145.am/db/1340128/Bpifrance>,
        <https://1145.am/db/138639/Bpifrance>,
        <https://1145.am/db/1425377/Bpifrance>,
        <https://1145.am/db/1619295/Bpifrance>,
        <https://1145.am/db/1729336/Bpifrance>,
        <https://1145.am/db/1736066/Bpifrance>,
        <https://1145.am/db/1738123/Bpifrance>,
        <https://1145.am/db/1738402/Bpifrance>,
        <https://1145.am/db/1740686/Bpifrance>,
        <https://1145.am/db/1743917/Bpifrance>,
        <https://1145.am/db/1755422/Bpifrance>,
        <https://1145.am/db/1757335/Bpifrance>,
        <https://1145.am/db/1765235/Bpifrance>,
        <https://1145.am/db/1766105/Bpifrance>,
        <https://1145.am/db/1772647/Bpifrance>,
        <https://1145.am/db/1778476/Bpifrance>,
        <https://1145.am/db/1779102/Bpifrance>,
        <https://1145.am/db/1780075/Bpifrance>,
        <https://1145.am/db/1784774/Bpifrance>,
        <https://1145.am/db/1789716/Bpifrance>,
        <https://1145.am/db/1793731/Bpifrance>,
        <https://1145.am/db/1802558/Bpifrance>,
        <https://1145.am/db/1815650/Bpifrance>,
        <https://1145.am/db/1819930/Bpifrance>,
        <https://1145.am/db/1822009/Bpifrance>,
        <https://1145.am/db/1833939/Bpifrance>,
        <https://1145.am/db/1843366/Bpifrance>,
        <https://1145.am/db/1850048/Bpifrance>,
        <https://1145.am/db/1850876/Bpifrance>,
        <https://1145.am/db/192069/Bpifrance>,
        <https://1145.am/db/1936366/Bpifrance>,
        <https://1145.am/db/2041687/Bpifrance>,
        <https://1145.am/db/2043428/Bpifrance>,
        <https://1145.am/db/2053176/Bpifrance>,
        <https://1145.am/db/2073336/Bpifrance>,
        <https://1145.am/db/2125294/Bpifrance>,
        <https://1145.am/db/2152036/Bpifrance>,
        <https://1145.am/db/2288699/Bpifrance>,
        <https://1145.am/db/2293867/Bpifrance>,
        <https://1145.am/db/2294502/Bpifrance>,
        <https://1145.am/db/2339692/Bpifrance>,
        <https://1145.am/db/2369774/Bpifrance>,
        <https://1145.am/db/2427385/Bpifrance>,
        <https://1145.am/db/2657775/Bpifrance>,
        <https://1145.am/db/2658787/Bpifrance>,
        <https://1145.am/db/2676704/Bpifrance>,
        <https://1145.am/db/295295/Bpifrance>,
        <https://1145.am/db/371811/Bpifrance>,
        <https://1145.am/db/372639/Bpifrance>,
        <https://1145.am/db/447174/Bpifrance>,
        <https://1145.am/db/506384/Bpifrance>,
        <https://1145.am/db/526109/Bpifrance>,
        <https://1145.am/db/564585/Bpifrance>,
        <https://1145.am/db/566971/Bpifrance>,
        <https://1145.am/db/652159/Bpifrance>,
        <https://1145.am/db/654786/Bpifrance>,
        <https://1145.am/db/685746/Bpifrance>,
        <https://1145.am/db/704156/Bpifrance>,
        <https://1145.am/db/810584/Bpifrance>,
        <https://1145.am/db/883525/Bpifrance>,
        <https://1145.am/db/908198/Bpifrance>,
        <https://1145.am/db/908706/Bpifrance>,
        <https://1145.am/db/955355/Bpifrance> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367846/Industrial_Projects_Of_The_Future> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "a pharma company" ;
    ns1:documentDate "2015-11-12T20:15:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CROSSJECT secures 6.7 million in funding for the development of three new drugs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crossject-secures-%E2%82%AC6-7-million-funding-for-development-of-three-new-drugs> ;
    ns1:foundName "Industrial",
        "Industrial Projects of the Future (Projets Industriels d'Avenir or PIAVE)" ;
    ns1:investor <https://1145.am/db/2367846/Investment_Bpifrance_Crossject_Industrial_Projects_Of_The_Future_Has_Not_Happened> ;
    ns1:name "Industrial Projects of the Future" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367969/Andrew_Saik> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "NEW YORK" ;
    ns1:description "Chief Financial Officer" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:foundName "Andrew Saik" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Andrew Saik" ;
    ns1:protagonist <https://1145.am/db/2367969/Investment_Andrew_Saik_Warburg_Pincus_Completed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367969/Vertice_Pharma> a org:Organization ;
    ns1:buyer <https://1145.am/db/2367969/Vistapharm_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:foundName "Vertice Pharma" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Vertice Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1048520/Verisim_Life>,
        <https://1145.am/db/1050156/Verisim_Life>,
        <https://1145.am/db/2016088/Veristat>,
        <https://1145.am/db/2287029/Vernalis>,
        <https://1145.am/db/2292389/Vernalis>,
        <https://1145.am/db/2296117/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/2306662/Velos>,
        <https://1145.am/db/2315571/Verus_Pharmaceuticals>,
        <https://1145.am/db/2319687/Vgx_Pharmaceuticals_Inc>,
        <https://1145.am/db/2321953/Vasogenix_Pharmaceuticals>,
        <https://1145.am/db/2323302/Vernalis>,
        <https://1145.am/db/2324389/Vernalis>,
        <https://1145.am/db/2325394/Vectura>,
        <https://1145.am/db/2333624/Vela>,
        <https://1145.am/db/2356180/Veloxis_Pharmaceuticals_A_S>,
        <https://1145.am/db/2367976/Vertice_Pharma>,
        <https://1145.am/db/2369661/Vertice_Pharma>,
        <https://1145.am/db/2370342/Vertice_Pharma>,
        <https://1145.am/db/2560607/Veru>,
        <https://1145.am/db/411039/Vectura_Group_Plc>,
        <https://1145.am/db/668220/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/668964/Venatorx_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367969/Warburg_Pincus> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York" ;
    ns1:description "growth investing" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:foundName "Warburg Pincus" ;
    ns1:industry "private equity" ;
    ns1:name "Warburg Pincus" ;
    ns1:protagonist <https://1145.am/db/2367969/Investment_Andrew_Saik_Warburg_Pincus_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/107233/Warburg_Pincus>,
        <https://1145.am/db/1077261/Warburg_Pincus>,
        <https://1145.am/db/108315/Warburg_Pincus>,
        <https://1145.am/db/1149542/Warburg_Pincus>,
        <https://1145.am/db/1153239/Warburg_Pincus>,
        <https://1145.am/db/129974/Warburg_Pincus>,
        <https://1145.am/db/1317266/Warburg_Pincus>,
        <https://1145.am/db/1349968/Warburg_Pincus_Llc>,
        <https://1145.am/db/1378133/Apax_Partners>,
        <https://1145.am/db/1405696/Warburg_Pincus>,
        <https://1145.am/db/1433001/Warburg_Pincus_Lcc>,
        <https://1145.am/db/156114/Warburg_Pincus_International>,
        <https://1145.am/db/157827/Warburg_Pincus_International>,
        <https://1145.am/db/157887/Warburg_Pincus_International>,
        <https://1145.am/db/1655979/Warburg_Pincus>,
        <https://1145.am/db/1674046/Warbug_Pincus>,
        <https://1145.am/db/1676487/Warburg_Pincus>,
        <https://1145.am/db/1716813/Warburg_Pincus>,
        <https://1145.am/db/1726154/Apax_Partners>,
        <https://1145.am/db/1763980/Apax_Funds>,
        <https://1145.am/db/1790731/Warburg_Pincus>,
        <https://1145.am/db/1831318/Warburg_Pincus>,
        <https://1145.am/db/1862907/Warburg_Pincus>,
        <https://1145.am/db/1870054/Warburg_Pincus>,
        <https://1145.am/db/1874806/Warburg_Pincus>,
        <https://1145.am/db/1887816/Warburg_Pincus>,
        <https://1145.am/db/196955/Warburg_Pincus>,
        <https://1145.am/db/1995465/Apax>,
        <https://1145.am/db/1997451/Warburg_Pincus>,
        <https://1145.am/db/1997970/Warburg_Pincus>,
        <https://1145.am/db/1998744/Warburg_Pincus>,
        <https://1145.am/db/2001027/Warburg_Pincus>,
        <https://1145.am/db/2065567/Warburg_Pincus>,
        <https://1145.am/db/2072166/Apax>,
        <https://1145.am/db/2072812/Apax>,
        <https://1145.am/db/2076122/Warburg_Pincus>,
        <https://1145.am/db/2080624/Ta_Associates_And_Warburg_Pincus_Llc>,
        <https://1145.am/db/2081192/Warburg_Pincus>,
        <https://1145.am/db/2098398/Apax>,
        <https://1145.am/db/2132018/Warburg_Pincus>,
        <https://1145.am/db/2207195/Warburg_Pincus>,
        <https://1145.am/db/2214443/Apax_Partners_Llp>,
        <https://1145.am/db/2288758/Warburg_Pincus>,
        <https://1145.am/db/2300214/Warburg_Pincus>,
        <https://1145.am/db/2308601/Warburg_Pincus>,
        <https://1145.am/db/2316851/Warburg_Pincus_Ventures>,
        <https://1145.am/db/2319237/Warburg_Pincus>,
        <https://1145.am/db/2324915/Apax_Partners>,
        <https://1145.am/db/2327248/Warburg_Pincus>,
        <https://1145.am/db/2327264/Warburg_Pincus>,
        <https://1145.am/db/2348272/Warburg_Pincus_Llc>,
        <https://1145.am/db/2360639/Warburg_Pincus>,
        <https://1145.am/db/2367976/Warburg_Pincus>,
        <https://1145.am/db/238604/Warburg_Pincus>,
        <https://1145.am/db/239134/Warburg_Pincus_Capital_Corporation_I-A>,
        <https://1145.am/db/2562224/Warburg_Pincus>,
        <https://1145.am/db/2578179/Warburg_Pincus_Montagu_Private_Equity>,
        <https://1145.am/db/2647818/Apax>,
        <https://1145.am/db/2650891/Apax>,
        <https://1145.am/db/2651063/Apax>,
        <https://1145.am/db/2660508/Apax_Partners>,
        <https://1145.am/db/2664134/Warburg_Pincus_Apax>,
        <https://1145.am/db/2668430/Warburg_Pincus>,
        <https://1145.am/db/2669352/Apax_Partners>,
        <https://1145.am/db/2677923/Apax>,
        <https://1145.am/db/2679079/Apax_Partners>,
        <https://1145.am/db/2695363/Warburg_Pincus>,
        <https://1145.am/db/271314/Warburg_Pincus>,
        <https://1145.am/db/2722001/Warburg_Pincus>,
        <https://1145.am/db/272400/Warburg_Pincus>,
        <https://1145.am/db/2732060/Warburg_Pincus>,
        <https://1145.am/db/2747164/Warburg_Pincus>,
        <https://1145.am/db/2800144/Warburg_Pincus>,
        <https://1145.am/db/359185/Warburg_Pincus>,
        <https://1145.am/db/455601/Apax_Partners>,
        <https://1145.am/db/455601/Warburg_Pincus_Llc>,
        <https://1145.am/db/463733/Warburg_Pincus>,
        <https://1145.am/db/478732/Warburg_Pincus>,
        <https://1145.am/db/582835/Warburg_Pincus>,
        <https://1145.am/db/821887/Apax_Partners>,
        <https://1145.am/db/824983/Apax_Partners>,
        <https://1145.am/db/825385/Apax_Partners_Llp>,
        <https://1145.am/db/944277/Warburg_Pincus> ;
    ns1:sameAsMedium <https://1145.am/db/1106851/Warburg_Pincus>,
        <https://1145.am/db/1121839/Warburg_Pincus>,
        <https://1145.am/db/1138823/Warburg_Pincus>,
        <https://1145.am/db/1141070/Warburg_Pincus>,
        <https://1145.am/db/1153356/Warburg_Pincus>,
        <https://1145.am/db/1216854/Warburg_Pincus>,
        <https://1145.am/db/1244609/Warburg_Pincus>,
        <https://1145.am/db/1245131/Warburg_Pincus>,
        <https://1145.am/db/1361475/Warburg_Pincus>,
        <https://1145.am/db/1656176/Warburg_Pincus>,
        <https://1145.am/db/1721480/Warburg_Pincus>,
        <https://1145.am/db/1722916/Warburg_Pincus>,
        <https://1145.am/db/1742050/Warburg_Pincus>,
        <https://1145.am/db/1742981/Warburg_Pincus>,
        <https://1145.am/db/1748765/Warburg_Pincus>,
        <https://1145.am/db/1754511/Warburg_Pincus>,
        <https://1145.am/db/1758165/Warburg_Pincus>,
        <https://1145.am/db/1762611/Warburg_Pincus>,
        <https://1145.am/db/1766425/Warburg_Pincus>,
        <https://1145.am/db/1777495/Warburg_Pincus>,
        <https://1145.am/db/1783572/Warburg_Pincus>,
        <https://1145.am/db/1788883/Warburg_Pincus>,
        <https://1145.am/db/1789335/Warburg_Pincus>,
        <https://1145.am/db/1802244/Warburg_Pincus>,
        <https://1145.am/db/1807465/Warburg_Pincus>,
        <https://1145.am/db/1812233/Warburg_Pincus>,
        <https://1145.am/db/1854800/Warburg_Pincus>,
        <https://1145.am/db/1969536/Warburg_Pincus>,
        <https://1145.am/db/1993235/Warburg_Pincus>,
        <https://1145.am/db/2069862/Warburg_Pincus>,
        <https://1145.am/db/2097376/Warburg_Pincus>,
        <https://1145.am/db/2134779/Warburg_Pincus>,
        <https://1145.am/db/2183196/Warburg_Pincus>,
        <https://1145.am/db/2183330/Warburg_Pincus>,
        <https://1145.am/db/2238793/Warburg_Pincus>,
        <https://1145.am/db/2270672/Warburg_Pincus>,
        <https://1145.am/db/2291095/Warburg_Pincus>,
        <https://1145.am/db/2296562/Warburg_Pincus>,
        <https://1145.am/db/2300064/Warburg_Pincus>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2315159/Warburg_Pincus>,
        <https://1145.am/db/2318581/Warburg_Pincus>,
        <https://1145.am/db/2319236/Warburg_Pincus>,
        <https://1145.am/db/2324159/Warburg_Pincus>,
        <https://1145.am/db/2326119/Warburg_Pincus>,
        <https://1145.am/db/2352277/Warburg_Pincus>,
        <https://1145.am/db/2353256/Warburg_Pincus>,
        <https://1145.am/db/2353260/Warburg_Pincus>,
        <https://1145.am/db/235654/Warburg_Pincus_Llc>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2543471/Warburg_Pincus>,
        <https://1145.am/db/2544488/Warburg_Pincus>,
        <https://1145.am/db/2547596/Warburg_Pincus>,
        <https://1145.am/db/254889/Warburg_Pincus>,
        <https://1145.am/db/2560285/Warburg_Pincus>,
        <https://1145.am/db/2579025/Warburg_Pincus>,
        <https://1145.am/db/2596296/Warburg_Pincus>,
        <https://1145.am/db/2638371/Warburg_Pincus>,
        <https://1145.am/db/268598/Warburg_Pincus>,
        <https://1145.am/db/2688027/Warburg_Pincus>,
        <https://1145.am/db/2735857/Warburg_Pincus>,
        <https://1145.am/db/299488/Warburg_Pincus>,
        <https://1145.am/db/405249/Warburg_Pincus>,
        <https://1145.am/db/460556/Warburg_Pincus>,
        <https://1145.am/db/489663/Warburg_Pincus>,
        <https://1145.am/db/505222/Warburg_Pincus>,
        <https://1145.am/db/539514/Warburg_Pincus>,
        <https://1145.am/db/542434/Warburg_Pincus>,
        <https://1145.am/db/547444/Warburg_Pincus>,
        <https://1145.am/db/556611/Warburg_Pincus>,
        <https://1145.am/db/601860/Warburg_Pincus>,
        <https://1145.am/db/606291/Warburg_Pincus>,
        <https://1145.am/db/627360/Warburg_Pincus>,
        <https://1145.am/db/721581/Warburg_Pincus>,
        <https://1145.am/db/745350/Warburg_Pincus_Llc>,
        <https://1145.am/db/768222/Warburg_Pincus>,
        <https://1145.am/db/817588/Warburg_Pincus>,
        <https://1145.am/db/823283/Warburg_Pincus>,
        <https://1145.am/db/829348/Warburg_Pincus>,
        <https://1145.am/db/85758/Warburg_Pincus>,
        <https://1145.am/db/867907/Warburg_Pincus>,
        <https://1145.am/db/934889/Warburg_Pincus>,
        <https://1145.am/db/962121/Warburg_Pincus>,
        <https://1145.am/db/963964/Warburg_Pincus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368321/Rtw_Investments> a org:Organization ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "RTW Investments" ;
    ns1:investor <https://1145.am/db/2368321/Investment_Eli_Lilly_And_Company_Immunocore_Malin_Corporation_Rtw_Investments_Woodford_Investment_Management_Completed> ;
    ns1:name "RTW Investments" ;
    ns1:sameAsMedium <https://1145.am/db/1181658/Rtw_Investments>,
        <https://1145.am/db/1780665/Rtw_Investments>,
        <https://1145.am/db/1928388/Rtw_Investments>,
        <https://1145.am/db/1975490/Rtw_Investments>,
        <https://1145.am/db/2087289/Rtw_Investments>,
        <https://1145.am/db/2281211/Rtw_Investments>,
        <https://1145.am/db/2369974/Rtw_Investments>,
        <https://1145.am/db/277078/Rtw_Investments_Lp>,
        <https://1145.am/db/428737/Rtw_Investments>,
        <https://1145.am/db/739411/Rtw_Investments>,
        <https://1145.am/db/838323/Rtw_Investments>,
        <https://1145.am/db/842953/Rtw_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Adage_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS, Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Adage Capital Management" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Adage Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1770748/Adage_Capital_Management>,
        <https://1145.am/db/2285893/Adage_Capital_Management>,
        <https://1145.am/db/2307845/Adage_Capital_Management>,
        <https://1145.am/db/2307846/Adage_Capital_Management>,
        <https://1145.am/db/2327488/Adage_Capital_Management_Lp>,
        <https://1145.am/db/2335748/Adage_Capital_Management>,
        <https://1145.am/db/2338428/Adage_Capital_Management>,
        <https://1145.am/db/2340819/Adage_Capital_Management>,
        <https://1145.am/db/2356216/Adage_Capital_Management>,
        <https://1145.am/db/2360266/Adage_Capital_Management>,
        <https://1145.am/db/2369974/Adage_Capital_Management>,
        <https://1145.am/db/281538/Adage_Capital_Management_Lp>,
        <https://1145.am/db/341984/Adage_Capital_Management>,
        <https://1145.am/db/341990/Adage_Capital_Management>,
        <https://1145.am/db/683988/Adage_Capital_Management>,
        <https://1145.am/db/888513/Adage_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Lilly_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS, Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Lilly Ventures" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Lilly Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2301739/Lilly_Ventures>,
        <https://1145.am/db/2317455/Lilly_Ventures>,
        <https://1145.am/db/2318733/Lilly_Ventures>,
        <https://1145.am/db/2319777/Lilly_Ventures>,
        <https://1145.am/db/2320082/Lilly_Ventures>,
        <https://1145.am/db/2322022/Lilly_Ventures>,
        <https://1145.am/db/2322984/Lilly_Ventures>,
        <https://1145.am/db/2323003/Lilly_Ventures>,
        <https://1145.am/db/2324042/Lilly_Ventures>,
        <https://1145.am/db/2326222/Lilly_Ventures>,
        <https://1145.am/db/2327441/Lilly_Ventures>,
        <https://1145.am/db/2327442/Lilly_Ventures>,
        <https://1145.am/db/2332864/Lilly_Ventures>,
        <https://1145.am/db/2332868/Lilly_Ventures>,
        <https://1145.am/db/2336328/Lilly_Ventures>,
        <https://1145.am/db/2339666/Lilly_Ventures>,
        <https://1145.am/db/2340096/Lilly_Ventures>,
        <https://1145.am/db/2340942/Lilly_Ventures>,
        <https://1145.am/db/2343723/Lilly_Ventures>,
        <https://1145.am/db/2343724/Lilly_Ventures>,
        <https://1145.am/db/2347682/Lilly_Ventures>,
        <https://1145.am/db/2348448/Lilly_Ventures>,
        <https://1145.am/db/2352414/Lilly_Ventures>,
        <https://1145.am/db/2353439/Lilly_Ventures>,
        <https://1145.am/db/2355586/Lilly_Ventures>,
        <https://1145.am/db/2356048/Lilly_Ventures>,
        <https://1145.am/db/2357676/Lilly_Ventures>,
        <https://1145.am/db/2357679/Lilly_Ventures>,
        <https://1145.am/db/2357682/Lilly_Ventures>,
        <https://1145.am/db/2361581/Lilly_Ventures>,
        <https://1145.am/db/2362715/Lilly_Ventures>,
        <https://1145.am/db/2363396/Lilly_Ventures>,
        <https://1145.am/db/2368240/Lilly_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Pharmstandard_International> a org:Organization ;
    ns1:basedInLowRaw "S.A" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Pharmstandard International, S.A" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Pharmstandard International" ;
    ns1:sameAsMedium <https://1145.am/db/2315027/Pharmstandard_International>,
        <https://1145.am/db/2347983/Pharmstandard_International>,
        <https://1145.am/db/2354196/Pharmstandard_International_Sa>,
        <https://1145.am/db/2360313/Pharmstandard_International>,
        <https://1145.am/db/2360317/Pharmstandard_International_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Starfish_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS, Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Starfish Ventures" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Starfish Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1830016/Starfish_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1893938/Starfish_Ventures>,
        <https://1145.am/db/2361581/Starfish_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Biomed_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "BioMed Ventures" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "BioMed Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2335675/Biomed_Ventures>,
        <https://1145.am/db/2336102/Biomed_Ventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2354295/Biomed_Ventures>,
        <https://1145.am/db/2366046/Biomed_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/2569522/Biomed_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Bvf_Partners_Lp> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "BVF Partners L.P." ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "BVF Partners L.P." ;
    ns1:sameAsMedium <https://1145.am/db/1293978/Bvf_Partners_Lp>,
        <https://1145.am/db/1294718/Bvf_Partners_Lp>,
        <https://1145.am/db/1334624/Bvf_Partners_Lp>,
        <https://1145.am/db/1352333/Bvf_Partners_Lp>,
        <https://1145.am/db/1387524/Bvf_Partners_Lp>,
        <https://1145.am/db/1581637/Bvf_Partners_Lp>,
        <https://1145.am/db/1623159/Bvf_Partners_Lp>,
        <https://1145.am/db/2075754/Bvf_Partners>,
        <https://1145.am/db/2153860/Bvf_Partners>,
        <https://1145.am/db/2280707/Bvf_Partners>,
        <https://1145.am/db/2291277/Bvf_Partners_Lp>,
        <https://1145.am/db/2352162/Bvf_Partners_Lp>,
        <https://1145.am/db/474852/Bvf_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Celator_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Ewing" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5097751/about.rdf> ;
    ns1:basedInHighRaw "Ewing, NJ" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Celator Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2368333/Investment_Celator_Pharmaceuticals_Has_Not_Happened> ;
    ns1:name "Celator Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1081367/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1192310/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1215794/Creso_Pharma_Ltd>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1396752/Cevec_Pharmaceuticals>,
        <https://1145.am/db/1633177/Cincor_Pharma>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2156297/Cerevel>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2287377/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2301933/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2301947/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2302649/Ecr_Pharmaceuticals>,
        <https://1145.am/db/2309970/Eurand_Pharmaceuticals>,
        <https://1145.am/db/2311099/Celator_Pharmaceuticals>,
        <https://1145.am/db/2313397/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2313471/Celator_Pharmaceuticals>,
        <https://1145.am/db/2314551/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2314554/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2320852/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2320853/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2322242/Cerimon_Pharmaceuticals>,
        <https://1145.am/db/2326327/Provectus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2328825/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2330539/Celator_Pharmaceuticals>,
        <https://1145.am/db/2335675/Laguna_Pharmaceuticals>,
        <https://1145.am/db/2335677/Laguna_Pharmaceuticals>,
        <https://1145.am/db/2338173/Celator_Pharmaceuticals>,
        <https://1145.am/db/2339182/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2344274/Momenta_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353209/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355936/Celator_Pharmaceuticals>,
        <https://1145.am/db/2355938/Celator_Pharmaceuticals>,
        <https://1145.am/db/2361666/Celator_Pharmaceuticals>,
        <https://1145.am/db/2364675/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364774/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2364776/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2365376/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2365795/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2366302/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2367051/Calando_Pharmaceuticals>,
        <https://1145.am/db/2367072/Provectus_Pharmaceuticals>,
        <https://1145.am/db/2367292/Cempra_Pharmaceuticals>,
        <https://1145.am/db/2537737/Cevec_Pharmaceuticals>,
        <https://1145.am/db/2539508/Caraco>,
        <https://1145.am/db/2553248/Cenes_Pharmaceutical>,
        <https://1145.am/db/2574942/Celator_Pharmaceuticals>,
        <https://1145.am/db/958376/Cardior_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2330549/Celator_Pharmaceuticals>,
        <https://1145.am/db/2353210/Celator_Pharmaceuticals>,
        <https://1145.am/db/2358532/Celator_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Hbm_Healthcare_Investments> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "HBM Healthcare Investments" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "HBM Healthcare Investments" ;
    ns1:sameAsMedium <https://1145.am/db/1200212/Hbm_Healthcare_Investments>,
        <https://1145.am/db/1200886/Hbm_Healthcare_Investments>,
        <https://1145.am/db/1519613/Hbm_Healthcare_Investments>,
        <https://1145.am/db/1519799/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2032047/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2080575/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2155730/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2280707/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2292160/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2297827/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2297840/Hbm_Healthcare_Investments>,
        <https://1145.am/db/2359404/Hbm_Healthcare_Investments_Ltd>,
        <https://1145.am/db/2369165/Hbm_Healthcare_Investments>,
        <https://1145.am/db/683988/Hbm_Healthcare_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Longwood_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Longwood Capital Partners" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "Longwood Capital Partners" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Novo_A_S> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Novo A/S" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "Novo A/S" ;
    ns1:sameAsMedium <https://1145.am/db/1753148/Novo>,
        <https://1145.am/db/1754034/Novo>,
        <https://1145.am/db/2288016/Novo_A_S>,
        <https://1145.am/db/2296606/Novo_A_S>,
        <https://1145.am/db/2298077/Novo_A_S>,
        <https://1145.am/db/2298277/Novo_A_S>,
        <https://1145.am/db/2299423/Novo_As>,
        <https://1145.am/db/2299645/Novo>,
        <https://1145.am/db/2300653/Novo_A_S>,
        <https://1145.am/db/2301290/Novo>,
        <https://1145.am/db/2301494/Novo_A_S>,
        <https://1145.am/db/2302994/Novo_A_S>,
        <https://1145.am/db/2302995/Novo_A_S>,
        <https://1145.am/db/2303767/Novo_A_S>,
        <https://1145.am/db/2304335/Novo_A_S>,
        <https://1145.am/db/2304340/Novo_A_S>,
        <https://1145.am/db/2308758/Novo_A_S>,
        <https://1145.am/db/2309506/Novo_A_S>,
        <https://1145.am/db/2309507/Novo_A_S>,
        <https://1145.am/db/2311133/Novo_A_S>,
        <https://1145.am/db/2311274/Novo>,
        <https://1145.am/db/2312120/Novo_A_S>,
        <https://1145.am/db/2314546/Novo_A_S>,
        <https://1145.am/db/2318733/Novo_A_S>,
        <https://1145.am/db/2319236/Novo_A_S>,
        <https://1145.am/db/2319416/Novo_A_S>,
        <https://1145.am/db/2319433/Novo_A_S>,
        <https://1145.am/db/2319784/Novo_A_S>,
        <https://1145.am/db/2321216/Novo_A_S>,
        <https://1145.am/db/2321861/Novo_A_S>,
        <https://1145.am/db/2321870/Novo_A_S>,
        <https://1145.am/db/2325116/Novo_A_S>,
        <https://1145.am/db/2329010/Novo_A_S>,
        <https://1145.am/db/2329011/Novo_A_S>,
        <https://1145.am/db/2329224/Novo_A_S>,
        <https://1145.am/db/2335700/Novo_A_S>,
        <https://1145.am/db/2338817/Novo_A_S>,
        <https://1145.am/db/2339692/Novo_A_S>,
        <https://1145.am/db/2340612/Novo_A_S>,
        <https://1145.am/db/2341934/Novo>,
        <https://1145.am/db/2342284/Novo_A_S>,
        <https://1145.am/db/2345268/Novo_A_S>,
        <https://1145.am/db/2345273/Novo_A_S>,
        <https://1145.am/db/2346452/Novo_A_S>,
        <https://1145.am/db/2349013/Novo_A_S>,
        <https://1145.am/db/2349048/Novo_A_S>,
        <https://1145.am/db/2349050/Novo_A_S>,
        <https://1145.am/db/2349406/Novo_A_S>,
        <https://1145.am/db/2353241/Novo_A_S>,
        <https://1145.am/db/2355183/Novo_A_S>,
        <https://1145.am/db/2356861/Novo_A_S>,
        <https://1145.am/db/2356876/Novo_A_S>,
        <https://1145.am/db/2357109/Novo_A_S>,
        <https://1145.am/db/2358233/Novo_A_S>,
        <https://1145.am/db/2358246/Novo_As>,
        <https://1145.am/db/2358271/Novo_A_S>,
        <https://1145.am/db/2358272/Novo_A_S>,
        <https://1145.am/db/2358459/Novo>,
        <https://1145.am/db/2358464/Novo_A_S>,
        <https://1145.am/db/2358542/Novo_A_S>,
        <https://1145.am/db/2359510/Novo_A_S>,
        <https://1145.am/db/2359683/Novo_A_S>,
        <https://1145.am/db/2360562/Novo>,
        <https://1145.am/db/2361588/Novo_A_S>,
        <https://1145.am/db/2363535/Novo_A_S>,
        <https://1145.am/db/2364505/Novo_A_S>,
        <https://1145.am/db/2364508/Novo_A_S>,
        <https://1145.am/db/2365700/Novo_A_S>,
        <https://1145.am/db/2365701/Novo_A_S>,
        <https://1145.am/db/2366187/Novo_A_S>,
        <https://1145.am/db/2366333/Novo_A_S>,
        <https://1145.am/db/2367275/Novo_A_S>,
        <https://1145.am/db/2367364/Novo_A_S>,
        <https://1145.am/db/2367368/Novo_A_S>,
        <https://1145.am/db/2368297/Novo_A_S>,
        <https://1145.am/db/2368572/Novo_A_S>,
        <https://1145.am/db/2543793/Novo>,
        <https://1145.am/db/2544115/Novo>,
        <https://1145.am/db/2552947/Novo>,
        <https://1145.am/db/2557027/Novo>,
        <https://1145.am/db/2581901/Novo_A_S>,
        <https://1145.am/db/2581902/Novo_A_S>,
        <https://1145.am/db/2584056/Novo_A_S>,
        <https://1145.am/db/360351/Novo>,
        <https://1145.am/db/751135/Novo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/R___D_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Switzerland's Piqur Therapeutics just raised $ 19 million for its cancer drug R & D specializing in PI3K and mTOR inhibition." ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368333/Piqur_Therapeutics>,
        <https://1145.am/db/2368333/R___d> ;
    ns1:targetName "R & D" ;
    ns1:valueRaw "$ 19 million" ;
    ns1:whereGeoName "Switzerland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:whereRaw "Switzerland" .

<https://1145.am/db/2368501/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:description "investment" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsHigh <https://1145.am/db/2080575/Sr_One_Capital_Management>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/456089/Sr_One_Capital_Management>,
        <https://1145.am/db/458377/Sr_One_Capital_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368501/Topspin_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "Topspin Partners" ;
    ns1:investor <https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> ;
    ns1:name "Topspin Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1758719/Topspin_Partners>,
        <https://1145.am/db/2362565/Topspin_Partners>,
        <https://1145.am/db/2362566/Topspin_Partners>,
        <https://1145.am/db/2370208/Topspin_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Abbvie> a org:Organization ;
    ns1:basedInLowRaw "NEW YORK" ;
    ns1:description "life science" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "AbbVie" ;
    ns1:industry "life science" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "AbbVie" ;
    ns1:sameAsHigh <https://1145.am/db/2281991/Abbvie>,
        <https://1145.am/db/2296703/Abpro>,
        <https://1145.am/db/2306961/Abl>,
        <https://1145.am/db/2557303/Abbvie> ;
    ns1:sameAsMedium <https://1145.am/db/1428452/Abbvie>,
        <https://1145.am/db/1433467/Abbvie>,
        <https://1145.am/db/166064/Abbvie>,
        <https://1145.am/db/1819526/Abbvie>,
        <https://1145.am/db/2152172/Abbvie>,
        <https://1145.am/db/2152271/Abbvie>,
        <https://1145.am/db/2152401/Abbvie>,
        <https://1145.am/db/2153268/Abbvie>,
        <https://1145.am/db/2155491/Abbvie>,
        <https://1145.am/db/2197717/Abbvie>,
        <https://1145.am/db/2281151/Abbvie>,
        <https://1145.am/db/2283244/Abbvie>,
        <https://1145.am/db/2283377/Abbvie>,
        <https://1145.am/db/2285137/Abbvie>,
        <https://1145.am/db/2286189/Abbvie>,
        <https://1145.am/db/2286404/Abbvie>,
        <https://1145.am/db/2287533/Abbvie>,
        <https://1145.am/db/2292991/Abbvie>,
        <https://1145.am/db/2293472/Abbvie>,
        <https://1145.am/db/2293662/Abbvie>,
        <https://1145.am/db/2316298/Abbvie>,
        <https://1145.am/db/2325897/Abbvie>,
        <https://1145.am/db/2337662/Abbvie>,
        <https://1145.am/db/2338430/Abbvie>,
        <https://1145.am/db/2339733/Abbvie_Inc>,
        <https://1145.am/db/2340575/Abbvie>,
        <https://1145.am/db/2342791/Abbvie_Inc>,
        <https://1145.am/db/2348742/Abbvie>,
        <https://1145.am/db/2348750/Abbvie>,
        <https://1145.am/db/2351315/Abbvie>,
        <https://1145.am/db/2351897/Abbvie>,
        <https://1145.am/db/2352289/Abbvie>,
        <https://1145.am/db/2352906/Abbvie>,
        <https://1145.am/db/2356340/Abbvie>,
        <https://1145.am/db/2356358/Abbvie>,
        <https://1145.am/db/2357032/Abbvie>,
        <https://1145.am/db/2357429/Abbvie>,
        <https://1145.am/db/2362638/Abbvie_Inc>,
        <https://1145.am/db/2362641/Abbvie>,
        <https://1145.am/db/2363364/Abbvie>,
        <https://1145.am/db/2369358/Abbvie_Inc>,
        <https://1145.am/db/2369370/Abbvie>,
        <https://1145.am/db/2370316/Abbvie>,
        <https://1145.am/db/2370523/Abbvie>,
        <https://1145.am/db/2537089/Abbvie>,
        <https://1145.am/db/2540681/Abbvie>,
        <https://1145.am/db/2540723/Abbvie>,
        <https://1145.am/db/2542218/Abbvie>,
        <https://1145.am/db/2542814/Abbvie>,
        <https://1145.am/db/2545631/Abbvie>,
        <https://1145.am/db/2548056/Abbvie>,
        <https://1145.am/db/2548589/Abbvie_Inc>,
        <https://1145.am/db/2548859/Abbvie>,
        <https://1145.am/db/2549367/Abbvie>,
        <https://1145.am/db/2553748/Abbvie>,
        <https://1145.am/db/2553958/Abbvie>,
        <https://1145.am/db/2556154/Abbvie>,
        <https://1145.am/db/2557185/Abbvie>,
        <https://1145.am/db/2557200/Abbvie>,
        <https://1145.am/db/2557201/Abbvie>,
        <https://1145.am/db/2560663/Abbvie>,
        <https://1145.am/db/2561314/Abbvie>,
        <https://1145.am/db/2561318/Abbvie_Inc>,
        <https://1145.am/db/2564196/Abbvie>,
        <https://1145.am/db/2569165/Abbvie>,
        <https://1145.am/db/2569187/Abbvie>,
        <https://1145.am/db/2570289/Abbvie>,
        <https://1145.am/db/2570419/Abbvie>,
        <https://1145.am/db/2570807/Abbvie>,
        <https://1145.am/db/2572559/Abbvie>,
        <https://1145.am/db/2573508/Abbvie>,
        <https://1145.am/db/2573935/Abbvie>,
        <https://1145.am/db/2574443/Abbvie>,
        <https://1145.am/db/2574891/Abbvie>,
        <https://1145.am/db/2578319/Abbvie>,
        <https://1145.am/db/2580279/Abbvie>,
        <https://1145.am/db/2580747/Abbvie>,
        <https://1145.am/db/2581261/Abbvie>,
        <https://1145.am/db/2582265/Abbvie>,
        <https://1145.am/db/2583177/Abbvie>,
        <https://1145.am/db/2585132/Abbvie>,
        <https://1145.am/db/2586132/Abbvie>,
        <https://1145.am/db/2587094/Abbvie>,
        <https://1145.am/db/2588832/Abbvie_Inc>,
        <https://1145.am/db/2595202/Abbvie>,
        <https://1145.am/db/2595691/Abbvie>,
        <https://1145.am/db/2596312/Abbvie>,
        <https://1145.am/db/2788920/Abbvie_Inc>,
        <https://1145.am/db/80587/Abbvie_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Accelerator_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:description "life science investment and management" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Accelerator Corporation" ;
    ns1:industry "life science" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Accelerator Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2306713/Accelerator_Corporation>,
        <https://1145.am/db/2306713/Accelerator_Iii>,
        <https://1145.am/db/2315446/Accelerator_Corporation>,
        <https://1145.am/db/2330560/Accelerator_Corporation>,
        <https://1145.am/db/2345223/Accelerator_Corporation>,
        <https://1145.am/db/2368999/Accelerator> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Harris___Harris_Group> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Harris & Harris Group, Inc." ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Harris & Harris Group" ;
    ns1:sameAsMedium <https://1145.am/db/2309865/Harris___Harris_Group>,
        <https://1145.am/db/2309872/Harris___Harris_Group>,
        <https://1145.am/db/2322312/Harris_And_Harris_Group>,
        <https://1145.am/db/2324756/Harris_And_Harris_Group>,
        <https://1145.am/db/2325681/Harris___Harris_Group>,
        <https://1145.am/db/2337971/Harris_And_Harris_Group>,
        <https://1145.am/db/2337972/Harris_And_Harris_Group>,
        <https://1145.am/db/2343184/Harris___Harris_Group>,
        <https://1145.am/db/2343185/Harris___Harris_Group>,
        <https://1145.am/db/2344356/Harris___Harris_Group>,
        <https://1145.am/db/2449833/Harris___Harris_Group>,
        <https://1145.am/db/2545510/Harris___Harris_Group>,
        <https://1145.am/db/2587938/Harris_And_Harris_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Innovate_Ny_Fund> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Innovate NY Fund" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Innovate NY Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Johnson___Johnson_Innovation_-_Jjdc_Inc> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Johnson & Johnson Innovation - JJDC, Inc",
        "Johnson & Johnson Innovation - JJDC, Inc." ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Johnson & Johnson Innovation",
        "Johnson & Johnson Innovation - JJDC, Inc." ;
    ns1:sameAsMedium <https://1145.am/db/1553175/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1553459/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1620209/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1624707/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1690992/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1928208/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/2042773/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/2114450/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/768105/Johnson_And_Johnson_Innovation-Jjdc_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Pfizer_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "New York" ;
    ns1:description "life science investment" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Pfizer Venture Investments" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Pfizer Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Pfizer_Ventures>,
        <https://1145.am/db/2154844/Pfizer_Ventures>,
        <https://1145.am/db/2306549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318310/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2319442/Pfizer_Venture_Investments>,
        <https://1145.am/db/2322984/Pfizer_Venture_Investments>,
        <https://1145.am/db/2323003/Pfizer_Venture_Investments>,
        <https://1145.am/db/2325726/Pfizer_Ventures>,
        <https://1145.am/db/2341896/Pfizer_Ventures>,
        <https://1145.am/db/2348066/Pfizer_Venture_Investments>,
        <https://1145.am/db/2354296/Pfizer_Venture_Investments>,
        <https://1145.am/db/2355043/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356290/Pfizer_Venture_Investments>,
        <https://1145.am/db/2359321/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364458/Pfizer_Venture_Investments>,
        <https://1145.am/db/587045/Pfizer_Ventures>,
        <https://1145.am/db/591613/Pfizer_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2299758/Pfizer_Venture_Investments>,
        <https://1145.am/db/2336335/Pfizer_Venture_Investments>,
        <https://1145.am/db/2337971/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338527/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338528/Pfizer_Venture_Investments>,
        <https://1145.am/db/2340096/Pfizer_Venture_Investments>,
        <https://1145.am/db/2346978/Pfizer_Venture_Investments>,
        <https://1145.am/db/2349143/Pfizer_Venture_Investments>,
        <https://1145.am/db/2352226/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356287/Pfizer_Venture_Investments>,
        <https://1145.am/db/2362862/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364457/Pfizer_Venture_Investments>,
        <https://1145.am/db/2367549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2587938/Pfizer_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/The_Partnership_Fund_For_New_York_City> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "The Partnership Fund for New York City" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "The Partnership Fund for New York City" ;
    ns1:sameAsHigh <https://1145.am/db/1955344/Partnership_Fund_For_Nyc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Watson_Fund> a org:Organization ;
    ns1:basedInLowRaw "New York" ;
    ns1:description "life science investment" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Watson Fund" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Watson Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2296113/Watson_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Weill_Cornell_Medicine> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York City" ;
    ns1:description "treating cancer and metabolic diseases" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Weill Cornell Medicine" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Weill Cornell Medicine" ;
    ns1:sameAsMedium <https://1145.am/db/1238375/Weill_Cornell_Medicine>,
        <https://1145.am/db/1621076/Weill_Cornell_Medicine> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Bdc_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "BDC Capital" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "BDC Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1060623/Bdc_Capital>,
        <https://1145.am/db/1098879/Bdc_Capital>,
        <https://1145.am/db/1272747/Bdc_Capital>,
        <https://1145.am/db/1273347/Bdc_Capital>,
        <https://1145.am/db/1523231/Bdc_Capital>,
        <https://1145.am/db/1597608/Bdc_Capital>,
        <https://1145.am/db/1598335/Bdc_Capital>,
        <https://1145.am/db/1702003/Bdc_Capital>,
        <https://1145.am/db/1715547/Bdc_Capital>,
        <https://1145.am/db/1745965/Bdc_Capital>,
        <https://1145.am/db/1751527/Bdc_Capital>,
        <https://1145.am/db/2311099/Bdc_Capital>,
        <https://1145.am/db/2311128/Bdc_Capital>,
        <https://1145.am/db/2311133/Bdc_Capital_Inc>,
        <https://1145.am/db/2316214/Bdc_Capital>,
        <https://1145.am/db/258189/Bdc_Capital>,
        <https://1145.am/db/907361/Bdc_Capital>,
        <https://1145.am/db/961790/Bdc_Capital>,
        <https://1145.am/db/962670/Bdc_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Cti_Life_Sciences_Fund> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "CTI Life Sciences Fund" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "CTI Life Sciences Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2314850/Cti_Life_Sciences_Fund>,
        <https://1145.am/db/2352633/Cti_Life_Sciences_Fund>,
        <https://1145.am/db/2365679/Cti_Life_Sciences_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Fonds_De_Solidarit_Ftq> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:buyer <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Fonds de solidarit FTQ",
        "the Fonds de solidarit FTQ" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Fonds de solidarit FTQ" ;
    ns1:sameAsMedium <https://1145.am/db/1084305/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1139252/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1185297/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1422234/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1422725/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1523124/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/1524137/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2284506/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2304242/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2304258/Fonds_De_Solidarite_Ftq>,
        <https://1145.am/db/2306251/Fonds_De_Solidarite_Ftq>,
        <https://1145.am/db/2341904/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2350915/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2353983/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2368517/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2610112/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/2702871/Fonds_De_Solidarit_Ftq>,
        <https://1145.am/db/764838/Fonds_De_Solidarit_Ftq> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Lumira_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Lumira Capital" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Lumira Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2298869/Lumira_Capital>,
        <https://1145.am/db/2300233/Lumira_Capital>,
        <https://1145.am/db/2341904/Lumira_Capital>,
        <https://1145.am/db/2347977/Lumira_Capital>,
        <https://1145.am/db/2347983/Lumira_Capital>,
        <https://1145.am/db/2353522/Lumira_Capital>,
        <https://1145.am/db/2359637/Lumira_Capital>,
        <https://1145.am/db/2360317/Lumira_Capital>,
        <https://1145.am/db/2363442/Lumira_Capital>,
        <https://1145.am/db/2572436/Lumira_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Merlin_Nexus> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Merlin Nexus" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Merlin Nexus" ;
    ns1:sameAsMedium <https://1145.am/db/2316823/Merlin_Nexus>,
        <https://1145.am/db/2328502/Merlin_Nexus>,
        <https://1145.am/db/2328514/Merlin_Nexus>,
        <https://1145.am/db/2343298/Merlin_Nexus>,
        <https://1145.am/db/2594141/Merlin_Nexus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Northleaf_Venture_Catalyst_Fund> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Northleaf Venture Catalyst Fund" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Northleaf Venture Catalyst Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2350915/Northleaf_Venture_Catalyst_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Perceptive_Advisors> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Perceptive Advisors" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Perceptive Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1164709/Perceptive_Advisors>,
        <https://1145.am/db/1166452/Perceptive_Advisors>,
        <https://1145.am/db/1181658/Perceptive_Advisors>,
        <https://1145.am/db/1285613/Perceptive_Advisors>,
        <https://1145.am/db/1506505/Perceptive_Advisors>,
        <https://1145.am/db/1509205/Perceptive_Advisors>,
        <https://1145.am/db/1737730/Perceptive_Advisors>,
        <https://1145.am/db/1747873/Perceptive_Advisors>,
        <https://1145.am/db/1773135/Perceptive_Advisors>,
        <https://1145.am/db/2095032/Perceptive_Advisors>,
        <https://1145.am/db/2152209/Perceptive_Advisors>,
        <https://1145.am/db/2152471/Perceptive_Advisors>,
        <https://1145.am/db/2152752/Perceptive_Advisors>,
        <https://1145.am/db/2198816/Perceptive_Advisors>,
        <https://1145.am/db/2284412/Perceptive_Advisors>,
        <https://1145.am/db/2291882/Perceptive_Advisors>,
        <https://1145.am/db/2294284/Perceptive_Advisors>,
        <https://1145.am/db/2296003/Perceptive_Advisors>,
        <https://1145.am/db/230667/Perceptive_Advisors>,
        <https://1145.am/db/2336221/Perceptive_Advisors>,
        <https://1145.am/db/2351897/Perceptive_Advisors>,
        <https://1145.am/db/2360277/Perceptive_Advisors_Llc>,
        <https://1145.am/db/2361337/Perceptive_Advisors>,
        <https://1145.am/db/2363364/Perceptive_Advisors>,
        <https://1145.am/db/2368386/Perceptive_Advisors>,
        <https://1145.am/db/2368579/Perceptive_Advisors>,
        <https://1145.am/db/2538761/Perceptive_Advisors>,
        <https://1145.am/db/2572177/Perceptive_Advisors>,
        <https://1145.am/db/452712/Perceptive_Advisors>,
        <https://1145.am/db/677591/Perceptive_Advisors>,
        <https://1145.am/db/681970/Perceptive_Advisors>,
        <https://1145.am/db/694272/Perceptive_Advisors>,
        <https://1145.am/db/837743/Perceptive_Advisors>,
        <https://1145.am/db/847232/Perceptive_Advisors>,
        <https://1145.am/db/884787/Perceptive_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Teralys_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Teralys Capital" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Teralys Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2338059/Teralys_Capital>,
        <https://1145.am/db/2350915/Teralys_Capital>,
        <https://1145.am/db/2357738/Teralys_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Hbm_Healthcare_Investments_Cormorant_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "South San Francisco" ;
    ns1:description "Healthcare Investments" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "Cormorant Asset Management",
        "HBM Healthcare Investments",
        "HBM Healthcare Investments, Cormorant Asset Management" ;
    ns1:investor <https://1145.am/db/2369169/Series_C_Investment_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Iconic_Therapeutics_Osage_University_Partners_Completed> ;
    ns1:name "Cormorant Asset Management",
        "HBM Healthcare Investments",
        "HBM Healthcare Investments, Cormorant Asset Management" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Lundbeckfond_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "Lundbeckfond Ventures" ;
    ns1:investor <https://1145.am/db/2369169/Series_C_Investment_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Iconic_Therapeutics_Osage_University_Partners_Completed> ;
    ns1:name "Lundbeckfond Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296062/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2300680/Lundbeckfond_Ventures>,
        <https://1145.am/db/2301536/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2326981/Lundbeckfond_Ventures>,
        <https://1145.am/db/2336716/Lundbeckfond_Ventures>,
        <https://1145.am/db/2338527/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349048/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349050/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349405/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349406/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352357/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352361/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353098/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353917/Lundbeckfond_Ventures>,
        <https://1145.am/db/2354401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356402/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356411/Lundbeckfond_Ventures>,
        <https://1145.am/db/2359401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362148/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362156/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363947/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363950/Lundbeckfond_Ventures>,
        <https://1145.am/db/2364492/Lundbeckfond_Ventures>,
        <https://1145.am/db/2365826/Lundbeckfond_Ventures>,
        <https://1145.am/db/2366303/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369953/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544138/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544140/Lundbeckfond_Ventures>,
        <https://1145.am/db/2573068/Lundbeckfond_Ventures>,
        <https://1145.am/db/281538/Lundbeckfonden_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Mpm_Capital_Hig_Capital> a org:Organization ;
    ns1:basedInLowRaw "South San Francisco" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "MPM Capital, H.I.G. Capital" ;
    ns1:investor <https://1145.am/db/2369169/Series_C_Investment_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Iconic_Therapeutics_Osage_University_Partners_Completed> ;
    ns1:name "MPM Capital, H.I.G. Capital" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Osage_University_Partners> a org:Organization ;
    ns1:basedInLowRaw "South San Francisco" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "Osage University Partners" ;
    ns1:investor <https://1145.am/db/2369169/Series_C_Investment_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Iconic_Therapeutics_Osage_University_Partners_Completed> ;
    ns1:name "Osage University Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1441781/Osage_University_Partners>,
        <https://1145.am/db/1533327/Osage_University_Partners>,
        <https://1145.am/db/1533685/Osage_University_Partners>,
        <https://1145.am/db/1619110/Osage_University_Partners>,
        <https://1145.am/db/1696377/Osage_University_Partners>,
        <https://1145.am/db/1759759/Osage_University_Partners>,
        <https://1145.am/db/1774684/Osage_University_Partners>,
        <https://1145.am/db/1782234/Osage_University_Partners>,
        <https://1145.am/db/1802088/Osage_University_Partners>,
        <https://1145.am/db/1810714/Osage_University_Partners>,
        <https://1145.am/db/1823287/Osage_University_Partners>,
        <https://1145.am/db/1858399/Osage_University_Partners>,
        <https://1145.am/db/2153910/Osage_University_Partners>,
        <https://1145.am/db/2278799/Osage_University_Partners>,
        <https://1145.am/db/2292287/Osage_University_Partners>,
        <https://1145.am/db/2294753/Osage_University_Partners>,
        <https://1145.am/db/2301464/Osage_University_Partners>,
        <https://1145.am/db/2319360/Osage_University_Partners>,
        <https://1145.am/db/2336032/Osage_University_Partners>,
        <https://1145.am/db/2336221/Osage_University_Partners>,
        <https://1145.am/db/2340284/Osage_University_Partners>,
        <https://1145.am/db/2340888/Osage_University_Partners>,
        <https://1145.am/db/2341896/Osage_University_Partners>,
        <https://1145.am/db/2349691/Osage_University_Partners>,
        <https://1145.am/db/2349838/Osage_University_Partners>,
        <https://1145.am/db/2350044/Osage_University_Partners>,
        <https://1145.am/db/2350199/Osage_University_Partners>,
        <https://1145.am/db/2352349/Osage_University_Partners>,
        <https://1145.am/db/2352350/Osage_University_Partners>,
        <https://1145.am/db/2353771/Osage_University_Partners>,
        <https://1145.am/db/2353789/Osage_University_Partners>,
        <https://1145.am/db/2358430/Osage_University_Partners>,
        <https://1145.am/db/2359404/Osage_University_Partners>,
        <https://1145.am/db/2360521/Osage_University_Partners>,
        <https://1145.am/db/2360526/Osage_University_Partners>,
        <https://1145.am/db/2368351/Osage_University_Partners>,
        <https://1145.am/db/2369165/Osage_University_Partners>,
        <https://1145.am/db/2370626/Osage_University_Partners>,
        <https://1145.am/db/2569831/Osage_University_Partners>,
        <https://1145.am/db/425953/Osage_University_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Ipsen> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Ipsen" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "Ipsen" ;
    ns1:sameAsHigh <https://1145.am/db/2561454/Ipsen> ;
    ns1:sameAsMedium <https://1145.am/db/1161944/Ipsen>,
        <https://1145.am/db/1161957/Ipsen>,
        <https://1145.am/db/1163844/Ipsen_Sa>,
        <https://1145.am/db/1163848/Ipsen>,
        <https://1145.am/db/1163855/Ipsen>,
        <https://1145.am/db/1167451/Ipsen_Sa>,
        <https://1145.am/db/1176544/Ipsen>,
        <https://1145.am/db/1200853/Ipsen_Sa>,
        <https://1145.am/db/1202151/Ipsen_Sa>,
        <https://1145.am/db/1257196/Ipsen_Sa>,
        <https://1145.am/db/1257350/Ipsen_Sa>,
        <https://1145.am/db/1276041/Ipsen>,
        <https://1145.am/db/1626341/Ipsen>,
        <https://1145.am/db/1633106/Ipsen_Sa>,
        <https://1145.am/db/1633169/Ipsen_Sa>,
        <https://1145.am/db/1644477/Ipsen>,
        <https://1145.am/db/1645222/Ipsen>,
        <https://1145.am/db/2152544/Ipsen>,
        <https://1145.am/db/2153682/Ipsen>,
        <https://1145.am/db/2153782/Ipsen>,
        <https://1145.am/db/2153982/Ipsen>,
        <https://1145.am/db/2154368/Ipsen>,
        <https://1145.am/db/2155620/Ipsen>,
        <https://1145.am/db/2288192/Ipsen>,
        <https://1145.am/db/2288500/Ipsen>,
        <https://1145.am/db/2294817/Ipsen>,
        <https://1145.am/db/2295271/Ipsen>,
        <https://1145.am/db/2301863/Ipsen>,
        <https://1145.am/db/2302740/Ipsen>,
        <https://1145.am/db/2302958/Ipsen>,
        <https://1145.am/db/2309378/Ipsen_Sa>,
        <https://1145.am/db/2324027/Ipsen>,
        <https://1145.am/db/2329638/Ipsen>,
        <https://1145.am/db/2332815/Ipsen>,
        <https://1145.am/db/2336604/Ipsen>,
        <https://1145.am/db/2336987/Ipsen>,
        <https://1145.am/db/2337102/Ipsen>,
        <https://1145.am/db/2337689/Ipsen>,
        <https://1145.am/db/2339031/Ipsen>,
        <https://1145.am/db/2343954/Ipsen>,
        <https://1145.am/db/2346204/Ipsen>,
        <https://1145.am/db/2352361/Ipsen>,
        <https://1145.am/db/2354464/Ipsen>,
        <https://1145.am/db/2355419/Ipsen>,
        <https://1145.am/db/2359873/Ipsen>,
        <https://1145.am/db/2360217/Ipsen>,
        <https://1145.am/db/2360232/Ipsen>,
        <https://1145.am/db/2364637/Ipsen>,
        <https://1145.am/db/2367100/Ipsen>,
        <https://1145.am/db/2367129/Ipsen>,
        <https://1145.am/db/2370067/Ipsen>,
        <https://1145.am/db/2371455/Ipsen>,
        <https://1145.am/db/2539925/Ipsen>,
        <https://1145.am/db/2541727/Ipsen>,
        <https://1145.am/db/2544894/Ipsen>,
        <https://1145.am/db/2544901/Ipsen>,
        <https://1145.am/db/2567081/Ipsen>,
        <https://1145.am/db/534524/Ipsen>,
        <https://1145.am/db/538860/Ipsen>,
        <https://1145.am/db/586242/Ipsen>,
        <https://1145.am/db/772473/Ipsen>,
        <https://1145.am/db/773879/Ipsen>,
        <https://1145.am/db/835053/Ipsen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "MPM Capital" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Pfizer_Ventures> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Pfizer Ventures" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "Pfizer Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1156304/Pfizer_Ventures>,
        <https://1145.am/db/2313175/Pfizer_Investments_Netherlands_Bv>,
        <https://1145.am/db/2317455/Pfizer_Strategic_Investments_Group>,
        <https://1145.am/db/2325726/Pfizer_Ventures>,
        <https://1145.am/db/2353326/Pfizer>,
        <https://1145.am/db/2359321/Pfizer_Venture_Investments>,
        <https://1145.am/db/2367549/Pfizer_Venture_Investments> ;
    ns1:sameAsMedium <https://1145.am/db/1334624/Pfizer_Ventures>,
        <https://1145.am/db/2154844/Pfizer_Ventures>,
        <https://1145.am/db/2340888/Pfizer_Ventures>,
        <https://1145.am/db/2341896/Pfizer_Ventures>,
        <https://1145.am/db/2365171/Pfizer_Ventures>,
        <https://1145.am/db/2365184/Pfizer_Ventures>,
        <https://1145.am/db/587045/Pfizer_Ventures>,
        <https://1145.am/db/591613/Pfizer_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Wellington_Management_Company> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Wellington Management Company" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "Wellington Management Company" ;
    ns1:sameAsHigh <https://1145.am/db/1307531/Wellington_Management>,
        <https://1145.am/db/1334895/Wellington_Management>,
        <https://1145.am/db/1467324/Wellington_Management>,
        <https://1145.am/db/1469737/Wellington_Management>,
        <https://1145.am/db/1575153/Wellington_Management>,
        <https://1145.am/db/1680280/Wellington_Partners>,
        <https://1145.am/db/1758975/Wellington_Management_Company>,
        <https://1145.am/db/1760375/Wellington_Management>,
        <https://1145.am/db/1768283/Wellington_Management_Company>,
        <https://1145.am/db/1769965/Wellington_Management_Company>,
        <https://1145.am/db/1821883/Wellington_Partners>,
        <https://1145.am/db/1828037/Wellington_Partners>,
        <https://1145.am/db/1830280/Wellington_Management>,
        <https://1145.am/db/1834220/Wellington_Partners>,
        <https://1145.am/db/1978877/Wellington_Management>,
        <https://1145.am/db/2082068/Wellington_Management>,
        <https://1145.am/db/2190702/Wellington_Management>,
        <https://1145.am/db/2285762/Wellington_Management>,
        <https://1145.am/db/2291277/Wellington_Management_Company_Llp>,
        <https://1145.am/db/301469/Wellington_Management>,
        <https://1145.am/db/441151/Wellington_Management_Company_Llp>,
        <https://1145.am/db/468910/Wellington_Management_And_Coatue_Management>,
        <https://1145.am/db/696617/Wellington_Management>,
        <https://1145.am/db/924334/Wellington_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1151052/Wellington_Management>,
        <https://1145.am/db/132304/Wellington_Management>,
        <https://1145.am/db/1467932/Wellington_Management>,
        <https://1145.am/db/1482048/Wellington_Management>,
        <https://1145.am/db/1556206/Wellington_Management>,
        <https://1145.am/db/1702048/Wellington_Management>,
        <https://1145.am/db/1742254/Wellington_Management_Company>,
        <https://1145.am/db/1751553/Wellington_Management>,
        <https://1145.am/db/1762175/Wellington_Management>,
        <https://1145.am/db/1767835/Wellington_Management_Company>,
        <https://1145.am/db/1770748/Wellington_Management>,
        <https://1145.am/db/1781428/Wellington_Management>,
        <https://1145.am/db/1786253/Wellington_Management>,
        <https://1145.am/db/1802882/Wellington_Management_Company>,
        <https://1145.am/db/1806226/Wellington_Management_Company>,
        <https://1145.am/db/1809858/Wellington_Management>,
        <https://1145.am/db/1839749/Wellington_Management_Company>,
        <https://1145.am/db/1840852/Wellington_Management>,
        <https://1145.am/db/1841784/Wellington_Management_Company>,
        <https://1145.am/db/1848134/Wellington_Management_Company>,
        <https://1145.am/db/187899/Wellington_Management>,
        <https://1145.am/db/2001112/Wellington_Management>,
        <https://1145.am/db/2060433/Wellington_Management>,
        <https://1145.am/db/2063964/Wellington_Management>,
        <https://1145.am/db/2152146/Wellington_Management_Company>,
        <https://1145.am/db/2185229/Wellington_Management_Company>,
        <https://1145.am/db/2188974/Wellington_Management>,
        <https://1145.am/db/220837/Wellington_Management>,
        <https://1145.am/db/2286541/Wellington_Management_Company>,
        <https://1145.am/db/2346063/Wellington_Management_Company>,
        <https://1145.am/db/2346773/Wellington_Management>,
        <https://1145.am/db/2346775/Wellington_Management>,
        <https://1145.am/db/2355029/Wellington_Management>,
        <https://1145.am/db/2360266/Wellington_Management_Company>,
        <https://1145.am/db/273675/Wellington_Management>,
        <https://1145.am/db/429084/Wellington_Management>,
        <https://1145.am/db/474872/Wellington_Management>,
        <https://1145.am/db/531354/Wellington_Management>,
        <https://1145.am/db/532510/Wellington_Management>,
        <https://1145.am/db/687305/Wellington_Management>,
        <https://1145.am/db/699689/Wellington_Management>,
        <https://1145.am/db/701112/Wellington_Management>,
        <https://1145.am/db/847232/Wellington_Management>,
        <https://1145.am/db/924729/Wellington_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369359/Adams_Street_Partners> a org:Organization ;
    ns1:basedInLowRaw "Palo Alto, CA" ;
    ns1:documentDate "2015-08-19T15:13:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Orbus snags $32.5M round for PhIII study; Merck and union leaders in overtime row;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbus-snags-32-5m-round-for-phiii-study-merck-and-union-leaders-overtime-row> ;
    ns1:foundName "Adams Street Partners" ;
    ns1:investor <https://1145.am/db/2369359/A_Investment_Adams_Street_Partners_Bioventures_Longitude_Capital_Orbus_Therapeutics_Completed> ;
    ns1:name "Adams Street Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1151052/Adams_Street_Partners>,
        <https://1145.am/db/1163164/Adams_Street_Partners>,
        <https://1145.am/db/1166225/Adams_Street_Partners>,
        <https://1145.am/db/1248471/Adams_Street_Partners>,
        <https://1145.am/db/1249040/Adams_Street_Partners>,
        <https://1145.am/db/1351661/Adams_Street_Partners>,
        <https://1145.am/db/1352625/Adams_Street_Partners>,
        <https://1145.am/db/1352945/Adams_Street_Partners>,
        <https://1145.am/db/1354185/Adams_Street_Partners>,
        <https://1145.am/db/1369238/Adams_Street_Partners>,
        <https://1145.am/db/1369876/Adams_Street_Partners>,
        <https://1145.am/db/1395257/Adams_Street_Partners>,
        <https://1145.am/db/1480201/Adams_Street_Partners>,
        <https://1145.am/db/1528582/Adams_Street_Partners>,
        <https://1145.am/db/1747870/Adams_Street_Partners>,
        <https://1145.am/db/1749294/Adams_Street_Partners>,
        <https://1145.am/db/1755127/Adams_Street_Partners>,
        <https://1145.am/db/1796380/Adams_Street_Partners>,
        <https://1145.am/db/1823041/Adams_Street_Partners>,
        <https://1145.am/db/1843607/Adams_Street_Partners>,
        <https://1145.am/db/1844474/Adams_Street_Partners>,
        <https://1145.am/db/1845463/Adams_Street_Partners>,
        <https://1145.am/db/1846040/Adams_Street_Partners>,
        <https://1145.am/db/1847894/Adams_Street_Partners>,
        <https://1145.am/db/1864601/Adams_Street_Partners>,
        <https://1145.am/db/1880209/Adams_Street_Partners>,
        <https://1145.am/db/1886915/Adams_Street_Partners>,
        <https://1145.am/db/1902164/Adams_Street_Partners>,
        <https://1145.am/db/1932511/Adams_Street_Partners>,
        <https://1145.am/db/2257512/Adams_Street_Partners>,
        <https://1145.am/db/2294721/Adams_Street_Partners>,
        <https://1145.am/db/2308828/Adams_Street_Partners>,
        <https://1145.am/db/2308841/Adams_Street_Partners>,
        <https://1145.am/db/2329550/Adams_Street_Partners>,
        <https://1145.am/db/2331820/Adams_Street_Partners>,
        <https://1145.am/db/2335743/Adams_Street_Partners>,
        <https://1145.am/db/2337166/Adams_Street_Partners>,
        <https://1145.am/db/2341068/Adams_Street_Partners>,
        <https://1145.am/db/2341074/Adams_Street_Partners>,
        <https://1145.am/db/2357487/Adams_Street_Partners>,
        <https://1145.am/db/2366519/Adams_Street_Partners>,
        <https://1145.am/db/2370694/Adams_Street_Partners>,
        <https://1145.am/db/396100/Adams_Street_Partners>,
        <https://1145.am/db/731028/Adams_Street_Partners>,
        <https://1145.am/db/936906/Adams_Street_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369359/Bioventures> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto, CA" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-08-19T15:13:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Orbus snags $32.5M round for PhIII study; Merck and union leaders in overtime row;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbus-snags-32-5m-round-for-phiii-study-merck-and-union-leaders-overtime-row> ;
    ns1:foundName "BioVentures" ;
    ns1:investor <https://1145.am/db/2369359/A_Investment_Adams_Street_Partners_Bioventures_Longitude_Capital_Orbus_Therapeutics_Completed> ;
    ns1:name "BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/1006794/Elevate_Ventures>,
        <https://1145.am/db/1117048/Studio_Vc>,
        <https://1145.am/db/1140521/Elevation_Capital>,
        <https://1145.am/db/1213119/Fin_Capital>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1219982/Thirty_Five_Ventures>,
        <https://1145.am/db/1230379/Advantage_Capital>,
        <https://1145.am/db/1307987/Venture_Highway>,
        <https://1145.am/db/1352420/Necessary_Ventures>,
        <https://1145.am/db/1504977/Advantage_Capital>,
        <https://1145.am/db/1668144/Applied_Ventures>,
        <https://1145.am/db/1688359/Necessary_Ventures>,
        <https://1145.am/db/1698464/Cathay_Innovation>,
        <https://1145.am/db/1702554/Main_Sequence_Ventures>,
        <https://1145.am/db/1719362/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1724979/Institutional_Venture_Partners>,
        <https://1145.am/db/1730174/Incubic_Venture_Capital>,
        <https://1145.am/db/1741725/Discovery_Ventures>,
        <https://1145.am/db/1746456/Active_Capital>,
        <https://1145.am/db/1747943/Firstround_Capital>,
        <https://1145.am/db/1749347/Main_Sequence_Ventures>,
        <https://1145.am/db/1752158/Hbcuvc>,
        <https://1145.am/db/1753744/Elevate_Ventures>,
        <https://1145.am/db/1754080/Cathay_Innovation>,
        <https://1145.am/db/1754580/Elevation_Capital>,
        <https://1145.am/db/1754765/Inventure>,
        <https://1145.am/db/1755479/Seed_Capital>,
        <https://1145.am/db/1760794/Appworks>,
        <https://1145.am/db/1761999/Access_Technology_Ventures>,
        <https://1145.am/db/1764278/Okta_Ventures>,
        <https://1145.am/db/1768909/Venture_Highway>,
        <https://1145.am/db/1769525/Seed_Capital>,
        <https://1145.am/db/1800466/Inventure>,
        <https://1145.am/db/1806610/Institutional_Venture_Partners>,
        <https://1145.am/db/1806644/Institutional_Venture_Partners>,
        <https://1145.am/db/1808735/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1809854/Institutional_Venture_Partners>,
        <https://1145.am/db/1810769/Institutional_Venture_Partners>,
        <https://1145.am/db/1811872/Seedcamp>,
        <https://1145.am/db/1821378/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1823230/Innovative_Venture_Fund_Investment>,
        <https://1145.am/db/1825866/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1826126/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1828008/Institutional_Venture_Partners>,
        <https://1145.am/db/1830014/Institutional_Venture_Partners>,
        <https://1145.am/db/1831764/Institutional_Venture_Partners>,
        <https://1145.am/db/1836984/Launch_Capital>,
        <https://1145.am/db/1844931/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1845205/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1849969/Institutional_Venture_Partners>,
        <https://1145.am/db/1849969/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1854098/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860406/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1860644/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1868593/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1870791/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1872971/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1891856/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Institutional_Venture_Partners>,
        <https://1145.am/db/1892105/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/1896364/Launch_Capital>,
        <https://1145.am/db/1907771/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/1911076/Ata_Ventures>,
        <https://1145.am/db/1932453/Framework_Ventures>,
        <https://1145.am/db/2144387/New_Age_Ventures>,
        <https://1145.am/db/2230414/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/229368/Essence_Ventures>,
        <https://1145.am/db/2305256/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2310485/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2312700/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2313567/Kleiner_Perkins_Caufield_And_Byers>,
        <https://1145.am/db/2326444/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2332010/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2339214/Adage_Capital>,
        <https://1145.am/db/2341487/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2347571/Amunix>,
        <https://1145.am/db/2348618/Amunix>,
        <https://1145.am/db/2355531/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2359987/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2364492/Bioventures>,
        <https://1145.am/db/244100/Creative_Ventures>,
        <https://1145.am/db/2629526/Kleiner_Perkins_Caufield___Byers>,
        <https://1145.am/db/2656715/Institutional_Venture_Partners>,
        <https://1145.am/db/319155/Emergent_Ventures>,
        <https://1145.am/db/430525/Acapital>,
        <https://1145.am/db/449505/Elevate_Ventures>,
        <https://1145.am/db/491609/Emergent_Ventures>,
        <https://1145.am/db/517818/Cathay_Innovation>,
        <https://1145.am/db/626399/Embedded_Ventures>,
        <https://1145.am/db/674609/Main_Sequence_Ventures>,
        <https://1145.am/db/678162/Main_Sequence_Ventures>,
        <https://1145.am/db/696051/Framework_Ventures>,
        <https://1145.am/db/697473/Framework_Ventures>,
        <https://1145.am/db/718563/Creative_Ventures>,
        <https://1145.am/db/724376/Ten_Innovate>,
        <https://1145.am/db/730448/Seed_Capital>,
        <https://1145.am/db/734449/Evolve_Ventures>,
        <https://1145.am/db/751176/Core_Innovationcapital>,
        <https://1145.am/db/768154/Compound_Ventures>,
        <https://1145.am/db/830571/Okta_Ventures>,
        <https://1145.am/db/889658/Propel_Venture>,
        <https://1145.am/db/890529/Embedded_Ventures>,
        <https://1145.am/db/891145/Advantage_Capital>,
        <https://1145.am/db/937210/Cathay_Innovation>,
        <https://1145.am/db/971415/Firstround_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/175048/Bioventures_Gmbh>,
        <https://1145.am/db/2359510/Bioventures_Llc>,
        <https://1145.am/db/2359512/Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369359/Longitude_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto, CA" ;
    ns1:documentDate "2015-08-19T15:13:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Orbus snags $32.5M round for PhIII study; Merck and union leaders in overtime row;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbus-snags-32-5m-round-for-phiii-study-merck-and-union-leaders-overtime-row> ;
    ns1:foundName "Longitude Capital, H.I.G",
        "Longitude Capital, H.I.G." ;
    ns1:investor <https://1145.am/db/2369359/A_Investment_Adams_Street_Partners_Bioventures_Longitude_Capital_Orbus_Therapeutics_Completed> ;
    ns1:name "Longitude Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1467975/Longitude_Capital>,
        <https://1145.am/db/1482048/Longitude_Capital>,
        <https://1145.am/db/1503165/Longitude_Capital>,
        <https://1145.am/db/1519688/Longitude_Capital>,
        <https://1145.am/db/1520070/Longitude_Capital>,
        <https://1145.am/db/2075754/Longitude_Capital>,
        <https://1145.am/db/2152399/Longitude_Capital>,
        <https://1145.am/db/2155668/Longitude_Capital>,
        <https://1145.am/db/2182698/Longitude_Capital>,
        <https://1145.am/db/2198647/Longitude_Capital>,
        <https://1145.am/db/2288251/Longitude_Capital>,
        <https://1145.am/db/2290453/Longitude_Capital>,
        <https://1145.am/db/2297930/Longitude_Capital>,
        <https://1145.am/db/2298634/Longitude_Capital>,
        <https://1145.am/db/2300708/Longitude_Capital>,
        <https://1145.am/db/2330799/Longitude_Capital>,
        <https://1145.am/db/2337591/Longitude_Capital>,
        <https://1145.am/db/2338428/Longitude_Capital>,
        <https://1145.am/db/2339214/Longitude_Capital>,
        <https://1145.am/db/2339223/Longitude_Capital>,
        <https://1145.am/db/2340204/Longitude_Capital>,
        <https://1145.am/db/2340207/Longitude_Capital>,
        <https://1145.am/db/2351129/Longitude_Capital>,
        <https://1145.am/db/2352167/Longitude_Capital>,
        <https://1145.am/db/2352170/Longitude_Capital>,
        <https://1145.am/db/2365501/Longitude_Capital>,
        <https://1145.am/db/2366753/Longitude_Capital>,
        <https://1145.am/db/2368232/Longitude_Capital>,
        <https://1145.am/db/2564563/Longitude_Capital>,
        <https://1145.am/db/2583466/Longitude_Capital>,
        <https://1145.am/db/955355/Longitude_Capital>,
        <https://1145.am/db/958767/Longitude_Capital>,
        <https://1145.am/db/959519/Longitude_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369363/Celsus> a org:Organization ;
    ns1:buyer <https://1145.am/db/2369363/Akari_Therapeutics_Acquisition>,
        <https://1145.am/db/2369363/Volution_Acquisition> ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-08-19T14:56:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reborn Akari grabs $75M in financing for another Soliris rival" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/reborn-akari-grabs-75m-financing-for-another-soliris-rival> ;
    ns1:foundName "Celsus" ;
    ns1:industry "biotech" ;
    ns1:name "Celsus" ;
    ns1:sameAsHigh <https://1145.am/db/2153042/Cerevance>,
        <https://1145.am/db/2153124/Cerevance>,
        <https://1145.am/db/2153811/Cerevel>,
        <https://1145.am/db/2280232/Shouti>,
        <https://1145.am/db/2336263/Cerebain_Biotech>,
        <https://1145.am/db/2364438/Ulis>,
        <https://1145.am/db/2580671/Themis_Bioscience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369411/Investment_Ucl_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-20T16:44:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "UCL is today launching the UCL Technology Fund to invest 50 million in commercialising its world-leading research emerging over the next five years." ;
    ns1:documentTitle "UCL launches 50 million technology investment fund" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ucl-launches-%C2%A350-million-technology-investment-fund> ;
    ns1:foundName "invest",
        "launching" ;
    ns1:name "invest",
        "launching" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2369411/Ucl> ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2369419/Investment_Wellcome_Trust_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-21T14:43:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Mucosis snagged 3.7 million ($ 4.0 million) from the Wellcome Trust to finance a Phase I trial of its intranasal respiratory syncytial virus (RSV) vaccine, SynGEM." ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/eurobiotech-more-articles-of-note-10> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2369419/Mucosis>,
        <https://1145.am/db/2369419/Syngem>,
        <https://1145.am/db/2369419/Wellcome_Trust> ;
    ns1:targetName "SynGEM" ;
    ns1:valueRaw "$ 4.0 million",
        "3.7 million" ;
    ns1:whereGeoName "Europe",
        "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf>,
        <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe",
        "London" .

<https://1145.am/db/2369548/Novartis_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment> ;
    ns1:description "financing" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369548/Pontifax> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment> ;
    ns1:description "financing" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "Pontifax" ;
    ns1:name "Pontifax" ;
    ns1:sameAsHigh <https://1145.am/db/146274/Pontifax> ;
    ns1:sameAsMedium <https://1145.am/db/2089412/Pontifax>,
        <https://1145.am/db/2288761/Pontifax>,
        <https://1145.am/db/2293867/Pontifax>,
        <https://1145.am/db/2297507/Pontifax>,
        <https://1145.am/db/2297644/Pontifax>,
        <https://1145.am/db/2334481/Pontifax>,
        <https://1145.am/db/725571/Pontifax> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369549/Alaska_Permanent_Fund> a org:Organization ;
    ns1:basedInLowRaw "Alaska" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "Alaska Permanent Fund",
        "the Alaska Permanent Fund" ;
    ns1:investor <https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> ;
    ns1:name "Alaska Permanent Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1392816/Alaska_Permanent_Fund_Corp>,
        <https://1145.am/db/1740798/Alaska_Permanent_Fund_Corp>,
        <https://1145.am/db/2282072/Alaska_Permanent_Fund_Corporation>,
        <https://1145.am/db/2335773/Alaska_Permanent_Fund>,
        <https://1145.am/db/2356027/Alaska_Permanent_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Foresite_Capital_Sectoral_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "Mutual fund and healthcare investors",
        "healthcare investors" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Foresite Capital",
        "Foresite Capital, Sectoral Asset Management",
        "Sectoral Asset Management" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "Foresite Capital",
        "Foresite Capital, Sectoral Asset Management",
        "Sectoral Asset Management" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Janus_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "mutual fund and healthcare investors" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Janus Capital Management" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "Janus Capital Management" ;
    ns1:sameAsHigh <https://1145.am/db/1608803/Janus_Henderson_Investors> ;
    ns1:sameAsMedium <https://1145.am/db/1840793/Janus_Capital_Group>,
        <https://1145.am/db/2296562/Janus_Capital_Management>,
        <https://1145.am/db/2307845/Janus_Capital_Group>,
        <https://1145.am/db/2307846/Janus_Capital_Group>,
        <https://1145.am/db/2335743/Janus_Capital_Management_Llc>,
        <https://1145.am/db/2345047/Janus_Capital_Management>,
        <https://1145.am/db/2355023/Janus_Capital_Management_Llc>,
        <https://1145.am/db/2569522/Janus_Capital_Management_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Orbimed_Healthcare_Fund_Management> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "OrbiMed HealthCare Fund Management" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "OrbiMed HealthCare Fund Management" ;
    ns1:sameAsMedium <https://1145.am/db/2349628/Orbimed_Healthcare_Fund_Management>,
        <https://1145.am/db/2370094/Orbimed_Healthcare_Fund_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369962/Oberland_Capital_Management_Llc> a org:Organization ;
    ns1:basedInLowRaw "Mass",
        "United States" ;
    ns1:description "Business" ;
    ns1:documentDate "2015-09-09T11:02:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Agenus Inc. Completes $115 Million Non-Dilutive Royalty Transaction with Oberland Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agenus-inc-completes-115-million-non-dilutive-royalty-transaction-oberland-capital> ;
    ns1:foundName "Oberland Capital",
        "Oberland Capital Management, LLC" ;
    ns1:investor <https://1145.am/db/2369962/Note_Purchase_Investment_Agenus_Inc_Oberland_Capital_Management_Llc_Completed> ;
    ns1:name "Oberland Capital",
        "Oberland Capital Management, LLC" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/LRM> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "finance" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "LRM" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "LRM" ;
    ns1:sameAsHigh <https://1145.am/db/1138548/Finout>,
        <https://1145.am/db/1140110/Finout>,
        <https://1145.am/db/1265804/Q4_Inc>,
        <https://1145.am/db/1315596/Jan3>,
        <https://1145.am/db/1606288/Creatd>,
        <https://1145.am/db/2287840/J___j>,
        <https://1145.am/db/2670604/Bt>,
        <https://1145.am/db/548888/Ws>,
        <https://1145.am/db/951631/Comed> ;
    ns1:sameAsMedium <https://1145.am/db/1060208/LRM>,
        <https://1145.am/db/2293248/LRM>,
        <https://1145.am/db/2336923/LRM>,
        <https://1145.am/db/2336927/LRM>,
        <https://1145.am/db/2346397/LRM>,
        <https://1145.am/db/2350031/LRM>,
        <https://1145.am/db/2370786/LRM> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/PMV> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "life sciences" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "PMV" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "PMV" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/PMV>,
        <https://1145.am/db/2339425/PMV>,
        <https://1145.am/db/2346397/PMV>,
        <https://1145.am/db/2370764/PMV> ;
    ns1:sameAsMedium <https://1145.am/db/1297146/PMV>,
        <https://1145.am/db/1545620/PMV>,
        <https://1145.am/db/1546297/PMV>,
        <https://1145.am/db/1549508/PMV>,
        <https://1145.am/db/2301464/PMV>,
        <https://1145.am/db/2356419/PMV>,
        <https://1145.am/db/2370786/PMV>,
        <https://1145.am/db/938290/PMV> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Sofinnova> a org:Organization ;
    ns1:basedInLowRaw "Russia" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Sofinnova" ;
    ns1:investor <https://1145.am/db/2370680/Investment_Asceneurons_Alzheimers_R___D_Sofinnova_Has_Not_Happened> ;
    ns1:name "Sofinnova" ;
    ns1:sameAsMedium <https://1145.am/db/1059848/Sofinnova>,
        <https://1145.am/db/1862390/Sofinnova>,
        <https://1145.am/db/1881434/Sofinnova>,
        <https://1145.am/db/1890664/Sofinnova>,
        <https://1145.am/db/2292168/Sofinnova>,
        <https://1145.am/db/2294127/Sofinnova>,
        <https://1145.am/db/2368973/Sofinnova>,
        <https://1145.am/db/704198/Sofinnova> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Vesalius_Biocapital> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "autoimmune biotech" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Vesalius Biocapital" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "Vesalius Biocapital" ;
    ns1:sameAsMedium <https://1145.am/db/2152317/Vesalius_Biocapital>,
        <https://1145.am/db/2310041/Vesalius_Biocapital>,
        <https://1145.am/db/2336923/Vesalius_Biocapital>,
        <https://1145.am/db/2336927/Vesalius_Biocapital>,
        <https://1145.am/db/2346397/Vesalius_Biocapital>,
        <https://1145.am/db/2370786/Vesalius_Biocapital>,
        <https://1145.am/db/2790236/Vesalius_Biocapital>,
        <https://1145.am/db/831774/Vesalius_Biocapital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Wales_Life_Sciences_Fund> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "life sciences" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Wales Life Sciences Fund" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "Wales Life Sciences Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2370786/Wales_Life_Sciences_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Wyvern> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "finance" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Wyvern" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "Wyvern" ;
    ns1:sameAsMedium <https://1145.am/db/1463603/Wyvern>,
        <https://1145.am/db/1764852/Wyvern>,
        <https://1145.am/db/2370786/Wyvern>,
        <https://1145.am/db/763083/Wyvern> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Chiesi_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Chiesi Ventures" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Chiesi Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289884/Chiesi_Ventures>,
        <https://1145.am/db/2337659/Chiesi_Ventures>,
        <https://1145.am/db/2337664/Chiesi_Ventures>,
        <https://1145.am/db/281538/Chiesi_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Healthequity> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "HealthEquity" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "HealthEquity" ;
    ns1:sameAsMedium <https://1145.am/db/1026779/Healthequity>,
        <https://1145.am/db/1313487/Healthequity>,
        <https://1145.am/db/508095/Healthequity>,
        <https://1145.am/db/524268/Healthequity> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Idinvest_Partners> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Idinvest Partners" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Idinvest Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1736066/Idinvest_Partners>,
        <https://1145.am/db/1738123/Idinvest_Partners>,
        <https://1145.am/db/1740498/Idinvest_Partners>,
        <https://1145.am/db/1750172/Idinvest_Partners>,
        <https://1145.am/db/1755422/Idinvest_Partners>,
        <https://1145.am/db/1757815/Idinvest_Partners>,
        <https://1145.am/db/1769445/Idinvest_Partners>,
        <https://1145.am/db/1772963/Idinvest_Partners>,
        <https://1145.am/db/1773328/Idinvest_Partners>,
        <https://1145.am/db/1776250/Idinvest_Partners>,
        <https://1145.am/db/1787342/Idinvest_Partners>,
        <https://1145.am/db/1790627/Idinvest_Partners>,
        <https://1145.am/db/1793731/Idinvest_Partners>,
        <https://1145.am/db/1793936/Idinvest_Partners>,
        <https://1145.am/db/1811087/Idinvest_Partners>,
        <https://1145.am/db/1813827/Idinvest_Partners>,
        <https://1145.am/db/1819930/Idinvest_Partners>,
        <https://1145.am/db/1828275/Idinvest_Partners>,
        <https://1145.am/db/1832549/Idinvest_Partners>,
        <https://1145.am/db/1833939/Idinvest_Partners>,
        <https://1145.am/db/1851854/Idinvest_Partners>,
        <https://1145.am/db/1869732/Idinvest_Partners>,
        <https://1145.am/db/1913303/Idinvest_Partners>,
        <https://1145.am/db/2154431/Idinvest_Partners>,
        <https://1145.am/db/2154909/Idinvest_Partners>,
        <https://1145.am/db/2293867/Idinvest_Partners>,
        <https://1145.am/db/2348506/Idinvest_Partners>,
        <https://1145.am/db/2348523/Idinvest_Partners>,
        <https://1145.am/db/2351191/Idinvest_Partners>,
        <https://1145.am/db/2351192/Idinvest_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Kurma_Partners> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Kurma Partners" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Kurma Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1173939/Kurma_Partners>,
        <https://1145.am/db/1185895/Kurma_Partners>,
        <https://1145.am/db/1187596/Kurma_Partners>,
        <https://1145.am/db/1933419/Kurma_Partners>,
        <https://1145.am/db/2135197/Kurma_Partners>,
        <https://1145.am/db/2154909/Kurma_Partners>,
        <https://1145.am/db/2293867/Kurma_Partners>,
        <https://1145.am/db/571769/Kurma_Partners>,
        <https://1145.am/db/641046/Kurma_Partners>,
        <https://1145.am/db/645428/Kurma_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Roche_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Roche Venture Fund" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Roche Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2299180/Roche_($_Rhhby)_Venture_Fund>,
        <https://1145.am/db/2302731/Roche_Venture_Fund>,
        <https://1145.am/db/2306549/Roche_Venture_Fund>,
        <https://1145.am/db/2313985/Roche_Venture_Fund>,
        <https://1145.am/db/2317779/Roche_Venture_Fund>,
        <https://1145.am/db/2326222/Roche_Venture_Fund>,
        <https://1145.am/db/2327441/Roche_Venture_Fund>,
        <https://1145.am/db/2327442/Roche_Venture_Fund>,
        <https://1145.am/db/2330668/Roche_Venture_Fund>,
        <https://1145.am/db/2336328/Roche_Venture_Fund>,
        <https://1145.am/db/2336333/Roche_Venture_Fund>,
        <https://1145.am/db/2336335/Roche_Venture_Fund>,
        <https://1145.am/db/2337958/Roche_Venture_Fund>,
        <https://1145.am/db/2337974/Roche_Venture_Fund>,
        <https://1145.am/db/2343301/Roche_Venture_Fund>,
        <https://1145.am/db/2346534/Roche_Venture_Fund>,
        <https://1145.am/db/2349143/Roche_Venture_Fund>,
        <https://1145.am/db/2352203/Roche_Venture_Fund>,
        <https://1145.am/db/2352204/Roche_Venture_Fund>,
        <https://1145.am/db/2352216/Roche_Venture_Fund>,
        <https://1145.am/db/2352436/Roche_Venture_Fund>,
        <https://1145.am/db/2352442/Roche_Venture_Fund>,
        <https://1145.am/db/2355043/Roche_Venture_Fund>,
        <https://1145.am/db/2358496/Roche_Venture_Fund>,
        <https://1145.am/db/2358502/Roche_Venture_Fund>,
        <https://1145.am/db/2362533/Roche_Venture_Fund>,
        <https://1145.am/db/2362715/Roche_Venture_Fund>,
        <https://1145.am/db/2363396/Roche_Venture_Fund>,
        <https://1145.am/db/2364249/Roche_Venture_Fund>,
        <https://1145.am/db/2364255/Roche_Venture_Fund>,
        <https://1145.am/db/2364283/Roche_Venture_Fund>,
        <https://1145.am/db/2365748/Roche_Venture_Fund>,
        <https://1145.am/db/2367549/Roche_Venture_Fund>,
        <https://1145.am/db/2370694/Roche_Venture_Fund>,
        <https://1145.am/db/829447/Roche_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371188/The_Big_Pharma> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-10-15T10:08:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gamida Cell pockets $5M from Novartis ahead of mooted financing round" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/gamida-cell-pockets-5m-from-novartis-ahead-of-mooted-financing-round> ;
    ns1:foundName "The Big Pharma" ;
    ns1:investor <https://1145.am/db/2371188/Stake_Investment_Gamida_Cell_The_Big_Pharma_Completed> ;
    ns1:name "The Big Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/2153796/The_Big_Pharma>,
        <https://1145.am/db/2155711/The_Big_Pharma>,
        <https://1145.am/db/2280925/The_Big_Pharma>,
        <https://1145.am/db/2281130/The_Big_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2152045/Big_Pharma>,
        <https://1145.am/db/2153099/The_Big_Pharma>,
        <https://1145.am/db/2155713/The_Big_Pharma>,
        <https://1145.am/db/2279108/Big_Pharmas>,
        <https://1145.am/db/2279221/Big_Pharma>,
        <https://1145.am/db/2279371/Big_Pharma>,
        <https://1145.am/db/2279498/The_Big_Pharma>,
        <https://1145.am/db/2283171/Big_Pharma>,
        <https://1145.am/db/2283795/The_Big_Pharma>,
        <https://1145.am/db/2283867/Big_Pharma>,
        <https://1145.am/db/2284393/The_Big_Pharma>,
        <https://1145.am/db/2284454/The_Big_Pharma>,
        <https://1145.am/db/2299941/The_Big_Pharma>,
        <https://1145.am/db/2340793/Big_Pharma>,
        <https://1145.am/db/2362893/Big_Pharma>,
        <https://1145.am/db/2548034/Big_Pharma>,
        <https://1145.am/db/2550837/Big_Pharma>,
        <https://1145.am/db/2588468/Big_Pharma>,
        <https://1145.am/db/2800359/Big_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371301/Nantworks> a org:Organization ;
    ns1:basedInLowRaw "Dallas" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "NantWorks" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2371301/Precision_Biologics_Interest_Investment> ;
    ns1:name "NantWorks" ;
    ns1:sameAsHigh <https://1145.am/db/2336825/Nanthealth>,
        <https://1145.am/db/2354367/Nantworks>,
        <https://1145.am/db/2369538/Nantcell>,
        <https://1145.am/db/2370170/Nantcell>,
        <https://1145.am/db/2584573/Nantworks> ;
    ns1:sameAsMedium <https://1145.am/db/2297585/Nantworks>,
        <https://1145.am/db/2353343/Nantworks>,
        <https://1145.am/db/2584574/Nantworks>,
        <https://1145.am/db/2590887/Nantworks> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371301/Soon-Shiong> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2371301/Assets_Acquisition_Amgen_Soon-Shiong_Completed>,
        <https://1145.am/db/2371301/Conkwest_Assets_Acquisition> ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "Soon-Shiong" ;
    ns1:name "Soon-Shiong" ;
    ns1:sameAsMedium <https://1145.am/db/2277899/Soon-Shiong>,
        <https://1145.am/db/2315122/Soon-Shiong>,
        <https://1145.am/db/2367918/Soon-Shiong>,
        <https://1145.am/db/2368721/Soon-Shiong> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371333/Alzheimers_Research_Uk> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "LONDON" ;
    ns1:documentDate "2015-10-21T15:40:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Launch of Dementia Discovery Fund - New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/launch-of-dementia-discovery-fund-new-fund-raises-100-million-to-deliver-novel-approaches> ;
    ns1:foundName "Alzheimer's Research UK" ;
    ns1:investor <https://1145.am/db/2371333/Investment_Alzheimers_Research_Uk_Takeda_The_Dementia_Discovery_Fund_Uk_Governments_Department_Of_Health_Completed> ;
    ns1:name "Alzheimer's Research UK" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371333/Takeda> a org:Organization ;
    ns1:basedInLowRaw "Japan" ;
    ns1:description "pharmaceutical companies" ;
    ns1:documentDate "2015-10-21T15:40:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Launch of Dementia Discovery Fund - New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/launch-of-dementia-discovery-fund-new-fund-raises-100-million-to-deliver-novel-approaches> ;
    ns1:foundName "Takeda" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2371333/Investment_Alzheimers_Research_Uk_Takeda_The_Dementia_Discovery_Fund_Uk_Governments_Department_Of_Health_Completed> ;
    ns1:name "Takeda" ;
    ns1:sameAsHigh <https://1145.am/db/106729/Takeda_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/107857/Takeda_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/1150157/Takeda>,
        <https://1145.am/db/1151492/Takeda>,
        <https://1145.am/db/142937/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/1574488/Takeda>,
        <https://1145.am/db/1574492/Takeda>,
        <https://1145.am/db/1575638/Takeda_Pharmaceutical>,
        <https://1145.am/db/1668664/Takeda>,
        <https://1145.am/db/1668666/Takeda>,
        <https://1145.am/db/180188/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/1975094/Takeda_Pharmaceutical_Company>,
        <https://1145.am/db/1988943/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/215095/Takeda>,
        <https://1145.am/db/2153840/Takeda>,
        <https://1145.am/db/2155490/Takeda>,
        <https://1145.am/db/216525/Takeda>,
        <https://1145.am/db/217464/Takeda_Pharmaceutical_Co>,
        <https://1145.am/db/2197540/Takeda>,
        <https://1145.am/db/2198945/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2218929/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2278972/Takeda>,
        <https://1145.am/db/2279007/Takeda>,
        <https://1145.am/db/2279093/Takeda>,
        <https://1145.am/db/2280026/Takeda>,
        <https://1145.am/db/2283833/Takeda>,
        <https://1145.am/db/2288188/Takeda>,
        <https://1145.am/db/2292839/Takeda>,
        <https://1145.am/db/2296208/Takeda>,
        <https://1145.am/db/2296243/Takeda>,
        <https://1145.am/db/2301452/Takeda>,
        <https://1145.am/db/2302901/Takeda_Pharmaceutical>,
        <https://1145.am/db/2306582/Takeda>,
        <https://1145.am/db/2306598/Takeda_Pharmaceutical>,
        <https://1145.am/db/2308468/Takeda_Canada>,
        <https://1145.am/db/2309473/Takeda_Canada>,
        <https://1145.am/db/2309473/Takeda_Pharmaceutical>,
        <https://1145.am/db/2310517/Takeda>,
        <https://1145.am/db/2311296/Takeda>,
        <https://1145.am/db/2312787/Takeda>,
        <https://1145.am/db/2321910/Takeda>,
        <https://1145.am/db/2321912/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2321912/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2322135/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2322153/Takeda>,
        <https://1145.am/db/2322954/Takeda_Pharmaceuticals_North_America>,
        <https://1145.am/db/2323181/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2326403/Takeda>,
        <https://1145.am/db/2329621/Takeda>,
        <https://1145.am/db/2330973/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2336287/Takeda_Pharmaceutical>,
        <https://1145.am/db/2336541/Takeda>,
        <https://1145.am/db/2340683/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2342077/Takeda>,
        <https://1145.am/db/2344150/Takeda>,
        <https://1145.am/db/2344177/Takeda>,
        <https://1145.am/db/2344308/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2346017/Takeda>,
        <https://1145.am/db/2346025/Takeda_America_Holdings>,
        <https://1145.am/db/2350521/Takeda_America_Holdings>,
        <https://1145.am/db/2350531/Takeda_America_Holdings>,
        <https://1145.am/db/2350536/Takeda_America_Holdings>,
        <https://1145.am/db/2350537/Takeda_Pharmaceutical>,
        <https://1145.am/db/2352975/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2352987/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2354708/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2355270/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2355270/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2355271/Takeda>,
        <https://1145.am/db/2355308/Takeda>,
        <https://1145.am/db/2360132/Takeda>,
        <https://1145.am/db/2366698/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2369446/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2370761/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2536497/Takeda_Pharmaceuticals_International>,
        <https://1145.am/db/2536510/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2540077/Takeda>,
        <https://1145.am/db/2543228/Takeda>,
        <https://1145.am/db/2544087/Takeda_Ventures>,
        <https://1145.am/db/2544223/Takeda>,
        <https://1145.am/db/2544726/Takeda>,
        <https://1145.am/db/2544912/Takeda>,
        <https://1145.am/db/2546262/Takeda>,
        <https://1145.am/db/2546291/Takeda>,
        <https://1145.am/db/2546489/Takeda_Pharmaceutical>,
        <https://1145.am/db/2546495/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2547136/Takeda_Pharmaceutical>,
        <https://1145.am/db/2547277/Takeda>,
        <https://1145.am/db/2547420/Takeda_Pharmaceutical_Company>,
        <https://1145.am/db/2547508/Takeda_Pharmaceutical>,
        <https://1145.am/db/2547983/Takeda>,
        <https://1145.am/db/2548859/Takeda>,
        <https://1145.am/db/2548920/Takeda>,
        <https://1145.am/db/2548979/Takeda>,
        <https://1145.am/db/2549989/Takeda>,
        <https://1145.am/db/2550985/Takeda>,
        <https://1145.am/db/2551003/Takeda>,
        <https://1145.am/db/2551019/Takeda>,
        <https://1145.am/db/2551052/Takeda>,
        <https://1145.am/db/2551329/Takeda>,
        <https://1145.am/db/2551601/Takeda_Pharmaceutical>,
        <https://1145.am/db/2551607/Takeda_Pharmaceutical>,
        <https://1145.am/db/2551805/Takeda>,
        <https://1145.am/db/2552455/Takeda>,
        <https://1145.am/db/2552653/Takeda_Pharmaceuticals_Usa>,
        <https://1145.am/db/2552662/Takeda_Pharmaceuticals_Usa_Inc>,
        <https://1145.am/db/2552794/Takeda>,
        <https://1145.am/db/2553276/Takeda_Pharmaceutical>,
        <https://1145.am/db/2553676/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2556816/Takeda>,
        <https://1145.am/db/2558648/Takeda>,
        <https://1145.am/db/2558927/Takeda>,
        <https://1145.am/db/2560469/Takeda>,
        <https://1145.am/db/2560737/Takeda_Pharmaceutical>,
        <https://1145.am/db/2561541/Takeda>,
        <https://1145.am/db/2562500/Takeda_Pharmaceutical>,
        <https://1145.am/db/2563175/Takeda>,
        <https://1145.am/db/2563623/Takeda>,
        <https://1145.am/db/2564191/Takeda>,
        <https://1145.am/db/2564200/Takeda>,
        <https://1145.am/db/2564268/Takeda>,
        <https://1145.am/db/2564427/Takeda_Pharmaceutical>,
        <https://1145.am/db/2564462/Takeda>,
        <https://1145.am/db/2564899/Takeda>,
        <https://1145.am/db/2566092/Takeda>,
        <https://1145.am/db/2566361/Takeda>,
        <https://1145.am/db/2566716/Takeda>,
        <https://1145.am/db/2566950/Takeda>,
        <https://1145.am/db/2568923/Takeda_Gmbh>,
        <https://1145.am/db/2568923/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2568927/Takeda>,
        <https://1145.am/db/2569709/Takeda>,
        <https://1145.am/db/2570052/Takeda>,
        <https://1145.am/db/2571277/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2573391/Takeda_Pharmaceutical>,
        <https://1145.am/db/2573392/Takeda_America_Holdings_Inc>,
        <https://1145.am/db/2573392/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2573404/Takeda_Pharmaceutical>,
        <https://1145.am/db/2574063/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2575016/Takeda_Pharmaceutical>,
        <https://1145.am/db/2575051/Takeda>,
        <https://1145.am/db/2575986/Takeda_Pharmaceutical>,
        <https://1145.am/db/2575988/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/2576284/Takeda>,
        <https://1145.am/db/2577736/Takeda_Pharmaceutical>,
        <https://1145.am/db/2583022/Takeda>,
        <https://1145.am/db/2583803/Takeda_Pharmaceutical>,
        <https://1145.am/db/2587155/Takeda_Pharmaceuticals>,
        <https://1145.am/db/2588017/Takeda_Pharmaceuticals_International_Gmbh>,
        <https://1145.am/db/2589969/Takeda>,
        <https://1145.am/db/2593463/Japans_Takeda_Pharmaceutical>,
        <https://1145.am/db/2595145/Takeda_Pharmaceutical>,
        <https://1145.am/db/2598589/Takeda_Pharmaceutical>,
        <https://1145.am/db/2803749/Takeda>,
        <https://1145.am/db/295168/Takeda>,
        <https://1145.am/db/2976/Takeda>,
        <https://1145.am/db/576631/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/745360/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/940930/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/944999/Takeda>,
        <https://1145.am/db/970732/Takeda_Pharmaceutical_Company_Limited>,
        <https://1145.am/db/973118/Takeda_Pharmaceutical_Company_Limited> ;
    ns1:sameAsMedium <https://1145.am/db/2298018/Takeda>,
        <https://1145.am/db/2326444/Takeda>,
        <https://1145.am/db/2543904/Takeda>,
        <https://1145.am/db/2548805/Takeda>,
        <https://1145.am/db/2555040/Takeda>,
        <https://1145.am/db/2562545/Takeda>,
        <https://1145.am/db/2565955/Takeda>,
        <https://1145.am/db/946330/Takeda> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371333/Uk_Governments_Department_Of_Health> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "LONDON" ;
    ns1:documentDate "2015-10-21T15:40:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Launch of Dementia Discovery Fund - New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/launch-of-dementia-discovery-fund-new-fund-raises-100-million-to-deliver-novel-approaches> ;
    ns1:foundName "the UK Government's Department of Health" ;
    ns1:investor <https://1145.am/db/2371333/Investment_Alzheimers_Research_Uk_Takeda_The_Dementia_Discovery_Fund_Uk_Governments_Department_Of_Health_Completed> ;
    ns1:name "UK Government's Department of Health" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2538419/Garden_Hills_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-08-12T10:36:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In December of last year, Abbott navigated political tensions between Russia and the West that scared Germany's Fresenius out of a partnership in the country and concluded a deal to buy Russia's Veropharm for 16.7 billion rubles ($ 305 million) via the purchase of holding company Garden Hills-which owns about 98 % of Veropharm-from local billionaire Roman Avdeev." ;
    ns1:documentTitle "Pharma M&A, investment in Russia leading to exports, RBC Daily says" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pharma-m-a-investment-russia-leading-to-exports-rbc-daily-says> ;
    ns1:foundName "buy",
        "purchase" ;
    ns1:name "buy",
        "purchase" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2538419/Garden_Hills>,
        <https://1145.am/db/2538419/Roman_Avdeev> ;
    ns1:targetName "Garden Hills" ;
    ns1:vendor <https://1145.am/db/2538419/Roman_Avdeev> ;
    ns1:whenRaw "December of last year" ;
    ns1:whereGeoName "Russian Federation" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:whereRaw "Russia" .

<https://1145.am/db/2538444/Aurobindo_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Aurobindo Pharma" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2538444/Investment_Aurobindo_Pharma_Has_Not_Happened> ;
    ns1:name "Aurobindo Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1264124/Albireo_Pharma>,
        <https://1145.am/db/2304127/Aurobindo_Pharma>,
        <https://1145.am/db/2311319/Aurobindo_Pharma>,
        <https://1145.am/db/2337164/Chamaeleo_Pharma>,
        <https://1145.am/db/2337692/Chamaeleo_Pharma>,
        <https://1145.am/db/2364742/Amira_Pharmaceuticals>,
        <https://1145.am/db/2540629/Aurobindo_Pharma>,
        <https://1145.am/db/2540942/Aurobindo_Pharma>,
        <https://1145.am/db/2543548/Aurobindo_Pharma>,
        <https://1145.am/db/2543904/Aurobindo_Pharma>,
        <https://1145.am/db/2544552/Aurobindo_Pharma>,
        <https://1145.am/db/2544910/Aurobindo_Pharma>,
        <https://1145.am/db/2547409/Aurobindo_Pharma>,
        <https://1145.am/db/2547583/Aurobindo_Pharma_Limited>,
        <https://1145.am/db/2549151/Aurobindo_Pharma>,
        <https://1145.am/db/2550678/Aurobindo_Pharma_Limited>,
        <https://1145.am/db/2552641/Aurobindo_Pharma>,
        <https://1145.am/db/2553480/Aurobindo_Pharma>,
        <https://1145.am/db/2558316/Aurobindo_Pharma>,
        <https://1145.am/db/2561438/Aurobindo_Pharma>,
        <https://1145.am/db/2564695/Aurobindo_Pharma>,
        <https://1145.am/db/2565968/Aurobindo_Pharma>,
        <https://1145.am/db/2566019/Aurobindo_Pharma>,
        <https://1145.am/db/2571723/Aurobindo_Pharma>,
        <https://1145.am/db/940935/Insud_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2541326/Aurobindo_Pharma>,
        <https://1145.am/db/2552643/Aurobindo_Pharma_Usa_Inc>,
        <https://1145.am/db/2579398/Aurobindo_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Jifeng_Capital> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Jifeng Capital" ;
    ns1:investor <https://1145.am/db/2538444/Series_A+_Investment_Burning_Rock_Biotech_Jifeng_Capital_Legend_Star_Sequoia_Capital_Completed> ;
    ns1:name "Jifeng Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2320622/Jifeng_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Legend_Star> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Legend Star" ;
    ns1:investor <https://1145.am/db/2538444/Series_A+_Investment_Burning_Rock_Biotech_Jifeng_Capital_Legend_Star_Sequoia_Capital_Completed> ;
    ns1:name "Legend Star" ;
    ns1:sameAsMedium <https://1145.am/db/1748652/Legend_Star>,
        <https://1145.am/db/2320622/Legend_Star> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Sequoia_Capital> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Sequoia Capital" ;
    ns1:investor <https://1145.am/db/2538444/Series_A+_Investment_Burning_Rock_Biotech_Jifeng_Capital_Legend_Star_Sequoia_Capital_Completed> ;
    ns1:name "Sequoia Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043275/Sequoia_Capital>,
        <https://1145.am/db/1045208/Sequoia_Capital>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1046480/Sequoia_Capital>,
        <https://1145.am/db/1079492/Sequoia_Capital>,
        <https://1145.am/db/1080353/Sequoia_Capital>,
        <https://1145.am/db/10865/Sequoia_Capital>,
        <https://1145.am/db/1100325/Sequoia_Capital>,
        <https://1145.am/db/1100813/Sequoia_Capital>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1156925/Sequoia_Capital>,
        <https://1145.am/db/1157294/Sequoia_Capital>,
        <https://1145.am/db/1177298/Sequoia_Capital>,
        <https://1145.am/db/1238490/Sequoia_Capital>,
        <https://1145.am/db/1268357/Sequoia_Capital>,
        <https://1145.am/db/127229/Sequoia_Capital>,
        <https://1145.am/db/1319807/Sequoia_Capital>,
        <https://1145.am/db/1343813/Sequoia_Capital>,
        <https://1145.am/db/1374986/Sequoia_Capital>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1695423/Sequoia_Capital>,
        <https://1145.am/db/1697031/Sequoia_Capital>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697327/Sequoia_Capital>,
        <https://1145.am/db/1698270/Sequoia_Capital>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702319/Sequoia_Capital>,
        <https://1145.am/db/1704248/Sequoia_Capital>,
        <https://1145.am/db/1707286/Sequoia_Capital>,
        <https://1145.am/db/1709808/Sequoia_Capital>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1722924/Sequoia_Capital>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725546/Sequoia_Capital>,
        <https://1145.am/db/1728375/Sequoia_Capital>,
        <https://1145.am/db/1734791/Sequoia_Capital>,
        <https://1145.am/db/1736130/Sequoia_Capital>,
        <https://1145.am/db/1736614/Sequoia_Capital>,
        <https://1145.am/db/1737036/Sequoia_Capital>,
        <https://1145.am/db/1737079/Sequoia_Capital>,
        <https://1145.am/db/1738378/Sequoia_Capital>,
        <https://1145.am/db/1738401/Sequoia_Capital>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1741183/Sequoia_Capital>,
        <https://1145.am/db/1742891/Sequoia_Capital>,
        <https://1145.am/db/1743290/Sequoia_Capital>,
        <https://1145.am/db/1743541/Sequoia_Capital>,
        <https://1145.am/db/1743766/Sequoia_Capital>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1745768/Sequoia_Capital>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1746537/Sequoia_Capital>,
        <https://1145.am/db/1747112/Sequoia_Capital>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747701/Sequoia_Capital>,
        <https://1145.am/db/1753537/Sequoia_Capital>,
        <https://1145.am/db/1755748/Sequoia_Capital>,
        <https://1145.am/db/1757479/Sequoia_Capital>,
        <https://1145.am/db/1757844/Sequoia_Capital>,
        <https://1145.am/db/1760517/Sequoia_Capital>,
        <https://1145.am/db/1760696/Sequoia_Capital>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1762558/Sequoia_Capital>,
        <https://1145.am/db/1763433/Sequoia_Capital>,
        <https://1145.am/db/1763809/Sequoia_Capital>,
        <https://1145.am/db/1763953/Sequoia_Capital>,
        <https://1145.am/db/1764479/Sequoia_Capital>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1768327/Sequoia_Capital>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1768978/Sequoia_Capital>,
        <https://1145.am/db/1769352/Sequoia_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1772123/Sequoia_Capital>,
        <https://1145.am/db/1772826/Sequoia_Capital>,
        <https://1145.am/db/1774753/Sequoia_Capital>,
        <https://1145.am/db/1774992/Sequoia_Capital>,
        <https://1145.am/db/1776480/Sequoia_Capital>,
        <https://1145.am/db/1778394/Sequoia_Capital>,
        <https://1145.am/db/1779452/Sequoia_Capital>,
        <https://1145.am/db/1782707/Sequoia_Capital>,
        <https://1145.am/db/1783956/Sequoia_Capital>,
        <https://1145.am/db/1785147/Sequoia_Capital>,
        <https://1145.am/db/1785263/Sequoia_Capital>,
        <https://1145.am/db/1785432/Sequoia_Capital>,
        <https://1145.am/db/1785875/Sequoia_Capital>,
        <https://1145.am/db/1786813/Sequoia_Capital>,
        <https://1145.am/db/1788160/Sequoia_Capital>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1790664/Sequoia_Capital>,
        <https://1145.am/db/1790671/Sequoia_Capital>,
        <https://1145.am/db/1791222/Sequoia_Capital>,
        <https://1145.am/db/1792007/Sequoia_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792421/Sequoia_Capital>,
        <https://1145.am/db/1792732/Sequoia_Capital>,
        <https://1145.am/db/1793029/Sequoia_Capital>,
        <https://1145.am/db/1793530/Sequoia_Capital>,
        <https://1145.am/db/1794871/Sequoia_Capital>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795761/Sequoia_Capital>,
        <https://1145.am/db/1796604/Sequoia_Capital>,
        <https://1145.am/db/1796828/Sequoia_Capital>,
        <https://1145.am/db/1797477/Sequoia_Capital>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797691/Sequoia_Capital>,
        <https://1145.am/db/1798000/Sequoia_Capital>,
        <https://1145.am/db/1801332/Sequoia_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802825/Sequoia_Capital>,
        <https://1145.am/db/1802882/Sequoia_Capital>,
        <https://1145.am/db/1806430/Sequoia_Capital>,
        <https://1145.am/db/1806610/Sequoia_Capital>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809610/Sequoia_Capital>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811030/Sequoia_Capital>,
        <https://1145.am/db/1811178/Sequoia_Capital>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1814972/Sequoia_Capital>,
        <https://1145.am/db/1815537/Sequoia_Capital>,
        <https://1145.am/db/1816382/Sequoia_Capital>,
        <https://1145.am/db/1818570/Sequoia_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1824878/Sequoia_Capital>,
        <https://1145.am/db/1826922/Sequoia_Capital>,
        <https://1145.am/db/1828157/Sequoia_Capital>,
        <https://1145.am/db/1829111/Sequoia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832015/Sequoia_Capital>,
        <https://1145.am/db/1832607/Sequoia_Capital>,
        <https://1145.am/db/1832611/Sequoia_Capital>,
        <https://1145.am/db/1833935/Sequoia_Capital>,
        <https://1145.am/db/1834382/Sequoia_Capital>,
        <https://1145.am/db/1835098/Sequoia_Capital>,
        <https://1145.am/db/1835200/Sequoia_Capital>,
        <https://1145.am/db/1836193/Sequoia_Capital>,
        <https://1145.am/db/1836620/Sequoia_Capital>,
        <https://1145.am/db/1838305/Sequoia_Capital>,
        <https://1145.am/db/1839533/Sequoia_Capital>,
        <https://1145.am/db/1839816/Sequoia_Capital>,
        <https://1145.am/db/1842500/Sequoia_Capital>,
        <https://1145.am/db/1842707/Sequoia_Capital>,
        <https://1145.am/db/1843209/Sequoia_Capital>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844405/Sequoia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1845216/Sequoia_Capital>,
        <https://1145.am/db/1847160/Sequoia_Capital>,
        <https://1145.am/db/1847214/Sequoia_Capital>,
        <https://1145.am/db/1847903/Sequoia_Capital>,
        <https://1145.am/db/1848058/Sequoia_Capital>,
        <https://1145.am/db/1848120/Sequoia_Capital>,
        <https://1145.am/db/1848444/Sequoia_Capital>,
        <https://1145.am/db/1848585/Sequoia_Capital>,
        <https://1145.am/db/1849108/Sequoia_Capital>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850973/Sequoia_Capital>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851703/Sequoia_Capital>,
        <https://1145.am/db/1852048/Sequoia_Capital>,
        <https://1145.am/db/1852761/Sequoia_Capital>,
        <https://1145.am/db/1852911/Sequoia_Capital>,
        <https://1145.am/db/1854098/Sequoia_Capital>,
        <https://1145.am/db/1854488/Sequoia_Capital>,
        <https://1145.am/db/1854820/Sequoia_Capital>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1858346/Sequoia_Capital>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858650/Sequoia_Capital>,
        <https://1145.am/db/1859428/Sequoia_Capital>,
        <https://1145.am/db/1859578/Sequoia_Capital>,
        <https://1145.am/db/1859944/Sequoia_Capital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1862233/Sequoia_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1866257/Sequoia_Capital>,
        <https://1145.am/db/1867912/Sequoia_Capital>,
        <https://1145.am/db/1870374/Sequoia_Capital>,
        <https://1145.am/db/1871205/Sequoia_Capital>,
        <https://1145.am/db/1871557/Sequoia_Capital>,
        <https://1145.am/db/1875358/Sequoia_Capital>,
        <https://1145.am/db/1876841/Sequoia_Capital>,
        <https://1145.am/db/1884076/Sequoia_Capital>,
        <https://1145.am/db/1885336/Sequoia_Capital>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1887194/Sequoia_Capital>,
        <https://1145.am/db/1887526/Sequoia_Capital>,
        <https://1145.am/db/1888482/Sequoia_Capital>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1891998/Sequoia_Capital>,
        <https://1145.am/db/1892913/Sequoia_Capital>,
        <https://1145.am/db/1893811/Sequoia_Capital>,
        <https://1145.am/db/1895268/Sequoia_Capital>,
        <https://1145.am/db/1896149/Sequoia_Capital>,
        <https://1145.am/db/1899684/Sequoia_Capital>,
        <https://1145.am/db/1905153/Sequoia_Capital>,
        <https://1145.am/db/1916750/Sequoia_Capital>,
        <https://1145.am/db/1917378/Sequoia_Capital>,
        <https://1145.am/db/1917393/Sequoia_Capital>,
        <https://1145.am/db/1921318/Sequoia_Capital>,
        <https://1145.am/db/1921869/Sequoia_Capital>,
        <https://1145.am/db/1922138/Sequoia_Capital>,
        <https://1145.am/db/1922580/Sequoia_Capital>,
        <https://1145.am/db/1958229/Sequoia_Capital>,
        <https://1145.am/db/1967182/Sequoia_Capital>,
        <https://1145.am/db/2023555/Sequoia_Capital>,
        <https://1145.am/db/2026695/Sequoia_Capital>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2229117/Sequoia_Capital>,
        <https://1145.am/db/2237473/Sequoia_Capital>,
        <https://1145.am/db/2290257/Sequoia_Capital>,
        <https://1145.am/db/2295700/Sequoia_Capital>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2297413/Sequoia_Capital>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2300264/Sequoia_Capital>,
        <https://1145.am/db/2304511/Sequoia_Capital>,
        <https://1145.am/db/2306134/Sequoia_Capital>,
        <https://1145.am/db/2320622/Sequoia_Capital>,
        <https://1145.am/db/2333966/Sequoia_Capital>,
        <https://1145.am/db/2360088/Sequoia_Capital>,
        <https://1145.am/db/2369135/Sequoia_Capital>,
        <https://1145.am/db/2422223/Sequoia_Capital>,
        <https://1145.am/db/2545370/Sequoia_Capital>,
        <https://1145.am/db/2625778/Sequoia_Capital>,
        <https://1145.am/db/2662560/Sequoia_Capital>,
        <https://1145.am/db/2677219/Sequoia_Capital>,
        <https://1145.am/db/271327/Sequoia_Capital>,
        <https://1145.am/db/2758809/Sequoia_Capital>,
        <https://1145.am/db/2765057/Sequoia_Capital>,
        <https://1145.am/db/289656/Sequoia_Capital>,
        <https://1145.am/db/294983/Sequoia_Capital>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/347571/Sequoia_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/405004/Sequoia_Capital>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/522301/Sequoia_Capital>,
        <https://1145.am/db/574921/Sequoia_Capital>,
        <https://1145.am/db/642593/Sequoia_Capital>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/707126/Sequoia_Capital>,
        <https://1145.am/db/709798/Sequoia_Capital>,
        <https://1145.am/db/749014/Sequoia_Capital>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/767209/Sequoia_Capital>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/873571/Sequoia_Capital>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/939164/Sequoia_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/993347/Sequoia_Capital>,
        <https://1145.am/db/995137/Sequoia_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Shanghai_Zhangjiang_Science___Technology_Investment_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Shanghai Zhangjiang Science & Technology Investment Corporation",
        "Zhangjiang Science & Technology Investment Corporation" ;
    ns1:investor <https://1145.am/db/2538444/Investment_Anpac_Bio-Medical_Science_Shanghai_Zhangjiang_Science___Technology_Investment_Corporation_Completed> ;
    ns1:name "Shanghai Zhangjiang Science & Technology Investment Corporation",
        "Zhangjiang Science & Technology Investment Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2321667/Shanghai_Zhangjiang_Science___Technology_Investment_Corporation>,
        <https://1145.am/db/2538449/Shanghai_Zhangjiang_Science___Technology_Investment_Corporation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540193/Praktikerinvest> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "making joint investment of SEK 28 million in Pharmanest AB" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "Praktikerinvest" ;
    ns1:investor <https://1145.am/db/2540193/Shares_Investment_Karolinska_Development_Ab_Praktikerinvest_Recipharm_Venture_Fund_Ab_Stersjstiftelsen_Completed> ;
    ns1:name "Praktikerinvest" ;
    ns1:sameAsHigh <https://1145.am/db/2335035/Praktikerinvest> ;
    ns1:sameAsMedium <https://1145.am/db/2370797/Praktikerinvest_Ab> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540193/Recipharm_Venture_Fund_Ab> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "Business" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "Recipharm",
        "Recipharm Venture Fund AB",
        "Venture Fund AB" ;
    ns1:investor <https://1145.am/db/2540193/Investment_Pharmanest_Recipharm_Venture_Fund_Ab_Has_Not_Happened>,
        <https://1145.am/db/2540193/Shares_Investment_Karolinska_Development_Ab_Praktikerinvest_Recipharm_Venture_Fund_Ab_Stersjstiftelsen_Completed> ;
    ns1:name "Recipharm",
        "Recipharm Venture Fund AB",
        "Venture Fund AB" ;
    ns1:sameAsHigh <https://1145.am/db/2370797/Recipharm_Venture_Fund_Ab> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540193/Stersjstiftelsen> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "making joint investments" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "stersjstiftelsen" ;
    ns1:investor <https://1145.am/db/2540193/Shares_Investment_Karolinska_Development_Ab_Praktikerinvest_Recipharm_Venture_Fund_Ab_Stersjstiftelsen_Completed> ;
    ns1:name "stersjstiftelsen" ;
    ns1:sameAsHigh <https://1145.am/db/2335035/Stersjstiftelsen> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540203/Investment_Syntheall_Pharmaceutical_Co_Ltd_Wuxi_Pharmatech_(cayman)_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-13T15:25:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SHANGHAI, July 10, 2015 /PRNewswire/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX) , a leading open-access R & D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, today announced that SynTheAll Pharmaceutical Co. Ltd. (STA) , WuXi's small-molecule manufacturing subsidiary, has entered into an agreement in connection with a planned private placement of 7,160,000 common shares of STA stock, representing approximately 6 % of STA's current shares outstanding, for RMB 498,694,000 in cash, or approximately $ 80 million at current exchange rates." ;
    ns1:documentTitle "WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/wuxi-pharmatech-s-china-based-small-molecule-manufacturing-subsidiary-sta-enters-into> ;
    ns1:foundName "private placement" ;
    ns1:name "private placement" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2540203/Syntheall_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2540203/Wuxi_Pharmatech_(cayman)_Inc> ;
    ns1:valueRaw "RMB 498,694,000",
        "approximately $ 80 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2541146/Pfizer> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2541146/Hospira_Acquisition> ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "Pfizer" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Pfizer" ;
    ns1:sameAsHigh <https://1145.am/db/1018723/Pfizer_Inc>,
        <https://1145.am/db/1042002/Pfizer_Inc>,
        <https://1145.am/db/1045477/Pfizer_Inc>,
        <https://1145.am/db/1046923/Pfizer>,
        <https://1145.am/db/1053698/Pfizer>,
        <https://1145.am/db/1054558/Pfizer_Inc>,
        <https://1145.am/db/1065617/Pfizer_Inc>,
        <https://1145.am/db/1066444/Pfizer_Inc>,
        <https://1145.am/db/1097779/GSK>,
        <https://1145.am/db/1097915/GSK>,
        <https://1145.am/db/1097915/Pfizer>,
        <https://1145.am/db/1098950/GSK>,
        <https://1145.am/db/1123210/Pfizer_Inc>,
        <https://1145.am/db/1124362/Pfizer_Inc>,
        <https://1145.am/db/1138594/Pfizer_Inc>,
        <https://1145.am/db/118625/GSK>,
        <https://1145.am/db/1209318/Glaxosmithkline>,
        <https://1145.am/db/1258904/Pfizer_Inc>,
        <https://1145.am/db/1260932/Pfizer_Inc>,
        <https://1145.am/db/1261278/Pfizer_Inc>,
        <https://1145.am/db/1262347/Pfizer_Inc>,
        <https://1145.am/db/1262354/Pfizer_Inc>,
        <https://1145.am/db/1264461/Pfizer_Inc>,
        <https://1145.am/db/1264475/Pfizer_Inc>,
        <https://1145.am/db/1271008/Pfizer>,
        <https://1145.am/db/1361734/GSK>,
        <https://1145.am/db/1369714/GSK>,
        <https://1145.am/db/1385939/Pfizer_Inc>,
        <https://1145.am/db/1390822/Pfizer_Inc>,
        <https://1145.am/db/1394279/Pfizer_Inc>,
        <https://1145.am/db/1395353/Pfizer_Inc>,
        <https://1145.am/db/1549114/Pfizer_Inc>,
        <https://1145.am/db/1550950/Pfizer_Inc>,
        <https://1145.am/db/1684001/Pfizer_Inc>,
        <https://1145.am/db/1936001/Pfizer_Inc>,
        <https://1145.am/db/1936167/Pfizer_Inc>,
        <https://1145.am/db/1952785/Pfizer_Inc>,
        <https://1145.am/db/1972441/GSK>,
        <https://1145.am/db/2009165/Pfizer_Inc>,
        <https://1145.am/db/2013022/Pfizer_Inc>,
        <https://1145.am/db/2057315/Pfizer>,
        <https://1145.am/db/2070468/Pfizer>,
        <https://1145.am/db/2088776/Pfizer>,
        <https://1145.am/db/2119099/Pfizer>,
        <https://1145.am/db/2137303/GSK>,
        <https://1145.am/db/2138577/GSK>,
        <https://1145.am/db/2152849/Pfizer>,
        <https://1145.am/db/2152862/Pfizer>,
        <https://1145.am/db/2207119/Pfizer_Inc>,
        <https://1145.am/db/2221589/Pfizer>,
        <https://1145.am/db/2278803/GSK>,
        <https://1145.am/db/2279140/Pfizer>,
        <https://1145.am/db/2280707/Pfizer>,
        <https://1145.am/db/2280718/Pfizer>,
        <https://1145.am/db/2280933/Pfizer>,
        <https://1145.am/db/2281080/GSK>,
        <https://1145.am/db/2281622/Pfizer>,
        <https://1145.am/db/2281629/Pfizer>,
        <https://1145.am/db/2281879/Pfizer>,
        <https://1145.am/db/2283867/GSK>,
        <https://1145.am/db/2284235/Pfizer>,
        <https://1145.am/db/2285463/Pfizer>,
        <https://1145.am/db/2285764/Pfizer>,
        <https://1145.am/db/2289503/Pfizer>,
        <https://1145.am/db/2290507/Glaxosmithkline>,
        <https://1145.am/db/2291302/Glaxosmithkline>,
        <https://1145.am/db/2293631/Glaxosmithkline>,
        <https://1145.am/db/2293980/Pfizer>,
        <https://1145.am/db/2294613/Pfizer>,
        <https://1145.am/db/2295427/Pfizer>,
        <https://1145.am/db/2295635/Glaxosmithkline>,
        <https://1145.am/db/2296000/Pfizer>,
        <https://1145.am/db/2297455/Pfizer>,
        <https://1145.am/db/2297477/Pfizer>,
        <https://1145.am/db/2298256/Pfizer>,
        <https://1145.am/db/2301922/Pfizer>,
        <https://1145.am/db/230344/GSK>,
        <https://1145.am/db/230344/Glaxosmithkline>,
        <https://1145.am/db/2303447/Pfizer>,
        <https://1145.am/db/2304647/Pfizer>,
        <https://1145.am/db/2306213/Glaxosmithkline>,
        <https://1145.am/db/2306799/Glaxosmithkline>,
        <https://1145.am/db/2308656/Pfizer>,
        <https://1145.am/db/2308807/Pfizer>,
        <https://1145.am/db/2309065/Pfizer>,
        <https://1145.am/db/2309488/P_g>,
        <https://1145.am/db/2310071/Pfizer_Inc>,
        <https://1145.am/db/2310072/Pfizer>,
        <https://1145.am/db/2310168/Pfizer>,
        <https://1145.am/db/2310241/Pfizer>,
        <https://1145.am/db/2311347/Pfizer>,
        <https://1145.am/db/2311570/Pfizer_Inc>,
        <https://1145.am/db/2312314/Pfizer>,
        <https://1145.am/db/2312321/Pfizer_Inc>,
        <https://1145.am/db/2312865/Pfizer>,
        <https://1145.am/db/2312994/Pfizer>,
        <https://1145.am/db/2312995/Pfizer_Inc>,
        <https://1145.am/db/2313383/Pfizer_Inc>,
        <https://1145.am/db/2314928/Pfizer>,
        <https://1145.am/db/2315552/Pfizer>,
        <https://1145.am/db/2316517/Pfizer>,
        <https://1145.am/db/2316538/Pfizer_Inc>,
        <https://1145.am/db/2316843/Pfizer>,
        <https://1145.am/db/2317128/Pfizer-Wyeth>,
        <https://1145.am/db/2317915/Pfizer>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2318922/Pfizer>,
        <https://1145.am/db/2320509/Pfizer>,
        <https://1145.am/db/2322306/Pfizer>,
        <https://1145.am/db/2322307/Pfizer>,
        <https://1145.am/db/2322620/Pfizer>,
        <https://1145.am/db/2322633/Pfizer_Inc>,
        <https://1145.am/db/2322733/Pfizer>,
        <https://1145.am/db/2322786/Pfizer>,
        <https://1145.am/db/2324128/Pfizer>,
        <https://1145.am/db/2324155/Pfizer>,
        <https://1145.am/db/2326266/Glaxosmithkline_(gsk)>,
        <https://1145.am/db/2327511/Pfizer_Inc>,
        <https://1145.am/db/2328681/GSK>,
        <https://1145.am/db/2328712/Pfizer>,
        <https://1145.am/db/2329902/Pfizer>,
        <https://1145.am/db/2329920/Pfizer_Inc>,
        <https://1145.am/db/2330817/Pfizer_Inc>,
        <https://1145.am/db/2330955/Pfizer>,
        <https://1145.am/db/2332552/Pfizer>,
        <https://1145.am/db/2332767/Pfizer_Ltd>,
        <https://1145.am/db/2334133/Pfizer_Inc>,
        <https://1145.am/db/2335568/Glaxosmithkline>,
        <https://1145.am/db/2335573/GSK>,
        <https://1145.am/db/2335634/Pfizer>,
        <https://1145.am/db/2335717/Pfizer>,
        <https://1145.am/db/2336060/Glaxosmithkline>,
        <https://1145.am/db/2336333/Pfizer>,
        <https://1145.am/db/2336704/GSK>,
        <https://1145.am/db/2337788/Pfizer>,
        <https://1145.am/db/2339633/Pfizer_Inc>,
        <https://1145.am/db/2340055/Pfizer>,
        <https://1145.am/db/2340072/GSK>,
        <https://1145.am/db/2340260/Glaxosmithkline>,
        <https://1145.am/db/2340321/Pfizer_Inc>,
        <https://1145.am/db/2340324/Pfizer_Inc>,
        <https://1145.am/db/2340325/Pfizer_Inc>,
        <https://1145.am/db/2340331/Pfizer_Inc>,
        <https://1145.am/db/2340890/Pfizer>,
        <https://1145.am/db/2341325/Pfizer>,
        <https://1145.am/db/2341516/Pfizer>,
        <https://1145.am/db/2342559/Pfizer_Inc>,
        <https://1145.am/db/2343237/Pfizer_Inc>,
        <https://1145.am/db/2343273/Pfizer_Inc>,
        <https://1145.am/db/2343298/Pfizer_Inc>,
        <https://1145.am/db/2343344/Pfizer>,
        <https://1145.am/db/2343861/Glaxosmithkline>,
        <https://1145.am/db/2344023/Glaxosmithkline>,
        <https://1145.am/db/2345065/Pfizer>,
        <https://1145.am/db/2345251/GSK>,
        <https://1145.am/db/2346602/Pfizer_Inc>,
        <https://1145.am/db/2347383/Pfizer_Inc>,
        <https://1145.am/db/2348510/Pfizer_Inc>,
        <https://1145.am/db/2351730/Pfizer_Inc>,
        <https://1145.am/db/2353039/Pfizer_Inc>,
        <https://1145.am/db/2353325/Pfizer>,
        <https://1145.am/db/2353326/Pfizer>,
        <https://1145.am/db/2353337/Pfizer>,
        <https://1145.am/db/2353364/Pfizer>,
        <https://1145.am/db/2353376/Pfizer>,
        <https://1145.am/db/2354567/Pfizer>,
        <https://1145.am/db/2355021/Pfizer>,
        <https://1145.am/db/2355025/Pfizer_Inc>,
        <https://1145.am/db/2355472/Pfizer_Inc>,
        <https://1145.am/db/2355641/GSK>,
        <https://1145.am/db/2355916/Pfizer_Inc>,
        <https://1145.am/db/2356124/Pfizer_Inc>,
        <https://1145.am/db/2356559/Glaxosmithkline>,
        <https://1145.am/db/2356597/Pfizer>,
        <https://1145.am/db/2356599/Pfizer>,
        <https://1145.am/db/2356811/GSK>,
        <https://1145.am/db/2357232/Pfizer>,
        <https://1145.am/db/2357308/Pfizer_Inc>,
        <https://1145.am/db/2358128/Pfizer>,
        <https://1145.am/db/2359697/Pfizer>,
        <https://1145.am/db/2359727/GSK>,
        <https://1145.am/db/2359727/Glaxosmithkline>,
        <https://1145.am/db/2359858/GSK>,
        <https://1145.am/db/2359858/Glaxosmithkline>,
        <https://1145.am/db/2360562/GSK>,
        <https://1145.am/db/2360647/Pfizer_Inc>,
        <https://1145.am/db/2361700/GSK>,
        <https://1145.am/db/2361705/GSK>,
        <https://1145.am/db/2362439/Pfizer_Inc>,
        <https://1145.am/db/2362851/Pfizer_Inc>,
        <https://1145.am/db/2363435/Gsk_Pfizer>,
        <https://1145.am/db/2363446/Pfizer_Inc>,
        <https://1145.am/db/2363896/Pfizer>,
        <https://1145.am/db/2364087/Pfizer_Inc>,
        <https://1145.am/db/2364813/Glaxosmithkline>,
        <https://1145.am/db/2365103/Glaxosmithkline>,
        <https://1145.am/db/2366395/Pfizer_Inc>,
        <https://1145.am/db/2367283/Pfizer_Inc>,
        <https://1145.am/db/2367982/Pfizer>,
        <https://1145.am/db/2368146/Pfizer>,
        <https://1145.am/db/2369451/Glaxosmithkline>,
        <https://1145.am/db/2369755/GSK>,
        <https://1145.am/db/2369761/Glaxosmithkline>,
        <https://1145.am/db/2369876/Pfizer>,
        <https://1145.am/db/2369909/Pfizer_Inc>,
        <https://1145.am/db/2370016/Pfizer>,
        <https://1145.am/db/2370635/GSK>,
        <https://1145.am/db/2370843/Glaxosmithkline>,
        <https://1145.am/db/238329/GSK>,
        <https://1145.am/db/2507041/Pfizer>,
        <https://1145.am/db/2536358/Pfizer_Inc>,
        <https://1145.am/db/2536361/Pfizer_Inc>,
        <https://1145.am/db/2536362/Pfizer_Inc>,
        <https://1145.am/db/2536365/Pfizer_Inc>,
        <https://1145.am/db/2536475/Pfizer>,
        <https://1145.am/db/2536493/Glaxosmithkline>,
        <https://1145.am/db/2536856/Pfizer>,
        <https://1145.am/db/2537054/Pfizer_Inc>,
        <https://1145.am/db/2537057/Pfizer_Inc>,
        <https://1145.am/db/2537171/Pfizer>,
        <https://1145.am/db/2537597/Pfizer>,
        <https://1145.am/db/2537699/Glaxosmithkline>,
        <https://1145.am/db/2538568/Pfizer_Inc>,
        <https://1145.am/db/2538861/Pfizer>,
        <https://1145.am/db/2538924/Pfizer>,
        <https://1145.am/db/2539516/Pfizer>,
        <https://1145.am/db/2539695/GSK>,
        <https://1145.am/db/2540020/Glaxosmithkline>,
        <https://1145.am/db/2540170/Glaxosmithkline>,
        <https://1145.am/db/2540356/Pfizer>,
        <https://1145.am/db/2541091/GSK>,
        <https://1145.am/db/2541139/Pfizer_Inc>,
        <https://1145.am/db/2542064/GSK>,
        <https://1145.am/db/2542067/Pfizer_Inc>,
        <https://1145.am/db/2542072/Pfizer>,
        <https://1145.am/db/2542499/Pfizer>,
        <https://1145.am/db/2543278/Pfizer>,
        <https://1145.am/db/2543533/Pfizer>,
        <https://1145.am/db/2543826/Pfizer>,
        <https://1145.am/db/2543957/Pfizer>,
        <https://1145.am/db/2544062/Glaxosmithkline>,
        <https://1145.am/db/2544074/Pfizer>,
        <https://1145.am/db/2545058/Pfizer>,
        <https://1145.am/db/2545122/Pfizer>,
        <https://1145.am/db/2545537/Glaxosmithkline>,
        <https://1145.am/db/2545618/Pfizer>,
        <https://1145.am/db/2545634/Pfizer>,
        <https://1145.am/db/2545818/Pfizer>,
        <https://1145.am/db/2545847/GSK>,
        <https://1145.am/db/2546136/Glaxosmithkline>,
        <https://1145.am/db/2546260/Glaxosmithkline>,
        <https://1145.am/db/2546577/Glaxosmithkline>,
        <https://1145.am/db/2546583/Pfizer>,
        <https://1145.am/db/2546596/Pfizer>,
        <https://1145.am/db/2547000/Pfizer>,
        <https://1145.am/db/2547653/Pfizer>,
        <https://1145.am/db/2547954/Glaxosmithkline>,
        <https://1145.am/db/2548244/Pfizer_Inc>,
        <https://1145.am/db/2548674/Pfizer>,
        <https://1145.am/db/2548752/GSK>,
        <https://1145.am/db/2548752/Pfizer>,
        <https://1145.am/db/2548986/Pfizer>,
        <https://1145.am/db/2549151/Pfizer>,
        <https://1145.am/db/2549598/Glaxosmithkline>,
        <https://1145.am/db/2549673/Pfizer>,
        <https://1145.am/db/2549694/Glaxosmithkline>,
        <https://1145.am/db/2549719/Pfizer>,
        <https://1145.am/db/2549876/Glaxosmithkline>,
        <https://1145.am/db/2550054/Glaxosmithkline>,
        <https://1145.am/db/2550445/Pfizer>,
        <https://1145.am/db/2550460/GSK>,
        <https://1145.am/db/2550662/Glaxosmithkline>,
        <https://1145.am/db/2550685/Pfizer>,
        <https://1145.am/db/2551402/Glaxosmithkline>,
        <https://1145.am/db/2552165/Glaxosmithkline>,
        <https://1145.am/db/2552684/Pfizer>,
        <https://1145.am/db/2552794/Glaxosmithkline>,
        <https://1145.am/db/2553974/Pfizer>,
        <https://1145.am/db/2554044/Glaxosmithkline>,
        <https://1145.am/db/2554937/Pfizer>,
        <https://1145.am/db/2555012/Glaxosmithkline>,
        <https://1145.am/db/2555896/Pfizer>,
        <https://1145.am/db/2555992/Pfizer>,
        <https://1145.am/db/2556407/Glaxosmithkline>,
        <https://1145.am/db/2557064/Pfizer>,
        <https://1145.am/db/2557083/Pfizer>,
        <https://1145.am/db/2557221/Glaxosmithkline>,
        <https://1145.am/db/2557221/Pfizer>,
        <https://1145.am/db/2558268/Pfizer>,
        <https://1145.am/db/2558417/Pfizer>,
        <https://1145.am/db/2558464/Pfizer>,
        <https://1145.am/db/2558862/GSK>,
        <https://1145.am/db/2558970/Pfizer>,
        <https://1145.am/db/2558971/Pfizer>,
        <https://1145.am/db/2559649/Pfizer>,
        <https://1145.am/db/2560282/Pfizer>,
        <https://1145.am/db/2560633/Glaxosmithkline>,
        <https://1145.am/db/2560720/Pfizer>,
        <https://1145.am/db/2561231/Pfizer>,
        <https://1145.am/db/2561650/GSK>,
        <https://1145.am/db/2561650/Pfizer>,
        <https://1145.am/db/2562102/Pfizer_Inc>,
        <https://1145.am/db/2562701/Pfizer>,
        <https://1145.am/db/2562773/GSK>,
        <https://1145.am/db/2562951/Glaxosmithkline>,
        <https://1145.am/db/2563857/Pfizer>,
        <https://1145.am/db/2563889/Pfizer>,
        <https://1145.am/db/2564032/Pfizer>,
        <https://1145.am/db/2564695/Glaxosmithkline>,
        <https://1145.am/db/2564884/GSK>,
        <https://1145.am/db/2566186/GSK>,
        <https://1145.am/db/2568121/Pfizer>,
        <https://1145.am/db/2568519/Pfizer>,
        <https://1145.am/db/2568899/Pfizer>,
        <https://1145.am/db/2568973/Glaxosmithkline>,
        <https://1145.am/db/2570369/Pfizer_Inc>,
        <https://1145.am/db/2570791/Glaxosmithkline>,
        <https://1145.am/db/2571798/Pfizer_Inc>,
        <https://1145.am/db/2572036/Pfizer>,
        <https://1145.am/db/2572429/Glaxosmithkline>,
        <https://1145.am/db/2572927/Pfizer>,
        <https://1145.am/db/2573173/Pfizer>,
        <https://1145.am/db/2573463/Pfizer>,
        <https://1145.am/db/2573465/Pfizer_Inc>,
        <https://1145.am/db/2573466/Pfizer>,
        <https://1145.am/db/2573551/Pfizer_Inc>,
        <https://1145.am/db/2573558/Pfizer_Inc>,
        <https://1145.am/db/2573562/Pfizer>,
        <https://1145.am/db/2573707/Pfizer>,
        <https://1145.am/db/2574332/Pfizer>,
        <https://1145.am/db/2574459/Pfizer_Inc>,
        <https://1145.am/db/2574461/Pfizer_Inc>,
        <https://1145.am/db/2574687/Pfizer>,
        <https://1145.am/db/2574691/Pfizer_Inc>,
        <https://1145.am/db/2575139/Pfizer_Inc>,
        <https://1145.am/db/2575145/Pfizer_Inc>,
        <https://1145.am/db/2575320/Pfizer>,
        <https://1145.am/db/2575471/Pfizer>,
        <https://1145.am/db/2575505/Pfizer_Inc>,
        <https://1145.am/db/2575575/Pfizer>,
        <https://1145.am/db/2575712/GSK>,
        <https://1145.am/db/2575723/Pfizer>,
        <https://1145.am/db/2576330/Pfizer_Inc>,
        <https://1145.am/db/2576526/Pfizer>,
        <https://1145.am/db/2576759/Pfizer>,
        <https://1145.am/db/2576762/Pfizer>,
        <https://1145.am/db/2577077/Pfizer>,
        <https://1145.am/db/2577226/Glaxosmithkline>,
        <https://1145.am/db/2577258/Pfizer_Inc>,
        <https://1145.am/db/2577655/Pfizer>,
        <https://1145.am/db/2577778/Glaxosmithkline>,
        <https://1145.am/db/2578528/GSK>,
        <https://1145.am/db/2579205/Glaxosmithkline>,
        <https://1145.am/db/2579252/Pfizer>,
        <https://1145.am/db/2579709/Pfizer_Inc>,
        <https://1145.am/db/2579716/Pfizer>,
        <https://1145.am/db/2580940/Pfizer>,
        <https://1145.am/db/2581331/Pfizer_Inc>,
        <https://1145.am/db/2581334/Pfizer_Inc>,
        <https://1145.am/db/2581339/Pfizer>,
        <https://1145.am/db/2581394/Pfizer>,
        <https://1145.am/db/2581659/GSK>,
        <https://1145.am/db/2581659/Pfizer>,
        <https://1145.am/db/2581661/Pfizer_Inc>,
        <https://1145.am/db/2582158/Pfizer_Inc>,
        <https://1145.am/db/2582160/Pfizer_Inc>,
        <https://1145.am/db/2582233/Glaxosmithkline>,
        <https://1145.am/db/2582343/Pfizer_Inc>,
        <https://1145.am/db/2582879/Pfizer_Inc>,
        <https://1145.am/db/2583155/Pfizer_Inc>,
        <https://1145.am/db/2583163/Pfizer>,
        <https://1145.am/db/2583165/Pfizer_Inc>,
        <https://1145.am/db/2583172/Pfizer>,
        <https://1145.am/db/2583242/Pfizer_Inc>,
        <https://1145.am/db/2583245/Pfizer_Inc>,
        <https://1145.am/db/2583337/Pfizer_Inc>,
        <https://1145.am/db/2583783/Pfizer>,
        <https://1145.am/db/2584085/Pfizer_Inc>,
        <https://1145.am/db/2584601/Pfizer_Inc>,
        <https://1145.am/db/2584968/Pfizer>,
        <https://1145.am/db/2585700/Pfizer>,
        <https://1145.am/db/2585908/New_York-Pfizer_Inc>,
        <https://1145.am/db/2585908/Pfizer>,
        <https://1145.am/db/2585912/Pfizer>,
        <https://1145.am/db/2586034/Pfizer_Inc>,
        <https://1145.am/db/2586047/Pfizer_Inc>,
        <https://1145.am/db/2586804/GSK>,
        <https://1145.am/db/2587282/Glaxosmithkline>,
        <https://1145.am/db/2587387/Pfizer>,
        <https://1145.am/db/2587673/Pfizer>,
        <https://1145.am/db/2587770/Glaxosmithkline>,
        <https://1145.am/db/2588134/Pfizer_Inc>,
        <https://1145.am/db/2589365/Pfizer>,
        <https://1145.am/db/2589701/GSK>,
        <https://1145.am/db/2590549/Pfizer_Inc>,
        <https://1145.am/db/2590887/Pfizer>,
        <https://1145.am/db/2590988/Pfizer>,
        <https://1145.am/db/2590989/Pfizer>,
        <https://1145.am/db/2591081/Pfizer_Inc>,
        <https://1145.am/db/2591091/Pfizer>,
        <https://1145.am/db/2591092/Pfizer_Inc>,
        <https://1145.am/db/2591281/Pfizer>,
        <https://1145.am/db/2591652/Pfizer>,
        <https://1145.am/db/2591691/Pfizer>,
        <https://1145.am/db/2591733/Pfizer>,
        <https://1145.am/db/2592975/Pfizer_Inc>,
        <https://1145.am/db/2592977/Pfizer_Inc>,
        <https://1145.am/db/2592980/Pfizer>,
        <https://1145.am/db/2592987/Glaxosmithkline>,
        <https://1145.am/db/2592990/Pfizer_Inc>,
        <https://1145.am/db/2592992/Pfizer_Inc>,
        <https://1145.am/db/2593150/Pfizer>,
        <https://1145.am/db/2593886/Pfizer>,
        <https://1145.am/db/2593961/Pfizer_Inc>,
        <https://1145.am/db/2594141/Pfizer_Inc>,
        <https://1145.am/db/2594268/Pfizer_Inc>,
        <https://1145.am/db/2594422/Pfizer>,
        <https://1145.am/db/2594489/Pfizer_Inc>,
        <https://1145.am/db/2594574/Pfizer>,
        <https://1145.am/db/2594581/Pfizer>,
        <https://1145.am/db/2594992/Pfizer>,
        <https://1145.am/db/2595320/Pfizer_Inc>,
        <https://1145.am/db/2595472/Pfizer>,
        <https://1145.am/db/2595499/Pfizer>,
        <https://1145.am/db/2596344/Pfizer>,
        <https://1145.am/db/2596754/Pfizer_Inc>,
        <https://1145.am/db/2596778/Pfizer>,
        <https://1145.am/db/2596874/Pfizer>,
        <https://1145.am/db/2597173/Pfizer>,
        <https://1145.am/db/2597183/Pfizer_Inc>,
        <https://1145.am/db/2597220/Glaxosmithkline>,
        <https://1145.am/db/2597643/Pfizer_Inc>,
        <https://1145.am/db/2597650/Pfizer>,
        <https://1145.am/db/2597651/Pfizer_Inc>,
        <https://1145.am/db/2597712/Pfizer>,
        <https://1145.am/db/2598461/Glaxosmithkline>,
        <https://1145.am/db/274660/Pfizer_Inc>,
        <https://1145.am/db/274739/Pfizer_Inc>,
        <https://1145.am/db/2792911/Pfizer>,
        <https://1145.am/db/2797157/GSK>,
        <https://1145.am/db/286227/Glaxosmithkline>,
        <https://1145.am/db/318295/Pfizer_Inc>,
        <https://1145.am/db/338190/GSK>,
        <https://1145.am/db/338242/Glaxosmithkline>,
        <https://1145.am/db/377761/Glaxosmithkline>,
        <https://1145.am/db/377769/Glaxosmithkline>,
        <https://1145.am/db/385094/GSK>,
        <https://1145.am/db/385100/GSK>,
        <https://1145.am/db/422377/Pfizer_Inc>,
        <https://1145.am/db/422378/Pfizer_Inc>,
        <https://1145.am/db/423571/Pfizer_Inc>,
        <https://1145.am/db/424190/Pfizer_Inc>,
        <https://1145.am/db/424896/Pfizer_Inc>,
        <https://1145.am/db/425689/Pfizer_Inc>,
        <https://1145.am/db/426841/Pfizer_Inc>,
        <https://1145.am/db/428975/Pfizer_Inc>,
        <https://1145.am/db/494811/GSK>,
        <https://1145.am/db/582690/GSK>,
        <https://1145.am/db/582690/Glaxosmithkline>,
        <https://1145.am/db/626832/Pfizer_Inc>,
        <https://1145.am/db/627349/Pfizer_Inc>,
        <https://1145.am/db/631317/Pfizer_Inc>,
        <https://1145.am/db/635031/Pfizer>,
        <https://1145.am/db/661291/GSK>,
        <https://1145.am/db/692994/Pfizer_Inc>,
        <https://1145.am/db/694218/Pfizer_Inc>,
        <https://1145.am/db/694224/Pfizer_Inc>,
        <https://1145.am/db/696927/Pfizer_Inc>,
        <https://1145.am/db/699199/Pfizer>,
        <https://1145.am/db/704642/Glaxosmithkline_Plc>,
        <https://1145.am/db/76007/Pfizer>,
        <https://1145.am/db/761748/Pfizer>,
        <https://1145.am/db/764460/Pfizer>,
        <https://1145.am/db/797138/Pfizer_Inc>,
        <https://1145.am/db/800318/Pfizer_Inc>,
        <https://1145.am/db/87287/Glaxosmithkline>,
        <https://1145.am/db/896566/Pfizer_Inc>,
        <https://1145.am/db/897457/Pfizer_Inc>,
        <https://1145.am/db/962850/Pfizer_Inc>,
        <https://1145.am/db/962851/Pfizer_Inc>,
        <https://1145.am/db/962899/Pfizer_Inc>,
        <https://1145.am/db/965490/Pfizer_Inc>,
        <https://1145.am/db/968220/Pfizer_Inc>,
        <https://1145.am/db/971984/Pfizer_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1146707/Pfizer>,
        <https://1145.am/db/1262545/Pfizer_Inc>,
        <https://1145.am/db/1270781/Pfizer_Inc>,
        <https://1145.am/db/1308148/Pfizer_Inc>,
        <https://1145.am/db/1308675/Pfizer_Inc>,
        <https://1145.am/db/1936264/Pfizer_Inc>,
        <https://1145.am/db/1983382/Pfizer_Inc>,
        <https://1145.am/db/2007025/Pfizer_Inc>,
        <https://1145.am/db/2009856/Pfizer>,
        <https://1145.am/db/2313175/Pfizer_Limited>,
        <https://1145.am/db/2325165/Pfizer_Inc>,
        <https://1145.am/db/2327506/Pfizer>,
        <https://1145.am/db/2332830/Pfizer>,
        <https://1145.am/db/2334165/Pfizer_Inc>,
        <https://1145.am/db/2343454/Pfizer_Inc>,
        <https://1145.am/db/2350231/Pfizer>,
        <https://1145.am/db/2354370/Pfizer_Inc>,
        <https://1145.am/db/2360633/Pfizer>,
        <https://1145.am/db/2371512/Pfizer>,
        <https://1145.am/db/2538915/Pfizer_Inc>,
        <https://1145.am/db/2539787/Pfizer>,
        <https://1145.am/db/2541721/Pfizer>,
        <https://1145.am/db/2548137/Pfizer>,
        <https://1145.am/db/2550761/Pfizer>,
        <https://1145.am/db/2554938/Pfizer>,
        <https://1145.am/db/2569378/Pfizer>,
        <https://1145.am/db/2573245/Pfizer_Inc>,
        <https://1145.am/db/2576064/Pfizer>,
        <https://1145.am/db/2584258/Pfizer_Inc>,
        <https://1145.am/db/2595930/Pfizer>,
        <https://1145.am/db/2596947/Pfizer>,
        <https://1145.am/db/2597185/Pfizer_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541146/Sanquin_Blood_Supply> a org:Organization ;
    ns1:description "blood" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "Sanquin Blood Supply" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Sanquin Blood Supply" ;
    ns1:protagonist <https://1145.am/db/2541146/Viropharma_Acquisition> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541146/Shire> a org:Organization ;
    ns1:buyer <https://1145.am/db/2541146/Viropharma_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "Shire" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2541146/Investment_Shire_Has_Not_Happened>,
        <https://1145.am/db/2541146/Viropharma_Acquisition> ;
    ns1:name "Shire" ;
    ns1:sameAsHigh <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2311383/Shire_Pharmaceuticals>,
        <https://1145.am/db/2311393/Shire_Pharmaceuticals_Group>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2315296/Shire_Biochem>,
        <https://1145.am/db/2315308/Shire_Biochem_Inc>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328700/Shire_Laboratories>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Board>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578086/So_Shire>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592336/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sameAsMedium <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2341068/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2351734/Shire_Llc>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357487/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2365826/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2577114/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2585132/Shire> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2542049/Sterigenics_International> a org:Organization ;
    ns1:basedInHighGeoName "Deerfield" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4889668/about.rdf> ;
    ns1:basedInHighRaw "Deerfield, IL" ;
    ns1:buyer <https://1145.am/db/2542049/Companhia_Brasileira_De_Esterilizao_Acquisition> ;
    ns1:description "irradiation services" ;
    ns1:documentDate "2015-08-27T13:46:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sterilization specialist on expansion streak" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/sterilization-specialist-on-expansion-streak> ;
    ns1:foundName "Sterigenics International" ;
    ns1:investor <https://1145.am/db/2542049/Companhia_Brasileira_De_Esterilizao_Acquisition> ;
    ns1:name "Sterigenics International" ;
    ns1:sameAsMedium <https://1145.am/db/2293979/Sterigenics_International> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2543345/Alkem> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:buyer <https://1145.am/db/2543345/Krebs_Biochemicals_Stake_Investment> ;
    ns1:description "drugmakers" ;
    ns1:documentDate "2015-11-04T12:25:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Indian drugmakers on the hunt for money and growth" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/indian-drugmakers-on-hunt-for-money-and-growth> ;
    ns1:foundName "Alkem Laboratories" ;
    ns1:industry "drugmakers" ;
    ns1:name "Alkem" ;
    ns1:sameAsHigh <https://1145.am/db/2036830/Alkermes>,
        <https://1145.am/db/2350061/Amakem_Nv>,
        <https://1145.am/db/2536597/Alkermes>,
        <https://1145.am/db/2545314/Alkermes>,
        <https://1145.am/db/2564905/Alnylam>,
        <https://1145.am/db/2573130/Alkermes>,
        <https://1145.am/db/2587657/Alkermes> ;
    ns1:sameAsMedium <https://1145.am/db/2538392/Alkem> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2543345/Ipca_Laboratories> a org:Organization ;
    ns1:basedInHighGeoName "Mumbai" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1275339/about.rdf> ;
    ns1:basedInHighRaw "Mumbai" ;
    ns1:basedInLowRaw "India" ;
    ns1:description "chemical synthesis, fermentation and enzymatic technologies" ;
    ns1:documentDate "2015-11-04T12:25:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Indian drugmakers on the hunt for money and growth" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/indian-drugmakers-on-hunt-for-money-and-growth> ;
    ns1:foundName "Ipca",
        "Ipca Laboratories" ;
    ns1:industry "drugmakers" ;
    ns1:investor <https://1145.am/db/2543345/Investment_Ipca_Laboratories_Ipca_Laboratories_Has_Not_Happened>,
        <https://1145.am/db/2543345/Krebs_Biochemicals_Stake_Investment> ;
    ns1:name "Ipca",
        "Ipca Laboratories" ;
    ns1:sameAsHigh <https://1145.am/db/2588034/Ifpma> ;
    ns1:sameAsMedium <https://1145.am/db/1979875/Ipca_Laboratories>,
        <https://1145.am/db/2304934/Ipca_Laboratories>,
        <https://1145.am/db/2596135/Ipca_Laboratories> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2545141/The_Riverside_Company> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:buyer <https://1145.am/db/2545141/Euromed_Acquisition> ;
    ns1:description "business-to-business" ;
    ns1:documentDate "2015-12-01T12:33:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Meda divests manufacturing unit Euromed in Spain" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/meda-divests-manufacturing-unit-euromed-spain> ;
    ns1:foundName "The Riverside Company" ;
    ns1:name "The Riverside Company" ;
    ns1:sameAsHigh <https://1145.am/db/2585674/The_Riverside_Company> ;
    ns1:sameAsMedium <https://1145.am/db/1050858/The_Riverside_Company>,
        <https://1145.am/db/1052406/The_Riverside_Company>,
        <https://1145.am/db/1088892/The_Riverside_Company>,
        <https://1145.am/db/1135346/The_Riverside_Company>,
        <https://1145.am/db/1272775/The_Riverside_Company>,
        <https://1145.am/db/1294264/The_Riverside_Company>,
        <https://1145.am/db/1334483/The_Riverside_Company>,
        <https://1145.am/db/1335151/The_Riverside_Company>,
        <https://1145.am/db/1386576/The_Riverside_Company>,
        <https://1145.am/db/1392277/The_Riverside_Company>,
        <https://1145.am/db/1616393/The_Riverside_Company>,
        <https://1145.am/db/1784131/The_Riverside_Company>,
        <https://1145.am/db/1791894/The_Riverside_Company>,
        <https://1145.am/db/2116788/The_Riverside_Company>,
        <https://1145.am/db/2234198/The_Riverside_Company>,
        <https://1145.am/db/2266819/The_Riverside_Company>,
        <https://1145.am/db/2284170/The_Riverside_Company>,
        <https://1145.am/db/2404090/The_Riverside_Company>,
        <https://1145.am/db/2540702/The_Riverside_Company>,
        <https://1145.am/db/2541629/The_Riverside_Company>,
        <https://1145.am/db/2545140/The_Riverside_Co>,
        <https://1145.am/db/2696270/The_Riverside_Company>,
        <https://1145.am/db/417679/The_Riverside_Company>,
        <https://1145.am/db/442035/The_Riverside_Company>,
        <https://1145.am/db/539969/The_Riverside_Company>,
        <https://1145.am/db/605890/The_Riverside_Company>,
        <https://1145.am/db/666064/The_Riverside_Company>,
        <https://1145.am/db/885184/The_Riverside_Company>,
        <https://1145.am/db/988410/The_Riverside_Company>,
        <https://1145.am/db/989512/The_Riverside_Company> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546157/It> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:buyer <https://1145.am/db/2546157/Nitin_Lifesciences_Stake_Acquisition> ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "It" ;
    ns1:industry "drugmaker" ;
    ns1:name "It" ;
    ns1:sameAsHigh <https://1145.am/db/2155064/It>,
        <https://1145.am/db/2556430/It>,
        <https://1145.am/db/2589781/It> ;
    ns1:sameAsMedium <https://1145.am/db/1693861/It>,
        <https://1145.am/db/1707513/It>,
        <https://1145.am/db/1734258/It>,
        <https://1145.am/db/1735972/It>,
        <https://1145.am/db/1737274/It>,
        <https://1145.am/db/1738867/It>,
        <https://1145.am/db/1739707/It>,
        <https://1145.am/db/1740696/It>,
        <https://1145.am/db/1740866/It>,
        <https://1145.am/db/1743678/It>,
        <https://1145.am/db/1745645/It>,
        <https://1145.am/db/1747675/It>,
        <https://1145.am/db/1749500/It>,
        <https://1145.am/db/1751227/It>,
        <https://1145.am/db/1751564/It>,
        <https://1145.am/db/1752211/It>,
        <https://1145.am/db/1753887/It>,
        <https://1145.am/db/1755228/It>,
        <https://1145.am/db/1758390/It>,
        <https://1145.am/db/1761888/It>,
        <https://1145.am/db/1762451/It>,
        <https://1145.am/db/1764997/It>,
        <https://1145.am/db/1765235/It>,
        <https://1145.am/db/1766628/It>,
        <https://1145.am/db/1767354/It>,
        <https://1145.am/db/1767785/It>,
        <https://1145.am/db/1768741/It>,
        <https://1145.am/db/1772453/It>,
        <https://1145.am/db/1773508/It>,
        <https://1145.am/db/1775573/It>,
        <https://1145.am/db/1776477/It>,
        <https://1145.am/db/1777425/It>,
        <https://1145.am/db/1786264/It>,
        <https://1145.am/db/1787870/It>,
        <https://1145.am/db/1792698/It>,
        <https://1145.am/db/1796246/It>,
        <https://1145.am/db/1798085/It>,
        <https://1145.am/db/1800827/It>,
        <https://1145.am/db/1802907/It>,
        <https://1145.am/db/1803641/It>,
        <https://1145.am/db/1807573/It>,
        <https://1145.am/db/1808030/It>,
        <https://1145.am/db/1810946/It>,
        <https://1145.am/db/1812081/It>,
        <https://1145.am/db/1813315/It>,
        <https://1145.am/db/1815437/It>,
        <https://1145.am/db/1835993/It>,
        <https://1145.am/db/1838862/It>,
        <https://1145.am/db/1842642/It>,
        <https://1145.am/db/1850622/It>,
        <https://1145.am/db/1851480/It>,
        <https://1145.am/db/1854547/It>,
        <https://1145.am/db/1855967/It>,
        <https://1145.am/db/1857634/It>,
        <https://1145.am/db/1973758/It>,
        <https://1145.am/db/2180225/It>,
        <https://1145.am/db/2288720/It>,
        <https://1145.am/db/2290651/It>,
        <https://1145.am/db/2299331/It>,
        <https://1145.am/db/2333314/It>,
        <https://1145.am/db/2389572/It>,
        <https://1145.am/db/2555681/It>,
        <https://1145.am/db/2560472/It>,
        <https://1145.am/db/2573197/It>,
        <https://1145.am/db/2701548/It>,
        <https://1145.am/db/724064/It> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Accuron> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "Singapore" ;
    ns1:description "Singapore sovereign wealth fund" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "Accuron" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2546405/Series_C_Investment_Aslan_Pharmaceuticals_Accuron_Ascletis_Goldman_Sachs_Mabspace_Completed> ;
    ns1:name "Accuron" ;
    ns1:sameAsHigh <https://1145.am/db/1097779/Affinivax>,
        <https://1145.am/db/1098950/Affinivax>,
        <https://1145.am/db/2154845/Audentes>,
        <https://1145.am/db/2155994/Amryt_Pharma>,
        <https://1145.am/db/2156002/Amryt_Pharma>,
        <https://1145.am/db/2279429/Enalare>,
        <https://1145.am/db/2281842/Affinivax>,
        <https://1145.am/db/2282014/Affinivax>,
        <https://1145.am/db/2282380/Aristea>,
        <https://1145.am/db/2294806/Aclaris>,
        <https://1145.am/db/2306115/Aesrx>,
        <https://1145.am/db/2312649/Topotarget_A_S>,
        <https://1145.am/db/2313223/Accera>,
        <https://1145.am/db/2318986/Algorx_Pharmaceuticals>,
        <https://1145.am/db/2319675/Accu-Break_Pharmaceuticals>,
        <https://1145.am/db/2321150/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2325394/Innovata>,
        <https://1145.am/db/2336225/Acorda>,
        <https://1145.am/db/2337999/Akorn>,
        <https://1145.am/db/2347488/Amira>,
        <https://1145.am/db/2351796/Aryx>,
        <https://1145.am/db/2360349/Aryx>,
        <https://1145.am/db/2364495/Topotarget>,
        <https://1145.am/db/2365406/Ampion>,
        <https://1145.am/db/2366633/Accera_Inc>,
        <https://1145.am/db/2366637/Accera_Inc>,
        <https://1145.am/db/2368351/Enlibrium>,
        <https://1145.am/db/2368992/Akorn>,
        <https://1145.am/db/2369883/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2371014/Amryt>,
        <https://1145.am/db/2536762/Acrux>,
        <https://1145.am/db/2538595/Acambis>,
        <https://1145.am/db/2540502/Advent_International>,
        <https://1145.am/db/2546531/Alvogen>,
        <https://1145.am/db/2549982/Aimmune>,
        <https://1145.am/db/2554400/Acambis>,
        <https://1145.am/db/2556798/Accugenix>,
        <https://1145.am/db/2556968/Alvogen>,
        <https://1145.am/db/2556979/Alvogen>,
        <https://1145.am/db/2558955/Amdipharm>,
        <https://1145.am/db/2559262/Alvogen>,
        <https://1145.am/db/2560886/Acambis>,
        <https://1145.am/db/2569024/Akorn_Inc>,
        <https://1145.am/db/2569029/Akorn>,
        <https://1145.am/db/2571068/Afexa>,
        <https://1145.am/db/2573398/Acino>,
        <https://1145.am/db/2593443/Aton> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Ascletis> a org:Organization ;
    ns1:basedInLowRaw "Singapore" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "Ascletis" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2546405/Series_C_Investment_Aslan_Pharmaceuticals_Accuron_Ascletis_Goldman_Sachs_Mabspace_Completed> ;
    ns1:name "Ascletis" ;
    ns1:sameAsHigh <https://1145.am/db/2301611/Ascletis>,
        <https://1145.am/db/2360860/Ascletis> ;
    ns1:sameAsMedium <https://1145.am/db/2155814/Ascletis>,
        <https://1145.am/db/2288534/Ascletis>,
        <https://1145.am/db/2363240/Ascletis>,
        <https://1145.am/db/2363247/Ascletis>,
        <https://1145.am/db/2368258/Ascletis>,
        <https://1145.am/db/2545385/Ascletis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Goldman_Sachs> a org:Organization ;
    ns1:basedInLowRaw "Singapore" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "Goldman Sachs" ;
    ns1:investor <https://1145.am/db/2546405/Series_C_Investment_Aslan_Pharmaceuticals_Accuron_Ascletis_Goldman_Sachs_Mabspace_Completed> ;
    ns1:name "Goldman Sachs" ;
    ns1:sameAsMedium <https://1145.am/db/1006297/Goldman_Sachs>,
        <https://1145.am/db/1047510/Goldman_Sachs>,
        <https://1145.am/db/1102089/Goldman_Sachs>,
        <https://1145.am/db/1142600/Goldman_Sachs>,
        <https://1145.am/db/1207590/Goldman_Sachs>,
        <https://1145.am/db/1208555/Goldman_Sachs>,
        <https://1145.am/db/1387975/Goldman_Sachs>,
        <https://1145.am/db/1390068/Goldman_Sachs>,
        <https://1145.am/db/1401543/Goldman_Sachs>,
        <https://1145.am/db/1462447/Goldman_Sachs>,
        <https://1145.am/db/1462820/Goldman_Sachs>,
        <https://1145.am/db/150562/Goldman_Sachs>,
        <https://1145.am/db/1540064/Goldman_Sachs>,
        <https://1145.am/db/158562/Goldman_Sachs>,
        <https://1145.am/db/1627942/Goldman_Sachs>,
        <https://1145.am/db/1631621/Goldman_Sachs>,
        <https://1145.am/db/1668001/Goldman_Sachs>,
        <https://1145.am/db/1694241/Goldman_Sachs>,
        <https://1145.am/db/1697693/Goldman_Sachs>,
        <https://1145.am/db/1703860/Goldman_Sachs>,
        <https://1145.am/db/1721158/Goldman_Sachs>,
        <https://1145.am/db/1725220/Goldman_Sachs>,
        <https://1145.am/db/1730048/Goldman_Sachs>,
        <https://1145.am/db/1732135/Goldman_Sachs>,
        <https://1145.am/db/1734775/Goldman_Sachs>,
        <https://1145.am/db/1735554/Goldman_Sachs>,
        <https://1145.am/db/1737385/Goldman_Sachs>,
        <https://1145.am/db/1744154/Goldman_Sachs>,
        <https://1145.am/db/1745516/Goldman_Sachs>,
        <https://1145.am/db/1746577/Goldman_Sachs>,
        <https://1145.am/db/1747060/Goldman_Sachs>,
        <https://1145.am/db/1747571/Goldman_Sachs>,
        <https://1145.am/db/1753279/Goldman_Sachs>,
        <https://1145.am/db/1753418/Goldman_Sachs>,
        <https://1145.am/db/1761940/Goldman_Sachs>,
        <https://1145.am/db/1764779/Goldman_Sachs>,
        <https://1145.am/db/1764853/Goldman_Sachs>,
        <https://1145.am/db/1770648/Goldman_Sachs>,
        <https://1145.am/db/1774767/Goldman_Sachs>,
        <https://1145.am/db/1775794/Goldman_Sachs>,
        <https://1145.am/db/1779303/Goldman_Sachs>,
        <https://1145.am/db/1782131/Goldman_Sachs>,
        <https://1145.am/db/1783737/Goldman_Sachs>,
        <https://1145.am/db/1783766/Goldman_Sachs>,
        <https://1145.am/db/1785371/Goldman_Sachs>,
        <https://1145.am/db/1787609/Goldman_Sachs>,
        <https://1145.am/db/1789188/Goldman_Sachs>,
        <https://1145.am/db/1790097/Goldman_Sachs>,
        <https://1145.am/db/1791222/Goldman_Sachs>,
        <https://1145.am/db/1792241/Goldman_Sachs>,
        <https://1145.am/db/1798631/Goldman_Sachs>,
        <https://1145.am/db/1805753/Goldman_Sachs>,
        <https://1145.am/db/1808604/Goldman_Sachs>,
        <https://1145.am/db/1808918/Goldman_Sachs>,
        <https://1145.am/db/1811126/Goldman_Sachs>,
        <https://1145.am/db/1816027/Goldman_Sachs>,
        <https://1145.am/db/1822403/Goldman_Sachs>,
        <https://1145.am/db/1834722/Goldman_Sachs>,
        <https://1145.am/db/1839749/Goldman_Sachs>,
        <https://1145.am/db/1841784/Goldman_Sachs>,
        <https://1145.am/db/1843449/Goldman_Sachs>,
        <https://1145.am/db/1849103/Goldman_Sachs>,
        <https://1145.am/db/1849797/Goldman_Sachs>,
        <https://1145.am/db/1852207/Goldman_Sachs>,
        <https://1145.am/db/1856702/Goldman_Sachs>,
        <https://1145.am/db/1858690/Goldman_Sachs>,
        <https://1145.am/db/1876344/Goldman_Sachs>,
        <https://1145.am/db/1877642/Goldman_Sachs>,
        <https://1145.am/db/1892777/Goldman_Sachs>,
        <https://1145.am/db/1895233/Goldman_Sachs>,
        <https://1145.am/db/1918332/Goldman_Sachs>,
        <https://1145.am/db/2029866/Goldman_Sachs>,
        <https://1145.am/db/2053424/Goldman_Sachs>,
        <https://1145.am/db/2067772/Goldman_Sachs>,
        <https://1145.am/db/2087870/Goldman_Sachs>,
        <https://1145.am/db/2093383/Goldman_Sachs>,
        <https://1145.am/db/2099475/Goldman_Sachs>,
        <https://1145.am/db/2114078/Goldman_Sachs>,
        <https://1145.am/db/2116159/Goldman_Sachs>,
        <https://1145.am/db/2119173/Goldman_Sachs>,
        <https://1145.am/db/214285/Goldman_Sachs>,
        <https://1145.am/db/2143574/Goldman_Sachs>,
        <https://1145.am/db/2159060/Goldman_Sachs>,
        <https://1145.am/db/2189089/Goldman_Sachs>,
        <https://1145.am/db/2229181/Goldman_Sachs>,
        <https://1145.am/db/2243776/Goldman_Sachs>,
        <https://1145.am/db/2280482/Goldman_Sachs>,
        <https://1145.am/db/2296358/Goldman_Sachs>,
        <https://1145.am/db/2304832/Goldman_Sachs>,
        <https://1145.am/db/2304844/Goldman_Sachs>,
        <https://1145.am/db/2309558/Goldman_Sachs>,
        <https://1145.am/db/2316391/Goldman_Sachs>,
        <https://1145.am/db/2326028/Goldman_Sachs___Co>,
        <https://1145.am/db/2368258/Goldman_Sachs>,
        <https://1145.am/db/2485927/Goldman_Sachs>,
        <https://1145.am/db/2545376/Goldman_Sachs>,
        <https://1145.am/db/2545385/Goldman_Sachs>,
        <https://1145.am/db/2554610/Goldman_Sachs>,
        <https://1145.am/db/2609875/Goldman_Sachs>,
        <https://1145.am/db/2623208/Goldman_Sachs>,
        <https://1145.am/db/2636409/Goldman_Sachs>,
        <https://1145.am/db/2645972/Goldman_Sachs>,
        <https://1145.am/db/265373/Goldman_Sachs>,
        <https://1145.am/db/2688475/Goldman_Sachs>,
        <https://1145.am/db/2691118/Goldman_Sachs>,
        <https://1145.am/db/2703231/Goldman_Sachs>,
        <https://1145.am/db/2720436/Goldman_Sachs>,
        <https://1145.am/db/274611/Goldman_Sachs>,
        <https://1145.am/db/2800393/Goldman_Sachs>,
        <https://1145.am/db/307789/Goldman_Sachs>,
        <https://1145.am/db/308562/Goldman_Sachs>,
        <https://1145.am/db/331288/Goldman_Sachs>,
        <https://1145.am/db/360476/Goldman_Sachs>,
        <https://1145.am/db/363100/Goldman_Sachs>,
        <https://1145.am/db/367651/Goldman_Sachs>,
        <https://1145.am/db/367735/Goldman_Sachs>,
        <https://1145.am/db/373566/Goldman_Sachs>,
        <https://1145.am/db/417305/Goldman_Sachs>,
        <https://1145.am/db/427871/Goldman_Sachs>,
        <https://1145.am/db/472129/Goldman_Sachs>,
        <https://1145.am/db/473009/Goldman_Sachs>,
        <https://1145.am/db/476326/Goldman_Sachs>,
        <https://1145.am/db/512780/Goldman_Sachs>,
        <https://1145.am/db/534085/Goldman_Sachs>,
        <https://1145.am/db/536638/Goldman_Sachs>,
        <https://1145.am/db/547965/Goldman_Sachs>,
        <https://1145.am/db/610092/Goldman_Sachs>,
        <https://1145.am/db/675103/Goldman_Sachs>,
        <https://1145.am/db/699689/Goldman_Sachs>,
        <https://1145.am/db/702810/Goldman_Sachs>,
        <https://1145.am/db/711018/Goldman_Sachs>,
        <https://1145.am/db/746914/Goldman_Sachs>,
        <https://1145.am/db/751030/Goldman_Sachs>,
        <https://1145.am/db/788125/Goldman_Sachs>,
        <https://1145.am/db/863024/Goldman_Sachs>,
        <https://1145.am/db/863541/Goldman_Sachs>,
        <https://1145.am/db/867879/Goldman_Sachs>,
        <https://1145.am/db/886532/Goldman_Sachs>,
        <https://1145.am/db/894391/Goldman_Sachs>,
        <https://1145.am/db/930479/Goldman_Sachs>,
        <https://1145.am/db/968901/Goldman_Sachs> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Investment_Pharmaron_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Funding for a broad swath of healthcare-related firms with China connections flowed nicely in the past month, with the latest of note being a $ 280 million fundraising effort for Beijing-U.S. CRO Pharmaron." ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "Funding",
        "fundraising" ;
    ns1:name "Funding",
        "fundraising" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2546405/Pharmaron> ;
    ns1:valueRaw "$ 280 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2546405/Mabspace> a org:Organization ;
    ns1:basedInLowRaw "Singapore" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "MabSpace" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2546405/Series_C_Investment_Aslan_Pharmaceuticals_Accuron_Ascletis_Goldman_Sachs_Mabspace_Completed> ;
    ns1:name "MabSpace" ;
    ns1:sameAsHigh <https://1145.am/db/2364430/Mab_Pharm> ;
    ns1:sameAsMedium <https://1145.am/db/2154451/Mabspace>,
        <https://1145.am/db/2543328/Mabspace> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2548449/Nanjing_Xinjiekou_Department_Store_Co_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:buyer <https://1145.am/db/2548449/China_Cord_Blood_Corporation_Equity_Interest_Investment> ;
    ns1:description "Business" ;
    ns1:documentDate "2016-01-12T13:45:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China Cord Blood Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma-asia/golden-meditech-enters-into-agreements-nanjing-xinjiekou-to-sell-china-cord-blood> ;
    ns1:foundName "Nanjing Xinjiekou",
        "Nanjing Xinjiekou Department Store Co., Ltd" ;
    ns1:investor <https://1145.am/db/2548449/China_Cord_Blood_Corporation_Equity_Interest_Investment> ;
    ns1:name "Nanjing Xinjiekou Department Store Co., Ltd" ;
    ns1:sameAsHigh <https://1145.am/db/2538400/Nanjing_Xinjiekou_Department_Store> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/Eight_Roads_Ventures_China> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "Eight Roads Ventures China" ;
    ns1:investor <https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> ;
    ns1:name "Eight Roads Ventures China" ;
    ns1:sameAsHigh <https://1145.am/db/142497/Eight_Roads>,
        <https://1145.am/db/1775080/Eight_Roads_Ventures>,
        <https://1145.am/db/1789003/Eight_Roads>,
        <https://1145.am/db/2369644/Eight_Roads_Ventures_China>,
        <https://1145.am/db/2549507/Eight_Roads_Ventures_China>,
        <https://1145.am/db/406679/Eight_Roads> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/Fidelity_Biosciences> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "F-Prime Capital" ;
    ns1:investor <https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> ;
    ns1:name "Fidelity Biosciences" ;
    ns1:sameAsMedium <https://1145.am/db/1801792/Fidelity_Biosciences>,
        <https://1145.am/db/1849746/Fidelity_Biosciences>,
        <https://1145.am/db/2223723/Fidelity_Biosciences>,
        <https://1145.am/db/2303275/Fidelity_Biosciences>,
        <https://1145.am/db/2304028/Fidelity_Biosciences>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2306790/Fidelity_Biosciences>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2316601/Fidelity_Biosciences>,
        <https://1145.am/db/2316605/Fidelity_Biosciences>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2336890/Fidelity_Biosciences>,
        <https://1145.am/db/2337971/Fidelity_Biosciences>,
        <https://1145.am/db/2337972/Fidelity_Biosciences>,
        <https://1145.am/db/2339666/Fidelity_Biosciences>,
        <https://1145.am/db/2340581/Fidelity_Biosciences>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2342754/Fidelity_Biosciences>,
        <https://1145.am/db/2342768/Fidelity_Biosciences>,
        <https://1145.am/db/2342771/Fidelity_Biosciences>,
        <https://1145.am/db/2344017/Fidelity_Biosciences>,
        <https://1145.am/db/2348149/Fidelity_Biosciences>,
        <https://1145.am/db/2349048/Fidelity_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2350891/Fidelity_Biosciences>,
        <https://1145.am/db/2352349/Fidelity_Biosciences>,
        <https://1145.am/db/2352350/Fidelity_Biosciences>,
        <https://1145.am/db/2354537/Fidelity_Biosciences>,
        <https://1145.am/db/2356048/Fidelity_Biosciences>,
        <https://1145.am/db/2356124/Fidelity_Biosciences>,
        <https://1145.am/db/2357722/Fidelity_Biosciences>,
        <https://1145.am/db/2359227/Fidelity_Biosciences>,
        <https://1145.am/db/2359240/Fidelity_Biosciences>,
        <https://1145.am/db/2359287/Fidelity_Biosciences>,
        <https://1145.am/db/2359562/Fidelity_Biosciences>,
        <https://1145.am/db/2359683/Fidelity_Biosciences>,
        <https://1145.am/db/2361065/Fidelity_Biosciences>,
        <https://1145.am/db/2363510/Fidelity_Biosciences>,
        <https://1145.am/db/2366710/Fidelity_Biosciences>,
        <https://1145.am/db/2366712/Fidelity_Biosciences>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367381/Fidelity_Biosciences>,
        <https://1145.am/db/2369644/Fidelity_Biosciences>,
        <https://1145.am/db/2549507/Fidelity_Biosciences>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2569831/Fidelity_Biosciences>,
        <https://1145.am/db/2587938/Fidelity_Biosciences>,
        <https://1145.am/db/2588372/Fidelity_Biosciences> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/Gp_Healthcare_Capital> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "GP Healthcare Capital" ;
    ns1:investor <https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> ;
    ns1:name "GP Healthcare Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2293618/Gp_Healthcare_Capital>,
        <https://1145.am/db/2369644/Gp_Healthcare_Capital>,
        <https://1145.am/db/2549507/Gp_Healthcare_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/New_World_Tmt> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "\"New World TMT" ;
    ns1:investor <https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> ;
    ns1:name "New World TMT" ;
    ns1:sameAsMedium <https://1145.am/db/2369644/New_World_Tmt>,
        <https://1145.am/db/2549507/New_World_Tmt> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/Wuxi_Corporate_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "WuXi Corporate Venture Fund" ;
    ns1:investor <https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> ;
    ns1:name "WuXi Corporate Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2322852/Wuxi_Corporate_Venture_Fund>,
        <https://1145.am/db/2350891/Wuxi_Venture_Fund>,
        <https://1145.am/db/2369644/Wuxi_Corporate_Venture_Fund>,
        <https://1145.am/db/2549507/Wuxi_Corporate_Venture_Fund>,
        <https://1145.am/db/2550682/Wuxi_Corporate_Venture_Fund> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570523/Venbio> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2015-08-17T19:59:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/checkmate-pharmaceuticals-debuts-20-million-series-a-investment-for-development-of> ;
    ns1:foundName "venBio" ;
    ns1:investor <https://1145.am/db/2570523/Series_A_Investment_Checkmate_Pharmaceuticals_Cytos_Biotechnology_Ltd_Sofinnova_Ventures_Venbio_Completed> ;
    ns1:name "venBio" ;
    ns1:sameAsMedium <https://1145.am/db/2336503/Venbio>,
        <https://1145.am/db/2336505/Venbio>,
        <https://1145.am/db/2336524/Venbio>,
        <https://1145.am/db/2346293/Venbio>,
        <https://1145.am/db/2352349/Venbio>,
        <https://1145.am/db/2352350/Venbio>,
        <https://1145.am/db/2359468/Venbio>,
        <https://1145.am/db/2360647/Venbio>,
        <https://1145.am/db/2360667/Venbio>,
        <https://1145.am/db/2364514/Venbio>,
        <https://1145.am/db/2364518/Venbio>,
        <https://1145.am/db/2570520/Venbio>,
        <https://1145.am/db/2575687/Venbio>,
        <https://1145.am/db/2583013/Venbio>,
        <https://1145.am/db/428737/Venbio>,
        <https://1145.am/db/560096/Venbio>,
        <https://1145.am/db/704198/Venbio> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578827/Hikma_Mallinckrodt> a org:Organization ;
    ns1:basedInLowRaw "German" ;
    ns1:buyer <https://1145.am/db/2578827/Roxane_Labs_Assets_Acquisition>,
        <https://1145.am/db/2578827/Unit_Acquisition_Boehringer_Hikma_Mallinckrodt_Perrigo_Has_Not_Happened>,
        <https://1145.am/db/2578827/Unit_Merger_Boehringer_Hikma_Mallinckrodt_Has_Not_Happened> ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "Hikma, Mallinckrodt" ;
    ns1:industry "drugmaker" ;
    ns1:name "Hikma, Mallinckrodt" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578827/Perrigo> a org:Organization ;
    ns1:basedInLowRaw "German" ;
    ns1:buyer <https://1145.am/db/2578827/Roxane_Labs_Assets_Acquisition>,
        <https://1145.am/db/2578827/Unit_Acquisition_Boehringer_Hikma_Mallinckrodt_Perrigo_Has_Not_Happened> ;
    ns1:description "drugmaker" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "Perrigo" ;
    ns1:industry "drugmaker" ;
    ns1:name "Perrigo" ;
    ns1:sameAsHigh <https://1145.am/db/140347/Perrigo>,
        <https://1145.am/db/2301756/Pergamum_Ab>,
        <https://1145.am/db/2305515/Perrigo_Company>,
        <https://1145.am/db/2319220/Perrigo_Company>,
        <https://1145.am/db/2319399/Perrigo>,
        <https://1145.am/db/2319885/Perrigo_Company>,
        <https://1145.am/db/2322083/Perrigo>,
        <https://1145.am/db/2328536/Perrigo_Company>,
        <https://1145.am/db/2341767/Perrigo>,
        <https://1145.am/db/2349480/Perosphere_Inc>,
        <https://1145.am/db/2350515/Perosphere_Inc>,
        <https://1145.am/db/2355339/Perrigo_Pharmaceuticals>,
        <https://1145.am/db/2537398/Perrigo>,
        <https://1145.am/db/2538031/Perrigo>,
        <https://1145.am/db/2538653/Perrigo>,
        <https://1145.am/db/2540105/Perrigo>,
        <https://1145.am/db/2540521/Perrigo>,
        <https://1145.am/db/2541499/Perrigo>,
        <https://1145.am/db/2544762/Perrigo>,
        <https://1145.am/db/2546145/Perrigo>,
        <https://1145.am/db/2546149/Perrigo>,
        <https://1145.am/db/2546959/Perrigo>,
        <https://1145.am/db/2561423/Perrigo>,
        <https://1145.am/db/2562362/Perrigo>,
        <https://1145.am/db/2563325/Perrigo>,
        <https://1145.am/db/2563341/Perrigo>,
        <https://1145.am/db/2563450/Perrigo>,
        <https://1145.am/db/2569075/Perrigo>,
        <https://1145.am/db/2569076/Perrigo>,
        <https://1145.am/db/2570437/Perrigo>,
        <https://1145.am/db/2571324/Perrigo>,
        <https://1145.am/db/2571355/Perrigo>,
        <https://1145.am/db/2572093/Perrigo>,
        <https://1145.am/db/2572985/Perrigo>,
        <https://1145.am/db/2575861/Perrigo>,
        <https://1145.am/db/2575863/Perrigo>,
        <https://1145.am/db/2576144/Perrigo>,
        <https://1145.am/db/2577804/Perrigo>,
        <https://1145.am/db/2577810/Perrigo>,
        <https://1145.am/db/2578176/Perrigo>,
        <https://1145.am/db/2578808/Perrigo>,
        <https://1145.am/db/2579630/Perrigo>,
        <https://1145.am/db/2581325/Perrigo>,
        <https://1145.am/db/2583414/Perrigo>,
        <https://1145.am/db/2583676/Perrigo>,
        <https://1145.am/db/2584589/Perrigo>,
        <https://1145.am/db/2584909/Perrigo>,
        <https://1145.am/db/2585327/Perrigo_Company>,
        <https://1145.am/db/2585605/Perrigo>,
        <https://1145.am/db/2587506/Perrigo>,
        <https://1145.am/db/2587539/Perrigo>,
        <https://1145.am/db/2588053/Perrigo>,
        <https://1145.am/db/2589750/Perrigo>,
        <https://1145.am/db/2594992/Perrigo>,
        <https://1145.am/db/2595051/Perrigo>,
        <https://1145.am/db/2595564/Perrigo>,
        <https://1145.am/db/2595684/Perrigo>,
        <https://1145.am/db/2595688/Perrigo>,
        <https://1145.am/db/2598736/Perrigo> ;
    ns1:sameAsMedium <https://1145.am/db/1466026/Perrigo>,
        <https://1145.am/db/2306691/Perrigo_Company>,
        <https://1145.am/db/2311233/Perrigo>,
        <https://1145.am/db/2322064/Perrigo_Company>,
        <https://1145.am/db/2325736/Perrigo_Company>,
        <https://1145.am/db/2334551/Perrigo>,
        <https://1145.am/db/2339612/Perrigo>,
        <https://1145.am/db/2343835/Perrigo>,
        <https://1145.am/db/2354155/Perrigo>,
        <https://1145.am/db/252316/Perrigo>,
        <https://1145.am/db/2538226/Perrigo>,
        <https://1145.am/db/2539012/Perrigo>,
        <https://1145.am/db/2549203/Perrigo>,
        <https://1145.am/db/2553219/Perrigo>,
        <https://1145.am/db/2555939/Perrigo>,
        <https://1145.am/db/2562354/Perrigo>,
        <https://1145.am/db/2564219/Perrigo>,
        <https://1145.am/db/2568858/Perrigo>,
        <https://1145.am/db/2572018/Perrigo>,
        <https://1145.am/db/2572085/Perrigo>,
        <https://1145.am/db/2576104/Perrigo>,
        <https://1145.am/db/2577809/Perrigo>,
        <https://1145.am/db/2578160/Perrigo>,
        <https://1145.am/db/2581804/Perrigo>,
        <https://1145.am/db/2584598/Perrigo>,
        <https://1145.am/db/2584603/Perrigo>,
        <https://1145.am/db/2585584/Perrigo>,
        <https://1145.am/db/2585604/Perrigo>,
        <https://1145.am/db/2585606/Perrigo>,
        <https://1145.am/db/2586571/Perrigo>,
        <https://1145.am/db/2586572/Perrigo>,
        <https://1145.am/db/2587513/Perrigo>,
        <https://1145.am/db/2588051/Perrigo>,
        <https://1145.am/db/2590594/Perrigo>,
        <https://1145.am/db/2592352/Perrigo>,
        <https://1145.am/db/2593465/Perrigo>,
        <https://1145.am/db/2594877/Perrigo> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/Casdin_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Casdin Capital" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Casdin Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Casdin_Capital>,
        <https://1145.am/db/1045411/Casdin_Capital>,
        <https://1145.am/db/1220031/Casdin_Capital>,
        <https://1145.am/db/1247997/Casdin_Capital>,
        <https://1145.am/db/1519613/Casdin_Capital>,
        <https://1145.am/db/1519799/Casdin_Capital>,
        <https://1145.am/db/1779452/Casdin_Capital>,
        <https://1145.am/db/1984721/Casdin_Capital>,
        <https://1145.am/db/2069495/Casdin_Capital>,
        <https://1145.am/db/2152471/Casdin_Capital>,
        <https://1145.am/db/2181257/Casdin_Capital>,
        <https://1145.am/db/2181449/Casdin_Capital>,
        <https://1145.am/db/2286541/Casdin_Capital_Llc>,
        <https://1145.am/db/2287519/Casdin_Capital>,
        <https://1145.am/db/2291403/Casdin_Capital>,
        <https://1145.am/db/230667/Casdin_Capital>,
        <https://1145.am/db/2308713/Casdin_Capital>,
        <https://1145.am/db/2309619/Casdin_Capital>,
        <https://1145.am/db/2330486/Casdin_Capital>,
        <https://1145.am/db/2342754/Casdin_Capital>,
        <https://1145.am/db/2342768/Casdin_Capital>,
        <https://1145.am/db/2342771/Casdin_Capital>,
        <https://1145.am/db/2345099/Casdin_Capital>,
        <https://1145.am/db/2346063/Casdin_Capital>,
        <https://1145.am/db/2351302/Casdin_Capital>,
        <https://1145.am/db/2361695/Casdin_Capital>,
        <https://1145.am/db/2362106/Casdin_Capital>,
        <https://1145.am/db/2369304/Casdin_Capital>,
        <https://1145.am/db/2541350/Casdin_Capital>,
        <https://1145.am/db/365631/Casdin_Capital>,
        <https://1145.am/db/471253/Casdin_Capital>,
        <https://1145.am/db/490696/Casdin_Capital>,
        <https://1145.am/db/522651/Casdin_Capital>,
        <https://1145.am/db/527072/Casdin_Capital>,
        <https://1145.am/db/571769/Casdin_Capital>,
        <https://1145.am/db/604944/Casdin_Capital>,
        <https://1145.am/db/641046/Casdin_Capital>,
        <https://1145.am/db/645428/Casdin_Capital>,
        <https://1145.am/db/683648/Casdin_Capital>,
        <https://1145.am/db/708134/Casdin_Capital>,
        <https://1145.am/db/711539/Casdin_Capital>,
        <https://1145.am/db/745407/Casdin_Capital>,
        <https://1145.am/db/769568/Casdin_Capital>,
        <https://1145.am/db/912943/Casdin_Capital>,
        <https://1145.am/db/915003/Casdin_Capital>,
        <https://1145.am/db/922439/Casdin_Capital>,
        <https://1145.am/db/932769/Casdin_Capital>,
        <https://1145.am/db/936819/Casdin_Capital>,
        <https://1145.am/db/937281/Casdin_Capital>,
        <https://1145.am/db/938108/Casdin_Capital>,
        <https://1145.am/db/948499/Casdin_Capital>,
        <https://1145.am/db/953800/Casdin_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "biotechnology investors" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/Transformational_Healthcare_Opportunity> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "private investors" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Transformational Healthcare Opportunity" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Transformational Healthcare Opportunity" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586575/Cinven> a org:Organization ;
    ns1:basedInLowRaw "European" ;
    ns1:buyer <https://1145.am/db/2586575/Amdipharm_Mercury_Limited_Acquisition> ;
    ns1:description "private equity" ;
    ns1:documentDate "2015-09-08T15:25:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Concordia Healthcare to Acquire Amdipharm Mercury Limited (AMCo) for US$3.5 Billion Creating a Global Platform to Facilitate Future Growth" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/concordia-healthcare-to-acquire-amdipharm-mercury-limited-amco-for-us-3-5-billion-creating-a> ;
    ns1:foundName "Cinven1" ;
    ns1:industry "private equity firm" ;
    ns1:investor <https://1145.am/db/2586575/Amdipharm_Mercury_Limited_Acquisition> ;
    ns1:name "Cinven" ;
    ns1:sameAsHigh <https://1145.am/db/1048903/Permira>,
        <https://1145.am/db/1244609/Permira>,
        <https://1145.am/db/1245131/Permira>,
        <https://1145.am/db/1252489/Corinthian_Capital_Group>,
        <https://1145.am/db/1281057/Kainos_Capital>,
        <https://1145.am/db/1281551/Kainos_Capital>,
        <https://1145.am/db/1354354/Permira>,
        <https://1145.am/db/1358758/Cinven>,
        <https://1145.am/db/137792/Cerberus_Capital_Management>,
        <https://1145.am/db/1394310/Cinven>,
        <https://1145.am/db/1395418/Cinven>,
        <https://1145.am/db/1420562/CVC>,
        <https://1145.am/db/1525260/Permira>,
        <https://1145.am/db/1599593/CVC>,
        <https://1145.am/db/164559/CVC>,
        <https://1145.am/db/1655263/Permira>,
        <https://1145.am/db/1656974/Kain_Capital_Llc>,
        <https://1145.am/db/1680141/Cinven>,
        <https://1145.am/db/1693626/Cinven>,
        <https://1145.am/db/1695857/Cinven>,
        <https://1145.am/db/1804060/Permira>,
        <https://1145.am/db/1815260/Cinven_Permira>,
        <https://1145.am/db/1823926/Citic_Private_Equity>,
        <https://1145.am/db/1824518/Permira>,
        <https://1145.am/db/186968/Permira>,
        <https://1145.am/db/1921869/Cm-Cic_Private_Equity>,
        <https://1145.am/db/1927657/Permira>,
        <https://1145.am/db/195233/Permira>,
        <https://1145.am/db/195237/Permira>,
        <https://1145.am/db/1958910/Columbia_Capital>,
        <https://1145.am/db/1959233/Columbia_Capital>,
        <https://1145.am/db/1970606/Cvc_Capital>,
        <https://1145.am/db/2049137/Ilion_Capital_Partners>,
        <https://1145.am/db/2071409/Permira>,
        <https://1145.am/db/2078232/Kainos_Capital>,
        <https://1145.am/db/2083832/Kainos_Capital>,
        <https://1145.am/db/209348/CVC>,
        <https://1145.am/db/2101144/Citic_Capital_Holdings_Limited>,
        <https://1145.am/db/2106529/Permira>,
        <https://1145.am/db/2126881/Cinven>,
        <https://1145.am/db/2133089/Cinven>,
        <https://1145.am/db/2153971/Cicc_Capital>,
        <https://1145.am/db/2266293/Cerberus_Capital_Management>,
        <https://1145.am/db/2284380/Permira>,
        <https://1145.am/db/2288000/Cinven>,
        <https://1145.am/db/2288010/Cinven>,
        <https://1145.am/db/2311826/Cinven>,
        <https://1145.am/db/2311831/Cinven>,
        <https://1145.am/db/2315088/Cinven>,
        <https://1145.am/db/2321753/Cinven>,
        <https://1145.am/db/2321757/Cinven>,
        <https://1145.am/db/2353087/Cinven>,
        <https://1145.am/db/2552934/Permira_Funds>,
        <https://1145.am/db/2558953/Cinven>,
        <https://1145.am/db/2558955/Cinven>,
        <https://1145.am/db/2562184/Permira>,
        <https://1145.am/db/2565596/Permira>,
        <https://1145.am/db/2591584/Cinven>,
        <https://1145.am/db/2597618/Cinven>,
        <https://1145.am/db/2629313/Permira>,
        <https://1145.am/db/2651185/CVC>,
        <https://1145.am/db/2654019/Cinven>,
        <https://1145.am/db/2659745/Permira>,
        <https://1145.am/db/2667474/Cinven>,
        <https://1145.am/db/2667842/Permira>,
        <https://1145.am/db/2682053/Permira>,
        <https://1145.am/db/2718055/Permira>,
        <https://1145.am/db/307190/Citic_Private_Equity>,
        <https://1145.am/db/307216/Citic_Private_Equity>,
        <https://1145.am/db/351293/Cinven>,
        <https://1145.am/db/376447/Permira>,
        <https://1145.am/db/377058/Claritas_Capital>,
        <https://1145.am/db/414406/Permira>,
        <https://1145.am/db/414463/Permira>,
        <https://1145.am/db/540063/Permira>,
        <https://1145.am/db/596291/Cinven>,
        <https://1145.am/db/626988/Permira>,
        <https://1145.am/db/629527/Permira>,
        <https://1145.am/db/710410/Cinven>,
        <https://1145.am/db/710798/Cinven>,
        <https://1145.am/db/740656/Permira>,
        <https://1145.am/db/745347/Kainos_Capital>,
        <https://1145.am/db/808384/The_Capstreet_Group>,
        <https://1145.am/db/95036/Permira>,
        <https://1145.am/db/984833/Cvc_Capital_Partners_Viii> ;
    ns1:sameAsMedium <https://1145.am/db/1591188/Cinven>,
        <https://1145.am/db/1768282/Cinven>,
        <https://1145.am/db/1935998/Cinven>,
        <https://1145.am/db/1953984/Cinven>,
        <https://1145.am/db/1995783/Cinven>,
        <https://1145.am/db/2053902/Cinven>,
        <https://1145.am/db/2060280/Cinven>,
        <https://1145.am/db/2296000/Cinven>,
        <https://1145.am/db/2315100/Cinven>,
        <https://1145.am/db/2322814/Cinven>,
        <https://1145.am/db/2324915/Cinven>,
        <https://1145.am/db/2329224/Cinven>,
        <https://1145.am/db/2349572/Cinven>,
        <https://1145.am/db/2367825/Cinven>,
        <https://1145.am/db/2578808/Cinven>,
        <https://1145.am/db/2580123/Cinven>,
        <https://1145.am/db/2582081/Cinven>,
        <https://1145.am/db/2583998/Cinven>,
        <https://1145.am/db/2586574/Cinven>,
        <https://1145.am/db/2597612/Cinven>,
        <https://1145.am/db/2654009/Cinven>,
        <https://1145.am/db/2654828/Cinven>,
        <https://1145.am/db/2655776/Cinven>,
        <https://1145.am/db/2656748/Cinven>,
        <https://1145.am/db/2656768/Cinven>,
        <https://1145.am/db/2673106/Cinven>,
        <https://1145.am/db/332682/Cinven>,
        <https://1145.am/db/595717/Cinven>,
        <https://1145.am/db/616385/Cinven>,
        <https://1145.am/db/889342/Cinven>,
        <https://1145.am/db/889382/Cinven>,
        <https://1145.am/db/892372/Cinven> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587565/Gho_Capital> a org:Organization ;
    ns1:buyer <https://1145.am/db/2587565/Dna_Diagnostics_Center_Acquisition> ;
    ns1:description "healthcare investor" ;
    ns1:documentDate "2015-10-15T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GHO Capital Announces Acquisition of DNA Diagnostics Center" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/gho-capital-announces-acquisition-of-dna-diagnostics-center> ;
    ns1:foundName "GHO Capital" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2587565/Dna_Diagnostics_Center_Acquisition> ;
    ns1:name "GHO Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2285911/Gho_Capital>,
        <https://1145.am/db/2304996/Gho_Capital>,
        <https://1145.am/db/2327071/Gho_Capital>,
        <https://1145.am/db/2572187/Gho_Capital>,
        <https://1145.am/db/2587566/Gho_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1615485/Gho_Capital>,
        <https://1145.am/db/2298376/Gho_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588562/Cortec_Group_Fund_V_Lp> a org:Organization ;
    ns1:basedInHighGeoName "New York City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:basedInHighRaw "New York" ;
    ns1:basedInLowRaw "U.S" ;
    ns1:buyer <https://1145.am/db/2588562/Community_Veterinary_Partners_Acquisition> ;
    ns1:description "investing in middle market healthcare, specialty service, consumer, and distribution businesses",
        "middle market healthcare, specialty service, consumer, and distribution businesses" ;
    ns1:documentDate "2015-11-23T13:43:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cortec Group buys Community Veterinary Partners" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/cortec-group-buys-community-veterinary-partners> ;
    ns1:foundName "Cortec Group",
        "Cortec Group Fund V, L.P." ;
    ns1:industry "private equity" ;
    ns1:investor <https://1145.am/db/2588562/Community_Veterinary_Partners_Acquisition> ;
    ns1:name "Cortec Group",
        "Cortec Group Fund V, L.P." ;
    ns1:participant <https://1145.am/db/2588562/Community_Veterinary_Partners_Acquisition> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Agriculture> a org:Organization ;
    ns1:basedInHighGeoName "Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:basedInHighRaw "Ireland" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "industry" ;
    ns1:name "agriculture" ;
    ns1:protagonist <https://1145.am/db/2588578/Joint_Venture_The_Us_State_Department_Agriculture_Completed> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Institute_For_Infectious_Diseases> a org:Organization ;
    ns1:basedInHighGeoName "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Texas" ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "Infectious Diseases" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "Institute for Infectious Diseases",
        "for Infectious Diseases" ;
    ns1:investor <https://1145.am/db/2588578/Investment_Institute_For_Infectious_Diseases_Science_And_Technology_Directorate_Texas_A___M_College_Of_Veterinary_Medicine___Biomedical_Sciences_Has_Not_Happened> ;
    ns1:name "Institute",
        "Institute for Infectious Diseases" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Science_And_Technology_Directorate> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "Science and Technology" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "Science and Technology Directorate",
        "and Technology Directorate" ;
    ns1:investor <https://1145.am/db/2588578/Investment_Institute_For_Infectious_Diseases_Science_And_Technology_Directorate_Texas_A___M_College_Of_Veterinary_Medicine___Biomedical_Sciences_Has_Not_Happened> ;
    ns1:name "Science",
        "Science and Technology Directorate" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Sequent_Scientific> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:buyer <https://1145.am/db/2588578/Topkim_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "Sequent Scientific" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Sequent Scientific" ;
    ns1:sameAsHigh <https://1145.am/db/2552735/Sequent_Scientific> ;
    ns1:sameAsMedium <https://1145.am/db/2553755/Sequent_Scientific> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Tangerine_Group> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "U.K." ;
    ns1:buyer <https://1145.am/db/2588578/Joint_Venture_Tangerine_Group_Has_Not_Happened> ;
    ns1:description "veterinary drugmaker" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "Tangerine Group" ;
    ns1:industry "veterinary drugmaker" ;
    ns1:name "Tangerine Group" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/The_Us_State_Department> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "The U.S. State Department",
        "U.S. State Department" ;
    ns1:name "The U.S. State Department",
        "U.S. State Department" ;
    ns1:protagonist <https://1145.am/db/2588578/Joint_Venture_The_Us_State_Department_Agriculture_Completed>,
        <https://1145.am/db/2588578/Joint_Venture_The_Us_State_Department_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2099798/Us_State_Department>,
        <https://1145.am/db/2504983/The_Us_State_Department> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Cdt_Veterinary_Therapeutics> a org:Organization ;
    ns1:description "developing cancer drugs for the veterinary market" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "CDT Veterinary Therapeutics" ;
    ns1:name "CDT Veterinary Therapeutics" ;
    ns1:protagonist <https://1145.am/db/2588584/Merger_Cdt_Veterinary_Therapeutics_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2588590/Cdt_Veterinary_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Louisiana_State_University> a org:Organization ;
    ns1:basedInLowRaw "Australia" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "Louisiana State University" ;
    ns1:investor <https://1145.am/db/2588584/Investment_Henry_Schein_Has_Not_Happened> ;
    ns1:name "Louisiana State University" ;
    ns1:sameAsMedium <https://1145.am/db/549886/Louisiana_State_University> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/Food_Emergency_Response_Network> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Food Emergency Response Network",
        "federal" ;
    ns1:investor <https://1145.am/db/2589535/Investment_Food_Emergency_Response_Network_The_California_Animal_Health_And_Food_Safety_Laboratory_System_Has_Not_Happened> ;
    ns1:name "Food Emergency Response Network" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/Huvepharma> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Bulgaria" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/732800/about.rdf> ;
    ns1:basedInHighRaw "Bulgaria" ;
    ns1:buyer <https://1145.am/db/2589535/Factories_Acquisition_Animal_Health_Giant_Huvepharma_Completed> ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Huvepharma" ;
    ns1:industry "Animal health" ;
    ns1:name "Huvepharma" ;
    ns1:sameAsHigh <https://1145.am/db/2317128/Boehringer_Ingelheim_Animal_Health>,
        <https://1145.am/db/2358257/Pfizer_Animal_Health>,
        <https://1145.am/db/2546156/Huvepharma>,
        <https://1145.am/db/2554269/Merck>,
        <https://1145.am/db/2559940/Vgx_Animal_Health>,
        <https://1145.am/db/2561990/Pfizer_Animal_Health>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2570042/Huvepharma>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2576933/Animal_Health>,
        <https://1145.am/db/2577432/Pfizer_Animal_Health>,
        <https://1145.am/db/2578874/Novartis_Animal_Health>,
        <https://1145.am/db/2578876/Novartis_Animal_Health>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2587611/Pharmaq>,
        <https://1145.am/db/2588540/Merck>,
        <https://1145.am/db/2588547/Pharmaq>,
        <https://1145.am/db/2589700/Novartis_Animal_Health>,
        <https://1145.am/db/2590486/Novartis_Animal_Health>,
        <https://1145.am/db/2590993/Janssen_Pharmaceutica_Nv>,
        <https://1145.am/db/2590999/Janssen_Pharmaceutica_Nv>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2594485/Novartis_Animal_Health>,
        <https://1145.am/db/352041/Huvepharma> ;
    ns1:sameAsMedium <https://1145.am/db/2547130/Huvepharma>,
        <https://1145.am/db/2570023/Huvepharma>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2589536/Huvepharma>,
        <https://1145.am/db/366235/Huvepharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2600867/Atlantic_Tele-Network> a org:Organization ;
    ns1:basedInLowRaw "Bermuda" ;
    ns1:buyer <https://1145.am/db/2600867/Keytech_Interest_Investment> ;
    ns1:description "business" ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "Atlantic Tele-Network" ;
    ns1:investor <https://1145.am/db/2600867/Keytech_Interest_Investment> ;
    ns1:name "Atlantic Tele-Network" ;
    ns1:sameAsHigh <https://1145.am/db/2600849/Atlantic_Tele-Network_Atn_Inc>,
        <https://1145.am/db/2643151/Atlantic_Tele-Network>,
        <https://1145.am/db/2667130/Atlantic_Tele-Network>,
        <https://1145.am/db/2671406/Atlantic_Tele-Network>,
        <https://1145.am/db/2684609/Atlantic-Tele_Network>,
        <https://1145.am/db/2685047/Atlantic-Tele_Network> ;
    ns1:sameAsMedium <https://1145.am/db/2666095/Atlantic_Tele-Network>,
        <https://1145.am/db/2683799/Atlantic_Tele-Network>,
        <https://1145.am/db/2685877/Atlantic_Tele-Network>,
        <https://1145.am/db/2686087/Atlantic-Tele_Network> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2600867/D___S_Communications> a org:Organization ;
    ns1:basedInLowRaw "New Zealand" ;
    ns1:buyer <https://1145.am/db/2600867/Mako_Networks_Assets_Acquisition> ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "D & S Communications" ;
    ns1:name "D & S Communications" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2661968/Altice> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:buyer <https://1145.am/db/2661968/Cablevision_Acquisition> ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Altice" ;
    ns1:investor <https://1145.am/db/2661968/Cablevision_Acquisition> ;
    ns1:name "Altice" ;
    ns1:sameAsMedium <https://1145.am/db/158688/Altice>,
        <https://1145.am/db/1778898/Altice>,
        <https://1145.am/db/1823376/Altice>,
        <https://1145.am/db/1857753/Altice>,
        <https://1145.am/db/2108865/Altice>,
        <https://1145.am/db/2111004/Altice>,
        <https://1145.am/db/2156880/Altice_Sa>,
        <https://1145.am/db/2157452/Altice>,
        <https://1145.am/db/2159307/Altice>,
        <https://1145.am/db/2159990/Altice>,
        <https://1145.am/db/2159996/Altice>,
        <https://1145.am/db/2160527/Altice_Nv>,
        <https://1145.am/db/2160569/Altice_Nv>,
        <https://1145.am/db/2160671/Altice>,
        <https://1145.am/db/2160683/Altice>,
        <https://1145.am/db/2162126/Altice>,
        <https://1145.am/db/2162820/Altice>,
        <https://1145.am/db/2164289/Altice>,
        <https://1145.am/db/2165008/Altice>,
        <https://1145.am/db/2165023/Altice_Nv>,
        <https://1145.am/db/2165731/Altice>,
        <https://1145.am/db/2166440/Altice>,
        <https://1145.am/db/2167192/Altice_Nv>,
        <https://1145.am/db/2168683/Altice>,
        <https://1145.am/db/2169452/Altice_Nv>,
        <https://1145.am/db/2169458/Altice_Nv>,
        <https://1145.am/db/2171023/Altice>,
        <https://1145.am/db/2171752/Altice>,
        <https://1145.am/db/2171869/Altice_Nv>,
        <https://1145.am/db/2171886/Altice_Nv>,
        <https://1145.am/db/2172300/Altice>,
        <https://1145.am/db/2172571/Altice>,
        <https://1145.am/db/2172699/Altice>,
        <https://1145.am/db/2172709/Altice>,
        <https://1145.am/db/2173475/Altice_Nv>,
        <https://1145.am/db/2174247/Altice>,
        <https://1145.am/db/2174317/Altice>,
        <https://1145.am/db/2175078/Altice>,
        <https://1145.am/db/2176320/Altice>,
        <https://1145.am/db/2176347/Altice>,
        <https://1145.am/db/2176723/Altice>,
        <https://1145.am/db/2176879/Altice_Sa>,
        <https://1145.am/db/2176883/Altice_Sa>,
        <https://1145.am/db/2176886/Altice_Sa>,
        <https://1145.am/db/2176887/Altice>,
        <https://1145.am/db/2176891/Altice_Sa>,
        <https://1145.am/db/2176893/Altice_Sa>,
        <https://1145.am/db/2176902/Altice_Sa>,
        <https://1145.am/db/2177528/Altice_Nv>,
        <https://1145.am/db/2598834/Altice>,
        <https://1145.am/db/2599895/Altice>,
        <https://1145.am/db/2599901/Altice>,
        <https://1145.am/db/2601526/Altice>,
        <https://1145.am/db/2601574/Altice>,
        <https://1145.am/db/2610009/Altice_Uk>,
        <https://1145.am/db/2612142/Altice>,
        <https://1145.am/db/2616591/Altice>,
        <https://1145.am/db/2617789/Altice>,
        <https://1145.am/db/2648714/Altice>,
        <https://1145.am/db/2650891/Altice>,
        <https://1145.am/db/2650993/Altice>,
        <https://1145.am/db/2651003/Altice>,
        <https://1145.am/db/2651361/Altice>,
        <https://1145.am/db/2651395/Altice>,
        <https://1145.am/db/2651766/Altice>,
        <https://1145.am/db/2652384/Altice>,
        <https://1145.am/db/2652387/Altice>,
        <https://1145.am/db/2652416/Altice>,
        <https://1145.am/db/2653160/Altice>,
        <https://1145.am/db/2654827/Altice>,
        <https://1145.am/db/2654828/Altice>,
        <https://1145.am/db/2654869/Altice>,
        <https://1145.am/db/2655768/Altice>,
        <https://1145.am/db/2656802/Altice>,
        <https://1145.am/db/2656807/Altice>,
        <https://1145.am/db/2657961/Altice>,
        <https://1145.am/db/2658756/Altice>,
        <https://1145.am/db/2658778/Altice>,
        <https://1145.am/db/2658794/Altice>,
        <https://1145.am/db/2659913/Altice>,
        <https://1145.am/db/2660343/Altice>,
        <https://1145.am/db/2660907/Altice>,
        <https://1145.am/db/2660912/Altice>,
        <https://1145.am/db/2661952/Altice>,
        <https://1145.am/db/2662097/Altice>,
        <https://1145.am/db/2666278/Altice>,
        <https://1145.am/db/2666408/Altice>,
        <https://1145.am/db/2667465/Altice>,
        <https://1145.am/db/2667476/Altice>,
        <https://1145.am/db/2667483/Altice>,
        <https://1145.am/db/2667499/Altice>,
        <https://1145.am/db/2668578/Altice>,
        <https://1145.am/db/2668601/Altice>,
        <https://1145.am/db/2670028/Altice>,
        <https://1145.am/db/2671825/Altice>,
        <https://1145.am/db/2673106/Altice>,
        <https://1145.am/db/2675345/Altice>,
        <https://1145.am/db/2676545/Altice>,
        <https://1145.am/db/2679056/Altice>,
        <https://1145.am/db/2679067/Altice>,
        <https://1145.am/db/2679078/Altice>,
        <https://1145.am/db/2679079/Altice>,
        <https://1145.am/db/2680115/Altice>,
        <https://1145.am/db/2680134/Altice>,
        <https://1145.am/db/348524/Altice_Uk>,
        <https://1145.am/db/492277/Altice> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661968/Helios_Partners> a org:Organization ;
    ns1:basedInLowRaw "Kenya" ;
    ns1:buyer <https://1145.am/db/2661968/Orange_Stake_Acquisition>,
        <https://1145.am/db/2661968/Stake_Acquisition_Helios_Partners_Orange_Has_Not_Happened> ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Helios Partners" ;
    ns1:investor <https://1145.am/db/2661968/Stake_Investment_Helios_Partners_Has_Not_Happened> ;
    ns1:name "Helios Partners" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661968/Vivendi> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Vivendi" ;
    ns1:investor <https://1145.am/db/2661968/Telecom_Italia_Stake_Investment> ;
    ns1:name "Vivendi" ;
    ns1:sameAsMedium <https://1145.am/db/1040495/Vivendi>,
        <https://1145.am/db/1149070/Vivendi>,
        <https://1145.am/db/1387326/Vivendi>,
        <https://1145.am/db/1446747/Vivendi>,
        <https://1145.am/db/1478723/Vivendi>,
        <https://1145.am/db/1512124/Vivendi>,
        <https://1145.am/db/1526556/Vivendi>,
        <https://1145.am/db/1543097/Vivendi>,
        <https://1145.am/db/1627765/Vivendi>,
        <https://1145.am/db/172306/Vivendi>,
        <https://1145.am/db/1747495/Vivendi_Sa>,
        <https://1145.am/db/179572/Vivendi>,
        <https://1145.am/db/1813320/Vivendi>,
        <https://1145.am/db/183768/Vivendi>,
        <https://1145.am/db/183813/Vivendi>,
        <https://1145.am/db/1872318/Vivendi>,
        <https://1145.am/db/1930787/Vivendi>,
        <https://1145.am/db/1936074/Vivendi>,
        <https://1145.am/db/1952876/Vivendi>,
        <https://1145.am/db/1960685/Vivendi>,
        <https://1145.am/db/1966172/Vivendi>,
        <https://1145.am/db/1974476/Vivendi>,
        <https://1145.am/db/1978622/Vivendi>,
        <https://1145.am/db/1996629/Vivendi>,
        <https://1145.am/db/1998852/Vivendi>,
        <https://1145.am/db/2032696/Vivendi>,
        <https://1145.am/db/2039210/Vivendi>,
        <https://1145.am/db/2040974/Vivendi>,
        <https://1145.am/db/2041760/Vivendi>,
        <https://1145.am/db/2055330/Vivendi>,
        <https://1145.am/db/205539/Vivendi>,
        <https://1145.am/db/2071102/Vivendi>,
        <https://1145.am/db/213110/Vivendi>,
        <https://1145.am/db/2136594/Vivendi>,
        <https://1145.am/db/214621/Vivendi>,
        <https://1145.am/db/215138/Vivendi>,
        <https://1145.am/db/2163038/Vivendi>,
        <https://1145.am/db/2167707/Vivendi>,
        <https://1145.am/db/2168368/Vivendi>,
        <https://1145.am/db/2169413/Vivendi>,
        <https://1145.am/db/2172051/Vivendi>,
        <https://1145.am/db/2172059/Vivendi>,
        <https://1145.am/db/235506/Vivendi>,
        <https://1145.am/db/2506820/Vivendi>,
        <https://1145.am/db/257168/Vivendi>,
        <https://1145.am/db/2602077/Vivendi>,
        <https://1145.am/db/2604246/Vivendi>,
        <https://1145.am/db/2604382/Vivendi>,
        <https://1145.am/db/2605925/Vivendi>,
        <https://1145.am/db/2605929/Vivendi>,
        <https://1145.am/db/2606695/Vivendi>,
        <https://1145.am/db/2607297/Vivendi>,
        <https://1145.am/db/2607476/Vivendi>,
        <https://1145.am/db/2610422/Vivendi>,
        <https://1145.am/db/2610513/Vivendi>,
        <https://1145.am/db/2611263/Vivendi>,
        <https://1145.am/db/2613293/Vivendi>,
        <https://1145.am/db/2613866/Vivendi>,
        <https://1145.am/db/2614862/Vivendi>,
        <https://1145.am/db/2616305/Vivendi>,
        <https://1145.am/db/2616537/Vivendi>,
        <https://1145.am/db/2617187/Vivendi>,
        <https://1145.am/db/2617717/Vivendi>,
        <https://1145.am/db/2631186/Vivendi>,
        <https://1145.am/db/2650838/Vivendi>,
        <https://1145.am/db/2650898/Vivendi>,
        <https://1145.am/db/2651156/Vivendi>,
        <https://1145.am/db/2651496/Vivendi>,
        <https://1145.am/db/2651657/Vivendi>,
        <https://1145.am/db/2651782/Vivendi>,
        <https://1145.am/db/2652387/Vivendi>,
        <https://1145.am/db/2653966/Vivendi>,
        <https://1145.am/db/2654132/Vivendi>,
        <https://1145.am/db/2654609/Vivendi>,
        <https://1145.am/db/2654812/Vivendi>,
        <https://1145.am/db/2654869/Vivendi>,
        <https://1145.am/db/2655001/Vivendi>,
        <https://1145.am/db/2655569/Vivendi>,
        <https://1145.am/db/2655800/Vivendi>,
        <https://1145.am/db/2655927/Vivendi>,
        <https://1145.am/db/2656193/Vivendi>,
        <https://1145.am/db/2657814/Vivendi>,
        <https://1145.am/db/2658891/Vivendi>,
        <https://1145.am/db/2659542/Vivendi>,
        <https://1145.am/db/2659919/Vivendi>,
        <https://1145.am/db/2660795/Vivendi>,
        <https://1145.am/db/2662747/Vivendi>,
        <https://1145.am/db/2662802/Vivendi>,
        <https://1145.am/db/2663091/Vivendi>,
        <https://1145.am/db/2663159/Vivendi>,
        <https://1145.am/db/2664250/Vivendi>,
        <https://1145.am/db/2665318/Vivendi>,
        <https://1145.am/db/2665333/Vivendi>,
        <https://1145.am/db/2666389/Vivendi>,
        <https://1145.am/db/2666400/Vivendi>,
        <https://1145.am/db/2666429/Vivendi>,
        <https://1145.am/db/2666923/Vivendi>,
        <https://1145.am/db/2667465/Vivendi>,
        <https://1145.am/db/2667476/Vivendi>,
        <https://1145.am/db/2667532/Vivendi>,
        <https://1145.am/db/2668299/Vivendi>,
        <https://1145.am/db/2668596/Vivendi>,
        <https://1145.am/db/2668926/Vivendi>,
        <https://1145.am/db/2669512/Vivendi>,
        <https://1145.am/db/2669629/Vivendi>,
        <https://1145.am/db/2670684/Vivendi>,
        <https://1145.am/db/2671927/Vivendi>,
        <https://1145.am/db/2674199/Vivendi>,
        <https://1145.am/db/2674236/Vivendi>,
        <https://1145.am/db/2674300/Vivendi>,
        <https://1145.am/db/2675499/Vivendi>,
        <https://1145.am/db/2677625/Vivendi>,
        <https://1145.am/db/2677655/Vivendi>,
        <https://1145.am/db/2677850/Vivendi>,
        <https://1145.am/db/2678113/Vivendi>,
        <https://1145.am/db/2679034/Vivendi>,
        <https://1145.am/db/2681332/Vivendi>,
        <https://1145.am/db/269889/Vivendi>,
        <https://1145.am/db/2715752/Vivendi>,
        <https://1145.am/db/2717950/Vivendi>,
        <https://1145.am/db/2719659/Vivendi>,
        <https://1145.am/db/2796223/Vivendi>,
        <https://1145.am/db/310170/Vivendi>,
        <https://1145.am/db/345500/Vivendi>,
        <https://1145.am/db/350901/Vivendi>,
        <https://1145.am/db/352665/Vivendi>,
        <https://1145.am/db/352726/Vivendi>,
        <https://1145.am/db/353883/Vivendi>,
        <https://1145.am/db/357136/Vivendi_Se>,
        <https://1145.am/db/357140/Vivendi>,
        <https://1145.am/db/357152/Vivendi>,
        <https://1145.am/db/357976/Vivendi>,
        <https://1145.am/db/358143/Vivendi>,
        <https://1145.am/db/358454/Vivendi>,
        <https://1145.am/db/378467/Vivendi>,
        <https://1145.am/db/385184/Vivendi>,
        <https://1145.am/db/395427/Vivendi>,
        <https://1145.am/db/395435/Vivendi>,
        <https://1145.am/db/439737/Vivendi>,
        <https://1145.am/db/470995/Vivendi>,
        <https://1145.am/db/477953/Vivendi>,
        <https://1145.am/db/480972/Vivendi>,
        <https://1145.am/db/638445/Vivendi>,
        <https://1145.am/db/682474/Vivendi>,
        <https://1145.am/db/685343/Vivendi>,
        <https://1145.am/db/763147/Vivendi>,
        <https://1145.am/db/764637/Vivendi>,
        <https://1145.am/db/767649/Vivendi>,
        <https://1145.am/db/844041/Vivendi>,
        <https://1145.am/db/844185/Vivendi>,
        <https://1145.am/db/85758/Vivendi_Sa> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664679/Digital_Bridge_Holdings> a org:Organization ;
    ns1:documentDate "2015-07-23T15:57:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "C Spire doubles spectrum used for LTE; ExteNet gets $1B for recapitalization" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/c-spire-doubles-spectrum-used-for-lte-extenet-gets-1b-for-recapitalization> ;
    ns1:foundName "Digital Bridge Holdings" ;
    ns1:investor <https://1145.am/db/2664679/Investment_Digital_Bridge_Holdings_Extenet_Systems_Stonepeak_Infrastructure_Partners_Has_Not_Happened> ;
    ns1:name "Digital Bridge Holdings" ;
    ns1:sameAsMedium <https://1145.am/db/2618736/Digital_Bridge_Holdings> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2664679/Stonepeak_Infrastructure_Partners> a org:Organization ;
    ns1:documentDate "2015-07-23T15:57:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "C Spire doubles spectrum used for LTE; ExteNet gets $1B for recapitalization" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/c-spire-doubles-spectrum-used-for-lte-extenet-gets-1b-for-recapitalization> ;
    ns1:foundName "Stonepeak Infrastructure Partners" ;
    ns1:investor <https://1145.am/db/2664679/Investment_Digital_Bridge_Holdings_Extenet_Systems_Stonepeak_Infrastructure_Partners_Has_Not_Happened> ;
    ns1:name "Stonepeak Infrastructure Partners" ;
    ns1:sameAsMedium <https://1145.am/db/137056/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/138044/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/139607/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/235660/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/2607072/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/2613243/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/2615212/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/2618736/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/2621459/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/302501/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/323184/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/441259/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/529649/Stonepeak_Infrastructure_Partners>,
        <https://1145.am/db/619809/Stonepeak_Infrastructure_Partners> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2665165/Investment_Turk_Telekom_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Turk Telekom signed five-year loan agreements with 14 banks amounting to 420 million euros ($ 446 million) and $ 380 million." ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "loan" ;
    ns1:name "loan" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2665165/Turk_Telekom> ;
    ns1:valueRaw "$ 380 million",
        "$ 446 million",
        "420 million euros" ;
    ns1:whereGeoName "South Africa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/953987/about.rdf> ;
    ns1:whereRaw "South Africa" .

<https://1145.am/db/2665165/Series_C_Investment_Jolla_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Jolla, the company behind the alternative smartphone platform Sailfish OS, will lay off half its workforce and try to restructure its debt after it failed to close a $ 10.6 million (10 million) Series C round quickly enough." ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "lay" ;
    ns1:name "lay" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2665165/Jolla> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 10.6 million",
        "10 million" ;
    ns1:whereGeoName "South Africa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/953987/about.rdf> ;
    ns1:whereRaw "South Africa" .

<https://1145.am/db/2665165/Vodacom> a org:Organization ;
    ns1:basedInLowRaw "South Africa" ;
    ns1:buyer <https://1145.am/db/2665165/Acquisition_Vodacom_Has_Not_Happened>,
        <https://1145.am/db/2665165/Isp_Acquisition> ;
    ns1:description "ISP" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "Vodacom" ;
    ns1:name "Vodacom" ;
    ns1:sameAsMedium <https://1145.am/db/1209519/Vodacom>,
        <https://1145.am/db/1489536/Vodacom>,
        <https://1145.am/db/2643398/Vodacom>,
        <https://1145.am/db/2654966/Vodacom>,
        <https://1145.am/db/2654987/Vodacom>,
        <https://1145.am/db/2655001/Vodacom>,
        <https://1145.am/db/2660422/Vodacom>,
        <https://1145.am/db/2664123/Vodacom>,
        <https://1145.am/db/2667485/Vodacom>,
        <https://1145.am/db/2668608/Vodacom>,
        <https://1145.am/db/2669512/Vodacom>,
        <https://1145.am/db/2672377/Vodacom>,
        <https://1145.am/db/2672455/Vodacom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2157170/Bright_House_Networks> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "MSO" ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "Bright House Networks" ;
    ns1:name "Bright House Networks" ;
    ns1:sameAsHigh <https://1145.am/db/2172802/Bright_House_Networks>,
        <https://1145.am/db/2655042/Bright_House_Networks> ;
    ns1:sameAsMedium <https://1145.am/db/2157151/Bright_House_Networks>,
        <https://1145.am/db/2160691/Bright_House_Networks>,
        <https://1145.am/db/2162864/Bright_House_Networks>,
        <https://1145.am/db/2163534/Bright_House_Networks>,
        <https://1145.am/db/2165021/Bright_House_Networks>,
        <https://1145.am/db/2165723/Bright_House_Networks>,
        <https://1145.am/db/2166448/Bright_House_Networks>,
        <https://1145.am/db/2166465/Bright_House_Networks>,
        <https://1145.am/db/2168689/Bright_House_Networks>,
        <https://1145.am/db/2168694/Bright_House_Networks>,
        <https://1145.am/db/2169480/Bright_House_Networks>,
        <https://1145.am/db/2169509/Bright_House_Networks>,
        <https://1145.am/db/2171028/Bright_House_Networks>,
        <https://1145.am/db/2171082/Bright_House_Networks>,
        <https://1145.am/db/2171843/Bright_House_Networks>,
        <https://1145.am/db/2171872/Bright_House_Networks>,
        <https://1145.am/db/2171884/Bright_House_Networks>,
        <https://1145.am/db/2171885/Bright_House_Networks>,
        <https://1145.am/db/2172665/Bright_House_Networks>,
        <https://1145.am/db/2172689/Bright_House_Networks>,
        <https://1145.am/db/2172805/Bright_House_Networks>,
        <https://1145.am/db/2173637/Bright_House_Networks>,
        <https://1145.am/db/2173640/Bright_House_Networks>,
        <https://1145.am/db/2173644/Bright_House_Networks>,
        <https://1145.am/db/2176875/Bright_House_Networks>,
        <https://1145.am/db/2177557/Bright_House_Networks>,
        <https://1145.am/db/2599209/Bright_House_Networks>,
        <https://1145.am/db/2611393/Bright_House_Networks>,
        <https://1145.am/db/2614043/Bright_House_Networks>,
        <https://1145.am/db/2617127/Bright_House_Networks>,
        <https://1145.am/db/2617142/Bright_House_Networks>,
        <https://1145.am/db/2660355/Bright_House_Networks>,
        <https://1145.am/db/2672185/Bright_House_Networks> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2157170/Bright_House_Networks_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The bond issuance punctuates a busy week for Charter, as it tries not only to purchase TWC, but also attempts to close its $ 10.4 billion acquisition of privately held Bright House Networks." ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "acquisition",
        "purchase" ;
    ns1:name "acquisition",
        "purchase" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2157170/Bright_House_Networks> ;
    ns1:targetName "Bright House Networks" ;
    ns1:valueRaw "$ 10.4 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2157170/Merger_Charter_Communications_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The bond issuance punctuates a busy week for Charter, as it tries not only to purchase TWC, but also attempts to close its $ 10.4 billion acquisition of privately held Bright House Networks." ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 10.4 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2157170/Time_Warner_Cable> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "Time Warner Cable" ;
    ns1:name "Time Warner Cable" ;
    ns1:sameAsMedium <https://1145.am/db/1830309/Time_Warner_Cable>,
        <https://1145.am/db/1842356/Time_Warner_Cable>,
        <https://1145.am/db/1871548/Time_Warner_Cable>,
        <https://1145.am/db/1877355/Time_Warner_Cable>,
        <https://1145.am/db/1880703/Time_Warner_Cable>,
        <https://1145.am/db/2156985/Time_Warner_Cable>,
        <https://1145.am/db/2156992/Time_Warner_Cable>,
        <https://1145.am/db/2156994/Time_Warner_Cable>,
        <https://1145.am/db/2157021/Time_Warner_Cable>,
        <https://1145.am/db/2157151/Time_Warner_Cable>,
        <https://1145.am/db/2157309/Time_Warner_Cable>,
        <https://1145.am/db/2157452/Time_Warner_Cable>,
        <https://1145.am/db/2157471/Time_Warner_Cable>,
        <https://1145.am/db/2157724/Time_Warner_Cable>,
        <https://1145.am/db/2157958/Time_Warner_Cable>,
        <https://1145.am/db/2158180/Time_Warner_Cable>,
        <https://1145.am/db/2158535/Time_Warner_Cable>,
        <https://1145.am/db/2158559/Time_Warner_Cable>,
        <https://1145.am/db/2158730/Time_Warner_Cable>,
        <https://1145.am/db/2159428/Time_Warner_Cable>,
        <https://1145.am/db/2159439/Time_Warner_Cable>,
        <https://1145.am/db/2159998/Time_Warner_Cable>,
        <https://1145.am/db/2160003/Time_Warner_Cable>,
        <https://1145.am/db/2162107/Time_Warner_Cable>,
        <https://1145.am/db/2162834/Time_Warner_Cable>,
        <https://1145.am/db/2162972/Time_Warner_Cable>,
        <https://1145.am/db/2162994/Time_Warner_Cable>,
        <https://1145.am/db/2163000/Time_Warner_Cable>,
        <https://1145.am/db/2163534/Time_Warner_Cable>,
        <https://1145.am/db/2163553/Time_Warner_Cable>,
        <https://1145.am/db/2164394/Time_Warner_Cable>,
        <https://1145.am/db/2164419/Time_Warner_Cable>,
        <https://1145.am/db/2164442/Time_Warner_Cable>,
        <https://1145.am/db/2165723/Time_Warner_Cable>,
        <https://1145.am/db/2166465/Time_Warner_Cable>,
        <https://1145.am/db/2167924/Time_Warner_Cable>,
        <https://1145.am/db/2167942/Time_Warner_Cable>,
        <https://1145.am/db/2168082/Time_Warner_Cable>,
        <https://1145.am/db/2168683/Time_Warner_Cable>,
        <https://1145.am/db/2168689/Time_Warner_Cable>,
        <https://1145.am/db/2170965/Time_Warner_Cable>,
        <https://1145.am/db/2171028/Time_Warner_Cable>,
        <https://1145.am/db/2171084/Time_Warner_Cable>,
        <https://1145.am/db/2172103/Time_Warner_Cable>,
        <https://1145.am/db/2172655/Time_Warner_Cable>,
        <https://1145.am/db/2172665/Time_Warner_Cable>,
        <https://1145.am/db/2172858/Time_Warner_Cable>,
        <https://1145.am/db/2173404/Time_Warner_Cable>,
        <https://1145.am/db/2173614/Time_Warner_Cable>,
        <https://1145.am/db/2174389/Time_Warner_Cable_Inc>,
        <https://1145.am/db/2174439/Time_Warner_Cable>,
        <https://1145.am/db/2175213/Time_Warner_Cable>,
        <https://1145.am/db/2175243/Time_Warner_Cable>,
        <https://1145.am/db/2175260/Time_Warner_Cable>,
        <https://1145.am/db/2175879/Time_Warner_Cable>,
        <https://1145.am/db/2176080/Time_Warner_Cable>,
        <https://1145.am/db/2176671/Time_Warner_Cable>,
        <https://1145.am/db/2176865/Time_Warner_Cable>,
        <https://1145.am/db/2176875/Time_Warner_Cable>,
        <https://1145.am/db/2176883/Time_Warner_Cable>,
        <https://1145.am/db/2176893/Time_Warner_Cable>,
        <https://1145.am/db/2176902/Time_Warner_Cable>,
        <https://1145.am/db/2176918/Time_Warner_Cable>,
        <https://1145.am/db/2177463/Time_Warner_Cable>,
        <https://1145.am/db/2177493/Time_Warner_Cable>,
        <https://1145.am/db/2177557/Time_Warner_Cable>,
        <https://1145.am/db/2177565/Time_Warner_Cable>,
        <https://1145.am/db/2178417/Time_Warner_Cable>,
        <https://1145.am/db/2599209/Time_Warner_Cable>,
        <https://1145.am/db/2599217/Time_Warner_Cable>,
        <https://1145.am/db/2601574/Time_Warner_Cable>,
        <https://1145.am/db/2602693/Time_Warner_Cable>,
        <https://1145.am/db/2603004/Time_Warner_Cable>,
        <https://1145.am/db/2603019/Time_Warner_Cable>,
        <https://1145.am/db/2608082/Time_Warner_Cable>,
        <https://1145.am/db/2608326/Time_Warner_Cable>,
        <https://1145.am/db/2610562/Time_Warner_Cable>,
        <https://1145.am/db/2611144/Time_Warner_Cable>,
        <https://1145.am/db/2611374/Time_Warner_Cable>,
        <https://1145.am/db/2613776/Time_Warner_Cable>,
        <https://1145.am/db/2617127/Time_Warner_Cable>,
        <https://1145.am/db/2617142/Time_Warner_Cable>,
        <https://1145.am/db/2617208/Time_Warner_Cable>,
        <https://1145.am/db/2657564/Time_Warner_Cable>,
        <https://1145.am/db/2660355/Time_Warner_Cable>,
        <https://1145.am/db/2661434/Time_Warner_Cable>,
        <https://1145.am/db/2666575/Time_Warner_Cable>,
        <https://1145.am/db/2670351/Time_Warner_Cable>,
        <https://1145.am/db/2675231/Time_Warner_Cable>,
        <https://1145.am/db/2677493/Time_Warner_Cable> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2157170/Time_Warner_Cable_Merger> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-07-09T14:49:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Charter Communications (NASDAQ: CHTR) has issued a much-anticipated high-grade M & A bond as part of its $ 31 funding plan for the acquisition of Time Warner Cable (NYSE: TWC) ." ;
    ns1:documentTitle "Charter issues M&A bond, part of $31B funding plan for TWC purchase" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/charter-issues-m-a-bond-part-31b-funding-plan-for-twc-purchase> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2157170/Time_Warner_Cable> ;
    ns1:targetName "Time Warner Cable" ;
    ns1:valueRaw "$ 31" .

<https://1145.am/db/2162866/Comcast_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "Comcast" ;
    ns1:investor <https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> ;
    ns1:name "Comcast Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1299924/Comcast_Ventures>,
        <https://1145.am/db/1751686/Comcast_Ventures>,
        <https://1145.am/db/1752390/Comcast_Ventures>,
        <https://1145.am/db/1760254/Comcast_Ventures>,
        <https://1145.am/db/1773703/Comcast_Ventures>,
        <https://1145.am/db/1774002/Comcast_Ventures>,
        <https://1145.am/db/1776485/Comcast_Ventures>,
        <https://1145.am/db/1785905/Comcast_Ventures>,
        <https://1145.am/db/1790986/Comcast_Ventures>,
        <https://1145.am/db/1801835/Comcast_Ventures>,
        <https://1145.am/db/1802525/Comcast_Ventures>,
        <https://1145.am/db/1816027/Comcast_Ventures>,
        <https://1145.am/db/1824980/Comcast_Ventures>,
        <https://1145.am/db/1826314/Comcast_Ventures>,
        <https://1145.am/db/1830368/Comcast_Ventures>,
        <https://1145.am/db/1830819/Comcast_Ventures>,
        <https://1145.am/db/1848084/Comcast_Ventures>,
        <https://1145.am/db/1852806/Comcast_Ventures>,
        <https://1145.am/db/1859219/Comcast_Ventures>,
        <https://1145.am/db/1877243/Comcast_Ventures>,
        <https://1145.am/db/1879716/Comcast_Ventures>,
        <https://1145.am/db/1882598/Comcast_Ventures>,
        <https://1145.am/db/2060189/Comcast_Ventures>,
        <https://1145.am/db/2158161/Comcast>,
        <https://1145.am/db/2170995/Comcast_Ventures>,
        <https://1145.am/db/2175828/Comcast_Ventures>,
        <https://1145.am/db/2178079/Comcast_Ventures>,
        <https://1145.am/db/526175/Comcast_Ventures>,
        <https://1145.am/db/893810/Comcast_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1717967/Comcast_Ventures>,
        <https://1145.am/db/1749991/Comcast_Ventures>,
        <https://1145.am/db/1769541/Comcast_Ventures>,
        <https://1145.am/db/1772047/Comcast_Ventures>,
        <https://1145.am/db/1773477/Comcast_Ventures>,
        <https://1145.am/db/1793500/Comcast_Ventures>,
        <https://1145.am/db/1804876/Comcast_Ventures>,
        <https://1145.am/db/1815712/Comcast_Ventures>,
        <https://1145.am/db/1838088/Comcast_Ventures>,
        <https://1145.am/db/1838678/Comcast_Ventures>,
        <https://1145.am/db/1844398/Comcast_Ventures>,
        <https://1145.am/db/1849355/Comcast_Ventures>,
        <https://1145.am/db/1852048/Comcast_Ventures>,
        <https://1145.am/db/1856736/Comcast_Ventures>,
        <https://1145.am/db/1864172/Comcast_Ventures>,
        <https://1145.am/db/1870252/Comcast_Ventures>,
        <https://1145.am/db/1887797/Comcast_Ventures>,
        <https://1145.am/db/2163468/Comcast_Ventures>,
        <https://1145.am/db/2164273/Comcast_Ventures>,
        <https://1145.am/db/2605255/Comcast_Ventures> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2162866/Nextvr> a org:Organization ;
    ns1:basedInHighGeoName "Laguna Beach" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5364275/about.rdf> ;
    ns1:basedInHighRaw "Laguna Beach, Calif." ;
    ns1:description "broadcasts events in virtual reality" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "NextVR" ;
    ns1:name "NextVR" ;
    ns1:sameAsMedium <https://1145.am/db/1758374/Nextvr>,
        <https://1145.am/db/1794288/Nextvr>,
        <https://1145.am/db/1804876/Nextvr>,
        <https://1145.am/db/1814731/Nextvr>,
        <https://1145.am/db/2159062/Nextvr>,
        <https://1145.am/db/2178319/Nextvr> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Beobab_Studios> a org:Organization ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Beobab Studios" ;
    ns1:name "Beobab Studios" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Comcast_Ventures> a org:Organization ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Comcast Ventures" ;
    ns1:investor <https://1145.am/db/2164273/Investment_Beobab_Studios_Comcast_Ventures_Has_Not_Happened> ;
    ns1:name "Comcast Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1299924/Comcast_Ventures>,
        <https://1145.am/db/1717967/Comcast_Ventures>,
        <https://1145.am/db/1749991/Comcast_Ventures>,
        <https://1145.am/db/1751686/Comcast_Ventures>,
        <https://1145.am/db/1752390/Comcast_Ventures>,
        <https://1145.am/db/1760254/Comcast_Ventures>,
        <https://1145.am/db/1769541/Comcast_Ventures>,
        <https://1145.am/db/1772047/Comcast_Ventures>,
        <https://1145.am/db/1773477/Comcast_Ventures>,
        <https://1145.am/db/1773703/Comcast_Ventures>,
        <https://1145.am/db/1774002/Comcast_Ventures>,
        <https://1145.am/db/1776485/Comcast_Ventures>,
        <https://1145.am/db/1785905/Comcast_Ventures>,
        <https://1145.am/db/1790986/Comcast_Ventures>,
        <https://1145.am/db/1793500/Comcast_Ventures>,
        <https://1145.am/db/1801835/Comcast_Ventures>,
        <https://1145.am/db/1802525/Comcast_Ventures>,
        <https://1145.am/db/1804876/Comcast_Ventures>,
        <https://1145.am/db/1815712/Comcast_Ventures>,
        <https://1145.am/db/1816027/Comcast_Ventures>,
        <https://1145.am/db/1824980/Comcast_Ventures>,
        <https://1145.am/db/1826314/Comcast_Ventures>,
        <https://1145.am/db/1830368/Comcast_Ventures>,
        <https://1145.am/db/1830819/Comcast_Ventures>,
        <https://1145.am/db/1838088/Comcast_Ventures>,
        <https://1145.am/db/1838678/Comcast_Ventures>,
        <https://1145.am/db/1844398/Comcast_Ventures>,
        <https://1145.am/db/1848084/Comcast_Ventures>,
        <https://1145.am/db/1849355/Comcast_Ventures>,
        <https://1145.am/db/1852048/Comcast_Ventures>,
        <https://1145.am/db/1852806/Comcast_Ventures>,
        <https://1145.am/db/1856736/Comcast_Ventures>,
        <https://1145.am/db/1859219/Comcast_Ventures>,
        <https://1145.am/db/1864172/Comcast_Ventures>,
        <https://1145.am/db/1870252/Comcast_Ventures>,
        <https://1145.am/db/1877243/Comcast_Ventures>,
        <https://1145.am/db/1879716/Comcast_Ventures>,
        <https://1145.am/db/1882598/Comcast_Ventures>,
        <https://1145.am/db/1887797/Comcast_Ventures>,
        <https://1145.am/db/2060189/Comcast_Ventures>,
        <https://1145.am/db/2162866/Comcast_Ventures>,
        <https://1145.am/db/2163468/Comcast_Ventures>,
        <https://1145.am/db/2170995/Comcast_Ventures>,
        <https://1145.am/db/2175828/Comcast_Ventures>,
        <https://1145.am/db/2178079/Comcast_Ventures>,
        <https://1145.am/db/2605255/Comcast_Ventures>,
        <https://1145.am/db/526175/Comcast_Ventures>,
        <https://1145.am/db/893810/Comcast_Ventures> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Comporium> a org:Organization ;
    ns1:basedInHighGeoName "Rock Hill" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4593142/about.rdf> ;
    ns1:basedInHighRaw "Rock Hill" ;
    ns1:buyer <https://1145.am/db/2164273/Comporium_Completed> ;
    ns1:description "Internet service" ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Comporium" ;
    ns1:name "Comporium" ;
    ns1:sameAsMedium <https://1145.am/db/1248788/Comporium>,
        <https://1145.am/db/1249178/Comporium>,
        <https://1145.am/db/1312763/Comporium>,
        <https://1145.am/db/1537326/Comporium>,
        <https://1145.am/db/1538669/Comporium>,
        <https://1145.am/db/1618222/Comporium>,
        <https://1145.am/db/1620191/Comporium>,
        <https://1145.am/db/1857887/Comporium>,
        <https://1145.am/db/2166438/Comporium> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Comporium_Completed> a ns1:CorporateFinanceActivity ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Rock Hill, S.C. - based operator Comporium has deployed 1 Gbps Internet service in Midlands, S.C." ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Hollywood" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5357527/about.rdf> ;
    ns1:whereRaw "Hollywood" .

<https://1145.am/db/2164273/Investment_Beobab_Studios_Comcast_Ventures_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Comcast Ventures has invested in another virtual reality start-up, leading a $ 6 million funding round for Beobab Studios." ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "funding",
        "invested" ;
    ns1:name "funding",
        "invested" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2164273/Beobab_Studios> ;
    ns1:valueRaw "$ 6 million" ;
    ns1:whereGeoName "Hollywood" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5357527/about.rdf> ;
    ns1:whereRaw "Hollywood" .

<https://1145.am/db/2164273/Pace> a org:Organization ;
    ns1:basedInHighGeoName "Federative Republic of Brazil" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:basedInHighRaw "Brazil" ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "Pace" ;
    ns1:name "Pace" ;
    ns1:sameAsMedium <https://1145.am/db/1264677/Pace>,
        <https://1145.am/db/1767867/Pace>,
        <https://1145.am/db/2157099/Pace>,
        <https://1145.am/db/2157808/Pace>,
        <https://1145.am/db/2158395/Pace>,
        <https://1145.am/db/2158400/Pace>,
        <https://1145.am/db/2158404/Pace>,
        <https://1145.am/db/2161435/Pace>,
        <https://1145.am/db/2162029/Pace>,
        <https://1145.am/db/2162107/Pace>,
        <https://1145.am/db/2163579/Pace>,
        <https://1145.am/db/2164194/Pace>,
        <https://1145.am/db/2164267/Pace>,
        <https://1145.am/db/2165000/Pace>,
        <https://1145.am/db/2168612/Pace_Plc>,
        <https://1145.am/db/2171733/Pace>,
        <https://1145.am/db/2174823/Pace>,
        <https://1145.am/db/2175076/Pace_Plc>,
        <https://1145.am/db/2175235/Pace>,
        <https://1145.am/db/2175240/Pace>,
        <https://1145.am/db/2607391/Pace>,
        <https://1145.am/db/2615513/Pace>,
        <https://1145.am/db/917638/Pace>,
        <https://1145.am/db/918598/Pace> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164273/Pace_Merger> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Arris said it has received preliminary approval from Brazil for its $ 2.1 billion purchase of Pace, putting the merger on track to close in January." ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2164273/Pace> ;
    ns1:targetName "Pace" ;
    ns1:valueRaw "$ 2.1 billion" ;
    ns1:whereGeoName "Federative Republic of Brazil" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3469034/about.rdf> ;
    ns1:whereRaw "Brazil" .

<https://1145.am/db/2164273/Sling_Tv_Completed> a ns1:CorporateFinanceActivity ;
    ns1:documentDate "2015-12-03T17:22:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Sling TV has rolled out the first phase of an interface upgrade for Roku." ;
    ns1:documentTitle "Arris gets regulatory sign-off from Brazil; Comcast Ventures backs another VR start-up" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/arris-gets-regulatory-sign-off-from-brazil-comcast-ventures-backs-another-vr-start-up> ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Hollywood" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5357527/about.rdf> ;
    ns1:whereRaw "Hollywood" .

<https://1145.am/db/2164290/Acquisition_Amazon_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The deal comes amid consolidation in the video infrastructure business - in September, for example, Ericsson (NASDAQ: ERIC) acquired Envivio for $ 125 million, while Amazon (NASDAQ: AMZN) paid $ 500 million for Elemental Technologies." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "paid" ;
    ns1:name "paid" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 500 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2164290/Acquisition_Ericsson_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The deal comes amid consolidation in the video infrastructure business - in September, for example, Ericsson (NASDAQ: ERIC) acquired Envivio for $ 125 million, while Amazon (NASDAQ: AMZN) paid $ 500 million for Elemental Technologies." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 125 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2164290/Clearleap> a org:Organization ;
    ns1:description "streaming video processing and asset management" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Clearleap" ;
    ns1:name "Clearleap" ;
    ns1:sameAsMedium <https://1145.am/db/1793057/Clearleap>,
        <https://1145.am/db/1828258/Clearleap>,
        <https://1145.am/db/2170718/Clearleap>,
        <https://1145.am/db/2170755/Clearleap>,
        <https://1145.am/db/2609659/Clearleap> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Clearleap_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In two major deals involving key pay-TV video services vendors, IBM has agreed to acquire Clearleap for an undisclosed sum, while Harmonic has entered an agreement to buy France's Thomson Video Networks in a deal valued at $ 90 million." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2164290/Clearleap> ;
    ns1:targetName "Clearleap" ;
    ns1:valueRaw "$ 90 million" .

<https://1145.am/db/2164290/Envivio> a org:Organization ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Envivio" ;
    ns1:industry "video infrastructure" ;
    ns1:name "Envivio" ;
    ns1:sameAsHigh <https://1145.am/db/2159270/Envivio>,
        <https://1145.am/db/2178135/Envivio> ;
    ns1:sameAsMedium <https://1145.am/db/2169982/Envivio>,
        <https://1145.am/db/2174783/Envivio>,
        <https://1145.am/db/2660897/Envivio> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Merger_Harmonic_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Harmonic, meanwhile, will pay $ 75 million in cash and $ 15 million in post-closing adjustments for Thomson, marking the merger of two companies specializing in video compression and infrastructure services." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 15 million",
        "$ 500 million",
        "$ 75 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2164290/Thomson_Video_Networks> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "video compression and infrastructure services" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "Thomson",
        "Thomson Video Networks" ;
    ns1:industry "pay-TV video services" ;
    ns1:name "Thomson",
        "Thomson Video Networks" ;
    ns1:sameAsMedium <https://1145.am/db/2170718/Thomson_Video_Networks> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2164290/Thomson_Video_Networks_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Harmonic, meanwhile, will pay $ 75 million in cash and $ 15 million in post-closing adjustments for Thomson, marking the merger of two companies specializing in video compression and infrastructure services.",
        "In two major deals involving key pay-TV video services vendors, IBM has agreed to acquire Clearleap for an undisclosed sum, while Harmonic has entered an agreement to buy France's Thomson Video Networks in a deal valued at $ 90 million." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "buy",
        "merger" ;
    ns1:name "buy",
        "merger" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2164290/Thomson_Video_Networks> ;
    ns1:targetName "Thomson",
        "Thomson Video Networks" ;
    ns1:valueRaw "$ 15 million",
        "$ 75 million",
        "$ 90 million" ;
    ns1:whereGeoName "Republic of France",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "France",
        "U.S" .

<https://1145.am/db/2166438/Clemson_University> a org:Organization ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "Clemson" ;
    ns1:name "Clemson University" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2166438/Investment_Clemson_University_Comporium_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Comporium has made a $ 3 million pledge to Clemson University's new Watt Family Innovation Center." ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "pledge" ;
    ns1:name "pledge" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2166438/Clemson_University>,
        <https://1145.am/db/2166438/Comporium> ;
    ns1:valueRaw "$ 3 million" ;
    ns1:whereGeoName "Clemson",
        "University" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/11494925/about.rdf>,
        <https://sws.geonames.org/4574989/about.rdf> ;
    ns1:whereRaw "Clemson University" .

<https://1145.am/db/2166438/Telenet> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "wireless operator" ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "Telenet" ;
    ns1:industry "wireless operator" ;
    ns1:name "Telenet" ;
    ns1:sameAsHigh <https://1145.am/db/2629796/Telfort>,
        <https://1145.am/db/2633593/Telsim> ;
    ns1:sameAsMedium <https://1145.am/db/1120979/Telenet>,
        <https://1145.am/db/1121916/Telenet>,
        <https://1145.am/db/2175222/Telenet>,
        <https://1145.am/db/2616067/Telenet>,
        <https://1145.am/db/2654021/Telenet>,
        <https://1145.am/db/2658223/Telenet>,
        <https://1145.am/db/2661991/Telenet>,
        <https://1145.am/db/2664159/Telenet>,
        <https://1145.am/db/931110/Telenet> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2166438/Telenet_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> John Malone and Liberty Global are close to gaining regulatory approval for their purchase of Belgian wireless operator Telenet." ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "purchase" ;
    ns1:name "purchase" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2166438/Telenet> ;
    ns1:targetName "Telenet" ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2170734/Jw_Player> a org:Organization ;
    ns1:description "an online video platform" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "JW Player" ;
    ns1:name "JW Player" ;
    ns1:sameAsMedium <https://1145.am/db/1649072/Jw_Player>,
        <https://1145.am/db/1649209/Jw_Player>,
        <https://1145.am/db/1857823/Jw_Player>,
        <https://1145.am/db/2166757/Jw_Player>,
        <https://1145.am/db/415580/Jw_Player>,
        <https://1145.am/db/998980/Jw_Player> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2208603/Kyruus> a org:Organization ;
    ns1:basedInLowRaw "Boston" ;
    ns1:description "Patient access and referral management software" ;
    ns1:documentDate "2015-09-18T15:58:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kyruus raises $25M in funding; BIDMC's John Halamka on the next big challenges for CIOs;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/kyruus-raises-25m-funding-bidmc-s-john-halamka-next-big-challenges-for-cios> ;
    ns1:foundName "Kyruus" ;
    ns1:industry "software" ;
    ns1:name "Kyruus" ;
    ns1:sameAsMedium <https://1145.am/db/1171615/Kyruus>,
        <https://1145.am/db/1172470/Kyruus>,
        <https://1145.am/db/1336890/Kyruus>,
        <https://1145.am/db/1338622/Kyruus>,
        <https://1145.am/db/1986102/Kyruus>,
        <https://1145.am/db/2181204/Kyruus>,
        <https://1145.am/db/2188492/Kyruus>,
        <https://1145.am/db/804344/Kyruus>,
        <https://1145.am/db/955098/Kyruus>,
        <https://1145.am/db/955776/Kyruus> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2252863/Daughters_Of_Charity> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2015-07-20T19:25:01+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Daughters of Charity finds another potential savior" ;
    ns1:documentURL <https://www.fiercehealthcare.com/finance/daughters-charity-finds-another-potential-savior> ;
    ns1:foundName "Daughters of Charity" ;
    ns1:industry "healthcare" ;
    ns1:name "Daughters of Charity" ;
    ns1:sameAsHigh <https://1145.am/db/2188994/Sisters_Of_Charity_Health_System>,
        <https://1145.am/db/2272525/Catholic_Daughters_Of_Charity>,
        <https://1145.am/db/2273452/Daughters_Of_Charity>,
        <https://1145.am/db/2273462/Daughters_Of_Charity>,
        <https://1145.am/db/2274293/Daughters_Of_Charity>,
        <https://1145.am/db/2275151/Daughters_Of_Charity> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2252863/Investment_Daughters_Of_Charity_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-20T19:25:01+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Daughters of Charity, the California healthcare system on the brink of insolvency, has apparently found a financial savior: a private equity firm willing to pump hundreds of millions of dollars into the faith - based hospital operator, according to the Los Angeles Times.",
        "New York - based BlueMountain Capital Management would put $ 250 million into Daughters of Charity, which operates six hospitals in the Los Angeles and San Jose areas." ;
    ns1:documentTitle "Daughters of Charity finds another potential savior" ;
    ns1:documentURL <https://www.fiercehealthcare.com/finance/daughters-charity-finds-another-potential-savior> ;
    ns1:foundName "pump",
        "purchase",
        "put" ;
    ns1:name "pump",
        "purchase",
        "put" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2252863/Daughters_Of_Charity> ;
    ns1:targetName "Daughters of Charity" ;
    ns1:valueRaw "$ 250 million",
        "hundreds of millions of dollars" ;
    ns1:whereGeoName "California",
        "Los Angeles County",
        "San Jos" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3621849/about.rdf>,
        <https://sws.geonames.org/5332921/about.rdf>,
        <https://sws.geonames.org/5368381/about.rdf> ;
    ns1:whereRaw "California",
        "Los Angeles and San Jose" .

<https://1145.am/db/2268481/Akron_General_Health_System> a org:Organization ;
    ns1:basedInHighGeoName "Ohio" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5165418/about.rdf> ;
    ns1:basedInHighRaw "Ohio" ;
    ns1:documentDate "2015-08-31T16:43:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cleveland Clinic to take full ownership of Akron General Health System" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-to-take-full-ownership-akron-general-health-system> ;
    ns1:foundName "Akron General Health System" ;
    ns1:industry "health care" ;
    ns1:name "Akron General Health System" ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2268481/Akron_General_Health_System_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-08-31T16:43:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A year after buying a minority stake in Ohio's Akron General Health System, Cleveland Clinic is exercising an option to take full control of the system, according to Crain's Cleveland Business." ;
    ns1:documentTitle "Cleveland Clinic to take full ownership of Akron General Health System" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/cleveland-clinic-to-take-full-ownership-akron-general-health-system> ;
    ns1:foundName "buying",
        "take" ;
    ns1:name "buying",
        "take" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2268481/Akron_General_Health_System> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Akron General Health System" ;
    ns1:whenRaw "2014" ;
    ns1:whereGeoName "Ohio" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5165418/about.rdf> ;
    ns1:whereRaw "Ohio" .

<https://1145.am/db/2304997/Dna_Diagnostics_Center_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-02T15:39:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Quotient acquisition marks GHO's second deal, following a 104 million October buyout of testing specialist DNA Diagnostics Center." ;
    ns1:documentTitle "Quotient Clinical snapped up by Gillings-founded buyout firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/quotient-clinical-snapped-up-by-gillings-founded-buyout-firm> ;
    ns1:foundName "buyout" ;
    ns1:name "buyout" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2304997/Dna_Diagnostics_Center> ;
    ns1:targetName "DNA Diagnostics Center" ;
    ns1:valueRaw "104 million" ;
    ns1:whenRaw "October" ;
    ns1:whereGeoName "London" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London" .

<https://1145.am/db/2304997/Quotient> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "U.K." ;
    ns1:description "healthcare" ;
    ns1:documentDate "2015-12-02T15:39:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Quotient Clinical snapped up by Gillings-founded buyout firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/quotient-clinical-snapped-up-by-gillings-founded-buyout-firm> ;
    ns1:foundName "Quotient",
        "U.K. CRO Quotient Clinical" ;
    ns1:industry "healthcare" ;
    ns1:name "Quotient" ;
    ns1:sameAsMedium <https://1145.am/db/1007344/Quotient_Limited>,
        <https://1145.am/db/1158843/Quotient_Limited>,
        <https://1145.am/db/1158857/Quotient_Limited>,
        <https://1145.am/db/1160664/Quotient_Limited>,
        <https://1145.am/db/1171541/Quotient_Limited>,
        <https://1145.am/db/1178677/Quotient_Limited>,
        <https://1145.am/db/522200/Quotient_Limited>,
        <https://1145.am/db/632182/Quotient_Limited> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2304997/Quotient_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-12-02T15:39:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Quotient acquisition marks GHO's second deal, following a 104 million October buyout of testing specialist DNA Diagnostics Center.",
        "U.K. CRO Quotient Clinical has changed private equity hands, as a European healthcare fund co-founded by former Quintiles ($ Q) CEO Dennis Gillings has acquired the company for an undisclosed sum." ;
    ns1:documentTitle "Quotient Clinical snapped up by Gillings-founded buyout firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/quotient-clinical-snapped-up-by-gillings-founded-buyout-firm> ;
    ns1:foundName "acquired",
        "acquisition" ;
    ns1:name "acquired",
        "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2304997/Quotient> ;
    ns1:targetName "Quotient" ;
    ns1:valueRaw "104 million" ;
    ns1:whereGeoName "London",
        "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf>,
        <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:whereRaw "London",
        "U.K." .

<https://1145.am/db/2306945/Acquisition_Recipharm_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Swedish contract drugmaker Recipharm raised SEK 276 million ($ 32.5 million) to help close its pending acquisition of an Indian contract manufacturer." ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 32.5 million",
        "SEK 276 million" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2306945/Q-Biologicals> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Belgium" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:basedInHighRaw "Belgium" ;
    ns1:description "CDMO" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "Q-Biologicals" ;
    ns1:name "Q-Biologicals" ;
    ns1:sameAsMedium <https://1145.am/db/2306946/Q-Biologicals>,
        <https://1145.am/db/2573050/Q-Biologicals>,
        <https://1145.am/db/2590489/Q-Biologicals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306945/Q-Biologicals_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> French CDMO Amatsigroup bought Belgium's Q-Biologicals for an undisclosed sum." ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "bought" ;
    ns1:name "bought" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2306945/Q-Biologicals> ;
    ns1:targetName "Q-Biologicals" ;
    ns1:whereGeoName "Kingdom of Belgium" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2802361/about.rdf> ;
    ns1:whereRaw "Belgium" .

<https://1145.am/db/2306945/Recipharm> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:buyer <https://1145.am/db/2306945/Acquisition_Recipharm_Has_Not_Happened>,
        <https://1145.am/db/2306945/Nitin_Lifesciences_Stake_Acquisition> ;
    ns1:description "contract drugmaker" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "Recipharm" ;
    ns1:industry "contract drugmaker" ;
    ns1:investor <https://1145.am/db/2306945/Nitin_Lifesciences_Stake_Acquisition> ;
    ns1:name "Recipharm" ;
    ns1:sameAsHigh <https://1145.am/db/1486363/Alcami>,
        <https://1145.am/db/1486654/Alcami_Corporation>,
        <https://1145.am/db/213083/Recipharm>,
        <https://1145.am/db/2330430/Lusomedicameta>,
        <https://1145.am/db/2330430/The_Pharmaceutical_Contract_Development_And_Manufacturing_Organisation_Recipharm_Ab>,
        <https://1145.am/db/2334118/Recipharm>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2358476/Scm_Pharma>,
        <https://1145.am/db/2360484/Scm_Pharma>,
        <https://1145.am/db/2361676/Scm_Pharma>,
        <https://1145.am/db/2369468/Cirrus_Pharmaceuticals>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2552528/Recipharm>,
        <https://1145.am/db/2560286/Lusomedicameta>,
        <https://1145.am/db/2560286/Pharmaceutical_Contract_Development_And_Manufacturing_Organisation_Recipharm_Ab>,
        <https://1145.am/db/2563369/3sbio> ;
    ns1:sameAsMedium <https://1145.am/db/172278/Recipharm>,
        <https://1145.am/db/2330439/Recipharm>,
        <https://1145.am/db/2330456/Recipharm>,
        <https://1145.am/db/2334606/Recipharm>,
        <https://1145.am/db/2334608/Recipharm>,
        <https://1145.am/db/2337242/Recipharm>,
        <https://1145.am/db/2339242/Recipharm>,
        <https://1145.am/db/2346119/Recipharm>,
        <https://1145.am/db/2369512/Recipharm>,
        <https://1145.am/db/2371408/Recipharm>,
        <https://1145.am/db/2537635/Recipharm>,
        <https://1145.am/db/2539816/Recipharm>,
        <https://1145.am/db/2540958/Recipharm>,
        <https://1145.am/db/2543483/Recipharm>,
        <https://1145.am/db/2544071/Recipharm_Ab>,
        <https://1145.am/db/2544074/Recipharm>,
        <https://1145.am/db/2544452/Recipharm>,
        <https://1145.am/db/2545962/Recipharm>,
        <https://1145.am/db/2546145/Recipharm>,
        <https://1145.am/db/2546157/Recipharm>,
        <https://1145.am/db/2546170/Recipharm>,
        <https://1145.am/db/2546440/Recipharm>,
        <https://1145.am/db/2547189/Recipharm>,
        <https://1145.am/db/2548220/Recipharm_Ab>,
        <https://1145.am/db/2548222/Recipharm>,
        <https://1145.am/db/2549102/Recipharm>,
        <https://1145.am/db/2550420/Recipharm>,
        <https://1145.am/db/2557799/Recipharm>,
        <https://1145.am/db/2560286/Recipharm>,
        <https://1145.am/db/2560291/Recipharm>,
        <https://1145.am/db/2561087/Recipharm>,
        <https://1145.am/db/2561326/Recipharm>,
        <https://1145.am/db/2561334/Recipharm>,
        <https://1145.am/db/2562556/Recipharm>,
        <https://1145.am/db/2564095/Recipharm>,
        <https://1145.am/db/2569549/Recipharm>,
        <https://1145.am/db/2577345/Recipharm_Ab>,
        <https://1145.am/db/2594031/Recipharm_Ab>,
        <https://1145.am/db/2594032/Recipharm> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2314063/Saranas> a org:Organization ;
    ns1:basedInHighGeoName "Houston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4699066/about.rdf> ;
    ns1:basedInHighRaw "Houston" ;
    ns1:description "entrepreneurs" ;
    ns1:documentDate "2015-06-23T14:46:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Saranas raises $4.5M for sensor-enabled sheath to detect internal bleeding" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/saranas-raises-4-5m-for-sensor-enabled-sheath-to-detect-internal-bleeding> ;
    ns1:foundName "Saranas" ;
    ns1:name "Saranas" ;
    ns1:sameAsMedium <https://1145.am/db/1686809/Saranas_Inc>,
        <https://1145.am/db/2295758/Saranas> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2315072/The_Broad_Institute> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2015-06-24T11:56:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Broad Institute bags $20M for drug-resistant TB research" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/broad-institute-bags-20m-for-drug-resistant-tb-research> ;
    ns1:foundName "The Broad Institute of MIT and Harvard" ;
    ns1:name "The Broad Institute" ;
    ns1:sameAsMedium <https://1145.am/db/2352915/The_Broad_Institute> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2316161/Dynatronics> a org:Organization ;
    ns1:description "Rehabilitation and physical therapy product maker" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "Dynatronics" ;
    ns1:industry "Rehabilitation and physical therapy product" ;
    ns1:name "Dynatronics" ;
    ns1:sameAsHigh <https://1145.am/db/1190118/Dynatronics_Corporation>,
        <https://1145.am/db/2370485/Dynatronics_Corporation>,
        <https://1145.am/db/771230/Dynatronics_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2316161/Investment_Dynatronics_Prettybrook_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Rehabilitation and physical therapy product maker Dynatronics ($ DYNT) has raised $ 4 million in a private placement led by Prettybrook Partners to support organic growth and strategic acquisitions." ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "private placement",
        "raised" ;
    ns1:name "private placement",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2316161/Dynatronics> ;
    ns1:targetName "Dynatronics" ;
    ns1:valueRaw "$ 4 million" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada",
        "Microchips Biotech" .

<https://1145.am/db/2317269/Advandx> a org:Organization ;
    ns1:description "blood cultures" ;
    ns1:documentDate "2015-07-14T19:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck invests $6M in microbial diagnostics specialist OpGen" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/merck-invests-6m-microbial-diagnostics-specialist-opgen> ;
    ns1:foundName "AdvanDx" ;
    ns1:name "AdvanDx" ;
    ns1:sameAsMedium <https://1145.am/db/2287767/Advandx>,
        <https://1145.am/db/2299782/Advandx>,
        <https://1145.am/db/2299792/Advandx>,
        <https://1145.am/db/2305964/Advandx>,
        <https://1145.am/db/2305977/Advandx> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317269/Opgen> a org:Organization ;
    ns1:buyer <https://1145.am/db/2317269/Advandx_Acquisition> ;
    ns1:description "microbial genetics" ;
    ns1:documentDate "2015-07-14T19:21:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck invests $6M in microbial diagnostics specialist OpGen" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/merck-invests-6m-microbial-diagnostics-specialist-opgen> ;
    ns1:foundName "OpGen" ;
    ns1:name "OpGen" ;
    ns1:sameAsHigh <https://1145.am/db/2299682/Opgen> ;
    ns1:sameAsMedium <https://1145.am/db/1002574/Opgen>,
        <https://1145.am/db/1382901/Opgen>,
        <https://1145.am/db/1391249/Opgen>,
        <https://1145.am/db/1637266/Opgen>,
        <https://1145.am/db/2305015/Opgen>,
        <https://1145.am/db/2325681/Opgen>,
        <https://1145.am/db/2343184/Opgen>,
        <https://1145.am/db/2343185/Opgen>,
        <https://1145.am/db/2348194/Opgen>,
        <https://1145.am/db/2349191/Opgen>,
        <https://1145.am/db/2349200/Opgen>,
        <https://1145.am/db/2365134/Opgen>,
        <https://1145.am/db/2365135/Opgen>,
        <https://1145.am/db/558114/Opgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317269/Opgen_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-14T19:21:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Merck Global Health Innovation Fund invested $ 6 million in OpGen ($ OPGN) on the same day the microbial genetics specialist announced it will acquire AdvanDx, a maker of molecular tests for blood cultures." ;
    ns1:documentTitle "Merck invests $6M in microbial diagnostics specialist OpGen" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/merck-invests-6m-microbial-diagnostics-specialist-opgen> ;
    ns1:foundName "invested" ;
    ns1:name "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2317269/Opgen> ;
    ns1:targetName "OpGen" .

<https://1145.am/db/2317270/Cavidi> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:documentDate "2015-07-15T12:08:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Swedish biotech ropes in $11M for automated HIV testing device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/swedish-biotech-ropes-11m-for-automated-hiv-testing-device> ;
    ns1:foundName "Cavidi" ;
    ns1:industry "biotech" ;
    ns1:name "Cavidi" ;
    ns1:sameAsMedium <https://1145.am/db/2317266/Cavidi> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2317270/Investment_Cavidi_European_Investment_Bank_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-15T12:08:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Swedish biotech outfit Cavidi snagged a 10 million ($ 11 million) loan from the European Investment Bank (EIB) to develop its next-generation automated testing device for HIV." ;
    ns1:documentTitle "Swedish biotech ropes in $11M for automated HIV testing device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/swedish-biotech-ropes-11m-for-automated-hiv-testing-device> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2317270/Cavidi> ;
    ns1:valueRaw "$ 11 million",
        "10 million" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2318396/Castle_Biosciences> a org:Organization ;
    ns1:description "cancer diagnostic tools" ;
    ns1:documentDate "2015-07-28T12:28:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Castle Biosciences reels in $11M for cancer Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/castle-biosciences-reels-11m-for-cancer-dx> ;
    ns1:foundName "Castle Biosciences" ;
    ns1:name "Castle Biosciences" ;
    ns1:sameAsMedium <https://1145.am/db/1008995/Castle_Biosciences>,
        <https://1145.am/db/1011227/Castle_Biosciences>,
        <https://1145.am/db/2291088/Castle_Biosciences>,
        <https://1145.am/db/2325308/Castle_Biosciences>,
        <https://1145.am/db/2367602/Castle_Biosciences>,
        <https://1145.am/db/317075/Castle_Biosciences_Inc>,
        <https://1145.am/db/328260/Castle_Biosciences>,
        <https://1145.am/db/572381/Castle_Biosciences>,
        <https://1145.am/db/674490/Castle_Biosciences>,
        <https://1145.am/db/951783/Castle_Biosciences_Inc>,
        <https://1145.am/db/953533/Castle_Biosciences_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2318396/Series_F_Investment_Castle_Biosciences_Industry_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-28T12:28:03+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Castle Biosciences closed the first tranche of a $ 20 million Series F round, roping in $ 11.7 million to ramp up marketing for its cutaneous melanoma test and R & D for its cancer diagnostic tools." ;
    ns1:documentTitle "Castle Biosciences reels in $11M for cancer Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/castle-biosciences-reels-11m-for-cancer-dx> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2318396/Castle_Biosciences> ;
    ns1:targetDetails "Series F" ;
    ns1:valueRaw "$ 11.7 million",
        "$ 20 million" .

<https://1145.am/db/2320569/Histosonics> a org:Organization ;
    ns1:basedInHighGeoName "Michigan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5001836/about.rdf> ;
    ns1:basedInHighRaw "Michigan" ;
    ns1:documentDate "2015-08-10T15:11:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "HistoSonics raises $2M to develop its ultrasound-based ablation device" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/histosonics-raises-2m-to-develop-its-ultrasound-based-ablation-device> ;
    ns1:foundName "HistoSonics" ;
    ns1:name "HistoSonics" ;
    ns1:sameAsMedium <https://1145.am/db/2288339/Histosonics>,
        <https://1145.am/db/2583663/Histosonics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Hatteras_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Irish" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "Hatteras Venture Partners" ;
    ns1:name "Hatteras Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1115103/Hatteras_Venture_Partners>,
        <https://1145.am/db/1335370/Hatteras_Venture_Partners>,
        <https://1145.am/db/1464210/Hatteras_Venture_Partners>,
        <https://1145.am/db/1465033/Hatteras_Venture_Partners>,
        <https://1145.am/db/1565424/Hatteras_Venture_Partners>,
        <https://1145.am/db/1896251/Hatteras_Venture_Partners>,
        <https://1145.am/db/1957179/Hatteras_Venture_Partners>,
        <https://1145.am/db/2153141/Hatteras_Venture_Partners>,
        <https://1145.am/db/2224522/Hatteras_Venture_Partners>,
        <https://1145.am/db/2236817/Hatteras_Venture_Partners>,
        <https://1145.am/db/2284028/Hatteras_Venture_Partners>,
        <https://1145.am/db/2306163/Hatteras_Venture_Partners>,
        <https://1145.am/db/2315247/Hatteras_Venture_Partners>,
        <https://1145.am/db/2315248/Hatteras_Venture_Partners>,
        <https://1145.am/db/2319640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2323511/Hatteras_Venture_Partners>,
        <https://1145.am/db/2328194/Hatteras_Venture_Partners>,
        <https://1145.am/db/2328196/Hatteras_Venture_Partners>,
        <https://1145.am/db/2332459/Hatteras_Venture_Partners>,
        <https://1145.am/db/2339206/Hatteras_Venture_Partners>,
        <https://1145.am/db/2349717/Hatteras_Venture_Partners>,
        <https://1145.am/db/2349722/Hatteras_Venture_Partners>,
        <https://1145.am/db/2351316/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353671/Hatteras_Venture_Partners>,
        <https://1145.am/db/2353674/Hatteras_Venture_Partners>,
        <https://1145.am/db/2354648/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358640/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358657/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358658/Hatteras_Venture_Partners>,
        <https://1145.am/db/2358812/Hatteras_Venture_Partners>,
        <https://1145.am/db/2359452/Hatteras_Venture_Partners>,
        <https://1145.am/db/2360521/Hatteras_Venture_Partners>,
        <https://1145.am/db/2360526/Hatteras_Venture_Partners>,
        <https://1145.am/db/2363396/Hatteras_Venture_Partners>,
        <https://1145.am/db/2363442/Hatteras_Venture_Partners>,
        <https://1145.am/db/2364853/Hatteras_Venture_Partners>,
        <https://1145.am/db/2365171/Hatteras_Venture_Partners>,
        <https://1145.am/db/495996/Hatteras_Venture_Partners>,
        <https://1145.am/db/496377/Hatteras_Venture_Partners>,
        <https://1145.am/db/601404/Hatteras_Venture_Partners>,
        <https://1145.am/db/885068/Hatteras_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Investment_Jaan_Health_Malin_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Irish life sciences investment vehicle Malin has completed its first round of investment with two deals: the investment of $ 15 million to $ 20 million in Hatteras Venture Partners and the investment of up to $ 1 million in mobile healthcare technology company Jaan Health." ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2321694/Jaan_Health> ;
    ns1:valueRaw "up to $ 1 million" ;
    ns1:whereGeoName "Irish" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5983801/about.rdf> ;
    ns1:whereRaw "Irish" .

<https://1145.am/db/2321694/Renal_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Colorado" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:basedInHighRaw "Colorado" ;
    ns1:description "dialysis" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "Renal Ventures" ;
    ns1:industry "Healthcare" ;
    ns1:name "Renal Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2251023/Renal_Ventures_Management>,
        <https://1145.am/db/2341403/Renal_Ventures_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Renal_Ventures_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> DaVita Healthcare ($ DVA) will acquire Colorado - based dialysis provider Renal Ventures, which has 36 dialysis clinics in 6 states for $ 415 million." ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2321694/Renal_Ventures> ;
    ns1:targetName "Renal Ventures" ;
    ns1:valueRaw "$ 415 million" ;
    ns1:whereGeoName "Colorado" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "Colorado" .

<https://1145.am/db/2321707/Bio-Reference_Laboratories> a org:Organization ;
    ns1:basedInHighGeoName "Miami" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:basedInHighRaw "Miami, FL" ;
    ns1:description "sequencing" ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "Bio-Reference Laboratories" ;
    ns1:industry "sequencing" ;
    ns1:name "Bio-Reference Laboratories" ;
    ns1:sameAsMedium <https://1145.am/db/2312928/Bio-Reference_Laboratories>,
        <https://1145.am/db/2358587/Bio-Reference_Laboratories> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321707/Bio-Reference_Laboratories_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Miami, FL - based OPKO Health sealed its $ 1.47 billion deal for sequencing company Bio-Reference Laboratories." ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "IPO",
        "deal" ;
    ns1:name "IPO",
        "deal" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2321707/Bio-Reference_Laboratories> ;
    ns1:targetName "Bio-Reference Laboratories" ;
    ns1:valueRaw "$ 1.47 billion" ;
    ns1:whereGeoName "Miami" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4164138/about.rdf> ;
    ns1:whereRaw "Miami, FL" .

<https://1145.am/db/2321707/Ipo_Vermillion_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Vermillion ($ VRML) snagged CareFirst Blue Cross/Blue Shield coverage for its OVA1 ovarian cancer test." ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereRaw "RainDance Technologies" .

<https://1145.am/db/2321707/Raindance_Technologies> a org:Organization ;
    ns1:description "business" ;
    ns1:documentDate "2015-08-26T12:23:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Myriad brings cancer tests to India; OPKO finalizes $1.47B Bio-Reference Laboratories deal;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/myriad-brings-cancer-tests-to-india-opko-finalizes-1-47b-bio-reference-laboratories> ;
    ns1:foundName "RainDance Technologies" ;
    ns1:name "RainDance Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2340429/Raindance_Technologies>,
        <https://1145.am/db/2359729/Raindance_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2289564/Raindance_Technologies>,
        <https://1145.am/db/2299625/Raindance_Technologies>,
        <https://1145.am/db/2306519/Raindance_Technologies>,
        <https://1145.am/db/2321785/Raindance_Technologies>,
        <https://1145.am/db/2336262/Raindance_Technologies>,
        <https://1145.am/db/2338153/Raindance_Technologies>,
        <https://1145.am/db/2370559/Raindance_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322734/Lake_Region_Medical> a org:Organization ;
    ns1:basedInLowRaw "Frisco, TX" ;
    ns1:documentDate "2015-08-27T13:17:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Greatbatch grabs Lake Regional Medical for $1.7B to expand surgical offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/greatbatch-grabs-lake-regional-medical-for-1-7b-to-expand-surgical-offerings> ;
    ns1:foundName "Lake Region Medical" ;
    ns1:name "Lake Region Medical" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2322734/Lake_Region_Medical_Unit_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "divestment" ;
    ns1:documentDate "2015-08-27T13:17:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Greatbatch ($ GB) is snatching up Lake Region Medical for $ 1.73 billion to beef up its offerings and expand its global reach, months after the company announced it would spin off its neurostimulation unit to focus on building out its portfolio." ;
    ns1:documentTitle "Greatbatch grabs Lake Regional Medical for $1.7B to expand surgical offerings" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/greatbatch-grabs-lake-regional-medical-for-1-7b-to-expand-surgical-offerings> ;
    ns1:foundName "snatching",
        "spin off" ;
    ns1:name "snatching",
        "spin off" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2322734/Lake_Region_Medical> ;
    ns1:targetDetails "unit" ;
    ns1:targetName "Lake Region Medical" ;
    ns1:valueRaw "$ 1.73 billion",
        "478 million",
        "about $ 1.73 billion" ;
    ns1:whereGeoName "Frisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4692559/about.rdf> ;
    ns1:whereRaw "Frisco, TX" .

<https://1145.am/db/2323825/Delphinus_Medical_Technologies> a org:Organization ;
    ns1:documentDate "2015-09-10T14:00:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delphinus raises $39M+ to back pivotal trial of more effective dense breast tissue ultrasound imaging" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/delphinus-raises-39m-to-back-pivotal-trial-more-effective-dense-breast-tissue> ;
    ns1:foundName "Delphinus Medical Technologies" ;
    ns1:industry "medical" ;
    ns1:name "Delphinus Medical Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2245695/Delphi_Corporation>,
        <https://1145.am/db/2300316/Delphinus_Medical_Technologies>,
        <https://1145.am/db/2450523/Delphi_Medical_Systems> ;
    ns1:sameAsMedium <https://1145.am/db/1679319/Delphinus_Medical_Technologies>,
        <https://1145.am/db/2094639/Delphinus_Medical_Technologies>,
        <https://1145.am/db/2133469/Delphinus_Medical_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2323825/Softvue> a org:Organization ;
    ns1:documentDate "2015-09-10T14:00:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Delphinus raises $39M+ to back pivotal trial of more effective dense breast tissue ultrasound imaging" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/delphinus-raises-39m-to-back-pivotal-trial-more-effective-dense-breast-tissue> ;
    ns1:foundName "SoftVue" ;
    ns1:industry "Medical" ;
    ns1:name "SoftVue" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2325043/Core_Informatics> a org:Organization ;
    ns1:description "LIMS and ELN" ;
    ns1:documentDate "2015-07-08T10:34:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Core Informatics snags $17.5M to fuel lab software land grab" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/core-informatics-snags-17-5m-to-fuel-lab-software-land-grab> ;
    ns1:foundName "Core Informatics" ;
    ns1:industry "software" ;
    ns1:name "Core Informatics" ;
    ns1:sameAsMedium <https://1145.am/db/2325044/Core_Informatics>,
        <https://1145.am/db/2357314/Core_Informatics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2325043/Series_B_Investment_Core_Informatics_Oak_Hc_Ft_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-08T10:34:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A little more than one year later, Core Informatics has tapped investors again, this time bringing new backer Oak HC/FT on board to lead a $ 17.5 million Series B round.",
        "Core Informatics has closed a $ 17.5 million Series B round to bankroll its campaign to capture an ever-growing slice of the LIMS and ELN markets.",
        "Having established this base, Core Informatics shifted gears last year, wrapping up a $ 5 million Series A round to support the expansion of its teams, notably in software engineering, product development and customer support." ;
    ns1:documentTitle "Core Informatics snags $17.5M to fuel lab software land grab" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/core-informatics-snags-17-5m-to-fuel-lab-software-land-grab> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2325043/Core_Informatics> ;
    ns1:targetDetails "Series A",
        "Series B" ;
    ns1:valueRaw "$ 17.5 million" .

<https://1145.am/db/2328257/Complete_Genomics> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "whole human genome sequencing" ;
    ns1:documentDate "2015-10-06T11:46:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity Supersequencer" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/complete-genomics-announces-uk-epilepsy-society-s-acquisition-of-its-revolocity%E2%84%A2-supersequencer> ;
    ns1:foundName "Complete Genomics",
        "Complete Genomics, Inc." ;
    ns1:name "Complete Genomics" ;
    ns1:sameAsHigh <https://1145.am/db/2309491/Complete_Genomics_Inc>,
        <https://1145.am/db/2331149/Complete_Genomics>,
        <https://1145.am/db/2352804/Complete_Genomics>,
        <https://1145.am/db/2360068/Complete_Genomics>,
        <https://1145.am/db/2360069/Complete_Genomics>,
        <https://1145.am/db/2360075/Complete_Genomics> ;
    ns1:sameAsMedium <https://1145.am/db/2309490/Complete_Genomics>,
        <https://1145.am/db/2331148/Complete_Genomics>,
        <https://1145.am/db/2340834/Complete_Genomics>,
        <https://1145.am/db/2352807/Complete_Genomics>,
        <https://1145.am/db/2360628/Complete_Genomics>,
        <https://1145.am/db/2360631/Complete_Genomics>,
        <https://1145.am/db/2364122/Complete_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328257/Revolocity> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "genetics" ;
    ns1:documentDate "2015-10-06T11:46:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity Supersequencer" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/complete-genomics-announces-uk-epilepsy-society-s-acquisition-of-its-revolocity%E2%84%A2-supersequencer> ;
    ns1:foundName "Revolocity",
        "Revolocity" ;
    ns1:name "Revolocity" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328257/Revolocity_Joint_Venture> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "joint venture" ;
    ns1:documentDate "2015-10-06T11:46:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity Supersequencer.",
        "MOUNTAIN VIEW, Calif., Oct. 6, 2015 /PRNewswire/ - Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company's newly introduced Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing." ;
    ns1:documentTitle "Complete Genomics Announces UK Epilepsy Society's Acquisition of Its Revolocity Supersequencer" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/complete-genomics-announces-uk-epilepsy-society-s-acquisition-of-its-revolocity%E2%84%A2-supersequencer> ;
    ns1:foundName "Acquisition" ;
    ns1:name "Acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2328257/Revolocity> ;
    ns1:targetName "Revolocity" ;
    ns1:vendor <https://1145.am/db/2328257/Complete_Genomics> ;
    ns1:whereGeoName "Mountain View",
        "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf>,
        <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:whereRaw "MOUNTAIN VIEW, Calif.",
        "UK" .

<https://1145.am/db/2329404/Desktop_Genetics_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "London",
        "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf>,
        <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "LONDON & SAN DIEGO" ;
    ns1:description "software" ;
    ns1:documentDate "2015-12-11T15:16:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-receives-strategic-investment-from-illumina-to-advance-genome-editing-software> ;
    ns1:foundName "Desktop Genetics Ltd" ;
    ns1:industry "software" ;
    ns1:name "Desktop Genetics Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2305441/Desktop_Genetics_Ltd>,
        <https://1145.am/db/2329403/Desktop_Genetics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2329404/Investment_Desktop_Genetics_Ltd_Illumina_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-11T15:16:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LONDON & SAN DIEGO- (BUSINESS WIRE) -Desktop Genetics Ltd (\"DTG\" or \"the Company\") , a software company revolutionizing the way biologists use CRISPR gene editing technology, announced today that it has received investment funding from Illumina, Inc. (NASDAQ: ILMN) , the global leader in next-generation sequencing (NGS) technology." ;
    ns1:documentTitle "Desktop Genetics Receives Strategic Investment from Illumina to Advance Genome Editing Software Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/desktop-genetics-receives-strategic-investment-from-illumina-to-advance-genome-editing-software> ;
    ns1:foundName "funding",
        "investment" ;
    ns1:name "funding",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2329404/Desktop_Genetics_Ltd> ;
    ns1:whereGeoName "London",
        "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2643743/about.rdf>,
        <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "LONDON & SAN DIEGO" .

<https://1145.am/db/2331421/Investment_Molecular_Health_Dievini_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-18T16:02:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Healthcare IT outfit Molecular Health raked in 25 million ($ 26.6 million) in financing to spur commercialization for its healthcare informatics platform, giving the company a boost as it charges ahead with product development and expands its global footprint.",
        "The recent round, which was led by current investor dievini, brings Molecular Health's total amount raised to 100 million." ;
    ns1:documentTitle "Molecular Health ropes in 25M for Big Data platforms" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/molecular-health-ropes-eu25m-for-big-data-platforms> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2331421/Molecular_Health> ;
    ns1:valueRaw "$ 26.6 million",
        "100 million",
        "25 million" ;
    ns1:whereRaw "global" .

<https://1145.am/db/2331421/Molecular_Health> a org:Organization ;
    ns1:description "Healthcare IT" ;
    ns1:documentDate "2015-11-18T16:02:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Molecular Health ropes in 25M for Big Data platforms" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/molecular-health-ropes-eu25m-for-big-data-platforms> ;
    ns1:foundName "Molecular Health" ;
    ns1:industry "Healthcare IT" ;
    ns1:name "Molecular Health" ;
    ns1:sameAsHigh <https://1145.am/db/2329372/Molecular_Health> ;
    ns1:sameAsMedium <https://1145.am/db/2329371/Molecular_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331446/Coherex_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "Salt Lake City" ;
    ns1:documentDate "2015-11-20T16:51:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "J&J enters market for implants to prevent stroke via acquisition of Coherex Medical" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/j-j-enters-market-for-implants-to-prevent-stroke-via-acquisition-coherex-medical> ;
    ns1:foundName "Salt Lake City's Coherex Medical" ;
    ns1:industry "med tech" ;
    ns1:name "Coherex Medical" ;
    ns1:sameAsHigh <https://1145.am/db/2182583/Moxe_Health>,
        <https://1145.am/db/2295966/Forus_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331446/Coherex_Wavecrest_Left_Atrial_Appendage_Occlusion_System_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-11-20T16:51:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Johnson & Johnson's ($ JNJ) Biosense Webster added to its antistroke offerings with the acquisition of Salt Lake City's Coherex Medical, maker of the CE-marked Coherex WaveCrest Left Atrial Appendage Occlusion System, for an undisclosed sum." ;
    ns1:documentTitle "J&J enters market for implants to prevent stroke via acquisition of Coherex Medical" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/j-j-enters-market-for-implants-to-prevent-stroke-via-acquisition-coherex-medical> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2331446/Coherex_Medical> ;
    ns1:targetName "Coherex Medical",
        "Coherex WaveCrest Left Atrial Appendage Occlusion System" ;
    ns1:whereGeoName "Salt Lake City",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5780993/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Salt Lake City",
        "United States" .

<https://1145.am/db/2331453/Cardiodiagnostics> a org:Organization ;
    ns1:basedInHighGeoName "Wilmington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4145381/about.rdf> ;
    ns1:basedInHighRaw "Wilmington, DE" ;
    ns1:description "a patient" ;
    ns1:documentDate "2015-11-23T15:25:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CardioDiagnostics gets in on patient monitoring with plans for $7M fundraise" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiodiagnostics-gets-patient-monitoring-plans-for-7m-fundraise> ;
    ns1:foundName "CardioDiagnostics" ;
    ns1:name "CardioDiagnostics" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331453/Seed_Investment_Berytech_Cardiodiagnostics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-23T15:25:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Wilmington, DE - based CardioDiagnostics has already collected $ 540,000 in seed funding from a Beirut - based fund, Berytech, and plans to raise $ 7 million in the first quarter of 2016 to spur development, The Wall Street Journal reports." ;
    ns1:documentTitle "CardioDiagnostics gets in on patient monitoring with plans for $7M fundraise" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/cardiodiagnostics-gets-patient-monitoring-plans-for-7m-fundraise> ;
    ns1:foundName "funding",
        "raise" ;
    ns1:name "funding",
        "raise" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2331453/Cardiodiagnostics> ;
    ns1:targetDetails "seed" ;
    ns1:valueRaw "$ 540,000",
        "$ 7 million" ;
    ns1:whereGeoName "Beirut" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/276781/about.rdf> ;
    ns1:whereRaw "Beirut" .

<https://1145.am/db/2332441/Harpoon_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Baltimore County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:basedInHighRaw "Baltimore" ;
    ns1:description "M & A" ;
    ns1:documentDate "2015-12-09T16:52:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Edwards grabs option to acquire transcatheter mitral valve repair startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/edwards-grabs-option-to-acquire-transcatheter-mitral-valve-repair-startup> ;
    ns1:foundName "Baltimore's Harpoon Medical",
        "Harpoon Medical" ;
    ns1:name "Harpoon Medical" ;
    ns1:sameAsMedium <https://1145.am/db/2290338/Harpoon_Medical>,
        <https://1145.am/db/2332447/Harpoon_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333326/Investment_Independent_Grants_For_Learning___Change_The_Department_Of_Medicine_At_The_Icahn_School_Of_Medicine_At_Mount_Sinai_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-21T17:01:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The Department of Medicine at the Icahn School of Medicine at Mount Sinai has received a half-million-dollar grant to develop evidence - based diagnostics of venous thromboembolism." ;
    ns1:documentTitle "Spotlight On... Struggling Toshiba considers selling stake in its device unit; Mount Sinai gets $500K grant for venous thromboembolism; SI-Bone secures some Medicare coverage; and more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/spotlight-struggling-toshiba-considers-selling-stake-its-device-unit-mount-sinai> ;
    ns1:foundName "grant",
        "received" ;
    ns1:name "grant",
        "received" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2333326/The_Department_Of_Medicine_At_The_Icahn_School_Of_Medicine_At_Mount_Sinai> ;
    ns1:valueRaw "half-million-dollar" ;
    ns1:whereGeoName "Japan" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:whereRaw "Japan" .

<https://1145.am/db/2333326/The_Department_Of_Medicine_At_The_Icahn_School_Of_Medicine_At_Mount_Sinai> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "research" ;
    ns1:documentDate "2015-12-21T17:01:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Struggling Toshiba considers selling stake in its device unit; Mount Sinai gets $500K grant for venous thromboembolism; SI-Bone secures some Medicare coverage; and more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/spotlight-struggling-toshiba-considers-selling-stake-its-device-unit-mount-sinai> ;
    ns1:foundName "The Department of Medicine at the Icahn School of Medicine at Mount Sinai" ;
    ns1:name "The Department of Medicine at the Icahn School of Medicine at Mount Sinai" ;
    ns1:sameAsHigh <https://1145.am/db/1503627/Icahn_School_Of_Medicine_At_Mount_Sinai>,
        <https://1145.am/db/2050386/Icahn_School_Of_Medicine_At_Mount_Sinai>,
        <https://1145.am/db/2125008/Icahn_School_Of_Medicine_At_Mount_Sinai> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333326/Toshiba> a org:Organization ;
    ns1:basedInHighGeoName "Japan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1861060/about.rdf> ;
    ns1:basedInHighRaw "Japan" ;
    ns1:description "accounting scandal" ;
    ns1:documentDate "2015-12-21T17:01:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Struggling Toshiba considers selling stake in its device unit; Mount Sinai gets $500K grant for venous thromboembolism; SI-Bone secures some Medicare coverage; and more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/spotlight-struggling-toshiba-considers-selling-stake-its-device-unit-mount-sinai> ;
    ns1:foundName "Toshiba" ;
    ns1:industry "medical equipment" ;
    ns1:name "Toshiba" ;
    ns1:sameAsHigh <https://1145.am/db/2200254/Toshiba_America_Medical_Systems_Inc>,
        <https://1145.am/db/2292759/Toshiba_America_Medical_Systems>,
        <https://1145.am/db/2299389/Toshiba>,
        <https://1145.am/db/2306346/Toshiba>,
        <https://1145.am/db/2307400/Toshiba>,
        <https://1145.am/db/2333983/Toshiba_Medical_Systems>,
        <https://1145.am/db/2334963/Toshiba_Medical_Systems>,
        <https://1145.am/db/2368602/Toshiba_America_Medical_Systems> ;
    ns1:sameAsMedium <https://1145.am/db/1084299/Toshiba_Corp>,
        <https://1145.am/db/1089984/Toshiba>,
        <https://1145.am/db/1114441/Toshiba_Corp>,
        <https://1145.am/db/1154756/Toshiba_Corp>,
        <https://1145.am/db/1164577/Toshiba_Corp>,
        <https://1145.am/db/1166254/Toshiba_Corp>,
        <https://1145.am/db/1173215/Toshiba_Corp>,
        <https://1145.am/db/1184804/Toshiba_Corp>,
        <https://1145.am/db/1218616/Toshiba_Corp>,
        <https://1145.am/db/1304663/Toshiba_Corp>,
        <https://1145.am/db/1350261/Toshiba_Corp>,
        <https://1145.am/db/1358630/Toshiba>,
        <https://1145.am/db/1400028/Toshiba_Corp>,
        <https://1145.am/db/1414769/Toshiba_Corp>,
        <https://1145.am/db/1414954/Toshiba_Corp>,
        <https://1145.am/db/1437742/Toshiba>,
        <https://1145.am/db/1451615/Toshiba>,
        <https://1145.am/db/1468602/Toshiba_Corp>,
        <https://1145.am/db/1483671/Toshiba_Corp>,
        <https://1145.am/db/1504788/Toshiba_Corp>,
        <https://1145.am/db/1566503/Toshiba_Corp>,
        <https://1145.am/db/1588881/Toshiba_Corp>,
        <https://1145.am/db/1599530/Toshiba_Corp>,
        <https://1145.am/db/1600849/Toshiba_Corp>,
        <https://1145.am/db/1668755/Toshiba_Corp>,
        <https://1145.am/db/1860256/Toshiba>,
        <https://1145.am/db/1870429/Toshiba>,
        <https://1145.am/db/1882562/Toshiba>,
        <https://1145.am/db/1902929/Toshiba>,
        <https://1145.am/db/1945285/Toshiba_Corp>,
        <https://1145.am/db/1947686/Toshiba_Corp>,
        <https://1145.am/db/1995400/Toshiba_Corp>,
        <https://1145.am/db/2030379/Toshiba_Corp>,
        <https://1145.am/db/2071516/Toshiba_Corp>,
        <https://1145.am/db/2086086/Toshiba>,
        <https://1145.am/db/2118052/Toshiba>,
        <https://1145.am/db/2121867/Toshiba>,
        <https://1145.am/db/2290211/Toshiba>,
        <https://1145.am/db/2308499/Toshiba>,
        <https://1145.am/db/2318362/Toshiba>,
        <https://1145.am/db/259333/Toshiba_Corp>,
        <https://1145.am/db/2635647/Toshiba>,
        <https://1145.am/db/2636025/Toshiba>,
        <https://1145.am/db/2655238/Toshiba>,
        <https://1145.am/db/2670216/Toshiba>,
        <https://1145.am/db/2672316/Toshiba>,
        <https://1145.am/db/2686514/Toshiba>,
        <https://1145.am/db/301456/Toshiba_Corp>,
        <https://1145.am/db/301508/Toshiba>,
        <https://1145.am/db/305946/Toshiba_Corp>,
        <https://1145.am/db/306856/Toshiba_Corp>,
        <https://1145.am/db/306905/Toshiba_Corp>,
        <https://1145.am/db/306924/Toshiba>,
        <https://1145.am/db/311114/Toshiba_Corp>,
        <https://1145.am/db/312126/Toshiba_Corp>,
        <https://1145.am/db/329311/Toshiba_Corp>,
        <https://1145.am/db/329412/Toshiba_Corp>,
        <https://1145.am/db/351309/Toshiba_Corp>,
        <https://1145.am/db/351970/Toshiba_Corp>,
        <https://1145.am/db/362794/Toshiba_Corp>,
        <https://1145.am/db/362850/Toshiba>,
        <https://1145.am/db/542916/Toshiba_Corp>,
        <https://1145.am/db/807542/Toshiba_Corp>,
        <https://1145.am/db/811135/Toshiba_Corporation>,
        <https://1145.am/db/865766/Toshiba_Corp>,
        <https://1145.am/db/870126/Toshiba>,
        <https://1145.am/db/926802/Toshiba_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334507/Vertiflex> a org:Organization ;
    ns1:basedInHighGeoName "San Clemente" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391791/about.rdf> ;
    ns1:basedInHighRaw "San Clemente, CA" ;
    ns1:description "spinal startup" ;
    ns1:documentDate "2016-01-14T16:18:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "VertiFlex raises $27M on heels of PMA approval, reimbursement breakthroughs in 2015" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vertiflex-raises-27m-heels-pma-approval-reimbursement-breakthroughs-2015> ;
    ns1:foundName "VertiFlex" ;
    ns1:name "VertiFlex" ;
    ns1:sameAsMedium <https://1145.am/db/2152834/Vertiflex>,
        <https://1145.am/db/2152848/Vertiflex>,
        <https://1145.am/db/2297720/Vertiflex>,
        <https://1145.am/db/2301239/Vertiflex> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334948/Jan_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Mountain View" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:basedInHighRaw "Mountain View, CA" ;
    ns1:documentDate "2016-01-25T16:03:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "German radiosurgery player Brainlab invests $7M+ in Jan Medical for portable concussion Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/german-radiosurgery-player-brainlab-invests-7m-jan-medical-for-portable-concussion> ;
    ns1:foundName "Jan Medical" ;
    ns1:name "Jan Medical" ;
    ns1:sameAsMedium <https://1145.am/db/2291840/Jan_Medical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334948/Series_C_Investment_Brainlab_Jan_Medical_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-25T16:03:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Munich - based radiotherapy company, Brainlab, has invested a $ 7.5 million Series C financing into Mountain View, CA - based startup Jan Medical." ;
    ns1:documentTitle "German radiosurgery player Brainlab invests $7M+ in Jan Medical for portable concussion Dx" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/german-radiosurgery-player-brainlab-invests-7m-jan-medical-for-portable-concussion> ;
    ns1:foundName "financing",
        "invested" ;
    ns1:name "financing",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2334948/Jan_Medical> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 7.5 million" ;
    ns1:whereGeoName "Munich" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2867714/about.rdf> ;
    ns1:whereRaw "Munich" .

<https://1145.am/db/2334981/Aptus_Endosystems> a org:Organization ;
    ns1:description "endovascular stent graft market" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Flow Technologies raises $14M+ for its prosthetic vascular graft" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vascular-flow-technologies-raises-14m-for-its-prosthetic-vascular-graft> ;
    ns1:foundName "Aptus Endosystems" ;
    ns1:industry "endovascular stent graft market" ;
    ns1:name "Aptus Endosystems" ;
    ns1:sameAsMedium <https://1145.am/db/2287981/Aptus_Endosystems>,
        <https://1145.am/db/2288251/Aptus_Endosystems>,
        <https://1145.am/db/2314052/Aptus_Endosystems>,
        <https://1145.am/db/2322757/Aptus_Endosystems>,
        <https://1145.am/db/2335371/Aptus_Endosystems>,
        <https://1145.am/db/2357832/Aptus_Endosystems> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334981/Arsenal_Aaa> a org:Organization ;
    ns1:description "developing a foam and accompanying delivery mechanism to fill the aneurysmal sac around" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Flow Technologies raises $14M+ for its prosthetic vascular graft" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vascular-flow-technologies-raises-14m-for-its-prosthetic-vascular-graft> ;
    ns1:foundName "Arsenal AAA" ;
    ns1:industry "endovascular stent graft market" ;
    ns1:name "Arsenal AAA" ;
    ns1:sameAsHigh <https://1145.am/db/2314036/Arsenal_Aaa> ;
    ns1:sameAsMedium <https://1145.am/db/2322757/Arsenal_Aaa>,
        <https://1145.am/db/2335371/Arsenal_Aaa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367519/Nuritas> a org:Organization ;
    ns1:basedInHighGeoName "Dublin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2964574/about.rdf> ;
    ns1:basedInHighRaw "Dublin" ;
    ns1:description "health and wellness" ;
    ns1:documentDate "2015-10-26T15:15:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Nuritas sets Irish record with $3.2M first round financing led by New Protein Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nuritas-sets-irish-record-3-2m-first-round-financing-led-by-new-protein-capital> ;
    ns1:foundName "Nuritas" ;
    ns1:industry "health and wellness" ;
    ns1:name "Nuritas" ;
    ns1:sameAsMedium <https://1145.am/db/1061627/Nuritas> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367675/Ankasa_Regenerative_Therapeutics> a org:Organization ;
    ns1:description "Stem Cell Growth Factor Therapy" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Ankasa Regenerative Therapeutics",
        "Ankasa Regenerative Therapeutics, Inc",
        "Ankasa Regenerative Therapeutics, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Ankasa Regenerative Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2367673/Ankasa_Regenerative_Therapeutics>,
        <https://1145.am/db/2367676/Ankasa_Regenerative_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367675/Heraeus_Medical> a org:Organization ;
    ns1:basedInHighGeoName "Main-Kinzig-Kreis" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2874242/about.rdf> ;
    ns1:basedInHighRaw "Hanau, Germany" ;
    ns1:description "a global business unit from the technology company Heraeus" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Heraeus of Hanau, Germany" ;
    ns1:investor <https://1145.am/db/2367675/Series_A_Investment_Ankasa_Regenerative_Therapeutics_Avalon_Ventures_Correlation_Ventures_Heraeus_Medical_Heraeus_Of_Hanau_Completed> ;
    ns1:name "Heraeus Medical" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Brace_Pharma_Capital> a org:Organization ;
    ns1:basedInLowRaw "Colorado" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "Brace Pharma Capital" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "Brace Pharma Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2319433/Brace_Pharma_Capital>,
        <https://1145.am/db/2359683/Brace_Pharma_Capital>,
        <https://1145.am/db/2369027/Brace_Pharma_Capital>,
        <https://1145.am/db/2369999/Brace_Pharma_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Miragen_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Boulder County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5574999/about.rdf> ;
    ns1:basedInHighRaw "BOULDER, Colo." ;
    ns1:description "a biopharmaceutical company",
        "developing innovative microRNA - based therapeutics" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "MiRagen Therapeutics",
        "miRagen Therapeutics" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "MiRagen Therapeutics",
        "miRagen Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2330852/Miragen_Therapeutics>,
        <https://1145.am/db/2331870/Miragen_Therapeutics>,
        <https://1145.am/db/2353524/Miragen_Therapeutics>,
        <https://1145.am/db/2353525/Miragen_Therapeutics>,
        <https://1145.am/db/2353526/Miragen_Therapeutics>,
        <https://1145.am/db/2363716/Miragen_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367782/Mydicar> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:description "research or development" ;
    ns1:documentDate "2015-06-26T10:43:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Provides Business Update" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-provides-business-update> ;
    ns1:foundName "MYDICAR" ;
    ns1:name "MYDICAR" ;
    ns1:sameAsMedium <https://1145.am/db/2338527/Mydicar> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367846/Crossject> a org:Organization ;
    ns1:description "Business" ;
    ns1:documentDate "2015-11-12T20:15:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CROSSJECT secures 6.7 million in funding for the development of three new drugs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crossject-secures-%E2%82%AC6-7-million-funding-for-development-of-three-new-drugs> ;
    ns1:foundName "CROSSJECT" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "CROSSJECT" ;
    ns1:sameAsHigh <https://1145.am/db/2315602/Crosslink> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367969/Vistapharm> a org:Organization ;
    ns1:description "pain medications" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:foundName "VistaPharm" ;
    ns1:industry "Pharma" ;
    ns1:name "VistaPharm" ;
    ns1:sameAsHigh <https://1145.am/db/1593149/Vistagen>,
        <https://1145.am/db/1593884/Vistagen>,
        <https://1145.am/db/1660765/Vistagen>,
        <https://1145.am/db/2131891/Vistagen_Therapeutics>,
        <https://1145.am/db/2283570/Vistagen>,
        <https://1145.am/db/2364379/Vistagen_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2568151/Vistapharm> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367969/Vistapharm_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Vertice Pharma also announced it has reached a definitive merger agreement to acquire VistaPharm, a specialized generics manufacturer of liquid and unit dosage pain medications for the hospital market, retail pharmacy and outpatient clinics." ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:foundName "acquire",
        "merger" ;
    ns1:name "acquire",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2367969/Vistapharm> ;
    ns1:targetName "VistaPharm" .

<https://1145.am/db/2368319/Woodford_Investment_Management> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-07-16T11:22:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: T-cell pioneer Immunocore scores a record-breaking $320M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-t-cell-pioneer-immunocore-scores-a-record-breaking-320m-round> ;
    ns1:foundName "Woodford Investment Management" ;
    ns1:investor <https://1145.am/db/2368319/Investment_Immunocore_Malin_Woodford_Investment_Management_Has_Not_Happened> ;
    ns1:name "Woodford Investment Management" ;
    ns1:sameAsHigh <https://1145.am/db/1767777/Woodford_Investment_Management>,
        <https://1145.am/db/1769692/Woodford_Investment_Management>,
        <https://1145.am/db/1802314/Woodford_Investment_Management>,
        <https://1145.am/db/2292675/Woodford_Investment_Management>,
        <https://1145.am/db/2318529/Woodford_Investment_Management>,
        <https://1145.am/db/2318537/Woodford_Investment_Management>,
        <https://1145.am/db/2322761/Woodford_Investment_Management>,
        <https://1145.am/db/2348796/Woodford_Investment_Management>,
        <https://1145.am/db/2348798/Woodford_Investment_Management>,
        <https://1145.am/db/2354401/Woodford_Investment_Management>,
        <https://1145.am/db/2359267/Woodford_Im> ;
    ns1:sameAsMedium <https://1145.am/db/1822473/Woodford_Investment_Management>,
        <https://1145.am/db/2296990/Woodford_Investment_Management>,
        <https://1145.am/db/2348797/Woodford_Investment_Management>,
        <https://1145.am/db/2368321/Woodford_Investment_Management>,
        <https://1145.am/db/2370468/Woodford_Investment_Management_Llp>,
        <https://1145.am/db/2370709/Woodford_Investment_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368321/Woodford_Investment_Management> a org:Organization ;
    ns1:description "private financing round" ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "Woodford Investment Management" ;
    ns1:investor <https://1145.am/db/2368321/Investment_Eli_Lilly_And_Company_Immunocore_Malin_Corporation_Rtw_Investments_Woodford_Investment_Management_Completed> ;
    ns1:name "Woodford Investment Management" ;
    ns1:sameAsHigh <https://1145.am/db/2370709/Woodford_Investment_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1767777/Woodford_Investment_Management>,
        <https://1145.am/db/1769692/Woodford_Investment_Management>,
        <https://1145.am/db/1802314/Woodford_Investment_Management>,
        <https://1145.am/db/1822473/Woodford_Investment_Management>,
        <https://1145.am/db/2292675/Woodford_Investment_Management>,
        <https://1145.am/db/2296990/Woodford_Investment_Management>,
        <https://1145.am/db/2318529/Woodford_Investment_Management>,
        <https://1145.am/db/2318537/Woodford_Investment_Management>,
        <https://1145.am/db/2322761/Woodford_Investment_Management>,
        <https://1145.am/db/2348796/Woodford_Investment_Management>,
        <https://1145.am/db/2348797/Woodford_Investment_Management>,
        <https://1145.am/db/2348798/Woodford_Investment_Management>,
        <https://1145.am/db/2354401/Woodford_Investment_Management>,
        <https://1145.am/db/2368319/Woodford_Investment_Management>,
        <https://1145.am/db/2370468/Woodford_Investment_Management_Llp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS, Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Johnson___Johnson_Innovation> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Johnson & Johnson Innovation - JJDC" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Johnson & Johnson Innovation" ;
    ns1:sameAsMedium <https://1145.am/db/1118732/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1464782/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1745868/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2095032/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2155668/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2196895/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2280368/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2283006/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2284205/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2293709/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2295278/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2297195/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2297644/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2298631/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2301381/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2333993/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2334956/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2339206/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2360562/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2369157/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2369951/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2586501/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2586502/Johnson___Johnson_Innovation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Protagonist_Therapeutics> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Protagonist Therapeutics",
        "Protagonist Therapeutics, Inc." ;
    ns1:name "Protagonist Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2154007/Enterprise_Therapeutics>,
        <https://1145.am/db/2298501/Protagonist_Therapeutics>,
        <https://1145.am/db/2354196/Protagonist_Therapeutics>,
        <https://1145.am/db/2360582/Protagonist_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/1471957/Protagonist_Therapeutics>,
        <https://1145.am/db/2298906/Protagonist_Therapeutics>,
        <https://1145.am/db/2361581/Protagonist_Therapeutics>,
        <https://1145.am/db/2370074/Protagonist_Therapeutics>,
        <https://1145.am/db/2370139/Protagonist_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Anaptysbio> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "AnaptysBio" ;
    ns1:name "AnaptysBio" ;
    ns1:sameAsMedium <https://1145.am/db/2296080/Anaptysbio>,
        <https://1145.am/db/2330205/Anaptysbio>,
        <https://1145.am/db/2345066/Anaptysbio>,
        <https://1145.am/db/2357866/Anaptysbio>,
        <https://1145.am/db/2363331/Anaptysbio>,
        <https://1145.am/db/2368423/Anaptysbio>,
        <https://1145.am/db/2579346/Anaptysbio>,
        <https://1145.am/db/2594350/Anaptysbio>,
        <https://1145.am/db/660183/Anaptysbio>,
        <https://1145.am/db/919968/Anaptysbio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Frazier_Healthcare> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Frazier Healthcare" ;
    ns1:industry "Healthcare" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "Frazier Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335817/Frazier_Life_Sciences>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346532/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2338625/Frazier_Healthcare>,
        <https://1145.am/db/2339925/Frazier_Healthcare>,
        <https://1145.am/db/2340207/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366700/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2584561/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/Investment_Celator_Pharmaceuticals_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Ewing, NJ - based Celator Pharmaceuticals has begun enrolling patients in a Phase II clinical study evaluating CPX-351 (cyatarabine: daunorubicin) Liposome Injection as a treatment for patients with newly diagnosed Acute Myeloid Leukemia." ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "San Diego" .

<https://1145.am/db/2368333/Piqur_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "cancer drug R & D" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Piqur Therapeutics" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Piqur Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1024248/Pionyr>,
        <https://1145.am/db/2362527/Piqur>,
        <https://1145.am/db/522107/Proqr_Therapeutics_Nv> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368333/R___d> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "Research and development" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "R & D" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "R & D" ;
    ns1:sameAsHigh <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1028098/A2pg>,
        <https://1145.am/db/1028744/Apnimed>,
        <https://1145.am/db/1029882/Apnimed>,
        <https://1145.am/db/1041428/Dr>,
        <https://1145.am/db/1042161/Wellgistics>,
        <https://1145.am/db/1042221/Wellgistics>,
        <https://1145.am/db/1096114/Astorg>,
        <https://1145.am/db/1096677/Astorg>,
        <https://1145.am/db/1138447/Apnimed>,
        <https://1145.am/db/1139445/Apnimed>,
        <https://1145.am/db/1152269/Alpha-5>,
        <https://1145.am/db/1163849/Productlife_Group>,
        <https://1145.am/db/1172760/Apexigen>,
        <https://1145.am/db/1215735/Astorg>,
        <https://1145.am/db/1219810/Prokidney_Corp>,
        <https://1145.am/db/1271008/Reviral_Ltd>,
        <https://1145.am/db/1272754/Prokidney_Corp>,
        <https://1145.am/db/1294637/LTS>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1309648/Achrom>,
        <https://1145.am/db/1323486/Glo_Pharma>,
        <https://1145.am/db/1374672/Sp_Industries>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1391799/Pharnext>,
        <https://1145.am/db/1454905/Aquestive>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1540522/Atec>,
        <https://1145.am/db/1541946/Abiomed>,
        <https://1145.am/db/1562763/Indivior>,
        <https://1145.am/db/1576115/R___D_Capabilities>,
        <https://1145.am/db/1613904/Apnimed_Inc>,
        <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/1617770/Pharnext_Sa>,
        <https://1145.am/db/1648815/Indevr>,
        <https://1145.am/db/1681016/Enveric_Biosciences>,
        <https://1145.am/db/1745685/Drugstoc>,
        <https://1145.am/db/1746277/Seeqc>,
        <https://1145.am/db/1838777/Medikly>,
        <https://1145.am/db/1936167/Reviral_Ltd>,
        <https://1145.am/db/1962783/Ora_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2051589/Ora_Inc>,
        <https://1145.am/db/2060641/Abionyx_Pharma>,
        <https://1145.am/db/2073336/Ose>,
        <https://1145.am/db/2132018/Solutions>,
        <https://1145.am/db/2139917/Leo_Pharma>,
        <https://1145.am/db/2151848/D___D_Pharmatech>,
        <https://1145.am/db/2152469/Sobi003>,
        <https://1145.am/db/2152499/Highchem>,
        <https://1145.am/db/2152633/Themis>,
        <https://1145.am/db/2152849/Therachon>,
        <https://1145.am/db/2152901/Abcellera>,
        <https://1145.am/db/2154166/Leo_Pharma>,
        <https://1145.am/db/2154252/Phoremost>,
        <https://1145.am/db/2155490/Enterome>,
        <https://1145.am/db/2155631/Achillion>,
        <https://1145.am/db/2155863/Therachon>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2235873/M3_Usa>,
        <https://1145.am/db/2244405/Seek>,
        <https://1145.am/db/2281535/Eqt_Life_Sciences>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2281797/Verily>,
        <https://1145.am/db/2283559/Oric>,
        <https://1145.am/db/2283918/Indivior>,
        <https://1145.am/db/2286215/Pandion>,
        <https://1145.am/db/2289550/Well>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2292788/R___d>,
        <https://1145.am/db/2294621/Pharmaceutics_International>,
        <https://1145.am/db/2296235/Apexigen>,
        <https://1145.am/db/2297631/Clarient>,
        <https://1145.am/db/2298376/Caprion>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2302863/Amri>,
        <https://1145.am/db/2303412/Hologic>,
        <https://1145.am/db/2303415/Amevive>,
        <https://1145.am/db/2303612/Intradigm_Corporation>,
        <https://1145.am/db/2303675/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2303720/Covance>,
        <https://1145.am/db/2305572/Covance_Inc>,
        <https://1145.am/db/2305703/Pinnacle_Bioventures>,
        <https://1145.am/db/2306640/Atryn>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2306725/Prevalere_Life_Sciences_Inc>,
        <https://1145.am/db/2306946/Amatsigroup>,
        <https://1145.am/db/2307526/Bioserv_Corporation>,
        <https://1145.am/db/2307529/Bioserv>,
        <https://1145.am/db/2307714/GTCR>,
        <https://1145.am/db/2308069/Bionomics>,
        <https://1145.am/db/2308807/Etrials_Worldwide>,
        <https://1145.am/db/2309352/Epicept_Corporation>,
        <https://1145.am/db/2309696/Encap>,
        <https://1145.am/db/2309697/Encap>,
        <https://1145.am/db/2310711/R___d>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2312191/Medigene_Ag>,
        <https://1145.am/db/2312788/Leo_Pharma>,
        <https://1145.am/db/2312797/Leo_Pharma_A_S>,
        <https://1145.am/db/2312994/Upm>,
        <https://1145.am/db/2313383/Company>,
        <https://1145.am/db/2314613/Advent_International>,
        <https://1145.am/db/2315373/Nitromed>,
        <https://1145.am/db/2315424/Covance_Inc>,
        <https://1145.am/db/2316707/Catalyst_Pharmaceutical>,
        <https://1145.am/db/2316856/Viranative_Ab>,
        <https://1145.am/db/2317006/Amri>,
        <https://1145.am/db/2317060/Ception>,
        <https://1145.am/db/2317144/Leo_Pharma>,
        <https://1145.am/db/2317334/Aesica>,
        <https://1145.am/db/2317369/Relthy>,
        <https://1145.am/db/2320351/Prochieve>,
        <https://1145.am/db/2320947/Nitromed>,
        <https://1145.am/db/2321633/R___d>,
        <https://1145.am/db/2321635/Celator>,
        <https://1145.am/db/2322824/Amri>,
        <https://1145.am/db/2322826/Amri>,
        <https://1145.am/db/2323790/Amri>,
        <https://1145.am/db/2323861/Amri>,
        <https://1145.am/db/2324112/Nitromed>,
        <https://1145.am/db/2324118/Rem_Medical_Corporation>,
        <https://1145.am/db/2324350/Celmed_Biosciences_Inc>,
        <https://1145.am/db/2324394/Amdl>,
        <https://1145.am/db/2324985/Amri>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2327076/Amri>,
        <https://1145.am/db/2327088/Covance>,
        <https://1145.am/db/2327241/Preotact_(r)>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327374/Diamedica_Inc>,
        <https://1145.am/db/2327403/C2l>,
        <https://1145.am/db/2327424/Innopharm>,
        <https://1145.am/db/2328008/Epicept_Corporation>,
        <https://1145.am/db/2328318/Medpointe>,
        <https://1145.am/db/2328713/Sepracor>,
        <https://1145.am/db/2329333/Biopharma_Services_Inc>,
        <https://1145.am/db/2330808/Sepracor>,
        <https://1145.am/db/2331911/Clarient>,
        <https://1145.am/db/2332005/R___d>,
        <https://1145.am/db/2332200/Compendia_Bioscience>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333644/Targent>,
        <https://1145.am/db/2334020/Accovion>,
        <https://1145.am/db/2336287/Biomotiv>,
        <https://1145.am/db/2336355/Correvio>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2336998/Medivation_Inc>,
        <https://1145.am/db/2337028/Medivation>,
        <https://1145.am/db/2337078/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2338371/Inc>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2338939/Nuevolution_A_S>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2339997/(Appa)>,
        <https://1145.am/db/2340054/Amri>,
        <https://1145.am/db/2340115/Mission>,
        <https://1145.am/db/2340160/Intercell_Ag>,
        <https://1145.am/db/2340507/Rho>,
        <https://1145.am/db/2341572/Aesica>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2341959/R___d>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2344595/Mabxience>,
        <https://1145.am/db/2347172/Medivir_Ab>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2348448/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2348675/Signum_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2349373/Asmacure>,
        <https://1145.am/db/2349740/Signum_Biosciences_Inc>,
        <https://1145.am/db/2349983/Leading_Biosciences_Inc>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2350847/Covance>,
        <https://1145.am/db/2351198/(Ptc)>,
        <https://1145.am/db/2351259/Biotime_Inc>,
        <https://1145.am/db/2352414/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2353223/Medivation_Inc>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2356488/Cerulean_Pharma>,
        <https://1145.am/db/2358197/Biopharma_Services_Inc>,
        <https://1145.am/db/2358403/Pht_Corporation>,
        <https://1145.am/db/2358637/Eurand>,
        <https://1145.am/db/2358638/Eurand_Nv>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2358953/Abgent>,
        <https://1145.am/db/2359025/Nectid>,
        <https://1145.am/db/2359113/Eurand_Nv>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359577/Geno>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2359951/Entremed>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360702/Cominnex>,
        <https://1145.am/db/2360922/Nuevolution_A_S>,
        <https://1145.am/db/2361675/Amri>,
        <https://1145.am/db/2361747/Servier>,
        <https://1145.am/db/2361926/Pharm-Olam_International_Ltd>,
        <https://1145.am/db/2362453/Pharnext>,
        <https://1145.am/db/2362607/Abide_Therapeutics>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367298/Amri>,
        <https://1145.am/db/2368106/Obseva>,
        <https://1145.am/db/2368242/Symic>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368329/Amri>,
        <https://1145.am/db/2368332/Amri>,
        <https://1145.am/db/2368601/Promosome>,
        <https://1145.am/db/2368824/Almirall_Inc>,
        <https://1145.am/db/2369042/Abide_Therapeutics>,
        <https://1145.am/db/2369128/Aegerion>,
        <https://1145.am/db/2369269/R___d>,
        <https://1145.am/db/2369446/Presage_Biosciences>,
        <https://1145.am/db/2369490/Medivation>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2370156/Pharming_Group_Nv>,
        <https://1145.am/db/2370164/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370265/Ose_Pharma>,
        <https://1145.am/db/2370267/Ose_Pharma>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370557/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370579/Arvinas>,
        <https://1145.am/db/2370659/Nuevolution>,
        <https://1145.am/db/2370828/Nuevolution>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/2371408/Business_Management>,
        <https://1145.am/db/2536140/Scinopharm>,
        <https://1145.am/db/2536209/TPG>,
        <https://1145.am/db/2536305/Radient>,
        <https://1145.am/db/2536469/Agila_Specialties>,
        <https://1145.am/db/2536473/Encap>,
        <https://1145.am/db/2536575/G___w>,
        <https://1145.am/db/2536576/G___w>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2536776/Oramed>,
        <https://1145.am/db/2538112/Pharmedium>,
        <https://1145.am/db/2539816/P___R_Group>,
        <https://1145.am/db/2539858/Aesica>,
        <https://1145.am/db/2539890/Scinopharm>,
        <https://1145.am/db/2540218/Amri>,
        <https://1145.am/db/2540222/Amri>,
        <https://1145.am/db/2540931/Accucaps>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541469/Agila_Specialties>,
        <https://1145.am/db/2542113/Profectus_Biosciences>,
        <https://1145.am/db/2542472/Aesica>,
        <https://1145.am/db/2543530/Covance>,
        <https://1145.am/db/2544087/Univercells>,
        <https://1145.am/db/2544258/C___O_Pharmaceutical_Technology>,
        <https://1145.am/db/2544596/Bioton>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545545/Agila_Specialties>,
        <https://1145.am/db/2546430/Bal_Pharma>,
        <https://1145.am/db/2546892/Aphena>,
        <https://1145.am/db/2547568/Amec>,
        <https://1145.am/db/2548137/Innopharm>,
        <https://1145.am/db/2548674/Sepracor>,
        <https://1145.am/db/2548840/Btcp_Pharma_Llc>,
        <https://1145.am/db/2549082/British_Company>,
        <https://1145.am/db/2549201/Rexall_Health>,
        <https://1145.am/db/2550632/Amri>,
        <https://1145.am/db/2550638/Amri>,
        <https://1145.am/db/2553761/Mabxience>,
        <https://1145.am/db/2553978/Bioverativ>,
        <https://1145.am/db/2554838/Amri>,
        <https://1145.am/db/2555168/Prokidney>,
        <https://1145.am/db/2555326/Leo_Pharma>,
        <https://1145.am/db/2556356/Medivation>,
        <https://1145.am/db/2556744/Leo_Pharma>,
        <https://1145.am/db/2557034/West_Pharmaceutical>,
        <https://1145.am/db/2557482/Idifarma>,
        <https://1145.am/db/2558133/Lifehealth>,
        <https://1145.am/db/2559160/West_Pharmaceutical>,
        <https://1145.am/db/2560277/Aesica>,
        <https://1145.am/db/2560277/Consort>,
        <https://1145.am/db/2560766/Accucaps>,
        <https://1145.am/db/2560808/Novamedica>,
        <https://1145.am/db/2561121/Bioserv>,
        <https://1145.am/db/2562459/Eurand>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563772/Apiject>,
        <https://1145.am/db/2564003/Leo_Pharma>,
        <https://1145.am/db/2564490/Accucaps>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2565613/Servier>,
        <https://1145.am/db/2566037/Almirall>,
        <https://1145.am/db/2566348/Indivior>,
        <https://1145.am/db/2566348/Opiant>,
        <https://1145.am/db/2568711/West_Pharmaceutical>,
        <https://1145.am/db/2569107/Almirall_Sa>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569393/R___d>,
        <https://1145.am/db/2570064/Aegerion>,
        <https://1145.am/db/2570177/Oramed>,
        <https://1145.am/db/2572329/Incivo>,
        <https://1145.am/db/2572567/Northera>,
        <https://1145.am/db/2573050/Amatsigroup>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2575143/Almirall>,
        <https://1145.am/db/2576254/Fougera>,
        <https://1145.am/db/2576550/TPG>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2576925/Pharmgate>,
        <https://1145.am/db/2577894/Advance_Properties_Ood>,
        <https://1145.am/db/2578052/Advent_International>,
        <https://1145.am/db/2578052/United_Medical>,
        <https://1145.am/db/2578645/Almirall>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2578667/Fycompa>,
        <https://1145.am/db/2579211/Proximagen>,
        <https://1145.am/db/2581197/Irom_Pharmaceutical>,
        <https://1145.am/db/2581832/West>,
        <https://1145.am/db/2586253/United_Biosource_Corporation>,
        <https://1145.am/db/2586420/Acuform>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2589178/Oriel>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590489/Amatsigroup>,
        <https://1145.am/db/2590528/C___O_Pharmaceutical>,
        <https://1145.am/db/2590556/Nycomed_Us>,
        <https://1145.am/db/2590827/Affairs>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593060/Inventiv_Health>,
        <https://1145.am/db/2593265/Leo_Pharma>,
        <https://1145.am/db/2594186/Agila_Specialties>,
        <https://1145.am/db/2594699/Osi>,
        <https://1145.am/db/2595688/Fougera>,
        <https://1145.am/db/2598181/Amri>,
        <https://1145.am/db/2666163/R___d>,
        <https://1145.am/db/2669228/Bt>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2761916/R___d)>,
        <https://1145.am/db/2791590/Civica>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/317543/Productlife_Group>,
        <https://1145.am/db/423883/Sohm_Inc>,
        <https://1145.am/db/449041/Advent_International>,
        <https://1145.am/db/515764/Sohm_Inc>,
        <https://1145.am/db/524289/Research_Solutions_Inc>,
        <https://1145.am/db/529358/Research_Solutions_Inc>,
        <https://1145.am/db/561196/Pharnext_Sa>,
        <https://1145.am/db/618115/Sohm>,
        <https://1145.am/db/652159/R___d>,
        <https://1145.am/db/654786/R___d>,
        <https://1145.am/db/654792/Innobic>,
        <https://1145.am/db/676564/Alvotech>,
        <https://1145.am/db/716162/Pharnext_Sa>,
        <https://1145.am/db/769904/Iff>,
        <https://1145.am/db/806327/Pharma_Nobis_Llc>,
        <https://1145.am/db/807295/Pharma_Nobis_Llc>,
        <https://1145.am/db/832306/Research_Solutions_Inc>,
        <https://1145.am/db/834480/Pharnext_Sa>,
        <https://1145.am/db/835269/Grand_Pharmaceutical_Group_Limited>,
        <https://1145.am/db/837157/Leo_Pharma_Inc>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/872336/Sohm_Inc>,
        <https://1145.am/db/882142/Aim>,
        <https://1145.am/db/886663/Tha>,
        <https://1145.am/db/888994/Tha>,
        <https://1145.am/db/943000/Pharnext>,
        <https://1145.am/db/965490/Reviral_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2290342/R___d>,
        <https://1145.am/db/2324274/R___d>,
        <https://1145.am/db/2330985/R___d>,
        <https://1145.am/db/2331542/R___d>,
        <https://1145.am/db/2332797/R___d>,
        <https://1145.am/db/2342265/R___d>,
        <https://1145.am/db/2369178/R___d> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368493/Flagship_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:buyer <https://1145.am/db/2368493/Rubius_Therapeutics_Joint_Venture> ;
    ns1:description "healthcare and sustainability" ;
    ns1:documentDate "2015-12-09T13:08:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flagship-ventures-launches-rubius-to-develop-red-cell-therapeutics%E2%84%A2> ;
    ns1:foundName "Flagship",
        "Flagship Ventures" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2368493/Rubius_Therapeutics_Joint_Venture> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368493/Rubius_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:description "healthcare" ;
    ns1:documentDate "2015-12-09T13:08:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flagship-ventures-launches-rubius-to-develop-red-cell-therapeutics%E2%84%A2> ;
    ns1:foundName "Rubius Therapeutics" ;
    ns1:industry "healthcare" ;
    ns1:name "Rubius Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1206026/Rubius_Therapeutics>,
        <https://1145.am/db/763995/Revir_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2284905/Rubius_Therapeutics>,
        <https://1145.am/db/2293241/Rubius_Therapeutics>,
        <https://1145.am/db/2297545/Rubius_Therapeutics>,
        <https://1145.am/db/437931/Rubius_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368501/Constellation_Pharmaceuticals> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "Constellation Pharmaceuticals, Inc." ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Constellation Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2283028/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2284167/Constellation>,
        <https://1145.am/db/2307336/Constellation_Pharmaceuticals_Inc>,
        <https://1145.am/db/2307337/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2309348/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2310482/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2313872/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2313879/Constellation_Pharmaceuticals_Inc>,
        <https://1145.am/db/2327474/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2347351/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2350364/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2350365/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2359323/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2359334/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2365781/Constellation_Pharmaceuticals>,
        <https://1145.am/db/2369498/Constellation_Pharmaceuticals>,
        <https://1145.am/db/380327/Constellation_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368501/The_Column_Group> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:description "investment" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "The Column Group" ;
    ns1:investor <https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsHigh <https://1145.am/db/1347054/Column_Capital_Corp>,
        <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2362566/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336503/The_Column_Group>,
        <https://1145.am/db/2336505/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359468/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362565/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/2584561/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368501/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:description "investing" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/1782938/Third_Kind_Venture_Capital>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368719/Acquisition_Merck_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-07-28T12:34:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Merck ($ MRK) , maker of the pioneering immuno-oncology treatment Keytruda, is investing in the next generation of cancer therapies that harness the body's natural defenses, agreeing to pay as much as $ 605 million for an Israeli biotech at work in the field." ;
    ns1:documentTitle "Merck signs a $605M deal to bulk up in cancer immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/merck-signs-a-605m-deal-to-bulk-up-cancer-immunotherapy> ;
    ns1:foundName "pay" ;
    ns1:name "pay" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "as much as $ 605 million" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2368719/Ccam_Biotherapeutics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-07-28T12:34:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Merck ($ MRK) , maker of the pioneering immuno-oncology treatment Keytruda, is investing in the next generation of cancer therapies that harness the body's natural defenses, agreeing to pay as much as $ 605 million for an Israeli biotech at work in the field.",
        "The New Jersey pharma giant has agreed to spend $ 95 million up front on cCAM Biotherapeutics and its lead asset, an early-stage treatment similar to Keytruda." ;
    ns1:documentTitle "Merck signs a $605M deal to bulk up in cancer immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/merck-signs-a-605m-deal-to-bulk-up-cancer-immunotherapy> ;
    ns1:foundName "pay" ;
    ns1:name "pay" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2368719/Ccam_Biotherapeutics> ;
    ns1:targetName "cCAM Biotherapeutics" ;
    ns1:valueRaw "$ 95 million",
        "as much as $ 605 million" ;
    ns1:whereGeoName "Bailiwick of Jersey" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3042142/about.rdf> ;
    ns1:whereRaw "New Jersey" .

<https://1145.am/db/2368719/Merck> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2368719/Acquisition_Merck_Has_Not_Happened>,
        <https://1145.am/db/2368719/Ccam_Biotherapeutics_Acquisition> ;
    ns1:description "cancer therapies" ;
    ns1:documentDate "2015-07-28T12:34:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck signs a $605M deal to bulk up in cancer immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/merck-signs-a-605m-deal-to-bulk-up-cancer-immunotherapy> ;
    ns1:foundName "Merck" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Merck" ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2355800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367218/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368808/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/769856/Merck>,
        <https://1145.am/db/866117/Merck> ;
    ns1:sameAsMedium <https://1145.am/db/1098407/Merck_Kgaa>,
        <https://1145.am/db/1149563/Merck>,
        <https://1145.am/db/1153272/Merck>,
        <https://1145.am/db/1153273/Merck>,
        <https://1145.am/db/1467892/Merck_Kgaa>,
        <https://1145.am/db/1524293/Merck>,
        <https://1145.am/db/1525563/Merck>,
        <https://1145.am/db/1570995/Merck>,
        <https://1145.am/db/1571146/Merck>,
        <https://1145.am/db/1635899/Merck>,
        <https://1145.am/db/1968247/Merck>,
        <https://1145.am/db/2220801/Merck_Kgaa>,
        <https://1145.am/db/2287767/Merck>,
        <https://1145.am/db/2293662/Merck>,
        <https://1145.am/db/2303087/Merck_Kgaa>,
        <https://1145.am/db/2304635/Merck>,
        <https://1145.am/db/2305972/Merck___Co>,
        <https://1145.am/db/2306562/Merck>,
        <https://1145.am/db/2306873/Merck_Kgaa>,
        <https://1145.am/db/2307697/Merck_Kgaa>,
        <https://1145.am/db/2309914/Merck>,
        <https://1145.am/db/2315288/Merck_Kgaa>,
        <https://1145.am/db/2317398/Merck>,
        <https://1145.am/db/2318574/Merck>,
        <https://1145.am/db/2325702/Merck___Co>,
        <https://1145.am/db/2329475/Merck>,
        <https://1145.am/db/2329795/Merck_Kgaa>,
        <https://1145.am/db/2330692/Merck___Co>,
        <https://1145.am/db/2331756/Merck>,
        <https://1145.am/db/2333619/Merck_Kgaa>,
        <https://1145.am/db/2337072/Merck>,
        <https://1145.am/db/2348727/Merck>,
        <https://1145.am/db/2356800/Merck>,
        <https://1145.am/db/2358017/Merck_Kgaa>,
        <https://1145.am/db/2358663/Merck>,
        <https://1145.am/db/2362458/Merck_Kgaa>,
        <https://1145.am/db/2368838/Merck>,
        <https://1145.am/db/2537077/Merck>,
        <https://1145.am/db/2540072/Merck_Kgaa>,
        <https://1145.am/db/2542394/Merck_Kgaa>,
        <https://1145.am/db/2545631/Merck>,
        <https://1145.am/db/2546686/Merck>,
        <https://1145.am/db/2551984/Merck>,
        <https://1145.am/db/2553618/Merck_Kgaa>,
        <https://1145.am/db/2554244/Merck>,
        <https://1145.am/db/2554269/Merck>,
        <https://1145.am/db/2562722/Merck___Co>,
        <https://1145.am/db/2565626/Merck_Kgaa>,
        <https://1145.am/db/2571683/Merck>,
        <https://1145.am/db/2575465/Merck_Kgaa>,
        <https://1145.am/db/2578046/Merck>,
        <https://1145.am/db/2587981/Merck>,
        <https://1145.am/db/2588540/Merck>,
        <https://1145.am/db/2590687/Merck>,
        <https://1145.am/db/2591687/Merck_Kgaa>,
        <https://1145.am/db/2592013/Merck>,
        <https://1145.am/db/2594711/Merck>,
        <https://1145.am/db/2596909/Merck>,
        <https://1145.am/db/2598420/Merck>,
        <https://1145.am/db/2598428/Merck>,
        <https://1145.am/db/420173/Merck>,
        <https://1145.am/db/510419/Merck>,
        <https://1145.am/db/511540/Merck>,
        <https://1145.am/db/678858/Merck>,
        <https://1145.am/db/680862/Merck>,
        <https://1145.am/db/868747/Merck>,
        <https://1145.am/db/884408/Merck_Kgaa>,
        <https://1145.am/db/990890/Merck> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368808/Ccam_Biotherapeutics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-07-30T07:01:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Merck ($ MRK) struck a $ 605 million (548 million) deal to acquire cCAM Biotherapeutics.",
        "Misgav, Israel - based cCAM is pocketing $ 95 million in cash upfront, with the rest of the sum tied to clinical, regulatory and commercial milestones." ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/eurobiotech-more-articles-of-note-3> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2368808/Ccam_Biotherapeutics> ;
    ns1:targetName "cCAM",
        "cCAM Biotherapeutics" ;
    ns1:valueRaw "$ 605 million",
        "$ 95 million",
        "548 million" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2368808/Merck> a org:Organization ;
    ns1:basedInLowRaw "Germany" ;
    ns1:buyer <https://1145.am/db/2368808/Ccam_Biotherapeutics_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-07-30T07:01:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/eurobiotech-more-articles-of-note-3> ;
    ns1:foundName "> Merck",
        "Merck" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Merck" ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/1362602/Merck___Co_Inc>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/1570995/Merck>,
        <https://1145.am/db/1571146/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1635899/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2220801/Merck_Kgaa>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2304635/Merck>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2309914/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329475/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2329795/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2331756/Merck>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337072/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2355800/Merck>,
        <https://1145.am/db/2356800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2358663/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367218/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368719/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2546686/Merck>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2571683/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2574609/Merck_Specialities_Private_Ltd>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2577464/Sanofi-Aventis_And_Merck>,
        <https://1145.am/db/2577485/Sanofi-Aventis_And_Merck___Co_Inc>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2584136/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2587981/Merck>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2596909/Merck>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/420173/Merck>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/510419/Merck>,
        <https://1145.am/db/511540/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/678858/Merck>,
        <https://1145.am/db/680862/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/866117/Merck>,
        <https://1145.am/db/868747/Merck>,
        <https://1145.am/db/884408/Merck_Kgaa> ;
    ns1:sameAsMedium <https://1145.am/db/1098407/Merck_Kgaa>,
        <https://1145.am/db/1149563/Merck>,
        <https://1145.am/db/1153272/Merck>,
        <https://1145.am/db/1153273/Merck>,
        <https://1145.am/db/1467892/Merck_Kgaa>,
        <https://1145.am/db/1524293/Merck>,
        <https://1145.am/db/1525563/Merck>,
        <https://1145.am/db/1968247/Merck>,
        <https://1145.am/db/2287767/Merck>,
        <https://1145.am/db/2293662/Merck>,
        <https://1145.am/db/2303087/Merck_Kgaa>,
        <https://1145.am/db/2305972/Merck___Co>,
        <https://1145.am/db/2306562/Merck>,
        <https://1145.am/db/2306873/Merck_Kgaa>,
        <https://1145.am/db/2307697/Merck_Kgaa>,
        <https://1145.am/db/2315288/Merck_Kgaa>,
        <https://1145.am/db/2317398/Merck>,
        <https://1145.am/db/2318574/Merck>,
        <https://1145.am/db/2325702/Merck___Co>,
        <https://1145.am/db/2330692/Merck___Co>,
        <https://1145.am/db/2333619/Merck_Kgaa>,
        <https://1145.am/db/2348727/Merck>,
        <https://1145.am/db/2358017/Merck_Kgaa>,
        <https://1145.am/db/2362458/Merck_Kgaa>,
        <https://1145.am/db/2368838/Merck>,
        <https://1145.am/db/2537077/Merck>,
        <https://1145.am/db/2540072/Merck_Kgaa>,
        <https://1145.am/db/2542394/Merck_Kgaa>,
        <https://1145.am/db/2545631/Merck>,
        <https://1145.am/db/2551984/Merck>,
        <https://1145.am/db/2553618/Merck_Kgaa>,
        <https://1145.am/db/2554244/Merck>,
        <https://1145.am/db/2554269/Merck>,
        <https://1145.am/db/2562722/Merck___Co>,
        <https://1145.am/db/2565626/Merck_Kgaa>,
        <https://1145.am/db/2575465/Merck_Kgaa>,
        <https://1145.am/db/2578046/Merck>,
        <https://1145.am/db/2588540/Merck>,
        <https://1145.am/db/2590687/Merck>,
        <https://1145.am/db/2591687/Merck_Kgaa>,
        <https://1145.am/db/2592013/Merck>,
        <https://1145.am/db/2594711/Merck>,
        <https://1145.am/db/2598420/Merck>,
        <https://1145.am/db/2598428/Merck>,
        <https://1145.am/db/769856/Merck>,
        <https://1145.am/db/990890/Merck> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Polaris_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "Life Sciences" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "Polaris",
        "Polaris Partners" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "Polaris Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2319338/Polaris_Ventures>,
        <https://1145.am/db/2370208/Polaris_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1163164/Polaris_Partners>,
        <https://1145.am/db/1166225/Polaris_Partners>,
        <https://1145.am/db/1229314/Polaris_Partners>,
        <https://1145.am/db/127343/Polaris_Partners>,
        <https://1145.am/db/1340338/Polaris_Partners>,
        <https://1145.am/db/1406211/Polaris_Partners>,
        <https://1145.am/db/1412727/Polaris_Partners>,
        <https://1145.am/db/1545490/Polaris_Partners>,
        <https://1145.am/db/1793129/Polaris_Partners>,
        <https://1145.am/db/1796910/Polaris_Partners>,
        <https://1145.am/db/1803886/Polaris_Partners>,
        <https://1145.am/db/1813337/Polaris_Partners>,
        <https://1145.am/db/1817112/Polaris_Partners>,
        <https://1145.am/db/1830311/Polaris_Partners>,
        <https://1145.am/db/1834199/Polaris_Partners>,
        <https://1145.am/db/1835107/Polaris_Partners>,
        <https://1145.am/db/1845960/Polaris_Partners>,
        <https://1145.am/db/1854788/Polaris_Partners>,
        <https://1145.am/db/1858995/Polaris_Partners>,
        <https://1145.am/db/1947183/Polaris_Partners>,
        <https://1145.am/db/2181016/Polaris_Partners>,
        <https://1145.am/db/2187023/Polaris_Partners>,
        <https://1145.am/db/2193661/Polaris_Partners>,
        <https://1145.am/db/2194844/Polaris_Partners>,
        <https://1145.am/db/2196895/Polaris_Partners>,
        <https://1145.am/db/2198647/Polaris_Partners>,
        <https://1145.am/db/2223723/Polaris_Partners>,
        <https://1145.am/db/2282077/Polaris_Partners>,
        <https://1145.am/db/2282162/Polaris_Partners>,
        <https://1145.am/db/2318310/Polaris_Partners>,
        <https://1145.am/db/2335750/Polaris_Partners>,
        <https://1145.am/db/2335755/Polaris_Partners>,
        <https://1145.am/db/2341595/Polaris_Partners>,
        <https://1145.am/db/2341599/Polaris_Partners>,
        <https://1145.am/db/2341764/Polaris_Partners>,
        <https://1145.am/db/2345675/Polaris_Partners>,
        <https://1145.am/db/2346988/Polaris_Partners>,
        <https://1145.am/db/2354955/Polaris_Partners>,
        <https://1145.am/db/2364332/Polaris_Partners>,
        <https://1145.am/db/2364336/Polaris_Partners>,
        <https://1145.am/db/2368913/Polaris_Partners>,
        <https://1145.am/db/2369304/Polaris_Partners>,
        <https://1145.am/db/2369305/Polaris_Partners>,
        <https://1145.am/db/250010/Polaris_Partners>,
        <https://1145.am/db/2611628/Polaris_Partners>,
        <https://1145.am/db/2787561/Polaris_Partners>,
        <https://1145.am/db/364226/Polaris_Partners>,
        <https://1145.am/db/572097/Polaris_Partners>,
        <https://1145.am/db/612707/Polaris_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/The_Kraft_Group> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:description "financing" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "The Kraft Group" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "The Kraft Group" ;
    ns1:sameAsMedium <https://1145.am/db/1173387/The_Kraft_Group>,
        <https://1145.am/db/1215930/The_Kraft_Group>,
        <https://1145.am/db/1806318/The_Kraft_Group>,
        <https://1145.am/db/2298211/The_Kraft_Group>,
        <https://1145.am/db/2364332/The_Kraft_Group>,
        <https://1145.am/db/2364336/The_Kraft_Group>,
        <https://1145.am/db/2368913/The_Kraft_Group>,
        <https://1145.am/db/2369890/The_Kraft_Group>,
        <https://1145.am/db/2573068/The_Kraft_Group>,
        <https://1145.am/db/841377/The_Kraft_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Timothy_Springer> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "Timothy Springer" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "Timothy Springer" ;
    ns1:sameAsHigh <https://1145.am/db/1606177/Michael_Brauser>,
        <https://1145.am/db/2364332/Timothy_Springer>,
        <https://1145.am/db/2364336/Timothy_Springer>,
        <https://1145.am/db/2368913/Timothy_Springer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Polaris_Partners> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "Polaris Partners" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "Polaris Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1163164/Polaris_Partners>,
        <https://1145.am/db/1166225/Polaris_Partners>,
        <https://1145.am/db/127343/Polaris_Partners>,
        <https://1145.am/db/1340338/Polaris_Partners>,
        <https://1145.am/db/1406211/Polaris_Partners>,
        <https://1145.am/db/1412727/Polaris_Partners>,
        <https://1145.am/db/1545490/Polaris_Partners>,
        <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1796259/Polaris_Capital>,
        <https://1145.am/db/1803886/Polaris_Partners>,
        <https://1145.am/db/1817112/Polaris_Partners>,
        <https://1145.am/db/1845960/Polaris_Partners>,
        <https://1145.am/db/1854788/Polaris_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1885717/Polaris_Ventures>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/1947183/Polaris_Partners>,
        <https://1145.am/db/2140474/Polaris_Capital_Management>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2181016/Polaris_Partners>,
        <https://1145.am/db/2187023/Polaris_Partners>,
        <https://1145.am/db/2193661/Polaris_Partners>,
        <https://1145.am/db/2194844/Polaris_Partners>,
        <https://1145.am/db/2196895/Polaris_Partners>,
        <https://1145.am/db/2223723/Polaris_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2317918/Polaris_Ventures>,
        <https://1145.am/db/2318310/Polaris_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2335531/Flagship_Ventures_Polaris_Partners>,
        <https://1145.am/db/2335750/Polaris_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2341599/Polaris_Partners>,
        <https://1145.am/db/2343467/Polaris_Ventures>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2354955/Polaris_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2369304/Polaris_Partners>,
        <https://1145.am/db/2369305/Polaris_Partners>,
        <https://1145.am/db/250010/Polaris_Partners>,
        <https://1145.am/db/364226/Polaris_Partners>,
        <https://1145.am/db/572097/Polaris_Partners>,
        <https://1145.am/db/612707/Polaris_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1229314/Polaris_Partners>,
        <https://1145.am/db/1793129/Polaris_Partners>,
        <https://1145.am/db/1796910/Polaris_Partners>,
        <https://1145.am/db/1813337/Polaris_Partners>,
        <https://1145.am/db/1830311/Polaris_Partners>,
        <https://1145.am/db/1834199/Polaris_Partners>,
        <https://1145.am/db/1835107/Polaris_Partners>,
        <https://1145.am/db/1858995/Polaris_Partners>,
        <https://1145.am/db/2198647/Polaris_Partners>,
        <https://1145.am/db/2282077/Polaris_Partners>,
        <https://1145.am/db/2282162/Polaris_Partners>,
        <https://1145.am/db/2335755/Polaris_Partners>,
        <https://1145.am/db/2341595/Polaris_Partners>,
        <https://1145.am/db/2341764/Polaris_Partners>,
        <https://1145.am/db/2345675/Polaris_Partners>,
        <https://1145.am/db/2346988/Polaris_Partners>,
        <https://1145.am/db/2364332/Polaris_Partners>,
        <https://1145.am/db/2364336/Polaris_Partners>,
        <https://1145.am/db/2368912/Polaris_Partners>,
        <https://1145.am/db/2370208/Polaris_Partners>,
        <https://1145.am/db/2611628/Polaris_Partners>,
        <https://1145.am/db/2787561/Polaris_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/The_Kraft_Group> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "The Kraft Group" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "The Kraft Group" ;
    ns1:sameAsHigh <https://1145.am/db/1173387/The_Kraft_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1215930/The_Kraft_Group>,
        <https://1145.am/db/1806318/The_Kraft_Group>,
        <https://1145.am/db/2298211/The_Kraft_Group>,
        <https://1145.am/db/2364332/The_Kraft_Group>,
        <https://1145.am/db/2364336/The_Kraft_Group>,
        <https://1145.am/db/2368912/The_Kraft_Group>,
        <https://1145.am/db/2369890/The_Kraft_Group>,
        <https://1145.am/db/2573068/The_Kraft_Group>,
        <https://1145.am/db/841377/The_Kraft_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Timothy_Springer> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "Harvard-ARCH Venture Partners" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "Timothy Springer" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "Timothy Springer" ;
    ns1:sameAsHigh <https://1145.am/db/1606177/Michael_Brauser>,
        <https://1145.am/db/2364332/Timothy_Springer>,
        <https://1145.am/db/2364336/Timothy_Springer>,
        <https://1145.am/db/2368912/Timothy_Springer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368982/Antiva_Biosciences> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-08-06T15:23:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/antiva-biosciences-raises-16-million-series-b-financing-to-advance-lead-compound-for-human> ;
    ns1:foundName "Antiva Biosciences",
        "Antiva Biosciences, Inc",
        "Antiva Biosciences, Inc.",
        "Hera Therapeutics" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Antiva Biosciences" ;
    ns1:participant <https://1145.am/db/2368982/Series_B_Investment_Antiva_Biosciences_Antiva_Biosciences_Canaan_Partners_Sofinnova_Ventures_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/2300985/Antiva_Biosciences> ;
    ns1:sameAsMedium <https://1145.am/db/2280792/Antiva_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368982/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK, Calif" ;
    ns1:documentDate "2015-08-06T15:23:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/antiva-biosciences-raises-16-million-series-b-financing-to-advance-lead-compound-for-human> ;
    ns1:foundName "Canaan",
        "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2368982/Series_B_Investment_Antiva_Biosciences_Antiva_Biosciences_Canaan_Partners_Sofinnova_Ventures_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2332322/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Alexandria_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "New York" ;
    ns1:description "life science investment" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Alexandria Venture Investments" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Alexandria Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1087327/Alexandria_Venture_Investments>,
        <https://1145.am/db/1089424/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369305/Alexandria_Venture_Investments>,
        <https://1145.am/db/587045/Alexandria_Venture_Investments>,
        <https://1145.am/db/591613/Alexandria_Venture_Investments>,
        <https://1145.am/db/923059/Alexandria_Venture_Investments> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Alexandria_Venture_Investments>,
        <https://1145.am/db/1042269/Alexandria_Venture_Investments>,
        <https://1145.am/db/1156304/Alexandria_Venture_Investments>,
        <https://1145.am/db/1202633/Alexandria_Venture_Investments>,
        <https://1145.am/db/1203099/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214380/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214387/Alexandria_Venture_Investments>,
        <https://1145.am/db/1233008/Alexandria_Venture_Investments>,
        <https://1145.am/db/1238474/Alexandria_Venture_Investments>,
        <https://1145.am/db/1340338/Alexandria_Venture_Investments>,
        <https://1145.am/db/1416749/Alexandria_Venture_Investments>,
        <https://1145.am/db/1417475/Alexandria_Venture_Investments>,
        <https://1145.am/db/1536915/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553175/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553459/Alexandria_Venture_Investments>,
        <https://1145.am/db/1663572/Alexandria_Venture_Investments>,
        <https://1145.am/db/1665536/Alexandria_Venture_Investments>,
        <https://1145.am/db/1754964/Alexandria_Venture_Investments>,
        <https://1145.am/db/1984721/Alexandria_Venture_Investments>,
        <https://1145.am/db/2073480/Alexandria_Venture_Investments>,
        <https://1145.am/db/2114450/Alexandria_Venture_Investments>,
        <https://1145.am/db/2152096/Alexandria_Venture_Investments>,
        <https://1145.am/db/2197183/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279310/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279933/Alexandria_Venture_Investments>,
        <https://1145.am/db/2280707/Alexandria_Venture_Investments>,
        <https://1145.am/db/2281211/Alexandria_Venture_Investments>,
        <https://1145.am/db/2282162/Alexandria_Venture_Investments>,
        <https://1145.am/db/2285971/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287244/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287557/Alexandria_Venture_Investments>,
        <https://1145.am/db/2294202/Alexandria_Venture_Investments>,
        <https://1145.am/db/2296113/Alexandria_Venture_Investments>,
        <https://1145.am/db/2330338/Alexandria_Venture_Investment>,
        <https://1145.am/db/2337664/Alexandria_Venture_Investments>,
        <https://1145.am/db/2340634/Alexandria_Venture_Investments>,
        <https://1145.am/db/2341599/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343592/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343595/Alexandria_Venture_Investments>,
        <https://1145.am/db/2344782/Alexandria_Venture_Investments>,
        <https://1145.am/db/2347368/Alexandria_Venture_Investments>,
        <https://1145.am/db/2356456/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369304/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369549/Alexandria_Venture_Investments>,
        <https://1145.am/db/2787561/Alexandria_Venture_Investments>,
        <https://1145.am/db/4142/Alexandria_Venture_Investments_Llc>,
        <https://1145.am/db/471253/Alexandria_Venture_Investments>,
        <https://1145.am/db/504446/Alexandria_Venture_Investments>,
        <https://1145.am/db/506326/Alexandria_Venture_Investments>,
        <https://1145.am/db/531806/Alexandria_Venture_Investments>,
        <https://1145.am/db/571769/Alexandria_Venture_Investments>,
        <https://1145.am/db/601404/Alexandria_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Petra_Pharma> a org:Organization ;
    ns1:description "developing therapies for cancer and metabolic diseases" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Petra Pharma",
        "Petra Pharma Corporation" ;
    ns1:industry "BioPharma" ;
    ns1:name "Petra Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1072187/Petra_Pharma_Corporation>,
        <https://1145.am/db/2368999/Petra_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Wuxi_Pharmatech> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "WuXi PharmaTech" ;
    ns1:industry "life science" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "WuXi PharmaTech" ;
    ns1:sameAsHigh <https://1145.am/db/1328634/Wuxi_Sta>,
        <https://1145.am/db/1366554/Casi_Wuxi>,
        <https://1145.am/db/2300983/Wuxi>,
        <https://1145.am/db/2317074/Wuxi_Pharmatech>,
        <https://1145.am/db/2319622/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2323895/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2328362/Wuxi_Pharmatech>,
        <https://1145.am/db/2329325/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2330601/Wuxi_Apptec_Us>,
        <https://1145.am/db/2333351/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2334048/Wuxi_Pharmatech_(cayman)>,
        <https://1145.am/db/2334544/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2335732/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2341599/Wuxi_Pharmatech>,
        <https://1145.am/db/2350843/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2351683/Wuxi_Pharmatech>,
        <https://1145.am/db/2354723/Wuxi>,
        <https://1145.am/db/2355452/Fosun_Pharma_Cro_Wuxi_Pharmatech>,
        <https://1145.am/db/2357114/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2357202/Wuxi_Pharmatech>,
        <https://1145.am/db/2358953/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2360258/Wuxi_Pharmatech_Corporate_Ventures>,
        <https://1145.am/db/2367470/Wuxi>,
        <https://1145.am/db/2368287/Wuxi_Pharmatech>,
        <https://1145.am/db/2368649/Wuxi_Pharmatech>,
        <https://1145.am/db/2369250/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2369317/Wuxi_Pharmatech>,
        <https://1145.am/db/2536552/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2536795/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2536809/Wuxi_Pharmatech>,
        <https://1145.am/db/2538401/Wuxi_Pharmatech>,
        <https://1145.am/db/2538432/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2540203/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2544511/Wuxi_Pharmatech>,
        <https://1145.am/db/2546407/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2546449/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2548440/Wuxi_Apptec_Co_Ltd>,
        <https://1145.am/db/2550682/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2550951/Wuxis_Sta>,
        <https://1145.am/db/2551549/Wuxi>,
        <https://1145.am/db/2552704/Wuxi_Pharmatech>,
        <https://1145.am/db/2556261/Wuxi_Biologics>,
        <https://1145.am/db/2562693/Wuxi_Biologics>,
        <https://1145.am/db/2562693/Wuxi_Sta>,
        <https://1145.am/db/2562701/Wuxi_Biologics>,
        <https://1145.am/db/2563558/Wuxi_Biologics>,
        <https://1145.am/db/2565318/Wuxi_Apptec>,
        <https://1145.am/db/2567008/Wuxi_Biologics>,
        <https://1145.am/db/2584599/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2729766/Wuxi_Apptec>,
        <https://1145.am/db/274660/Wuxi_Biologics_Inc>,
        <https://1145.am/db/274739/Wuxi_Biologics_Inc>,
        <https://1145.am/db/2756477/Wuxi_Biologics>,
        <https://1145.am/db/2756477/Wuxi_Xdc>,
        <https://1145.am/db/685293/Wuhan_General_Group_(china)_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2302864/Wuxi_Pharmatech>,
        <https://1145.am/db/2305866/Wuxi_Pharmatech>,
        <https://1145.am/db/2308945/Wuxi_Pharmatec>,
        <https://1145.am/db/2312926/Wuxi_Pharmatech>,
        <https://1145.am/db/2317680/Wuxi_Pharmatech>,
        <https://1145.am/db/2318655/Wuxi_Pharmatech>,
        <https://1145.am/db/2321775/Wuxi_Pharmatech>,
        <https://1145.am/db/2322854/Wuxi_Pharmatech>,
        <https://1145.am/db/2327243/Wuxi_Pharmatech>,
        <https://1145.am/db/2327401/Wuxi_Pharmatech>,
        <https://1145.am/db/2328360/Wuxi_Pharmatech>,
        <https://1145.am/db/2329324/Wuxi_Pharmatech>,
        <https://1145.am/db/2330685/Wuxi_Pharmatech>,
        <https://1145.am/db/2331490/Wuxi_Pharmatech>,
        <https://1145.am/db/2331539/Wuxi_Pharmatech>,
        <https://1145.am/db/2331756/Wuxi_Pharmatech>,
        <https://1145.am/db/2332322/Wuxi_Pharmatech>,
        <https://1145.am/db/2332622/Wuxi_Pharmatech>,
        <https://1145.am/db/2332973/Wuxi_Pharmatech>,
        <https://1145.am/db/2332977/Wuxi_Pharmatech>,
        <https://1145.am/db/2332992/Wuxi_Pharmatech>,
        <https://1145.am/db/2333380/Wuxi_Pharmatech>,
        <https://1145.am/db/2334018/Wuxi_Pharmatech>,
        <https://1145.am/db/2336182/Wuxi_Pharmatech>,
        <https://1145.am/db/2339255/Wuxi_Pharmatech>,
        <https://1145.am/db/2345740/Wuxi_Pharmatech>,
        <https://1145.am/db/2345752/Wuxi_Pharmatech>,
        <https://1145.am/db/2346592/Wuxi_Pharmatech>,
        <https://1145.am/db/2351684/Wuxi_Pharmatech>,
        <https://1145.am/db/2354127/Wuxi_Pharmatech>,
        <https://1145.am/db/2355454/Wuxi_Pharmatech>,
        <https://1145.am/db/2356066/Wuxi_Pharmatech>,
        <https://1145.am/db/2358954/Wuxi_Pharmatech>,
        <https://1145.am/db/2369637/Wuxi_Pharmatech>,
        <https://1145.am/db/2536549/Wuxi_Pharmatech>,
        <https://1145.am/db/2536790/Wuxi_Pharmatech>,
        <https://1145.am/db/2538197/Wuxi_Pharmatech>,
        <https://1145.am/db/2546416/Wuxi_Pharmatech>,
        <https://1145.am/db/2548494/Wuxi_Pharmatech>,
        <https://1145.am/db/2549518/Wuxi_Pharmatech>,
        <https://1145.am/db/2553655/Wuxi_Pharmatech>,
        <https://1145.am/db/2555844/Wuxi_Pharmatech>,
        <https://1145.am/db/2572398/Wuxi_Pharmatech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Brace_Pharma_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Brace Pharma Capital" ;
    ns1:investor <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:name "Brace Pharma Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2319433/Brace_Pharma_Capital>,
        <https://1145.am/db/2359683/Brace_Pharma_Capital>,
        <https://1145.am/db/2367740/Brace_Pharma_Capital>,
        <https://1145.am/db/2369999/Brace_Pharma_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Kairos_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Vancouver" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6173331/about.rdf> ;
    ns1:basedInHighRaw "Vancouver" ;
    ns1:description "developing antibody drug conjugates" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Kairos Therapeutics" ;
    ns1:industry "biotech" ;
    ns1:name "Kairos Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2155111/Kymera_Therapeutics>,
        <https://1145.am/db/2155622/Amarna_Therapeutics>,
        <https://1145.am/db/2308305/Affimed_Therapeutics>,
        <https://1145.am/db/2311007/Millennium:>,
        <https://1145.am/db/2319412/Ifm_Therapeutics>,
        <https://1145.am/db/2329322/Redwood_Bioscience>,
        <https://1145.am/db/2337043/Affimed_Therapeutics>,
        <https://1145.am/db/2348753/Affimed_Therapeutics>,
        <https://1145.am/db/2349788/Akashi_Therapeutics_Inc>,
        <https://1145.am/db/2350239/Affimed_Therapeutics>,
        <https://1145.am/db/2362564/Arno_Therapeutics>,
        <https://1145.am/db/2364347/Akashi_Therapeutics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Iconic_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "South San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:basedInHighRaw "South San Francisco" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "Iconic Therapeutics" ;
    ns1:industry "life science" ;
    ns1:name "Iconic Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2354196/Protagonist_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2354368/Iconic_Therapeutics>,
        <https://1145.am/db/2364492/Iconic_Therapeutics>,
        <https://1145.am/db/2369165/Iconic_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Rhythm_Metabolic> a org:Organization ;
    ns1:basedInHighGeoName "Boston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:basedInHighRaw "BOSTON" ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "a novel peptide MC4 agonist for the treatment of obesity caused by genetic",
        "a pharmaceutical company" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Rhythm",
        "Rhythm Metabolic, Inc." ;
    ns1:industry "healthcare" ;
    ns1:name "Rhythm",
        "Rhythm Metabolic" ;
    ns1:participant <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1153383/Medtex_Ventures>,
        <https://1145.am/db/1272098/Medtex_Ventures>,
        <https://1145.am/db/1297744/Medical_Excellence_Capital_Partners>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2154383/Northpond_Ventures>,
        <https://1145.am/db/2289616/Ascension_Health_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2318657/Chl_Medical_Ventures>,
        <https://1145.am/db/2322102/Trevi_Health_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2364468/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/854386/Optum_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354307/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369359/Orbus_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Palo Alto" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5380748/about.rdf> ;
    ns1:basedInHighRaw "Palo Alto, CA" ;
    ns1:description "drug" ;
    ns1:documentDate "2015-08-19T15:13:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Orbus snags $32.5M round for PhIII study; Merck and union leaders in overtime row;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbus-snags-32-5m-round-for-phiii-study-merck-and-union-leaders-overtime-row> ;
    ns1:foundName "Orbus Therapeutics" ;
    ns1:name "Orbus Therapeutics" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369363/Akari_Therapeutics> a org:Organization ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-08-19T14:56:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reborn Akari grabs $75M in financing for another Soliris rival" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/reborn-akari-grabs-75m-financing-for-another-soliris-rival> ;
    ns1:foundName "Akari Therapeutics" ;
    ns1:industry "biotech" ;
    ns1:name "Akari Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1156401/Artios_Pharma_Limited>,
        <https://1145.am/db/1604485/Aeon_Biopharma>,
        <https://1145.am/db/1606180/Aeon_Biopharma>,
        <https://1145.am/db/2065968/Aeon_Biopharma>,
        <https://1145.am/db/2153279/Artios_Pharma>,
        <https://1145.am/db/2254330/Avecia_Biologics>,
        <https://1145.am/db/2281204/Adarx_Pharmaceuticals>,
        <https://1145.am/db/2290753/Karo_Pharma>,
        <https://1145.am/db/2293662/Artios_Pharma>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2319111/Aeras>,
        <https://1145.am/db/2322526/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2323608/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2339922/Biotech_Investment_Group>,
        <https://1145.am/db/2341380/Alexion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342894/Savara_Pharmaceuticals>,
        <https://1145.am/db/2345996/Alphacore_Pharma>,
        <https://1145.am/db/2347301/Aeras>,
        <https://1145.am/db/2349489/Alexza_Pharma>,
        <https://1145.am/db/2349856/Allena_Pharmaceuticals>,
        <https://1145.am/db/2351519/Allena_Pharmaceuticals>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2355318/Aeras>,
        <https://1145.am/db/2356408/Acadia_Pharmaceuticals>,
        <https://1145.am/db/2360526/Sideris_Pharmaceuticals>,
        <https://1145.am/db/2366977/Inspire_Pharmaceuticals>,
        <https://1145.am/db/2368346/Aeras>,
        <https://1145.am/db/2541473/Elona_Biotechnologies>,
        <https://1145.am/db/2545610/Altus_Pharmaceuticals>,
        <https://1145.am/db/726068/Akari_Therapeutics>,
        <https://1145.am/db/887508/Akari_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/1130767/Akari_Therapeutics_Plc>,
        <https://1145.am/db/1334270/Akari_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369363/Akari_Therapeutics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-08-19T14:56:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Celsus and Volution announced a few days ago that they had come up with a deal in which Celsus acquires Volution, with Volution shareholders winding up with 92 % of a new entity called Akari Therapeutics that will trade under the \"AKTX\" symbol." ;
    ns1:documentTitle "Reborn Akari grabs $75M in financing for another Soliris rival" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/reborn-akari-grabs-75m-financing-for-another-soliris-rival> ;
    ns1:foundName "acquires" ;
    ns1:name "acquires" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369363/Akari_Therapeutics> ;
    ns1:targetName "Akari Therapeutics" .

<https://1145.am/db/2369363/Volution> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-08-19T14:56:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Reborn Akari grabs $75M in financing for another Soliris rival" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/reborn-akari-grabs-75m-financing-for-another-soliris-rival> ;
    ns1:foundName "Volution" ;
    ns1:industry "biotech" ;
    ns1:name "Volution" ;
    ns1:sameAsHigh <https://1145.am/db/1157465/Oragenics>,
        <https://1145.am/db/1158575/Oragenics>,
        <https://1145.am/db/1441535/Micreos>,
        <https://1145.am/db/1509809/Novigenix>,
        <https://1145.am/db/1629918/Novotech>,
        <https://1145.am/db/1634976/Biontech>,
        <https://1145.am/db/1696213/23andme_Inc>,
        <https://1145.am/db/1696213/Genentech>,
        <https://1145.am/db/1950266/Concentra_Biosciences>,
        <https://1145.am/db/2049549/Biogen>,
        <https://1145.am/db/2078301/Oragenics>,
        <https://1145.am/db/2151717/Abcellera>,
        <https://1145.am/db/2152261/Inventiva>,
        <https://1145.am/db/2152981/Vividion>,
        <https://1145.am/db/2154072/Caelum_Biosciences>,
        <https://1145.am/db/2154521/Baergic_Bio>,
        <https://1145.am/db/2156117/Themis>,
        <https://1145.am/db/2156304/Puretech>,
        <https://1145.am/db/2279108/Anaveon>,
        <https://1145.am/db/2279595/Erytech>,
        <https://1145.am/db/2279911/Genetx>,
        <https://1145.am/db/2280707/Dren_Bio>,
        <https://1145.am/db/2280734/Forte_Biosciences>,
        <https://1145.am/db/2281936/Bioindustry_Association>,
        <https://1145.am/db/2285390/Cellarity>,
        <https://1145.am/db/2288986/Novogen>,
        <https://1145.am/db/2290381/Life_Sciences>,
        <https://1145.am/db/2290780/Medivir>,
        <https://1145.am/db/2291198/Novogen>,
        <https://1145.am/db/2292333/Biodesix>,
        <https://1145.am/db/2292843/Reviral>,
        <https://1145.am/db/2293654/Eleven_Bio>,
        <https://1145.am/db/2293654/Viventia>,
        <https://1145.am/db/2296000/Medivation>,
        <https://1145.am/db/2297083/Biogen_Idec>,
        <https://1145.am/db/2297963/Biogen>,
        <https://1145.am/db/2301170/Ablynx>,
        <https://1145.am/db/2301648/Achillion>,
        <https://1145.am/db/2301983/Biogen_Idec>,
        <https://1145.am/db/2302002/Biogen_Idec>,
        <https://1145.am/db/2306118/Biovex_Inc>,
        <https://1145.am/db/2307654/Bioton_Sa>,
        <https://1145.am/db/2308022/Cogenesys>,
        <https://1145.am/db/2309865/Biovex_Inc>,
        <https://1145.am/db/2309872/Biovex>,
        <https://1145.am/db/2310072/Encysive>,
        <https://1145.am/db/2313760/Sistemic_Ltd>,
        <https://1145.am/db/2315615/Anormed>,
        <https://1145.am/db/2319956/Cytovance>,
        <https://1145.am/db/2320138/Biogen_Idec>,
        <https://1145.am/db/2322304/Biovex>,
        <https://1145.am/db/2322312/Biovex_Inc>,
        <https://1145.am/db/2323591/Promedior>,
        <https://1145.am/db/2325718/Biogen>,
        <https://1145.am/db/2326139/Biovex_Inc>,
        <https://1145.am/db/2326588/Gpc_Biotech>,
        <https://1145.am/db/2327506/Esperion>,
        <https://1145.am/db/2331639/Bioprocessors_Corporation>,
        <https://1145.am/db/2331994/3sbio>,
        <https://1145.am/db/2332003/Neose>,
        <https://1145.am/db/2332883/Gpc_Biotech>,
        <https://1145.am/db/2336383/Biocrates_Life_Sciences_Ag>,
        <https://1145.am/db/2341010/GTC>,
        <https://1145.am/db/2341458/Coridon>,
        <https://1145.am/db/2343202/Promedior>,
        <https://1145.am/db/2344535/Biovex_Inc>,
        <https://1145.am/db/2345773/Exonhit>,
        <https://1145.am/db/2346300/Myr>,
        <https://1145.am/db/2352382/Hbm_Bioventures>,
        <https://1145.am/db/2355236/Stellar_Biotechnologies_Inc>,
        <https://1145.am/db/2355423/Biontech>,
        <https://1145.am/db/2357260/Inotrem>,
        <https://1145.am/db/2358297/Clal_Biotechnology>,
        <https://1145.am/db/2360127/Biomedinvest>,
        <https://1145.am/db/2362543/Micurx>,
        <https://1145.am/db/2366924/Biovex_Inc>,
        <https://1145.am/db/2367150/Biovex_Inc>,
        <https://1145.am/db/2367816/Conkwest>,
        <https://1145.am/db/2368688/Etubics_Corporation>,
        <https://1145.am/db/2369703/Promedior>,
        <https://1145.am/db/2369982/Reviral>,
        <https://1145.am/db/2370423/Nuevolution_A_S>,
        <https://1145.am/db/2370806/Alvotech>,
        <https://1145.am/db/2538176/Matritech>,
        <https://1145.am/db/2542993/Biogen_Idec>,
        <https://1145.am/db/2545426/Medivation>,
        <https://1145.am/db/2546456/3sbio>,
        <https://1145.am/db/2549151/Encysive>,
        <https://1145.am/db/2550495/Bioatla>,
        <https://1145.am/db/2554066/Erytech>,
        <https://1145.am/db/2557249/Biontech>,
        <https://1145.am/db/2558655/Biondvax>,
        <https://1145.am/db/2562577/Biogen>,
        <https://1145.am/db/2565174/Biocon_Viatris>,
        <https://1145.am/db/2572695/Biovex_Inc>,
        <https://1145.am/db/411454/Ensysce>,
        <https://1145.am/db/540784/Coherus_Biosciences_Inc>,
        <https://1145.am/db/679276/Biodesix_Inc>,
        <https://1145.am/db/767994/Biotech_Prokidney_Lp>,
        <https://1145.am/db/940935/Mabxience> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369363/Volution_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-08-19T14:56:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Celsus and Volution announced a few days ago that they had come up with a deal in which Celsus acquires Volution, with Volution shareholders winding up with 92 % of a new entity called Akari Therapeutics that will trade under the \"AKTX\" symbol." ;
    ns1:documentTitle "Reborn Akari grabs $75M in financing for another Soliris rival" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/reborn-akari-grabs-75m-financing-for-another-soliris-rival> ;
    ns1:foundName "acquires" ;
    ns1:name "acquires" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369363/Volution> ;
    ns1:targetName "Volution" .

<https://1145.am/db/2369411/Ucl> a org:Organization ;
    ns1:basedInLowRaw "United Kingdom" ;
    ns1:description "academics" ;
    ns1:documentDate "2016-01-20T16:44:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UCL launches 50 million technology investment fund" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ucl-launches-%C2%A350-million-technology-investment-fund> ;
    ns1:foundName "UCL" ;
    ns1:name "UCL" ;
    ns1:sameAsMedium <https://1145.am/db/1788547/Ucl> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369419/Mucosis> a org:Organization ;
    ns1:basedInLowRaw "London" ;
    ns1:description "vaccine" ;
    ns1:documentDate "2016-01-21T14:43:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/eurobiotech-more-articles-of-note-10> ;
    ns1:foundName "> Mucosis",
        "Mucosis" ;
    ns1:name "Mucosis" ;
    ns1:sameAsHigh <https://1145.am/db/2346822/Mucosis>,
        <https://1145.am/db/2353447/Mucosis_Bv>,
        <https://1145.am/db/2353448/Mucosis_Bv>,
        <https://1145.am/db/2558846/Mucosis>,
        <https://1145.am/db/2558848/Mucosis> ;
    ns1:sameAsMedium <https://1145.am/db/2346807/Mucosis>,
        <https://1145.am/db/2360067/Mucosis_Bv>,
        <https://1145.am/db/2360078/Mucosis_Bv>,
        <https://1145.am/db/2364259/Mucosis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369419/Syngem> a org:Organization ;
    ns1:basedInLowRaw "London" ;
    ns1:description "vaccine" ;
    ns1:documentDate "2016-01-21T14:43:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/eurobiotech-more-articles-of-note-10> ;
    ns1:foundName "SynGEM" ;
    ns1:name "SynGEM" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369548/Adicet_Bio> a org:Organization ;
    ns1:basedInHighGeoName "Menlo Park" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:basedInHighRaw "MENLO PARK, Calif." ;
    ns1:buyer <https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment> ;
    ns1:description "Biopharmaceutical" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "Adicet",
        "Adicet Bio",
        "Adicet Bio, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:investor <https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment>,
        <https://1145.am/db/2369548/Series_A_Investment_Adicet_Bio_Completed> ;
    ns1:name "Adicet",
        "Adicet Bio" ;
    ns1:sameAsHigh <https://1145.am/db/1536918/Adicet_Bio>,
        <https://1145.am/db/542992/Adicet_Bio> ;
    ns1:sameAsMedium <https://1145.am/db/2300495/Adicet_Bio>,
        <https://1145.am/db/2369550/Adicet_Bio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369548/Applied_Immune_Technologies> a org:Organization ;
    ns1:description "immunotherapy" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "Applied Immune Technologies",
        "Applied Immune Technologies, Ltd" ;
    ns1:name "Applied Immune Technologies" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369548/Series_A_Investment_Adicet_Bio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MENLO PARK, Calif., Jan. 27, 2016 /PRNewswire/ - Adicet Bio, Inc. (\"Adicet\") , a biopharmaceutical company focused on the development of next-generation cell immunotherapies, announced today that it closed a $ 51 million Series A financing." ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369548/Adicet_Bio> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 51 million" ;
    ns1:when "2016-01-27T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 27, 2016" ;
    ns1:whereGeoName "Menlo Park" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5372223/about.rdf> ;
    ns1:whereRaw "MENLO PARK" .

<https://1145.am/db/2369549/Alexandria_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "Alexandria Venture Investments" ;
    ns1:investor <https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> ;
    ns1:name "Alexandria Venture Investments" ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Alexandria_Venture_Investments>,
        <https://1145.am/db/1042269/Alexandria_Venture_Investments>,
        <https://1145.am/db/1087327/Alexandria_Venture_Investments>,
        <https://1145.am/db/1089424/Alexandria_Venture_Investments>,
        <https://1145.am/db/1156304/Alexandria_Venture_Investments>,
        <https://1145.am/db/1202633/Alexandria_Venture_Investments>,
        <https://1145.am/db/1203099/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214380/Alexandria_Venture_Investments>,
        <https://1145.am/db/1214387/Alexandria_Venture_Investments>,
        <https://1145.am/db/1233008/Alexandria_Venture_Investments>,
        <https://1145.am/db/1238474/Alexandria_Venture_Investments>,
        <https://1145.am/db/1340338/Alexandria_Venture_Investments>,
        <https://1145.am/db/1416749/Alexandria_Venture_Investments>,
        <https://1145.am/db/1417475/Alexandria_Venture_Investments>,
        <https://1145.am/db/1536915/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553175/Alexandria_Venture_Investments>,
        <https://1145.am/db/1553459/Alexandria_Venture_Investments>,
        <https://1145.am/db/1663572/Alexandria_Venture_Investments>,
        <https://1145.am/db/1665536/Alexandria_Venture_Investments>,
        <https://1145.am/db/1754964/Alexandria_Venture_Investments>,
        <https://1145.am/db/1984721/Alexandria_Venture_Investments>,
        <https://1145.am/db/2073480/Alexandria_Venture_Investments>,
        <https://1145.am/db/2114450/Alexandria_Venture_Investments>,
        <https://1145.am/db/2152096/Alexandria_Venture_Investments>,
        <https://1145.am/db/2197183/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279310/Alexandria_Venture_Investments>,
        <https://1145.am/db/2279933/Alexandria_Venture_Investments>,
        <https://1145.am/db/2280707/Alexandria_Venture_Investments>,
        <https://1145.am/db/2281211/Alexandria_Venture_Investments>,
        <https://1145.am/db/2282162/Alexandria_Venture_Investments>,
        <https://1145.am/db/2285971/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287244/Alexandria_Venture_Investments>,
        <https://1145.am/db/2287557/Alexandria_Venture_Investments>,
        <https://1145.am/db/2294202/Alexandria_Venture_Investments>,
        <https://1145.am/db/2296113/Alexandria_Venture_Investments>,
        <https://1145.am/db/2330338/Alexandria_Venture_Investment>,
        <https://1145.am/db/2337664/Alexandria_Venture_Investments>,
        <https://1145.am/db/2340634/Alexandria_Venture_Investments>,
        <https://1145.am/db/2341599/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343592/Alexandria_Venture_Investments>,
        <https://1145.am/db/2343595/Alexandria_Venture_Investments>,
        <https://1145.am/db/2344782/Alexandria_Venture_Investments>,
        <https://1145.am/db/2347368/Alexandria_Venture_Investments>,
        <https://1145.am/db/2356456/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369000/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369304/Alexandria_Venture_Investments>,
        <https://1145.am/db/2369305/Alexandria_Venture_Investments>,
        <https://1145.am/db/2787561/Alexandria_Venture_Investments>,
        <https://1145.am/db/4142/Alexandria_Venture_Investments_Llc>,
        <https://1145.am/db/471253/Alexandria_Venture_Investments>,
        <https://1145.am/db/504446/Alexandria_Venture_Investments>,
        <https://1145.am/db/506326/Alexandria_Venture_Investments>,
        <https://1145.am/db/531806/Alexandria_Venture_Investments>,
        <https://1145.am/db/571769/Alexandria_Venture_Investments>,
        <https://1145.am/db/587045/Alexandria_Venture_Investments>,
        <https://1145.am/db/591613/Alexandria_Venture_Investments>,
        <https://1145.am/db/601404/Alexandria_Venture_Investments>,
        <https://1145.am/db/923059/Alexandria_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369549/Codiak_Biosciences_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:description "exosome biology" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "Codiak BioSciences Inc." ;
    ns1:name "Codiak BioSciences Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2290402/Codiak_Biosciences> ;
    ns1:sameAsMedium <https://1145.am/db/1025539/Codiak_Biosciences>,
        <https://1145.am/db/1181398/Codiak_Biosciences>,
        <https://1145.am/db/1338044/Codiak_Biosciences>,
        <https://1145.am/db/415438/Codiak_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369549/Flagship_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Intellia_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "CRISPR/Cas9 gene-editing technology" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Intellia Therapeutics" ;
    ns1:name "Intellia Therapeutics" ;
    ns1:sameAsMedium <https://1145.am/db/1026539/Intellia_Therapeutics>,
        <https://1145.am/db/1544332/Intellia_Therapeutics>,
        <https://1145.am/db/1544700/Intellia_Therapeutics>,
        <https://1145.am/db/2155316/Intellia_Therapeutics>,
        <https://1145.am/db/2301643/Intellia_Therapeutics>,
        <https://1145.am/db/2349183/Intellia_Therapeutics>,
        <https://1145.am/db/2349185/Intellia_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369962/Agenus_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "LEXINGTON, Mass" ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Business",
        "discovering and developing innovative treatments for cancers and other diseases" ;
    ns1:documentDate "2015-09-09T11:02:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Agenus Inc. Completes $115 Million Non-Dilutive Royalty Transaction with Oberland Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agenus-inc-completes-115-million-non-dilutive-royalty-transaction-oberland-capital> ;
    ns1:foundName "Agenus Inc",
        "Agenus Inc." ;
    ns1:industry "immunology" ;
    ns1:name "Agenus Inc",
        "Agenus Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2064552/Agenus_Inc>,
        <https://1145.am/db/2367703/Agenus_Inc>,
        <https://1145.am/db/2368461/Agenus_Inc>,
        <https://1145.am/db/2545124/Agenus_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1334846/Agenus>,
        <https://1145.am/db/2105318/Agenus_Inc>,
        <https://1145.am/db/2345834/Agenus_Inc>,
        <https://1145.am/db/2353160/Agenus>,
        <https://1145.am/db/2353162/Agenus_Inc>,
        <https://1145.am/db/2367708/Agenus>,
        <https://1145.am/db/2369963/Agenus>,
        <https://1145.am/db/2545115/Agenus_Inc>,
        <https://1145.am/db/2583584/Agenus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369962/Note_Purchase_Investment_Agenus_Inc_Oberland_Capital_Management_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-09T11:02:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Agenus Inc. Completes $ 115 Million Non-Dilutive Royalty Transaction with Oberland Capital.",
        "LEXINGTON, Mass.- (BUSINESS WIRE) -Agenus Inc. (NASDAQ: AGEN) , an immunology company discovering and developing innovative treatments for cancers and other diseases, today announced a $ 115 million non-dilutive royalty transaction pursuant to a Note Purchase Agreement with an investor group led by Oberland Capital Management, LLC (Oberland Capital) ." ;
    ns1:documentTitle "Agenus Inc. Completes $115 Million Non-Dilutive Royalty Transaction with Oberland Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agenus-inc-completes-115-million-non-dilutive-royalty-transaction-oberland-capital> ;
    ns1:foundName "Purchase",
        "transaction" ;
    ns1:name "Purchase",
        "transaction" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369962/Agenus_Inc> ;
    ns1:targetDetails "Note",
        "Note Purchase",
        "Royalty" ;
    ns1:valueRaw "$ 115 Million",
        "$ 115 million" ;
    ns1:when "2015-09-09T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 09, 2015" ;
    ns1:whereGeoName "Daylight",
        "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf>,
        <https://sws.geonames.org/4617522/about.rdf> ;
    ns1:whereRaw "Eastern Daylight Time" .

<https://1145.am/db/2370540/Replimune_Ltd> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:description "cancer" ;
    ns1:documentDate "2015-09-24T15:22:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Replimune Ltd Raises $30 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/replimune-ltd-raises-30-million-series-a-financing> ;
    ns1:foundName "Replimune Ltd" ;
    ns1:name "Replimune Ltd" ;
    ns1:sameAsMedium <https://1145.am/db/2281603/Replimune>,
        <https://1145.am/db/2328069/Replimune> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370540/Series_A_Investment_Atlas_Venture_Replimune_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-24T15:22:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Replimune Ltd (Replimune) today announced the closing of a $ 30 million Series A financing led by Atlas Venture (Atlas) .",
        "Replimune Ltd Raises $ 30 Million Series A Financing." ;
    ns1:documentTitle "Replimune Ltd Raises $30 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/replimune-ltd-raises-30-million-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2370540/Replimune_Ltd> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:when "2015-09-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 24, 2015" ;
    ns1:whereGeoName "England" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6269131/about.rdf> ;
    ns1:whereRaw "England" .

<https://1145.am/db/2370680/Apitope> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:description "autoimmune" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Apitope" ;
    ns1:industry "biotech" ;
    ns1:name "Apitope" ;
    ns1:sameAsHigh <https://1145.am/db/2347173/Apitope_International_Nv>,
        <https://1145.am/db/2370683/Apitope>,
        <https://1145.am/db/2370713/Apitope>,
        <https://1145.am/db/2370786/Apitope> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Asceneurons_Alzheimers_R___D> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "research and development" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "Asceneuron",
        "Asceneuron's Alzheimer's R & D" ;
    ns1:name "Asceneuron",
        "Asceneuron's Alzheimer's R & D" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370680/Investment_Asceneurons_Alzheimers_R___D_Sofinnova_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "@ JohnCFierce: Sofinnova leads a $ 30.6M round for Asceneuron's Alzheimer's R & D." ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2370680/Asceneurons_Alzheimers_R___D> ;
    ns1:valueRaw "$ 30.6M" .

<https://1145.am/db/2370680/Wellcome_Trust> a org:Organization ;
    ns1:basedInLowRaw "Wales" ;
    ns1:description "autoimmune biotech" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "the Wellcome Trust" ;
    ns1:investor <https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> ;
    ns1:name "Wellcome Trust" ;
    ns1:sameAsMedium <https://1145.am/db/1803348/Wellcome_Trust>,
        <https://1145.am/db/1873138/Wellcome_Trust>,
        <https://1145.am/db/1877263/Wellcome_Trust>,
        <https://1145.am/db/2291581/Wellcome_Trust>,
        <https://1145.am/db/2297218/Wellcome_Trust>,
        <https://1145.am/db/2312120/Wellcome_Trust>,
        <https://1145.am/db/2330075/Wellcome_Trust>,
        <https://1145.am/db/2338829/Wellcome_Trust>,
        <https://1145.am/db/2338835/Wellcome_Trust>,
        <https://1145.am/db/2339419/Wellcome_Trust>,
        <https://1145.am/db/2339425/Wellcome_Trust>,
        <https://1145.am/db/2344045/Wellcome_Trust>,
        <https://1145.am/db/2354253/Wellcome_Trust>,
        <https://1145.am/db/2364481/Wellcome_Trust>,
        <https://1145.am/db/2369419/Wellcome_Trust>,
        <https://1145.am/db/2370786/Wellcome_Trust>,
        <https://1145.am/db/240593/Wellcome_Trust>,
        <https://1145.am/db/2559928/Wellcome_Trust>,
        <https://1145.am/db/2573020/Wellcome_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370698/Corvus_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "cancer" ;
    ns1:documentDate "2015-09-30T13:30:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Execs behind Imbruvica raise $75M for a new cancer project" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/execs-behind-imbruvica-raise-75m-for-a-new-cancer-project> ;
    ns1:foundName "Corvus Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Corvus Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2345913/Covis_Holdings>,
        <https://1145.am/db/2354359/Corbus_Pharmaceuticals_Holdings>,
        <https://1145.am/db/2370694/Corvus_Pharmaceuticals>,
        <https://1145.am/db/2569192/Covis_Pharma_Commercial_Assets> ;
    ns1:sameAsMedium <https://1145.am/db/1224602/Corvus_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370698/Investment_Corvus_Pharmaceuticals_Rock_Springs_Capital_Management_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-30T13:30:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Corvus Pharmaceuticals, led by some former Pharmacyclics executives, banked a $ 75 million B round to support its work on an oral treatment that uses the body's natural defenses to combat cancer." ;
    ns1:documentTitle "Execs behind Imbruvica raise $75M for a new cancer project" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/execs-behind-imbruvica-raise-75m-for-a-new-cancer-project> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2370698/Corvus_Pharmaceuticals> ;
    ns1:targetDetails "B" ;
    ns1:valueRaw "$ 75 million" ;
    ns1:whereGeoName "Capital Governorate",
        "Rock Springs" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5836898/about.rdf>,
        <https://sws.geonames.org/7090954/about.rdf> ;
    ns1:whereRaw "Rock Springs Capital Management" .

<https://1145.am/db/2371160/5am_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "San Francisco" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1747873/Northpond_Ventures>,
        <https://1145.am/db/2337659/Chiesi_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/442506/Morningside_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Cowen_Private_Investments> a org:Organization ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Cowen Private Investments" ;
    ns1:investor <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Cowen Private Investments" ;
    ns1:sameAsMedium <https://1145.am/db/2323785/Cowen_Private_Investments>,
        <https://1145.am/db/2359683/Cowen_Private_Investments>,
        <https://1145.am/db/2370694/Cowen_Private_Investments>,
        <https://1145.am/db/2371163/Cowen_Private_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/T_Rowe_Price_Associates> a org:Organization ;
    ns1:basedInLowRaw "San Francisco" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "T" ;
    ns1:investor <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "T. Rowe Price Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1519613/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1519799/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1734791/T_Rowe_Price_Associates>,
        <https://1145.am/db/1737508/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1737723/T_Rowe_Price_Associates>,
        <https://1145.am/db/1751589/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1760366/T_Rowe_Price_Associates>,
        <https://1145.am/db/1775170/T_Rowe_Price_Associates>,
        <https://1145.am/db/1777232/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1783318/T_Rowe_Price_Associates>,
        <https://1145.am/db/1830280/T_Rowe_Price_Associates>,
        <https://1145.am/db/1839749/T_Rowe_Price_Associates>,
        <https://1145.am/db/2080575/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/2095032/T_Rowe_Price_Associates>,
        <https://1145.am/db/2332944/T_Rowe_Price_Associates>,
        <https://1145.am/db/2342998/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/2371163/T_Rowe_Price_Associates>,
        <https://1145.am/db/504434/T_Rowe_Price_Associates>,
        <https://1145.am/db/583568/T_Rowe_Price_Associates>,
        <https://1145.am/db/677591/T_Rowe_Price_Associates>,
        <https://1145.am/db/835137/T_Rowe_Price_Associates>,
        <https://1145.am/db/904635/T_Rowe_Price_Associates>,
        <https://1145.am/db/93760/T_Rowe_Price_Associates_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/5am_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "investing" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2330075/5_Am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Cowen_Private_Investments> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Cowen Private Investments" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Cowen Private Investments" ;
    ns1:sameAsMedium <https://1145.am/db/2323785/Cowen_Private_Investments>,
        <https://1145.am/db/2359683/Cowen_Private_Investments>,
        <https://1145.am/db/2370694/Cowen_Private_Investments>,
        <https://1145.am/db/2371160/Cowen_Private_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/T_Rowe_Price_Associates> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "T. Rowe Price Associates, Inc." ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "T. Rowe Price Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1519613/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1519799/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1734791/T_Rowe_Price_Associates>,
        <https://1145.am/db/1737508/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1737723/T_Rowe_Price_Associates>,
        <https://1145.am/db/1751589/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1760366/T_Rowe_Price_Associates>,
        <https://1145.am/db/1775170/T_Rowe_Price_Associates>,
        <https://1145.am/db/1777232/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/1783318/T_Rowe_Price_Associates>,
        <https://1145.am/db/1830280/T_Rowe_Price_Associates>,
        <https://1145.am/db/1839749/T_Rowe_Price_Associates>,
        <https://1145.am/db/2080575/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/2095032/T_Rowe_Price_Associates>,
        <https://1145.am/db/2332944/T_Rowe_Price_Associates>,
        <https://1145.am/db/2342998/T_Rowe_Price_Associates_Inc>,
        <https://1145.am/db/2371160/T_Rowe_Price_Associates>,
        <https://1145.am/db/504434/T_Rowe_Price_Associates>,
        <https://1145.am/db/583568/T_Rowe_Price_Associates>,
        <https://1145.am/db/677591/T_Rowe_Price_Associates>,
        <https://1145.am/db/835137/T_Rowe_Price_Associates>,
        <https://1145.am/db/904635/T_Rowe_Price_Associates>,
        <https://1145.am/db/93760/T_Rowe_Price_Associates_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Caixa_Capital_Risc> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "'la Caixa",
        "Caixa Capital Risc" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Caixa Capital Risc" ;
    ns1:sameAsMedium <https://1145.am/db/1780120/Caixa_Capital_Risc>,
        <https://1145.am/db/2369157/Caixa_Capital_Risc>,
        <https://1145.am/db/2586501/Caixa_Capital_Risc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Minoryx_Therapeutics> a org:Organization ;
    ns1:description "disease" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Minoryx Therapeutics" ;
    ns1:industry "drug development" ;
    ns1:name "Minoryx Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2290040/Minoryx>,
        <https://1145.am/db/2371168/Minoryx_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371169/Ysios_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "Ysios",
        "Ysios Capital" ;
    ns1:investor <https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> ;
    ns1:name "Ysios Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1340128/Ysios_Capital>,
        <https://1145.am/db/2019705/Ysios_Capital>,
        <https://1145.am/db/2293102/Ysios_Capital>,
        <https://1145.am/db/2299771/Ysios_Capital>,
        <https://1145.am/db/2301093/Ysios_Capital>,
        <https://1145.am/db/2335750/Ysios_Capital>,
        <https://1145.am/db/2335755/Ysios_Capital>,
        <https://1145.am/db/2336622/Ysios_Capital>,
        <https://1145.am/db/2337659/Ysios_Capital>,
        <https://1145.am/db/2337664/Ysios_Capital>,
        <https://1145.am/db/2369953/Ysios_Capital>,
        <https://1145.am/db/2369987/Ysios_Capital>,
        <https://1145.am/db/2371168/Ysios_Capital>,
        <https://1145.am/db/2371209/Ysios_Capital>,
        <https://1145.am/db/2586501/Ysios_Capital>,
        <https://1145.am/db/281538/Ysios_Capital>,
        <https://1145.am/db/704198/Ysios_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371188/Gamida_Cell> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:description "stem cell blood cancer therapy" ;
    ns1:documentDate "2015-10-15T10:08:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gamida Cell pockets $5M from Novartis ahead of mooted financing round" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/gamida-cell-pockets-5m-from-novartis-ahead-of-mooted-financing-round> ;
    ns1:foundName "Gamida Cell" ;
    ns1:industry "Pharma" ;
    ns1:name "Gamida Cell" ;
    ns1:sameAsHigh <https://1145.am/db/2290821/Gamida_Cell>,
        <https://1145.am/db/2297561/Gamida_Cell>,
        <https://1145.am/db/2336028/Gamida_Cell>,
        <https://1145.am/db/2358297/Gamida_Cell>,
        <https://1145.am/db/2359165/Gamida_Cell>,
        <https://1145.am/db/2359179/Gamida_Cell>,
        <https://1145.am/db/795785/Gamida_Cell_Ltd>,
        <https://1145.am/db/798062/Gamida_Cell_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1126294/Gamida_Cell_Ltd>,
        <https://1145.am/db/1126812/Gamida_Cell_Ltd>,
        <https://1145.am/db/116908/Gamida_Cell_Ltd>,
        <https://1145.am/db/1351502/Gamida_Cell_Ltd>,
        <https://1145.am/db/1352315/Gamida_Cell_Ltd>,
        <https://1145.am/db/1374001/Gamida_Cell>,
        <https://1145.am/db/1374011/Gamida_Cell_Ltd>,
        <https://1145.am/db/1378888/Gamida_Cell>,
        <https://1145.am/db/1571043/Gamida_Cell_Ltd>,
        <https://1145.am/db/1571252/Gamida_Cell>,
        <https://1145.am/db/174550/Gamida_Cell>,
        <https://1145.am/db/176569/Gamida_Cell>,
        <https://1145.am/db/180537/Gamida_Cell_Ltd>,
        <https://1145.am/db/1973867/Gamida_Cell>,
        <https://1145.am/db/2290005/Gamida_Cell>,
        <https://1145.am/db/2358559/Gamida_Cell>,
        <https://1145.am/db/2358579/Gamida_Cell>,
        <https://1145.am/db/2359178/Gamida_Cell>,
        <https://1145.am/db/236253/Gamida_Cell_Ltd>,
        <https://1145.am/db/2371070/Gamida_Cell>,
        <https://1145.am/db/2371077/Gamida_Cell>,
        <https://1145.am/db/2371203/Gamida_Cell>,
        <https://1145.am/db/2577349/Gamida_Cell> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371301/Assets_Acquisition_Amgen_Soon-Shiong_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Over the past year Soon-Shiong has been spending, and raising, hundreds of millions of dollars to execute a long string of deals." ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:targetDetails "assets" ;
    ns1:valueRaw "hundreds of millions of dollars" ;
    ns1:vendor <https://1145.am/db/2371301/Amgen> .

<https://1145.am/db/2371301/Conkwest> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "R & D" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "Conkwest" ;
    ns1:name "Conkwest" ;
    ns1:sameAsMedium <https://1145.am/db/2367773/Conkwest>,
        <https://1145.am/db/2367788/Conkwest>,
        <https://1145.am/db/2367816/Conkwest>,
        <https://1145.am/db/2367918/Conkwest>,
        <https://1145.am/db/2368046/Conkwest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371301/Conkwest_Assets_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "ipo" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Over the past year Soon-Shiong has been spending, and raising, hundreds of millions of dollars to execute a long string of deals." ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "IPO",
        "acquisition" ;
    ns1:name "IPO",
        "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2371301/Conkwest> ;
    ns1:targetDetails "assets" ;
    ns1:targetName "Conkwest" ;
    ns1:valueRaw "$ 2.6 billion" ;
    ns1:vendor <https://1145.am/db/2371301/Amgen> .

<https://1145.am/db/2371301/Precision_Biologics> a org:Organization ;
    ns1:basedInHighGeoName "Dallas County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4684904/about.rdf> ;
    ns1:basedInHighRaw "Dallas" ;
    ns1:description "developing new immunotherapeutics for cancer" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "Precision Biologics" ;
    ns1:industry "biotech" ;
    ns1:name "Precision Biologics" ;
    ns1:sameAsHigh <https://1145.am/db/1079389/Precision_Biosciences>,
        <https://1145.am/db/1079790/Praxis_Precision_Medicines_Inc>,
        <https://1145.am/db/2287527/Praxis_Precision_Medicines>,
        <https://1145.am/db/2325547/Precision_Therapeutics>,
        <https://1145.am/db/2569831/Precision_Biosciences>,
        <https://1145.am/db/2580047/Precision>,
        <https://1145.am/db/2584573/Precision_Biologics>,
        <https://1145.am/db/2584574/Precision_Biologics>,
        <https://1145.am/db/601373/Precision_Biosciences>,
        <https://1145.am/db/7774/Precision_Therapeutics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2153278/Precision_Biologics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371301/Precision_Biologics_Interest_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The biotech billionaire's umbrella organization NantWorks has nabbed a majority interest in another cancer drug developer, this time paying $ 50 million for control of Dallas - based Precision Biologics." ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "nabbed" ;
    ns1:name "nabbed" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2371301/Precision_Biologics> ;
    ns1:targetDetails "interest" ;
    ns1:targetName "Precision Biologics" ;
    ns1:valueRaw "$ 50 million" ;
    ns1:whereGeoName "Dallas County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4684904/about.rdf> ;
    ns1:whereRaw "Dallas" .

<https://1145.am/db/2371333/The_Dementia_Discovery_Fund> a org:Organization ;
    ns1:basedInHighGeoName "London" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2643743/about.rdf> ;
    ns1:basedInHighRaw "LONDON" ;
    ns1:documentDate "2015-10-21T15:40:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Launch of Dementia Discovery Fund - New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/launch-of-dementia-discovery-fund-new-fund-raises-100-million-to-deliver-novel-approaches> ;
    ns1:foundName "The Dementia Discovery Fund" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "The Dementia Discovery Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1984558/Dementia_Discovery_Fund>,
        <https://1145.am/db/2297965/Dementia_Discovery_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2538419/Garden_Hills> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:documentDate "2015-08-12T10:36:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma M&A, investment in Russia leading to exports, RBC Daily says" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pharma-m-a-investment-russia-leading-to-exports-rbc-daily-says> ;
    ns1:foundName "Garden Hills" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Garden Hills" ;
    ns1:sameAsMedium <https://1145.am/db/2592843/Garden_Hills>,
        <https://1145.am/db/2596906/Garden_Hills> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/3sbio> a org:Organization ;
    ns1:basedInHighGeoName "Hong Kong Special Administrative Region" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1819730/about.rdf> ;
    ns1:basedInHighRaw "Hong Kong" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "3SBio" ;
    ns1:industry "medical device" ;
    ns1:name "3SBio" ;
    ns1:sameAsMedium <https://1145.am/db/2302565/3sbio>,
        <https://1145.am/db/2322486/3sbio_Inc>,
        <https://1145.am/db/2328477/3sbio_Inc>,
        <https://1145.am/db/2329577/3sbio>,
        <https://1145.am/db/2331994/3sbio>,
        <https://1145.am/db/2351625/3sbio>,
        <https://1145.am/db/2352857/3sbio>,
        <https://1145.am/db/2354456/3sbio>,
        <https://1145.am/db/2362792/3sbio>,
        <https://1145.am/db/2537340/3sbio>,
        <https://1145.am/db/2537821/3sbio>,
        <https://1145.am/db/2540242/3sbio>,
        <https://1145.am/db/2545366/3sbio>,
        <https://1145.am/db/2546456/3sbio>,
        <https://1145.am/db/2549495/3sbio>,
        <https://1145.am/db/2551126/3sbio>,
        <https://1145.am/db/2551575/3sbio>,
        <https://1145.am/db/2561243/3sbio>,
        <https://1145.am/db/2563324/3sbio>,
        <https://1145.am/db/2563369/3sbio>,
        <https://1145.am/db/2563371/3sbio_Inc>,
        <https://1145.am/db/2571841/3sbio_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Anpac_Bio-Medical_Science> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Anpac Bio-Medical Science" ;
    ns1:industry "medical device" ;
    ns1:name "Anpac Bio-Medical Science" ;
    ns1:sameAsMedium <https://1145.am/db/2321667/Anpac_Bio-Medical_Science> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Burning_Rock_Biotech> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "Burning Rock Biotech" ;
    ns1:industry "Biotech" ;
    ns1:name "Burning Rock Biotech" ;
    ns1:sameAsMedium <https://1145.am/db/1148397/Burning_Rock_Biotech>,
        <https://1145.am/db/1159023/Burning_Rock_Biotech_Limited>,
        <https://1145.am/db/1207866/Burning_Rock_Biotech_Limited>,
        <https://1145.am/db/2320622/Burning_Rock_Biotech> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2538444/Investment_Anpac_Bio-Medical_Science_Shanghai_Zhangjiang_Science___Technology_Investment_Corporation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> China's Anpac Bio-Medical Science CEO Chris Yu said the medical device maker has secured financing from venture capital firm Shanghai Zhangjiang Science & Technology Investment Corporation equivalent to \"several million\" dollars to help develop its early cancer detection technology." ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2538444/3sbio>,
        <https://1145.am/db/2538444/Anpac_Bio-Medical_Science> ;
    ns1:targetName "3SBio" ;
    ns1:valueRaw "\"several million\" dollars",
        "dollars" ;
    ns1:whereGeoName "Hong Kong Special Administrative Region",
        "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf>,
        <https://sws.geonames.org/1819730/about.rdf> ;
    ns1:whereRaw "China",
        "Hong Kong" .

<https://1145.am/db/2538444/Investment_Aurobindo_Pharma_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> India's Aurobindo Pharma has plans to build three formulation plants in the southern states of Andhra Pradesh and Telangana to meet expected demand from the U.S. market, Mint newspaper said." ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:foundName "build" ;
    ns1:name "build" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2540193/Investment_Pharmanest_Recipharm_Venture_Fund_Ab_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT." ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "invests" ;
    ns1:name "invests" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2540193/Pharmanest> ;
    ns1:valueRaw "SEK 8 million" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2540193/Karolinska_Development_Ab> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "Business" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "Karolinska Development AB" ;
    ns1:name "Karolinska Development AB" ;
    ns1:sameAsHigh <https://1145.am/db/2361344/Karolinska_Development_Ab>,
        <https://1145.am/db/2370775/Karolinska_Development>,
        <https://1145.am/db/2370797/Karolinska_Development_Ab> ;
    ns1:sameAsMedium <https://1145.am/db/2299349/Karolinska_Development>,
        <https://1145.am/db/2306665/Karolinska_Development>,
        <https://1145.am/db/2335908/Karolinska_Development>,
        <https://1145.am/db/2336910/Karolinska_Development_Ab>,
        <https://1145.am/db/2337309/Karolinska_Development>,
        <https://1145.am/db/2337319/Karolinska_Development>,
        <https://1145.am/db/2337680/Karolinska_Development>,
        <https://1145.am/db/2340612/Karolinska_Development>,
        <https://1145.am/db/2340615/Karolinska_Development>,
        <https://1145.am/db/2350239/Karolinska_Development>,
        <https://1145.am/db/2352829/Karolinska_Development>,
        <https://1145.am/db/2353853/Karolinska_Development>,
        <https://1145.am/db/2362396/Karolinska_Development>,
        <https://1145.am/db/2364322/Karolinska_Development>,
        <https://1145.am/db/2368273/Karolinska_Development>,
        <https://1145.am/db/2368278/Karolinska_Development_Ab>,
        <https://1145.am/db/2368618/Karolinska_Development_Ab>,
        <https://1145.am/db/2370612/Karolinska_Development> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540193/Kcif> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "Business" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "KCIF" ;
    ns1:name "KCIF" ;
    ns1:sameAsHigh <https://1145.am/db/2321074/Kci>,
        <https://1145.am/db/2602054/Kddi> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540193/Pharmanest> a org:Organization ;
    ns1:basedInLowRaw "Sweden" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "Pharmanest" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Pharmanest" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/Pharmajet>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/Pharmajet>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301362/Pharma_Two_B>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341828/Premacure_Ab>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347324/Anaphore_Inc>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367957/Pharma_Two_B>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551468/Pharmaniaga>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577652/Premacure_Ab>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/422407/Pharma_Two_B_Ltd>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/490458/Credence_Medsystems_Inc>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/Hr_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/Tha_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540203/Syntheall_Pharmaceutical_Co_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:description "small-molecule manufacturing" ;
    ns1:documentDate "2015-07-13T15:25:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/wuxi-pharmatech-s-china-based-small-molecule-manufacturing-subsidiary-sta-enters-into> ;
    ns1:foundName "SynTheAll Pharmaceutical Co. Ltd",
        "SynTheAll Pharmaceutical Co. Ltd." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "SynTheAll Pharmaceutical Co. Ltd",
        "SynTheAll Pharmaceutical Co. Ltd." ;
    ns1:sameAsHigh <https://1145.am/db/2536795/Syntheall_Pharmaceutical_Co_Ltd> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541146/Hospira> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "Hospira" ;
    ns1:name "Hospira" ;
    ns1:sameAsMedium <https://1145.am/db/2200864/Hospira>,
        <https://1145.am/db/2289450/Hospira>,
        <https://1145.am/db/2289959/Hospira>,
        <https://1145.am/db/2298256/Hospira>,
        <https://1145.am/db/2303619/Hospira>,
        <https://1145.am/db/2304496/Hospira>,
        <https://1145.am/db/2305724/Hospira>,
        <https://1145.am/db/2312865/Hospira>,
        <https://1145.am/db/2317789/Hospira>,
        <https://1145.am/db/2322733/Hospira>,
        <https://1145.am/db/2322747/Hospira>,
        <https://1145.am/db/2322786/Hospira>,
        <https://1145.am/db/2327889/Hospira>,
        <https://1145.am/db/2331220/Hospira>,
        <https://1145.am/db/2331222/Hospira>,
        <https://1145.am/db/2340812/Hospira>,
        <https://1145.am/db/2350126/Hospira>,
        <https://1145.am/db/2357411/Hospira>,
        <https://1145.am/db/2363446/Hospira>,
        <https://1145.am/db/2363467/Hospira>,
        <https://1145.am/db/2369876/Hospira>,
        <https://1145.am/db/2536206/Hospira>,
        <https://1145.am/db/2536928/Hospira>,
        <https://1145.am/db/2537451/Hospira>,
        <https://1145.am/db/2539516/Hospira>,
        <https://1145.am/db/2541139/Hospira>,
        <https://1145.am/db/2542067/Hospira>,
        <https://1145.am/db/2542072/Hospira>,
        <https://1145.am/db/2543481/Hospira>,
        <https://1145.am/db/2544074/Hospira>,
        <https://1145.am/db/2549426/Hospira>,
        <https://1145.am/db/2551469/Hospira>,
        <https://1145.am/db/2551471/Hospira>,
        <https://1145.am/db/2553232/Hospira>,
        <https://1145.am/db/2554855/Hospira>,
        <https://1145.am/db/2556356/Hospira>,
        <https://1145.am/db/2556795/Hospira>,
        <https://1145.am/db/2558080/Hospira>,
        <https://1145.am/db/2558095/Hospira>,
        <https://1145.am/db/2561169/Hospira>,
        <https://1145.am/db/2562223/Hospira>,
        <https://1145.am/db/2562258/Hospira>,
        <https://1145.am/db/2574863/Hospira>,
        <https://1145.am/db/2575224/Hospira>,
        <https://1145.am/db/2579095/Hospira>,
        <https://1145.am/db/2580303/Hospira>,
        <https://1145.am/db/2581430/Hospira>,
        <https://1145.am/db/2581431/Hospira>,
        <https://1145.am/db/2584601/Hospira>,
        <https://1145.am/db/2587292/Hospira>,
        <https://1145.am/db/2588893/Hospira>,
        <https://1145.am/db/2589204/Hospira>,
        <https://1145.am/db/2589337/Hospira>,
        <https://1145.am/db/2590041/Hospira_Inc>,
        <https://1145.am/db/2591596/Hospira>,
        <https://1145.am/db/2591947/Hospira>,
        <https://1145.am/db/2593370/Hospira>,
        <https://1145.am/db/2593372/Hospira>,
        <https://1145.am/db/2595382/Hospira>,
        <https://1145.am/db/2596439/Hospira>,
        <https://1145.am/db/2597170/Hospira>,
        <https://1145.am/db/2597173/Hospira>,
        <https://1145.am/db/2597183/Hospira>,
        <https://1145.am/db/2597185/Hospira>,
        <https://1145.am/db/2597712/Hospira>,
        <https://1145.am/db/2598340/Hospira> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2541146/Hospira_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Pfizer ($ PFE) says it has all of the antitrust approvals it needs and will close on its $ 15 billion buyout of Hospira ($ HSP) in early September." ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "buyout" ;
    ns1:name "buyout" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2541146/Hospira> ;
    ns1:targetName "Hospira" ;
    ns1:valueRaw "$ 15 billion" .

<https://1145.am/db/2541146/Investment_Shire_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Shire ($ SHPG) has a new agreement with Sanquin Blood Supply, which has been the exclusive manufacturer of Cinryze, the rare disease drug it got in its $ 4.2 billion buyout of ViroPharma, which will allow it to use other contractors to increase production of the drug." ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 4.2 billion" .

<https://1145.am/db/2541146/Viropharma> a org:Organization ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "ViroPharma" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "ViroPharma" ;
    ns1:sameAsHigh <https://1145.am/db/2307894/Viropharma>,
        <https://1145.am/db/2308922/Viropharma>,
        <https://1145.am/db/2332978/Viropharma_Incorporated>,
        <https://1145.am/db/2336709/Viropharma>,
        <https://1145.am/db/2341522/Viropharma>,
        <https://1145.am/db/2342570/Viropharma>,
        <https://1145.am/db/2349818/Viropharma>,
        <https://1145.am/db/2364071/Viropharma>,
        <https://1145.am/db/2364076/Viropharma>,
        <https://1145.am/db/2364554/Viropharma>,
        <https://1145.am/db/2364556/Viropharma>,
        <https://1145.am/db/2544588/Viropharma>,
        <https://1145.am/db/2556988/Viropharma>,
        <https://1145.am/db/2561438/Viropharma>,
        <https://1145.am/db/2569952/Viropharma>,
        <https://1145.am/db/2571521/Viropharma>,
        <https://1145.am/db/2571526/Viropharma>,
        <https://1145.am/db/2572335/Viropharma>,
        <https://1145.am/db/2577117/Viropharma>,
        <https://1145.am/db/2578086/Viropharma>,
        <https://1145.am/db/2579062/Viropharma> ;
    ns1:sameAsMedium <https://1145.am/db/2302151/Viropharma>,
        <https://1145.am/db/2577114/Viropharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2542049/Companhia_Brasileira_De_Esterilizao> a org:Organization ;
    ns1:basedInHighGeoName "So Paulo" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3448439/about.rdf> ;
    ns1:basedInHighRaw "Sao Paulo" ;
    ns1:description "irradiation services" ;
    ns1:documentDate "2015-08-27T13:46:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Sterilization specialist on expansion streak" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/sterilization-specialist-on-expansion-streak> ;
    ns1:foundName "Companhia Brasileira de Esterilizao" ;
    ns1:name "Companhia Brasileira de Esterilizao" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2543345/Investment_Ipca_Laboratories_Ipca_Laboratories_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-04T12:25:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Mumbai - based Ipca in February acquired 1.8 million shares in Krebs and signed an MOU outlining plans for Ipca to acquire joint management control." ;
    ns1:documentTitle "Indian drugmakers on the hunt for money and growth" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/indian-drugmakers-on-hunt-for-money-and-growth> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2543345/Krebs_Biochemicals> a org:Organization ;
    ns1:basedInHighGeoName "Hyderbd" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269843/about.rdf> ;
    ns1:basedInHighRaw "Hyderabad" ;
    ns1:basedInLowRaw "India" ;
    ns1:description "chemical synthesis, fermentation and enzymatic technologies" ;
    ns1:documentDate "2015-11-04T12:25:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Indian drugmakers on the hunt for money and growth" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/indian-drugmakers-on-hunt-for-money-and-growth> ;
    ns1:foundName "Krebs",
        "Krebs Biochemicals" ;
    ns1:industry "drugmakers" ;
    ns1:name "Krebs",
        "Krebs Biochemicals" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2545141/Euromed> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain." ;
    ns1:description "business-to-business manufacturer of herbal extracts and natural active substances" ;
    ns1:documentDate "2015-12-01T12:33:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Meda divests manufacturing unit Euromed in Spain" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/meda-divests-manufacturing-unit-euromed-spain> ;
    ns1:foundName "Euromed",
        "Euromed S.A." ;
    ns1:industry "herbal extracts and natural active substances" ;
    ns1:name "Euromed" ;
    ns1:sameAsMedium <https://1145.am/db/2545140/Euromed> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2545141/Euromed_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "divestment" ;
    ns1:documentDate "2015-12-01T12:33:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dec. 1, 2015 - Meda has entered into a definitive agreement with The Riverside Company (\"Riverside\") for the sale of Euromed S.A. (\"Euromed\") , a business-to-business manufacturer of herbal extracts and natural active substances located in Spain.",
        "Meda divests manufacturing unit Euromed in Spain." ;
    ns1:documentTitle "Meda divests manufacturing unit Euromed in Spain" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/meda-divests-manufacturing-unit-euromed-spain> ;
    ns1:foundName "divests",
        "sale" ;
    ns1:name "divests",
        "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2545141/Euromed> ;
    ns1:targetName "Euromed" ;
    ns1:valueRaw "EUR 82 million" ;
    ns1:vendor <https://1145.am/db/2545141/Meda> ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2545141/Meda> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2015-12-01T12:33:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Meda divests manufacturing unit Euromed in Spain" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/meda-divests-manufacturing-unit-euromed-spain> ;
    ns1:foundName "Meda" ;
    ns1:name "Meda" ;
    ns1:sameAsMedium <https://1145.am/db/2290257/Meda>,
        <https://1145.am/db/2303552/Meda>,
        <https://1145.am/db/2305020/Meda>,
        <https://1145.am/db/2312215/Meda_Ab>,
        <https://1145.am/db/2312221/Meda_Ab>,
        <https://1145.am/db/2314526/Meda>,
        <https://1145.am/db/2314613/Meda>,
        <https://1145.am/db/2315261/Meda>,
        <https://1145.am/db/2323185/Meda>,
        <https://1145.am/db/2328318/Meda>,
        <https://1145.am/db/2328330/Meda>,
        <https://1145.am/db/2349023/Meda>,
        <https://1145.am/db/2349031/Meda>,
        <https://1145.am/db/2349295/Meda>,
        <https://1145.am/db/2350975/Meda>,
        <https://1145.am/db/2357309/Meda>,
        <https://1145.am/db/2538017/Meda_Ab>,
        <https://1145.am/db/2540516/Meda>,
        <https://1145.am/db/2545140/Meda>,
        <https://1145.am/db/2561955/Meda>,
        <https://1145.am/db/2563029/Meda>,
        <https://1145.am/db/2572018/Meda>,
        <https://1145.am/db/2572066/Meda>,
        <https://1145.am/db/2575388/Meda>,
        <https://1145.am/db/2575393/Meda>,
        <https://1145.am/db/2577157/Meda>,
        <https://1145.am/db/2582902/Meda>,
        <https://1145.am/db/2582920/Meda>,
        <https://1145.am/db/2583226/Meda>,
        <https://1145.am/db/2583437/Meda>,
        <https://1145.am/db/2584750/Meda>,
        <https://1145.am/db/2593048/Meda>,
        <https://1145.am/db/2594168/Meda> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546157/Kaysersberg_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "Kaysersberg Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Kaysersberg Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1401649/Alexion>,
        <https://1145.am/db/2154072/Alexion>,
        <https://1145.am/db/2287505/Alexion>,
        <https://1145.am/db/2295262/Alexion>,
        <https://1145.am/db/2571525/Alexion>,
        <https://1145.am/db/455480/Kadmon_Holdings> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546157/Kaysersberg_Pharmaceuticals_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Recipharm announced today that is buying Kaysersberg Pharmaceuticals, from Novartis' Alcon unit, for 18 million ($ 19.7 million) .",
        "The acquisition of Kaysersberg Pharmaceuticals continues a buying spree for the Swedish company that has been picking up specialized assets around the world." ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "acquisition",
        "buying" ;
    ns1:name "acquisition",
        "buying" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2546157/Kaysersberg_Pharmaceuticals> ;
    ns1:targetName "Kaysersberg Pharmaceuticals" ;
    ns1:valueRaw "$ 19.7 million",
        "18 million" ;
    ns1:vendor <https://1145.am/db/2546157/Novartis> ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2546157/Nitin_Lifesciences_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "It recently announced it was paying about $ 105.2 million to buy a 74 % stake in Nitin Lifesciences, an Indian sterile injectables CMO." ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "buy",
        "paying" ;
    ns1:name "buy",
        "paying" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2546157/Nitin_Lifesciences> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Nitin Lifesciences" ;
    ns1:valueRaw "about $ 105.2 million" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2546157/Recipharm> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:buyer <https://1145.am/db/2546157/Kaysersberg_Pharmaceuticals_Acquisition> ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "Recipharm" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Recipharm" ;
    ns1:sameAsHigh <https://1145.am/db/172278/Recipharm>,
        <https://1145.am/db/2074741/Reata_Pharmaceuticals_Inc>,
        <https://1145.am/db/2100253/Reata_Pharmaceuticals_Inc>,
        <https://1145.am/db/213083/Recipharm>,
        <https://1145.am/db/2313448/Reata_Pharmaceuticals>,
        <https://1145.am/db/2334118/Recipharm>,
        <https://1145.am/db/2334606/Recipharm>,
        <https://1145.am/db/2337022/Recipharm_Pharmaceutical_Development_Ab>,
        <https://1145.am/db/2337166/Rempex_Pharmaceuticals>,
        <https://1145.am/db/2337242/Recipharm>,
        <https://1145.am/db/2338120/Rempex_Pharmaceuticals>,
        <https://1145.am/db/2338421/Recro_Pharma>,
        <https://1145.am/db/2339242/Recipharm>,
        <https://1145.am/db/2346119/Recipharm>,
        <https://1145.am/db/2356181/Recro_Pharma>,
        <https://1145.am/db/2367364/Reata_Pharmaceuticals>,
        <https://1145.am/db/2367368/Reata_Pharmaceuticals>,
        <https://1145.am/db/2368365/Recro_Pharma>,
        <https://1145.am/db/2369512/Recipharm>,
        <https://1145.am/db/2371408/Recipharm>,
        <https://1145.am/db/2536596/Recro_Pharma>,
        <https://1145.am/db/2537635/Recipharm>,
        <https://1145.am/db/2539816/Recipharm>,
        <https://1145.am/db/2540958/Recipharm>,
        <https://1145.am/db/2543483/Recipharm>,
        <https://1145.am/db/2544071/Recipharm_Ab>,
        <https://1145.am/db/2544452/Recipharm>,
        <https://1145.am/db/2545962/Recipharm>,
        <https://1145.am/db/2546145/Recipharm>,
        <https://1145.am/db/2547189/Recipharm>,
        <https://1145.am/db/2548220/Recipharm_Ab>,
        <https://1145.am/db/2548222/Recipharm>,
        <https://1145.am/db/2550420/Recipharm>,
        <https://1145.am/db/2552528/Recipharm>,
        <https://1145.am/db/2557799/Recipharm>,
        <https://1145.am/db/2560291/Recipharm>,
        <https://1145.am/db/2561326/Recipharm>,
        <https://1145.am/db/2561334/Recipharm>,
        <https://1145.am/db/2562556/Recipharm>,
        <https://1145.am/db/2568205/Reata_Pharmaceuticals>,
        <https://1145.am/db/2568375/Reata_Pharmaceuticals>,
        <https://1145.am/db/2569549/Recipharm>,
        <https://1145.am/db/2594032/Recipharm>,
        <https://1145.am/db/2765310/Reata_Pharmaceuticals>,
        <https://1145.am/db/406977/Recro_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2306945/Recipharm>,
        <https://1145.am/db/2330439/Recipharm>,
        <https://1145.am/db/2330456/Recipharm>,
        <https://1145.am/db/2334608/Recipharm>,
        <https://1145.am/db/2544074/Recipharm>,
        <https://1145.am/db/2546170/Recipharm>,
        <https://1145.am/db/2546440/Recipharm>,
        <https://1145.am/db/2549102/Recipharm>,
        <https://1145.am/db/2560286/Recipharm>,
        <https://1145.am/db/2561087/Recipharm>,
        <https://1145.am/db/2564095/Recipharm>,
        <https://1145.am/db/2577345/Recipharm_Ab>,
        <https://1145.am/db/2594031/Recipharm_Ab> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Aslan_Pharmaceuticals> a org:Organization ;
    ns1:basedInLowRaw "Singapore" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "ASLAN Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "ASLAN Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1207538/Astria_Therapeutics>,
        <https://1145.am/db/1208370/Astria_Therapeutics>,
        <https://1145.am/db/1467375/Astellas>,
        <https://1145.am/db/1579093/Astria_Therapeutics>,
        <https://1145.am/db/1590441/Astria_Therapeutics>,
        <https://1145.am/db/1591082/Astria_Therapeutics>,
        <https://1145.am/db/1650706/Asieris_Pharmaceuticals>,
        <https://1145.am/db/1974212/Astria_Therapeutics>,
        <https://1145.am/db/1988637/Astellas_Us_Holding_Inc>,
        <https://1145.am/db/2152056/Astellas>,
        <https://1145.am/db/2153678/Ascletis_Pharma>,
        <https://1145.am/db/2279458/Astellas>,
        <https://1145.am/db/2285050/Astellas>,
        <https://1145.am/db/2287489/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2290376/Astellas>,
        <https://1145.am/db/2300810/Astellas>,
        <https://1145.am/db/2300947/Astellas>,
        <https://1145.am/db/2305544/Astellas>,
        <https://1145.am/db/2308157/Asphelia_Pharmaceuticals>,
        <https://1145.am/db/2309154/Asphelia_Pharmaceuticals>,
        <https://1145.am/db/2323409/Astellas>,
        <https://1145.am/db/2326915/Theravance_And_Astellas_Pharma_Us>,
        <https://1145.am/db/2335729/Astellas_Scientific_And_Medical_Affairs>,
        <https://1145.am/db/2337343/Astellas_Pharma_Technologies>,
        <https://1145.am/db/2341816/Astellas>,
        <https://1145.am/db/2345071/Astellas>,
        <https://1145.am/db/2346775/Astellas>,
        <https://1145.am/db/2347117/Astellas>,
        <https://1145.am/db/2350538/Astellas>,
        <https://1145.am/db/2354062/Astellas>,
        <https://1145.am/db/2354083/Astellas>,
        <https://1145.am/db/2358412/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2358732/Astellas>,
        <https://1145.am/db/2364191/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365367/Astellas>,
        <https://1145.am/db/2367808/Astellas>,
        <https://1145.am/db/2371499/Astellas>,
        <https://1145.am/db/2536375/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2542315/Astellas>,
        <https://1145.am/db/2542648/Astellas>,
        <https://1145.am/db/2544340/Astellas>,
        <https://1145.am/db/2545376/Ascletis_Pharmaceuticals>,
        <https://1145.am/db/2545395/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2553232/Astellas>,
        <https://1145.am/db/2555326/Astellas>,
        <https://1145.am/db/2556744/Astellas>,
        <https://1145.am/db/2559490/Astellas>,
        <https://1145.am/db/2566420/Astellas_Biopharma>,
        <https://1145.am/db/2567625/Astellas>,
        <https://1145.am/db/2585861/Astrazeneca_Kk>,
        <https://1145.am/db/2588089/Astrazeneca>,
        <https://1145.am/db/2593265/Astellas>,
        <https://1145.am/db/2594699/Astellas>,
        <https://1145.am/db/2596838/Astex_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2551557/Aslan_Pharmaceuticals>,
        <https://1145.am/db/2566092/Aslan_Pharma> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Pharmaron> a org:Organization ;
    ns1:basedInHighGeoName "Beijing" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1816670/about.rdf> ;
    ns1:basedInHighRaw "Beijing" ;
    ns1:description "CRO" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName ". CRO Pharmaron",
        "Beijing-U.S. CRO Pharmaron" ;
    ns1:industry "healthcare" ;
    ns1:name "Pharmaron" ;
    ns1:sameAsHigh <https://1145.am/db/1340987/Pharmalex_Group>,
        <https://1145.am/db/1342768/Pharmalex_Group>,
        <https://1145.am/db/2344146/Pharmanet>,
        <https://1145.am/db/2358476/Scm_Pharma>,
        <https://1145.am/db/2360484/Scm_Pharma>,
        <https://1145.am/db/2558953/Amdipharm>,
        <https://1145.am/db/2583998/Amdipharm>,
        <https://1145.am/db/2596007/Scm_Pharma>,
        <https://1145.am/db/2788116/Pharmajet>,
        <https://1145.am/db/474598/Am-Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2286801/Pharmaron>,
        <https://1145.am/db/2288191/Pharmaron>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2306964/Pharmaron>,
        <https://1145.am/db/2546409/Pharmaron>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2564196/Pharmaron> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2548449/China_Cord_Blood_Corporation> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:description "Healthcare" ;
    ns1:documentDate "2016-01-12T13:45:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China Cord Blood Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma-asia/golden-meditech-enters-into-agreements-nanjing-xinjiekou-to-sell-china-cord-blood> ;
    ns1:foundName "China Cord Blood Corporation" ;
    ns1:industry "healthcare" ;
    ns1:name "China Cord Blood Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2312926/China_Cord_Blood_Corporation>,
        <https://1145.am/db/2539088/China_Cord_Blood_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/2357315/China_Cord_Blood_Corporation>,
        <https://1145.am/db/2538400/China_Cord_Blood> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2549505/Adagene> a org:Organization ;
    ns1:basedInHighGeoName "Suzhou" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1886760/about.rdf> ;
    ns1:basedInHighRaw "Suzhou" ;
    ns1:description "developing monospecific and bispecific antibodies" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "Adagene" ;
    ns1:industry "Healthcare" ;
    ns1:name "Adagene" ;
    ns1:sameAsHigh <https://1145.am/db/1782598/Ada_Health>,
        <https://1145.am/db/2283758/Ada>,
        <https://1145.am/db/2284203/Ada>,
        <https://1145.am/db/2369644/Adagene_Inc>,
        <https://1145.am/db/2549507/Adagene_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1521661/Adagene_Inc>,
        <https://1145.am/db/2154416/Adagene>,
        <https://1145.am/db/2350891/Adagene_Inc>,
        <https://1145.am/db/2369637/Adagene> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570523/Checkmate_Pharmaceuticals> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE" ;
    ns1:description "a biopharmaceutical company" ;
    ns1:documentDate "2015-08-17T19:59:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/checkmate-pharmaceuticals-debuts-20-million-series-a-investment-for-development-of> ;
    ns1:foundName "Checkmate Pharmaceuticals" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Checkmate Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/1035191/Checkmate_Pharmaceuticals_Inc>,
        <https://1145.am/db/1038605/Checkmate_Pharmaceuticals_Inc>,
        <https://1145.am/db/1065541/Checkmate_Pharmaceuticals_Inc>,
        <https://1145.am/db/1066194/Checkmate_Pharmaceuticals_Inc>,
        <https://1145.am/db/1100382/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/1104160/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/1177954/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/1254257/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/1768/Checkmate_Pharmaceuticals_Inc>,
        <https://1145.am/db/2152399/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/2282089/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/2283972/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/2570520/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/577056/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/798160/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/989858/Checkmate_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570523/Cytos_Biotechnology_Ltd> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2015-08-17T19:59:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/checkmate-pharmaceuticals-debuts-20-million-series-a-investment-for-development-of> ;
    ns1:foundName "Cytos Biotechnology Ltd" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Cytos Biotechnology Ltd" ;
    ns1:sameAsHigh <https://1145.am/db/2234316/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2317504/Cytos_Biotechnology>,
        <https://1145.am/db/2326766/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2337082/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2337092/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2341846/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2346293/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2362359/Cytos>,
        <https://1145.am/db/2368272/Cytos_Biotechnology_Ltd>,
        <https://1145.am/db/2570520/Cytos_Biotechnology_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2337082/Cytos_Biotechnology_Ag> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578827/Roxane_Labs> a org:Organization ;
    ns1:basedInHighGeoName "Columbus" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4509177/about.rdf> ;
    ns1:basedInHighRaw "Columbus, OH" ;
    ns1:description "developing and marketing Boehringer's generic drugs" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "Roxane Labs" ;
    ns1:industry "drugmaker" ;
    ns1:name "Roxane Labs" ;
    ns1:sameAsHigh <https://1145.am/db/2559641/Roxane_Laboratories> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2578827/Unit_Merger_Boehringer_Hikma_Mallinckrodt_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Boehringer is considering swapping assets or selling its Roxane Labs unit, with Hikma, Mallinckrodt and Perrigo reportedly laying down proposals." ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "swapping" ;
    ns1:name "swapping" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "assets",
        "unit" ;
    ns1:vendor <https://1145.am/db/2578827/Boehringer> ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "German" .

<https://1145.am/db/2584561/Frazier_Healthcare_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Frazier Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Frazier Healthcare Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1244886/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1245863/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1329605/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1374146/Frazier_Healthcare_Partners>,
        <https://1145.am/db/1813040/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2152824/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2154276/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2189855/Frazier_Healthcare>,
        <https://1145.am/db/2196903/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2245812/Frazier_Healthcare>,
        <https://1145.am/db/2278780/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2292109/Frazier_Healthcare>,
        <https://1145.am/db/2294202/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2303250/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303251/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2303257/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2305524/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307824/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2307829/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2308855/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2310795/Frazier_Healthcare>,
        <https://1145.am/db/2310798/Frazier_Healthcare>,
        <https://1145.am/db/2311551/Frazier_Healthcare>,
        <https://1145.am/db/2316391/Frazier_Healthcare>,
        <https://1145.am/db/2318274/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318276/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318577/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2318635/Frazier_Healthcare>,
        <https://1145.am/db/2321216/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2325326/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2326430/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327441/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2327442/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330075/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2330079/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2331784/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2334616/Frazier_Healthcare>,
        <https://1145.am/db/2334622/Frazier_Healthcare>,
        <https://1145.am/db/2334624/Frazier_Healthcare>,
        <https://1145.am/db/2335675/Frazier_Healthcare>,
        <https://1145.am/db/2335743/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2336032/Frazier_Healthcare>,
        <https://1145.am/db/2337166/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2338625/Frazier_Healthcare>,
        <https://1145.am/db/2338633/Frazier_Healthcare>,
        <https://1145.am/db/2339925/Frazier_Healthcare>,
        <https://1145.am/db/2339926/Frazier_Healthcare>,
        <https://1145.am/db/2340204/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2340207/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2342352/Frazier_Healthcare>,
        <https://1145.am/db/2342629/Frazier_Healthcare>,
        <https://1145.am/db/2346532/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2346542/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2348754/Frazier_Healthcare>,
        <https://1145.am/db/2351519/Frazier_Healthcare>,
        <https://1145.am/db/2351520/Frazier_Healthcare>,
        <https://1145.am/db/2356269/Frazier_Healthcare>,
        <https://1145.am/db/2356306/Frazier_Healthcare>,
        <https://1145.am/db/2361549/Frazier_Healthcare>,
        <https://1145.am/db/2361551/Frazier_Healthcare>,
        <https://1145.am/db/2365700/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366187/Frazier_Healthcare_Ventures>,
        <https://1145.am/db/2366700/Frazier_Healthcare>,
        <https://1145.am/db/2368333/Frazier_Healthcare>,
        <https://1145.am/db/2370761/Frazier_Healthcare_Partners>,
        <https://1145.am/db/2537423/Frazier_Healthcare>,
        <https://1145.am/db/2553555/Frazier_Healthcare>,
        <https://1145.am/db/2592685/Frazier_Healthcare>,
        <https://1145.am/db/490601/Frazier_Healthcare_Partners>,
        <https://1145.am/db/505366/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578056/Frazier_Healthcare_Partners>,
        <https://1145.am/db/578059/Frazier_Healthcare_Partners>,
        <https://1145.am/db/699981/Frazier_Healthcare_Partners>,
        <https://1145.am/db/770024/Frazier_Healthcare_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/Gritstone_Oncology> a org:Organization ;
    ns1:description "cancer immunotherapy" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Gritstone Oncology" ;
    ns1:industry "biotechnology" ;
    ns1:name "Gritstone Oncology" ;
    ns1:sameAsHigh <https://1145.am/db/1012217/Gritstone_Bio>,
        <https://1145.am/db/1053772/Coherus_Biosciences>,
        <https://1145.am/db/1206827/Immune-Onc>,
        <https://1145.am/db/1208637/Immune-Onc>,
        <https://1145.am/db/1267030/Gritstone_Bio>,
        <https://1145.am/db/1423012/Gritstone_Bio>,
        <https://1145.am/db/1622405/Immune-Onc>,
        <https://1145.am/db/1623196/Immune-Onc>,
        <https://1145.am/db/1657165/Res_Nova_Bio>,
        <https://1145.am/db/1986560/Cel-Sci>,
        <https://1145.am/db/2063128/Cel-Sci_Corporation>,
        <https://1145.am/db/2063212/Cel-Sci>,
        <https://1145.am/db/208436/The_Society_For_Immunotherapy_Of_Cancer>,
        <https://1145.am/db/2287565/Tizona>,
        <https://1145.am/db/2291879/Gritstone_Oncology>,
        <https://1145.am/db/2294202/Gritstone_Oncology>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2294623/Rigontec>,
        <https://1145.am/db/2327838/Biovest>,
        <https://1145.am/db/2331736/Cel-Sci>,
        <https://1145.am/db/2331737/Cel-Sci_Corporation>,
        <https://1145.am/db/2371216/Biothera_Pharmaceuticals>,
        <https://1145.am/db/480088/Gritstone_Bio>,
        <https://1145.am/db/648157/Gritstone_Bio>,
        <https://1145.am/db/704211/Gritstone_Bio_Inc>,
        <https://1145.am/db/784605/Gritstone_Bio>,
        <https://1145.am/db/818932/Gritstone_Bio> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/The_Column_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "The Column Group" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsHigh <https://1145.am/db/2362565/The_Column_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336503/The_Column_Group>,
        <https://1145.am/db/2336505/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359468/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362566/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2368501/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586501/Aelix_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Barcelona" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3128760/about.rdf> ;
    ns1:basedInHighRaw "BARCELONA, Spain" ;
    ns1:description "drug development" ;
    ns1:documentDate "2016-01-12T20:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aelix Therapeutics completes Series A funding of 11.5M ($12.7M) for therapeutic HIV vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/aelix-therapeutics-completes-series-a-funding-of-%E2%82%AC11-5m-12-7m-for-therapeutic-hiv-vaccine> ;
    ns1:foundName "I Aelix Therapeutics" ;
    ns1:industry "drug development" ;
    ns1:name "Aelix Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2369157/Aelix_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2586502/Aelix_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586501/Caixa_Capital_Risc> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2016-01-12T20:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aelix Therapeutics completes Series A funding of 11.5M ($12.7M) for therapeutic HIV vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/aelix-therapeutics-completes-series-a-funding-of-%E2%82%AC11-5m-12-7m-for-therapeutic-hiv-vaccine> ;
    ns1:foundName "'la Caixa'",
        "Caixa Capital Risc" ;
    ns1:investor <https://1145.am/db/2586501/Series_A_Investment_Aelix_Therapeutics_Caixa_Capital_Risc_Caixa_Capital_Risc_Johnson___Johnson_Innovation_Johnson___Johnson_Innovation_Ysios_Capital_Completed> ;
    ns1:name "Caixa Capital Risc" ;
    ns1:sameAsHigh <https://1145.am/db/1233008/Ocv_Partners>,
        <https://1145.am/db/1238474/Ocv_Partners>,
        <https://1145.am/db/1714839/Kolohala_Ventures>,
        <https://1145.am/db/1810976/Caixa_Capital>,
        <https://1145.am/db/438400/Cavu_Ventures>,
        <https://1145.am/db/791643/Lc_Ventures>,
        <https://1145.am/db/823971/Crescent_Ridge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1780120/Caixa_Capital_Risc>,
        <https://1145.am/db/2369157/Caixa_Capital_Risc>,
        <https://1145.am/db/2371169/Caixa_Capital_Risc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586501/Johnson___Johnson_Innovation> a org:Organization ;
    ns1:basedInLowRaw "Spain" ;
    ns1:documentDate "2016-01-12T20:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aelix Therapeutics completes Series A funding of 11.5M ($12.7M) for therapeutic HIV vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/aelix-therapeutics-completes-series-a-funding-of-%E2%82%AC11-5m-12-7m-for-therapeutic-hiv-vaccine> ;
    ns1:foundName "JJDC Inc",
        "Johnson & Johnson Innovation" ;
    ns1:investor <https://1145.am/db/2586501/Series_A_Investment_Aelix_Therapeutics_Caixa_Capital_Risc_Caixa_Capital_Risc_Johnson___Johnson_Innovation_Johnson___Johnson_Innovation_Ysios_Capital_Completed> ;
    ns1:name "Johnson & Johnson Innovation" ;
    ns1:sameAsMedium <https://1145.am/db/1118732/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1464782/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1745868/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2095032/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2155668/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2196895/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2280368/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2283006/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2284205/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2293709/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2295278/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2297195/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2297644/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2298631/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2301381/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2333993/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2334956/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2339206/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2360562/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2368322/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2369157/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2369951/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2586502/Johnson___Johnson_Innovation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586501/Ysios_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Spain" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:basedInHighRaw "Spain" ;
    ns1:description "a Spanish investment fund" ;
    ns1:documentDate "2016-01-12T20:39:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aelix Therapeutics completes Series A funding of 11.5M ($12.7M) for therapeutic HIV vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/aelix-therapeutics-completes-series-a-funding-of-%E2%82%AC11-5m-12-7m-for-therapeutic-hiv-vaccine> ;
    ns1:foundName "Ysios Capital" ;
    ns1:investor <https://1145.am/db/2586501/Series_A_Investment_Aelix_Therapeutics_Caixa_Capital_Risc_Caixa_Capital_Risc_Johnson___Johnson_Innovation_Johnson___Johnson_Innovation_Ysios_Capital_Completed> ;
    ns1:name "Ysios Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1340128/Ysios_Capital>,
        <https://1145.am/db/2019705/Ysios_Capital>,
        <https://1145.am/db/2293102/Ysios_Capital>,
        <https://1145.am/db/2299771/Ysios_Capital>,
        <https://1145.am/db/2301093/Ysios_Capital>,
        <https://1145.am/db/2335750/Ysios_Capital>,
        <https://1145.am/db/2335755/Ysios_Capital>,
        <https://1145.am/db/2336622/Ysios_Capital>,
        <https://1145.am/db/2337659/Ysios_Capital>,
        <https://1145.am/db/2337664/Ysios_Capital>,
        <https://1145.am/db/2369953/Ysios_Capital>,
        <https://1145.am/db/2369987/Ysios_Capital>,
        <https://1145.am/db/2371168/Ysios_Capital>,
        <https://1145.am/db/2371169/Ysios_Capital>,
        <https://1145.am/db/2371209/Ysios_Capital>,
        <https://1145.am/db/281538/Ysios_Capital>,
        <https://1145.am/db/704198/Ysios_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586575/Amdipharm_Mercury_Limited> a org:Organization ;
    ns1:basedInLowRaw "European" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-09-08T15:25:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Concordia Healthcare to Acquire Amdipharm Mercury Limited (AMCo) for US$3.5 Billion Creating a Global Platform to Facilitate Future Growth" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/concordia-healthcare-to-acquire-amdipharm-mercury-limited-amco-for-us-3-5-billion-creating-a> ;
    ns1:foundName "Amdipharm Mercury Limited" ;
    ns1:industry "Healthcare" ;
    ns1:name "Amdipharm Mercury Limited" ;
    ns1:sameAsHigh <https://1145.am/db/2586574/Amdipharm_Mercury>,
        <https://1145.am/db/2597612/Mercury_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2570007/Amdipharm_Mercury> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586575/Concordia_Healthcare_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Oakville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6092122/about.rdf> ;
    ns1:basedInHighRaw "OAKVILLE, ON" ;
    ns1:description "private equity firm" ;
    ns1:documentDate "2015-09-08T15:25:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Concordia Healthcare to Acquire Amdipharm Mercury Limited (AMCo) for US$3.5 Billion Creating a Global Platform to Facilitate Future Growth" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/concordia-healthcare-to-acquire-amdipharm-mercury-limited-amco-for-us-3-5-billion-creating-a> ;
    ns1:foundName "Concordia Healthcare Corp." ;
    ns1:industry "Healthcare" ;
    ns1:name "Concordia Healthcare Corp" ;
    ns1:sameAsHigh <https://1145.am/db/2586574/Concordia_Healthcare> ;
    ns1:sameAsMedium <https://1145.am/db/2569191/Concordia_Healthcare>,
        <https://1145.am/db/2569192/Concordia_Healthcare_Corp>,
        <https://1145.am/db/2570007/Concordia_Healthcare> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588562/Community_Veterinary_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Philadelphia" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4560349/about.rdf> ;
    ns1:basedInHighRaw "Philadelphia" ;
    ns1:description "Veterinary medicine" ;
    ns1:documentDate "2015-11-23T13:43:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cortec Group buys Community Veterinary Partners" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/cortec-group-buys-community-veterinary-partners> ;
    ns1:foundName "Community Veterinary Partners LLC",
        "Community Veterinary Partners, LLC" ;
    ns1:industry "Veterinary" ;
    ns1:name "Community Veterinary Partners" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Joint_Venture_Tangerine_Group_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> U.K. - based veterinary drugmaker Tangerine Group plans to open a U.S. subsidiary in Atlanta in February." ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "open" ;
    ns1:name "open" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2588578/Joint_Venture_The_Us_State_Department_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The U.S. State Department announced it has formed a research partnership with Ireland's agriculture industry focused largely on animal nutrition, reproduction and health." ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "formed" ;
    ns1:name "formed" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2588578/Texas_A___M_College_Of_Veterinary_Medicine___Biomedical_Sciences> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "Veterinary Medicine" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "The Texas A & M College of Veterinary Medicine & Biomedical Sciences" ;
    ns1:name "Texas A & M College of Veterinary Medicine & Biomedical Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1220019/Colorado_State_University>,
        <https://1145.am/db/2587605/Cornell_University_College_Of_Veterinary_Medicine> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Topkim> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Turkey" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/298795/about.rdf> ;
    ns1:basedInHighRaw "Turkey" ;
    ns1:description "drugs and vaccines for food animals" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "Topkim" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Topkim" ;
    ns1:sameAsHigh <https://1145.am/db/2287029/Hitgen>,
        <https://1145.am/db/2307239/Topigen_Pharmaceuticals_Inc>,
        <https://1145.am/db/2307246/Topigen>,
        <https://1145.am/db/2314438/Topigen_Pharmaceuticals_Inc>,
        <https://1145.am/db/2315530/Topigen_Pharmaceuticals>,
        <https://1145.am/db/2325344/Topotarget_A_S>,
        <https://1145.am/db/2325367/Topotarget_A_S>,
        <https://1145.am/db/2325553/Topaz_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326576/Topaz_Pharmaceuticals>,
        <https://1145.am/db/2332626/Topigen_Pharmaceuticals>,
        <https://1145.am/db/2332629/Topigen_Pharmaceuticals>,
        <https://1145.am/db/2348763/Topotarget_A_S>,
        <https://1145.am/db/2353441/Topaz_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364494/Topotarget_A_S>,
        <https://1145.am/db/2580479/Topigen_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588578/Topkim_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> India's Sequent Scientific acquired Turkey's Topkim, a maker of 67 drugs and vaccines for food animals, for 20.7 million Turkish lira ($ 7.1 million) ." ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2588578/Topkim> ;
    ns1:targetName "Topkim" ;
    ns1:valueRaw "$ 7.1 million",
        "20.7 million Turkish lira" ;
    ns1:whereGeoName "Republic of Turkey" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/298795/about.rdf> ;
    ns1:whereRaw "Turkey" .

<https://1145.am/db/2588584/Animalytix> a org:Organization ;
    ns1:basedInHighGeoName "Kansas City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4393217/about.rdf> ;
    ns1:basedInHighRaw "Kansas City" ;
    ns1:buyer <https://1145.am/db/2588584/Compendium_Of_Veterinary_Products_Acquisition> ;
    ns1:description "Animal Health" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "Animalytix" ;
    ns1:industry "Animal Health" ;
    ns1:name "Animalytix" ;
    ns1:sameAsHigh <https://1145.am/db/1135981/Inovet>,
        <https://1145.am/db/1152461/Zoetis_Inc>,
        <https://1145.am/db/1282864/Ceva_Animal_Health>,
        <https://1145.am/db/1370926/Covetrus>,
        <https://1145.am/db/1381791/Zoetis_Inc>,
        <https://1145.am/db/1382690/Zoetis_Inc>,
        <https://1145.am/db/1576959/Amlan_International>,
        <https://1145.am/db/194881/Elanco_Animal_Health>,
        <https://1145.am/db/2108474/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/227172/Elanco_Animal_Health>,
        <https://1145.am/db/2367825/Zoetis>,
        <https://1145.am/db/2546156/Zoetis>,
        <https://1145.am/db/2547130/Zoetis>,
        <https://1145.am/db/2559940/Vgx_Animal_Health>,
        <https://1145.am/db/2569196/Zoetis>,
        <https://1145.am/db/2571525/Lohmann>,
        <https://1145.am/db/2572277/Zoetis>,
        <https://1145.am/db/2575575/Wyeth>,
        <https://1145.am/db/2575912/Zoetis>,
        <https://1145.am/db/2579823/Zoetis>,
        <https://1145.am/db/2579831/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2579859/Zoetis_Inc>,
        <https://1145.am/db/2580831/Zoetis>,
        <https://1145.am/db/2581822/Integrated_Animal_Health>,
        <https://1145.am/db/2582942/Lohmann_Se>,
        <https://1145.am/db/2583700/Zoetis>,
        <https://1145.am/db/2583729/Jorgen_Kruuse>,
        <https://1145.am/db/2584705/Zoetis_Inc>,
        <https://1145.am/db/2586602/Integrated_Animal_Health>,
        <https://1145.am/db/2588540/Zoetis>,
        <https://1145.am/db/2588547/Zoetis_Inc>,
        <https://1145.am/db/2588580/Animalytix>,
        <https://1145.am/db/2589008/Zoetis>,
        <https://1145.am/db/2589014/Zoetis>,
        <https://1145.am/db/2589535/Animal_Health_Giant>,
        <https://1145.am/db/2589536/Zoetis>,
        <https://1145.am/db/2589960/Abbott_Animal_Health>,
        <https://1145.am/db/2589960/Zoetis_Inc>,
        <https://1145.am/db/2589962/Zoetis>,
        <https://1145.am/db/2589969/Zoetis>,
        <https://1145.am/db/2589971/Zoetis>,
        <https://1145.am/db/2590465/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2590487/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2592350/Zoetis_Inc>,
        <https://1145.am/db/2593450/Phw_Group>,
        <https://1145.am/db/2596312/Zoetis>,
        <https://1145.am/db/2596947/Zoetis>,
        <https://1145.am/db/498856/Ceva_Animal_Health>,
        <https://1145.am/db/499888/Ceva_Animal_Health>,
        <https://1145.am/db/555317/Zoetis_Inc>,
        <https://1145.am/db/558179/Zoetis_Inc>,
        <https://1145.am/db/636823/Amlan_International>,
        <https://1145.am/db/658410/Covenant_Animal_Health_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Compendium_Of_Veterinary_Products_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Animalytix, a company that's part of the Kansas City Animal Health Corridor, announced on December 1 that it has acquired the Compendium of Veterinary Products, the MSDS information system and related assets that were owned by North American Compendiums of Ontario." ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2588584/Compendium_Of_Veterinary_Products> ;
    ns1:targetName "Compendium of Veterinary Products" ;
    ns1:vendor <https://1145.am/db/2588584/North_American_Compendiums> ;
    ns1:when "2015-12-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 1" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2588584/Henry_Schein> a org:Organization ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "> Henry Schein",
        "Henry Schein" ;
    ns1:name "Henry Schein" ;
    ns1:sameAsMedium <https://1145.am/db/1061336/Henry_Schein>,
        <https://1145.am/db/1062559/Henry_Schein_Inc>,
        <https://1145.am/db/1114825/Henry_Schein_Inc>,
        <https://1145.am/db/1186707/Henry_Schein_Inc>,
        <https://1145.am/db/1188103/Henry_Schein_Inc>,
        <https://1145.am/db/1245128/Henry_Schein>,
        <https://1145.am/db/1245307/Henry_Schein>,
        <https://1145.am/db/1246119/Henry_Schein>,
        <https://1145.am/db/1246209/Henry_Schein>,
        <https://1145.am/db/1273924/Henry_Schein_Inc>,
        <https://1145.am/db/1274271/Henry_Schein_Inc>,
        <https://1145.am/db/1302445/Henry_Schein>,
        <https://1145.am/db/1305438/Henry_Schein>,
        <https://1145.am/db/1582951/Henry_Schein>,
        <https://1145.am/db/1585720/Henry_Schein>,
        <https://1145.am/db/1618805/Henry_Schein>,
        <https://1145.am/db/1619531/Henry_Schein>,
        <https://1145.am/db/1962754/Henry_Schein_Inc>,
        <https://1145.am/db/1994428/Henry_Schein>,
        <https://1145.am/db/1997275/Henry_Schein>,
        <https://1145.am/db/2061375/Henry_Schein>,
        <https://1145.am/db/2075081/Henry_Schein>,
        <https://1145.am/db/2075585/Henry_Schein>,
        <https://1145.am/db/2150122/Henry_Schein>,
        <https://1145.am/db/2299247/Henry_Schein>,
        <https://1145.am/db/2301488/Henry_Schein>,
        <https://1145.am/db/2368679/Henry_Schein>,
        <https://1145.am/db/2579815/Henry_Schein>,
        <https://1145.am/db/2580845/Henry_Schein>,
        <https://1145.am/db/2583729/Henry_Schein>,
        <https://1145.am/db/2583730/Henry_Schein>,
        <https://1145.am/db/2584666/Henry_Schein>,
        <https://1145.am/db/2584669/Henry_Schein_Inc>,
        <https://1145.am/db/2584696/Henry_Schein>,
        <https://1145.am/db/2585666/Henry_Schein>,
        <https://1145.am/db/2585668/Henry_Schein>,
        <https://1145.am/db/2587594/Henry_Schein>,
        <https://1145.am/db/2587605/Henry_Schein>,
        <https://1145.am/db/422376/Henry_Schein>,
        <https://1145.am/db/425687/Henry_Schein>,
        <https://1145.am/db/474722/Henry_Schein>,
        <https://1145.am/db/502542/Henry_Schein_Inc>,
        <https://1145.am/db/679312/Henry_Schein_Inc>,
        <https://1145.am/db/733730/Henry_Schein>,
        <https://1145.am/db/945512/Henry_Schein>,
        <https://1145.am/db/946640/Henry_Schein_Inc>,
        <https://1145.am/db/951087/Henry_Schein> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Investment_Jaguar_Animal_Health_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Jaguar Animal Health ($ JAGX) announced it has launched a pilot safety study with Louisiana State University to evaluate crofelemer for the treatment of diarrhea in horses with acute colitis." ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2588584/Jaguar_Animal_Health> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "Jaguar",
        "Jaguar Animal Health" ;
    ns1:industry "Animal Health" ;
    ns1:investor <https://1145.am/db/2588584/Investment_Henry_Schein_Has_Not_Happened>,
        <https://1145.am/db/2588584/Investment_Jaguar_Animal_Health_Completed> ;
    ns1:name "Jaguar Animal Health" ;
    ns1:sameAsHigh <https://1145.am/db/2349878/Jaguar_Animal_Health>,
        <https://1145.am/db/2358602/Jaguar_Animal_Health>,
        <https://1145.am/db/2368196/Jaguar_Animal_Health>,
        <https://1145.am/db/2370352/Jaguar_Animal_Health>,
        <https://1145.am/db/2537939/Jaguar_Animal_Health>,
        <https://1145.am/db/2577852/Jaguar_Animal_Health>,
        <https://1145.am/db/2577897/Jaguar_Animal_Health>,
        <https://1145.am/db/2583698/Jaguar_Animal_Health>,
        <https://1145.am/db/2584667/Jaguar_Animal_Health>,
        <https://1145.am/db/2585638/Jaguar_Animal_Health>,
        <https://1145.am/db/2589535/Jaguar_Animal_Health>,
        <https://1145.am/db/2590498/Jaguar_Animal_Health_Inc>,
        <https://1145.am/db/2590516/Jaguar_Animal_Health_Inc>,
        <https://1145.am/db/2591438/Jaguar_Animal_Health> ;
    ns1:sameAsMedium <https://1145.am/db/2585640/Jaguar_Animal_Health>,
        <https://1145.am/db/2586652/Jaguar_Animal_Health> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Merger_Cdt_Veterinary_Therapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Spotlight Innovation ($ STLT) announced it has formed a new subsidiary, CDT Veterinary Therapeutics, to develop cancer drugs for the veterinary market." ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "formed" ;
    ns1:name "formed" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2589535/Elanco_India> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:buyer <https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Eli_Lilly_Novartis_Completed>,
        <https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Jaguar_Animal_Health_Novartis_Completed> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Elanco India",
        "India" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Elanco India",
        "India" ;
    ns1:sameAsHigh <https://1145.am/db/2023900/Chowdary>,
        <https://1145.am/db/2539860/Bashir_Hansraj>,
        <https://1145.am/db/2543353/Indus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2543358/Indus_Pharmaceuticals>,
        <https://1145.am/db/2549718/Novartis_India> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/Factories_Acquisition_Animal_Health_Giant_Huvepharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Animal health giant ($ ZTS) , which has been rolling out a major cost-cutting plan over the past year, has made its first major move toward drastically reducing its manufacturing overhead.",
        "The company disclosed on December 22 that it has sold two factories in North Carolina and Colorado to Huvepharma, based in Sofia, Bulgaria." ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "sold" ;
    ns1:name "sold" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:targetDetails "factories" ;
    ns1:valueRaw "$ 40 million" ;
    ns1:vendor <https://1145.am/db/2589535/Animal_Health_Giant> ;
    ns1:when "2016-12-22T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 22" ;
    ns1:whereGeoName "Colorado",
        "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf>,
        <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "North Carolina and Colorado" .

<https://1145.am/db/2589535/Investment_Food_Emergency_Response_Network_The_California_Animal_Health_And_Food_Safety_Laboratory_System_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The California Animal Health and Food Safety Laboratory System, which is based at the University of California, Davis, received a $ 1.89 million, 5-year grant from the federal Food Emergency Response Network, which it will use to expand its toxicology services." ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "grant",
        "received" ;
    ns1:name "grant",
        "received" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2589535/The_California_Animal_Health_And_Food_Safety_Laboratory_System> ;
    ns1:valueRaw "$ 1.89 million" ;
    ns1:whereGeoName "Colorado",
        "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf>,
        <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "North Carolina and Colorado" .

<https://1145.am/db/2589535/Ipo_Jaguar_Animal_Health_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Jaguar Animal Health ($ JAGX) announced it has launched a pivotal clinical trial of Canalevia for the treatment of acute diarrhea in dogs." ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "Colorado",
        "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf>,
        <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "North Carolina and Colorado" .

<https://1145.am/db/2589535/Jaguar_Animal_Health> a org:Organization ;
    ns1:buyer <https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Jaguar_Animal_Health_Novartis_Completed>,
        <https://1145.am/db/2589535/Ipo_Jaguar_Animal_Health_Has_Not_Happened> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Jaguar",
        "Jaguar Animal Health" ;
    ns1:name "Jaguar Animal Health" ;
    ns1:sameAsHigh <https://1145.am/db/2588584/Jaguar_Animal_Health> ;
    ns1:sameAsMedium <https://1145.am/db/2349878/Jaguar_Animal_Health>,
        <https://1145.am/db/2358602/Jaguar_Animal_Health>,
        <https://1145.am/db/2368196/Jaguar_Animal_Health>,
        <https://1145.am/db/2370352/Jaguar_Animal_Health>,
        <https://1145.am/db/2537939/Jaguar_Animal_Health>,
        <https://1145.am/db/2577852/Jaguar_Animal_Health>,
        <https://1145.am/db/2577897/Jaguar_Animal_Health>,
        <https://1145.am/db/2583698/Jaguar_Animal_Health>,
        <https://1145.am/db/2584667/Jaguar_Animal_Health>,
        <https://1145.am/db/2585638/Jaguar_Animal_Health>,
        <https://1145.am/db/2585640/Jaguar_Animal_Health>,
        <https://1145.am/db/2586652/Jaguar_Animal_Health>,
        <https://1145.am/db/2590498/Jaguar_Animal_Health_Inc>,
        <https://1145.am/db/2590516/Jaguar_Animal_Health_Inc>,
        <https://1145.am/db/2591438/Jaguar_Animal_Health> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/The_California_Animal_Health_And_Food_Safety_Laboratory_System> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:description "Toxicology" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "The California Animal Health and Food Safety Laboratory System" ;
    ns1:name "The California Animal Health and Food Safety Laboratory System" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2600867/Keytech> a org:Organization ;
    ns1:basedInHighGeoName "Bermuda" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3573345/about.rdf> ;
    ns1:basedInHighRaw "Bermuda" ;
    ns1:description "business" ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "KeyTech" ;
    ns1:name "KeyTech" ;
    ns1:protagonist <https://1145.am/db/2600867/Keytech_Interest_Investment> ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2600867/Mako_Networks> a org:Organization ;
    ns1:basedInHighGeoName "New Zealand" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2186224/about.rdf> ;
    ns1:basedInHighRaw "New Zealand" ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "Mako Networks" ;
    ns1:name "Mako Networks" ;
    ns1:sourceName "Fierce Telecom" .

<https://1145.am/db/2600867/Mako_Networks_Assets_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> D & S Communications has acquired the assets of New Zealand company Mako Networks from the company's receivers." ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2600867/Mako_Networks> ;
    ns1:targetDetails "assets" ;
    ns1:targetName "Mako Networks" ;
    ns1:whereGeoName "New Zealand" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2186224/about.rdf> ;
    ns1:whereRaw "New Zealand" .

<https://1145.am/db/2661936/Ck_Hutchison> a org:Organization ;
    ns1:basedInHighGeoName "Hong Kong Special Administrative Region" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1819730/about.rdf> ;
    ns1:basedInHighRaw "Hong Kong" ;
    ns1:buyer <https://1145.am/db/2661936/O2_Uk_Acquisition>,
        <https://1145.am/db/2661936/Three_Uk_Merger> ;
    ns1:description "Business" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "CK Hutchison" ;
    ns1:name "CK Hutchison" ;
    ns1:sameAsHigh <https://1145.am/db/1055228/Three_Uk>,
        <https://1145.am/db/1566865/Ck_Hutchison_Holdings>,
        <https://1145.am/db/1780861/Ck_Hutchison>,
        <https://1145.am/db/2000699/Ck_Hutchison>,
        <https://1145.am/db/2626593/Ck_Hutchison>,
        <https://1145.am/db/2668411/Ck_Hutchison>,
        <https://1145.am/db/2671802/Ck_Hutchison>,
        <https://1145.am/db/2674126/Ck_Hutchison>,
        <https://1145.am/db/2723235/Ck_Hutchison_Holdings>,
        <https://1145.am/db/2723688/Ck_Hutchison_Holdings>,
        <https://1145.am/db/2734513/Ck_Hutchison>,
        <https://1145.am/db/480535/Ck_Hutchison>,
        <https://1145.am/db/733254/Ck_Hutchison> ;
    ns1:sameAsMedium <https://1145.am/db/171380/Ck_Hutchison>,
        <https://1145.am/db/1939108/Ck_Hutchison>,
        <https://1145.am/db/1969437/Ck_Hutchison>,
        <https://1145.am/db/1993312/Ck_Hutchison>,
        <https://1145.am/db/2005677/Ck_Hutchison>,
        <https://1145.am/db/2009302/Ck_Hutchison>,
        <https://1145.am/db/2029449/Ck_Hutchison>,
        <https://1145.am/db/2036731/Ck_Hutchison>,
        <https://1145.am/db/2037901/Ck_Hutchison>,
        <https://1145.am/db/220693/Ck_Hutchison>,
        <https://1145.am/db/2625867/Ck_Hutchison>,
        <https://1145.am/db/2629007/Ck_Hutchison>,
        <https://1145.am/db/2642043/Ck_Hutchison>,
        <https://1145.am/db/2646907/Ck_Hutchison>,
        <https://1145.am/db/2661978/Ck_Hutchison>,
        <https://1145.am/db/2664098/Ck_Hutchison>,
        <https://1145.am/db/2665206/Ck_Hutchison>,
        <https://1145.am/db/2666285/Ck_Hutchison>,
        <https://1145.am/db/2667366/Ck_Hutchison>,
        <https://1145.am/db/2668412/Ck_Hutchison>,
        <https://1145.am/db/2669505/Ck_Hutchison>,
        <https://1145.am/db/2669513/Ck_Hutchison>,
        <https://1145.am/db/2670595/Ck_Hutchison>,
        <https://1145.am/db/2671778/Ck_Hutchison>,
        <https://1145.am/db/2671810/Ck_Hutchison>,
        <https://1145.am/db/2671812/Ck_Hutchison>,
        <https://1145.am/db/2672991/Ck_Hutchison>,
        <https://1145.am/db/2676518/Ck_Hutchison>,
        <https://1145.am/db/2792664/Ck_Hutchison>,
        <https://1145.am/db/875920/Ck_Hutchison>,
        <https://1145.am/db/876581/Ck_Hutchison>,
        <https://1145.am/db/999407/Ck_Hutchison> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661936/Three_Uk> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "business" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "Three UK" ;
    ns1:name "Three UK" ;
    ns1:protagonist <https://1145.am/db/2661936/O2_Uk_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/1826002/3> ;
    ns1:sameAsMedium <https://1145.am/db/1055228/Three_Uk>,
        <https://1145.am/db/1797744/Three>,
        <https://1145.am/db/2037305/Three_Uk>,
        <https://1145.am/db/2149846/Three_Uk>,
        <https://1145.am/db/2653961/Three_Uk>,
        <https://1145.am/db/2659797/Three_Uk>,
        <https://1145.am/db/2667333/Three_Uk>,
        <https://1145.am/db/2668412/Three>,
        <https://1145.am/db/2669513/Three_Uk>,
        <https://1145.am/db/2671778/Three_Uk>,
        <https://1145.am/db/2672991/Three_Uk>,
        <https://1145.am/db/2674136/Three_Uk>,
        <https://1145.am/db/2746556/Three_Uk>,
        <https://1145.am/db/80982/Three_Uk> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661936/Three_Uk_Merger> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Financial Times reported that CK Hutchison, which wants to buy O2 UK from Telefnica and merge it with Three UK in a deal worth 10.3 billion (14 billion/ $ 16 billion) , has discussed the possibility of an initial public offering (IPO) for the combined business with external investors that have already committed 3 billion to fund the deal." ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "initial public offering" ;
    ns1:name "initial public offering" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2661936/Three_Uk> ;
    ns1:targetName "Three UK" ;
    ns1:valueRaw "3 billion",
        "14 billion" ;
    ns1:vendor <https://1145.am/db/2661936/Telefnica> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2661968/Cablevision> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "U.S." ;
    ns1:description "U.S." ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Cablevision" ;
    ns1:name "Cablevision" ;
    ns1:sameAsHigh <https://1145.am/db/2167993/Optimum> ;
    ns1:sameAsMedium <https://1145.am/db/2157950/Cablevision>,
        <https://1145.am/db/2159307/Cablevision>,
        <https://1145.am/db/2159990/Cablevision>,
        <https://1145.am/db/2159996/Cablevision>,
        <https://1145.am/db/2160683/Cablevision>,
        <https://1145.am/db/2160822/Cablevision>,
        <https://1145.am/db/2160845/Cablevision>,
        <https://1145.am/db/2162034/Cablevision>,
        <https://1145.am/db/2162126/Cablevision>,
        <https://1145.am/db/2162349/Cablevision>,
        <https://1145.am/db/2162567/Cablevision>,
        <https://1145.am/db/2164289/Cablevision>,
        <https://1145.am/db/2165023/Cablevision>,
        <https://1145.am/db/2167192/Cablevision>,
        <https://1145.am/db/2167325/Cablevision>,
        <https://1145.am/db/2168041/Cablevision>,
        <https://1145.am/db/2169452/Cablevision>,
        <https://1145.am/db/2169458/Cablevision>,
        <https://1145.am/db/2170408/Cablevision>,
        <https://1145.am/db/2171023/Cablevision>,
        <https://1145.am/db/2172008/Cablevision>,
        <https://1145.am/db/2172709/Cablevision>,
        <https://1145.am/db/2173652/Cablevision>,
        <https://1145.am/db/2174317/Cablevision>,
        <https://1145.am/db/2175078/Cablevision>,
        <https://1145.am/db/2176891/Cablevision>,
        <https://1145.am/db/2177466/Cablevision>,
        <https://1145.am/db/2599743/Cablevision>,
        <https://1145.am/db/2599895/Cablevision>,
        <https://1145.am/db/2599901/Cablevision>,
        <https://1145.am/db/2601526/Cablevision>,
        <https://1145.am/db/2601574/Cablevision>,
        <https://1145.am/db/2612142/Cablevision>,
        <https://1145.am/db/2614521/Cablevision>,
        <https://1145.am/db/2653375/Cablevision>,
        <https://1145.am/db/2657961/Cablevision>,
        <https://1145.am/db/2660912/Cablevision>,
        <https://1145.am/db/2675345/Cablevision> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661968/Orange_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Orange moved closer to a Kenya exit as reports suggest Helios Partners will buy its 70 per cent stake in the local Orange unit." ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2661968/Orange> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Orange" ;
    ns1:vendor <https://1145.am/db/2661968/Orange> ;
    ns1:whereGeoName "Republic of Kenya" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/192950/about.rdf> ;
    ns1:whereRaw "Kenya" .

<https://1145.am/db/2661968/Stake_Acquisition_Helios_Partners_Orange_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Orange moved closer to a Kenya exit as reports suggest Helios Partners will buy its 70 per cent stake in the local Orange unit." ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "stake" ;
    ns1:vendor <https://1145.am/db/2661968/Orange> ;
    ns1:whereGeoName "Republic of Kenya" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/192950/about.rdf> ;
    ns1:whereRaw "Kenya" .

<https://1145.am/db/2661968/Stake_Investment_Helios_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Orange moved closer to a Kenya exit as reports suggest Helios Partners will buy its 70 per cent stake in the local Orange unit." ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "increase" ;
    ns1:name "increase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "stake" ;
    ns1:whereGeoName "Republic of Kenya" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/192950/about.rdf> ;
    ns1:whereRaw "Kenya" .

<https://1145.am/db/2661968/Telecom_Italia> a org:Organization ;
    ns1:basedInLowRaw "Italia" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Telecom Italia" ;
    ns1:name "Telecom Italia" ;
    ns1:sameAsMedium <https://1145.am/db/1047409/Telecom_Italia>,
        <https://1145.am/db/1064464/Telecom_Italia>,
        <https://1145.am/db/1077234/Telecom_Italia>,
        <https://1145.am/db/1093535/Telecom_Italia>,
        <https://1145.am/db/1097773/Telecom_Italia>,
        <https://1145.am/db/1098957/Telecom_Italia>,
        <https://1145.am/db/1099220/Telecom_Italia>,
        <https://1145.am/db/1110477/Telecom_Italia>,
        <https://1145.am/db/112754/Telecom_Italia>,
        <https://1145.am/db/1149070/Telecom_Italia>,
        <https://1145.am/db/1184853/Telecom_Italia>,
        <https://1145.am/db/1186155/Telecom_Italia>,
        <https://1145.am/db/1243447/Telecom_Italia>,
        <https://1145.am/db/1331490/Telecom_Italia>,
        <https://1145.am/db/1403043/Telecom_Italia>,
        <https://1145.am/db/1406022/Telecom_Italia>,
        <https://1145.am/db/1416180/Telecom_Italia>,
        <https://1145.am/db/1426479/Telecom_Italia>,
        <https://1145.am/db/1447172/Telecom_Italia>,
        <https://1145.am/db/1475321/Telecom_Italia>,
        <https://1145.am/db/1478723/Telecom_Italia>,
        <https://1145.am/db/149545/Telecom_Italia>,
        <https://1145.am/db/1535631/Telecom_Italia>,
        <https://1145.am/db/1536342/Telecom_Italia>,
        <https://1145.am/db/1542728/Telecom_Italia>,
        <https://1145.am/db/1543853/Telecom_Italia>,
        <https://1145.am/db/1581801/Telecom_Italia>,
        <https://1145.am/db/1583032/Telecom_Italia>,
        <https://1145.am/db/1583069/Telecom_Italia>,
        <https://1145.am/db/1647651/Telecom_Italia>,
        <https://1145.am/db/1658979/Telecom_Italia>,
        <https://1145.am/db/1660846/Telecom_Italia>,
        <https://1145.am/db/1660963/Telecom_Italia>,
        <https://1145.am/db/1661435/Telecom_Italia>,
        <https://1145.am/db/1666847/Telecom_Italia>,
        <https://1145.am/db/1668839/Telecom_Italia>,
        <https://1145.am/db/1676231/Telecom_Italia>,
        <https://1145.am/db/167781/Telecom_Italia>,
        <https://1145.am/db/1692478/Telecom_Italia>,
        <https://1145.am/db/1693484/Telecom_Italia>,
        <https://1145.am/db/172769/Telecom_Italia>,
        <https://1145.am/db/172965/Telecom_Italia>,
        <https://1145.am/db/1927764/Telecom_Italia>,
        <https://1145.am/db/1929605/Telecom_Italia>,
        <https://1145.am/db/1937252/Telecom_Italia>,
        <https://1145.am/db/1938717/Telecom_Italia>,
        <https://1145.am/db/1951836/Telecom_Italia>,
        <https://1145.am/db/195572/Telecom_Italia>,
        <https://1145.am/db/1959850/Telecom_Italia>,
        <https://1145.am/db/1972192/Telecom_Italia>,
        <https://1145.am/db/1987484/Telecom_Italia>,
        <https://1145.am/db/1995490/Telecom_Italia>,
        <https://1145.am/db/1995594/Telecom_Italia>,
        <https://1145.am/db/1996605/Telecom_Italia>,
        <https://1145.am/db/2008367/Telecom_Italia>,
        <https://1145.am/db/2011778/Telecom_Italia>,
        <https://1145.am/db/2032776/Telecom_Italia>,
        <https://1145.am/db/2037739/Telecom_Italia>,
        <https://1145.am/db/2038947/Telecom_Italia>,
        <https://1145.am/db/2042348/Telecom_Italia>,
        <https://1145.am/db/2045904/Telecom_Italia>,
        <https://1145.am/db/2046870/Telecom_Italia>,
        <https://1145.am/db/2073937/Telecom_Italia>,
        <https://1145.am/db/2075473/Telecom_Italia>,
        <https://1145.am/db/2080075/Telecom_Italia>,
        <https://1145.am/db/2082516/Telecom_Italia>,
        <https://1145.am/db/2101709/Telecom_Italia>,
        <https://1145.am/db/2124401/Telecom_Italia>,
        <https://1145.am/db/2127688/Telecom_Italia>,
        <https://1145.am/db/2136594/Telecom_Italia>,
        <https://1145.am/db/2139470/Telecom_Italia>,
        <https://1145.am/db/2145209/Telecom_Italia>,
        <https://1145.am/db/2162594/Telecom_Italia>,
        <https://1145.am/db/2163998/Telecom_Italia>,
        <https://1145.am/db/2508331/Telecom_Italia>,
        <https://1145.am/db/2600218/Telecom_Italia>,
        <https://1145.am/db/2601362/Telecom_Italia_Spa>,
        <https://1145.am/db/2602323/Telecom_Italia>,
        <https://1145.am/db/2603489/Telecom_Italia>,
        <https://1145.am/db/2606732/Telecom_Italia>,
        <https://1145.am/db/2607781/Telecom_Italia>,
        <https://1145.am/db/2608115/Telecom_Italia>,
        <https://1145.am/db/2608327/Telecom_Italia>,
        <https://1145.am/db/2608856/Telecom_Italia>,
        <https://1145.am/db/2610513/Telecom_Italia>,
        <https://1145.am/db/2610893/Telecom_Italia_Spa>,
        <https://1145.am/db/2612025/Telecom_Italia>,
        <https://1145.am/db/2612676/Telecom_Italia>,
        <https://1145.am/db/2613788/Telecom_Italia>,
        <https://1145.am/db/2615514/Telecom_Italia>,
        <https://1145.am/db/2617203/Telecom_Italia>,
        <https://1145.am/db/2617659/Telecom_Italia>,
        <https://1145.am/db/2619260/Telecom_Italia>,
        <https://1145.am/db/2621105/Telecom_Italia>,
        <https://1145.am/db/2624036/Telecom_Italia>,
        <https://1145.am/db/2632874/Telecom_Italia>,
        <https://1145.am/db/2634897/Telecom_Italia>,
        <https://1145.am/db/2635893/Telecom_Italia>,
        <https://1145.am/db/2635899/Telecom_Italia>,
        <https://1145.am/db/2646874/Telecom_Italia>,
        <https://1145.am/db/2650838/Telecom_Italia>,
        <https://1145.am/db/2651739/Telecom_Italia>,
        <https://1145.am/db/2653078/Telecom_Italia>,
        <https://1145.am/db/2653302/Telecom_Italia>,
        <https://1145.am/db/2654129/Telecom_Italia>,
        <https://1145.am/db/2655008/Telecom_Italia>,
        <https://1145.am/db/2655774/Telecom_Italia>,
        <https://1145.am/db/2655907/Telecom_Italia>,
        <https://1145.am/db/2656800/Telecom_Italia>,
        <https://1145.am/db/2657126/Telecom_Italia>,
        <https://1145.am/db/2657127/Telecom_Italia>,
        <https://1145.am/db/2657316/Telecom_Italia>,
        <https://1145.am/db/2657327/Telecom_Italia>,
        <https://1145.am/db/2657331/Telecom_Italia>,
        <https://1145.am/db/2658308/Telecom_Italia>,
        <https://1145.am/db/2658881/Telecom_Italia>,
        <https://1145.am/db/2659115/Telecom_Italia>,
        <https://1145.am/db/2659515/Telecom_Italia>,
        <https://1145.am/db/2659746/Telecom_Italia>,
        <https://1145.am/db/2659882/Telecom_Italia>,
        <https://1145.am/db/2659958/Telecom_Italia>,
        <https://1145.am/db/2660246/Telecom_Italia>,
        <https://1145.am/db/2661955/Telecom_Italia>,
        <https://1145.am/db/2661989/Telecom_Italia>,
        <https://1145.am/db/2662795/Telecom_Italia>,
        <https://1145.am/db/2663032/Telecom_Italia>,
        <https://1145.am/db/2663175/Telecom_Italia>,
        <https://1145.am/db/2664131/Telecom_Italia>,
        <https://1145.am/db/2664229/Telecom_Italia>,
        <https://1145.am/db/2665211/Telecom_Italia>,
        <https://1145.am/db/2665365/Telecom_Italia>,
        <https://1145.am/db/2666402/Telecom_Italia>,
        <https://1145.am/db/2666438/Telecom_Italia>,
        <https://1145.am/db/2667077/Telecom_Italia>,
        <https://1145.am/db/2667503/Telecom_Italia>,
        <https://1145.am/db/2668429/Telecom_Italia>,
        <https://1145.am/db/2669512/Telecom_Italia>,
        <https://1145.am/db/2669518/Telecom_Italia>,
        <https://1145.am/db/2669521/Telecom_Italia>,
        <https://1145.am/db/2670611/Telecom_Italia>,
        <https://1145.am/db/2670631/Telecom_Italia>,
        <https://1145.am/db/2671068/Telecom_Italia>,
        <https://1145.am/db/2671564/Telecom_Italia>,
        <https://1145.am/db/2671968/Telecom_Italia>,
        <https://1145.am/db/2672143/Telecom_Italia>,
        <https://1145.am/db/2672150/Telecom_Italia>,
        <https://1145.am/db/2674090/Telecom_Italia>,
        <https://1145.am/db/2674235/Telecom_Italia>,
        <https://1145.am/db/2674259/Telecom_Italia>,
        <https://1145.am/db/2674269/Telecom_Italia>,
        <https://1145.am/db/2674286/Telecom_Italia>,
        <https://1145.am/db/2674300/Telecom_Italia>,
        <https://1145.am/db/2675454/Telecom_Italia>,
        <https://1145.am/db/2675459/Telecom_Italia>,
        <https://1145.am/db/2675493/Telecom_Italia>,
        <https://1145.am/db/2675675/Telecom_Italia>,
        <https://1145.am/db/2676194/Telecom_Italia>,
        <https://1145.am/db/2676297/Telecom_Italia>,
        <https://1145.am/db/2676606/Telecom_Italia>,
        <https://1145.am/db/2676636/Telecom_Italia>,
        <https://1145.am/db/2676652/Telecom_Italia>,
        <https://1145.am/db/2676659/Telecom_Italia>,
        <https://1145.am/db/2676671/Telecom_Italia>,
        <https://1145.am/db/2676682/Telecom_Italia>,
        <https://1145.am/db/2676704/Telecom_Italia>,
        <https://1145.am/db/2676711/Telecom_Italia>,
        <https://1145.am/db/2677796/Telecom_Italia>,
        <https://1145.am/db/2677868/Telecom_Italia>,
        <https://1145.am/db/2677962/Telecom_Italia>,
        <https://1145.am/db/2677977/Telecom_Italia_Spa>,
        <https://1145.am/db/2679067/Telecom_Italia>,
        <https://1145.am/db/2680055/Telecom_Italia>,
        <https://1145.am/db/2680090/Telecom_Italia>,
        <https://1145.am/db/2680106/Telecom_Italia>,
        <https://1145.am/db/2680111/Telecom_Italia>,
        <https://1145.am/db/2680130/Telecom_Italia>,
        <https://1145.am/db/2680847/Telecom_Italia>,
        <https://1145.am/db/2681060/Telecom_Italia>,
        <https://1145.am/db/2681869/Telecom_Italia>,
        <https://1145.am/db/2682880/Telecom_Italia>,
        <https://1145.am/db/2683245/Telecom_Italia>,
        <https://1145.am/db/2784489/Telecom_Italia>,
        <https://1145.am/db/2784659/Telecom_Italia>,
        <https://1145.am/db/2789780/Telecom_Italia>,
        <https://1145.am/db/2794220/Telecom_Italia>,
        <https://1145.am/db/2795446/Telecom_Italia>,
        <https://1145.am/db/2796223/Telecom_Italia>,
        <https://1145.am/db/2796657/Telecom_Italia>,
        <https://1145.am/db/2796864/Telecom_Italia>,
        <https://1145.am/db/2801896/Telecom_Italia>,
        <https://1145.am/db/295575/Telecom_Italia>,
        <https://1145.am/db/596244/Telecom_Italia>,
        <https://1145.am/db/597302/Telecom_Italia>,
        <https://1145.am/db/638312/Telecom_Italia>,
        <https://1145.am/db/639493/Telecom_Italia>,
        <https://1145.am/db/643839/Telecom_Italia>,
        <https://1145.am/db/644358/Telecom_Italia>,
        <https://1145.am/db/644418/Telecom_Italia>,
        <https://1145.am/db/649646/Telecom_Italia>,
        <https://1145.am/db/650038/Telecom_Italia>,
        <https://1145.am/db/651358/Telecom_Italia>,
        <https://1145.am/db/651798/Telecom_Italia>,
        <https://1145.am/db/652778/Telecom_Italia_Spa>,
        <https://1145.am/db/653953/Telecom_Italia>,
        <https://1145.am/db/654033/Telecom_Italia>,
        <https://1145.am/db/665056/Telecom_Italia>,
        <https://1145.am/db/667997/Telecom_Italia>,
        <https://1145.am/db/674055/Telecom_Italia>,
        <https://1145.am/db/675103/Telecom_Italia>,
        <https://1145.am/db/675999/Telecom_Italia>,
        <https://1145.am/db/693816/Telecom_Italia>,
        <https://1145.am/db/700123/Telecom_Italia>,
        <https://1145.am/db/733298/Telecom_Italia>,
        <https://1145.am/db/75387/Telecom_Italia>,
        <https://1145.am/db/76144/Telecom_Italia>,
        <https://1145.am/db/768028/Telecom_Italia>,
        <https://1145.am/db/770929/Telecom_Italia>,
        <https://1145.am/db/771860/Telecom_Italia>,
        <https://1145.am/db/77243/Telecom_Italia>,
        <https://1145.am/db/77455/Telecom_Italia>,
        <https://1145.am/db/789202/Telecom_Italia>,
        <https://1145.am/db/829559/Telecom_Italia>,
        <https://1145.am/db/857430/Telecom_Italia>,
        <https://1145.am/db/857455/Telecom_Italia>,
        <https://1145.am/db/872702/Telecom_Italia>,
        <https://1145.am/db/873053/Telecom_Italia>,
        <https://1145.am/db/882663/Telecom_Italia>,
        <https://1145.am/db/884392/Telecom_Italia>,
        <https://1145.am/db/893768/Telecom_Italia>,
        <https://1145.am/db/899462/Telecom_Italia>,
        <https://1145.am/db/912231/Telecom_Italia>,
        <https://1145.am/db/924993/Telecom_Italia>,
        <https://1145.am/db/929269/Telecom_Italia>,
        <https://1145.am/db/934007/Telecom_Italia>,
        <https://1145.am/db/943807/Telecom_Italia>,
        <https://1145.am/db/945189/Telecom_Italia>,
        <https://1145.am/db/950237/Telecom_Italia>,
        <https://1145.am/db/953014/Telecom_Italia>,
        <https://1145.am/db/963947/Telecom_Italia>,
        <https://1145.am/db/977823/Telecom_Italia>,
        <https://1145.am/db/995335/Telecom_Italia> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661968/Telecom_Italia_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Vivendi is reportedly making moves to increase its stake in Telecom Italia to 19 per cent from 15.49 per cent." ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "increase" ;
    ns1:name "increase" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2661968/Telecom_Italia> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Telecom Italia" ;
    ns1:whereGeoName "Italian Republic" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3175395/about.rdf> ;
    ns1:whereRaw "Italia" .

<https://1145.am/db/2664679/Extenet_Systems> a org:Organization ;
    ns1:documentDate "2015-07-23T15:57:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "C Spire doubles spectrum used for LTE; ExteNet gets $1B for recapitalization" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/c-spire-doubles-spectrum-used-for-lte-extenet-gets-1b-for-recapitalization> ;
    ns1:foundName "ExteNet Systems" ;
    ns1:name "ExteNet Systems" ;
    ns1:sameAsMedium <https://1145.am/db/2618736/Extenet_Systems>,
        <https://1145.am/db/2638206/Extenet_Systems> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2665165/Acquisition_Vodacom_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Vodacom starts talks with Neotel on revising the structure of its planned acquisition of the ISP." ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "South Africa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/953987/about.rdf> ;
    ns1:whereRaw "South Africa" .

<https://1145.am/db/2665165/Isp> a org:Organization ;
    ns1:basedInLowRaw "South Africa" ;
    ns1:description "Internet service provider" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "the ISP" ;
    ns1:name "ISP" ;
    ns1:sameAsHigh <https://1145.am/db/1751954/Internet_Service_Provider> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2665165/Isp_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Vodacom starts talks with Neotel on revising the structure of its planned acquisition of the ISP." ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2665165/Isp> ;
    ns1:targetName "ISP" ;
    ns1:whereGeoName "South Africa" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/953987/about.rdf> ;
    ns1:whereRaw "South Africa" .

<https://1145.am/db/2665165/Jolla> a org:Organization ;
    ns1:basedInLowRaw "Finland" ;
    ns1:description "Sailfish OS" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "Jolla" ;
    ns1:name "Jolla" ;
    ns1:sameAsHigh <https://1145.am/db/2674684/Jolla> ;
    ns1:sameAsMedium <https://1145.am/db/1799581/Jolla>,
        <https://1145.am/db/1814873/Jolla>,
        <https://1145.am/db/1817622/Jolla>,
        <https://1145.am/db/1835381/Jolla>,
        <https://1145.am/db/1840644/Jolla>,
        <https://1145.am/db/1853552/Jolla>,
        <https://1145.am/db/2651014/Jolla>,
        <https://1145.am/db/2677074/Jolla>,
        <https://1145.am/db/2680106/Jolla> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2665165/Turk_Telekom> a org:Organization ;
    ns1:basedInLowRaw "Turk" ;
    ns1:documentDate "2015-11-23T07:58:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Jolla plans debt restructuring and lays off staff; Vodacom wants to rework Neotel deal" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/jolla-plans-debt-restructuring-and-lays-off-staff-vodacom-wants-to-rework-neotel-deal> ;
    ns1:foundName "Turk Telekom" ;
    ns1:name "Turk Telekom" ;
    ns1:sameAsMedium <https://1145.am/db/2654838/Turk_Telekom>,
        <https://1145.am/db/2654858/Turk_Telekom>,
        <https://1145.am/db/703530/Turk_Telekom>,
        <https://1145.am/db/896089/Turk_Telekom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2667366/Ck_Hutchison> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:buyer <https://1145.am/db/2667366/O2_Uk_Acquisition> ;
    ns1:documentDate "2016-01-26T13:55:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Xavier Niel: Leaving no stone unturned" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/xavier-niel-leaving-no-stone-unturned> ;
    ns1:foundName "CK Hutchison" ;
    ns1:name "CK Hutchison" ;
    ns1:sameAsMedium <https://1145.am/db/171380/Ck_Hutchison>,
        <https://1145.am/db/1780861/Ck_Hutchison>,
        <https://1145.am/db/1939108/Ck_Hutchison>,
        <https://1145.am/db/1969437/Ck_Hutchison>,
        <https://1145.am/db/1993312/Ck_Hutchison>,
        <https://1145.am/db/2000699/Ck_Hutchison>,
        <https://1145.am/db/2005677/Ck_Hutchison>,
        <https://1145.am/db/2009302/Ck_Hutchison>,
        <https://1145.am/db/2029449/Ck_Hutchison>,
        <https://1145.am/db/2036731/Ck_Hutchison>,
        <https://1145.am/db/2037901/Ck_Hutchison>,
        <https://1145.am/db/220693/Ck_Hutchison>,
        <https://1145.am/db/2625867/Ck_Hutchison>,
        <https://1145.am/db/2626593/Ck_Hutchison>,
        <https://1145.am/db/2629007/Ck_Hutchison>,
        <https://1145.am/db/2642043/Ck_Hutchison>,
        <https://1145.am/db/2646907/Ck_Hutchison>,
        <https://1145.am/db/2661936/Ck_Hutchison>,
        <https://1145.am/db/2661978/Ck_Hutchison>,
        <https://1145.am/db/2664098/Ck_Hutchison>,
        <https://1145.am/db/2665206/Ck_Hutchison>,
        <https://1145.am/db/2666285/Ck_Hutchison>,
        <https://1145.am/db/2668411/Ck_Hutchison>,
        <https://1145.am/db/2668412/Ck_Hutchison>,
        <https://1145.am/db/2669505/Ck_Hutchison>,
        <https://1145.am/db/2669513/Ck_Hutchison>,
        <https://1145.am/db/2670595/Ck_Hutchison>,
        <https://1145.am/db/2671778/Ck_Hutchison>,
        <https://1145.am/db/2671802/Ck_Hutchison>,
        <https://1145.am/db/2671810/Ck_Hutchison>,
        <https://1145.am/db/2671812/Ck_Hutchison>,
        <https://1145.am/db/2672991/Ck_Hutchison>,
        <https://1145.am/db/2674126/Ck_Hutchison>,
        <https://1145.am/db/2676518/Ck_Hutchison>,
        <https://1145.am/db/2734513/Ck_Hutchison>,
        <https://1145.am/db/2792664/Ck_Hutchison>,
        <https://1145.am/db/480535/Ck_Hutchison>,
        <https://1145.am/db/733254/Ck_Hutchison>,
        <https://1145.am/db/875920/Ck_Hutchison>,
        <https://1145.am/db/876581/Ck_Hutchison>,
        <https://1145.am/db/999407/Ck_Hutchison> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2667366/O2_Uk_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2016-01-26T13:55:13+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The latest rumours to emerge this week are that he has also been exploring options to enter the UK market on the back of CK Hutchison's proposal to buy O2 UK and merge it with Three UK." ;
    ns1:documentTitle "Xavier Niel: Leaving no stone unturned" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/xavier-niel-leaving-no-stone-unturned> ;
    ns1:foundName "buy",
        "merge" ;
    ns1:name "buy",
        "merge" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2667366/O2_Uk> ;
    ns1:targetName "O2 UK" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2164290/Envivio_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-12-08T16:09:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The deal comes amid consolidation in the video infrastructure business - in September, for example, Ericsson (NASDAQ: ERIC) acquired Envivio for $ 125 million, while Amazon (NASDAQ: AMZN) paid $ 500 million for Elemental Technologies." ;
    ns1:documentTitle "IBM acquires Clearleap; Harmonic to buy Thomson Video Networks for $90 million" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/ibm-acquires-clearleap-harmonic-to-buy-thomson-video-networks-for-90-million> ;
    ns1:foundName "acquired",
        "paid" ;
    ns1:name "acquired",
        "paid" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2164290/Envivio> ;
    ns1:targetName "Envivio" ;
    ns1:valueRaw "$ 125 million",
        "$ 500 million" .

<https://1145.am/db/2166438/Comporium> a org:Organization ;
    ns1:basedInLowRaw "Clemson University" ;
    ns1:documentDate "2016-01-22T18:04:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aereo founder Kanojia set to take on cable Wi-Fi; Google paid Apple $1B in 2014 to stay in iOS search bar: report" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/aereo-founder-kanojia-set-to-take-cable-wi-fi-google-paid-apple-1b-2014-to-stay-ios-search> ;
    ns1:foundName "Comporium" ;
    ns1:investor <https://1145.am/db/2166438/Investment_Clemson_University_Comporium_Completed> ;
    ns1:name "Comporium" ;
    ns1:sameAsMedium <https://1145.am/db/1248788/Comporium>,
        <https://1145.am/db/1249178/Comporium>,
        <https://1145.am/db/1312763/Comporium>,
        <https://1145.am/db/1537326/Comporium>,
        <https://1145.am/db/1538669/Comporium>,
        <https://1145.am/db/1618222/Comporium>,
        <https://1145.am/db/1620191/Comporium>,
        <https://1145.am/db/1857887/Comporium>,
        <https://1145.am/db/2164273/Comporium> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2208603/McKesson_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Boston" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-09-18T15:58:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kyruus raises $25M in funding; BIDMC's John Halamka on the next big challenges for CIOs;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/kyruus-raises-25m-funding-bidmc-s-john-halamka-next-big-challenges-for-cios> ;
    ns1:foundName "McKesson Ventures" ;
    ns1:investor <https://1145.am/db/2208603/Investment_Kyruus_Mckesson_Ventures_New_Leaf_Venture_Partners_Providence_Health___Services_Completed> ;
    ns1:name "McKesson Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1018050/McKesson_Ventures>,
        <https://1145.am/db/2154031/McKesson_Ventures>,
        <https://1145.am/db/2184852/McKesson_Ventures>,
        <https://1145.am/db/2186148/McKesson_Ventures>,
        <https://1145.am/db/425188/McKesson_Ventures>,
        <https://1145.am/db/525844/McKesson_Ventures>,
        <https://1145.am/db/919784/McKesson_Ventures> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2304997/Dna_Diagnostics_Center> a org:Organization ;
    ns1:basedInLowRaw "London" ;
    ns1:description "testing" ;
    ns1:documentDate "2015-12-02T15:39:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Quotient Clinical snapped up by Gillings-founded buyout firm" ;
    ns1:documentURL <https://www.fiercebiotech.com/deals/quotient-clinical-snapped-up-by-gillings-founded-buyout-firm> ;
    ns1:foundName "DNA Diagnostics Center" ;
    ns1:industry "testing" ;
    ns1:name "DNA Diagnostics Center" ;
    ns1:sameAsHigh <https://1145.am/db/2327071/Dna_Diagnostics>,
        <https://1145.am/db/2587565/Dna_Diagnostics_Center>,
        <https://1145.am/db/2587566/Dna_Diagnostics> ;
    ns1:sameAsMedium <https://1145.am/db/2346331/Dna_Diagnostics_Center> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306945/Nitin_Lifesciences> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "Nitin Lifesciences" ;
    ns1:industry "biotech" ;
    ns1:name "Nitin Lifesciences" ;
    ns1:sameAsHigh <https://1145.am/db/2330623/Taris_Biomedical>,
        <https://1145.am/db/2590269/Taris_Biomedical> ;
    ns1:sameAsMedium <https://1145.am/db/2540508/Nitin_Lifesciences>,
        <https://1145.am/db/2540958/Nitin_Lifesciences>,
        <https://1145.am/db/2544071/Nitin_Lifesciences>,
        <https://1145.am/db/2544074/Nitin_Lifesciences>,
        <https://1145.am/db/2544452/Nitin_Lifesciences>,
        <https://1145.am/db/2546157/Nitin_Lifesciences>,
        <https://1145.am/db/2546440/Nitin_Lifesciences>,
        <https://1145.am/db/2547189/Nitin_Lifesciences>,
        <https://1145.am/db/2548222/Nitin_Lifesciences>,
        <https://1145.am/db/2564490/Nitin_Lifesciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306945/Nitin_Lifesciences_Stake_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2016-01-28T14:35:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Through the sale of Class B shares, Recipharm now has the capital it needs to take up a 74 % stake in Nitin Lifesciences, looking to wrap up a November agreement to buy a controlling share of the company for SEK 872 million ($ 105.2 million) ." ;
    ns1:documentTitle "Spotlight On... Recipharm looks to close a $105M deal; Analyst says biotech slump won't affect CROs; and much more..." ;
    ns1:documentURL <https://www.fiercebiotech.com/cro/spotlight-on-recipharm-looks-to-close-a-105m-deal-analyst-says-biotech-slump-won-t-affect-cros> ;
    ns1:foundName "buy",
        "take up" ;
    ns1:name "buy",
        "take up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2306945/Nitin_Lifesciences> ;
    ns1:targetDetails "share",
        "stake" ;
    ns1:targetName "Nitin Lifesciences" ;
    ns1:valueRaw "$ 105.2 million",
        "SEK 872 million" .

<https://1145.am/db/2316161/Microchips_Biotech> a org:Organization ;
    ns1:description "Biotech" ;
    ns1:documentDate "2015-07-01T15:57:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Dx whistleblower to share gains; Merck Serono launches latest Eeva test from Auxogyn;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/dx-whistleblower-to-share-gains-merck-serono-launches-latest-eeva-test-from-auxogyn> ;
    ns1:foundName "Microchips Biotech" ;
    ns1:name "Microchips Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/2155064/Microchips_Biotech>,
        <https://1145.am/db/2328031/Microchip_Biotechnologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Investment_Cleveland_Heartlab_And_Procter___Gamble_Hatteras_Venture_Partners_Malin_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Irish life sciences investment vehicle Malin has completed its first round of investment with two deals: the investment of $ 15 million to $ 20 million in Hatteras Venture Partners and the investment of up to $ 1 million in mobile healthcare technology company Jaan Health." ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2321694/Hatteras_Venture_Partners>,
        <https://1145.am/db/2321694/Jaan_Health> ;
    ns1:targetName "Hatteras Venture Partners",
        "Jaan Health" ;
    ns1:valueRaw "$ 15 million",
        "$ 20 million",
        "up to $ 1 million" ;
    ns1:whereGeoName "Irish" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5983801/about.rdf> ;
    ns1:whereRaw "Irish" .

<https://1145.am/db/2321694/Jaan_Health> a org:Organization ;
    ns1:basedInLowRaw "Irish" ;
    ns1:description "life sciences" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "Jaan Health" ;
    ns1:industry "healthcare technology" ;
    ns1:name "Jaan Health" ;
    ns1:sameAsHigh <https://1145.am/db/2369582/Jaan_Health> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2321694/Malin> a org:Organization ;
    ns1:basedInHighGeoName "Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:basedInHighRaw "Ireland" ;
    ns1:description "life sciences" ;
    ns1:documentDate "2015-08-24T15:53:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "DaVita buys Renal Ventures for $415M; Malin invests in Hatteras, Jaan;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/davita-buys-renal-ventures-for-415m-malin-invests-hatteras-jaan> ;
    ns1:foundName "Malin" ;
    ns1:industry "life sciences" ;
    ns1:investor <https://1145.am/db/2321694/Investment_Cleveland_Heartlab_And_Procter___Gamble_Hatteras_Venture_Partners_Malin_Completed>,
        <https://1145.am/db/2321694/Investment_Jaan_Health_Malin_Completed> ;
    ns1:name "Malin" ;
    ns1:sameAsHigh <https://1145.am/db/2075754/Malin_Corporation>,
        <https://1145.am/db/2319397/Malin>,
        <https://1145.am/db/2337627/Malin_Corporation>,
        <https://1145.am/db/2337633/Malin_Corporation>,
        <https://1145.am/db/2342975/Malin>,
        <https://1145.am/db/2351298/Malin>,
        <https://1145.am/db/2369576/Malin>,
        <https://1145.am/db/2539516/Malin>,
        <https://1145.am/db/2569496/Malin> ;
    ns1:sameAsMedium <https://1145.am/db/1503165/Malin_Corporation>,
        <https://1145.am/db/2292715/Malin>,
        <https://1145.am/db/2292738/Malin>,
        <https://1145.am/db/2368319/Malin>,
        <https://1145.am/db/2368321/Malin_Corporation>,
        <https://1145.am/db/2369582/Malin> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2323825/Investment_Delphinus_Medical_Technologies_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-10T14:00:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Now, startup Delphinus Medical Technologies has raised $ 39.5 million to support a pivotal trial of its ultrasound breast cancer system, SoftVue." ;
    ns1:documentTitle "Delphinus raises $39M+ to back pivotal trial of more effective dense breast tissue ultrasound imaging" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/delphinus-raises-39m-to-back-pivotal-trial-more-effective-dense-breast-tissue> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2323825/Delphinus_Medical_Technologies>,
        <https://1145.am/db/2323825/Softvue> ;
    ns1:targetName "SoftVue" ;
    ns1:valueRaw "$ 39.5 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2328288/San_Francisco-Verge_Genomics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "SAN FRANCISCO" ;
    ns1:description "Biopharmaceutical company",
        "accelerating drug development for neurodegenerative diseases" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "SAN FRANCISCO-Verge Genomics, Inc",
        "SAN FRANCISCO-Verge Genomics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "SAN FRANCISCO-Verge Genomics, Inc",
        "SAN FRANCISCO-Verge Genomics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1422547/Verge_Genomics>,
        <https://1145.am/db/1423293/Verge_Genomics>,
        <https://1145.am/db/1556632/Verge_Genomics>,
        <https://1145.am/db/1810710/Verge_Genomics>,
        <https://1145.am/db/2279118/Verge_Genomics>,
        <https://1145.am/db/2328288/Verge_Genomics>,
        <https://1145.am/db/505340/Verge_Genomics>,
        <https://1145.am/db/815461/Verge_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2328288/Verge_Genomics> a org:Organization ;
    ns1:description "developing treatments for neurodegenerative diseases" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Verge Genomics",
        "Verge Genomics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Verge Genomics" ;
    ns1:sameAsHigh <https://1145.am/db/1422547/Verge_Genomics>,
        <https://1145.am/db/1423293/Verge_Genomics>,
        <https://1145.am/db/1556632/Verge_Genomics>,
        <https://1145.am/db/1810710/Verge_Genomics>,
        <https://1145.am/db/2279118/Verge_Genomics>,
        <https://1145.am/db/2328288/San_Francisco-Verge_Genomics_Inc>,
        <https://1145.am/db/505340/Verge_Genomics>,
        <https://1145.am/db/815461/Verge_Genomics> ;
    ns1:sameAsMedium <https://1145.am/db/2293377/Verge_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332441/Harpoon_Medical_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-12-09T16:52:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Just as the flurry of M & A activity in the transcatheter mitral valve replacement arena appears to be dying down, with nearly all of the developers snapped up by industry bigwigs, TAVR pioneer Edwards Lifesciences ($ EW) is threatening to start a run on related minimally invasive mitral valve repair players too, thanks to the announcement of its exclusive option to acquire Baltimore's Harpoon Medical." ;
    ns1:documentTitle "Edwards grabs option to acquire transcatheter mitral valve repair startup" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/edwards-grabs-option-to-acquire-transcatheter-mitral-valve-repair-startup> ;
    ns1:foundName "acquire",
        "investment" ;
    ns1:name "acquire",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2332441/Harpoon_Medical> ;
    ns1:targetName "Harpoon Medical" ;
    ns1:whereGeoName "Baltimore County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4347790/about.rdf> ;
    ns1:whereRaw "Baltimore" .

<https://1145.am/db/2367519/Investment_Ali_Partovi_New_Protein_Capital_Nuritas_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-26T15:15:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Dublin, Ireland, October 26th - Nuritas, a start-up using artificial intelligence that is reinventing therapeutics discovery, announced a $ 3.2 million financing, the highest initial investment ever raised by an Irish company operating in this space." ;
    ns1:documentTitle "Nuritas sets Irish record with $3.2M first round financing led by New Protein Capital" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nuritas-sets-irish-record-3-2m-first-round-financing-led-by-new-protein-capital> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367519/Nuritas> ;
    ns1:valueRaw "$ 3.2 million" ;
    ns1:when "2015-10-26T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 26th" ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2367675/Avalon_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Avalon Ventures" ;
    ns1:investor <https://1145.am/db/2367675/Series_A_Investment_Ankasa_Regenerative_Therapeutics_Avalon_Ventures_Correlation_Ventures_Heraeus_Medical_Heraeus_Of_Hanau_Completed> ;
    ns1:name "Avalon Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1731233/Avalon_Ventures>,
        <https://1145.am/db/1783415/Avalon_Ventures>,
        <https://1145.am/db/1788701/Avalon_Ventures>,
        <https://1145.am/db/1830629/Avalon_Ventures>,
        <https://1145.am/db/1833567/Avalon_Ventures>,
        <https://1145.am/db/1835195/Avalon_Ventures>,
        <https://1145.am/db/1837950/Avalon_Ventures>,
        <https://1145.am/db/1841070/Avalon_Ventures>,
        <https://1145.am/db/1853099/Avalon_Ventures>,
        <https://1145.am/db/1872954/Avalon_Ventures>,
        <https://1145.am/db/1875916/Avalon_Ventures>,
        <https://1145.am/db/1889400/Avalon_Ventures>,
        <https://1145.am/db/1919661/Avalon_Ventures>,
        <https://1145.am/db/2156284/Avalon_Ventures>,
        <https://1145.am/db/2178960/Avalon_Ventures>,
        <https://1145.am/db/2293612/Avalon_Ventures>,
        <https://1145.am/db/2295967/Avalon_Ventures>,
        <https://1145.am/db/2298395/Avalon_Ventures>,
        <https://1145.am/db/2308758/Avalon_Ventures>,
        <https://1145.am/db/2321216/Avalon_Ventures>,
        <https://1145.am/db/2326130/Avalon_Ventures>,
        <https://1145.am/db/2326139/Avalon_Ventures>,
        <https://1145.am/db/2335943/Avalon_Ventures>,
        <https://1145.am/db/2336221/Avalon_Ventures>,
        <https://1145.am/db/2343765/Avalon_Ventures>,
        <https://1145.am/db/2345299/Avalon_Ventures>,
        <https://1145.am/db/2345318/Avalon_Ventures>,
        <https://1145.am/db/2359510/Avalon_Ventures>,
        <https://1145.am/db/2362475/Avalon_Ventures>,
        <https://1145.am/db/2366744/Avalon_Ventures>,
        <https://1145.am/db/2367673/Avalon_Ventures>,
        <https://1145.am/db/2367676/Avalon_Ventures>,
        <https://1145.am/db/2368351/Avalon_Ventures>,
        <https://1145.am/db/935242/Avalon_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367740/Atlas_Venture> a org:Organization ;
    ns1:basedInHighGeoName "Boulder County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5574999/about.rdf> ;
    ns1:basedInHighRaw "Boulder, Colorado" ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1752961/Atlassian_Ventures>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2250347/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2357928/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2369718/Atlas_Venture>,
        <https://1145.am/db/2370540/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/819502/Atlas_Ventures>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sameAsMedium <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354307/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2357905/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361022/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367782/Celladon_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:description "Research and development" ;
    ns1:documentDate "2015-06-26T10:43:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Celladon Corporation Provides Business Update" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/celladon-corporation-provides-business-update> ;
    ns1:foundName "Celladon Corporation" ;
    ns1:name "Celladon Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2312551/Celladon_Corporation>,
        <https://1145.am/db/2343563/Celladon_Corporation>,
        <https://1145.am/db/2344637/Celladon_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/2312417/Celladon>,
        <https://1145.am/db/2336269/Celladon_Corporation>,
        <https://1145.am/db/2338527/Celladon_Corporation>,
        <https://1145.am/db/2338528/Celladon>,
        <https://1145.am/db/2355590/Celladon>,
        <https://1145.am/db/2358615/Celladon_Corporation>,
        <https://1145.am/db/2358620/Celladon_Corporation>,
        <https://1145.am/db/2367991/Celladon> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367846/Investment_Bpifrance_Crossject_Industrial_Projects_Of_The_Future_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-12T20:15:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CROSSJECT secures 6.7 million in funding for the development of three new drugs.",
        "Chenve, France - November 6, 2015, 8.30am - CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ) , specialty pharma company specialized in self-injectable drugs for use in emergency situations, announces that it has been awarded by Bpifrance a refundable grant of 6.7 million, over three years, as part of the Industrial Projects of the Future (Projets Industriels d'Avenir or PIAVE) scheme." ;
    ns1:documentTitle "CROSSJECT secures 6.7 million in funding for the development of three new drugs" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/crossject-secures-%E2%82%AC6-7-million-funding-for-development-of-three-new-drugs> ;
    ns1:foundName "awarded",
        "grant" ;
    ns1:name "awarded",
        "grant" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2367846/Crossject> ;
    ns1:valueRaw "6.7 million" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2367969/Investment_Andrew_Saik_Warburg_Pincus_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-18T16:11:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW YORK /PRNewswire/ - Pharmaceutical industry veterans Don DeGolyer and Andrew Saik today announced that they have launched Vertice Pharma, LLC (\"Vertice Pharma\" or \"the Company\") in partnership with Warburg Pincus, a global private equity firm focused on growth investing." ;
    ns1:documentTitle "Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pharma-industry-veterans-launch-vertice-pharma-partnership-warburg-pincus-announce> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "New York City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:whereRaw "NEW YORK" .

<https://1145.am/db/2368319/Immunocore> a org:Organization ;
    ns1:basedInHighGeoName "Oxford" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2640729/about.rdf> ;
    ns1:basedInHighRaw "Oxford" ;
    ns1:description "T cell receptors" ;
    ns1:documentDate "2015-07-16T11:22:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: T-cell pioneer Immunocore scores a record-breaking $320M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-t-cell-pioneer-immunocore-scores-a-record-breaking-320m-round> ;
    ns1:foundName "Immunocore" ;
    ns1:name "Immunocore" ;
    ns1:sameAsHigh <https://1145.am/db/2368317/Immunocore> ;
    ns1:sameAsMedium <https://1145.am/db/2154218/Immunocore>,
        <https://1145.am/db/2154309/Immunocore>,
        <https://1145.am/db/2293727/Immunocore>,
        <https://1145.am/db/2312679/Immunocore_Limited>,
        <https://1145.am/db/2327416/Immunocore_Ltd>,
        <https://1145.am/db/2327421/Immunocore>,
        <https://1145.am/db/2336314/Immunocore>,
        <https://1145.am/db/2344006/Immunocore_Limited>,
        <https://1145.am/db/2353255/Immunocore>,
        <https://1145.am/db/2358194/Immunocore_Limited>,
        <https://1145.am/db/2360440/Immunocore>,
        <https://1145.am/db/2368321/Immunocore>,
        <https://1145.am/db/2368581/Immunocore>,
        <https://1145.am/db/2368735/Immunocore>,
        <https://1145.am/db/2368769/Immunocore_Limited> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368319/Investment_Immunocore_Malin_Woodford_Investment_Management_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T11:22:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In another example of the big bets being made on reengineering T cells to attack cancer, Oxford, U.K. - based Immunocore has come up with a monster $ 320 million venture round designed to push the pipeline well past positive early-stage data for its lead therapy." ;
    ns1:documentTitle "UPDATED: T-cell pioneer Immunocore scores a record-breaking $320M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-t-cell-pioneer-immunocore-scores-a-record-breaking-320m-round> ;
    ns1:foundName "venture" ;
    ns1:name "venture" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2368319/Immunocore> ;
    ns1:valueRaw "$ 320 million" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "U.K." .

<https://1145.am/db/2368319/Malin> a org:Organization ;
    ns1:basedInLowRaw "U.K." ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-07-16T11:22:38+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UPDATED: T-cell pioneer Immunocore scores a record-breaking $320M round" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/updated-t-cell-pioneer-immunocore-scores-a-record-breaking-320m-round> ;
    ns1:foundName "Malin" ;
    ns1:investor <https://1145.am/db/2368319/Investment_Immunocore_Malin_Woodford_Investment_Management_Has_Not_Happened> ;
    ns1:name "Malin" ;
    ns1:sameAsHigh <https://1145.am/db/1503165/Malin_Corporation>,
        <https://1145.am/db/2359662/Malin_Corporation_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/2075754/Malin_Corporation>,
        <https://1145.am/db/2292715/Malin>,
        <https://1145.am/db/2292738/Malin>,
        <https://1145.am/db/2319397/Malin>,
        <https://1145.am/db/2321694/Malin>,
        <https://1145.am/db/2337627/Malin_Corporation>,
        <https://1145.am/db/2337633/Malin_Corporation>,
        <https://1145.am/db/2342975/Malin>,
        <https://1145.am/db/2351298/Malin>,
        <https://1145.am/db/2368321/Malin_Corporation>,
        <https://1145.am/db/2369576/Malin>,
        <https://1145.am/db/2369582/Malin>,
        <https://1145.am/db/2539516/Malin>,
        <https://1145.am/db/2569496/Malin> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368321/Eli_Lilly_And_Company> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "financing" ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "Eli Lilly and Company" ;
    ns1:investor <https://1145.am/db/2368321/Investment_Eli_Lilly_And_Company_Immunocore_Malin_Corporation_Rtw_Investments_Woodford_Investment_Management_Completed> ;
    ns1:name "Eli Lilly and Company" ;
    ns1:sameAsMedium <https://1145.am/db/1038901/Eli_Lilly_And_Company>,
        <https://1145.am/db/1072187/Eli_Lilly_And_Company>,
        <https://1145.am/db/1087869/Eli_Lilly_And_Company>,
        <https://1145.am/db/1121894/Eli_Lilly_And_Company>,
        <https://1145.am/db/1217359/Eli_Lilly_And_Company>,
        <https://1145.am/db/1272276/Eli_Lilly_And_Company>,
        <https://1145.am/db/1340338/Eli_Lilly_And_Company>,
        <https://1145.am/db/1425255/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Eli_Lilly_And_Company>,
        <https://1145.am/db/1432746/Eli_Lilly>,
        <https://1145.am/db/1534004/Eli_Lilly_And_Company>,
        <https://1145.am/db/1534438/Eli_Lilly_And_Company>,
        <https://1145.am/db/1546070/Eli_Lilly_And_Company>,
        <https://1145.am/db/1553175/Eli_Lilly___Company>,
        <https://1145.am/db/1553459/Eli_Lilly___Company>,
        <https://1145.am/db/1663572/Eli_Lilly_And_Company>,
        <https://1145.am/db/1979697/Eli_Lilly>,
        <https://1145.am/db/1984558/Eli_Lilly_And_Company>,
        <https://1145.am/db/2045539/Eli_Lilly_And_Company>,
        <https://1145.am/db/2055009/Eli_Lilly_And_Company>,
        <https://1145.am/db/2058865/Eli_Lilly_And_Company>,
        <https://1145.am/db/2062260/Eli_Lilly>,
        <https://1145.am/db/2065629/Eli_Lilly_And_Company>,
        <https://1145.am/db/2109798/Eli_Lilly_And_Company>,
        <https://1145.am/db/2139015/Eli_Lilly_And_Company>,
        <https://1145.am/db/2154037/Eli_Lilly>,
        <https://1145.am/db/2154391/Eli_Lilly>,
        <https://1145.am/db/2279118/Eli_Lilly>,
        <https://1145.am/db/2280616/Eli_Lilly>,
        <https://1145.am/db/2281211/Eli_Lilly>,
        <https://1145.am/db/2282739/Eli_Lilly>,
        <https://1145.am/db/2282930/Eli_Lilly>,
        <https://1145.am/db/2283595/Eli_Lilly>,
        <https://1145.am/db/2285156/Eli_Lilly>,
        <https://1145.am/db/2285189/Eli_Lilly>,
        <https://1145.am/db/2285525/Eli_Lilly>,
        <https://1145.am/db/2286126/Eli_Lilly>,
        <https://1145.am/db/2286379/Eli_Lilly>,
        <https://1145.am/db/2286402/Eli_Lilly>,
        <https://1145.am/db/2286404/Eli_Lilly>,
        <https://1145.am/db/2286617/Eli_Lilly>,
        <https://1145.am/db/2286911/Eli_Lilly>,
        <https://1145.am/db/2286998/Eli_Lilly>,
        <https://1145.am/db/2287005/Eli_Lilly>,
        <https://1145.am/db/2288158/Eli_Lilly>,
        <https://1145.am/db/229232/Eli_Lilly>,
        <https://1145.am/db/2294118/Eli_Lilly>,
        <https://1145.am/db/2298022/Eli_Lilly>,
        <https://1145.am/db/2299157/Eli_Lilly>,
        <https://1145.am/db/2301879/Eli_Lilly_And_Company>,
        <https://1145.am/db/2302104/Eli_Lilly_And_Company>,
        <https://1145.am/db/2304319/Eli_Lilly_And_Company>,
        <https://1145.am/db/2305497/Eli_Lilly>,
        <https://1145.am/db/2305501/Eli_Lilly_And_Company>,
        <https://1145.am/db/2306807/Eli_Lilly_And_Company>,
        <https://1145.am/db/2307651/Eli_Lilly>,
        <https://1145.am/db/2309473/Eli_Lilly>,
        <https://1145.am/db/2309599/Eli_Lilly>,
        <https://1145.am/db/2310738/Eli_Lilly>,
        <https://1145.am/db/2314412/Eli_Lilly_And_Company>,
        <https://1145.am/db/2315325/Eli_Lilly>,
        <https://1145.am/db/2316092/Eli_Lilly>,
        <https://1145.am/db/2316549/Eli_Lilly>,
        <https://1145.am/db/2317682/Eli_Lilly>,
        <https://1145.am/db/2318587/Eli_Lilly>,
        <https://1145.am/db/2320006/Eli_Lilly>,
        <https://1145.am/db/2320338/Eli_Lilly>,
        <https://1145.am/db/2322619/Eli_Lilly_And_Company>,
        <https://1145.am/db/2323165/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325557/Eli_Lilly_And_Company>,
        <https://1145.am/db/2327587/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328522/Eli_Lilly>,
        <https://1145.am/db/2328527/Eli_Lilly>,
        <https://1145.am/db/2328554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328633/Eli_Lilly>,
        <https://1145.am/db/2328718/Eli_Lilly>,
        <https://1145.am/db/2329114/Eli_Lilly>,
        <https://1145.am/db/2329915/Eli_Lilly_And_Company>,
        <https://1145.am/db/2334645/Eli_Lilly>,
        <https://1145.am/db/2335594/Eli_Lilly_And_Company>,
        <https://1145.am/db/2336074/Eli_Lilly_And_Company>,
        <https://1145.am/db/2338059/Eli_Lilly>,
        <https://1145.am/db/2340948/Eli_Lilly>,
        <https://1145.am/db/2341481/Eli_Lilly>,
        <https://1145.am/db/2341496/Eli_Lilly>,
        <https://1145.am/db/2342503/Eli_Lilly_And_Company>,
        <https://1145.am/db/2343945/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344800/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344808/Eli_Lilly>,
        <https://1145.am/db/2344991/Eli_Lilly>,
        <https://1145.am/db/2345213/Eli_Lilly>,
        <https://1145.am/db/2345214/Eli_Lilly>,
        <https://1145.am/db/2349001/Eli_Lilly_And_Company>,
        <https://1145.am/db/2349020/Eli_Lilly_And_Company>,
        <https://1145.am/db/2349300/Eli_Lilly_And_Company>,
        <https://1145.am/db/2352358/Eli_Lilly>,
        <https://1145.am/db/2353350/Eli_Lilly>,
        <https://1145.am/db/2354761/Eli_Lilly_And_Company>,
        <https://1145.am/db/2354853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2359240/Eli_Lilly>,
        <https://1145.am/db/2360338/Eli_Lilly>,
        <https://1145.am/db/2361027/Eli_Lilly>,
        <https://1145.am/db/2361510/Eli_Lilly>,
        <https://1145.am/db/2364605/Eli_Lilly>,
        <https://1145.am/db/2365178/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366948/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366953/Eli_Lilly_And_Company>,
        <https://1145.am/db/2368562/Eli_Lilly_And_Company>,
        <https://1145.am/db/2369000/Eli_Lilly_And_Company>,
        <https://1145.am/db/2370162/Eli_Lilly>,
        <https://1145.am/db/2371016/Eli_Lilly>,
        <https://1145.am/db/2371058/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Eli_Lilly_And_Company>,
        <https://1145.am/db/2536960/Eli_Lilly>,
        <https://1145.am/db/2537335/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537665/Eli_Lilly>,
        <https://1145.am/db/2537666/Eli_Lilly>,
        <https://1145.am/db/2537817/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537826/Eli_Lilly_And_Company>,
        <https://1145.am/db/2539287/Eli_Lilly>,
        <https://1145.am/db/2539970/Eli_Lilly>,
        <https://1145.am/db/2543185/Eli_Lilly>,
        <https://1145.am/db/2545618/Eli_Lilly>,
        <https://1145.am/db/2549450/Eli_Lilly>,
        <https://1145.am/db/2550996/Eli_Lilly>,
        <https://1145.am/db/2551049/Eli_Lilly>,
        <https://1145.am/db/2551101/Eli_Lilly>,
        <https://1145.am/db/2553131/Eli_Lilly>,
        <https://1145.am/db/2553551/Eli_Lilly>,
        <https://1145.am/db/2556906/Eli_Lilly_And_Company>,
        <https://1145.am/db/2556969/Eli_Lilly>,
        <https://1145.am/db/2559125/Eli_Lilly_And_Company>,
        <https://1145.am/db/2560025/Eli_Lilly>,
        <https://1145.am/db/2560487/Eli_Lilly>,
        <https://1145.am/db/2561357/Eli_Lilly>,
        <https://1145.am/db/2561960/Eli_Lilly>,
        <https://1145.am/db/2562442/Eli_Lilly>,
        <https://1145.am/db/2562576/Eli_Lilly>,
        <https://1145.am/db/2562999/Eli_Lilly>,
        <https://1145.am/db/2564389/Eli_Lilly___Co>,
        <https://1145.am/db/2567343/Eli_Lilly>,
        <https://1145.am/db/2569829/Eli_Lilly>,
        <https://1145.am/db/2569849/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572312/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572711/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572957/Eli_Lilly_And_Company>,
        <https://1145.am/db/2573885/Eli_Lilly>,
        <https://1145.am/db/2574950/Eli_Lilly>,
        <https://1145.am/db/2575554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2575909/Eli_Lilly>,
        <https://1145.am/db/2575947/Eli_Lilly>,
        <https://1145.am/db/2575972/Eli_Lilly>,
        <https://1145.am/db/2576086/Eli_Lilly>,
        <https://1145.am/db/2576171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576460/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576462/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576858/Eli_Lilly___Co>,
        <https://1145.am/db/2576892/Eli_Lilly>,
        <https://1145.am/db/2576933/Eli_Lilly>,
        <https://1145.am/db/2576939/Eli_Lilly>,
        <https://1145.am/db/2576944/Eli_Lilly>,
        <https://1145.am/db/2577171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578048/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578603/Eli_Lilly>,
        <https://1145.am/db/2578874/Eli_Lilly>,
        <https://1145.am/db/2578876/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581745/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581804/Eli_Lilly>,
        <https://1145.am/db/2583703/Eli_Lilly>,
        <https://1145.am/db/2584135/Eli_Lilly>,
        <https://1145.am/db/2584766/Eli_Lilly_And_Company>,
        <https://1145.am/db/2585144/Eli_Lilly_And_Company>,
        <https://1145.am/db/2585710/Eli_Lilly>,
        <https://1145.am/db/2586687/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587215/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587605/Eli_Lilly>,
        <https://1145.am/db/2587690/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587699/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589156/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589535/Eli_Lilly>,
        <https://1145.am/db/2589700/Eli_Lilly>,
        <https://1145.am/db/2590071/Eli_Lilly_And_Company>,
        <https://1145.am/db/2590486/Eli_Lilly>,
        <https://1145.am/db/2590997/Eli_Lilly_And_Company>,
        <https://1145.am/db/2591001/Eli_Lilly>,
        <https://1145.am/db/2591708/Eli_Lilly_And_Company>,
        <https://1145.am/db/2593456/Eli_Lilly_And_Company>,
        <https://1145.am/db/2593780/Eli_Lilly>,
        <https://1145.am/db/2594485/Eli_Lilly_And_Company>,
        <https://1145.am/db/2594494/Eli_Lilly_And_Company>,
        <https://1145.am/db/2596644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597855/Eli_Lilly_And_Company>,
        <https://1145.am/db/2598317/Eli_Lilly>,
        <https://1145.am/db/461671/Eli_Lilly_And_Company>,
        <https://1145.am/db/768105/Eli_Lilly> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368321/Immunocore> a org:Organization ;
    ns1:basedInLowRaw "Europe" ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "Immunocore",
        "Immunocore Limited" ;
    ns1:industry "Life Sciences" ;
    ns1:name "Immunocore" ;
    ns1:sameAsHigh <https://1145.am/db/1115410/Immunomic_Therapeutics>,
        <https://1145.am/db/1116896/Immunomic_Therapeutics>,
        <https://1145.am/db/1186457/Immunic_Inc>,
        <https://1145.am/db/12026/Inmune_Bio>,
        <https://1145.am/db/1258391/Immunis_Inc>,
        <https://1145.am/db/1319236/Immunomic_Therapeutics>,
        <https://1145.am/db/1319455/Immunomic_Therapeutics>,
        <https://1145.am/db/1387524/Immunovant_Inc>,
        <https://1145.am/db/1756708/Immunai>,
        <https://1145.am/db/1969682/Immunis_Inc>,
        <https://1145.am/db/2052967/Immunome>,
        <https://1145.am/db/2129022/Immunis_Inc>,
        <https://1145.am/db/2133590/Immunome>,
        <https://1145.am/db/2152852/Immungene>,
        <https://1145.am/db/2153222/Immunomedics>,
        <https://1145.am/db/2153776/Immunomedics>,
        <https://1145.am/db/2154202/Immunochina>,
        <https://1145.am/db/2154218/Immunocore>,
        <https://1145.am/db/2282705/Immunorizon>,
        <https://1145.am/db/2291286/Immunomedics>,
        <https://1145.am/db/2293593/Immunic>,
        <https://1145.am/db/2298103/Medimmune>,
        <https://1145.am/db/2301244/Immunomet>,
        <https://1145.am/db/2304367/Immunogen>,
        <https://1145.am/db/2311024/Medimmune>,
        <https://1145.am/db/2314828/Immunomedics>,
        <https://1145.am/db/2315716/Medimmune>,
        <https://1145.am/db/2318484/Medimmune>,
        <https://1145.am/db/2319795/Immunogen>,
        <https://1145.am/db/2329497/Immunogen>,
        <https://1145.am/db/2335811/Immunogen>,
        <https://1145.am/db/2336065/Immunocellular>,
        <https://1145.am/db/2336314/Immunocore>,
        <https://1145.am/db/2341707/Immunogen>,
        <https://1145.am/db/2342707/Immunogen>,
        <https://1145.am/db/2343914/Immunovative_Inc>,
        <https://1145.am/db/2346963/Immunomedics_Inc>,
        <https://1145.am/db/2347940/Immunogen>,
        <https://1145.am/db/2347971/Medimmune>,
        <https://1145.am/db/2348009/Immunogen>,
        <https://1145.am/db/2349946/Immunogen>,
        <https://1145.am/db/2350060/Immunomedics>,
        <https://1145.am/db/2350971/Immunogen>,
        <https://1145.am/db/2351493/Immunaid_Pty_Ltd>,
        <https://1145.am/db/2352002/Immunogen>,
        <https://1145.am/db/2352243/Immunogen>,
        <https://1145.am/db/2352311/Immunomic_Therapeutics>,
        <https://1145.am/db/2352315/Immunomic_Therapeutics>,
        <https://1145.am/db/2353255/Immunocore>,
        <https://1145.am/db/2354135/Immunome_Inc>,
        <https://1145.am/db/2358194/Immunocore_Limited>,
        <https://1145.am/db/2359439/Medimmune>,
        <https://1145.am/db/2363638/Immungene>,
        <https://1145.am/db/2368317/Immunocore>,
        <https://1145.am/db/2368581/Immunocore>,
        <https://1145.am/db/2368735/Immunocore>,
        <https://1145.am/db/2368769/Immunocore_Limited>,
        <https://1145.am/db/2368876/Immunome>,
        <https://1145.am/db/2369455/Immunomedics_Inc>,
        <https://1145.am/db/2370724/Immunome>,
        <https://1145.am/db/2540845/Immunomedics>,
        <https://1145.am/db/2541039/Medimmune>,
        <https://1145.am/db/2545023/Medimmune>,
        <https://1145.am/db/2548940/Immunomedics>,
        <https://1145.am/db/2593020/Immunogen>,
        <https://1145.am/db/2799029/Immunome>,
        <https://1145.am/db/315940/Immunome>,
        <https://1145.am/db/378615/Immunomic_Therapeutics>,
        <https://1145.am/db/381061/Immunic_Inc>,
        <https://1145.am/db/440446/Immunicom>,
        <https://1145.am/db/441762/Immunicom>,
        <https://1145.am/db/441770/Immunicom>,
        <https://1145.am/db/491886/Immunogen_Inc>,
        <https://1145.am/db/492917/Immunogen_Inc>,
        <https://1145.am/db/530654/Immunicom>,
        <https://1145.am/db/532221/Immunicom>,
        <https://1145.am/db/627880/Immunogen_Inc>,
        <https://1145.am/db/75577/Immunomic_Therapeutics>,
        <https://1145.am/db/837533/Immunicom_Inc>,
        <https://1145.am/db/842538/Immunicom_Inc>,
        <https://1145.am/db/866952/Immunicom>,
        <https://1145.am/db/868903/Immunicom>,
        <https://1145.am/db/873778/Immunicom_Inc>,
        <https://1145.am/db/874777/Immunicom>,
        <https://1145.am/db/970255/Immunicom>,
        <https://1145.am/db/973655/Immunicom> ;
    ns1:sameAsMedium <https://1145.am/db/2154309/Immunocore>,
        <https://1145.am/db/2293727/Immunocore>,
        <https://1145.am/db/2312679/Immunocore_Limited>,
        <https://1145.am/db/2327416/Immunocore_Ltd>,
        <https://1145.am/db/2327421/Immunocore>,
        <https://1145.am/db/2344006/Immunocore_Limited>,
        <https://1145.am/db/2360440/Immunocore>,
        <https://1145.am/db/2368319/Immunocore> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368321/Malin_Corporation> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "financing" ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "Malin Corporation plc" ;
    ns1:investor <https://1145.am/db/2368321/Investment_Eli_Lilly_And_Company_Immunocore_Malin_Corporation_Rtw_Investments_Woodford_Investment_Management_Completed> ;
    ns1:name "Malin Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2342972/Malin_Corporation_Plc>,
        <https://1145.am/db/2569498/Malin_Corporation_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/1503165/Malin_Corporation>,
        <https://1145.am/db/2075754/Malin_Corporation>,
        <https://1145.am/db/2292715/Malin>,
        <https://1145.am/db/2292738/Malin>,
        <https://1145.am/db/2319397/Malin>,
        <https://1145.am/db/2321694/Malin>,
        <https://1145.am/db/2337627/Malin_Corporation>,
        <https://1145.am/db/2337633/Malin_Corporation>,
        <https://1145.am/db/2342975/Malin>,
        <https://1145.am/db/2351298/Malin>,
        <https://1145.am/db/2368319/Malin>,
        <https://1145.am/db/2369576/Malin>,
        <https://1145.am/db/2369582/Malin>,
        <https://1145.am/db/2539516/Malin>,
        <https://1145.am/db/2569496/Malin> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Foresite_Capital> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS, Calif" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "Foresite Capital" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "Foresite Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1061824/Foresite_Capital>,
        <https://1145.am/db/1411936/Foresite_Capital>,
        <https://1145.am/db/1412727/Foresite_Capital>,
        <https://1145.am/db/1664837/Foresite_Capital>,
        <https://1145.am/db/1745868/Foresite_Capital>,
        <https://1145.am/db/1747873/Foresite_Capital>,
        <https://1145.am/db/1750470/Foresite_Capital>,
        <https://1145.am/db/2075754/Foresite_Capital>,
        <https://1145.am/db/2129215/Foresite_Capital>,
        <https://1145.am/db/2153988/Foresite_Capital>,
        <https://1145.am/db/2155146/Foresite_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2181257/Foresite_Capital>,
        <https://1145.am/db/2198816/Foresite_Capital>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2291403/Foresite_Capital>,
        <https://1145.am/db/2292554/Foresite_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2339214/Foresite_Capital>,
        <https://1145.am/db/2339223/Foresite_Capital>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2345273/Foresite_Capital>,
        <https://1145.am/db/2361416/Foresite_Capital>,
        <https://1145.am/db/2361422/Foresite_Capital>,
        <https://1145.am/db/2361424/Foresite_Capital>,
        <https://1145.am/db/2364496/Foresite_Capital>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370436/Foresite_Capital>,
        <https://1145.am/db/2371160/Foresite_Capital>,
        <https://1145.am/db/2371163/Foresite_Capital>,
        <https://1145.am/db/248626/Foresite_Capital>,
        <https://1145.am/db/595702/Foresite_Capital>,
        <https://1145.am/db/694272/Foresite_Capital>,
        <https://1145.am/db/745407/Foresite_Capital>,
        <https://1145.am/db/873820/Foresite_Capital>,
        <https://1145.am/db/874843/Foresite_Capital>,
        <https://1145.am/db/884787/Foresite_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368322/Ra_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "MILPITAS" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "RA Capital Management" ;
    ns1:investor <https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> ;
    ns1:name "RA Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1134574/Ra_Capital_Management_Lp>,
        <https://1145.am/db/1164709/Ra_Capital_Management>,
        <https://1145.am/db/1166452/Ra_Capital_Management>,
        <https://1145.am/db/1198548/Ra_Capital_Management>,
        <https://1145.am/db/1219334/Ra_Capital_Management>,
        <https://1145.am/db/1219771/Ra_Capital_Management>,
        <https://1145.am/db/1293978/Ra_Capital_Management>,
        <https://1145.am/db/1294718/Ra_Capital_Management>,
        <https://1145.am/db/1334624/Ra_Capital_Management>,
        <https://1145.am/db/1503165/Ra_Capital_Management>,
        <https://1145.am/db/1735850/Ra_Capital_Management>,
        <https://1145.am/db/1926411/Ra_Capital_Management>,
        <https://1145.am/db/1928388/Ra_Capital_Management>,
        <https://1145.am/db/2011094/Ra_Capital_Management>,
        <https://1145.am/db/2075754/Ra_Capital_Management>,
        <https://1145.am/db/2089412/Ra_Capital_Management>,
        <https://1145.am/db/2109798/Ra_Capital_Management>,
        <https://1145.am/db/2153910/Ra_Capital_Management>,
        <https://1145.am/db/2155505/Ra_Capital_Management>,
        <https://1145.am/db/2280400/Ra_Capital_Management>,
        <https://1145.am/db/2282268/Ra_Capital_Management>,
        <https://1145.am/db/2282806/Ra_Capital_Management>,
        <https://1145.am/db/2285762/Ra_Capital_Management>,
        <https://1145.am/db/2286204/Ra_Capital_Management>,
        <https://1145.am/db/2298395/Ra_Capital_Management>,
        <https://1145.am/db/2298642/Ra_Capital_Management>,
        <https://1145.am/db/2335743/Ra_Capital_Management>,
        <https://1145.am/db/2336510/Ra_Capital_Management>,
        <https://1145.am/db/2336511/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2336957/Ra_Capital_Management>,
        <https://1145.am/db/2337599/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2338126/Ra_Capital_Management>,
        <https://1145.am/db/2338127/Ra_Capital_Management>,
        <https://1145.am/db/2339214/Ra_Capital_Management>,
        <https://1145.am/db/2339223/Ra_Capital_Management>,
        <https://1145.am/db/2339666/Ra_Capital_Management>,
        <https://1145.am/db/2340942/Ra_Capital_Management>,
        <https://1145.am/db/2346773/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2346775/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2347043/Ra_Capital_Management>,
        <https://1145.am/db/2348149/Ra_Capital_Management>,
        <https://1145.am/db/2355029/Ra_Capital_Management>,
        <https://1145.am/db/2356216/Ra_Capital_Management>,
        <https://1145.am/db/2357144/Ra_Capital_Management>,
        <https://1145.am/db/2357566/Ra_Capital_Management>,
        <https://1145.am/db/2360277/Ra_Capital_Management>,
        <https://1145.am/db/2360682/Ra_Capital_Management>,
        <https://1145.am/db/2363391/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2363442/Ra_Capital_Management>,
        <https://1145.am/db/2366735/Ra_Capital_Management>,
        <https://1145.am/db/2367678/Ra_Capital_Management>,
        <https://1145.am/db/2369974/Ra_Capital_Management>,
        <https://1145.am/db/2370436/Ra_Capital_Management>,
        <https://1145.am/db/2371160/Ra_Capital_Management>,
        <https://1145.am/db/2371163/Ra_Capital_Management>,
        <https://1145.am/db/2570481/Ra_Capital_Management>,
        <https://1145.am/db/2570483/Ra_Capital_Management>,
        <https://1145.am/db/387629/Ra_Capital_Management>,
        <https://1145.am/db/425953/Ra_Capital_Management>,
        <https://1145.am/db/441151/Ra_Capital_Management>,
        <https://1145.am/db/509733/Ra_Capital_Management>,
        <https://1145.am/db/572554/Ra_Capital_Management>,
        <https://1145.am/db/633100/Ra_Capital_Management>,
        <https://1145.am/db/677591/Ra_Capital_Management>,
        <https://1145.am/db/681970/Ra_Capital_Management>,
        <https://1145.am/db/820519/Ra_Capital_Management_Lp>,
        <https://1145.am/db/922552/Ra_Capital_Management>,
        <https://1145.am/db/923335/Ra_Capital_Management>,
        <https://1145.am/db/941871/Ra_Capital_Management>,
        <https://1145.am/db/979509/Ra_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368493/Rubius_Therapeutics_Joint_Venture> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "joint venture" ;
    ns1:documentDate "2015-12-09T13:08:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec. 9, 2015 /PRNewswire/ - Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases." ;
    ns1:documentTitle "Flagship Ventures Launches Rubius To Develop Red-Cell Therapeutics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flagship-ventures-launches-rubius-to-develop-red-cell-therapeutics%E2%84%A2> ;
    ns1:foundName "launched" ;
    ns1:name "launched" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2368493/Rubius_Therapeutics> ;
    ns1:targetName "Rubius Therapeutics" ;
    ns1:valueRaw "$ 25 million" ;
    ns1:when "2015-12-09T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2015-December-9" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2368501/Venrock> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:description "investment funds" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> ;
    ns1:name "Venrock" ;
    ns1:sameAsHigh <https://1145.am/db/1560920/Vectr7>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2307682/Venrock_Associates>,
        <https://1145.am/db/2350364/Venrock_Associates>,
        <https://1145.am/db/2367167/Venrock_Vi> ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368719/Ccam_Biotherapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Bailiwick of Jersey" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3042142/about.rdf> ;
    ns1:basedInHighRaw "New Jersey" ;
    ns1:description "cancer therapies" ;
    ns1:documentDate "2015-07-28T12:34:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck signs a $605M deal to bulk up in cancer immunotherapy" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/merck-signs-a-605m-deal-to-bulk-up-cancer-immunotherapy> ;
    ns1:foundName "cCAM Biotherapeutics" ;
    ns1:industry "pharma" ;
    ns1:name "cCAM Biotherapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2368712/Ccam_Biotherapeutics>,
        <https://1145.am/db/2368808/Ccam_Biotherapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2348174/Ccam_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368808/Ccam_Biotherapeutics> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:description "cCAM is pocketing $ 95 million in cash upfront, with the rest of the sum" ;
    ns1:documentDate "2015-07-30T07:01:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/eurobiotech-more-articles-of-note-3> ;
    ns1:foundName "cCAM",
        "cCAM Biotherapeutics" ;
    ns1:industry "Biotech" ;
    ns1:name "cCAM",
        "cCAM Biotherapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2368712/Ccam_Biotherapeutics>,
        <https://1145.am/db/2368719/Ccam_Biotherapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2348174/Ccam_Biotherapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Arch_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "ARCH Venture Partners" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "ARCH Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Arch_Venture_Partners>,
        <https://1145.am/db/1105790/Arch_Venture_Partners>,
        <https://1145.am/db/1108240/Arch_Venture_Partners>,
        <https://1145.am/db/1320499/Arch_Venture_Partners>,
        <https://1145.am/db/1334395/Arch_Venture_Partners>,
        <https://1145.am/db/1376077/Arch_Venture_Partners>,
        <https://1145.am/db/1406211/Arch_Venture_Partners>,
        <https://1145.am/db/1476658/Arch_Venture_Partners>,
        <https://1145.am/db/1519613/Arch_Venture_Partners>,
        <https://1145.am/db/1519799/Arch_Venture_Partners>,
        <https://1145.am/db/1553175/Arch_Venture_Partners>,
        <https://1145.am/db/1553459/Arch_Venture_Partners>,
        <https://1145.am/db/1582111/Arch_Venture_Partners>,
        <https://1145.am/db/1619794/Arch_Venture_Partners>,
        <https://1145.am/db/1663313/Arch_Venture_Partners>,
        <https://1145.am/db/1750401/Arch_Venture_Partners>,
        <https://1145.am/db/1791220/Arch_Venture_Partners>,
        <https://1145.am/db/1799828/Arch_Venture_Partners>,
        <https://1145.am/db/1928208/Arch_Venture_Partners>,
        <https://1145.am/db/1984721/Arch_Venture_Partners>,
        <https://1145.am/db/2095032/Arch_Venture_Partners>,
        <https://1145.am/db/2151983/Arch_Venture_Partners>,
        <https://1145.am/db/2181184/Arch_Venture_Partners>,
        <https://1145.am/db/2280315/Arch_Venture_Partners>,
        <https://1145.am/db/2281905/Arch_Venture_Partners>,
        <https://1145.am/db/2282162/Arch_Venture_Partners>,
        <https://1145.am/db/2284585/Arch_Venture_Partners>,
        <https://1145.am/db/2292675/Arch_Venture_Partners>,
        <https://1145.am/db/2294815/Arch_Venture_Partners>,
        <https://1145.am/db/2296113/Arch_Venture_Partners>,
        <https://1145.am/db/2301122/Arch_Venture_Partners>,
        <https://1145.am/db/2302047/Arch_Venture_Partners>,
        <https://1145.am/db/2305524/Arch_Venture_Partners>,
        <https://1145.am/db/2306529/Arch_Venture_Partners>,
        <https://1145.am/db/2315446/Arch_Venture_Partners>,
        <https://1145.am/db/2328599/Arch_Venture_Partners>,
        <https://1145.am/db/2330075/Arch_Venture_Partners>,
        <https://1145.am/db/2330712/Arch_Venture_Partners>,
        <https://1145.am/db/2330852/Arch_Venture_Partners>,
        <https://1145.am/db/2331754/Arch_Venture_Partners>,
        <https://1145.am/db/2331868/Arch_Venture_Partners>,
        <https://1145.am/db/2335701/Arch_Venture_Partners>,
        <https://1145.am/db/2335714/Arch_Venture_Partners>,
        <https://1145.am/db/2335773/Arch_Venture_Partners>,
        <https://1145.am/db/2336126/Arch_Venture_Partners>,
        <https://1145.am/db/2337140/Arch_Venture_Partners>,
        <https://1145.am/db/2339413/Arch_Venture_Partners>,
        <https://1145.am/db/2340344/Arch_Venture_Partners>,
        <https://1145.am/db/2340345/Arch_Venture_Partners>,
        <https://1145.am/db/2340348/Arch_Venture_Partners>,
        <https://1145.am/db/2341599/Arch_Venture_Partners>,
        <https://1145.am/db/2345223/Arch_Venture_Partners>,
        <https://1145.am/db/2345769/Arch_Venture_Partners>,
        <https://1145.am/db/2347368/Arch_Venture_Partners>,
        <https://1145.am/db/2347469/Arch_Venture_Partners>,
        <https://1145.am/db/2348074/Arch_Venture_Partners>,
        <https://1145.am/db/2356066/Arch_Venture_Partners>,
        <https://1145.am/db/2357253/Arch_Venture_Partners>,
        <https://1145.am/db/2357256/Arch_Venture_Partners>,
        <https://1145.am/db/2358725/Arch_Venture_Partners>,
        <https://1145.am/db/2359124/Arch_Venture_Partners>,
        <https://1145.am/db/2359447/Arch_Venture_Partners>,
        <https://1145.am/db/2359655/Arch_Venture_Partners>,
        <https://1145.am/db/2364332/Arch_Venture_Partners>,
        <https://1145.am/db/2364336/Arch_Venture_Partners>,
        <https://1145.am/db/2366536/Arch_Venture_Partners>,
        <https://1145.am/db/2366539/Arch_Venture_Partners>,
        <https://1145.am/db/2366654/Arch_Venture_Partners>,
        <https://1145.am/db/2369000/Arch_Venture_Partners>,
        <https://1145.am/db/2369549/Arch_Venture_Partners>,
        <https://1145.am/db/2371167/Arch_Venture_Partners>,
        <https://1145.am/db/2592611/Arch_Venture_Partners>,
        <https://1145.am/db/430986/Arch_Venture_Partners>,
        <https://1145.am/db/531806/Arch_Venture_Partners>,
        <https://1145.am/db/769568/Arch_Venture_Partners>,
        <https://1145.am/db/847865/Arch_Venture_Partners>,
        <https://1145.am/db/900779/Arch_Venture_Partners>,
        <https://1145.am/db/900943/Arch_Venture_Partners>,
        <https://1145.am/db/922192/Arch_Venture_Partners>,
        <https://1145.am/db/944358/Arch_Venture_Partners>,
        <https://1145.am/db/979509/Arch_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Ecor1_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "financing" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "EcoR1 Capital" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "EcoR1 Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2338428/Ecor1_Capital>,
        <https://1145.am/db/2344045/Ecor1_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1752458/Ecor1_Capital>,
        <https://1145.am/db/2282162/Ecor1_Capital>,
        <https://1145.am/db/2285718/Ecor1_Capital>,
        <https://1145.am/db/2286541/Ecor1_Capital>,
        <https://1145.am/db/2287230/Ecor1_Capital>,
        <https://1145.am/db/2291277/Ecor1_Capital>,
        <https://1145.am/db/2340634/Ecor1_Capital>,
        <https://1145.am/db/2344044/Ecor1_Capital>,
        <https://1145.am/db/2344782/Ecor1_Capital>,
        <https://1145.am/db/2361688/Ecor1_Capital>,
        <https://1145.am/db/2363330/Ecor1_Capital>,
        <https://1145.am/db/2364332/Ecor1_Capital>,
        <https://1145.am/db/2364336/Ecor1_Capital>,
        <https://1145.am/db/2368913/Ecor1_Capital>,
        <https://1145.am/db/2369718/Ecor1_Capital>,
        <https://1145.am/db/75445/Ecor1_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Scholar_Rock> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:description "discovering and developing drugs" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "Scholar Rock" ;
    ns1:industry "biotechnology" ;
    ns1:name "Scholar Rock" ;
    ns1:sameAsHigh <https://1145.am/db/2280540/Scholar_Rock>,
        <https://1145.am/db/2335808/Scholar_Rock>,
        <https://1145.am/db/2347762/Scholar_Rock>,
        <https://1145.am/db/2347789/Scholar_Rock>,
        <https://1145.am/db/2364332/Scholar_Rock>,
        <https://1145.am/db/2364336/Scholar_Rock>,
        <https://1145.am/db/2368426/Scholar_Rock>,
        <https://1145.am/db/2368913/Scholar_Rock>,
        <https://1145.am/db/2370720/Scholar_Rock> ;
    ns1:sameAsMedium <https://1145.am/db/1139562/Scholar_Rock>,
        <https://1145.am/db/1143776/Scholar_Rock>,
        <https://1145.am/db/1236562/Scholar_Rock>,
        <https://1145.am/db/1354671/Scholar_Rock>,
        <https://1145.am/db/1488522/Scholar_Rock>,
        <https://1145.am/db/1664021/Scholar_Rock>,
        <https://1145.am/db/1965327/Scholar_Rock>,
        <https://1145.am/db/2347772/Scholar_Rock>,
        <https://1145.am/db/411312/Scholar_Rock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Ecor1_Capital> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "EcoR1 Capital" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "EcoR1 Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1471278/Ecp>,
        <https://1145.am/db/1807582/Ec1_Capital>,
        <https://1145.am/db/1957990/Ecm_Investors>,
        <https://1145.am/db/2357253/Ecor1_Capital_Management>,
        <https://1145.am/db/75445/Ecor1_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1752458/Ecor1_Capital>,
        <https://1145.am/db/2282162/Ecor1_Capital>,
        <https://1145.am/db/2285718/Ecor1_Capital>,
        <https://1145.am/db/2286541/Ecor1_Capital>,
        <https://1145.am/db/2287230/Ecor1_Capital>,
        <https://1145.am/db/2291277/Ecor1_Capital>,
        <https://1145.am/db/2338428/Ecor1_Capital>,
        <https://1145.am/db/2340634/Ecor1_Capital>,
        <https://1145.am/db/2344044/Ecor1_Capital>,
        <https://1145.am/db/2344045/Ecor1_Capital>,
        <https://1145.am/db/2344782/Ecor1_Capital>,
        <https://1145.am/db/2361688/Ecor1_Capital>,
        <https://1145.am/db/2363330/Ecor1_Capital>,
        <https://1145.am/db/2364332/Ecor1_Capital>,
        <https://1145.am/db/2364336/Ecor1_Capital>,
        <https://1145.am/db/2368912/Ecor1_Capital>,
        <https://1145.am/db/2369718/Ecor1_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Scholar_Rock> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "biotech" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "Scholar Rock" ;
    ns1:industry "biotech" ;
    ns1:name "Scholar Rock" ;
    ns1:sameAsHigh <https://1145.am/db/1236562/Scholar_Rock>,
        <https://1145.am/db/2280540/Scholar_Rock>,
        <https://1145.am/db/2335808/Scholar_Rock>,
        <https://1145.am/db/2347762/Scholar_Rock>,
        <https://1145.am/db/2347789/Scholar_Rock>,
        <https://1145.am/db/2364332/Scholar_Rock>,
        <https://1145.am/db/2364336/Scholar_Rock>,
        <https://1145.am/db/2368426/Scholar_Rock>,
        <https://1145.am/db/2368912/Scholar_Rock>,
        <https://1145.am/db/2370720/Scholar_Rock> ;
    ns1:sameAsMedium <https://1145.am/db/1139562/Scholar_Rock>,
        <https://1145.am/db/1143776/Scholar_Rock>,
        <https://1145.am/db/1354671/Scholar_Rock>,
        <https://1145.am/db/1488522/Scholar_Rock>,
        <https://1145.am/db/1664021/Scholar_Rock>,
        <https://1145.am/db/1965327/Scholar_Rock>,
        <https://1145.am/db/2347772/Scholar_Rock>,
        <https://1145.am/db/411312/Scholar_Rock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Arch_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "New York" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "ARCH Venture Partners" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "ARCH Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Arch_Venture_Partners>,
        <https://1145.am/db/1105790/Arch_Venture_Partners>,
        <https://1145.am/db/1108240/Arch_Venture_Partners>,
        <https://1145.am/db/1320499/Arch_Venture_Partners>,
        <https://1145.am/db/1334395/Arch_Venture_Partners>,
        <https://1145.am/db/1376077/Arch_Venture_Partners>,
        <https://1145.am/db/1406211/Arch_Venture_Partners>,
        <https://1145.am/db/1476658/Arch_Venture_Partners>,
        <https://1145.am/db/1519613/Arch_Venture_Partners>,
        <https://1145.am/db/1519799/Arch_Venture_Partners>,
        <https://1145.am/db/1553175/Arch_Venture_Partners>,
        <https://1145.am/db/1553459/Arch_Venture_Partners>,
        <https://1145.am/db/1582111/Arch_Venture_Partners>,
        <https://1145.am/db/1619794/Arch_Venture_Partners>,
        <https://1145.am/db/1663313/Arch_Venture_Partners>,
        <https://1145.am/db/1750401/Arch_Venture_Partners>,
        <https://1145.am/db/1791220/Arch_Venture_Partners>,
        <https://1145.am/db/1799828/Arch_Venture_Partners>,
        <https://1145.am/db/1928208/Arch_Venture_Partners>,
        <https://1145.am/db/1984721/Arch_Venture_Partners>,
        <https://1145.am/db/2095032/Arch_Venture_Partners>,
        <https://1145.am/db/2151983/Arch_Venture_Partners>,
        <https://1145.am/db/2181184/Arch_Venture_Partners>,
        <https://1145.am/db/2280315/Arch_Venture_Partners>,
        <https://1145.am/db/2281905/Arch_Venture_Partners>,
        <https://1145.am/db/2282162/Arch_Venture_Partners>,
        <https://1145.am/db/2284585/Arch_Venture_Partners>,
        <https://1145.am/db/2292675/Arch_Venture_Partners>,
        <https://1145.am/db/2294815/Arch_Venture_Partners>,
        <https://1145.am/db/2296113/Arch_Venture_Partners>,
        <https://1145.am/db/2301122/Arch_Venture_Partners>,
        <https://1145.am/db/2302047/Arch_Venture_Partners>,
        <https://1145.am/db/2305524/Arch_Venture_Partners>,
        <https://1145.am/db/2306529/Arch_Venture_Partners>,
        <https://1145.am/db/2315446/Arch_Venture_Partners>,
        <https://1145.am/db/2328599/Arch_Venture_Partners>,
        <https://1145.am/db/2330075/Arch_Venture_Partners>,
        <https://1145.am/db/2330712/Arch_Venture_Partners>,
        <https://1145.am/db/2330852/Arch_Venture_Partners>,
        <https://1145.am/db/2331754/Arch_Venture_Partners>,
        <https://1145.am/db/2331868/Arch_Venture_Partners>,
        <https://1145.am/db/2335701/Arch_Venture_Partners>,
        <https://1145.am/db/2335714/Arch_Venture_Partners>,
        <https://1145.am/db/2335773/Arch_Venture_Partners>,
        <https://1145.am/db/2336126/Arch_Venture_Partners>,
        <https://1145.am/db/2337140/Arch_Venture_Partners>,
        <https://1145.am/db/2339413/Arch_Venture_Partners>,
        <https://1145.am/db/2340344/Arch_Venture_Partners>,
        <https://1145.am/db/2340345/Arch_Venture_Partners>,
        <https://1145.am/db/2340348/Arch_Venture_Partners>,
        <https://1145.am/db/2341599/Arch_Venture_Partners>,
        <https://1145.am/db/2345223/Arch_Venture_Partners>,
        <https://1145.am/db/2345769/Arch_Venture_Partners>,
        <https://1145.am/db/2347368/Arch_Venture_Partners>,
        <https://1145.am/db/2347469/Arch_Venture_Partners>,
        <https://1145.am/db/2348074/Arch_Venture_Partners>,
        <https://1145.am/db/2356066/Arch_Venture_Partners>,
        <https://1145.am/db/2357253/Arch_Venture_Partners>,
        <https://1145.am/db/2357256/Arch_Venture_Partners>,
        <https://1145.am/db/2358725/Arch_Venture_Partners>,
        <https://1145.am/db/2359124/Arch_Venture_Partners>,
        <https://1145.am/db/2359447/Arch_Venture_Partners>,
        <https://1145.am/db/2359655/Arch_Venture_Partners>,
        <https://1145.am/db/2364332/Arch_Venture_Partners>,
        <https://1145.am/db/2364336/Arch_Venture_Partners>,
        <https://1145.am/db/2366536/Arch_Venture_Partners>,
        <https://1145.am/db/2366539/Arch_Venture_Partners>,
        <https://1145.am/db/2366654/Arch_Venture_Partners>,
        <https://1145.am/db/2368912/Arch_Venture_Partners>,
        <https://1145.am/db/2369549/Arch_Venture_Partners>,
        <https://1145.am/db/2371167/Arch_Venture_Partners>,
        <https://1145.am/db/2592611/Arch_Venture_Partners>,
        <https://1145.am/db/430986/Arch_Venture_Partners>,
        <https://1145.am/db/531806/Arch_Venture_Partners>,
        <https://1145.am/db/769568/Arch_Venture_Partners>,
        <https://1145.am/db/847865/Arch_Venture_Partners>,
        <https://1145.am/db/900779/Arch_Venture_Partners>,
        <https://1145.am/db/900943/Arch_Venture_Partners>,
        <https://1145.am/db/922192/Arch_Venture_Partners>,
        <https://1145.am/db/944358/Arch_Venture_Partners>,
        <https://1145.am/db/979509/Arch_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369027/Zymeworks> a org:Organization ;
    ns1:basedInHighGeoName "Vancouver" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6173331/about.rdf> ;
    ns1:basedInHighRaw "Vancouver" ;
    ns1:buyer <https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "Zymeworks" ;
    ns1:name "Zymeworks" ;
    ns1:sameAsMedium <https://1145.am/db/1015645/Zymeworks_Inc>,
        <https://1145.am/db/1016632/Zymeworks_Inc>,
        <https://1145.am/db/1017937/Zymeworks_Inc>,
        <https://1145.am/db/1030113/Zymeworks_Inc>,
        <https://1145.am/db/1073750/Zymeworks>,
        <https://1145.am/db/1075621/Zymeworks>,
        <https://1145.am/db/1076106/Zymeworks>,
        <https://1145.am/db/1077389/Zymeworks_Inc>,
        <https://1145.am/db/1126412/Zymeworks>,
        <https://1145.am/db/1127032/Zymeworks>,
        <https://1145.am/db/1128241/Zymeworks_Inc>,
        <https://1145.am/db/1165468/Zymeworks_Inc>,
        <https://1145.am/db/1165674/Zymeworks_Inc>,
        <https://1145.am/db/1415410/Zymeworks_Inc>,
        <https://1145.am/db/2281273/Zymeworks>,
        <https://1145.am/db/2290504/Zymeworks>,
        <https://1145.am/db/2320465/Zymeworks_Inc>,
        <https://1145.am/db/2343759/Zymeworks_Inc>,
        <https://1145.am/db/2343771/Zymeworks>,
        <https://1145.am/db/2345918/Zymeworks_Inc>,
        <https://1145.am/db/2352633/Zymeworks_Inc>,
        <https://1145.am/db/2353635/Zymeworks>,
        <https://1145.am/db/2353983/Zymeworks_Inc>,
        <https://1145.am/db/2356853/Zymeworks_Inc>,
        <https://1145.am/db/607426/Zymeworks_Inc>,
        <https://1145.am/db/735769/Zymeworks_Inc>,
        <https://1145.am/db/736655/Zymeworks_Inc>,
        <https://1145.am/db/784103/Zymeworks_Inc>,
        <https://1145.am/db/786184/Zymeworks_Inc>,
        <https://1145.am/db/787862/Zymeworks_Inc>,
        <https://1145.am/db/788354/Zymeworks_Inc>,
        <https://1145.am/db/795471/Zymeworks_Inc>,
        <https://1145.am/db/796963/Zymeworks_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Deerfield_Management> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "healthcare investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "Deerfield Management" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "Deerfield Management" ;
    ns1:sameAsHigh <https://1145.am/db/2239059/Deerfield_Management_Company_Lp>,
        <https://1145.am/db/2305700/Deerfield_Management>,
        <https://1145.am/db/2317937/Deerfield_Management>,
        <https://1145.am/db/2321950/Deerfield_Management>,
        <https://1145.am/db/2328305/Deerfield_Management>,
        <https://1145.am/db/2328427/Deerfield_Management>,
        <https://1145.am/db/2328594/Deerfield_Management>,
        <https://1145.am/db/2360370/Deerfield_Management>,
        <https://1145.am/db/2361142/Deerfield_Management>,
        <https://1145.am/db/2366527/Deerfield_Management_Company>,
        <https://1145.am/db/542015/Deerfield_Management_Company> ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Deerfield_Management_Company>,
        <https://1145.am/db/1006175/Deerfield_Management_Company>,
        <https://1145.am/db/1102553/Deerfield_Management>,
        <https://1145.am/db/1106975/Deerfield_Management>,
        <https://1145.am/db/1177932/Deerfield_Management_Company>,
        <https://1145.am/db/1217674/Deerfield_Management>,
        <https://1145.am/db/1219334/Deerfield_Management>,
        <https://1145.am/db/1219771/Deerfield_Management>,
        <https://1145.am/db/1232497/Deerfield_Management>,
        <https://1145.am/db/1269807/Deerfield_Management_Company>,
        <https://1145.am/db/1279924/Deerfield_Management_Company>,
        <https://1145.am/db/1326655/Deerfield_Management>,
        <https://1145.am/db/1326957/Deerfield_Management>,
        <https://1145.am/db/1411936/Deerfield_Management_Company>,
        <https://1145.am/db/1468795/Deerfield_Management>,
        <https://1145.am/db/1519613/Deerfield_Management>,
        <https://1145.am/db/1519799/Deerfield_Management>,
        <https://1145.am/db/1620209/Deerfield_Management>,
        <https://1145.am/db/1624707/Deerfield_Management>,
        <https://1145.am/db/1771229/Deerfield_Management_Company>,
        <https://1145.am/db/1969781/Deerfield_Management>,
        <https://1145.am/db/2036223/Deerfield_Management>,
        <https://1145.am/db/2049332/Deerfield_Management>,
        <https://1145.am/db/2069495/Deerfield_Management>,
        <https://1145.am/db/2114372/Deerfield_Management>,
        <https://1145.am/db/2182698/Deerfield_Management>,
        <https://1145.am/db/2185095/Deerfield_Management_Company>,
        <https://1145.am/db/2198647/Deerfield_Management>,
        <https://1145.am/db/2198816/Deerfield_Management_Company>,
        <https://1145.am/db/2214553/Deerfield_Management>,
        <https://1145.am/db/2293172/Deerfield_Management>,
        <https://1145.am/db/2295295/Deerfield_Management>,
        <https://1145.am/db/2298642/Deerfield_Management>,
        <https://1145.am/db/2299549/Deerfield_Management>,
        <https://1145.am/db/2299794/Deerfield_Management_Company>,
        <https://1145.am/db/2302751/Deerfield_Management>,
        <https://1145.am/db/2311805/Deerfield_Management>,
        <https://1145.am/db/2311833/Deerfield_Management>,
        <https://1145.am/db/2313135/Deerfield_Management>,
        <https://1145.am/db/2317927/Deerfield_Management>,
        <https://1145.am/db/2324112/Deerfield_Management>,
        <https://1145.am/db/2325221/Deerfield_Management>,
        <https://1145.am/db/2325880/Deerfield_Management_Company>,
        <https://1145.am/db/2327266/Deerfield_Management>,
        <https://1145.am/db/2331436/Deerfield_Management>,
        <https://1145.am/db/2336511/Deerfield_Management_Company>,
        <https://1145.am/db/2337599/Deerfield_Management_Company>,
        <https://1145.am/db/2342543/Deerfield_Management_Company>,
        <https://1145.am/db/2346773/Deerfield_Management_Company>,
        <https://1145.am/db/2346775/Deerfield_Management_Company>,
        <https://1145.am/db/2347552/Deerfield_Management_Company>,
        <https://1145.am/db/2348857/Deerfield_Management>,
        <https://1145.am/db/2349834/Deerfield_Management>,
        <https://1145.am/db/2355531/Deerfield_Management>,
        <https://1145.am/db/2355543/Deerfield_Management>,
        <https://1145.am/db/2359227/Deerfield_Management>,
        <https://1145.am/db/2359404/Deerfield_Management>,
        <https://1145.am/db/2361147/Deerfield_Management>,
        <https://1145.am/db/2362106/Deerfield_Management_Company>,
        <https://1145.am/db/2362453/Deerfield_Management>,
        <https://1145.am/db/2365724/Deerfield_Management_Company>,
        <https://1145.am/db/2368667/Deerfield_Management>,
        <https://1145.am/db/2368723/Deerfield_Management>,
        <https://1145.am/db/2369304/Deerfield_Management_Company>,
        <https://1145.am/db/2369305/Deerfield_Management>,
        <https://1145.am/db/2370094/Deerfield_Management_Company>,
        <https://1145.am/db/2370436/Deerfield_Management>,
        <https://1145.am/db/2371160/Deerfield_Management_Company>,
        <https://1145.am/db/2371163/Deerfield_Management_Company>,
        <https://1145.am/db/2569551/Deerfield_Management>,
        <https://1145.am/db/2573058/Deerfield_Management>,
        <https://1145.am/db/2597025/Deerfield_Management_Company>,
        <https://1145.am/db/544859/Deerfield_Management_Company>,
        <https://1145.am/db/951064/Deerfield_Management_Company>,
        <https://1145.am/db/971622/Deerfield_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369419/Wellcome_Trust> a org:Organization ;
    ns1:description "medical research" ;
    ns1:documentDate "2016-01-21T14:43:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "EuroBiotech: More Articles of Note" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/eurobiotech-more-articles-of-note-10> ;
    ns1:foundName "Wellcome Trust" ;
    ns1:name "Wellcome Trust" ;
    ns1:sameAsHigh <https://1145.am/db/2312120/Wellcome_Trust>,
        <https://1145.am/db/2338829/Wellcome_Trust>,
        <https://1145.am/db/2346204/The_Wellcome_Trust>,
        <https://1145.am/db/2367399/The_Wellcome_Trust>,
        <https://1145.am/db/240593/Wellcome_Trust>,
        <https://1145.am/db/2559928/Wellcome_Trust> ;
    ns1:sameAsMedium <https://1145.am/db/1803348/Wellcome_Trust>,
        <https://1145.am/db/1873138/Wellcome_Trust>,
        <https://1145.am/db/1877263/Wellcome_Trust>,
        <https://1145.am/db/2291581/Wellcome_Trust>,
        <https://1145.am/db/2297218/Wellcome_Trust>,
        <https://1145.am/db/2330075/Wellcome_Trust>,
        <https://1145.am/db/2338835/Wellcome_Trust>,
        <https://1145.am/db/2339419/Wellcome_Trust>,
        <https://1145.am/db/2339425/Wellcome_Trust>,
        <https://1145.am/db/2344045/Wellcome_Trust>,
        <https://1145.am/db/2354253/Wellcome_Trust>,
        <https://1145.am/db/2364481/Wellcome_Trust>,
        <https://1145.am/db/2370680/Wellcome_Trust>,
        <https://1145.am/db/2370786/Wellcome_Trust>,
        <https://1145.am/db/2573020/Wellcome_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369549/Arch_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "ARCH",
        "ARCH Venture Partners" ;
    ns1:investor <https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> ;
    ns1:name "ARCH Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Arch_Venture_Partners>,
        <https://1145.am/db/1105790/Arch_Venture_Partners>,
        <https://1145.am/db/1108240/Arch_Venture_Partners>,
        <https://1145.am/db/1320499/Arch_Venture_Partners>,
        <https://1145.am/db/1334395/Arch_Venture_Partners>,
        <https://1145.am/db/1376077/Arch_Venture_Partners>,
        <https://1145.am/db/1406211/Arch_Venture_Partners>,
        <https://1145.am/db/1476658/Arch_Venture_Partners>,
        <https://1145.am/db/1519613/Arch_Venture_Partners>,
        <https://1145.am/db/1519799/Arch_Venture_Partners>,
        <https://1145.am/db/1553175/Arch_Venture_Partners>,
        <https://1145.am/db/1553459/Arch_Venture_Partners>,
        <https://1145.am/db/1582111/Arch_Venture_Partners>,
        <https://1145.am/db/1619794/Arch_Venture_Partners>,
        <https://1145.am/db/1663313/Arch_Venture_Partners>,
        <https://1145.am/db/1750401/Arch_Venture_Partners>,
        <https://1145.am/db/1791220/Arch_Venture_Partners>,
        <https://1145.am/db/1799828/Arch_Venture_Partners>,
        <https://1145.am/db/1928208/Arch_Venture_Partners>,
        <https://1145.am/db/1984721/Arch_Venture_Partners>,
        <https://1145.am/db/2095032/Arch_Venture_Partners>,
        <https://1145.am/db/2151983/Arch_Venture_Partners>,
        <https://1145.am/db/2181184/Arch_Venture_Partners>,
        <https://1145.am/db/2280315/Arch_Venture_Partners>,
        <https://1145.am/db/2281905/Arch_Venture_Partners>,
        <https://1145.am/db/2282162/Arch_Venture_Partners>,
        <https://1145.am/db/2284585/Arch_Venture_Partners>,
        <https://1145.am/db/2292675/Arch_Venture_Partners>,
        <https://1145.am/db/2294815/Arch_Venture_Partners>,
        <https://1145.am/db/2296113/Arch_Venture_Partners>,
        <https://1145.am/db/2301122/Arch_Venture_Partners>,
        <https://1145.am/db/2302047/Arch_Venture_Partners>,
        <https://1145.am/db/2305524/Arch_Venture_Partners>,
        <https://1145.am/db/2306529/Arch_Venture_Partners>,
        <https://1145.am/db/2315446/Arch_Venture_Partners>,
        <https://1145.am/db/2328599/Arch_Venture_Partners>,
        <https://1145.am/db/2330075/Arch_Venture_Partners>,
        <https://1145.am/db/2330712/Arch_Venture_Partners>,
        <https://1145.am/db/2330852/Arch_Venture_Partners>,
        <https://1145.am/db/2331754/Arch_Venture_Partners>,
        <https://1145.am/db/2331868/Arch_Venture_Partners>,
        <https://1145.am/db/2335701/Arch_Venture_Partners>,
        <https://1145.am/db/2335714/Arch_Venture_Partners>,
        <https://1145.am/db/2335773/Arch_Venture_Partners>,
        <https://1145.am/db/2336126/Arch_Venture_Partners>,
        <https://1145.am/db/2337140/Arch_Venture_Partners>,
        <https://1145.am/db/2339413/Arch_Venture_Partners>,
        <https://1145.am/db/2340344/Arch_Venture_Partners>,
        <https://1145.am/db/2340345/Arch_Venture_Partners>,
        <https://1145.am/db/2340348/Arch_Venture_Partners>,
        <https://1145.am/db/2341599/Arch_Venture_Partners>,
        <https://1145.am/db/2345223/Arch_Venture_Partners>,
        <https://1145.am/db/2345769/Arch_Venture_Partners>,
        <https://1145.am/db/2347368/Arch_Venture_Partners>,
        <https://1145.am/db/2347469/Arch_Venture_Partners>,
        <https://1145.am/db/2348074/Arch_Venture_Partners>,
        <https://1145.am/db/2356066/Arch_Venture_Partners>,
        <https://1145.am/db/2357253/Arch_Venture_Partners>,
        <https://1145.am/db/2357256/Arch_Venture_Partners>,
        <https://1145.am/db/2358725/Arch_Venture_Partners>,
        <https://1145.am/db/2359124/Arch_Venture_Partners>,
        <https://1145.am/db/2359447/Arch_Venture_Partners>,
        <https://1145.am/db/2359655/Arch_Venture_Partners>,
        <https://1145.am/db/2364332/Arch_Venture_Partners>,
        <https://1145.am/db/2364336/Arch_Venture_Partners>,
        <https://1145.am/db/2366536/Arch_Venture_Partners>,
        <https://1145.am/db/2366539/Arch_Venture_Partners>,
        <https://1145.am/db/2366654/Arch_Venture_Partners>,
        <https://1145.am/db/2368912/Arch_Venture_Partners>,
        <https://1145.am/db/2369000/Arch_Venture_Partners>,
        <https://1145.am/db/2371167/Arch_Venture_Partners>,
        <https://1145.am/db/2592611/Arch_Venture_Partners>,
        <https://1145.am/db/430986/Arch_Venture_Partners>,
        <https://1145.am/db/531806/Arch_Venture_Partners>,
        <https://1145.am/db/769568/Arch_Venture_Partners>,
        <https://1145.am/db/847865/Arch_Venture_Partners>,
        <https://1145.am/db/900779/Arch_Venture_Partners>,
        <https://1145.am/db/900943/Arch_Venture_Partners>,
        <https://1145.am/db/922192/Arch_Venture_Partners>,
        <https://1145.am/db/944358/Arch_Venture_Partners>,
        <https://1145.am/db/979509/Arch_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Atlas_Venture> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "investing" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1752961/Atlassian_Ventures>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2250347/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2357928/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2367740/Atlas_Venture>,
        <https://1145.am/db/2370540/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/819502/Atlas_Ventures>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sameAsMedium <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354307/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2357905/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361022/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Ecor1_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:description "healthcare investors" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "EcoR1 Capital" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "EcoR1 Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1752458/Ecor1_Capital>,
        <https://1145.am/db/2282162/Ecor1_Capital>,
        <https://1145.am/db/2285718/Ecor1_Capital>,
        <https://1145.am/db/2286541/Ecor1_Capital>,
        <https://1145.am/db/2287230/Ecor1_Capital>,
        <https://1145.am/db/2291277/Ecor1_Capital>,
        <https://1145.am/db/2338428/Ecor1_Capital>,
        <https://1145.am/db/2340634/Ecor1_Capital>,
        <https://1145.am/db/2344044/Ecor1_Capital>,
        <https://1145.am/db/2344045/Ecor1_Capital>,
        <https://1145.am/db/2344782/Ecor1_Capital>,
        <https://1145.am/db/2361688/Ecor1_Capital>,
        <https://1145.am/db/2363330/Ecor1_Capital>,
        <https://1145.am/db/2364332/Ecor1_Capital>,
        <https://1145.am/db/2364336/Ecor1_Capital>,
        <https://1145.am/db/2368912/Ecor1_Capital>,
        <https://1145.am/db/2368913/Ecor1_Capital>,
        <https://1145.am/db/75445/Ecor1_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370540/Atlas_Venture> a org:Organization ;
    ns1:basedInLowRaw "Atlas Venture (Atlas)" ;
    ns1:description "financing" ;
    ns1:documentDate "2015-09-24T15:22:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Replimune Ltd Raises $30 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/replimune-ltd-raises-30-million-series-a-financing> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2370540/Series_A_Investment_Atlas_Venture_Replimune_Ltd_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1752961/Atlassian_Ventures>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2250347/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2357928/Atlas_Venture_Partners_Innovation_Fund>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2367740/Atlas_Venture>,
        <https://1145.am/db/2369718/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/819502/Atlas_Ventures>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sameAsMedium <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354307/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2357905/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361022/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2370698/Rock_Springs_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "Rock Springs Capital Management" ;
    ns1:documentDate "2015-09-30T13:30:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Execs behind Imbruvica raise $75M for a new cancer project" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/execs-behind-imbruvica-raise-75m-for-a-new-cancer-project> ;
    ns1:foundName "Rock" ;
    ns1:investor <https://1145.am/db/2370698/Investment_Corvus_Pharmaceuticals_Rock_Springs_Capital_Management_Has_Not_Happened> ;
    ns1:name "Rock Springs Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/2346773/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2346775/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2357566/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2367678/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2368386/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2369974/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2370694/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2371160/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2371163/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2572177/Rock_Springs_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Audentes_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "San Francisco" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Audentes Therapeutics" ;
    ns1:industry "biotech" ;
    ns1:name "Audentes Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1118282/Autem_Therapeutics>,
        <https://1145.am/db/2285772/Audentes_Therapeutics>,
        <https://1145.am/db/2339886/Audentes_Therapeutics>,
        <https://1145.am/db/2349834/Audentes_Therapeutics>,
        <https://1145.am/db/2369729/Audentes_Therapeutics>,
        <https://1145.am/db/2551089/Auven_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2152613/Audentes_Therapeutics>,
        <https://1145.am/db/2339885/Audentes_Therapeutics>,
        <https://1145.am/db/2348857/Audentes_Therapeutics>,
        <https://1145.am/db/2356184/Audentes_Therapeutics>,
        <https://1145.am/db/2371163/Audentes_Therapeutics>,
        <https://1145.am/db/2542648/Audentes_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Deerfield_Management_Company> a org:Organization ;
    ns1:basedInLowRaw "San Francisco" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Deerfield Management Company" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Deerfield Management Company" ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Deerfield_Management_Company>,
        <https://1145.am/db/1006175/Deerfield_Management_Company>,
        <https://1145.am/db/1102553/Deerfield_Management>,
        <https://1145.am/db/1106975/Deerfield_Management>,
        <https://1145.am/db/1177932/Deerfield_Management_Company>,
        <https://1145.am/db/1217674/Deerfield_Management>,
        <https://1145.am/db/1219334/Deerfield_Management>,
        <https://1145.am/db/1219771/Deerfield_Management>,
        <https://1145.am/db/1232497/Deerfield_Management>,
        <https://1145.am/db/1269807/Deerfield_Management_Company>,
        <https://1145.am/db/1279924/Deerfield_Management_Company>,
        <https://1145.am/db/1326655/Deerfield_Management>,
        <https://1145.am/db/1326957/Deerfield_Management>,
        <https://1145.am/db/1411936/Deerfield_Management_Company>,
        <https://1145.am/db/1468795/Deerfield_Management>,
        <https://1145.am/db/1519613/Deerfield_Management>,
        <https://1145.am/db/1519799/Deerfield_Management>,
        <https://1145.am/db/1620209/Deerfield_Management>,
        <https://1145.am/db/1624707/Deerfield_Management>,
        <https://1145.am/db/1771229/Deerfield_Management_Company>,
        <https://1145.am/db/1969781/Deerfield_Management>,
        <https://1145.am/db/2036223/Deerfield_Management>,
        <https://1145.am/db/2049332/Deerfield_Management>,
        <https://1145.am/db/2069495/Deerfield_Management>,
        <https://1145.am/db/2114372/Deerfield_Management>,
        <https://1145.am/db/2182698/Deerfield_Management>,
        <https://1145.am/db/2185095/Deerfield_Management_Company>,
        <https://1145.am/db/2198647/Deerfield_Management>,
        <https://1145.am/db/2198816/Deerfield_Management_Company>,
        <https://1145.am/db/2214553/Deerfield_Management>,
        <https://1145.am/db/2293172/Deerfield_Management>,
        <https://1145.am/db/2295295/Deerfield_Management>,
        <https://1145.am/db/2298642/Deerfield_Management>,
        <https://1145.am/db/2299549/Deerfield_Management>,
        <https://1145.am/db/2299794/Deerfield_Management_Company>,
        <https://1145.am/db/2302751/Deerfield_Management>,
        <https://1145.am/db/2305700/Deerfield_Management>,
        <https://1145.am/db/2311805/Deerfield_Management>,
        <https://1145.am/db/2311833/Deerfield_Management>,
        <https://1145.am/db/2313135/Deerfield_Management>,
        <https://1145.am/db/2317927/Deerfield_Management>,
        <https://1145.am/db/2317937/Deerfield_Management>,
        <https://1145.am/db/2321950/Deerfield_Management>,
        <https://1145.am/db/2324112/Deerfield_Management>,
        <https://1145.am/db/2325221/Deerfield_Management>,
        <https://1145.am/db/2325880/Deerfield_Management_Company>,
        <https://1145.am/db/2327266/Deerfield_Management>,
        <https://1145.am/db/2328305/Deerfield_Management>,
        <https://1145.am/db/2328427/Deerfield_Management>,
        <https://1145.am/db/2328594/Deerfield_Management>,
        <https://1145.am/db/2331436/Deerfield_Management>,
        <https://1145.am/db/2336511/Deerfield_Management_Company>,
        <https://1145.am/db/2337599/Deerfield_Management_Company>,
        <https://1145.am/db/2342543/Deerfield_Management_Company>,
        <https://1145.am/db/2346773/Deerfield_Management_Company>,
        <https://1145.am/db/2346775/Deerfield_Management_Company>,
        <https://1145.am/db/2347552/Deerfield_Management_Company>,
        <https://1145.am/db/2348857/Deerfield_Management>,
        <https://1145.am/db/2349834/Deerfield_Management>,
        <https://1145.am/db/2355531/Deerfield_Management>,
        <https://1145.am/db/2355543/Deerfield_Management>,
        <https://1145.am/db/2359227/Deerfield_Management>,
        <https://1145.am/db/2359404/Deerfield_Management>,
        <https://1145.am/db/2360370/Deerfield_Management>,
        <https://1145.am/db/2361142/Deerfield_Management>,
        <https://1145.am/db/2361147/Deerfield_Management>,
        <https://1145.am/db/2362106/Deerfield_Management_Company>,
        <https://1145.am/db/2362453/Deerfield_Management>,
        <https://1145.am/db/2365724/Deerfield_Management_Company>,
        <https://1145.am/db/2366527/Deerfield_Management_Company>,
        <https://1145.am/db/2368667/Deerfield_Management>,
        <https://1145.am/db/2368723/Deerfield_Management>,
        <https://1145.am/db/2369202/Deerfield_Management>,
        <https://1145.am/db/2369304/Deerfield_Management_Company>,
        <https://1145.am/db/2369305/Deerfield_Management>,
        <https://1145.am/db/2370094/Deerfield_Management_Company>,
        <https://1145.am/db/2370436/Deerfield_Management>,
        <https://1145.am/db/2371163/Deerfield_Management_Company>,
        <https://1145.am/db/2569551/Deerfield_Management>,
        <https://1145.am/db/2573058/Deerfield_Management>,
        <https://1145.am/db/2597025/Deerfield_Management_Company>,
        <https://1145.am/db/542015/Deerfield_Management_Company>,
        <https://1145.am/db/544859/Deerfield_Management_Company>,
        <https://1145.am/db/951064/Deerfield_Management_Company>,
        <https://1145.am/db/971622/Deerfield_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Foresite_Capital> a org:Organization ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Foresite Capital" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed>,
        <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Foresite Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2313410/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2325831/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2353607/Bb_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/1061824/Foresite_Capital>,
        <https://1145.am/db/1411936/Foresite_Capital>,
        <https://1145.am/db/1412727/Foresite_Capital>,
        <https://1145.am/db/1664837/Foresite_Capital>,
        <https://1145.am/db/1745868/Foresite_Capital>,
        <https://1145.am/db/1747873/Foresite_Capital>,
        <https://1145.am/db/1750470/Foresite_Capital>,
        <https://1145.am/db/2075754/Foresite_Capital>,
        <https://1145.am/db/2129215/Foresite_Capital>,
        <https://1145.am/db/2153988/Foresite_Capital>,
        <https://1145.am/db/2155146/Foresite_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2181257/Foresite_Capital>,
        <https://1145.am/db/2198816/Foresite_Capital>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2291403/Foresite_Capital>,
        <https://1145.am/db/2292554/Foresite_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2339214/Foresite_Capital>,
        <https://1145.am/db/2339223/Foresite_Capital>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2345273/Foresite_Capital>,
        <https://1145.am/db/2361416/Foresite_Capital>,
        <https://1145.am/db/2361422/Foresite_Capital>,
        <https://1145.am/db/2361424/Foresite_Capital>,
        <https://1145.am/db/2364496/Foresite_Capital>,
        <https://1145.am/db/2368322/Foresite_Capital>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370436/Foresite_Capital>,
        <https://1145.am/db/2371163/Foresite_Capital>,
        <https://1145.am/db/248626/Foresite_Capital>,
        <https://1145.am/db/595702/Foresite_Capital>,
        <https://1145.am/db/694272/Foresite_Capital>,
        <https://1145.am/db/745407/Foresite_Capital>,
        <https://1145.am/db/873820/Foresite_Capital>,
        <https://1145.am/db/874843/Foresite_Capital>,
        <https://1145.am/db/884787/Foresite_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Ra_Capital_Management> a org:Organization ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "RA Capital Management" ;
    ns1:investor <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "RA Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1134574/Ra_Capital_Management_Lp>,
        <https://1145.am/db/1164709/Ra_Capital_Management>,
        <https://1145.am/db/1166452/Ra_Capital_Management>,
        <https://1145.am/db/1198548/Ra_Capital_Management>,
        <https://1145.am/db/1219334/Ra_Capital_Management>,
        <https://1145.am/db/1219771/Ra_Capital_Management>,
        <https://1145.am/db/1293978/Ra_Capital_Management>,
        <https://1145.am/db/1294718/Ra_Capital_Management>,
        <https://1145.am/db/1334624/Ra_Capital_Management>,
        <https://1145.am/db/1503165/Ra_Capital_Management>,
        <https://1145.am/db/1735850/Ra_Capital_Management>,
        <https://1145.am/db/1926411/Ra_Capital_Management>,
        <https://1145.am/db/1928388/Ra_Capital_Management>,
        <https://1145.am/db/2011094/Ra_Capital_Management>,
        <https://1145.am/db/2075754/Ra_Capital_Management>,
        <https://1145.am/db/2089412/Ra_Capital_Management>,
        <https://1145.am/db/2109798/Ra_Capital_Management>,
        <https://1145.am/db/2153910/Ra_Capital_Management>,
        <https://1145.am/db/2155505/Ra_Capital_Management>,
        <https://1145.am/db/2280400/Ra_Capital_Management>,
        <https://1145.am/db/2282268/Ra_Capital_Management>,
        <https://1145.am/db/2282806/Ra_Capital_Management>,
        <https://1145.am/db/2285762/Ra_Capital_Management>,
        <https://1145.am/db/2286204/Ra_Capital_Management>,
        <https://1145.am/db/2298395/Ra_Capital_Management>,
        <https://1145.am/db/2298642/Ra_Capital_Management>,
        <https://1145.am/db/2335743/Ra_Capital_Management>,
        <https://1145.am/db/2336510/Ra_Capital_Management>,
        <https://1145.am/db/2336511/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2336957/Ra_Capital_Management>,
        <https://1145.am/db/2337599/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2338126/Ra_Capital_Management>,
        <https://1145.am/db/2338127/Ra_Capital_Management>,
        <https://1145.am/db/2339214/Ra_Capital_Management>,
        <https://1145.am/db/2339223/Ra_Capital_Management>,
        <https://1145.am/db/2339666/Ra_Capital_Management>,
        <https://1145.am/db/2340942/Ra_Capital_Management>,
        <https://1145.am/db/2346773/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2346775/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2347043/Ra_Capital_Management>,
        <https://1145.am/db/2348149/Ra_Capital_Management>,
        <https://1145.am/db/2355029/Ra_Capital_Management>,
        <https://1145.am/db/2356216/Ra_Capital_Management>,
        <https://1145.am/db/2357144/Ra_Capital_Management>,
        <https://1145.am/db/2357566/Ra_Capital_Management>,
        <https://1145.am/db/2360277/Ra_Capital_Management>,
        <https://1145.am/db/2360682/Ra_Capital_Management>,
        <https://1145.am/db/2363391/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2363442/Ra_Capital_Management>,
        <https://1145.am/db/2366735/Ra_Capital_Management>,
        <https://1145.am/db/2367678/Ra_Capital_Management>,
        <https://1145.am/db/2368322/Ra_Capital_Management>,
        <https://1145.am/db/2369974/Ra_Capital_Management>,
        <https://1145.am/db/2370436/Ra_Capital_Management>,
        <https://1145.am/db/2371163/Ra_Capital_Management>,
        <https://1145.am/db/2570481/Ra_Capital_Management>,
        <https://1145.am/db/2570483/Ra_Capital_Management>,
        <https://1145.am/db/387629/Ra_Capital_Management>,
        <https://1145.am/db/425953/Ra_Capital_Management>,
        <https://1145.am/db/441151/Ra_Capital_Management>,
        <https://1145.am/db/509733/Ra_Capital_Management>,
        <https://1145.am/db/572554/Ra_Capital_Management>,
        <https://1145.am/db/633100/Ra_Capital_Management>,
        <https://1145.am/db/677591/Ra_Capital_Management>,
        <https://1145.am/db/681970/Ra_Capital_Management>,
        <https://1145.am/db/820519/Ra_Capital_Management_Lp>,
        <https://1145.am/db/922552/Ra_Capital_Management>,
        <https://1145.am/db/923335/Ra_Capital_Management>,
        <https://1145.am/db/941871/Ra_Capital_Management>,
        <https://1145.am/db/979509/Ra_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Redmile_Group> a org:Organization ;
    ns1:basedInLowRaw "San Francisco" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Redmile Group" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed>,
        <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Redmile Group" ;
    ns1:sameAsHigh <https://1145.am/db/602316/Redmile_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1086649/Redmile_Group>,
        <https://1145.am/db/1192327/Redmile_Group>,
        <https://1145.am/db/1533327/Redmile_Group>,
        <https://1145.am/db/1533685/Redmile_Group>,
        <https://1145.am/db/1752458/Redmile_Group>,
        <https://1145.am/db/1813216/Redmile_Group>,
        <https://1145.am/db/1822362/Redmile_Group>,
        <https://1145.am/db/1837663/Redmile_Group>,
        <https://1145.am/db/1984721/Redmile_Group>,
        <https://1145.am/db/2075963/Redmile_Group>,
        <https://1145.am/db/2080575/Redmile_Group>,
        <https://1145.am/db/2089412/Redmile_Group>,
        <https://1145.am/db/2152126/Redmile_Group>,
        <https://1145.am/db/2224478/Redmile_Group>,
        <https://1145.am/db/2236068/Redmile_Group>,
        <https://1145.am/db/2281211/Redmile_Group>,
        <https://1145.am/db/2285762/Redmile_Group>,
        <https://1145.am/db/2291414/Redmile_Group>,
        <https://1145.am/db/2291716/Redmile_Group>,
        <https://1145.am/db/2292160/Redmile_Group>,
        <https://1145.am/db/2307889/Redmile_Group>,
        <https://1145.am/db/2308540/Redmile_Group>,
        <https://1145.am/db/2321658/Redmile_Group>,
        <https://1145.am/db/2335748/Redmile_Group>,
        <https://1145.am/db/2341595/Redmile_Group>,
        <https://1145.am/db/2341599/Redmile_Group>,
        <https://1145.am/db/2360277/Redmile_Group>,
        <https://1145.am/db/2361695/Redmile_Group>,
        <https://1145.am/db/2362106/Redmile_Group>,
        <https://1145.am/db/2367043/Redmile_Group>,
        <https://1145.am/db/2368070/Redmile_Group>,
        <https://1145.am/db/2369304/Redmile_Group>,
        <https://1145.am/db/2371163/Redmile_Group>,
        <https://1145.am/db/2584561/Redmile_Group>,
        <https://1145.am/db/342182/Redmile_Group>,
        <https://1145.am/db/577785/Redmile_Group>,
        <https://1145.am/db/585936/Redmile_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Rock_Springs_Capital_Management> a org:Organization ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Rock Springs Capital Management LP" ;
    ns1:investor <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Rock Springs Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/2346773/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2346775/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2357566/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2367678/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2368386/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2369974/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2370694/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2370698/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2371163/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2572177/Rock_Springs_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Venrock> a org:Organization ;
    ns1:basedInLowRaw "San Francisco" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Venrock" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed>,
        <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Venrock" ;
    ns1:sameAsHigh <https://1145.am/db/2286204/Venbio_Partners>,
        <https://1145.am/db/704198/Venbio> ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Versant_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "San Francisco" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Audentes_Therapeutics> a org:Organization ;
    ns1:description "healthcare" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Audentes Therapeutics",
        "Audentes Therapeutics, Inc." ;
    ns1:industry "Healthcare" ;
    ns1:name "Audentes Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2279755/Auron_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2152613/Audentes_Therapeutics>,
        <https://1145.am/db/2285772/Audentes_Therapeutics>,
        <https://1145.am/db/2339885/Audentes_Therapeutics>,
        <https://1145.am/db/2339886/Audentes_Therapeutics>,
        <https://1145.am/db/2348857/Audentes_Therapeutics>,
        <https://1145.am/db/2349834/Audentes_Therapeutics>,
        <https://1145.am/db/2356184/Audentes_Therapeutics>,
        <https://1145.am/db/2369729/Audentes_Therapeutics>,
        <https://1145.am/db/2371160/Audentes_Therapeutics>,
        <https://1145.am/db/2542648/Audentes_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Deerfield_Management_Company> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Deerfield Management Company" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Deerfield Management Company" ;
    ns1:sameAsHigh <https://1145.am/db/1217674/Deerfield_Management>,
        <https://1145.am/db/1279924/Deerfield_Management_Company>,
        <https://1145.am/db/1326957/Deerfield_Management>,
        <https://1145.am/db/1468795/Deerfield_Management>,
        <https://1145.am/db/1519613/Deerfield_Management>,
        <https://1145.am/db/1519799/Deerfield_Management>,
        <https://1145.am/db/1624707/Deerfield_Management>,
        <https://1145.am/db/2036223/Deerfield_Management>,
        <https://1145.am/db/2114372/Deerfield_Management>,
        <https://1145.am/db/2185095/Deerfield_Management_Company>,
        <https://1145.am/db/2299794/Deerfield_Management_Company>,
        <https://1145.am/db/2313143/Alliancebernstein_Deerfield_Management>,
        <https://1145.am/db/2324112/Deerfield_Management>,
        <https://1145.am/db/2346773/Deerfield_Management_Company>,
        <https://1145.am/db/2347552/Deerfield_Management_Company>,
        <https://1145.am/db/2361695/Deerfield_Management_Perceptive_Advisors>,
        <https://1145.am/db/2363340/Deerfield_Management_Company_Lp>,
        <https://1145.am/db/2369305/Deerfield_Management>,
        <https://1145.am/db/2370436/Deerfield_Management>,
        <https://1145.am/db/2597025/Deerfield_Management_Company>,
        <https://1145.am/db/753759/Deer_Park> ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Deerfield_Management_Company>,
        <https://1145.am/db/1006175/Deerfield_Management_Company>,
        <https://1145.am/db/1102553/Deerfield_Management>,
        <https://1145.am/db/1106975/Deerfield_Management>,
        <https://1145.am/db/1177932/Deerfield_Management_Company>,
        <https://1145.am/db/1219334/Deerfield_Management>,
        <https://1145.am/db/1219771/Deerfield_Management>,
        <https://1145.am/db/1232497/Deerfield_Management>,
        <https://1145.am/db/1269807/Deerfield_Management_Company>,
        <https://1145.am/db/1326655/Deerfield_Management>,
        <https://1145.am/db/1411936/Deerfield_Management_Company>,
        <https://1145.am/db/1620209/Deerfield_Management>,
        <https://1145.am/db/1771229/Deerfield_Management_Company>,
        <https://1145.am/db/1969781/Deerfield_Management>,
        <https://1145.am/db/2049332/Deerfield_Management>,
        <https://1145.am/db/2069495/Deerfield_Management>,
        <https://1145.am/db/2182698/Deerfield_Management>,
        <https://1145.am/db/2198647/Deerfield_Management>,
        <https://1145.am/db/2198816/Deerfield_Management_Company>,
        <https://1145.am/db/2214553/Deerfield_Management>,
        <https://1145.am/db/2293172/Deerfield_Management>,
        <https://1145.am/db/2295295/Deerfield_Management>,
        <https://1145.am/db/2298642/Deerfield_Management>,
        <https://1145.am/db/2299549/Deerfield_Management>,
        <https://1145.am/db/2302751/Deerfield_Management>,
        <https://1145.am/db/2305700/Deerfield_Management>,
        <https://1145.am/db/2311805/Deerfield_Management>,
        <https://1145.am/db/2311833/Deerfield_Management>,
        <https://1145.am/db/2313135/Deerfield_Management>,
        <https://1145.am/db/2317927/Deerfield_Management>,
        <https://1145.am/db/2317937/Deerfield_Management>,
        <https://1145.am/db/2321950/Deerfield_Management>,
        <https://1145.am/db/2325221/Deerfield_Management>,
        <https://1145.am/db/2325880/Deerfield_Management_Company>,
        <https://1145.am/db/2327266/Deerfield_Management>,
        <https://1145.am/db/2328305/Deerfield_Management>,
        <https://1145.am/db/2328427/Deerfield_Management>,
        <https://1145.am/db/2328594/Deerfield_Management>,
        <https://1145.am/db/2331436/Deerfield_Management>,
        <https://1145.am/db/2336511/Deerfield_Management_Company>,
        <https://1145.am/db/2337599/Deerfield_Management_Company>,
        <https://1145.am/db/2342543/Deerfield_Management_Company>,
        <https://1145.am/db/2346775/Deerfield_Management_Company>,
        <https://1145.am/db/2348857/Deerfield_Management>,
        <https://1145.am/db/2349834/Deerfield_Management>,
        <https://1145.am/db/2355531/Deerfield_Management>,
        <https://1145.am/db/2355543/Deerfield_Management>,
        <https://1145.am/db/2359227/Deerfield_Management>,
        <https://1145.am/db/2359404/Deerfield_Management>,
        <https://1145.am/db/2360370/Deerfield_Management>,
        <https://1145.am/db/2361142/Deerfield_Management>,
        <https://1145.am/db/2361147/Deerfield_Management>,
        <https://1145.am/db/2362106/Deerfield_Management_Company>,
        <https://1145.am/db/2362453/Deerfield_Management>,
        <https://1145.am/db/2365724/Deerfield_Management_Company>,
        <https://1145.am/db/2366527/Deerfield_Management_Company>,
        <https://1145.am/db/2368667/Deerfield_Management>,
        <https://1145.am/db/2368723/Deerfield_Management>,
        <https://1145.am/db/2369202/Deerfield_Management>,
        <https://1145.am/db/2369304/Deerfield_Management_Company>,
        <https://1145.am/db/2370094/Deerfield_Management_Company>,
        <https://1145.am/db/2371160/Deerfield_Management_Company>,
        <https://1145.am/db/2569551/Deerfield_Management>,
        <https://1145.am/db/2573058/Deerfield_Management>,
        <https://1145.am/db/542015/Deerfield_Management_Company>,
        <https://1145.am/db/544859/Deerfield_Management_Company>,
        <https://1145.am/db/951064/Deerfield_Management_Company>,
        <https://1145.am/db/971622/Deerfield_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Foresite_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Foresite Capital" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Foresite Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1061824/Foresite_Capital>,
        <https://1145.am/db/1411936/Foresite_Capital>,
        <https://1145.am/db/1412727/Foresite_Capital>,
        <https://1145.am/db/1664837/Foresite_Capital>,
        <https://1145.am/db/1745868/Foresite_Capital>,
        <https://1145.am/db/1747873/Foresite_Capital>,
        <https://1145.am/db/1750470/Foresite_Capital>,
        <https://1145.am/db/2075754/Foresite_Capital>,
        <https://1145.am/db/2129215/Foresite_Capital>,
        <https://1145.am/db/2153988/Foresite_Capital>,
        <https://1145.am/db/2155146/Foresite_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2181257/Foresite_Capital>,
        <https://1145.am/db/2198816/Foresite_Capital>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2291403/Foresite_Capital>,
        <https://1145.am/db/2292554/Foresite_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2339214/Foresite_Capital>,
        <https://1145.am/db/2339223/Foresite_Capital>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2345273/Foresite_Capital>,
        <https://1145.am/db/2361416/Foresite_Capital>,
        <https://1145.am/db/2361422/Foresite_Capital>,
        <https://1145.am/db/2361424/Foresite_Capital>,
        <https://1145.am/db/2364496/Foresite_Capital>,
        <https://1145.am/db/2368322/Foresite_Capital>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370436/Foresite_Capital>,
        <https://1145.am/db/2371160/Foresite_Capital>,
        <https://1145.am/db/248626/Foresite_Capital>,
        <https://1145.am/db/595702/Foresite_Capital>,
        <https://1145.am/db/694272/Foresite_Capital>,
        <https://1145.am/db/745407/Foresite_Capital>,
        <https://1145.am/db/873820/Foresite_Capital>,
        <https://1145.am/db/874843/Foresite_Capital>,
        <https://1145.am/db/884787/Foresite_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Ra_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "RA Capital",
        "RA Capital Management" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "RA Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1134574/Ra_Capital_Management_Lp>,
        <https://1145.am/db/1164709/Ra_Capital_Management>,
        <https://1145.am/db/1166452/Ra_Capital_Management>,
        <https://1145.am/db/1198548/Ra_Capital_Management>,
        <https://1145.am/db/1219334/Ra_Capital_Management>,
        <https://1145.am/db/1219771/Ra_Capital_Management>,
        <https://1145.am/db/1293978/Ra_Capital_Management>,
        <https://1145.am/db/1294718/Ra_Capital_Management>,
        <https://1145.am/db/1334624/Ra_Capital_Management>,
        <https://1145.am/db/1503165/Ra_Capital_Management>,
        <https://1145.am/db/1735850/Ra_Capital_Management>,
        <https://1145.am/db/1926411/Ra_Capital_Management>,
        <https://1145.am/db/1928388/Ra_Capital_Management>,
        <https://1145.am/db/2011094/Ra_Capital_Management>,
        <https://1145.am/db/2075754/Ra_Capital_Management>,
        <https://1145.am/db/2089412/Ra_Capital_Management>,
        <https://1145.am/db/2109798/Ra_Capital_Management>,
        <https://1145.am/db/2153910/Ra_Capital_Management>,
        <https://1145.am/db/2155505/Ra_Capital_Management>,
        <https://1145.am/db/2280400/Ra_Capital_Management>,
        <https://1145.am/db/2282268/Ra_Capital_Management>,
        <https://1145.am/db/2282806/Ra_Capital_Management>,
        <https://1145.am/db/2285762/Ra_Capital_Management>,
        <https://1145.am/db/2286204/Ra_Capital_Management>,
        <https://1145.am/db/2298395/Ra_Capital_Management>,
        <https://1145.am/db/2298642/Ra_Capital_Management>,
        <https://1145.am/db/2335743/Ra_Capital_Management>,
        <https://1145.am/db/2336510/Ra_Capital_Management>,
        <https://1145.am/db/2336511/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2336957/Ra_Capital_Management>,
        <https://1145.am/db/2337599/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2338126/Ra_Capital_Management>,
        <https://1145.am/db/2338127/Ra_Capital_Management>,
        <https://1145.am/db/2339214/Ra_Capital_Management>,
        <https://1145.am/db/2339223/Ra_Capital_Management>,
        <https://1145.am/db/2339666/Ra_Capital_Management>,
        <https://1145.am/db/2340942/Ra_Capital_Management>,
        <https://1145.am/db/2346773/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2346775/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2347043/Ra_Capital_Management>,
        <https://1145.am/db/2348149/Ra_Capital_Management>,
        <https://1145.am/db/2355029/Ra_Capital_Management>,
        <https://1145.am/db/2356216/Ra_Capital_Management>,
        <https://1145.am/db/2357144/Ra_Capital_Management>,
        <https://1145.am/db/2357566/Ra_Capital_Management>,
        <https://1145.am/db/2360277/Ra_Capital_Management>,
        <https://1145.am/db/2360682/Ra_Capital_Management>,
        <https://1145.am/db/2363391/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2363442/Ra_Capital_Management>,
        <https://1145.am/db/2366735/Ra_Capital_Management>,
        <https://1145.am/db/2367678/Ra_Capital_Management>,
        <https://1145.am/db/2368322/Ra_Capital_Management>,
        <https://1145.am/db/2369974/Ra_Capital_Management>,
        <https://1145.am/db/2370436/Ra_Capital_Management>,
        <https://1145.am/db/2371160/Ra_Capital_Management>,
        <https://1145.am/db/2570481/Ra_Capital_Management>,
        <https://1145.am/db/2570483/Ra_Capital_Management>,
        <https://1145.am/db/387629/Ra_Capital_Management>,
        <https://1145.am/db/425953/Ra_Capital_Management>,
        <https://1145.am/db/441151/Ra_Capital_Management>,
        <https://1145.am/db/509733/Ra_Capital_Management>,
        <https://1145.am/db/572554/Ra_Capital_Management>,
        <https://1145.am/db/633100/Ra_Capital_Management>,
        <https://1145.am/db/677591/Ra_Capital_Management>,
        <https://1145.am/db/681970/Ra_Capital_Management>,
        <https://1145.am/db/820519/Ra_Capital_Management_Lp>,
        <https://1145.am/db/922552/Ra_Capital_Management>,
        <https://1145.am/db/923335/Ra_Capital_Management>,
        <https://1145.am/db/941871/Ra_Capital_Management>,
        <https://1145.am/db/979509/Ra_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Redmile_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Redmile Group" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Redmile Group" ;
    ns1:sameAsMedium <https://1145.am/db/1086649/Redmile_Group>,
        <https://1145.am/db/1192327/Redmile_Group>,
        <https://1145.am/db/1533327/Redmile_Group>,
        <https://1145.am/db/1533685/Redmile_Group>,
        <https://1145.am/db/1752458/Redmile_Group>,
        <https://1145.am/db/1813216/Redmile_Group>,
        <https://1145.am/db/1822362/Redmile_Group>,
        <https://1145.am/db/1837663/Redmile_Group>,
        <https://1145.am/db/1984721/Redmile_Group>,
        <https://1145.am/db/2075963/Redmile_Group>,
        <https://1145.am/db/2080575/Redmile_Group>,
        <https://1145.am/db/2089412/Redmile_Group>,
        <https://1145.am/db/2152126/Redmile_Group>,
        <https://1145.am/db/2224478/Redmile_Group>,
        <https://1145.am/db/2236068/Redmile_Group>,
        <https://1145.am/db/2281211/Redmile_Group>,
        <https://1145.am/db/2285762/Redmile_Group>,
        <https://1145.am/db/2291414/Redmile_Group>,
        <https://1145.am/db/2291716/Redmile_Group>,
        <https://1145.am/db/2292160/Redmile_Group>,
        <https://1145.am/db/2307889/Redmile_Group>,
        <https://1145.am/db/2308540/Redmile_Group>,
        <https://1145.am/db/2321658/Redmile_Group>,
        <https://1145.am/db/2335748/Redmile_Group>,
        <https://1145.am/db/2341595/Redmile_Group>,
        <https://1145.am/db/2341599/Redmile_Group>,
        <https://1145.am/db/2360277/Redmile_Group>,
        <https://1145.am/db/2361695/Redmile_Group>,
        <https://1145.am/db/2362106/Redmile_Group>,
        <https://1145.am/db/2367043/Redmile_Group>,
        <https://1145.am/db/2368070/Redmile_Group>,
        <https://1145.am/db/2369304/Redmile_Group>,
        <https://1145.am/db/2371160/Redmile_Group>,
        <https://1145.am/db/2584561/Redmile_Group>,
        <https://1145.am/db/342182/Redmile_Group>,
        <https://1145.am/db/577785/Redmile_Group>,
        <https://1145.am/db/585936/Redmile_Group>,
        <https://1145.am/db/602316/Redmile_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Rock_Springs_Capital_Management_Lp> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Rock Springs Capital Management LP" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Rock Springs Capital Management LP" ;
    ns1:sameAsMedium <https://1145.am/db/2346773/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2346775/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2357566/Rock_Springs_Capital_Management_Lp>,
        <https://1145.am/db/2367678/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2368386/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2369974/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2370694/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2370698/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2371160/Rock_Springs_Capital_Management>,
        <https://1145.am/db/2572177/Rock_Springs_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Venrock> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Venrock" ;
    ns1:sameAsHigh <https://1145.am/db/1106541/8vc>,
        <https://1145.am/db/1119433/8vc>,
        <https://1145.am/db/1150154/Virtu_Capital>,
        <https://1145.am/db/1171599/Gener8tor>,
        <https://1145.am/db/1172426/Gener8tor>,
        <https://1145.am/db/1221237/Rnr_Capital>,
        <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1265686/Vice_Ventures>,
        <https://1145.am/db/1287496/Atreides_Management>,
        <https://1145.am/db/1325968/8vc>,
        <https://1145.am/db/1326376/Vu_Venture_Partners>,
        <https://1145.am/db/1375007/Velosity_Capital>,
        <https://1145.am/db/1422571/8vc>,
        <https://1145.am/db/1423309/8vc>,
        <https://1145.am/db/1449316/Alter_Venture_Partners>,
        <https://1145.am/db/1454909/Valspring_Capital>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1720145/Atreides_Management_Lp>,
        <https://1145.am/db/1723472/8vc>,
        <https://1145.am/db/1726506/Strat-Tech>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736668/Votiv_Capital>,
        <https://1145.am/db/1739707/Launchub>,
        <https://1145.am/db/1742620/Atreides_Management>,
        <https://1145.am/db/1750121/8vc>,
        <https://1145.am/db/1751332/Vaizra_Capital>,
        <https://1145.am/db/1751743/Arkblu_Capital>,
        <https://1145.am/db/1751959/Venturra>,
        <https://1145.am/db/1754585/Revent>,
        <https://1145.am/db/1756027/Rocket_Capital>,
        <https://1145.am/db/1758274/8vc>,
        <https://1145.am/db/1758480/8vc>,
        <https://1145.am/db/1764967/Vu_Venture_Partners>,
        <https://1145.am/db/1766540/8vc>,
        <https://1145.am/db/1787227/8vc>,
        <https://1145.am/db/1795538/Venturra_Capital>,
        <https://1145.am/db/1799102/Vayner_Capital>,
        <https://1145.am/db/1809324/Venturra_Capital>,
        <https://1145.am/db/1810384/Venturra_Capital>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1842087/Visor_Capital>,
        <https://1145.am/db/1842128/Westcoast_Capital>,
        <https://1145.am/db/1846682/Vaizra>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2000764/Revent>,
        <https://1145.am/db/2014232/Ventureast>,
        <https://1145.am/db/2073127/8vc>,
        <https://1145.am/db/2187105/8vc>,
        <https://1145.am/db/2278983/Eurekare>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2295278/Aurum>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2310905/Protemix>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2621506/Atreides_Management>,
        <https://1145.am/db/281538/Velosity_Capital>,
        <https://1145.am/db/348442/Alter_Venture_Partners>,
        <https://1145.am/db/402434/8vc>,
        <https://1145.am/db/415668/8vc>,
        <https://1145.am/db/461176/Xv_Venture_Capital>,
        <https://1145.am/db/490696/8vc>,
        <https://1145.am/db/538403/Evolution_Vc>,
        <https://1145.am/db/540473/8vc>,
        <https://1145.am/db/541011/8vc>,
        <https://1145.am/db/542875/Evolution_Vc>,
        <https://1145.am/db/543432/Evolution_Vc>,
        <https://1145.am/db/545039/8vc>,
        <https://1145.am/db/669726/Morningstar_Ventures>,
        <https://1145.am/db/676747/8vc>,
        <https://1145.am/db/731044/8vc>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/866101/Alter_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2318934/Versant>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2350915/Versant_Venture_Capital_V_Lp>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371188/Stake_Investment_Gamida_Cell_The_Big_Pharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-15T10:08:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Jerusalem, Israel - based Gamida Cell is assessing its financing options as it nears the start of a Phase III trial of its stem cell blood cancer therapy.",
        "Novartis bought itself a front row seat for these events last year when it paid $ 35 million for a 15 % stake in Gamida Cell, company with which it has an eventful history.",
        "The Big Pharma handed over $ 5 million (4.4 million) for a 2.5 % stake in Gamida Cell this week-and promised to invest a further $ 10 million if its collaborator wraps up an equity financing by the end of 2017." ;
    ns1:documentTitle "Gamida Cell pockets $5M from Novartis ahead of mooted financing round" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/gamida-cell-pockets-5m-from-novartis-ahead-of-mooted-financing-round> ;
    ns1:foundName "buying",
        "financing",
        "invest",
        "paid" ;
    ns1:name "buying",
        "financing",
        "invest",
        "paid" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened",
        "stopped" ;
    ns1:target <https://1145.am/db/2371188/Gamida_Cell> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Gamida Cell" ;
    ns1:valueRaw "$ 35 million",
        "$ 5 million",
        "a further $ 10 million",
        "4.4 million" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2371301/Amgen> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2015-10-19T14:30:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biotech billionaire Soon-Shiong strikes $50M deal for control of cancer vaccines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biotech-billionaire-soon-shiong-strikes-50m-deal-for-control-of-cancer-vaccines> ;
    ns1:foundName "Amgen" ;
    ns1:name "Amgen" ;
    ns1:sameAsMedium <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1253935/Amgen>,
        <https://1145.am/db/1254815/Amgen>,
        <https://1145.am/db/1258904/Amgen_Inc>,
        <https://1145.am/db/1262006/Amgen>,
        <https://1145.am/db/1406211/Amgen>,
        <https://1145.am/db/1434130/Amgen>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1568872/Amgen_Inc>,
        <https://1145.am/db/1570839/Amgen_Inc>,
        <https://1145.am/db/1573831/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/1575688/Amgen_Inc>,
        <https://1145.am/db/1576668/Amgen_Inc>,
        <https://1145.am/db/1673901/Amgen>,
        <https://1145.am/db/1929668/Amgen>,
        <https://1145.am/db/1981398/Amgen>,
        <https://1145.am/db/198163/Amgen>,
        <https://1145.am/db/2008430/Amgen_Inc>,
        <https://1145.am/db/2008790/Amgen>,
        <https://1145.am/db/2009117/Amgen_Inc>,
        <https://1145.am/db/2011679/Amgen>,
        <https://1145.am/db/2012933/Amgen_Inc>,
        <https://1145.am/db/2013008/Amgen_Inc>,
        <https://1145.am/db/2016970/Amgen>,
        <https://1145.am/db/2043001/Amgen>,
        <https://1145.am/db/2046726/Amgen>,
        <https://1145.am/db/2098829/Amgen>,
        <https://1145.am/db/2105082/Amgen>,
        <https://1145.am/db/2106270/Amgen>,
        <https://1145.am/db/2107919/Amgen>,
        <https://1145.am/db/2117067/Amgen>,
        <https://1145.am/db/2117986/Amgen>,
        <https://1145.am/db/2138386/Amgen>,
        <https://1145.am/db/2152715/Amgen>,
        <https://1145.am/db/2153258/Amgen>,
        <https://1145.am/db/2154415/Amgen>,
        <https://1145.am/db/2155409/Amgen>,
        <https://1145.am/db/2155659/Amgen>,
        <https://1145.am/db/2249776/Amgen_Inc>,
        <https://1145.am/db/2282387/Amgen>,
        <https://1145.am/db/2282934/Amgen>,
        <https://1145.am/db/2283321/Amgen>,
        <https://1145.am/db/2285195/Amgen>,
        <https://1145.am/db/2285614/Amgen>,
        <https://1145.am/db/2285991/Amgen>,
        <https://1145.am/db/2286174/Amgen>,
        <https://1145.am/db/2291231/Amgen>,
        <https://1145.am/db/2292224/Amgen>,
        <https://1145.am/db/2292876/Amgen>,
        <https://1145.am/db/2299349/Amgen>,
        <https://1145.am/db/2302052/Amgen>,
        <https://1145.am/db/2303414/Amgen>,
        <https://1145.am/db/2312121/Amgen>,
        <https://1145.am/db/2313429/Amgen>,
        <https://1145.am/db/2317845/Amgen>,
        <https://1145.am/db/2318877/Amgen>,
        <https://1145.am/db/2320754/Amgen>,
        <https://1145.am/db/2320759/Amgen>,
        <https://1145.am/db/2320765/Amgen>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321459/Amgen>,
        <https://1145.am/db/2321989/Amgen>,
        <https://1145.am/db/2322040/Amgen>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2326533/Amgen>,
        <https://1145.am/db/2326559/Amgen>,
        <https://1145.am/db/2327526/Amgen>,
        <https://1145.am/db/2327547/Amgen>,
        <https://1145.am/db/2328748/Amgen>,
        <https://1145.am/db/2329762/Amgen>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2334046/Amgen>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337848/Amgen>,
        <https://1145.am/db/2338027/Amgen>,
        <https://1145.am/db/2338329/Amgen>,
        <https://1145.am/db/2338346/Amgen>,
        <https://1145.am/db/2338828/Amgen>,
        <https://1145.am/db/2340408/Amgen>,
        <https://1145.am/db/2340634/Amgen>,
        <https://1145.am/db/2340669/Amgen>,
        <https://1145.am/db/2343511/Amgen>,
        <https://1145.am/db/2343601/Amgen>,
        <https://1145.am/db/2343780/Amgen>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2344369/Amgen>,
        <https://1145.am/db/2344631/Amgen>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345191/Amgen>,
        <https://1145.am/db/2345783/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346293/Amgen>,
        <https://1145.am/db/2347966/Amgen>,
        <https://1145.am/db/2347970/Amgen>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2349030/Amgen>,
        <https://1145.am/db/2349444/Amgen>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350471/Amgen>,
        <https://1145.am/db/2352800/Amgen>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2354835/Amgen>,
        <https://1145.am/db/2355378/Amgen>,
        <https://1145.am/db/2355383/Amgen>,
        <https://1145.am/db/2355392/Amgen>,
        <https://1145.am/db/2355427/Amgen>,
        <https://1145.am/db/2357269/Amgen>,
        <https://1145.am/db/2357271/Amgen>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357336/Amgen>,
        <https://1145.am/db/2357451/Amgen>,
        <https://1145.am/db/2357454/Amgen>,
        <https://1145.am/db/2357920/Amgen>,
        <https://1145.am/db/2358934/Amgen>,
        <https://1145.am/db/2359165/Amgen>,
        <https://1145.am/db/2359462/Amgen>,
        <https://1145.am/db/2359481/Amgen>,
        <https://1145.am/db/2359498/Amgen>,
        <https://1145.am/db/2360080/Amgen>,
        <https://1145.am/db/2360086/Amgen>,
        <https://1145.am/db/2361037/Amgen>,
        <https://1145.am/db/2361971/Amgen>,
        <https://1145.am/db/2361972/Amgen>,
        <https://1145.am/db/2361973/Amgen>,
        <https://1145.am/db/2362552/Amgen>,
        <https://1145.am/db/2363673/Amgen>,
        <https://1145.am/db/2364216/Amgen>,
        <https://1145.am/db/2367430/Amgen_Inc>,
        <https://1145.am/db/2368788/Amgen_Inc>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370215/Amgen>,
        <https://1145.am/db/2370217/Amgen>,
        <https://1145.am/db/2538019/Amgen>,
        <https://1145.am/db/2539787/Amgen>,
        <https://1145.am/db/2540225/Amgen>,
        <https://1145.am/db/2543232/Amgen>,
        <https://1145.am/db/2543655/Amgen>,
        <https://1145.am/db/2544701/Amgen>,
        <https://1145.am/db/2545663/Amgen>,
        <https://1145.am/db/2545765/Amgen>,
        <https://1145.am/db/2548575/Amgen>,
        <https://1145.am/db/2550685/Amgen>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551883/Amgen>,
        <https://1145.am/db/2551884/Amgen>,
        <https://1145.am/db/2553162/Amgen>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554152/Amgen>,
        <https://1145.am/db/2555175/Amgen>,
        <https://1145.am/db/2556729/Amgen>,
        <https://1145.am/db/2557364/Amgen>,
        <https://1145.am/db/2558012/Amgen>,
        <https://1145.am/db/2558039/Amgen>,
        <https://1145.am/db/2558051/Amgen>,
        <https://1145.am/db/2558418/Amgen>,
        <https://1145.am/db/2559077/Amgen>,
        <https://1145.am/db/2561305/Amgen>,
        <https://1145.am/db/2561317/Amgen>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561650/Amgen>,
        <https://1145.am/db/2566335/Amgen>,
        <https://1145.am/db/2566348/Amgen>,
        <https://1145.am/db/2567468/Amgen>,
        <https://1145.am/db/2567517/Amgen>,
        <https://1145.am/db/2567960/Amgen>,
        <https://1145.am/db/2567981/Amgen>,
        <https://1145.am/db/2568005/Amgen>,
        <https://1145.am/db/2568075/Amgen>,
        <https://1145.am/db/2568519/Amgen>,
        <https://1145.am/db/2572535/Amgen>,
        <https://1145.am/db/2572655/Amgen>,
        <https://1145.am/db/2573455/Amgen>,
        <https://1145.am/db/2573903/Amgen>,
        <https://1145.am/db/2573924/Amgen>,
        <https://1145.am/db/2573976/Amgen>,
        <https://1145.am/db/2574586/Amgen>,
        <https://1145.am/db/2575263/Amgen>,
        <https://1145.am/db/2575289/Amgen>,
        <https://1145.am/db/2576018/Amgen>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576498/Amgen>,
        <https://1145.am/db/2577110/Amgen>,
        <https://1145.am/db/2577115/Amgen>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578110/Amgen>,
        <https://1145.am/db/2578164/Amgen>,
        <https://1145.am/db/2578286/Amgen>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2579278/Amgen>,
        <https://1145.am/db/2580209/Amgen>,
        <https://1145.am/db/2580211/Amgen>,
        <https://1145.am/db/2580383/Amgen_Inc>,
        <https://1145.am/db/2581309/Amgen>,
        <https://1145.am/db/2581359/Amgen>,
        <https://1145.am/db/2581917/Amgen>,
        <https://1145.am/db/2583990/Amgen>,
        <https://1145.am/db/2584352/Amgen>,
        <https://1145.am/db/2585068/Amgen>,
        <https://1145.am/db/2586068/Amgen>,
        <https://1145.am/db/2586750/Amgen>,
        <https://1145.am/db/2587009/Amgen>,
        <https://1145.am/db/2587770/Amgen>,
        <https://1145.am/db/258901/Amgen_Inc>,
        <https://1145.am/db/2589106/Amgen>,
        <https://1145.am/db/2590194/Amgen>,
        <https://1145.am/db/2590988/Amgen_Inc>,
        <https://1145.am/db/2590989/Amgen>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2592573/Amgen>,
        <https://1145.am/db/2592618/Amgen>,
        <https://1145.am/db/2592924/Amgen>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593465/Amgen>,
        <https://1145.am/db/2593681/Amgen>,
        <https://1145.am/db/2593973/Amgen>,
        <https://1145.am/db/2594099/Amgen>,
        <https://1145.am/db/2594285/Amgen>,
        <https://1145.am/db/2594292/Amgen>,
        <https://1145.am/db/2594298/Amgen>,
        <https://1145.am/db/2594347/Amgen>,
        <https://1145.am/db/2594990/Amgen>,
        <https://1145.am/db/2594993/Amgen>,
        <https://1145.am/db/2595020/Amgen>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595564/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2595605/Amgen>,
        <https://1145.am/db/2595608/Amgen>,
        <https://1145.am/db/2595930/Amgen>,
        <https://1145.am/db/2596467/Amgen>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597499/Amgen>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2716207/Amgen>,
        <https://1145.am/db/2789236/Amgen>,
        <https://1145.am/db/2802001/Amgen>,
        <https://1145.am/db/531806/Amgen_Inc>,
        <https://1145.am/db/559746/Amgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2538419/Roman_Avdeev> a org:Organization ;
    ns1:basedInHighGeoName "Russian Federation" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2017370/about.rdf> ;
    ns1:basedInHighRaw "Russia" ;
    ns1:description "business" ;
    ns1:documentDate "2015-08-12T10:36:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pharma M&A, investment in Russia leading to exports, RBC Daily says" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pharma-m-a-investment-russia-leading-to-exports-rbc-daily-says> ;
    ns1:foundName "Roman Avdeev" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Roman Avdeev" ;
    ns1:sameAsHigh <https://1145.am/db/2592843/Roman_Avdeev>,
        <https://1145.am/db/2593463/Roman_Avdeev> ;
    ns1:sameAsMedium <https://1145.am/db/2536755/Roman_Avdeev> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2540203/Wuxi_Pharmatech_(cayman)_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cayman Islands" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3580718/about.rdf> ;
    ns1:basedInHighRaw "Cayman" ;
    ns1:description "R & D" ;
    ns1:documentDate "2015-07-13T15:25:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "WuXi PharmaTech's China-Based Small-Molecule Manufacturing Subsidiary, STA, Enters into Private Placement Agreement" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/wuxi-pharmatech-s-china-based-small-molecule-manufacturing-subsidiary-sta-enters-into> ;
    ns1:foundName "WuXi PharmaTech (Cayman) Inc" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "WuXi PharmaTech (Cayman) Inc" ;
    ns1:sameAsHigh <https://1145.am/db/1328634/Wuxi_Sta>,
        <https://1145.am/db/1366554/Casi_Wuxi>,
        <https://1145.am/db/2300983/Wuxi>,
        <https://1145.am/db/2317074/Wuxi_Pharmatech>,
        <https://1145.am/db/2319622/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2323895/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2324944/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2327401/Wuxi_Pharmatech>,
        <https://1145.am/db/2328362/Wuxi_Pharmatech>,
        <https://1145.am/db/2329325/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2330601/Wuxi_Apptec_Us>,
        <https://1145.am/db/2333351/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2334048/Wuxi_Pharmatech_(cayman)>,
        <https://1145.am/db/2334544/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2335732/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2341599/Wuxi_Pharmatech>,
        <https://1145.am/db/2350843/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2351683/Wuxi_Pharmatech>,
        <https://1145.am/db/2354127/Wuxi_Pharmatech>,
        <https://1145.am/db/2354723/Wuxi>,
        <https://1145.am/db/2355452/Fosun_Pharma_Cro_Wuxi_Pharmatech>,
        <https://1145.am/db/2357114/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2357202/Wuxi_Pharmatech>,
        <https://1145.am/db/2358953/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2360258/Wuxi_Pharmatech_Corporate_Ventures>,
        <https://1145.am/db/2367470/Wuxi>,
        <https://1145.am/db/2368287/Wuxi_Pharmatech>,
        <https://1145.am/db/2368649/Wuxi_Pharmatech>,
        <https://1145.am/db/2369000/Wuxi_Pharmatech>,
        <https://1145.am/db/2369250/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2369317/Wuxi_Pharmatech>,
        <https://1145.am/db/2536552/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2536795/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2536809/Wuxi_Pharmatech>,
        <https://1145.am/db/2538401/Wuxi_Pharmatech>,
        <https://1145.am/db/2538432/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2544511/Wuxi_Pharmatech>,
        <https://1145.am/db/2546407/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2546449/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2548440/Wuxi_Apptec_Co_Ltd>,
        <https://1145.am/db/2550682/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2550951/Wuxis_Sta>,
        <https://1145.am/db/2551549/Wuxi>,
        <https://1145.am/db/2552704/Wuxi_Pharmatech>,
        <https://1145.am/db/2555844/Wuxi_Pharmatech>,
        <https://1145.am/db/2556261/Wuxi_Biologics>,
        <https://1145.am/db/2562693/Wuxi_Biologics>,
        <https://1145.am/db/2562693/Wuxi_Sta>,
        <https://1145.am/db/2562701/Wuxi_Biologics>,
        <https://1145.am/db/2563558/Wuxi_Biologics>,
        <https://1145.am/db/2565318/Wuxi_Apptec>,
        <https://1145.am/db/2567008/Wuxi_Biologics>,
        <https://1145.am/db/2584599/Wuxi_Pharmatech_(cayman)_Inc>,
        <https://1145.am/db/2729766/Wuxi_Apptec>,
        <https://1145.am/db/274660/Wuxi_Biologics_Inc>,
        <https://1145.am/db/274739/Wuxi_Biologics_Inc>,
        <https://1145.am/db/2756477/Wuxi_Biologics>,
        <https://1145.am/db/2756477/Wuxi_Xdc>,
        <https://1145.am/db/685293/Wuhan_General_Group_(china)_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2346595/Wuxi_Pharmatech_(cayman)_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2542049/Companhia_Brasileira_De_Esterilizao_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-08-27T13:46:03+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Earlier this month the Deerfield, IL - based company said it had acquired Sao Paulo - based Companhia Brasileira de Esterilizao (CBE) , the largest specialist in sterilization and microbial load reduction in Latin America.",
        "Sterigenics International, which counts vaccine and API sterilization among its irradiation services, is expanding." ;
    ns1:documentTitle "Sterilization specialist on expansion streak" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/sterilization-specialist-on-expansion-streak> ;
    ns1:foundName "acquired",
        "investing" ;
    ns1:name "acquired",
        "investing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2542049/Companhia_Brasileira_De_Esterilizao> ;
    ns1:targetName "Companhia Brasileira de Esterilizao" ;
    ns1:valueRaw "$ 10 million" ;
    ns1:whenRaw "Earlier this month" ;
    ns1:whereGeoName "Latin America" ;
    ns1:whereRaw "Latin America" .

<https://1145.am/db/2543345/Krebs_Biochemicals_Stake_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "ipo" ;
    ns1:documentDate "2015-11-04T12:25:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Indian drugmakers are on the hunt for money and growth with India's Alkem Laboratories planning a $ 210 million initial public offering the second week of December and Ipca Laboratories saying it has launched a bid for a 26 % stake in Krebs Biochemicals.",
        "Meanwhile, Ipca Laboratories said it will start an offer for 26 % of Hyderabad - based Krebs Biochemicals on Nov. 9, which will end on Nov. 24 and which should total about $ 3.01 million, according to a report from the news site India.com.",
        "Mumbai - based Ipca in February acquired 1.8 million shares in Krebs and signed an MOU outlining plans for Ipca to acquire joint management control." ;
    ns1:documentTitle "Indian drugmakers on the hunt for money and growth" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/indian-drugmakers-on-hunt-for-money-and-growth> ;
    ns1:foundName "acquire",
        "acquired",
        "bid",
        "initial public offering",
        "offer" ;
    ns1:name "acquire",
        "acquired",
        "bid",
        "initial public offering",
        "offer" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2543345/Krebs_Biochemicals> ;
    ns1:targetDetails "stake" ;
    ns1:targetName "Krebs",
        "Krebs Biochemicals" ;
    ns1:valueRaw "$ 210 million",
        "about $ 3.01 million" ;
    ns1:whenRaw "February" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2546157/Nitin_Lifesciences> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "Nitin Lifesciences" ;
    ns1:industry "Lifesciences" ;
    ns1:name "Nitin Lifesciences" ;
    ns1:sameAsHigh <https://1145.am/db/2153042/Nitrome_Biosciences>,
        <https://1145.am/db/2336954/Numedii>,
        <https://1145.am/db/2540508/Nitin_Lifesciences> ;
    ns1:sameAsMedium <https://1145.am/db/2306945/Nitin_Lifesciences>,
        <https://1145.am/db/2540958/Nitin_Lifesciences>,
        <https://1145.am/db/2544071/Nitin_Lifesciences>,
        <https://1145.am/db/2544074/Nitin_Lifesciences>,
        <https://1145.am/db/2544452/Nitin_Lifesciences>,
        <https://1145.am/db/2546440/Nitin_Lifesciences>,
        <https://1145.am/db/2547189/Nitin_Lifesciences>,
        <https://1145.am/db/2548222/Nitin_Lifesciences>,
        <https://1145.am/db/2564490/Nitin_Lifesciences> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2548449/China_Cord_Blood_Corporation_Equity_Interest_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "ipo" ;
    ns1:documentDate "2016-01-12T13:45:13+00:00"^^xsd:dateTime ;
    ns1:documentExtract "HONG KONG, Jan. 7, 2016 /PRNewswire/ - Golden Meditech Holdings Limited (SEHK stock code: 801, TWSE stock code: 910801) (\"Golden Meditech\" or the \"Company\", together with its subsidiaries, the \"Group\") , a leading integrated healthcare enterprise in China, announces that it entered into a conditional sale and purchase agreement with Nanjing Xinjiekou Department Store Co., Ltd. (SSE stock code: 600682) (\"Nanjing Xinjiekou\") on 6 January 2016 regarding the disposal of its 65.4 % equity interest (fully diluted) in China Cord Blood Corporation (NYSE stock code: CO) (\"CCBC\") for a total consideration of approximately RMB 5.76 billion." ;
    ns1:documentTitle "Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China Cord Blood Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma-asia/golden-meditech-enters-into-agreements-nanjing-xinjiekou-to-sell-china-cord-blood> ;
    ns1:foundName "disposal",
        "issue",
        "purchase",
        "sale" ;
    ns1:name "disposal",
        "issue",
        "purchase",
        "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2548449/China_Cord_Blood_Corporation>,
        <https://1145.am/db/2548449/Golden_Meditech_Holdings_Limited> ;
    ns1:targetDetails "equity interest" ;
    ns1:targetName "China Cord Blood Corporation" ;
    ns1:valueRaw "RMB2.5 billion",
        "approximately RMB 5.76 billion",
        "approximately RMB3.26 billion",
        "approximately US $ 504.8 million" ;
    ns1:vendor <https://1145.am/db/2548449/Golden_Meditech_Holdings_Limited> ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2548449/Golden_Meditech_Holdings_Limited> a org:Organization ;
    ns1:basedInHighGeoName "Peoples Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:description "Healthcare" ;
    ns1:documentDate "2016-01-12T13:45:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Golden Meditech Enters into Agreements with Nanjing Xinjiekou to Sell China Cord Blood Corporation" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma-asia/golden-meditech-enters-into-agreements-nanjing-xinjiekou-to-sell-china-cord-blood> ;
    ns1:foundName "Golden Meditech Holdings Limited" ;
    ns1:industry "healthcare" ;
    ns1:name "Golden Meditech Holdings Limited" ;
    ns1:sameAsHigh <https://1145.am/db/2539088/Golden_Meditech_Holdings_Limited>,
        <https://1145.am/db/2572395/Golden_Meditech_Holdings_Limited> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2570523/Series_A_Investment_Checkmate_Pharmaceuticals_Cytos_Biotechnology_Ltd_Sofinnova_Ventures_Venbio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-17T19:59:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass.- (BUSINESS WIRE) -Checkmate Pharmaceuticals, a biopharmaceutical company focused on developing novel approaches for cancer immunotherapy, announced today their $ 20 million Series A financing from Sofinnova Ventures and venBio." ;
    ns1:documentTitle "Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/checkmate-pharmaceuticals-debuts-20-million-series-a-investment-for-development-of> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2570523/Checkmate_Pharmaceuticals>,
        <https://1145.am/db/2570523/Cytos_Biotechnology_Ltd> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 20 million" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2578827/Roxane_Labs_Assets_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Boehringer is considering swapping assets or selling its Roxane Labs unit, with Hikma, Mallinckrodt and Perrigo reportedly laying down proposals." ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "selling",
        "swapping" ;
    ns1:name "selling",
        "swapping" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2578827/Roxane_Labs> ;
    ns1:targetDetails "assets" ;
    ns1:targetName "Roxane Labs" ;
    ns1:vendor <https://1145.am/db/2578827/Boehringer> ;
    ns1:whereGeoName "Columbus" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4509177/about.rdf> ;
    ns1:whereRaw "Columbus, OH" .

<https://1145.am/db/2578827/Unit_Acquisition_Boehringer_Hikma_Mallinckrodt_Perrigo_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Boehringer is considering swapping assets or selling its Roxane Labs unit, with Hikma, Mallinckrodt and Perrigo reportedly laying down proposals." ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "selling" ;
    ns1:name "selling" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:targetDetails "unit" ;
    ns1:vendor <https://1145.am/db/2578827/Boehringer> ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "German" .

<https://1145.am/db/2584561/Redmile_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Redmile Group" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Redmile Group" ;
    ns1:sameAsMedium <https://1145.am/db/1086649/Redmile_Group>,
        <https://1145.am/db/1192327/Redmile_Group>,
        <https://1145.am/db/1533327/Redmile_Group>,
        <https://1145.am/db/1533685/Redmile_Group>,
        <https://1145.am/db/1752458/Redmile_Group>,
        <https://1145.am/db/1813216/Redmile_Group>,
        <https://1145.am/db/1822362/Redmile_Group>,
        <https://1145.am/db/1837663/Redmile_Group>,
        <https://1145.am/db/1984721/Redmile_Group>,
        <https://1145.am/db/2075963/Redmile_Group>,
        <https://1145.am/db/2080575/Redmile_Group>,
        <https://1145.am/db/2089412/Redmile_Group>,
        <https://1145.am/db/2152126/Redmile_Group>,
        <https://1145.am/db/2224478/Redmile_Group>,
        <https://1145.am/db/2236068/Redmile_Group>,
        <https://1145.am/db/2281211/Redmile_Group>,
        <https://1145.am/db/2285762/Redmile_Group>,
        <https://1145.am/db/2291414/Redmile_Group>,
        <https://1145.am/db/2291716/Redmile_Group>,
        <https://1145.am/db/2292160/Redmile_Group>,
        <https://1145.am/db/2307889/Redmile_Group>,
        <https://1145.am/db/2308540/Redmile_Group>,
        <https://1145.am/db/2321658/Redmile_Group>,
        <https://1145.am/db/2335748/Redmile_Group>,
        <https://1145.am/db/2341595/Redmile_Group>,
        <https://1145.am/db/2341599/Redmile_Group>,
        <https://1145.am/db/2360277/Redmile_Group>,
        <https://1145.am/db/2361695/Redmile_Group>,
        <https://1145.am/db/2362106/Redmile_Group>,
        <https://1145.am/db/2367043/Redmile_Group>,
        <https://1145.am/db/2368070/Redmile_Group>,
        <https://1145.am/db/2369304/Redmile_Group>,
        <https://1145.am/db/2371160/Redmile_Group>,
        <https://1145.am/db/2371163/Redmile_Group>,
        <https://1145.am/db/342182/Redmile_Group>,
        <https://1145.am/db/577785/Redmile_Group>,
        <https://1145.am/db/585936/Redmile_Group>,
        <https://1145.am/db/602316/Redmile_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2584561/Versant_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "SAN FRANCISCO" ;
    ns1:description "biotechnology investors" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Versant Ventures" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1659694/Sis_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2354296/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586575/Amdipharm_Mercury_Limited_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-09-08T15:25:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "OAKVILLE, ON, Sept. 8, 2015 /CNW/ - Concordia Healthcare Corp. (\"Concordia\" or the \"Company\") (NASDAQ: CXRX) (TSX: CXR) today announced it has entered into a definitive agreement with Cinven1, a leading European private equity firm, and certain funds managed by it (collectively, \"Cinven\") and certain other persons, to acquire Amdipharm Mercury Limited (\"AMCo\") for approximately US $ 3.5 billion2 to be paid through a combination of cash, common shares of Concordia, and performance - based earn-out payable in cash." ;
    ns1:documentTitle "Concordia Healthcare to Acquire Amdipharm Mercury Limited (AMCo) for US$3.5 Billion Creating a Global Platform to Facilitate Future Growth" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/concordia-healthcare-to-acquire-amdipharm-mercury-limited-amco-for-us-3-5-billion-creating-a> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2586575/Amdipharm_Mercury_Limited> ;
    ns1:targetName "Amdipharm Mercury Limited" ;
    ns1:valueRaw "approximately US $ 3.5 billion2" ;
    ns1:vendor <https://1145.am/db/2586575/Concordia_Healthcare_Corp> .

<https://1145.am/db/2587565/Dna_Diagnostics_Center> a org:Organization ;
    ns1:description "DNA testing" ;
    ns1:documentDate "2015-10-15T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GHO Capital Announces Acquisition of DNA Diagnostics Center" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/gho-capital-announces-acquisition-of-dna-diagnostics-center> ;
    ns1:foundName "DNA Diagnostics Center" ;
    ns1:industry "healthcare" ;
    ns1:name "DNA Diagnostics Center" ;
    ns1:sameAsHigh <https://1145.am/db/2304997/Dna_Diagnostics_Center>,
        <https://1145.am/db/2327071/Dna_Diagnostics>,
        <https://1145.am/db/2587566/Dna_Diagnostics> ;
    ns1:sameAsMedium <https://1145.am/db/2346331/Dna_Diagnostics_Center> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2587565/Dna_Diagnostics_Center_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-10-15T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "GHO Capital Announces Acquisition of DNA Diagnostics Center.",
        "LONDON- (BUSINESS WIRE) -GHO Capital, the European specialist healthcare investor, today announces the acquisition of DNA Diagnostics Center (DDC or the Company) , a world leader in the provision of specialist DNA - based diagnostic services, for a total transaction value of 104 million." ;
    ns1:documentTitle "GHO Capital Announces Acquisition of DNA Diagnostics Center" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/gho-capital-announces-acquisition-of-dna-diagnostics-center> ;
    ns1:foundName "Acquisition",
        "acquisition" ;
    ns1:name "Acquisition",
        "acquisition" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2587565/Dna_Diagnostics_Center> ;
    ns1:targetName "DNA Diagnostics Center" ;
    ns1:valueRaw "104 million" ;
    ns1:whereGeoName "Daylight",
        "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf>,
        <https://sws.geonames.org/4617522/about.rdf> ;
    ns1:whereRaw "Eastern Daylight Time" .

<https://1145.am/db/2588578/Investment_Institute_For_Infectious_Diseases_Science_And_Technology_Directorate_Texas_A___M_College_Of_Veterinary_Medicine___Biomedical_Sciences_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The Texas A & M College of Veterinary Medicine & Biomedical Sciences received $ 1.2 million from the Department of Homeland Security's Science and Technology Directorate and the Institute for Infectious Diseases to develop a program that will teach animal researchers to commercialize their discoveries." ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "received" ;
    ns1:name "received" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2588578/Texas_A___M_College_Of_Veterinary_Medicine___Biomedical_Sciences> ;
    ns1:valueRaw "$ 1.2 million" ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2588578/Joint_Venture_The_Us_State_Department_Agriculture_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2015-11-30T13:27:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The U.S. State Department announced it has formed a research partnership with Ireland's agriculture industry focused largely on animal nutrition, reproduction and health." ;
    ns1:documentTitle "Zoetis and Voyce launch pain study in dogs; Sequent picks up Topkim for $7.1M; U.S. partners with Ireland on animal-health research;" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/zoetis-and-voyce-launch-pain-study-dogs-sequent-picks-up-topkim-for-7-1m-u-s-partners> ;
    ns1:foundName "formed" ;
    ns1:name "formed" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2963597/about.rdf> ;
    ns1:whereRaw "Ireland" .

<https://1145.am/db/2588584/Compendium_Of_Veterinary_Products> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "providing product labeling information and safety data sheets covering more than 14,000 products for animals" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "the Compendium of Veterinary Products" ;
    ns1:name "Compendium of Veterinary Products" ;
    ns1:sameAsHigh <https://1145.am/db/2588580/Compendium_Of_Veterinary_Products>,
        <https://1145.am/db/2588580/North_American_Compendiums>,
        <https://1145.am/db/2588584/North_American_Compendiums> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588584/Investment_Henry_Schein_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Henry Schein ($ HSIC) announced that its board of directors has authorized a $ 400 million share buyback program, adding to the $ 300 million share repurchase the company announced last December." ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "buyback" ;
    ns1:name "buyback" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2588584/Henry_Schein> ;
    ns1:targetName "Henry Schein" ;
    ns1:valueRaw "$ 300 million",
        "$ 400 million" ;
    ns1:whereGeoName "Commonwealth of Australia",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2077456/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "Australia",
        "United States" .

<https://1145.am/db/2588584/North_American_Compendiums> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:description "provides product labeling information and safety data sheets covering more than 14,000 products for animals" ;
    ns1:documentDate "2015-12-07T13:57:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Animalytix expands to Canada with acquisition of animal-health data service; Schein authorizes $400M share buyback; Jaguar launches drug study in horses with colitis; IAH tests oral fly repellent in beef cows; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-animalytix-expands-to-canada-acquisition-of-animal-health-data-service> ;
    ns1:foundName "North American Compendiums of Ontario" ;
    ns1:name "North American Compendiums" ;
    ns1:sameAsHigh <https://1145.am/db/2588580/Compendium_Of_Veterinary_Products>,
        <https://1145.am/db/2588580/North_American_Compendiums>,
        <https://1145.am/db/2588584/Compendium_Of_Veterinary_Products> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/Animal_Health_Giant> a org:Organization ;
    ns1:basedInLowRaw "Bulgaria" ;
    ns1:description "Animal health" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Animal health giant" ;
    ns1:industry "Animal health" ;
    ns1:name "Animal health giant" ;
    ns1:sameAsHigh <https://1145.am/db/1135981/Inovet>,
        <https://1145.am/db/1576959/Amlan_International>,
        <https://1145.am/db/194881/Elanco_Animal_Health>,
        <https://1145.am/db/2108474/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/227172/Elanco_Animal_Health>,
        <https://1145.am/db/2571525/Lohmann>,
        <https://1145.am/db/2579831/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2581822/Integrated_Animal_Health>,
        <https://1145.am/db/2582942/Lohmann_Se>,
        <https://1145.am/db/2583729/Jorgen_Kruuse>,
        <https://1145.am/db/2586602/Integrated_Animal_Health>,
        <https://1145.am/db/2588580/Animalytix>,
        <https://1145.am/db/2588584/Animalytix>,
        <https://1145.am/db/2589960/Abbott_Animal_Health>,
        <https://1145.am/db/2590465/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2590487/Phibro_Animal_Health_Corporation>,
        <https://1145.am/db/2593450/Phw_Group>,
        <https://1145.am/db/636823/Amlan_International>,
        <https://1145.am/db/658410/Covenant_Animal_Health_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Eli_Lilly_Novartis_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Novartis ($ NVS) India completed the sale of its assets to Elanco India, an affiliate of Eli Lilly ($ LLY) .",
        "> Novartis ($ NVS) India completed the sale of its assets to Elanco India, an affiliate of Eli Lilly ($ LLY)." ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:targetDetails "assets" ;
    ns1:vendor <https://1145.am/db/2589535/Elanco_India>,
        <https://1145.am/db/2589535/Novartis> ;
    ns1:whereGeoName "Colorado",
        "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf>,
        <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "North Carolina and Colorado" .

<https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Jaguar_Animal_Health_Novartis_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Novartis ($ NVS) India completed the sale of its assets to Elanco India, an affiliate of Eli Lilly ($ LLY) ." ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "sale" ;
    ns1:name "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:targetDetails "assets" ;
    ns1:vendor <https://1145.am/db/2589535/Novartis> ;
    ns1:whereGeoName "Colorado",
        "North Carolina" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4482348/about.rdf>,
        <https://sws.geonames.org/5417618/about.rdf> ;
    ns1:whereRaw "North Carolina and Colorado" .

<https://1145.am/db/2589535/Eli_Lilly> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Eli Lilly" ;
    ns1:name "Eli Lilly" ;
    ns1:participant <https://1145.am/db/2589535/Assets_Acquisition_Elanco_India_Eli_Lilly_Novartis_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/1038901/Eli_Lilly_And_Company>,
        <https://1145.am/db/1087869/Eli_Lilly_And_Company>,
        <https://1145.am/db/1217359/Eli_Lilly_And_Company>,
        <https://1145.am/db/1272276/Eli_Lilly_And_Company>,
        <https://1145.am/db/1272276/Lilly>,
        <https://1145.am/db/1340338/Eli_Lilly_And_Company>,
        <https://1145.am/db/1425255/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Lilly>,
        <https://1145.am/db/1432746/Eli_Lilly>,
        <https://1145.am/db/1534004/Eli_Lilly_And_Company>,
        <https://1145.am/db/1534438/Eli_Lilly_And_Company>,
        <https://1145.am/db/1553175/Eli_Lilly___Company>,
        <https://1145.am/db/1553459/Eli_Lilly___Company>,
        <https://1145.am/db/1663572/Eli_Lilly_And_Company>,
        <https://1145.am/db/174741/Eli_Lilly_And_Co>,
        <https://1145.am/db/1979697/Eli_Lilly>,
        <https://1145.am/db/1984558/Eli_Lilly_And_Company>,
        <https://1145.am/db/2045539/Eli_Lilly_And_Company>,
        <https://1145.am/db/2055009/Eli_Lilly_And_Company>,
        <https://1145.am/db/2058865/Eli_Lilly_And_Company>,
        <https://1145.am/db/2065629/Eli_Lilly_And_Company>,
        <https://1145.am/db/2134678/Eli_Lilly_And_Co>,
        <https://1145.am/db/2136466/Eli_Lilly_And_Co>,
        <https://1145.am/db/2139015/Eli_Lilly_And_Company>,
        <https://1145.am/db/2154391/Eli_Lilly>,
        <https://1145.am/db/2155453/Lilly_Usa>,
        <https://1145.am/db/2281211/Eli_Lilly>,
        <https://1145.am/db/2282739/Eli_Lilly>,
        <https://1145.am/db/2282930/Eli_Lilly>,
        <https://1145.am/db/2283595/Eli_Lilly>,
        <https://1145.am/db/2284615/Lilly>,
        <https://1145.am/db/2285156/Eli_Lilly>,
        <https://1145.am/db/2285525/Eli_Lilly>,
        <https://1145.am/db/2286402/Eli_Lilly>,
        <https://1145.am/db/2286404/Eli_Lilly>,
        <https://1145.am/db/2286911/Eli_Lilly>,
        <https://1145.am/db/2286998/Eli_Lilly>,
        <https://1145.am/db/2287005/Eli_Lilly>,
        <https://1145.am/db/2288158/Eli_Lilly>,
        <https://1145.am/db/229232/Eli_Lilly>,
        <https://1145.am/db/2294118/Eli_Lilly>,
        <https://1145.am/db/2298022/Eli_Lilly>,
        <https://1145.am/db/2299157/Eli_Lilly>,
        <https://1145.am/db/2301879/Eli_Lilly_And_Company>,
        <https://1145.am/db/2302104/Eli_Lilly_And_Company>,
        <https://1145.am/db/2305497/Eli_Lilly>,
        <https://1145.am/db/2306807/Eli_Lilly_And_Company>,
        <https://1145.am/db/2307651/Eli_Lilly>,
        <https://1145.am/db/2309473/Eli_Lilly>,
        <https://1145.am/db/2316092/Eli_Lilly>,
        <https://1145.am/db/2316549/Eli_Lilly>,
        <https://1145.am/db/2320006/Eli_Lilly>,
        <https://1145.am/db/2320338/Eli_Lilly>,
        <https://1145.am/db/2323165/Eli_Lilly_And_Company>,
        <https://1145.am/db/2326272/Lilly_Usa>,
        <https://1145.am/db/2327587/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328527/Eli_Lilly>,
        <https://1145.am/db/2328554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328718/Eli_Lilly>,
        <https://1145.am/db/2329107/Lilly>,
        <https://1145.am/db/2329114/Eli_Lilly>,
        <https://1145.am/db/2329115/Lilly>,
        <https://1145.am/db/2334645/Eli_Lilly>,
        <https://1145.am/db/2335594/Eli_Lilly_And_Company>,
        <https://1145.am/db/2336074/Eli_Lilly_And_Company>,
        <https://1145.am/db/2338059/Eli_Lilly>,
        <https://1145.am/db/2342503/Eli_Lilly_And_Company>,
        <https://1145.am/db/2343945/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344800/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344808/Eli_Lilly>,
        <https://1145.am/db/2344991/Eli_Lilly>,
        <https://1145.am/db/2345213/Eli_Lilly>,
        <https://1145.am/db/2345214/Eli_Lilly>,
        <https://1145.am/db/2346629/Novo_Nordisk_Eli_Lilly>,
        <https://1145.am/db/2349020/Eli_Lilly_And_Company>,
        <https://1145.am/db/2349300/Eli_Lilly_And_Company>,
        <https://1145.am/db/2353350/Eli_Lilly>,
        <https://1145.am/db/2354761/Eli_Lilly_And_Company>,
        <https://1145.am/db/2354853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2359240/Eli_Lilly>,
        <https://1145.am/db/2363310/Eli_Lilly_And_Company_(lly)>,
        <https://1145.am/db/2366948/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366948/Lilly>,
        <https://1145.am/db/2366953/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366953/Lilly>,
        <https://1145.am/db/2368562/Eli_Lilly_And_Company>,
        <https://1145.am/db/2369000/Eli_Lilly_And_Company>,
        <https://1145.am/db/2370162/Eli_Lilly>,
        <https://1145.am/db/2371016/Eli_Lilly>,
        <https://1145.am/db/2371058/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Lilly>,
        <https://1145.am/db/2536960/Eli_Lilly>,
        <https://1145.am/db/2537335/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537665/Eli_Lilly>,
        <https://1145.am/db/2537817/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537826/Eli_Lilly_And_Company>,
        <https://1145.am/db/2539287/Eli_Lilly>,
        <https://1145.am/db/2539970/Eli_Lilly>,
        <https://1145.am/db/2543185/Eli_Lilly>,
        <https://1145.am/db/2545618/Eli_Lilly>,
        <https://1145.am/db/2549450/Eli_Lilly>,
        <https://1145.am/db/2550996/Eli_Lilly>,
        <https://1145.am/db/2551101/Eli_Lilly>,
        <https://1145.am/db/2553131/Eli_Lilly>,
        <https://1145.am/db/2553551/Eli_Lilly>,
        <https://1145.am/db/2556906/Eli_Lilly_And_Company>,
        <https://1145.am/db/2556969/Eli_Lilly>,
        <https://1145.am/db/2559125/Eli_Lilly_And_Company>,
        <https://1145.am/db/2560487/Eli_Lilly>,
        <https://1145.am/db/2562442/Eli_Lilly>,
        <https://1145.am/db/2564389/Eli_Lilly___Co>,
        <https://1145.am/db/2566845/Lilly>,
        <https://1145.am/db/2567343/Eli_Lilly>,
        <https://1145.am/db/2572312/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572711/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572711/Lilly>,
        <https://1145.am/db/2572957/Eli_Lilly_And_Company>,
        <https://1145.am/db/2573885/Eli_Lilly>,
        <https://1145.am/db/2575554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2575909/Eli_Lilly>,
        <https://1145.am/db/2576171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576462/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576892/Eli_Lilly>,
        <https://1145.am/db/2576933/Eli_Lilly>,
        <https://1145.am/db/2576944/Eli_Lilly>,
        <https://1145.am/db/2577171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578048/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578874/Eli_Lilly>,
        <https://1145.am/db/2578876/Eli_Lilly_And_Company>,
        <https://1145.am/db/2580140/Boehringer_Ingelheim_And_Eli_Lilly>,
        <https://1145.am/db/2581257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581745/Eli_Lilly_And_Company>,
        <https://1145.am/db/2583703/Eli_Lilly>,
        <https://1145.am/db/2584766/Eli_Lilly_And_Company>,
        <https://1145.am/db/2585710/Eli_Lilly>,
        <https://1145.am/db/2586025/Lilly>,
        <https://1145.am/db/2587215/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587605/Elanco>,
        <https://1145.am/db/2587605/Eli_Lilly>,
        <https://1145.am/db/2587853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589700/Eli_Lilly>,
        <https://1145.am/db/2590071/Eli_Lilly_And_Company>,
        <https://1145.am/db/2590486/Eli_Lilly>,
        <https://1145.am/db/2590997/Eli_Lilly_And_Company>,
        <https://1145.am/db/2591001/Eli_Lilly>,
        <https://1145.am/db/2591708/Eli_Lilly_And_Company>,
        <https://1145.am/db/2593780/Eli_Lilly>,
        <https://1145.am/db/2594485/Eli_Lilly_And_Company>,
        <https://1145.am/db/2594494/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597855/Eli_Lilly_And_Company>,
        <https://1145.am/db/264619/Eli_Lilly_And_Co>,
        <https://1145.am/db/768105/Eli_Lilly>,
        <https://1145.am/db/86786/Eli_Lilly_And_Co> ;
    ns1:sameAsMedium <https://1145.am/db/1072187/Eli_Lilly_And_Company>,
        <https://1145.am/db/1121894/Eli_Lilly_And_Company>,
        <https://1145.am/db/1546070/Eli_Lilly_And_Company>,
        <https://1145.am/db/2062260/Eli_Lilly>,
        <https://1145.am/db/2109798/Eli_Lilly_And_Company>,
        <https://1145.am/db/2154037/Eli_Lilly>,
        <https://1145.am/db/2279118/Eli_Lilly>,
        <https://1145.am/db/2280616/Eli_Lilly>,
        <https://1145.am/db/2285189/Eli_Lilly>,
        <https://1145.am/db/2286126/Eli_Lilly>,
        <https://1145.am/db/2286379/Eli_Lilly>,
        <https://1145.am/db/2286617/Eli_Lilly>,
        <https://1145.am/db/2304319/Eli_Lilly_And_Company>,
        <https://1145.am/db/2305501/Eli_Lilly_And_Company>,
        <https://1145.am/db/2309599/Eli_Lilly>,
        <https://1145.am/db/2310738/Eli_Lilly>,
        <https://1145.am/db/2314412/Eli_Lilly_And_Company>,
        <https://1145.am/db/2315325/Eli_Lilly>,
        <https://1145.am/db/2317682/Eli_Lilly>,
        <https://1145.am/db/2318587/Eli_Lilly>,
        <https://1145.am/db/2322619/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325557/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328522/Eli_Lilly>,
        <https://1145.am/db/2328633/Eli_Lilly>,
        <https://1145.am/db/2329915/Eli_Lilly_And_Company>,
        <https://1145.am/db/2340948/Eli_Lilly>,
        <https://1145.am/db/2341481/Eli_Lilly>,
        <https://1145.am/db/2341496/Eli_Lilly>,
        <https://1145.am/db/2349001/Eli_Lilly_And_Company>,
        <https://1145.am/db/2352358/Eli_Lilly>,
        <https://1145.am/db/2360338/Eli_Lilly>,
        <https://1145.am/db/2361027/Eli_Lilly>,
        <https://1145.am/db/2361510/Eli_Lilly>,
        <https://1145.am/db/2364605/Eli_Lilly>,
        <https://1145.am/db/2365178/Eli_Lilly_And_Company>,
        <https://1145.am/db/2368321/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537666/Eli_Lilly>,
        <https://1145.am/db/2551049/Eli_Lilly>,
        <https://1145.am/db/2560025/Eli_Lilly>,
        <https://1145.am/db/2561357/Eli_Lilly>,
        <https://1145.am/db/2561960/Eli_Lilly>,
        <https://1145.am/db/2562576/Eli_Lilly>,
        <https://1145.am/db/2562999/Eli_Lilly>,
        <https://1145.am/db/2569829/Eli_Lilly>,
        <https://1145.am/db/2569849/Eli_Lilly_And_Company>,
        <https://1145.am/db/2574950/Eli_Lilly>,
        <https://1145.am/db/2575947/Eli_Lilly>,
        <https://1145.am/db/2575972/Eli_Lilly>,
        <https://1145.am/db/2576086/Eli_Lilly>,
        <https://1145.am/db/2576460/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576858/Eli_Lilly___Co>,
        <https://1145.am/db/2576939/Eli_Lilly>,
        <https://1145.am/db/2578603/Eli_Lilly>,
        <https://1145.am/db/2581804/Eli_Lilly>,
        <https://1145.am/db/2584135/Eli_Lilly>,
        <https://1145.am/db/2585144/Eli_Lilly_And_Company>,
        <https://1145.am/db/2586687/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587690/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587699/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589156/Eli_Lilly_And_Company>,
        <https://1145.am/db/2593456/Eli_Lilly_And_Company>,
        <https://1145.am/db/2596644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2598317/Eli_Lilly>,
        <https://1145.am/db/461671/Eli_Lilly_And_Company> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2661936/O2_Uk> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "business" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "O2 UK" ;
    ns1:name "O2 UK" ;
    ns1:sameAsHigh <https://1145.am/db/2202776/Opi_Sa>,
        <https://1145.am/db/2632668/O2>,
        <https://1145.am/db/2656247/O2>,
        <https://1145.am/db/2676558/O2_Uk>,
        <https://1145.am/db/755877/Odl>,
        <https://1145.am/db/756454/Odl> ;
    ns1:sameAsMedium <https://1145.am/db/1797744/O2>,
        <https://1145.am/db/1800033/O2>,
        <https://1145.am/db/2167342/O2>,
        <https://1145.am/db/249513/O2>,
        <https://1145.am/db/2624908/O2>,
        <https://1145.am/db/2625430/O2>,
        <https://1145.am/db/2629007/O2_Uk>,
        <https://1145.am/db/2638379/O2>,
        <https://1145.am/db/2640353/O2>,
        <https://1145.am/db/2643386/O2>,
        <https://1145.am/db/2650576/O2>,
        <https://1145.am/db/2651002/O2_Uk>,
        <https://1145.am/db/2651015/O2_Uk>,
        <https://1145.am/db/2651408/O2>,
        <https://1145.am/db/2651412/O2_Uk>,
        <https://1145.am/db/2651420/O2_Uk>,
        <https://1145.am/db/2651763/O2_Uk>,
        <https://1145.am/db/2651770/O2_Uk>,
        <https://1145.am/db/2653074/O2>,
        <https://1145.am/db/2653163/O2_Uk>,
        <https://1145.am/db/2653961/O2_Uk>,
        <https://1145.am/db/2654863/O2_Uk>,
        <https://1145.am/db/2654874/O2>,
        <https://1145.am/db/2657696/O2>,
        <https://1145.am/db/2659254/O2_Uk>,
        <https://1145.am/db/2660028/O2>,
        <https://1145.am/db/2661978/O2_Uk>,
        <https://1145.am/db/2664098/O2_Uk>,
        <https://1145.am/db/2664216/O2>,
        <https://1145.am/db/2665206/O2_Uk>,
        <https://1145.am/db/2666440/O2>,
        <https://1145.am/db/2667333/O2_Uk>,
        <https://1145.am/db/2667342/O2_Uk>,
        <https://1145.am/db/2667366/O2_Uk>,
        <https://1145.am/db/2668411/O2_Uk>,
        <https://1145.am/db/2668412/O2_Uk>,
        <https://1145.am/db/2669513/O2_Uk>,
        <https://1145.am/db/2670595/O2>,
        <https://1145.am/db/2671778/O2_Uk>,
        <https://1145.am/db/2671784/O2>,
        <https://1145.am/db/2671802/O2_Uk>,
        <https://1145.am/db/2671812/O2_Uk>,
        <https://1145.am/db/2672973/O2_Uk>,
        <https://1145.am/db/2672991/O2_Uk>,
        <https://1145.am/db/2682569/O2>,
        <https://1145.am/db/337315/O2>,
        <https://1145.am/db/80938/O2>,
        <https://1145.am/db/80982/O2>,
        <https://1145.am/db/90656/O2> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661936/O2_Uk_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Financial Times reported that CK Hutchison, which wants to buy O2 UK from Telefnica and merge it with Three UK in a deal worth 10.3 billion (14 billion/ $ 16 billion) , has discussed the possibility of an initial public offering (IPO) for the combined business with external investors that have already committed 3 billion to fund the deal." ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "buy",
        "initial public offering",
        "merge" ;
    ns1:name "buy",
        "initial public offering",
        "merge" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2661936/O2_Uk> ;
    ns1:targetName "O2 UK" ;
    ns1:valueRaw "$ 16 billion",
        "10.3 billion",
        "3 billion",
        "14 billion" ;
    ns1:vendor <https://1145.am/db/2661936/Telefnica> ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2661936/Telefnica> a org:Organization ;
    ns1:basedInLowRaw "Hong Kong" ;
    ns1:description "business" ;
    ns1:documentDate "2015-09-21T09:15:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Hutchison mulls IPO for merged O2-Three, but deeper EU probe looms" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/hutchison-mulls-ipo-for-merged-o2-three-but-deeper-eu-probe-looms> ;
    ns1:foundName "Telefnica" ;
    ns1:name "Telefnica" ;
    ns1:sameAsHigh <https://1145.am/db/1069736/Telefonica>,
        <https://1145.am/db/1231195/Telefonica>,
        <https://1145.am/db/1285688/Telefonica>,
        <https://1145.am/db/1382369/Telefonica>,
        <https://1145.am/db/1671318/Telefonica>,
        <https://1145.am/db/1735164/Telefonica>,
        <https://1145.am/db/1739933/Telefnica>,
        <https://1145.am/db/1914280/Telefnica_Europe>,
        <https://1145.am/db/2057136/Telefonica>,
        <https://1145.am/db/2157611/Telefnica>,
        <https://1145.am/db/2173980/Teliasonera>,
        <https://1145.am/db/255451/Telefonica_Sa>,
        <https://1145.am/db/2600640/Telefonica>,
        <https://1145.am/db/2602241/Telefonica_Uk>,
        <https://1145.am/db/2602311/Telefonica>,
        <https://1145.am/db/2605344/Telefonica_Sa>,
        <https://1145.am/db/2610778/Telefonica>,
        <https://1145.am/db/2611525/Teliasonera>,
        <https://1145.am/db/2613293/Telefonica>,
        <https://1145.am/db/2616305/Telefonica>,
        <https://1145.am/db/2617659/Telefonica>,
        <https://1145.am/db/2624746/Telefonica>,
        <https://1145.am/db/2625103/Teliasonera>,
        <https://1145.am/db/2648631/Telefnica>,
        <https://1145.am/db/2651361/Telefnica>,
        <https://1145.am/db/2651420/Telefnica>,
        <https://1145.am/db/2651498/Telefnica>,
        <https://1145.am/db/2651815/Teliasonera>,
        <https://1145.am/db/2652052/Telefonica>,
        <https://1145.am/db/2652760/Telefonica>,
        <https://1145.am/db/2652795/Telefonica>,
        <https://1145.am/db/2653604/Telefonica>,
        <https://1145.am/db/2655251/Telefonica>,
        <https://1145.am/db/2655754/Teliasonera>,
        <https://1145.am/db/2657196/Telefonica>,
        <https://1145.am/db/2657460/Telefonica>,
        <https://1145.am/db/2657933/Telefonica_Group>,
        <https://1145.am/db/2659115/Telefonica>,
        <https://1145.am/db/2659938/Telefnica>,
        <https://1145.am/db/2660250/Telefonica>,
        <https://1145.am/db/2661028/Teliasonera>,
        <https://1145.am/db/2661338/Telefonica>,
        <https://1145.am/db/2663040/Teliasonera>,
        <https://1145.am/db/2663257/Telefonica_Moviles>,
        <https://1145.am/db/2663738/Teliasonera>,
        <https://1145.am/db/2663846/Teliasonera>,
        <https://1145.am/db/2664470/Telefnica>,
        <https://1145.am/db/2665345/Telefnica>,
        <https://1145.am/db/2666446/Telefonica>,
        <https://1145.am/db/2668530/Telefonica>,
        <https://1145.am/db/2668591/Telefnica>,
        <https://1145.am/db/2670617/Telefnica>,
        <https://1145.am/db/2670631/Telefnica>,
        <https://1145.am/db/2670729/Telefnica>,
        <https://1145.am/db/2671793/Telefnica_Mexico>,
        <https://1145.am/db/2671938/Telefnica>,
        <https://1145.am/db/2672143/Telefonica>,
        <https://1145.am/db/2674289/Telefnica>,
        <https://1145.am/db/2674820/Teliasonera>,
        <https://1145.am/db/2675459/Telefnica>,
        <https://1145.am/db/2675499/Teliasonera>,
        <https://1145.am/db/2676038/Teliasonera>,
        <https://1145.am/db/2678311/Telefonica_Sa>,
        <https://1145.am/db/2678426/Teliasonera>,
        <https://1145.am/db/2679002/Telefnica>,
        <https://1145.am/db/2680056/Telefnica>,
        <https://1145.am/db/2681028/Telefonica>,
        <https://1145.am/db/2681079/Telefonica>,
        <https://1145.am/db/327861/Telefonica>,
        <https://1145.am/db/334351/Telefonica>,
        <https://1145.am/db/334414/Telefonica>,
        <https://1145.am/db/346206/Telefonica>,
        <https://1145.am/db/372003/Telefonica>,
        <https://1145.am/db/372697/Telefonica>,
        <https://1145.am/db/377907/Telefonica>,
        <https://1145.am/db/538065/Telefonica>,
        <https://1145.am/db/80938/Telefonica_Sa>,
        <https://1145.am/db/80982/Telefonica_Sa>,
        <https://1145.am/db/85758/Telefonica>,
        <https://1145.am/db/87741/Telefonica>,
        <https://1145.am/db/87823/Telefonica> ;
    ns1:sameAsMedium <https://1145.am/db/107126/Telefonica>,
        <https://1145.am/db/1104836/Telefonica>,
        <https://1145.am/db/131936/Telefonica>,
        <https://1145.am/db/1681856/Telefonica>,
        <https://1145.am/db/1742133/Telefnica>,
        <https://1145.am/db/1757691/Telefonica>,
        <https://1145.am/db/1797744/Telefonica>,
        <https://1145.am/db/1817110/Telefonica>,
        <https://1145.am/db/1889714/Telefonica>,
        <https://1145.am/db/2108234/Telefonica>,
        <https://1145.am/db/2108651/Telefonica>,
        <https://1145.am/db/2109170/Telefonica>,
        <https://1145.am/db/2165758/Telefonica_Sa>,
        <https://1145.am/db/2599743/Telefonica>,
        <https://1145.am/db/2605327/Telefonica>,
        <https://1145.am/db/2608993/Telefonica>,
        <https://1145.am/db/2613788/Telefonica>,
        <https://1145.am/db/2615714/Telefonica>,
        <https://1145.am/db/2616555/Telefonica>,
        <https://1145.am/db/2616820/Telefonica>,
        <https://1145.am/db/2618904/Telefnica>,
        <https://1145.am/db/2619705/Telefonica>,
        <https://1145.am/db/2621829/Telefonica>,
        <https://1145.am/db/2623208/Telefonica>,
        <https://1145.am/db/2624439/Telefnica>,
        <https://1145.am/db/2624908/Telefonica>,
        <https://1145.am/db/2625430/Telefonica>,
        <https://1145.am/db/2625845/Telefnica>,
        <https://1145.am/db/2629007/Telefnica>,
        <https://1145.am/db/2632044/Telefnica>,
        <https://1145.am/db/2638379/Telefonica>,
        <https://1145.am/db/2640353/Telefonica>,
        <https://1145.am/db/2643386/Telefonica>,
        <https://1145.am/db/2648737/Telefnica>,
        <https://1145.am/db/2648747/Telefnica>,
        <https://1145.am/db/2650838/Telefonica>,
        <https://1145.am/db/2650838/Telefnica>,
        <https://1145.am/db/2651152/Telefonica>,
        <https://1145.am/db/2651408/Telefnica>,
        <https://1145.am/db/2651739/Telefonica>,
        <https://1145.am/db/2651770/Telefnica>,
        <https://1145.am/db/2651830/Telefnica>,
        <https://1145.am/db/2651853/Telefnica>,
        <https://1145.am/db/2651887/Telefnica>,
        <https://1145.am/db/2651900/Telefnica>,
        <https://1145.am/db/2652365/Telefnica>,
        <https://1145.am/db/2652398/Telefnica>,
        <https://1145.am/db/2652548/Telefnica>,
        <https://1145.am/db/2653961/Telefnica>,
        <https://1145.am/db/2653966/Telefnica>,
        <https://1145.am/db/2653986/Telefnica>,
        <https://1145.am/db/2654121/Telefnica>,
        <https://1145.am/db/2654161/Telefonica>,
        <https://1145.am/db/2654380/Telefonica>,
        <https://1145.am/db/2654609/Telefonica>,
        <https://1145.am/db/2654761/Telefnica>,
        <https://1145.am/db/2654874/Telefnica>,
        <https://1145.am/db/2654922/Telefnica>,
        <https://1145.am/db/2654999/Telefnica>,
        <https://1145.am/db/2655000/Telefnica>,
        <https://1145.am/db/2655584/Telefonica>,
        <https://1145.am/db/2655826/Telefnica>,
        <https://1145.am/db/2656202/Telefonica>,
        <https://1145.am/db/2656247/Telefonica_Sa>,
        <https://1145.am/db/2656800/Telefonica>,
        <https://1145.am/db/2656915/Telefnica>,
        <https://1145.am/db/2657718/Telefonica>,
        <https://1145.am/db/2657816/Telefnica>,
        <https://1145.am/db/2657893/Telefnica>,
        <https://1145.am/db/2658169/Telefonica>,
        <https://1145.am/db/2658441/Telefonica>,
        <https://1145.am/db/2658877/Telefnica>,
        <https://1145.am/db/2659845/Telefnica>,
        <https://1145.am/db/2659970/Telefnica>,
        <https://1145.am/db/2660028/Telefonica>,
        <https://1145.am/db/2660258/Telefonica>,
        <https://1145.am/db/2660601/Telefonica>,
        <https://1145.am/db/2661978/Telefnica>,
        <https://1145.am/db/2662037/Telefnica>,
        <https://1145.am/db/2662075/Telefnica>,
        <https://1145.am/db/2662436/Telefonica>,
        <https://1145.am/db/2662686/Telefonica>,
        <https://1145.am/db/2662689/Telefnica>,
        <https://1145.am/db/2662695/Telefnica>,
        <https://1145.am/db/2663180/Telefnica>,
        <https://1145.am/db/2664098/Telefonica>,
        <https://1145.am/db/2664196/Telefnica>,
        <https://1145.am/db/2664227/Telefnica>,
        <https://1145.am/db/2665206/Telefnica>,
        <https://1145.am/db/2665365/Telefnica>,
        <https://1145.am/db/2665887/Telefonica>,
        <https://1145.am/db/2666285/Telefnica>,
        <https://1145.am/db/2666404/Telefnica>,
        <https://1145.am/db/2667338/Telefonica>,
        <https://1145.am/db/2667500/Telefnica>,
        <https://1145.am/db/2667525/Telefnica>,
        <https://1145.am/db/2668412/Telefonica>,
        <https://1145.am/db/2668528/Telefnica_Uk>,
        <https://1145.am/db/2669513/Telefonica>,
        <https://1145.am/db/2670200/Telefonica>,
        <https://1145.am/db/2670751/Telefnica>,
        <https://1145.am/db/2670756/Telefnica>,
        <https://1145.am/db/2670760/Telefnica>,
        <https://1145.am/db/2670779/Telefnica>,
        <https://1145.am/db/2671810/Telefnica>,
        <https://1145.am/db/2671812/Telefnica>,
        <https://1145.am/db/2671856/Telefnica>,
        <https://1145.am/db/2671886/Telefnica>,
        <https://1145.am/db/2671930/Telefnica>,
        <https://1145.am/db/2671968/Telefnica>,
        <https://1145.am/db/2673145/Telefnica>,
        <https://1145.am/db/2674090/Telefonica>,
        <https://1145.am/db/2674172/Telefnica>,
        <https://1145.am/db/2674214/Telefnica>,
        <https://1145.am/db/2674269/Telefnica>,
        <https://1145.am/db/2675369/Telefnica>,
        <https://1145.am/db/2675454/Telefnica>,
        <https://1145.am/db/2675482/Telefnica>,
        <https://1145.am/db/2676194/Telefonica>,
        <https://1145.am/db/2676539/Telefnica>,
        <https://1145.am/db/2677796/Telefnica>,
        <https://1145.am/db/2677836/Telefnica>,
        <https://1145.am/db/2678648/Telefonica>,
        <https://1145.am/db/2678650/Telefnica>,
        <https://1145.am/db/2679024/Telefnica>,
        <https://1145.am/db/2679056/Telefnica>,
        <https://1145.am/db/2679770/Telefnica>,
        <https://1145.am/db/2680055/Telefnica>,
        <https://1145.am/db/2680806/Telefnica>,
        <https://1145.am/db/2680808/Telefonica>,
        <https://1145.am/db/2681824/Telefnica>,
        <https://1145.am/db/2683245/Telefonica>,
        <https://1145.am/db/2788675/Telefonica>,
        <https://1145.am/db/337315/Telefonica>,
        <https://1145.am/db/346196/Telefonica>,
        <https://1145.am/db/400633/Telefnica>,
        <https://1145.am/db/469415/Telefonica>,
        <https://1145.am/db/721139/Telefonica>,
        <https://1145.am/db/81375/Telefonica>,
        <https://1145.am/db/81437/Telefonica> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2661968/Cablevision_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Altice raised 1.61 billion ($ 1.8 billion) in a share issue and priced a bond issue to raise $ 8.6 billion to finance its take over of U.S. - based Cablevision." ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "bond",
        "take over" ;
    ns1:name "bond",
        "take over" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2661968/Cablevision> ;
    ns1:targetName "Cablevision" ;
    ns1:valueRaw "$ 1.8 billion",
        "$ 8.6 billion",
        "1.61 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S" .

<https://1145.am/db/2664679/Investment_Digital_Bridge_Holdings_Extenet_Systems_Stonepeak_Infrastructure_Partners_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-23T15:57:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> ExteNet Systems said that Digital Bridge Holdings and Stonepeak Infrastructure Partners have committed or arranged for over $ 1 billion in a recapitalization of the company." ;
    ns1:documentTitle "C Spire doubles spectrum used for LTE; ExteNet gets $1B for recapitalization" ;
    ns1:documentURL <https://www.fiercewireless.com/wireless/c-spire-doubles-spectrum-used-for-lte-extenet-gets-1b-for-recapitalization> ;
    ns1:foundName "recapitalization" ;
    ns1:name "recapitalization" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2664679/Extenet_Systems> ;
    ns1:targetName "ExteNet Systems" ;
    ns1:valueRaw "over $ 1 billion" ;
    ns1:whereRaw "ExteNet Systems" .

<https://1145.am/db/2667366/O2_Uk> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "CK Hutchison" ;
    ns1:documentDate "2016-01-26T13:55:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Xavier Niel: Leaving no stone unturned" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/xavier-niel-leaving-no-stone-unturned> ;
    ns1:foundName "O2 UK" ;
    ns1:name "O2 UK" ;
    ns1:sameAsMedium <https://1145.am/db/1797744/O2>,
        <https://1145.am/db/1800033/O2>,
        <https://1145.am/db/2167342/O2>,
        <https://1145.am/db/249513/O2>,
        <https://1145.am/db/2624908/O2>,
        <https://1145.am/db/2625430/O2>,
        <https://1145.am/db/2629007/O2_Uk>,
        <https://1145.am/db/2632668/O2>,
        <https://1145.am/db/2638379/O2>,
        <https://1145.am/db/2640353/O2>,
        <https://1145.am/db/2643386/O2>,
        <https://1145.am/db/2650576/O2>,
        <https://1145.am/db/2651002/O2_Uk>,
        <https://1145.am/db/2651015/O2_Uk>,
        <https://1145.am/db/2651408/O2>,
        <https://1145.am/db/2651412/O2_Uk>,
        <https://1145.am/db/2651420/O2_Uk>,
        <https://1145.am/db/2651763/O2_Uk>,
        <https://1145.am/db/2651770/O2_Uk>,
        <https://1145.am/db/2653074/O2>,
        <https://1145.am/db/2653163/O2_Uk>,
        <https://1145.am/db/2653961/O2_Uk>,
        <https://1145.am/db/2654863/O2_Uk>,
        <https://1145.am/db/2654874/O2>,
        <https://1145.am/db/2656247/O2>,
        <https://1145.am/db/2657696/O2>,
        <https://1145.am/db/2659254/O2_Uk>,
        <https://1145.am/db/2660028/O2>,
        <https://1145.am/db/2661936/O2_Uk>,
        <https://1145.am/db/2661978/O2_Uk>,
        <https://1145.am/db/2664098/O2_Uk>,
        <https://1145.am/db/2664216/O2>,
        <https://1145.am/db/2665206/O2_Uk>,
        <https://1145.am/db/2666440/O2>,
        <https://1145.am/db/2667333/O2_Uk>,
        <https://1145.am/db/2667342/O2_Uk>,
        <https://1145.am/db/2668411/O2_Uk>,
        <https://1145.am/db/2668412/O2_Uk>,
        <https://1145.am/db/2669513/O2_Uk>,
        <https://1145.am/db/2670595/O2>,
        <https://1145.am/db/2671778/O2_Uk>,
        <https://1145.am/db/2671784/O2>,
        <https://1145.am/db/2671802/O2_Uk>,
        <https://1145.am/db/2671812/O2_Uk>,
        <https://1145.am/db/2672973/O2_Uk>,
        <https://1145.am/db/2672991/O2_Uk>,
        <https://1145.am/db/2676558/O2_Uk>,
        <https://1145.am/db/2682569/O2>,
        <https://1145.am/db/337315/O2>,
        <https://1145.am/db/80938/O2>,
        <https://1145.am/db/80982/O2>,
        <https://1145.am/db/90656/O2> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2208603/Investment_Kyruus_Mckesson_Ventures_New_Leaf_Venture_Partners_Providence_Health___Services_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-18T15:58:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Patient access and referral management software company Kyruus has raised $ 25 million in funding to support its ProviderMatch technology." ;
    ns1:documentTitle "Kyruus raises $25M in funding; BIDMC's John Halamka on the next big challenges for CIOs;" ;
    ns1:documentURL <https://www.fiercehealthcare.com/it/kyruus-raises-25m-funding-bidmc-s-john-halamka-next-big-challenges-for-cios> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2208603/Kyruus> ;
    ns1:valueRaw "$ 25 million" ;
    ns1:whereGeoName "Boston" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4930956/about.rdf> ;
    ns1:whereRaw "Boston" .

<https://1145.am/db/2317269/Advandx_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-07-14T19:21:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Armed with an infusion of cash, OpGen announced that it agreed to acquire AdvanDx in order to obtain FDA-approved rapid molecular tests, as a complement to the company's internal Acuitas MDRO (multidrug-resistant organism) gene tests.",
        "The Merck Global Health Innovation Fund invested $ 6 million in OpGen ($ OPGN) on the same day the microbial genetics specialist announced it will acquire AdvanDx, a maker of molecular tests for blood cultures." ;
    ns1:documentTitle "Merck invests $6M in microbial diagnostics specialist OpGen" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/merck-invests-6m-microbial-diagnostics-specialist-opgen> ;
    ns1:foundName "acquire",
        "invested" ;
    ns1:name "acquire",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2317269/Advandx> ;
    ns1:targetName "AdvanDx" .

<https://1145.am/db/2334981/Vascular_Flow_Technologies> a org:Organization ;
    ns1:basedInHighGeoName "Dundee" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2650752/about.rdf> ;
    ns1:basedInHighRaw "Dundee" ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "R & D" ;
    ns1:documentDate "2016-01-29T14:10:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Flow Technologies raises $14M+ for its prosthetic vascular graft" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/vascular-flow-technologies-raises-14m-for-its-prosthetic-vascular-graft> ;
    ns1:foundName "Vascular Flow",
        "Vascular Flow Technologies" ;
    ns1:industry "Medical Devices" ;
    ns1:name "Vascular Flow",
        "Vascular Flow Technologies" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2367675/Series_A_Investment_Ankasa_Regenerative_Therapeutics_Avalon_Ventures_Correlation_Ventures_Heraeus_Medical_Heraeus_Of_Hanau_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-06-23T14:53:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Ankasa Regenerative Therapeutics Receives $ 8.5 Million in First Tranche of $ 17 Million Series A Financing Led by Avalon Ventures.",
        "LA JOLLA, Calif.- (BUSINESS WIRE) -Ankasa Regenerative Therapeutics, Inc. (Ankasa) , a company focused on pharmaceutical preparations for reactivation of stem cells for organ and tissue regrowth, tissue repair and healing, has received $ 8.5 million in the first tranche of a $ 17 million Series A round of financing led by La Jolla - based Avalon Ventures." ;
    ns1:documentTitle "Ankasa Regenerative Therapeutics Receives $8.5 Million in First Tranche of $17 Million Series A Financing Led by Avalon Ventures" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ankasa-regenerative-therapeutics-receives-8-5-million-first-tranche-of-17-million-series-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367675/Ankasa_Regenerative_Therapeutics>,
        <https://1145.am/db/2367675/Heraeus_Medical> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 17 Million",
        "$ 17 million",
        "$ 8.5 Million",
        "$ 8.5 million" ;
    ns1:whereGeoName "La Jolla" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5363943/about.rdf> ;
    ns1:whereRaw "La Jolla" .

<https://1145.am/db/2368912/Fidelity_Management_And_Research_Company> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "Fidelity Management and Research Company" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "Fidelity Management and Research Company" ;
    ns1:sameAsMedium <https://1145.am/db/1113264/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1449316/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1514514/Fidelity_Management___Research>,
        <https://1145.am/db/1735285/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1737508/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1739125/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1742620/Fidelity_Management_And_Research>,
        <https://1145.am/db/1749806/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756163/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756934/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1759830/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1760432/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1779826/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1792378/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1793167/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1806318/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2052769/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2095032/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2142791/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2196875/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2198066/Fidelity_Management___Research>,
        <https://1145.am/db/220837/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2260778/Fidelity_Management___Research_Company>,
        <https://1145.am/db/227104/Fidelity_Management___Research_Co>,
        <https://1145.am/db/2278983/Fidelity_Management_And_Research>,
        <https://1145.am/db/2284585/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2291211/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2291403/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2293124/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2294326/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2339214/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2339223/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2356469/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2361695/Fidelity_Management___Research_Company>,
        <https://1145.am/db/236388/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/2368579/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2368913/Fidelity_Management_And_Research>,
        <https://1145.am/db/2369304/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369549/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369718/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2370694/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2541350/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2557987/Fidelity_Management___Research>,
        <https://1145.am/db/262651/Fidelity_Management___Research_Company>,
        <https://1145.am/db/262682/Fidelity_Management___Research_Company>,
        <https://1145.am/db/271327/Fidelity_Management___Research_Co>,
        <https://1145.am/db/317470/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/377391/Fidelity_Management_And_Research>,
        <https://1145.am/db/385136/Fidelity_Management___Research_Co>,
        <https://1145.am/db/385198/Fidelity_Management___Research_Co>,
        <https://1145.am/db/502886/Fidelity_Management_And_Research>,
        <https://1145.am/db/506085/Fidelity_Management_And_Research>,
        <https://1145.am/db/512324/Fidelity_Management___Research_Company>,
        <https://1145.am/db/571769/Fidelity_Management_And_Research>,
        <https://1145.am/db/583568/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637078/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637603/Fidelity_Management___Research>,
        <https://1145.am/db/677591/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/749014/Fidelity_Management_And_Research_Co>,
        <https://1145.am/db/782640/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/847232/Fidelity_Management___Research_Company>,
        <https://1145.am/db/888513/Fidelity_Management___Research_Company>,
        <https://1145.am/db/922192/Fidelity_Management___Research_Company>,
        <https://1145.am/db/93760/Fidelity_Management___Research>,
        <https://1145.am/db/970498/Fidelity_Management_And_Research> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Fidelity_Management_And_Research> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "Fidelity Management and Research" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "Fidelity Management and Research" ;
    ns1:sameAsMedium <https://1145.am/db/1113264/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1449316/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1514514/Fidelity_Management___Research>,
        <https://1145.am/db/1735285/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1737508/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1739125/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1742620/Fidelity_Management_And_Research>,
        <https://1145.am/db/1749806/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756163/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756934/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1759830/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1760432/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1779826/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1792378/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1793167/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1806318/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2052769/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2095032/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2142791/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2196875/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2198066/Fidelity_Management___Research>,
        <https://1145.am/db/220837/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2260778/Fidelity_Management___Research_Company>,
        <https://1145.am/db/227104/Fidelity_Management___Research_Co>,
        <https://1145.am/db/2278983/Fidelity_Management_And_Research>,
        <https://1145.am/db/2284585/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2291211/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2291403/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2293124/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2294326/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2339214/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2339223/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2356469/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2361695/Fidelity_Management___Research_Company>,
        <https://1145.am/db/236388/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/2368579/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2368912/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369304/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369549/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369718/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2370694/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2541350/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2557987/Fidelity_Management___Research>,
        <https://1145.am/db/262651/Fidelity_Management___Research_Company>,
        <https://1145.am/db/262682/Fidelity_Management___Research_Company>,
        <https://1145.am/db/271327/Fidelity_Management___Research_Co>,
        <https://1145.am/db/317470/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/377391/Fidelity_Management_And_Research>,
        <https://1145.am/db/385136/Fidelity_Management___Research_Co>,
        <https://1145.am/db/385198/Fidelity_Management___Research_Co>,
        <https://1145.am/db/502886/Fidelity_Management_And_Research>,
        <https://1145.am/db/506085/Fidelity_Management_And_Research>,
        <https://1145.am/db/512324/Fidelity_Management___Research_Company>,
        <https://1145.am/db/571769/Fidelity_Management_And_Research>,
        <https://1145.am/db/583568/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637078/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637603/Fidelity_Management___Research>,
        <https://1145.am/db/677591/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/749014/Fidelity_Management_And_Research_Co>,
        <https://1145.am/db/782640/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/847232/Fidelity_Management___Research_Company>,
        <https://1145.am/db/888513/Fidelity_Management___Research_Company>,
        <https://1145.am/db/922192/Fidelity_Management___Research_Company>,
        <https://1145.am/db/93760/Fidelity_Management___Research>,
        <https://1145.am/db/970498/Fidelity_Management_And_Research> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368982/Series_B_Investment_Antiva_Biosciences_Antiva_Biosciences_Canaan_Partners_Sofinnova_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-06T15:23:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Antiva Biosciences Raises $ 16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections.",
        "MENLO PARK, Calif., Aug. 6, 2015 /PRNewswire/ - Antiva Biosciences, Inc. (formerly Hera Therapeutics) , a biopharmaceutical company developing antiviral therapeutics, today announced that it has raised $ 16 million in a Series B financing, its first institutional round." ;
    ns1:documentTitle "Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/antiva-biosciences-raises-16-million-series-b-financing-to-advance-lead-compound-for-human> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368982/Antiva_Biosciences> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 Million",
        "$ 16 million" ;
    ns1:when "2015-08-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2015-08-06" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2368982/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "MENLO PARK, Calif" ;
    ns1:documentDate "2015-08-06T15:23:43+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Antiva Biosciences Raises $16 Million Series B Financing to Advance Lead Compound for Human Papillomavirus Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/antiva-biosciences-raises-16-million-series-b-financing-to-advance-lead-compound-for-human> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2368982/Series_B_Investment_Antiva_Biosciences_Antiva_Biosciences_Canaan_Partners_Sofinnova_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369000/Eli_Lilly_And_Company> a org:Organization ;
    ns1:basedInLowRaw "NEW YORK CITY" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "Eli Lilly and Company" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> ;
    ns1:name "Eli Lilly and Company" ;
    ns1:sameAsHigh <https://1145.am/db/1038901/Eli_Lilly_And_Company>,
        <https://1145.am/db/1072187/Eli_Lilly_And_Company>,
        <https://1145.am/db/1087869/Eli_Lilly_And_Company>,
        <https://1145.am/db/1133669/Boehringer_Ingelheim>,
        <https://1145.am/db/1135149/Boehringer_Ingelheim>,
        <https://1145.am/db/1217359/Eli_Lilly_And_Company>,
        <https://1145.am/db/1272276/Eli_Lilly_And_Company>,
        <https://1145.am/db/1272276/Lilly>,
        <https://1145.am/db/1340338/Eli_Lilly_And_Company>,
        <https://1145.am/db/1425255/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Lilly>,
        <https://1145.am/db/1432746/Eli_Lilly>,
        <https://1145.am/db/1534004/Eli_Lilly_And_Company>,
        <https://1145.am/db/1534438/Eli_Lilly_And_Company>,
        <https://1145.am/db/1537106/Boehringer_Ingelheim>,
        <https://1145.am/db/1537985/Boehringer_Ingelheim>,
        <https://1145.am/db/1546070/Eli_Lilly_And_Company>,
        <https://1145.am/db/1553175/Eli_Lilly___Company>,
        <https://1145.am/db/1553459/Eli_Lilly___Company>,
        <https://1145.am/db/1594413/Boehringer_Ingelheim>,
        <https://1145.am/db/1663572/Eli_Lilly_And_Company>,
        <https://1145.am/db/174741/Eli_Lilly_And_Co>,
        <https://1145.am/db/1979697/Eli_Lilly>,
        <https://1145.am/db/1984558/Eli_Lilly_And_Company>,
        <https://1145.am/db/2043001/Eli_Lilly_And_Co>,
        <https://1145.am/db/2045539/Eli_Lilly_And_Company>,
        <https://1145.am/db/2053734/Eli_Lilly_And_Co>,
        <https://1145.am/db/2055009/Eli_Lilly_And_Company>,
        <https://1145.am/db/2058865/Eli_Lilly_And_Company>,
        <https://1145.am/db/2062260/Eli_Lilly>,
        <https://1145.am/db/2065629/Eli_Lilly_And_Company>,
        <https://1145.am/db/2134678/Eli_Lilly_And_Co>,
        <https://1145.am/db/2136466/Eli_Lilly_And_Co>,
        <https://1145.am/db/2139015/Eli_Lilly_And_Company>,
        <https://1145.am/db/2152172/Boehringer_Ingelheim>,
        <https://1145.am/db/2152174/Boehringer_Ingelheim>,
        <https://1145.am/db/2152285/Boehringer>,
        <https://1145.am/db/2154037/Eli_Lilly>,
        <https://1145.am/db/2154391/Eli_Lilly>,
        <https://1145.am/db/2154401/Boehringer_Ingelheim>,
        <https://1145.am/db/2155453/Lilly_Usa>,
        <https://1145.am/db/2281211/Eli_Lilly>,
        <https://1145.am/db/2282739/Eli_Lilly>,
        <https://1145.am/db/2282930/Eli_Lilly>,
        <https://1145.am/db/2283595/Eli_Lilly>,
        <https://1145.am/db/2284615/Lilly>,
        <https://1145.am/db/2285156/Eli_Lilly>,
        <https://1145.am/db/2285189/Eli_Lilly>,
        <https://1145.am/db/2285525/Eli_Lilly>,
        <https://1145.am/db/2286402/Eli_Lilly>,
        <https://1145.am/db/2286404/Eli_Lilly>,
        <https://1145.am/db/2286617/Eli_Lilly>,
        <https://1145.am/db/2286657/Boehringer_Ingelheim>,
        <https://1145.am/db/2286911/Eli_Lilly>,
        <https://1145.am/db/2286998/Eli_Lilly>,
        <https://1145.am/db/2287005/Eli_Lilly>,
        <https://1145.am/db/2288158/Eli_Lilly>,
        <https://1145.am/db/2290507/Boehringer_Ingelheim>,
        <https://1145.am/db/2290919/Boehringer_Ingelheim>,
        <https://1145.am/db/229232/Eli_Lilly>,
        <https://1145.am/db/2293168/Boehringer_Ingelheim>,
        <https://1145.am/db/2294118/Eli_Lilly>,
        <https://1145.am/db/2298022/Eli_Lilly>,
        <https://1145.am/db/2299157/Eli_Lilly>,
        <https://1145.am/db/2301879/Eli_Lilly_And_Company>,
        <https://1145.am/db/2302104/Eli_Lilly_And_Company>,
        <https://1145.am/db/2303974/Boehringer_Ingelheim_Gmbh>,
        <https://1145.am/db/2303980/Boehringer_Ingelheim>,
        <https://1145.am/db/2305497/Eli_Lilly>,
        <https://1145.am/db/2306173/Boehringer_Ingelheim>,
        <https://1145.am/db/2306807/Eli_Lilly_And_Company>,
        <https://1145.am/db/2307651/Eli_Lilly>,
        <https://1145.am/db/2309473/Eli_Lilly>,
        <https://1145.am/db/2309599/Eli_Lilly>,
        <https://1145.am/db/2313544/Boehringer_Ingelheim>,
        <https://1145.am/db/2314412/Eli_Lilly_And_Company>,
        <https://1145.am/db/2316092/Eli_Lilly>,
        <https://1145.am/db/2316549/Eli_Lilly>,
        <https://1145.am/db/2318248/Boehringer_Ingelheim>,
        <https://1145.am/db/2318587/Eli_Lilly>,
        <https://1145.am/db/2320006/Eli_Lilly>,
        <https://1145.am/db/2320338/Eli_Lilly>,
        <https://1145.am/db/2322619/Eli_Lilly_And_Company>,
        <https://1145.am/db/2323165/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325525/Boehringer_Ingelheim>,
        <https://1145.am/db/2325557/Eli_Lilly_And_Company>,
        <https://1145.am/db/2326272/Lilly_Usa>,
        <https://1145.am/db/2327587/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328527/Eli_Lilly>,
        <https://1145.am/db/2328554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328718/Eli_Lilly>,
        <https://1145.am/db/2329107/Lilly>,
        <https://1145.am/db/2329114/Eli_Lilly>,
        <https://1145.am/db/2329115/Lilly>,
        <https://1145.am/db/2334645/Eli_Lilly>,
        <https://1145.am/db/2335594/Eli_Lilly_And_Company>,
        <https://1145.am/db/2335703/Boehringer_Ingelheim>,
        <https://1145.am/db/2335705/Boehringer_Ingelheim>,
        <https://1145.am/db/2335908/Boehringer>,
        <https://1145.am/db/2336074/Eli_Lilly_And_Company>,
        <https://1145.am/db/2338059/Eli_Lilly>,
        <https://1145.am/db/2340948/Eli_Lilly>,
        <https://1145.am/db/2341481/Eli_Lilly>,
        <https://1145.am/db/2341496/Eli_Lilly>,
        <https://1145.am/db/2342503/Eli_Lilly_And_Company>,
        <https://1145.am/db/2343945/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344800/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344808/Eli_Lilly>,
        <https://1145.am/db/2344991/Eli_Lilly>,
        <https://1145.am/db/2345213/Eli_Lilly>,
        <https://1145.am/db/2345214/Eli_Lilly>,
        <https://1145.am/db/2346629/Novo_Nordisk_Eli_Lilly>,
        <https://1145.am/db/2349020/Eli_Lilly_And_Company>,
        <https://1145.am/db/2349300/Eli_Lilly_And_Company>,
        <https://1145.am/db/2352358/Eli_Lilly>,
        <https://1145.am/db/2353350/Eli_Lilly>,
        <https://1145.am/db/2354380/Boehringer_Ingelheim>,
        <https://1145.am/db/2354388/Boehringer_Ingelheim>,
        <https://1145.am/db/2354761/Eli_Lilly_And_Company>,
        <https://1145.am/db/2354853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2359240/Eli_Lilly>,
        <https://1145.am/db/2360080/Boehringer_Ingelheim>,
        <https://1145.am/db/2360086/Boehringer_Ingelheim>,
        <https://1145.am/db/2361027/Eli_Lilly>,
        <https://1145.am/db/2363310/Eli_Lilly_And_Company_(lly)>,
        <https://1145.am/db/2364605/Eli_Lilly>,
        <https://1145.am/db/2364810/Boehringer_Ingelheim>,
        <https://1145.am/db/2365178/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366948/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366948/Lilly>,
        <https://1145.am/db/2366953/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366953/Lilly>,
        <https://1145.am/db/2367430/Boehringer_Ingelheim>,
        <https://1145.am/db/2368562/Eli_Lilly_And_Company>,
        <https://1145.am/db/2370162/Eli_Lilly>,
        <https://1145.am/db/2370523/Boehringer>,
        <https://1145.am/db/2371016/Eli_Lilly>,
        <https://1145.am/db/2371058/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Lilly>,
        <https://1145.am/db/2536400/Boehringer_Ingelheim>,
        <https://1145.am/db/2536960/Eli_Lilly>,
        <https://1145.am/db/2537335/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537665/Eli_Lilly>,
        <https://1145.am/db/2537666/Eli_Lilly>,
        <https://1145.am/db/2537817/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537826/Eli_Lilly_And_Company>,
        <https://1145.am/db/2539012/Boehringer_Ingelheim>,
        <https://1145.am/db/2539287/Eli_Lilly>,
        <https://1145.am/db/2539970/Eli_Lilly>,
        <https://1145.am/db/2540249/Boehringer_Ingelheim>,
        <https://1145.am/db/2541725/Boehringer_Ingelheim>,
        <https://1145.am/db/2543185/Eli_Lilly>,
        <https://1145.am/db/2545618/Eli_Lilly>,
        <https://1145.am/db/2546160/Boehringer_Ingelheim>,
        <https://1145.am/db/2546781/Boehringer_Ingelheim>,
        <https://1145.am/db/2547189/Boehringer_Ingelheim>,
        <https://1145.am/db/2549450/Eli_Lilly>,
        <https://1145.am/db/2550996/Eli_Lilly>,
        <https://1145.am/db/2551049/Eli_Lilly>,
        <https://1145.am/db/2551101/Eli_Lilly>,
        <https://1145.am/db/2553131/Boehringer_Ingelheim>,
        <https://1145.am/db/2553131/Eli_Lilly>,
        <https://1145.am/db/2553551/Eli_Lilly>,
        <https://1145.am/db/2553750/Boehringer_Ingelheim>,
        <https://1145.am/db/2554242/Boehringer_Ingelheim>,
        <https://1145.am/db/2554535/Boehringer_Ingelheim>,
        <https://1145.am/db/2555393/Boehringer_Ingelheim>,
        <https://1145.am/db/2555921/Boehringer_Ingelheim_Group_Of_Companies>,
        <https://1145.am/db/2555925/Boehringer_Ingelheim_Plant>,
        <https://1145.am/db/2556906/Eli_Lilly_And_Company>,
        <https://1145.am/db/2556969/Eli_Lilly>,
        <https://1145.am/db/2557861/Boehringer_Ingelheim>,
        <https://1145.am/db/2558025/Boehringer_Ingelheim>,
        <https://1145.am/db/2558026/Boehringer_Ingelheim>,
        <https://1145.am/db/2559125/Eli_Lilly_And_Company>,
        <https://1145.am/db/2560253/Boehringer_Ingelheim>,
        <https://1145.am/db/2560487/Eli_Lilly>,
        <https://1145.am/db/2560865/Boehringer_Ingelheim>,
        <https://1145.am/db/2561357/Eli_Lilly>,
        <https://1145.am/db/2561960/Eli_Lilly>,
        <https://1145.am/db/2562442/Eli_Lilly>,
        <https://1145.am/db/2562576/Eli_Lilly>,
        <https://1145.am/db/2564389/Eli_Lilly___Co>,
        <https://1145.am/db/2566845/Lilly>,
        <https://1145.am/db/2567343/Eli_Lilly>,
        <https://1145.am/db/2567800/Boehringer_Ingelheim>,
        <https://1145.am/db/2569425/Boehringer_Ingelheim>,
        <https://1145.am/db/2569829/Eli_Lilly>,
        <https://1145.am/db/2571316/Boehringer_Ingelheim>,
        <https://1145.am/db/2571525/Boehringer_Ingelheim>,
        <https://1145.am/db/2572312/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572711/Eli_Lilly_And_Company>,
        <https://1145.am/db/2572711/Lilly>,
        <https://1145.am/db/2572957/Eli_Lilly_And_Company>,
        <https://1145.am/db/2573259/Boehringer_Ingelheim>,
        <https://1145.am/db/2573885/Eli_Lilly>,
        <https://1145.am/db/2574421/Boehringer_Ingelheim_Group_Of_Companies>,
        <https://1145.am/db/2575554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2575575/Boehringer_Ingelheim>,
        <https://1145.am/db/2575909/Eli_Lilly>,
        <https://1145.am/db/2575972/Eli_Lilly>,
        <https://1145.am/db/2576086/Eli_Lilly>,
        <https://1145.am/db/2576171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576460/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576462/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576892/Eli_Lilly>,
        <https://1145.am/db/2576933/Eli_Lilly>,
        <https://1145.am/db/2576944/Eli_Lilly>,
        <https://1145.am/db/2577171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578048/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578603/Eli_Lilly>,
        <https://1145.am/db/2578745/Boehringer_Ingelheim>,
        <https://1145.am/db/2578827/Boehringer>,
        <https://1145.am/db/2578874/Eli_Lilly>,
        <https://1145.am/db/2578876/Eli_Lilly_And_Company>,
        <https://1145.am/db/2580140/Boehringer_Ingelheim_And_Eli_Lilly>,
        <https://1145.am/db/2580383/Boehringer_Ingelheim>,
        <https://1145.am/db/2581257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581309/Boehringer_Ingelheim>,
        <https://1145.am/db/2581745/Eli_Lilly_And_Company>,
        <https://1145.am/db/2582681/Boehringer_Ingelheim>,
        <https://1145.am/db/2583703/Eli_Lilly>,
        <https://1145.am/db/2584135/Eli_Lilly>,
        <https://1145.am/db/2584766/Eli_Lilly_And_Company>,
        <https://1145.am/db/2585710/Eli_Lilly>,
        <https://1145.am/db/2586025/Lilly>,
        <https://1145.am/db/2586687/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587099/Boehringer>,
        <https://1145.am/db/2587104/Boehringer_Ingelheim_Plant>,
        <https://1145.am/db/2587215/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587605/Elanco>,
        <https://1145.am/db/2587605/Eli_Lilly>,
        <https://1145.am/db/2587690/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587699/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589156/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589535/Eli_Lilly>,
        <https://1145.am/db/2589700/Eli_Lilly>,
        <https://1145.am/db/2590071/Eli_Lilly_And_Company>,
        <https://1145.am/db/2590486/Eli_Lilly>,
        <https://1145.am/db/2590739/Boehringer_Ingelheim>,
        <https://1145.am/db/2590997/Eli_Lilly_And_Company>,
        <https://1145.am/db/2591001/Eli_Lilly>,
        <https://1145.am/db/2591708/Eli_Lilly_And_Company>,
        <https://1145.am/db/2592790/Boehringer_Ingelheim_Usa_Corporation>,
        <https://1145.am/db/2592924/Boehringer_Ingelheim>,
        <https://1145.am/db/2593232/Boehringer_Ingelheim>,
        <https://1145.am/db/2593463/Boehringer_Ingelheim>,
        <https://1145.am/db/2593780/Eli_Lilly>,
        <https://1145.am/db/2594262/Boehringer_Ingelheim>,
        <https://1145.am/db/2594485/Eli_Lilly_And_Company>,
        <https://1145.am/db/2594494/Eli_Lilly_And_Company>,
        <https://1145.am/db/2595226/Boehringer_Ingelheim>,
        <https://1145.am/db/2596644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597855/Eli_Lilly_And_Company>,
        <https://1145.am/db/2598317/Eli_Lilly>,
        <https://1145.am/db/264619/Eli_Lilly_And_Co>,
        <https://1145.am/db/385093/Boehringer_Ingelheim>,
        <https://1145.am/db/461671/Eli_Lilly_And_Company>,
        <https://1145.am/db/768105/Eli_Lilly>,
        <https://1145.am/db/86786/Eli_Lilly_And_Co> ;
    ns1:sameAsMedium <https://1145.am/db/1121894/Eli_Lilly_And_Company>,
        <https://1145.am/db/2109798/Eli_Lilly_And_Company>,
        <https://1145.am/db/2279118/Eli_Lilly>,
        <https://1145.am/db/2280616/Eli_Lilly>,
        <https://1145.am/db/2286126/Eli_Lilly>,
        <https://1145.am/db/2286379/Eli_Lilly>,
        <https://1145.am/db/2304319/Eli_Lilly_And_Company>,
        <https://1145.am/db/2305501/Eli_Lilly_And_Company>,
        <https://1145.am/db/2310738/Eli_Lilly>,
        <https://1145.am/db/2315325/Eli_Lilly>,
        <https://1145.am/db/2317682/Eli_Lilly>,
        <https://1145.am/db/2325257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328522/Eli_Lilly>,
        <https://1145.am/db/2328633/Eli_Lilly>,
        <https://1145.am/db/2329915/Eli_Lilly_And_Company>,
        <https://1145.am/db/2349001/Eli_Lilly_And_Company>,
        <https://1145.am/db/2360338/Eli_Lilly>,
        <https://1145.am/db/2361510/Eli_Lilly>,
        <https://1145.am/db/2368321/Eli_Lilly_And_Company>,
        <https://1145.am/db/2560025/Eli_Lilly>,
        <https://1145.am/db/2562999/Eli_Lilly>,
        <https://1145.am/db/2569849/Eli_Lilly_And_Company>,
        <https://1145.am/db/2574950/Eli_Lilly>,
        <https://1145.am/db/2575947/Eli_Lilly>,
        <https://1145.am/db/2576858/Eli_Lilly___Co>,
        <https://1145.am/db/2576939/Eli_Lilly>,
        <https://1145.am/db/2581804/Eli_Lilly>,
        <https://1145.am/db/2585144/Eli_Lilly_And_Company>,
        <https://1145.am/db/2593456/Eli_Lilly_And_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369202/Orbimed> a org:Organization ;
    ns1:basedInLowRaw "BOSTON" ;
    ns1:description "Private Equity" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "OrbiMed" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened>,
        <https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> ;
    ns1:name "OrbiMed" ;
    ns1:sameAsHigh <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2300061/Orbimed>,
        <https://1145.am/db/2335764/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2371160/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Orbimed>,
        <https://1145.am/db/1086582/Orbimed>,
        <https://1145.am/db/1089269/Orbimed>,
        <https://1145.am/db/1140378/Orbimed>,
        <https://1145.am/db/1213048/Orbimed>,
        <https://1145.am/db/1334863/Orbimed>,
        <https://1145.am/db/1340338/Orbimed>,
        <https://1145.am/db/1690914/Orbimed>,
        <https://1145.am/db/2032047/Orbimed>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2192716/Orbimed>,
        <https://1145.am/db/2198716/Orbimed>,
        <https://1145.am/db/2281204/Orbimed>,
        <https://1145.am/db/2281272/Orbimed>,
        <https://1145.am/db/2283935/Orbimed>,
        <https://1145.am/db/2286245/Orbimed>,
        <https://1145.am/db/2286541/Orbimed>,
        <https://1145.am/db/2288436/Orbimed>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2292284/Orbimed>,
        <https://1145.am/db/2293508/Orbimed>,
        <https://1145.am/db/2293540/Orbimed>,
        <https://1145.am/db/2293893/Orbimed>,
        <https://1145.am/db/2295525/Orbimed>,
        <https://1145.am/db/2297224/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2297514/Orbimed>,
        <https://1145.am/db/2297930/Orbimed>,
        <https://1145.am/db/2299411/Orbimed>,
        <https://1145.am/db/2299645/Orbimed>,
        <https://1145.am/db/2300653/Orbimed>,
        <https://1145.am/db/2301464/Orbimed>,
        <https://1145.am/db/2304258/Orbimed>,
        <https://1145.am/db/2318134/Orbimed>,
        <https://1145.am/db/2323243/Orbimed>,
        <https://1145.am/db/2330389/Orbimed>,
        <https://1145.am/db/2337043/Orbimed>,
        <https://1145.am/db/2337667/Orbimed>,
        <https://1145.am/db/2340942/Orbimed>,
        <https://1145.am/db/2341484/Orbimed>,
        <https://1145.am/db/2341487/Orbimed>,
        <https://1145.am/db/2343545/Orbimed>,
        <https://1145.am/db/2344045/Orbimed>,
        <https://1145.am/db/2347103/Orbimed>,
        <https://1145.am/db/2347885/Orbimed>,
        <https://1145.am/db/2348149/Orbimed>,
        <https://1145.am/db/2348857/Orbimed>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2353515/Orbimed>,
        <https://1145.am/db/2355023/Orbimed>,
        <https://1145.am/db/2361337/Orbimed>,
        <https://1145.am/db/2362768/Orbimed>,
        <https://1145.am/db/236388/Orbimed>,
        <https://1145.am/db/2368872/Orbimed>,
        <https://1145.am/db/2369548/Orbimed>,
        <https://1145.am/db/2369982/Orbimed>,
        <https://1145.am/db/2369999/Orbimed>,
        <https://1145.am/db/2370694/Orbimed>,
        <https://1145.am/db/2370799/Orbimed>,
        <https://1145.am/db/2371163/Orbimed>,
        <https://1145.am/db/2718732/Orbimed>,
        <https://1145.am/db/2787561/Orbimed>,
        <https://1145.am/db/474852/Orbimed>,
        <https://1145.am/db/713335/Orbimed>,
        <https://1145.am/db/714498/Orbimed>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed>,
        <https://1145.am/db/867907/Orbimed>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369359/A_Investment_Adams_Street_Partners_Bioventures_Longitude_Capital_Orbus_Therapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-19T15:13:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Palo Alto, CA - based Orbus Therapeutics has raised $ 32.5 million in an A round from Longitude Capital, H.I.G." ;
    ns1:documentTitle "Orbus snags $32.5M round for PhIII study; Merck and union leaders in overtime row;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/orbus-snags-32-5m-round-for-phiii-study-merck-and-union-leaders-overtime-row> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369359/Orbus_Therapeutics> ;
    ns1:targetDetails "A" ;
    ns1:valueRaw "$ 32.5 million" ;
    ns1:whereGeoName "Palo Alto County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4870630/about.rdf> ;
    ns1:whereRaw "Palo Alto" .

<https://1145.am/db/2369548/Orbimed> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment> ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "OrbiMed" ;
    ns1:name "OrbiMed" ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1042080/Orbimed>,
        <https://1145.am/db/1086582/Orbimed>,
        <https://1145.am/db/1089269/Orbimed>,
        <https://1145.am/db/1140378/Orbimed>,
        <https://1145.am/db/1213048/Orbimed>,
        <https://1145.am/db/1334863/Orbimed>,
        <https://1145.am/db/1340338/Orbimed>,
        <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/1690914/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2032047/Orbimed>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2192716/Orbimed>,
        <https://1145.am/db/2198716/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2281204/Orbimed>,
        <https://1145.am/db/2281272/Orbimed>,
        <https://1145.am/db/2283935/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2286245/Orbimed>,
        <https://1145.am/db/2286541/Orbimed>,
        <https://1145.am/db/2288436/Orbimed>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2292284/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2293508/Orbimed>,
        <https://1145.am/db/2293540/Orbimed>,
        <https://1145.am/db/2293893/Orbimed>,
        <https://1145.am/db/2295525/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2297224/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2297514/Orbimed>,
        <https://1145.am/db/2297930/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2299411/Orbimed>,
        <https://1145.am/db/2299645/Orbimed>,
        <https://1145.am/db/2300061/Orbimed>,
        <https://1145.am/db/2300653/Orbimed>,
        <https://1145.am/db/2301464/Orbimed>,
        <https://1145.am/db/2304258/Orbimed>,
        <https://1145.am/db/2318134/Orbimed>,
        <https://1145.am/db/2323243/Orbimed>,
        <https://1145.am/db/2330389/Orbimed>,
        <https://1145.am/db/2335764/Orbimed>,
        <https://1145.am/db/2337043/Orbimed>,
        <https://1145.am/db/2337667/Orbimed>,
        <https://1145.am/db/2340942/Orbimed>,
        <https://1145.am/db/2341484/Orbimed>,
        <https://1145.am/db/2341487/Orbimed>,
        <https://1145.am/db/2343545/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2344045/Orbimed>,
        <https://1145.am/db/2347103/Orbimed>,
        <https://1145.am/db/2347885/Orbimed>,
        <https://1145.am/db/2348149/Orbimed>,
        <https://1145.am/db/2348857/Orbimed>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2353515/Orbimed>,
        <https://1145.am/db/2355023/Orbimed>,
        <https://1145.am/db/2361337/Orbimed>,
        <https://1145.am/db/2362768/Orbimed>,
        <https://1145.am/db/236388/Orbimed>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2368872/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2369202/Orbimed>,
        <https://1145.am/db/2369982/Orbimed>,
        <https://1145.am/db/2369999/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370694/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2370799/Orbimed>,
        <https://1145.am/db/2371160/Orbimed>,
        <https://1145.am/db/2371163/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/2718732/Orbimed>,
        <https://1145.am/db/2787561/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/474852/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed>,
        <https://1145.am/db/713335/Orbimed>,
        <https://1145.am/db/714498/Orbimed>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed>,
        <https://1145.am/db/867907/Orbimed>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369549/Fidelity_Management_And_Research_Company> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:foundName "Fidelity Management and Research Company" ;
    ns1:investor <https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> ;
    ns1:name "Fidelity Management and Research Company" ;
    ns1:sameAsMedium <https://1145.am/db/1113264/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1449316/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1514514/Fidelity_Management___Research>,
        <https://1145.am/db/1735285/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1737508/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1739125/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1742620/Fidelity_Management_And_Research>,
        <https://1145.am/db/1749806/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756163/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756934/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1759830/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1760432/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1779826/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1792378/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1793167/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1806318/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2052769/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2095032/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2142791/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2196875/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2198066/Fidelity_Management___Research>,
        <https://1145.am/db/220837/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2260778/Fidelity_Management___Research_Company>,
        <https://1145.am/db/227104/Fidelity_Management___Research_Co>,
        <https://1145.am/db/2278983/Fidelity_Management_And_Research>,
        <https://1145.am/db/2284585/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2291211/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2291403/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2293124/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2294326/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2339214/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2339223/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2356469/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2361695/Fidelity_Management___Research_Company>,
        <https://1145.am/db/236388/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/2368579/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2368912/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2368913/Fidelity_Management_And_Research>,
        <https://1145.am/db/2369304/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369718/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2370694/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2541350/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2557987/Fidelity_Management___Research>,
        <https://1145.am/db/262651/Fidelity_Management___Research_Company>,
        <https://1145.am/db/262682/Fidelity_Management___Research_Company>,
        <https://1145.am/db/271327/Fidelity_Management___Research_Co>,
        <https://1145.am/db/317470/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/377391/Fidelity_Management_And_Research>,
        <https://1145.am/db/385136/Fidelity_Management___Research_Co>,
        <https://1145.am/db/385198/Fidelity_Management___Research_Co>,
        <https://1145.am/db/502886/Fidelity_Management_And_Research>,
        <https://1145.am/db/506085/Fidelity_Management_And_Research>,
        <https://1145.am/db/512324/Fidelity_Management___Research_Company>,
        <https://1145.am/db/571769/Fidelity_Management_And_Research>,
        <https://1145.am/db/583568/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637078/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637603/Fidelity_Management___Research>,
        <https://1145.am/db/677591/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/749014/Fidelity_Management_And_Research_Co>,
        <https://1145.am/db/782640/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/847232/Fidelity_Management___Research_Company>,
        <https://1145.am/db/888513/Fidelity_Management___Research_Company>,
        <https://1145.am/db/922192/Fidelity_Management___Research_Company>,
        <https://1145.am/db/93760/Fidelity_Management___Research>,
        <https://1145.am/db/970498/Fidelity_Management_And_Research> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Fidelity_Management_And_Research_Company> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Fidelity Management and Research Company" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "Fidelity Management and Research Company" ;
    ns1:sameAsMedium <https://1145.am/db/1113264/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1449316/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1514514/Fidelity_Management___Research>,
        <https://1145.am/db/1735285/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1737508/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1739125/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1742620/Fidelity_Management_And_Research>,
        <https://1145.am/db/1749806/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756163/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1756934/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1759830/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1760432/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1779826/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1792378/Fidelity_Management___Research_Company>,
        <https://1145.am/db/1793167/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/1806318/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2052769/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2095032/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2142791/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2196875/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2198066/Fidelity_Management___Research>,
        <https://1145.am/db/220837/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2260778/Fidelity_Management___Research_Company>,
        <https://1145.am/db/227104/Fidelity_Management___Research_Co>,
        <https://1145.am/db/2278983/Fidelity_Management_And_Research>,
        <https://1145.am/db/2284585/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2291211/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2291403/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2293124/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2294326/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2339214/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2339223/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2356469/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2361695/Fidelity_Management___Research_Company>,
        <https://1145.am/db/236388/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/2368579/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2368912/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2368913/Fidelity_Management_And_Research>,
        <https://1145.am/db/2369304/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2369549/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2370694/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/2541350/Fidelity_Management___Research_Company>,
        <https://1145.am/db/2557987/Fidelity_Management___Research>,
        <https://1145.am/db/262651/Fidelity_Management___Research_Company>,
        <https://1145.am/db/262682/Fidelity_Management___Research_Company>,
        <https://1145.am/db/271327/Fidelity_Management___Research_Co>,
        <https://1145.am/db/317470/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/377391/Fidelity_Management_And_Research>,
        <https://1145.am/db/385136/Fidelity_Management___Research_Co>,
        <https://1145.am/db/385198/Fidelity_Management___Research_Co>,
        <https://1145.am/db/502886/Fidelity_Management_And_Research>,
        <https://1145.am/db/506085/Fidelity_Management_And_Research>,
        <https://1145.am/db/512324/Fidelity_Management___Research_Company>,
        <https://1145.am/db/571769/Fidelity_Management_And_Research>,
        <https://1145.am/db/583568/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637078/Fidelity_Management___Research_Company>,
        <https://1145.am/db/637603/Fidelity_Management___Research>,
        <https://1145.am/db/677591/Fidelity_Management_And_Research_Company>,
        <https://1145.am/db/749014/Fidelity_Management_And_Research_Co>,
        <https://1145.am/db/782640/Fidelity_Management___Research_Llc>,
        <https://1145.am/db/847232/Fidelity_Management___Research_Company>,
        <https://1145.am/db/888513/Fidelity_Management___Research_Company>,
        <https://1145.am/db/922192/Fidelity_Management___Research_Company>,
        <https://1145.am/db/93760/Fidelity_Management___Research>,
        <https://1145.am/db/970498/Fidelity_Management_And_Research> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369718/Novartis> a org:Organization ;
    ns1:basedInLowRaw "Mass" ;
    ns1:description "healthcare investors" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Novartis" ;
    ns1:industry "healthcare" ;
    ns1:investor <https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1986468/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371160/Orbimed> a org:Organization ;
    ns1:basedInHighGeoName "San Francisco" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:basedInHighRaw "San Francisco" ;
    ns1:description "biotech" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "OrbiMed" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed> ;
    ns1:name "OrbiMed" ;
    ns1:sameAsHigh <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2348857/Orbimed>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2369202/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2371163/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1042080/Orbimed>,
        <https://1145.am/db/1086582/Orbimed>,
        <https://1145.am/db/1089269/Orbimed>,
        <https://1145.am/db/1140378/Orbimed>,
        <https://1145.am/db/1213048/Orbimed>,
        <https://1145.am/db/1334863/Orbimed>,
        <https://1145.am/db/1340338/Orbimed>,
        <https://1145.am/db/1690914/Orbimed>,
        <https://1145.am/db/2032047/Orbimed>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2192716/Orbimed>,
        <https://1145.am/db/2198716/Orbimed>,
        <https://1145.am/db/2281204/Orbimed>,
        <https://1145.am/db/2281272/Orbimed>,
        <https://1145.am/db/2283935/Orbimed>,
        <https://1145.am/db/2286245/Orbimed>,
        <https://1145.am/db/2286541/Orbimed>,
        <https://1145.am/db/2288436/Orbimed>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2292284/Orbimed>,
        <https://1145.am/db/2293508/Orbimed>,
        <https://1145.am/db/2293540/Orbimed>,
        <https://1145.am/db/2293893/Orbimed>,
        <https://1145.am/db/2295525/Orbimed>,
        <https://1145.am/db/2297224/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2297514/Orbimed>,
        <https://1145.am/db/2297930/Orbimed>,
        <https://1145.am/db/2299411/Orbimed>,
        <https://1145.am/db/2299645/Orbimed>,
        <https://1145.am/db/2300061/Orbimed>,
        <https://1145.am/db/2300653/Orbimed>,
        <https://1145.am/db/2301464/Orbimed>,
        <https://1145.am/db/2304258/Orbimed>,
        <https://1145.am/db/2318134/Orbimed>,
        <https://1145.am/db/2323243/Orbimed>,
        <https://1145.am/db/2330389/Orbimed>,
        <https://1145.am/db/2335764/Orbimed>,
        <https://1145.am/db/2337043/Orbimed>,
        <https://1145.am/db/2337667/Orbimed>,
        <https://1145.am/db/2340942/Orbimed>,
        <https://1145.am/db/2341484/Orbimed>,
        <https://1145.am/db/2341487/Orbimed>,
        <https://1145.am/db/2343545/Orbimed>,
        <https://1145.am/db/2344045/Orbimed>,
        <https://1145.am/db/2347103/Orbimed>,
        <https://1145.am/db/2347885/Orbimed>,
        <https://1145.am/db/2348149/Orbimed>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2353515/Orbimed>,
        <https://1145.am/db/2355023/Orbimed>,
        <https://1145.am/db/2361337/Orbimed>,
        <https://1145.am/db/2362768/Orbimed>,
        <https://1145.am/db/236388/Orbimed>,
        <https://1145.am/db/2368872/Orbimed>,
        <https://1145.am/db/2369548/Orbimed>,
        <https://1145.am/db/2369982/Orbimed>,
        <https://1145.am/db/2369999/Orbimed>,
        <https://1145.am/db/2370694/Orbimed>,
        <https://1145.am/db/2370799/Orbimed>,
        <https://1145.am/db/2718732/Orbimed>,
        <https://1145.am/db/2787561/Orbimed>,
        <https://1145.am/db/474852/Orbimed>,
        <https://1145.am/db/713335/Orbimed>,
        <https://1145.am/db/714498/Orbimed>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed>,
        <https://1145.am/db/867907/Orbimed>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Orbimed> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "OrbiMed" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "OrbiMed" ;
    ns1:sameAsHigh <https://1145.am/db/1042080/Orbimed>,
        <https://1145.am/db/1086582/Orbimed>,
        <https://1145.am/db/1089269/Orbimed>,
        <https://1145.am/db/1213048/Orbimed>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2348857/Orbimed>,
        <https://1145.am/db/2353515/Orbimed>,
        <https://1145.am/db/2361337/Orbimed>,
        <https://1145.am/db/2371160/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Orbimed>,
        <https://1145.am/db/1140378/Orbimed>,
        <https://1145.am/db/1334863/Orbimed>,
        <https://1145.am/db/1340338/Orbimed>,
        <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1608803/Orbimed>,
        <https://1145.am/db/1690914/Orbimed>,
        <https://1145.am/db/194149/Orbimed>,
        <https://1145.am/db/2032047/Orbimed>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2151717/Orbimed>,
        <https://1145.am/db/2192716/Orbimed>,
        <https://1145.am/db/2198716/Orbimed>,
        <https://1145.am/db/2280770/Orbimed>,
        <https://1145.am/db/2281204/Orbimed>,
        <https://1145.am/db/2281272/Orbimed>,
        <https://1145.am/db/2283935/Orbimed>,
        <https://1145.am/db/2286207/Orbimed>,
        <https://1145.am/db/2286245/Orbimed>,
        <https://1145.am/db/2286541/Orbimed>,
        <https://1145.am/db/2288436/Orbimed>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2290069/Orbimed>,
        <https://1145.am/db/2290337/Orbimed>,
        <https://1145.am/db/2290766/Orbimed>,
        <https://1145.am/db/2292284/Orbimed>,
        <https://1145.am/db/2293503/Orbimed>,
        <https://1145.am/db/2293508/Orbimed>,
        <https://1145.am/db/2293540/Orbimed>,
        <https://1145.am/db/2293893/Orbimed>,
        <https://1145.am/db/2295525/Orbimed>,
        <https://1145.am/db/2295713/Orbimed>,
        <https://1145.am/db/2297224/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2297514/Orbimed>,
        <https://1145.am/db/2297930/Orbimed>,
        <https://1145.am/db/2298642/Orbimed>,
        <https://1145.am/db/2299411/Orbimed>,
        <https://1145.am/db/2299645/Orbimed>,
        <https://1145.am/db/2300061/Orbimed>,
        <https://1145.am/db/2300653/Orbimed>,
        <https://1145.am/db/2301464/Orbimed>,
        <https://1145.am/db/2304258/Orbimed>,
        <https://1145.am/db/2318134/Orbimed>,
        <https://1145.am/db/2323243/Orbimed>,
        <https://1145.am/db/2330389/Orbimed>,
        <https://1145.am/db/2335764/Orbimed>,
        <https://1145.am/db/2337043/Orbimed>,
        <https://1145.am/db/2337667/Orbimed>,
        <https://1145.am/db/2340942/Orbimed>,
        <https://1145.am/db/2341484/Orbimed>,
        <https://1145.am/db/2341487/Orbimed>,
        <https://1145.am/db/2343545/Orbimed>,
        <https://1145.am/db/2344044/Orbimed>,
        <https://1145.am/db/2344045/Orbimed>,
        <https://1145.am/db/2347103/Orbimed>,
        <https://1145.am/db/2347885/Orbimed>,
        <https://1145.am/db/2348149/Orbimed>,
        <https://1145.am/db/2349834/Orbimed>,
        <https://1145.am/db/2349838/Orbimed>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2355023/Orbimed>,
        <https://1145.am/db/2362768/Orbimed>,
        <https://1145.am/db/236388/Orbimed>,
        <https://1145.am/db/2363947/Orbimed>,
        <https://1145.am/db/2368872/Orbimed>,
        <https://1145.am/db/2369135/Orbimed>,
        <https://1145.am/db/2369140/Orbimed>,
        <https://1145.am/db/2369202/Orbimed>,
        <https://1145.am/db/2369548/Orbimed>,
        <https://1145.am/db/2369982/Orbimed>,
        <https://1145.am/db/2369999/Orbimed>,
        <https://1145.am/db/2370208/Orbimed>,
        <https://1145.am/db/2370295/Orbimed>,
        <https://1145.am/db/2370694/Orbimed>,
        <https://1145.am/db/2370782/Orbimed>,
        <https://1145.am/db/2370799/Orbimed>,
        <https://1145.am/db/2547469/Orbimed>,
        <https://1145.am/db/2548437/Orbimed>,
        <https://1145.am/db/2718732/Orbimed>,
        <https://1145.am/db/2787561/Orbimed>,
        <https://1145.am/db/402604/Orbimed>,
        <https://1145.am/db/474852/Orbimed>,
        <https://1145.am/db/581662/Orbimed>,
        <https://1145.am/db/583614/Orbimed>,
        <https://1145.am/db/676857/Orbimed>,
        <https://1145.am/db/713335/Orbimed>,
        <https://1145.am/db/714498/Orbimed>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed>,
        <https://1145.am/db/867907/Orbimed>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing in biotechnology" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1070743/Novateur_Ventures>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1283038/Arkin_Bio_Ventures>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1657080/Alpha_Wave_Ventures>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/2282410/Lumira_Ventures>,
        <https://1145.am/db/2301824/Sagamore_Bioventures>,
        <https://1145.am/db/2302897/Sagamore_Bioventures>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2325348/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2331988/Bioventures_Investors>,
        <https://1145.am/db/2339932/Biogeneration_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349011/Sofinnova_Ventures_And_Novo_A_S>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2353607/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2355586/Amgen_Ventures>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2361588/Agechem_Venture>,
        <https://1145.am/db/2367203/Bionest_Partners_Finance>,
        <https://1145.am/db/2367206/Bionest_Partners_Finance>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2550552/Lightstone_Ventures>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/527072/Biobrit_Llc>,
        <https://1145.am/db/545842/Hx_Bio_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/674484/Trinity_Ventures>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/992046/Sofinnova_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371188/Novartis> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2015-10-15T10:08:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Gamida Cell pockets $5M from Novartis ahead of mooted financing round" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/gamida-cell-pockets-5m-from-novartis-ahead-of-mooted-financing-round> ;
    ns1:foundName "Novartis" ;
    ns1:investor <https://1145.am/db/2371188/Stake_Investment_Gamida_Cell_The_Big_Pharma_Completed> ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1048908/Johnson___Johnson>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/1262552/Johnson___Johnson>,
        <https://1145.am/db/1270868/Johnson___Johnson>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/1673527/Johnson___Johnson>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1822601/Johnson___Johnson>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2057335/Johnson___Johnson>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2089281/Johnson___Johnson>,
        <https://1145.am/db/2103283/Johnson___Johnson>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2153410/Johnson___Johnson>,
        <https://1145.am/db/2154194/Johnson___Johnson>,
        <https://1145.am/db/2154521/Johnson___Johnson>,
        <https://1145.am/db/2193661/Johnson___Johnson>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280422/Johnson___Johnson>,
        <https://1145.am/db/2282888/Johnson_And_Johnson>,
        <https://1145.am/db/2282888/Johnson___Johnson>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285587/Johnson___Johnson>,
        <https://1145.am/db/2286603/Johnson___Johnson>,
        <https://1145.am/db/2287377/Johnson___Johnson>,
        <https://1145.am/db/2290342/Johnson___Johnson>,
        <https://1145.am/db/2290894/Johnson___Johnson>,
        <https://1145.am/db/2291777/Johnson___Johnson>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2296402/Johnson___Johnson>,
        <https://1145.am/db/2296598/Johnson___Johnson>,
        <https://1145.am/db/2298037/Johnson___Johnson>,
        <https://1145.am/db/2298501/Johnson___Johnson>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2309930/Johnson___Johnson>,
        <https://1145.am/db/2310118/Johnson___Johnson>,
        <https://1145.am/db/2314331/Johnson___Johnson>,
        <https://1145.am/db/2315481/Johnson___Johnson>,
        <https://1145.am/db/2317181/Johnson___Johnson>,
        <https://1145.am/db/2317639/Johnson___Johnson>,
        <https://1145.am/db/2318685/Johnson___Johnson>,
        <https://1145.am/db/2319656/Johnson___Johnson>,
        <https://1145.am/db/2322024/Johnson___Johnson>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323000/Johnson___Johnson>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2327024/Johnson___Johnson>,
        <https://1145.am/db/2329487/Johnson___Johnson>,
        <https://1145.am/db/2330734/Johnson___Johnson>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2336790/Johnson___Johnson>,
        <https://1145.am/db/2336797/Johnson___Johnson>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2340071/Johnson___Johnson>,
        <https://1145.am/db/2341850/Johnson___Johnson>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344683/Johnson___Johnson>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2350116/Johnson___Johnson>,
        <https://1145.am/db/2350440/Johnson___Johnson_Inc>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2354402/Johnson___Johnson>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2359302/Johnson___Johnson>,
        <https://1145.am/db/2360309/Novartis_Pharma_Ag>,
        <https://1145.am/db/2360754/Johnson___Johnson>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364601/Johnson___Johnson>,
        <https://1145.am/db/2366653/Johnson___Johnson>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367616/Johnson___Johnson>,
        <https://1145.am/db/2367617/Johnson___Johnson>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2369449/Novartis_Pharma_Ag>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370259/Johnson___Johnson>,
        <https://1145.am/db/2536264/Johnson___Johnson>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2543863/Johnson___Johnson>,
        <https://1145.am/db/2545522/Johnson___Johnson>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546172/Johnson___Johnson>,
        <https://1145.am/db/2547152/Johnson___Johnson>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2553024/Johnson___Johnson>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2553852/Johnson___Johnson>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2560372/Johnson___Johnson>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2564032/Johnson___Johnson>,
        <https://1145.am/db/2564462/Johnson___Johnson_Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2566147/Johnson___Johnson>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2572466/Johnson___Johnson>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573373/Johnson___Johnson>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574347/Johnson___Johnson>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575492/Johnson___Johnson>,
        <https://1145.am/db/2575496/Johnson___Johnson>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575810/Novartis_Pharma_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576439/Johnson___Johnson>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576962/Johnson___Johnson>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2583189/Johnson___Johnson>,
        <https://1145.am/db/2584383/Johnson___Johnson>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2585710/Johnson___Johnson>,
        <https://1145.am/db/2587143/Johnson___Johnson>,
        <https://1145.am/db/2587177/Johnson___Johnson>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588074/Johnson___Johnson>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589402/Johnson___Johnson>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2591073/Johnson___Johnson>,
        <https://1145.am/db/2591074/Johnson___Johnson>,
        <https://1145.am/db/2591076/Johnson___Johnson>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592534/Johnson___Johnson>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2593889/Johnson___Johnson>,
        <https://1145.am/db/2594106/Johnson___Johnson>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597135/Johnson___Johnson>,
        <https://1145.am/db/2598439/Johnson___Johnson_Inc>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/2787550/Johnson___Johnson>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/699695/Johnson___Johnson>,
        <https://1145.am/db/712016/Novartis> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371333/Investment_Alzheimers_Research_Uk_Takeda_The_Dementia_Discovery_Fund_Uk_Governments_Department_Of_Health_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-21T15:40:38+00:00"^^xsd:dateTime ;
    ns1:documentExtract "LONDON- (BUSINESS WIRE) -The Dementia Discovery Fund (DDF) , an innovative new global investment fund to support discovery and development of novel dementia treatments has launched, raising $ 100 Million from investors including the UK Government's Department of Health (DoH) and Alzheimer's Research UK alongside world-leading major pharmaceutical companies including Biogen, GlaxoSmithKline, Johnson & Johnson, Lilly, Pfizer and Takeda." ;
    ns1:documentTitle "Launch of Dementia Discovery Fund - New Fund Raises $100 Million to Deliver Novel Approaches to Treatment of Dementia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/launch-of-dementia-discovery-fund-new-fund-raises-100-million-to-deliver-novel-approaches> ;
    ns1:foundName "investment",
        "raising" ;
    ns1:name "investment",
        "raising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2371333/The_Dementia_Discovery_Fund> ;
    ns1:valueRaw "$ 100 Million" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2538444/Series_A+_Investment_Burning_Rock_Biotech_Jifeng_Capital_Legend_Star_Sequoia_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-20T11:02:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> China - based Burning Rock Biotech raised $ 23 million in Series A+ finance for efforts to develop diagnostic tests for solid tumor cancers that can indicate the best treatment option, the company said in a press release." ;
    ns1:documentTitle "Burning Rock raises $23M in Series A+; 3Sbio added to HKEx index;" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/burning-rock-raises-23m-series-a-3sbio-added-to-hkex-index> ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2538444/Burning_Rock_Biotech> ;
    ns1:targetDetails "Series A+" ;
    ns1:valueRaw "$ 23 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2540193/Shares_Investment_Karolinska_Development_Ab_Praktikerinvest_Recipharm_Venture_Fund_Ab_Stersjstiftelsen_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-09T11:19:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Recipharm Venture Fund AB has together with stersjstiftelsen and Praktikerinvest made a joint investment of SEK 28 million in Pharmanest AB." ;
    ns1:documentTitle "Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest's lead drug candidate SHACT" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/recipharm-invests-sek-8-million-pharmanest-to-support-development-of-pharmanest-s> ;
    ns1:foundName "investment",
        "sell" ;
    ns1:name "investment",
        "sell" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2540193/Karolinska_Development_Ab>,
        <https://1145.am/db/2540193/Kcif> ;
    ns1:targetDetails "shares" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2541146/Viropharma_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-08-25T11:20:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Shire ($ SHPG) has a new agreement with Sanquin Blood Supply, which has been the exclusive manufacturer of Cinryze, the rare disease drug it got in its $ 4.2 billion buyout of ViroPharma, which will allow it to use other contractors to increase production of the drug." ;
    ns1:documentTitle "Pfizer to close Hospira deal in September; U.K. cell manufacturing facility moves forward;" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/pfizer-to-close-hospira-deal-september-u-k-cell-manufacturing-facility-moves-forward> ;
    ns1:foundName "buyout" ;
    ns1:name "buyout" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2541146/Viropharma> ;
    ns1:targetName "ViroPharma" ;
    ns1:valueRaw "$ 4.2 billion",
        "55 million" .

<https://1145.am/db/2570523/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2015-08-17T19:59:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Checkmate Pharmaceuticals Debuts with $20 Million Series A Investment for Development of Novel Immuno-Oncology Product Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/checkmate-pharmaceuticals-debuts-20-million-series-a-investment-for-development-of> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2570523/Series_A_Investment_Checkmate_Pharmaceuticals_Cytos_Biotechnology_Ltd_Sofinnova_Ventures_Venbio_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2586501/Series_A_Investment_Aelix_Therapeutics_Caixa_Capital_Risc_Caixa_Capital_Risc_Johnson___Johnson_Innovation_Johnson___Johnson_Innovation_Ysios_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-12T20:39:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BARCELONA, Spain I January 11, 2016 I Aelix Therapeutics, a drug development company specialized in the discovery and development of immunotherapies against HIV infection, today announces that it has completed a Series A funding round of 11.5 M ($ 12.7 M) ." ;
    ns1:documentTitle "Aelix Therapeutics completes Series A funding of 11.5M ($12.7M) for therapeutic HIV vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/aelix-therapeutics-completes-series-a-funding-of-%E2%82%AC11-5m-12-7m-for-therapeutic-hiv-vaccine> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2586501/Aelix_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 12.7 M",
        "11.5 M" ;
    ns1:when "2016-01-11T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "January 11, 2016" ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2588562/Community_Veterinary_Partners_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2015-11-23T13:43:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "(New York, NY) - Cortec Group (\"Cortec\") , a New York private equity firm which invests in middle market healthcare, specialty service, consumer, and distribution businesses, announced that on October 30, 2015, a group led by its affiliate, Cortec Group Fund V, L.P. (\"Cortec Fund V\") , in partnership with management, recapitalized Community Veterinary Partners, LLC (\"CVP\" or the \"Company\") .",
        "(New York, NY) - Cortec Group (\"Cortec\") , a New York private equity firm which invests in middle market healthcare, specialty service, consumer, and distribution businesses, announced that on October 30, 2015, a group led by its affiliate, Cortec Group Fund V, L.P. (\"Cortec Fund V\") , in partnership with management, recapitalized Community Veterinary Partners, LLC (\"CVP\" or the \"Company\").",
        "Cortec Group has acquired Community Veterinary Partners LLC via recapitalization." ;
    ns1:documentTitle "Cortec Group buys Community Veterinary Partners" ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/cortec-group-buys-community-veterinary-partners> ;
    ns1:foundName "acquired",
        "recapitalized" ;
    ns1:name "acquired",
        "recapitalized" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2588562/Community_Veterinary_Partners> ;
    ns1:targetName "Community Veterinary Partners" ;
    ns1:when "2015-10-30T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 30, 2015" ;
    ns1:whereGeoName "New York City",
        "Philadelphia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4560349/about.rdf>,
        <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:whereRaw "New York",
        "Philadelphia" .

<https://1145.am/db/2600867/Keytech_Interest_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "merger" ;
    ns1:documentDate "2015-10-07T13:27:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Atlantic Tele-Network (ATN) has signed an agreement to take controlling interest in Bermuda - based KeyTech, ahead of the proposed business combination of KeyTech." ;
    ns1:documentTitle "ATN to purchase Bermuda-based KeyTech; Vonage granted seven new patents" ;
    ns1:documentURL <https://www.fiercetelecom.com/telecom/atn-to-purchase-bermuda-based-keytech-vonage-granted-seven-new-patents> ;
    ns1:foundName "business combination",
        "take" ;
    ns1:name "business combination",
        "take" ;
    ns1:sourceName "Fierce Telecom" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2600867/Keytech> ;
    ns1:targetDetails "interest" ;
    ns1:targetName "KeyTech" ;
    ns1:whereGeoName "Bermuda" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3573345/about.rdf> ;
    ns1:whereRaw "Bermuda" .

<https://1145.am/db/2661968/Orange> a org:Organization ;
    ns1:basedInLowRaw "Kenya" ;
    ns1:documentDate "2015-10-02T05:48:10+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Apple eyes ring wearable; Vivendi tipped for further Telecom Italia stake rise" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/apple-eyes-ring-wearable-vivendi-tipped-for-further-telecom-italia-stake-rise> ;
    ns1:foundName "Orange" ;
    ns1:name "Orange" ;
    ns1:sameAsMedium <https://1145.am/db/1004187/Orange>,
        <https://1145.am/db/1226110/Orange>,
        <https://1145.am/db/1240352/Orange>,
        <https://1145.am/db/145211/Orange>,
        <https://1145.am/db/1475460/Orange>,
        <https://1145.am/db/1512124/Orange>,
        <https://1145.am/db/1627765/Orange>,
        <https://1145.am/db/1658556/Orange>,
        <https://1145.am/db/1671307/Orange>,
        <https://1145.am/db/1691407/Orange>,
        <https://1145.am/db/1701725/Orange>,
        <https://1145.am/db/1750943/Orange>,
        <https://1145.am/db/1790627/Orange>,
        <https://1145.am/db/1802203/Orange>,
        <https://1145.am/db/1813320/Orange>,
        <https://1145.am/db/1900191/Orange>,
        <https://1145.am/db/1929686/Orange>,
        <https://1145.am/db/1957827/Orange>,
        <https://1145.am/db/1968571/Orange>,
        <https://1145.am/db/1987684/Orange>,
        <https://1145.am/db/2049904/Orange>,
        <https://1145.am/db/2168368/Orange>,
        <https://1145.am/db/256990/Orange>,
        <https://1145.am/db/2603223/Orange>,
        <https://1145.am/db/2604558/Orange>,
        <https://1145.am/db/2608608/Orange>,
        <https://1145.am/db/2610211/Orange>,
        <https://1145.am/db/2636446/Orange_Uk>,
        <https://1145.am/db/2648707/Orange>,
        <https://1145.am/db/2650990/Orange>,
        <https://1145.am/db/2651122/Orange>,
        <https://1145.am/db/2651574/Orange_Uk>,
        <https://1145.am/db/2651775/Orange>,
        <https://1145.am/db/2651808/Orange>,
        <https://1145.am/db/2652375/Orange>,
        <https://1145.am/db/2652404/Orange>,
        <https://1145.am/db/2652416/Orange>,
        <https://1145.am/db/2653163/Orange>,
        <https://1145.am/db/2653171/Orange>,
        <https://1145.am/db/2653801/Orange>,
        <https://1145.am/db/2653808/Orange>,
        <https://1145.am/db/2653910/Orange>,
        <https://1145.am/db/2653979/Orange>,
        <https://1145.am/db/2654870/Orange>,
        <https://1145.am/db/2655767/Orange>,
        <https://1145.am/db/2656778/Orange>,
        <https://1145.am/db/2656937/Orange>,
        <https://1145.am/db/2657745/Orange>,
        <https://1145.am/db/2657848/Orange>,
        <https://1145.am/db/2658777/Orange>,
        <https://1145.am/db/2658787/Orange>,
        <https://1145.am/db/2658880/Orange>,
        <https://1145.am/db/2658935/Orange>,
        <https://1145.am/db/2659808/Orange>,
        <https://1145.am/db/2659913/Orange>,
        <https://1145.am/db/2662109/Orange>,
        <https://1145.am/db/2662969/Orange_Uk>,
        <https://1145.am/db/2663177/Orange>,
        <https://1145.am/db/2664269/Orange>,
        <https://1145.am/db/2665208/Orange>,
        <https://1145.am/db/2665849/Orange>,
        <https://1145.am/db/2666278/Orange>,
        <https://1145.am/db/2666650/Orange>,
        <https://1145.am/db/2667222/Orange>,
        <https://1145.am/db/2667341/Orange>,
        <https://1145.am/db/2668414/Orange>,
        <https://1145.am/db/2669541/Orange>,
        <https://1145.am/db/2669649/Orange>,
        <https://1145.am/db/2669683/Orange>,
        <https://1145.am/db/2670731/Orange>,
        <https://1145.am/db/2671793/Orange>,
        <https://1145.am/db/2675257/Orange_Uk>,
        <https://1145.am/db/2675378/Orange>,
        <https://1145.am/db/2676661/Orange>,
        <https://1145.am/db/2676704/Orange>,
        <https://1145.am/db/276804/Orange>,
        <https://1145.am/db/2788578/Orange>,
        <https://1145.am/db/286998/Orange>,
        <https://1145.am/db/326109/Orange>,
        <https://1145.am/db/353380/Orange_Ev>,
        <https://1145.am/db/644489/Orange>,
        <https://1145.am/db/649381/Orange>,
        <https://1145.am/db/650597/Orange>,
        <https://1145.am/db/741970/Orange>,
        <https://1145.am/db/777031/Orange>,
        <https://1145.am/db/790844/Orange>,
        <https://1145.am/db/815233/Orange>,
        <https://1145.am/db/885960/Orange> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2170734/Series_D_Investment_Cueball_Capital_Greenspring_Associates_Greycroft_Growth_Jw_Player_Eventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-05T22:04:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "JW Player's latest round of fundraising brings its total funding to $ 45.6 million - it raised $ 20 million in its Series C round in 2014, $ 4 million in its 2012 Series B round, and started with a $ 1.6 million angel investment.",
        "JW Player, which built a niche for itself providing an online video platform targeted to enterprises, capped off a year of growth by completing a $ 20 million Series D funding round led by existing investors including Greycroft Growth, Greenspring Associates, Cueball Capital, and e.ventures." ;
    ns1:documentTitle "JW Player gets $20M funding boost to expand its online video platform" ;
    ns1:documentURL <https://www.streamtvinsider.com/online-video/jw-player-gets-20m-funding-boost-to-expand-its-online-video-platform> ;
    ns1:foundName "funding",
        "fundraising" ;
    ns1:name "funding",
        "fundraising" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2170734/Jw_Player> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 20 million",
        "$ 45.6 million" ;
    ns1:whenRaw "2014" .

<https://1145.am/db/2368321/Investment_Eli_Lilly_And_Company_Immunocore_Malin_Corporation_Rtw_Investments_Woodford_Investment_Management_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T13:33:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Immunocore Limited, a world-leading biotechnology company developing novel T cell receptor (TCR) based biological drugs to treat cancer, viral infections and autoimmune disease, today announced the completion of a US $ 320 million (GBP 205 million) private financing round.",
        "Immunocore Secures $ 320 Million (205 Million) in Europe's Largest Private Life Sciences Financing." ;
    ns1:documentTitle "Immunocore Secures $320 Million (205 Million) in Europe's Largest Private Life Sciences Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/immunocore-secures-320-million-%C2%A3205-million-europe-s-largest-private-life-sciences> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2368321/Immunocore> ;
    ns1:valueRaw "$ 320 Million",
        "GBP 205 million",
        "US $ 320 million",
        "205 Million" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2368333/Cormorant_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "Cormorant Asset Management" ;
    ns1:investor <https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> ;
    ns1:name "Cormorant Asset Management" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Cormorant_Asset_Management>,
        <https://1145.am/db/1247479/Cormorant_Asset_Management>,
        <https://1145.am/db/1448487/Cormorant_Asset_Management>,
        <https://1145.am/db/1519613/Cormorant_Asset_Management>,
        <https://1145.am/db/1519799/Cormorant_Asset_Management>,
        <https://1145.am/db/1665536/Cormorant_Asset_Management>,
        <https://1145.am/db/2062003/Cormorant_Asset_Management>,
        <https://1145.am/db/2069394/Cormorant_Asset_Management>,
        <https://1145.am/db/2080575/Cormorant_Asset_Management>,
        <https://1145.am/db/2095032/Cormorant_Asset_Management>,
        <https://1145.am/db/2154559/Cormorant_Asset_Management>,
        <https://1145.am/db/2155505/Cormorant_Asset_Management>,
        <https://1145.am/db/2287244/Cormorant_Asset_Management>,
        <https://1145.am/db/2291882/Cormorant_Asset_Management>,
        <https://1145.am/db/2293667/Cormorant_Asset_Management>,
        <https://1145.am/db/2323785/Cormorant_Asset_Management>,
        <https://1145.am/db/2333314/Cormorant_Asset_Management>,
        <https://1145.am/db/2357566/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2361688/Cormorant_Asset_Management>,
        <https://1145.am/db/2361695/Cormorant_Asset_Management>,
        <https://1145.am/db/2367541/Cormorant_Asset_Management>,
        <https://1145.am/db/2368386/Cormorant_Asset_Management>,
        <https://1145.am/db/2368912/Cormorant_Asset_Management>,
        <https://1145.am/db/2368913/Cormorant_Asset_Management>,
        <https://1145.am/db/2369165/Cormorant_Asset_Management>,
        <https://1145.am/db/2370018/Cormorant_Asset_Management>,
        <https://1145.am/db/2370022/Cormorant_Asset_Management>,
        <https://1145.am/db/2370694/Cormorant_Asset_Management>,
        <https://1145.am/db/2371160/Cormorant_Asset_Management>,
        <https://1145.am/db/2371163/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2572177/Cormorant_Asset_Management>,
        <https://1145.am/db/2787561/Cormorant_Asset_Management>,
        <https://1145.am/db/488687/Cormorant_Asset_Management>,
        <https://1145.am/db/509733/Cormorant_Asset_Management>,
        <https://1145.am/db/683988/Cormorant_Asset_Management>,
        <https://1145.am/db/734448/Cormorant_Asset_Management>,
        <https://1145.am/db/735920/Cormorant_Asset_Management>,
        <https://1145.am/db/747020/Cormorant_Asset_Management>,
        <https://1145.am/db/862503/Cormorant_Asset_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368912/Cormorant_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "Cormorant Asset Management" ;
    ns1:investor <https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> ;
    ns1:name "Cormorant Asset Management" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Cormorant_Asset_Management>,
        <https://1145.am/db/1247479/Cormorant_Asset_Management>,
        <https://1145.am/db/1448487/Cormorant_Asset_Management>,
        <https://1145.am/db/1519613/Cormorant_Asset_Management>,
        <https://1145.am/db/1519799/Cormorant_Asset_Management>,
        <https://1145.am/db/1665536/Cormorant_Asset_Management>,
        <https://1145.am/db/2062003/Cormorant_Asset_Management>,
        <https://1145.am/db/2069394/Cormorant_Asset_Management>,
        <https://1145.am/db/2080575/Cormorant_Asset_Management>,
        <https://1145.am/db/2095032/Cormorant_Asset_Management>,
        <https://1145.am/db/2154559/Cormorant_Asset_Management>,
        <https://1145.am/db/2155505/Cormorant_Asset_Management>,
        <https://1145.am/db/2287244/Cormorant_Asset_Management>,
        <https://1145.am/db/2291882/Cormorant_Asset_Management>,
        <https://1145.am/db/2293667/Cormorant_Asset_Management>,
        <https://1145.am/db/2323785/Cormorant_Asset_Management>,
        <https://1145.am/db/2333314/Cormorant_Asset_Management>,
        <https://1145.am/db/2357566/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2361688/Cormorant_Asset_Management>,
        <https://1145.am/db/2361695/Cormorant_Asset_Management>,
        <https://1145.am/db/2367541/Cormorant_Asset_Management>,
        <https://1145.am/db/2368333/Cormorant_Asset_Management>,
        <https://1145.am/db/2368386/Cormorant_Asset_Management>,
        <https://1145.am/db/2368913/Cormorant_Asset_Management>,
        <https://1145.am/db/2369165/Cormorant_Asset_Management>,
        <https://1145.am/db/2370018/Cormorant_Asset_Management>,
        <https://1145.am/db/2370022/Cormorant_Asset_Management>,
        <https://1145.am/db/2370694/Cormorant_Asset_Management>,
        <https://1145.am/db/2371160/Cormorant_Asset_Management>,
        <https://1145.am/db/2371163/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2572177/Cormorant_Asset_Management>,
        <https://1145.am/db/2787561/Cormorant_Asset_Management>,
        <https://1145.am/db/488687/Cormorant_Asset_Management>,
        <https://1145.am/db/509733/Cormorant_Asset_Management>,
        <https://1145.am/db/683988/Cormorant_Asset_Management>,
        <https://1145.am/db/734448/Cormorant_Asset_Management>,
        <https://1145.am/db/735920/Cormorant_Asset_Management>,
        <https://1145.am/db/747020/Cormorant_Asset_Management>,
        <https://1145.am/db/862503/Cormorant_Asset_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2368913/Cormorant_Asset_Management> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "Investing" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "Cormorant Asset Management" ;
    ns1:investor <https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> ;
    ns1:name "Cormorant Asset Management" ;
    ns1:sameAsHigh <https://1145.am/db/1042269/Cormorant_Asset_Management>,
        <https://1145.am/db/1448487/Cormorant_Asset_Management>,
        <https://1145.am/db/1519613/Cormorant_Asset_Management>,
        <https://1145.am/db/1519799/Cormorant_Asset_Management>,
        <https://1145.am/db/1665536/Cormorant_Asset_Management>,
        <https://1145.am/db/2069394/Cormorant_Asset_Management>,
        <https://1145.am/db/2080575/Cormorant_Asset_Management>,
        <https://1145.am/db/2095032/Cormorant_Asset_Management>,
        <https://1145.am/db/2291882/Cormorant_Asset_Management>,
        <https://1145.am/db/488687/Cormorant_Asset_Management>,
        <https://1145.am/db/509733/Cormorant_Asset_Management>,
        <https://1145.am/db/683988/Cormorant_Asset_Management>,
        <https://1145.am/db/734448/Cormorant_Asset_Management>,
        <https://1145.am/db/735920/Cormorant_Asset_Management>,
        <https://1145.am/db/747020/Cormorant_Asset_Management>,
        <https://1145.am/db/862503/Cormorant_Asset_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1247479/Cormorant_Asset_Management>,
        <https://1145.am/db/2062003/Cormorant_Asset_Management>,
        <https://1145.am/db/2154559/Cormorant_Asset_Management>,
        <https://1145.am/db/2155505/Cormorant_Asset_Management>,
        <https://1145.am/db/2287244/Cormorant_Asset_Management>,
        <https://1145.am/db/2293667/Cormorant_Asset_Management>,
        <https://1145.am/db/2323785/Cormorant_Asset_Management>,
        <https://1145.am/db/2333314/Cormorant_Asset_Management>,
        <https://1145.am/db/2357566/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2361688/Cormorant_Asset_Management>,
        <https://1145.am/db/2361695/Cormorant_Asset_Management>,
        <https://1145.am/db/2367541/Cormorant_Asset_Management>,
        <https://1145.am/db/2368333/Cormorant_Asset_Management>,
        <https://1145.am/db/2368386/Cormorant_Asset_Management>,
        <https://1145.am/db/2368912/Cormorant_Asset_Management>,
        <https://1145.am/db/2369165/Cormorant_Asset_Management>,
        <https://1145.am/db/2370018/Cormorant_Asset_Management>,
        <https://1145.am/db/2370022/Cormorant_Asset_Management>,
        <https://1145.am/db/2370694/Cormorant_Asset_Management>,
        <https://1145.am/db/2371160/Cormorant_Asset_Management>,
        <https://1145.am/db/2371163/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2572177/Cormorant_Asset_Management>,
        <https://1145.am/db/2787561/Cormorant_Asset_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2369169/Series_C_Investment_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Hbm_Healthcare_Investments_Cormorant_Asset_Management_Iconic_Therapeutics_Osage_University_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-12T16:52:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "South San Francisco's Iconic Therapeutics raised $ 40 million in Series C cash to support its work on treatments for eye cancer, moving toward clinical trials with its ocular melanoma program." ;
    ns1:documentTitle "Iconic Therapeutics snags $40M for eye disease R&D" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/iconic-therapeutics-snags-40m-for-eye-disease-r-d> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369169/Iconic_Therapeutics> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 40 million" ;
    ns1:whereGeoName "South San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5397765/about.rdf> ;
    ns1:whereRaw "South San Francisco" .

<https://1145.am/db/2371160/Cormorant_Asset_Management> a org:Organization ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Cormorant Asset Management" ;
    ns1:investor <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Cormorant Asset Management" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Cormorant_Asset_Management>,
        <https://1145.am/db/1247479/Cormorant_Asset_Management>,
        <https://1145.am/db/1448487/Cormorant_Asset_Management>,
        <https://1145.am/db/1519613/Cormorant_Asset_Management>,
        <https://1145.am/db/1519799/Cormorant_Asset_Management>,
        <https://1145.am/db/1665536/Cormorant_Asset_Management>,
        <https://1145.am/db/2062003/Cormorant_Asset_Management>,
        <https://1145.am/db/2069394/Cormorant_Asset_Management>,
        <https://1145.am/db/2080575/Cormorant_Asset_Management>,
        <https://1145.am/db/2095032/Cormorant_Asset_Management>,
        <https://1145.am/db/2154559/Cormorant_Asset_Management>,
        <https://1145.am/db/2155505/Cormorant_Asset_Management>,
        <https://1145.am/db/2287244/Cormorant_Asset_Management>,
        <https://1145.am/db/2291882/Cormorant_Asset_Management>,
        <https://1145.am/db/2293667/Cormorant_Asset_Management>,
        <https://1145.am/db/2323785/Cormorant_Asset_Management>,
        <https://1145.am/db/2333314/Cormorant_Asset_Management>,
        <https://1145.am/db/2357566/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2361688/Cormorant_Asset_Management>,
        <https://1145.am/db/2361695/Cormorant_Asset_Management>,
        <https://1145.am/db/2367541/Cormorant_Asset_Management>,
        <https://1145.am/db/2368333/Cormorant_Asset_Management>,
        <https://1145.am/db/2368386/Cormorant_Asset_Management>,
        <https://1145.am/db/2368912/Cormorant_Asset_Management>,
        <https://1145.am/db/2368913/Cormorant_Asset_Management>,
        <https://1145.am/db/2369165/Cormorant_Asset_Management>,
        <https://1145.am/db/2370018/Cormorant_Asset_Management>,
        <https://1145.am/db/2370022/Cormorant_Asset_Management>,
        <https://1145.am/db/2370694/Cormorant_Asset_Management>,
        <https://1145.am/db/2371163/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2572177/Cormorant_Asset_Management>,
        <https://1145.am/db/2787561/Cormorant_Asset_Management>,
        <https://1145.am/db/488687/Cormorant_Asset_Management>,
        <https://1145.am/db/509733/Cormorant_Asset_Management>,
        <https://1145.am/db/683988/Cormorant_Asset_Management>,
        <https://1145.am/db/734448/Cormorant_Asset_Management>,
        <https://1145.am/db/735920/Cormorant_Asset_Management>,
        <https://1145.am/db/747020/Cormorant_Asset_Management>,
        <https://1145.am/db/862503/Cormorant_Asset_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2371163/Cormorant_Asset_Management_Llc> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "Cormorant Asset Management LLC" ;
    ns1:investor <https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> ;
    ns1:name "Cormorant Asset Management LLC" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Cormorant_Asset_Management>,
        <https://1145.am/db/1247479/Cormorant_Asset_Management>,
        <https://1145.am/db/1448487/Cormorant_Asset_Management>,
        <https://1145.am/db/1519613/Cormorant_Asset_Management>,
        <https://1145.am/db/1519799/Cormorant_Asset_Management>,
        <https://1145.am/db/1665536/Cormorant_Asset_Management>,
        <https://1145.am/db/2062003/Cormorant_Asset_Management>,
        <https://1145.am/db/2069394/Cormorant_Asset_Management>,
        <https://1145.am/db/2080575/Cormorant_Asset_Management>,
        <https://1145.am/db/2095032/Cormorant_Asset_Management>,
        <https://1145.am/db/2154559/Cormorant_Asset_Management>,
        <https://1145.am/db/2155505/Cormorant_Asset_Management>,
        <https://1145.am/db/2287244/Cormorant_Asset_Management>,
        <https://1145.am/db/2291882/Cormorant_Asset_Management>,
        <https://1145.am/db/2293667/Cormorant_Asset_Management>,
        <https://1145.am/db/2323785/Cormorant_Asset_Management>,
        <https://1145.am/db/2333314/Cormorant_Asset_Management>,
        <https://1145.am/db/2357566/Cormorant_Asset_Management_Llc>,
        <https://1145.am/db/2361688/Cormorant_Asset_Management>,
        <https://1145.am/db/2361695/Cormorant_Asset_Management>,
        <https://1145.am/db/2367541/Cormorant_Asset_Management>,
        <https://1145.am/db/2368333/Cormorant_Asset_Management>,
        <https://1145.am/db/2368386/Cormorant_Asset_Management>,
        <https://1145.am/db/2368912/Cormorant_Asset_Management>,
        <https://1145.am/db/2368913/Cormorant_Asset_Management>,
        <https://1145.am/db/2369165/Cormorant_Asset_Management>,
        <https://1145.am/db/2370018/Cormorant_Asset_Management>,
        <https://1145.am/db/2370022/Cormorant_Asset_Management>,
        <https://1145.am/db/2370694/Cormorant_Asset_Management>,
        <https://1145.am/db/2371160/Cormorant_Asset_Management>,
        <https://1145.am/db/2572177/Cormorant_Asset_Management>,
        <https://1145.am/db/2787561/Cormorant_Asset_Management>,
        <https://1145.am/db/488687/Cormorant_Asset_Management>,
        <https://1145.am/db/509733/Cormorant_Asset_Management>,
        <https://1145.am/db/683988/Cormorant_Asset_Management>,
        <https://1145.am/db/734448/Cormorant_Asset_Management>,
        <https://1145.am/db/735920/Cormorant_Asset_Management>,
        <https://1145.am/db/747020/Cormorant_Asset_Management>,
        <https://1145.am/db/862503/Cormorant_Asset_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2546157/Novartis> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2015-12-22T13:57:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novartis selling French Alcon plant to Recipharm" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/novartis-selling-french-alcon-plant-to-recipharm> ;
    ns1:foundName "Novartis" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1048908/Johnson___Johnson>,
        <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/1262552/Johnson___Johnson>,
        <https://1145.am/db/1270868/Johnson___Johnson>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/1673527/Johnson___Johnson>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1822601/Johnson___Johnson>,
        <https://1145.am/db/1986468/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2057335/Johnson___Johnson>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2089281/Johnson___Johnson>,
        <https://1145.am/db/2103283/Johnson___Johnson>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2153410/Johnson___Johnson>,
        <https://1145.am/db/2154194/Johnson___Johnson>,
        <https://1145.am/db/2154521/Johnson___Johnson>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2193661/Johnson___Johnson>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2280422/Johnson___Johnson>,
        <https://1145.am/db/2282888/Johnson_And_Johnson>,
        <https://1145.am/db/2282888/Johnson___Johnson>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2285587/Johnson___Johnson>,
        <https://1145.am/db/2286603/Johnson___Johnson>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2287377/Johnson___Johnson>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2290342/Johnson___Johnson>,
        <https://1145.am/db/2290894/Johnson___Johnson>,
        <https://1145.am/db/2291777/Johnson___Johnson>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296402/Johnson___Johnson>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2296598/Johnson___Johnson>,
        <https://1145.am/db/2298037/Johnson___Johnson>,
        <https://1145.am/db/2298501/Johnson___Johnson>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2309930/Johnson___Johnson>,
        <https://1145.am/db/2310118/Johnson___Johnson>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2314331/Johnson___Johnson>,
        <https://1145.am/db/2315481/Johnson___Johnson>,
        <https://1145.am/db/2317181/Johnson___Johnson>,
        <https://1145.am/db/2317639/Johnson___Johnson>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318685/Johnson___Johnson>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2319656/Johnson___Johnson>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322024/Johnson___Johnson>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323000/Johnson___Johnson>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327024/Johnson___Johnson>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329487/Johnson___Johnson>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2330734/Johnson___Johnson>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2336790/Johnson___Johnson>,
        <https://1145.am/db/2336797/Johnson___Johnson>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340071/Johnson___Johnson>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2341850/Johnson___Johnson>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2344683/Johnson___Johnson>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2350116/Johnson___Johnson>,
        <https://1145.am/db/2350440/Johnson___Johnson_Inc>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2354402/Johnson___Johnson>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359302/Johnson___Johnson>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360309/Novartis_Pharma_Ag>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2360754/Johnson___Johnson>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364601/Johnson___Johnson>,
        <https://1145.am/db/2366653/Johnson___Johnson>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367616/Johnson___Johnson>,
        <https://1145.am/db/2367617/Johnson___Johnson>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369449/Novartis_Pharma_Ag>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370259/Johnson___Johnson>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536264/Johnson___Johnson>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2543863/Johnson___Johnson>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545522/Johnson___Johnson>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546172/Johnson___Johnson>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547152/Johnson___Johnson>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Johnson___Johnson>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2553852/Johnson___Johnson>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2560372/Johnson___Johnson>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564032/Johnson___Johnson>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564462/Johnson___Johnson_Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2566147/Johnson___Johnson>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572466/Johnson___Johnson>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573373/Johnson___Johnson>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574347/Johnson___Johnson>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575492/Johnson___Johnson>,
        <https://1145.am/db/2575496/Johnson___Johnson>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575810/Novartis_Pharma_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576439/Johnson___Johnson>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2576962/Johnson___Johnson>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2583189/Johnson___Johnson>,
        <https://1145.am/db/2584383/Johnson___Johnson>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2585710/Johnson___Johnson>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587143/Johnson___Johnson>,
        <https://1145.am/db/2587177/Johnson___Johnson>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588074/Johnson___Johnson>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2589402/Johnson___Johnson>,
        <https://1145.am/db/2589535/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2591073/Johnson___Johnson>,
        <https://1145.am/db/2591074/Johnson___Johnson>,
        <https://1145.am/db/2591076/Johnson___Johnson>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592534/Johnson___Johnson>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2593889/Johnson___Johnson>,
        <https://1145.am/db/2594106/Johnson___Johnson>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597135/Johnson___Johnson>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598439/Johnson___Johnson_Inc>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/2787550/Johnson___Johnson>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/699695/Johnson___Johnson>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546405/Series_C_Investment_Aslan_Pharmaceuticals_Accuron_Ascletis_Goldman_Sachs_Mabspace_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-14T13:07:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Separately, greater China - focused ASLAN Pharmaceuticals gained $ 34 million in Series C financing last week, led by Singapore sovereign wealth fund Temasek's subsidiary Accuron." ;
    ns1:documentTitle "China connection aids $280M in new funding for Pharmaron" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/china-connection-aids-280m-new-funding-for-pharmaron> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2546405/Aslan_Pharmaceuticals> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 15 million",
        "$ 20 million",
        "$ 34 million" ;
    ns1:when "2023-10-15T00:57:51.111163"^^xsd:dateTime,
        "2023-10-15T00:57:51.348930"^^xsd:dateTime,
        "2023-10-15T00:57:52.418844"^^xsd:dateTime ;
    ns1:whenRaw "last week" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2578827/Boehringer> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "drugmaker" ;
    ns1:documentDate "2015-06-30T13:30:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt" ;
    ns1:documentURL <https://www.fiercepharma.com/m-a/boehringer-charges-ahead-sale-of-u-s-generics-biz-bids-from-hikma-mallinckrodt> ;
    ns1:foundName "Boehringer" ;
    ns1:industry "drugmaker" ;
    ns1:name "Boehringer" ;
    ns1:sameAsHigh <https://1145.am/db/1038901/Eli_Lilly_And_Company>,
        <https://1145.am/db/1072187/Eli_Lilly_And_Company>,
        <https://1145.am/db/1087869/Eli_Lilly_And_Company>,
        <https://1145.am/db/1133669/Boehringer_Ingelheim>,
        <https://1145.am/db/1135149/Boehringer_Ingelheim>,
        <https://1145.am/db/1272276/Eli_Lilly_And_Company>,
        <https://1145.am/db/1340338/Eli_Lilly_And_Company>,
        <https://1145.am/db/1428583/Eli_Lilly_And_Company>,
        <https://1145.am/db/1432746/Eli_Lilly>,
        <https://1145.am/db/1537106/Boehringer_Ingelheim>,
        <https://1145.am/db/1537985/Boehringer_Ingelheim>,
        <https://1145.am/db/1546070/Eli_Lilly_And_Company>,
        <https://1145.am/db/1594413/Boehringer_Ingelheim>,
        <https://1145.am/db/174741/Eli_Lilly_And_Co>,
        <https://1145.am/db/1979697/Eli_Lilly>,
        <https://1145.am/db/2043001/Eli_Lilly_And_Co>,
        <https://1145.am/db/2053734/Eli_Lilly_And_Co>,
        <https://1145.am/db/2062260/Eli_Lilly>,
        <https://1145.am/db/2134678/Eli_Lilly_And_Co>,
        <https://1145.am/db/2136466/Eli_Lilly_And_Co>,
        <https://1145.am/db/2152172/Boehringer_Ingelheim>,
        <https://1145.am/db/2152174/Boehringer_Ingelheim>,
        <https://1145.am/db/2152285/Boehringer>,
        <https://1145.am/db/2154037/Eli_Lilly>,
        <https://1145.am/db/2154391/Eli_Lilly>,
        <https://1145.am/db/2154401/Boehringer_Ingelheim>,
        <https://1145.am/db/2282739/Eli_Lilly>,
        <https://1145.am/db/2282930/Eli_Lilly>,
        <https://1145.am/db/2285156/Eli_Lilly>,
        <https://1145.am/db/2285189/Eli_Lilly>,
        <https://1145.am/db/2285525/Eli_Lilly>,
        <https://1145.am/db/2286402/Eli_Lilly>,
        <https://1145.am/db/2286404/Eli_Lilly>,
        <https://1145.am/db/2286617/Eli_Lilly>,
        <https://1145.am/db/2286657/Boehringer_Ingelheim>,
        <https://1145.am/db/2286911/Eli_Lilly>,
        <https://1145.am/db/2286998/Eli_Lilly>,
        <https://1145.am/db/2287005/Eli_Lilly>,
        <https://1145.am/db/2288158/Eli_Lilly>,
        <https://1145.am/db/2290507/Boehringer_Ingelheim>,
        <https://1145.am/db/2290919/Boehringer_Ingelheim>,
        <https://1145.am/db/229232/Eli_Lilly>,
        <https://1145.am/db/2293168/Boehringer_Ingelheim>,
        <https://1145.am/db/2294118/Eli_Lilly>,
        <https://1145.am/db/2298022/Eli_Lilly>,
        <https://1145.am/db/2299157/Eli_Lilly>,
        <https://1145.am/db/2301879/Eli_Lilly_And_Company>,
        <https://1145.am/db/2302104/Eli_Lilly_And_Company>,
        <https://1145.am/db/2303974/Boehringer_Ingelheim_Gmbh>,
        <https://1145.am/db/2303980/Boehringer_Ingelheim>,
        <https://1145.am/db/2305497/Eli_Lilly>,
        <https://1145.am/db/2306173/Boehringer_Ingelheim>,
        <https://1145.am/db/2306807/Eli_Lilly_And_Company>,
        <https://1145.am/db/2307651/Eli_Lilly>,
        <https://1145.am/db/2309473/Eli_Lilly>,
        <https://1145.am/db/2309599/Eli_Lilly>,
        <https://1145.am/db/2313544/Boehringer_Ingelheim>,
        <https://1145.am/db/2314412/Eli_Lilly_And_Company>,
        <https://1145.am/db/2316092/Eli_Lilly>,
        <https://1145.am/db/2316549/Eli_Lilly>,
        <https://1145.am/db/2318248/Boehringer_Ingelheim>,
        <https://1145.am/db/2318587/Eli_Lilly>,
        <https://1145.am/db/2320006/Eli_Lilly>,
        <https://1145.am/db/2320338/Eli_Lilly>,
        <https://1145.am/db/2322619/Eli_Lilly_And_Company>,
        <https://1145.am/db/2323165/Eli_Lilly_And_Company>,
        <https://1145.am/db/2325525/Boehringer_Ingelheim>,
        <https://1145.am/db/2325557/Eli_Lilly_And_Company>,
        <https://1145.am/db/2328527/Eli_Lilly>,
        <https://1145.am/db/2328554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2329114/Eli_Lilly>,
        <https://1145.am/db/2334645/Eli_Lilly>,
        <https://1145.am/db/2335594/Eli_Lilly_And_Company>,
        <https://1145.am/db/2335703/Boehringer_Ingelheim>,
        <https://1145.am/db/2335705/Boehringer_Ingelheim>,
        <https://1145.am/db/2335908/Boehringer>,
        <https://1145.am/db/2336074/Eli_Lilly_And_Company>,
        <https://1145.am/db/2338059/Eli_Lilly>,
        <https://1145.am/db/2340948/Eli_Lilly>,
        <https://1145.am/db/2341481/Eli_Lilly>,
        <https://1145.am/db/2341496/Eli_Lilly>,
        <https://1145.am/db/2342503/Eli_Lilly_And_Company>,
        <https://1145.am/db/2344800/Eli_Lilly_And_Company>,
        <https://1145.am/db/2346629/Novo_Nordisk_Eli_Lilly>,
        <https://1145.am/db/2349300/Eli_Lilly_And_Company>,
        <https://1145.am/db/2352358/Eli_Lilly>,
        <https://1145.am/db/2353350/Eli_Lilly>,
        <https://1145.am/db/2354380/Boehringer_Ingelheim>,
        <https://1145.am/db/2354388/Boehringer_Ingelheim>,
        <https://1145.am/db/2354761/Eli_Lilly_And_Company>,
        <https://1145.am/db/2354853/Eli_Lilly_And_Company>,
        <https://1145.am/db/2360080/Boehringer_Ingelheim>,
        <https://1145.am/db/2360086/Boehringer_Ingelheim>,
        <https://1145.am/db/2361027/Eli_Lilly>,
        <https://1145.am/db/2363310/Eli_Lilly_And_Company_(lly)>,
        <https://1145.am/db/2364605/Eli_Lilly>,
        <https://1145.am/db/2364810/Boehringer_Ingelheim>,
        <https://1145.am/db/2365178/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366948/Eli_Lilly_And_Company>,
        <https://1145.am/db/2366953/Eli_Lilly_And_Company>,
        <https://1145.am/db/2367430/Boehringer_Ingelheim>,
        <https://1145.am/db/2369000/Eli_Lilly_And_Company>,
        <https://1145.am/db/2370162/Eli_Lilly>,
        <https://1145.am/db/2370523/Boehringer>,
        <https://1145.am/db/2371016/Eli_Lilly>,
        <https://1145.am/db/2371058/Eli_Lilly_And_Company>,
        <https://1145.am/db/2371075/Eli_Lilly_And_Company>,
        <https://1145.am/db/2536400/Boehringer_Ingelheim>,
        <https://1145.am/db/2537335/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537665/Eli_Lilly>,
        <https://1145.am/db/2537666/Eli_Lilly>,
        <https://1145.am/db/2537817/Eli_Lilly_And_Company>,
        <https://1145.am/db/2537826/Eli_Lilly_And_Company>,
        <https://1145.am/db/2539012/Boehringer_Ingelheim>,
        <https://1145.am/db/2539287/Eli_Lilly>,
        <https://1145.am/db/2540249/Boehringer_Ingelheim>,
        <https://1145.am/db/2541725/Boehringer_Ingelheim>,
        <https://1145.am/db/2543185/Eli_Lilly>,
        <https://1145.am/db/2545618/Eli_Lilly>,
        <https://1145.am/db/2546160/Boehringer_Ingelheim>,
        <https://1145.am/db/2546781/Boehringer_Ingelheim>,
        <https://1145.am/db/2547189/Boehringer_Ingelheim>,
        <https://1145.am/db/2550996/Eli_Lilly>,
        <https://1145.am/db/2551049/Eli_Lilly>,
        <https://1145.am/db/2551101/Eli_Lilly>,
        <https://1145.am/db/2553131/Boehringer_Ingelheim>,
        <https://1145.am/db/2553551/Eli_Lilly>,
        <https://1145.am/db/2553750/Boehringer_Ingelheim>,
        <https://1145.am/db/2554242/Boehringer_Ingelheim>,
        <https://1145.am/db/2554535/Boehringer_Ingelheim>,
        <https://1145.am/db/2555393/Boehringer_Ingelheim>,
        <https://1145.am/db/2555921/Boehringer_Ingelheim_Group_Of_Companies>,
        <https://1145.am/db/2555925/Boehringer_Ingelheim_Plant>,
        <https://1145.am/db/2557861/Boehringer_Ingelheim>,
        <https://1145.am/db/2558025/Boehringer_Ingelheim>,
        <https://1145.am/db/2558026/Boehringer_Ingelheim>,
        <https://1145.am/db/2560253/Boehringer_Ingelheim>,
        <https://1145.am/db/2560487/Eli_Lilly>,
        <https://1145.am/db/2560865/Boehringer_Ingelheim>,
        <https://1145.am/db/2561357/Eli_Lilly>,
        <https://1145.am/db/2561960/Eli_Lilly>,
        <https://1145.am/db/2562442/Eli_Lilly>,
        <https://1145.am/db/2562576/Eli_Lilly>,
        <https://1145.am/db/2564389/Eli_Lilly___Co>,
        <https://1145.am/db/2567343/Eli_Lilly>,
        <https://1145.am/db/2567800/Boehringer_Ingelheim>,
        <https://1145.am/db/2569425/Boehringer_Ingelheim>,
        <https://1145.am/db/2569829/Eli_Lilly>,
        <https://1145.am/db/2571316/Boehringer_Ingelheim>,
        <https://1145.am/db/2571525/Boehringer_Ingelheim>,
        <https://1145.am/db/2572711/Eli_Lilly_And_Company>,
        <https://1145.am/db/2573259/Boehringer_Ingelheim>,
        <https://1145.am/db/2574421/Boehringer_Ingelheim_Group_Of_Companies>,
        <https://1145.am/db/2575554/Eli_Lilly_And_Company>,
        <https://1145.am/db/2575575/Boehringer_Ingelheim>,
        <https://1145.am/db/2575909/Eli_Lilly>,
        <https://1145.am/db/2575972/Eli_Lilly>,
        <https://1145.am/db/2576086/Eli_Lilly>,
        <https://1145.am/db/2576171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576460/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576462/Eli_Lilly_And_Company>,
        <https://1145.am/db/2576933/Eli_Lilly>,
        <https://1145.am/db/2577171/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578048/Eli_Lilly_And_Company>,
        <https://1145.am/db/2578603/Eli_Lilly>,
        <https://1145.am/db/2578745/Boehringer_Ingelheim>,
        <https://1145.am/db/2578874/Eli_Lilly>,
        <https://1145.am/db/2580140/Boehringer_Ingelheim_And_Eli_Lilly>,
        <https://1145.am/db/2580383/Boehringer_Ingelheim>,
        <https://1145.am/db/2581257/Eli_Lilly_And_Company>,
        <https://1145.am/db/2581309/Boehringer_Ingelheim>,
        <https://1145.am/db/2581745/Eli_Lilly_And_Company>,
        <https://1145.am/db/2582681/Boehringer_Ingelheim>,
        <https://1145.am/db/2584135/Eli_Lilly>,
        <https://1145.am/db/2584766/Eli_Lilly_And_Company>,
        <https://1145.am/db/2585710/Eli_Lilly>,
        <https://1145.am/db/2586687/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587099/Boehringer>,
        <https://1145.am/db/2587104/Boehringer_Ingelheim_Plant>,
        <https://1145.am/db/2587215/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587690/Eli_Lilly_And_Company>,
        <https://1145.am/db/2587699/Eli_Lilly_And_Company>,
        <https://1145.am/db/2589156/Eli_Lilly_And_Company>,
        <https://1145.am/db/2590071/Eli_Lilly_And_Company>,
        <https://1145.am/db/2590486/Eli_Lilly>,
        <https://1145.am/db/2590739/Boehringer_Ingelheim>,
        <https://1145.am/db/2590997/Eli_Lilly_And_Company>,
        <https://1145.am/db/2591708/Eli_Lilly_And_Company>,
        <https://1145.am/db/2592790/Boehringer_Ingelheim_Usa_Corporation>,
        <https://1145.am/db/2592924/Boehringer_Ingelheim>,
        <https://1145.am/db/2593232/Boehringer_Ingelheim>,
        <https://1145.am/db/2593463/Boehringer_Ingelheim>,
        <https://1145.am/db/2594262/Boehringer_Ingelheim>,
        <https://1145.am/db/2594494/Eli_Lilly_And_Company>,
        <https://1145.am/db/2595226/Boehringer_Ingelheim>,
        <https://1145.am/db/2596644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597644/Eli_Lilly_And_Company>,
        <https://1145.am/db/2597855/Eli_Lilly_And_Company>,
        <https://1145.am/db/2598317/Eli_Lilly>,
        <https://1145.am/db/264619/Eli_Lilly_And_Co>,
        <https://1145.am/db/385093/Boehringer_Ingelheim>,
        <https://1145.am/db/461671/Eli_Lilly_And_Company>,
        <https://1145.am/db/86786/Eli_Lilly_And_Co> ;
    ns1:sameAsMedium <https://1145.am/db/2286661/Boehringer>,
        <https://1145.am/db/2301645/Boehringer>,
        <https://1145.am/db/2370979/Boehringer>,
        <https://1145.am/db/2544235/Boehringer> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2162866/Series_A_Investment_Comcast_Ventures_Dick_Clark_Productions_Madison_Square_Garden_Company_Nextvr_Rse_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-12T16:39:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The venture capital arms of cable companies Comcast (NASDAQ: CMCSA) and Time Warner Inc. are participating in a $ 30.5 million funding round for NextVR, a Laguna Beach, Calif., startup that broadcasts events in virtual reality." ;
    ns1:documentTitle "Comcast, Time Warner Inc. venture arms invest in virtual reality start-up NextVR" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/comcast-time-warner-inc-venture-arms-invest-virtual-reality-start-up-nextvr> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2162866/Nextvr> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 30.5 million" .

<https://1145.am/db/2368501/Investment_Constellation_Pharmaceuticals_Sr_One_The_Column_Group_Third_Rock_Ventures_Topspin_Partners_Venrock_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-12-09T21:32:43+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, MA- (Marketwired - Dec 9, 2015) - Constellation Pharmaceuticals, Inc., a leader in the rapidly expanding field of epigenetics, today announced the successful completion of a $ 55 million mezzanine round of financing.",
        "Constellation Pharmaceuticals, Inc. Raises $ 55 Million in Mezzanine Financing." ;
    ns1:documentTitle "Constellation Pharmaceuticals, Inc. Raises $55 Million in Mezzanine Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/constellation-pharmaceuticals-inc-raises-55-million-mezzanine-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368501/Constellation_Pharmaceuticals> ;
    ns1:valueRaw "$ 55 Million",
        "$ 55 million" ;
    ns1:when "2015-12-09T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2015-Dec-9" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2369548/Applied_Immune_Technologies_Series_A_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2016-01-27T12:46:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Adicet Bio Announces Closing of $ 51 Million Series A Financing and Acquisition of Applied Immune Technologies.",
        "Adicet also announced the acquisition of Applied Immune Technologies, Ltd. (\"AIT\") , an Israel - based company that develops immunotherapies directed to the intracellular proteome." ;
    ns1:documentTitle "Adicet Bio Announces Closing of $51 Million Series A Financing and Acquisition of Applied Immune Technologies" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/adicet-bio-announces-closing-of-51-million-series-a-financing-and-acquisition-of-applied> ;
    ns1:foundName "Acquisition",
        "acquisition" ;
    ns1:name "Acquisition",
        "acquisition" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369548/Applied_Immune_Technologies> ;
    ns1:targetDetails "Series A" ;
    ns1:targetName "Applied Immune Technologies" ;
    ns1:valueRaw "$ 51 Million" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2369549/Series_B_Investment_Arch_Venture_Partners_Alaska_Permanent_Fund_Alexandria_Venture_Investments_Codiak_Biosciences_Inc_Fidelity_Management_And_Research_Company_Flagship_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-26T16:02:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Jan. 26, 2016 /PRNewswire/ - Codiak BioSciences Inc., a leading company in the field of exosome biology, today announced the closing of its $ 61 million Series B round, bringing total investment in its combined Series A and B financing, announced in November 2015, to $ 92 million." ;
    ns1:documentTitle "Codiak BioSciences Closes $61 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/codiak-biosciences-closes-61-million-series-b-financing> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369549/Codiak_Biosciences_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 61 million",
        "$ 92 million" ;
    ns1:when "2016-01-26T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Jan. 26, 2016" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2371160/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "San Francisco" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:industry "biotech" ;
    ns1:investor <https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed>,
        <https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1070743/Novateur_Ventures>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/Convivialit_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/Agla_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/Agla_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/Agla_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/Convivialit_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2282410/Lumira_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_Grnderfonds>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_Grnderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349011/Sofinnova_Ventures_And_Novo_A_S>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367203/Bionest_Partners_Finance>,
        <https://1145.am/db/2367206/Bionest_Partners_Finance>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2550552/Lightstone_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_Grnderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/992046/Sofinnova_Partners>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2549505/Series_B_Investment_Adagene_Eight_Roads_Ventures_China_Fidelity_Biosciences_Gp_Healthcare_Capital_New_World_Tmt_Wuxi_Corporate_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-29T07:13:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "At the same time as Qiming's announcement, Suzhou - based Adagene said it had secured a $ 28 million Series B financing led by GP Healthcare Capital." ;
    ns1:documentTitle "Cash flows for China biotech, healthcare plays show pace" ;
    ns1:documentURL <https://www.fiercepharma.com/financials/cash-flows-for-china-biotech-healthcare-plays-show-pace> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2549505/Adagene> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 28 million" ;
    ns1:whereGeoName "Peoples Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2589535/Novartis> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:documentDate "2016-01-04T13:03:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Spotlight On... Zoetis offloads three manufacturing plants to Huvepharma for $40M; Novartis India completes animal health sale to Lilly; Jaguar launches pivotal trial of lead dog drug; UC Davis scores federal animal health grant; and more..." ;
    ns1:documentURL <https://www.fiercepharma.com/animal-health/spotlight-on-zoetis-offloads-three-manufacturing-plants-to-huvepharma-for-40m> ;
    ns1:foundName "Novartis" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Novartis" ;
    ns1:sameAsHigh <https://1145.am/db/1176158/Novartis>,
        <https://1145.am/db/1177562/Novartis>,
        <https://1145.am/db/131136/Novartis>,
        <https://1145.am/db/132002/Novartis>,
        <https://1145.am/db/1328753/Novartis>,
        <https://1145.am/db/1507918/Novartis_Ag>,
        <https://1145.am/db/156403/Novartis>,
        <https://1145.am/db/1567521/Novartis>,
        <https://1145.am/db/1578114/Novartis>,
        <https://1145.am/db/1628428/Novalgen_Ltd>,
        <https://1145.am/db/1629605/Novartis>,
        <https://1145.am/db/1629663/Novartis>,
        <https://1145.am/db/165056/Novartis>,
        <https://1145.am/db/176334/Novartis>,
        <https://1145.am/db/177096/Novartis>,
        <https://1145.am/db/1986468/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/2033677/Novartis>,
        <https://1145.am/db/2062728/Novan>,
        <https://1145.am/db/2107835/Novartis>,
        <https://1145.am/db/2129754/Novartis>,
        <https://1145.am/db/2152605/Novartis>,
        <https://1145.am/db/2152618/Novartis>,
        <https://1145.am/db/2153059/Novartis>,
        <https://1145.am/db/2154527/Novartis>,
        <https://1145.am/db/2155069/Novartis>,
        <https://1145.am/db/2155665/Novartis>,
        <https://1145.am/db/2190363/Novartis_Ag>,
        <https://1145.am/db/2194161/Novartis>,
        <https://1145.am/db/2279108/Novartis>,
        <https://1145.am/db/2279232/Novartis>,
        <https://1145.am/db/2279829/Novartis>,
        <https://1145.am/db/2280153/Novartis>,
        <https://1145.am/db/2280350/Novartis>,
        <https://1145.am/db/2283590/Novartis>,
        <https://1145.am/db/2283645/Novartis>,
        <https://1145.am/db/2285311/Novartis>,
        <https://1145.am/db/2286604/Novartis>,
        <https://1145.am/db/2288851/Novartis>,
        <https://1145.am/db/2289846/Novartis>,
        <https://1145.am/db/2290022/Novartis>,
        <https://1145.am/db/2293323/Novartis>,
        <https://1145.am/db/2293342/Novartis>,
        <https://1145.am/db/2293591/Novartis>,
        <https://1145.am/db/2294026/Novartis>,
        <https://1145.am/db/2294585/Novartis>,
        <https://1145.am/db/2296504/Novartis>,
        <https://1145.am/db/2296552/Novartis>,
        <https://1145.am/db/2298606/Novartis>,
        <https://1145.am/db/2301066/Novartis>,
        <https://1145.am/db/2301089/Novartis>,
        <https://1145.am/db/2301705/Novasep>,
        <https://1145.am/db/2301735/Novartis>,
        <https://1145.am/db/2301857/Novartis>,
        <https://1145.am/db/2302724/Novartis>,
        <https://1145.am/db/2302727/Novartis>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/230344/Swiss_Drugmaker_Novartis>,
        <https://1145.am/db/2304113/Novartis>,
        <https://1145.am/db/2304373/Novartis>,
        <https://1145.am/db/2304374/Novartis>,
        <https://1145.am/db/2305192/Novartis>,
        <https://1145.am/db/2305244/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2307228/Novadel_Pharma_Inc>,
        <https://1145.am/db/2307347/Novartis>,
        <https://1145.am/db/2307847/Novartis>,
        <https://1145.am/db/2307863/Novartis>,
        <https://1145.am/db/2307998/Novartis>,
        <https://1145.am/db/2308010/Novartis>,
        <https://1145.am/db/2308298/Novartis>,
        <https://1145.am/db/2308765/Novartis>,
        <https://1145.am/db/2308812/Novartis>,
        <https://1145.am/db/2308946/Novartis_Ag>,
        <https://1145.am/db/2309065/Novartis_Intercell>,
        <https://1145.am/db/2310150/Novartis>,
        <https://1145.am/db/2312008/Novartis>,
        <https://1145.am/db/2312018/Novartis_International_Ag>,
        <https://1145.am/db/2312088/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2312436/Novartis>,
        <https://1145.am/db/2317845/Novadel>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2317951/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318994/Novadel>,
        <https://1145.am/db/2319412/Novartis>,
        <https://1145.am/db/2320828/Novartis>,
        <https://1145.am/db/2321067/Novartis>,
        <https://1145.am/db/2322266/Novartis>,
        <https://1145.am/db/2323188/Novartis>,
        <https://1145.am/db/2323692/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2325073/Novartis>,
        <https://1145.am/db/2325869/Novartis>,
        <https://1145.am/db/2326949/Novartis>,
        <https://1145.am/db/2327560/Novartis>,
        <https://1145.am/db/2329413/Novadel_Pharma_Inc>,
        <https://1145.am/db/2329475/Novadel_Pharma>,
        <https://1145.am/db/2329597/Novartis>,
        <https://1145.am/db/2330648/Novartis>,
        <https://1145.am/db/2331875/Novadel>,
        <https://1145.am/db/2332005/Novartis>,
        <https://1145.am/db/2332788/Novartis_Ag>,
        <https://1145.am/db/2332796/Novadel_Pharma_Inc>,
        <https://1145.am/db/2332872/Novartis>,
        <https://1145.am/db/2334206/Novartis>,
        <https://1145.am/db/2334645/Novast>,
        <https://1145.am/db/2336028/Novartis>,
        <https://1145.am/db/2336704/Novartis>,
        <https://1145.am/db/2339656/Novartis>,
        <https://1145.am/db/2339669/Novartis>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2340948/Novartis>,
        <https://1145.am/db/2344017/Novartis>,
        <https://1145.am/db/2344434/Novartis>,
        <https://1145.am/db/2346576/Novadel_Pharma_Inc>,
        <https://1145.am/db/2346629/Novartis>,
        <https://1145.am/db/2348176/Novartis>,
        <https://1145.am/db/2349068/Novartis>,
        <https://1145.am/db/2352045/Novartis>,
        <https://1145.am/db/2352046/Novartis>,
        <https://1145.am/db/2354148/Novartis>,
        <https://1145.am/db/2358273/Novartis>,
        <https://1145.am/db/2358297/Novartis>,
        <https://1145.am/db/2359165/Novartis>,
        <https://1145.am/db/2359179/Novartis>,
        <https://1145.am/db/2359915/Novadel_Pharma_Inc>,
        <https://1145.am/db/2360526/Novartis>,
        <https://1145.am/db/2360633/Novartis>,
        <https://1145.am/db/2362448/Novadel_Pharma_Inc>,
        <https://1145.am/db/2363618/Novartis_Uk>,
        <https://1145.am/db/2367118/Novabay_Pharmaceuticals>,
        <https://1145.am/db/2367207/Novartis>,
        <https://1145.am/db/2367829/Novartis_International_Ag>,
        <https://1145.am/db/2367836/Novartis_International_Ag>,
        <https://1145.am/db/2367993/Novabay>,
        <https://1145.am/db/2368571/Novartis>,
        <https://1145.am/db/2368646/Novartis>,
        <https://1145.am/db/2368659/Novartis>,
        <https://1145.am/db/2369183/Novartis>,
        <https://1145.am/db/2369450/Novartis>,
        <https://1145.am/db/2369451/Novartis>,
        <https://1145.am/db/2369555/Swiss_Pharma_Giant_Novartis>,
        <https://1145.am/db/2369718/Novartis>,
        <https://1145.am/db/2370010/Novartis>,
        <https://1145.am/db/2370013/Novartis>,
        <https://1145.am/db/2370615/Novartis>,
        <https://1145.am/db/2370635/Novartis>,
        <https://1145.am/db/2371070/Novartis>,
        <https://1145.am/db/2371077/Novartis>,
        <https://1145.am/db/2371323/Novartis>,
        <https://1145.am/db/2371326/Novartis>,
        <https://1145.am/db/2434670/Novartis>,
        <https://1145.am/db/2536325/Novartis>,
        <https://1145.am/db/2536882/Novartis>,
        <https://1145.am/db/2536914/Novartis>,
        <https://1145.am/db/2537064/Novartis>,
        <https://1145.am/db/2537477/Novartis>,
        <https://1145.am/db/2537482/Novacea>,
        <https://1145.am/db/2538344/Novartis>,
        <https://1145.am/db/2538791/Novartis>,
        <https://1145.am/db/2539541/Novasep>,
        <https://1145.am/db/2539787/Novartis>,
        <https://1145.am/db/2539925/Novartis>,
        <https://1145.am/db/2540187/Novartis>,
        <https://1145.am/db/2541511/Novartis>,
        <https://1145.am/db/2542938/Novartis>,
        <https://1145.am/db/2543689/Novartis>,
        <https://1145.am/db/2544236/Novartis>,
        <https://1145.am/db/2544326/Novartis>,
        <https://1145.am/db/2545284/Novartis>,
        <https://1145.am/db/2545651/Novartis>,
        <https://1145.am/db/2545966/Novartis>,
        <https://1145.am/db/2545986/Novartis>,
        <https://1145.am/db/2546157/Novartis>,
        <https://1145.am/db/2546170/Novartis>,
        <https://1145.am/db/2546603/Novartis>,
        <https://1145.am/db/2547397/Novartis>,
        <https://1145.am/db/2548223/Novartis>,
        <https://1145.am/db/2548224/Novartis_Group>,
        <https://1145.am/db/2549043/Novartis>,
        <https://1145.am/db/2549631/Novast>,
        <https://1145.am/db/2550855/Novartis>,
        <https://1145.am/db/2551143/Novartis>,
        <https://1145.am/db/2551693/Novartis>,
        <https://1145.am/db/2551694/Novartis>,
        <https://1145.am/db/2552165/Novartis>,
        <https://1145.am/db/2552258/Novartis>,
        <https://1145.am/db/2553024/Novartis>,
        <https://1145.am/db/2553276/Novartis>,
        <https://1145.am/db/2553480/Novartis>,
        <https://1145.am/db/2553740/Novasep>,
        <https://1145.am/db/2553810/Novartis>,
        <https://1145.am/db/2553846/Novartis>,
        <https://1145.am/db/2554060/Novartis>,
        <https://1145.am/db/2554669/Novasep>,
        <https://1145.am/db/2555555/Novartis>,
        <https://1145.am/db/2555561/Novartis>,
        <https://1145.am/db/2556030/Novartis>,
        <https://1145.am/db/2556543/Novartis>,
        <https://1145.am/db/2557588/Novartis>,
        <https://1145.am/db/2558316/Novartis>,
        <https://1145.am/db/2558415/Novartis>,
        <https://1145.am/db/2558779/Novartis>,
        <https://1145.am/db/2558927/Novartis>,
        <https://1145.am/db/2559306/Novartis>,
        <https://1145.am/db/2559655/Novartis>,
        <https://1145.am/db/2559797/Novartis>,
        <https://1145.am/db/2559802/Novartis>,
        <https://1145.am/db/2559810/Switzerlands_Novartis>,
        <https://1145.am/db/2560023/Novartis>,
        <https://1145.am/db/2560079/Novartis>,
        <https://1145.am/db/2561162/Novasep>,
        <https://1145.am/db/2561268/Novartis>,
        <https://1145.am/db/2561541/Novartis>,
        <https://1145.am/db/2561955/Novartis>,
        <https://1145.am/db/2562202/Novartis>,
        <https://1145.am/db/2562695/Novartis>,
        <https://1145.am/db/2562951/Novartis>,
        <https://1145.am/db/2563497/Novartis>,
        <https://1145.am/db/2563987/Novartis>,
        <https://1145.am/db/2564141/Novartis>,
        <https://1145.am/db/2564268/Novartis>,
        <https://1145.am/db/2564695/Novartis>,
        <https://1145.am/db/2565142/Novartis>,
        <https://1145.am/db/2565794/Novartis>,
        <https://1145.am/db/2565844/Novartis>,
        <https://1145.am/db/2567283/Novartis>,
        <https://1145.am/db/2567300/Novartis>,
        <https://1145.am/db/2567942/Novartis>,
        <https://1145.am/db/2568308/Novartis>,
        <https://1145.am/db/2568932/Novartis>,
        <https://1145.am/db/2568968/Novartis>,
        <https://1145.am/db/2568973/Novartis>,
        <https://1145.am/db/2570214/Novartis>,
        <https://1145.am/db/2570791/Novartis>,
        <https://1145.am/db/2570932/Novartis>,
        <https://1145.am/db/2570937/Novartis_Uk>,
        <https://1145.am/db/2571513/Novartis>,
        <https://1145.am/db/2571519/Novartis>,
        <https://1145.am/db/2571527/Novartis>,
        <https://1145.am/db/2572713/Novartis>,
        <https://1145.am/db/2572904/Novartis_Group>,
        <https://1145.am/db/2572985/Novartis>,
        <https://1145.am/db/2573002/Novartis>,
        <https://1145.am/db/2573473/Novartis>,
        <https://1145.am/db/2573517/Novartis>,
        <https://1145.am/db/2573611/Novartis>,
        <https://1145.am/db/2574958/Novartis>,
        <https://1145.am/db/2575047/Novartis>,
        <https://1145.am/db/2575310/Novartis>,
        <https://1145.am/db/2575313/Novartis>,
        <https://1145.am/db/2575488/Novartis>,
        <https://1145.am/db/2575545/Novartis>,
        <https://1145.am/db/2575625/Novartis>,
        <https://1145.am/db/2575702/Novartis>,
        <https://1145.am/db/2575712/Novartis>,
        <https://1145.am/db/2575810/Novartis_Ag>,
        <https://1145.am/db/2575813/Novartis>,
        <https://1145.am/db/2576242/Novartis>,
        <https://1145.am/db/2576254/Novartis>,
        <https://1145.am/db/2576547/Novartis>,
        <https://1145.am/db/2576933/Novartis>,
        <https://1145.am/db/2577129/Novartis>,
        <https://1145.am/db/2577419/Novartis>,
        <https://1145.am/db/2577998/Novartis>,
        <https://1145.am/db/2579507/Novartis>,
        <https://1145.am/db/2579519/Novartis>,
        <https://1145.am/db/2580047/Novartis>,
        <https://1145.am/db/2580401/Novartis>,
        <https://1145.am/db/2580963/Novartis>,
        <https://1145.am/db/2581378/Novartis>,
        <https://1145.am/db/2581394/Novartis>,
        <https://1145.am/db/2581397/Novartis>,
        <https://1145.am/db/2581493/Novartis>,
        <https://1145.am/db/2581716/Novartis>,
        <https://1145.am/db/2582355/Novartis>,
        <https://1145.am/db/2582395/Novartis>,
        <https://1145.am/db/2582400/Novartis>,
        <https://1145.am/db/2582402/Novartis>,
        <https://1145.am/db/2582623/Novartis>,
        <https://1145.am/db/2582643/Novartis>,
        <https://1145.am/db/2583067/Novartis>,
        <https://1145.am/db/2584538/Novartis>,
        <https://1145.am/db/2585039/Novartis>,
        <https://1145.am/db/2585121/Novartis>,
        <https://1145.am/db/2586661/Novatis>,
        <https://1145.am/db/2586670/Novartis>,
        <https://1145.am/db/2587047/Novartis>,
        <https://1145.am/db/2587857/Novartis>,
        <https://1145.am/db/2588196/Novartis>,
        <https://1145.am/db/2589178/Novartis>,
        <https://1145.am/db/2591905/Novartis>,
        <https://1145.am/db/2592351/Novartis>,
        <https://1145.am/db/2592505/Novartis>,
        <https://1145.am/db/2592895/Novartis>,
        <https://1145.am/db/2592987/Novartis>,
        <https://1145.am/db/2593443/Novartis>,
        <https://1145.am/db/2594494/Novartis>,
        <https://1145.am/db/2594935/Novartis>,
        <https://1145.am/db/2594940/Novartis>,
        <https://1145.am/db/2595048/Novartis>,
        <https://1145.am/db/2595150/Novartis>,
        <https://1145.am/db/2595688/Novartis>,
        <https://1145.am/db/2596344/Novartis>,
        <https://1145.am/db/2597197/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2598636/Novartis>,
        <https://1145.am/db/2787530/Novartis>,
        <https://1145.am/db/282192/Novartis>,
        <https://1145.am/db/346162/Novartis>,
        <https://1145.am/db/488391/Novartis>,
        <https://1145.am/db/509708/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/595011/Novartis>,
        <https://1145.am/db/601300/Novabay_Pharmaceuticals_Inc>,
        <https://1145.am/db/637582/Novartis>,
        <https://1145.am/db/652831/Novartis>,
        <https://1145.am/db/661296/Novartis>,
        <https://1145.am/db/691279/Novartis>,
        <https://1145.am/db/712016/Novartis>,
        <https://1145.am/db/895235/Novan> ;
    ns1:sameAsMedium <https://1145.am/db/1151476/Novartis>,
        <https://1145.am/db/1629127/Novartis>,
        <https://1145.am/db/1630421/Novartis>,
        <https://1145.am/db/2033933/Novartis>,
        <https://1145.am/db/2036487/Novartis_Ag>,
        <https://1145.am/db/2065993/Novartis_Ag>,
        <https://1145.am/db/2076347/Novartis>,
        <https://1145.am/db/2155042/Novartis>,
        <https://1145.am/db/2186148/Novartis>,
        <https://1145.am/db/2290898/Novartis>,
        <https://1145.am/db/2291090/Novartis>,
        <https://1145.am/db/2291713/Novartis>,
        <https://1145.am/db/2293419/Novartis>,
        <https://1145.am/db/2294680/Novartis>,
        <https://1145.am/db/2299847/Novartis>,
        <https://1145.am/db/2307851/Novartis>,
        <https://1145.am/db/2309347/Novartis>,
        <https://1145.am/db/2321958/Novartis>,
        <https://1145.am/db/2325386/Novartis>,
        <https://1145.am/db/2332408/Novartis>,
        <https://1145.am/db/2333390/Novartis>,
        <https://1145.am/db/2336990/Novartis>,
        <https://1145.am/db/2337976/Novartis>,
        <https://1145.am/db/2342687/Novartis>,
        <https://1145.am/db/2343460/Novartis>,
        <https://1145.am/db/2352178/Novartis>,
        <https://1145.am/db/2358559/Novartis>,
        <https://1145.am/db/2358579/Novartis>,
        <https://1145.am/db/2361451/Novartis>,
        <https://1145.am/db/2369178/Novartis>,
        <https://1145.am/db/2371165/Novartis>,
        <https://1145.am/db/2371188/Novartis>,
        <https://1145.am/db/2371203/Novartis>,
        <https://1145.am/db/2536538/Novartis>,
        <https://1145.am/db/2537155/Novartis>,
        <https://1145.am/db/2544350/Novartis>,
        <https://1145.am/db/2544409/Novartis>,
        <https://1145.am/db/2550764/Novartis>,
        <https://1145.am/db/2551001/Novartis>,
        <https://1145.am/db/2551402/Novartis>,
        <https://1145.am/db/2552856/Novartis>,
        <https://1145.am/db/2553487/Novartis>,
        <https://1145.am/db/2557204/Novartis>,
        <https://1145.am/db/2560238/Novartis>,
        <https://1145.am/db/2562442/Novartis>,
        <https://1145.am/db/2565564/Novartis>,
        <https://1145.am/db/2566121/Novartis>,
        <https://1145.am/db/2568734/Novartis>,
        <https://1145.am/db/2569724/Novartis>,
        <https://1145.am/db/2570062/Novartis>,
        <https://1145.am/db/2570721/Novartis>,
        <https://1145.am/db/2571462/Novartis>,
        <https://1145.am/db/2573984/Novartis>,
        <https://1145.am/db/2574584/Novartis>,
        <https://1145.am/db/2574950/Novartis>,
        <https://1145.am/db/2575947/Novartis>,
        <https://1145.am/db/2576892/Novartis>,
        <https://1145.am/db/2578046/Novartis>,
        <https://1145.am/db/2579890/Novartis>,
        <https://1145.am/db/2581804/Novartis>,
        <https://1145.am/db/2582646/Novartis>,
        <https://1145.am/db/2583163/Novartis>,
        <https://1145.am/db/2584135/Novartis>,
        <https://1145.am/db/2584245/Novartis>,
        <https://1145.am/db/2587048/Novartis>,
        <https://1145.am/db/2587805/Novartis>,
        <https://1145.am/db/2588333/Novartis>,
        <https://1145.am/db/2588691/Novartis>,
        <https://1145.am/db/2589799/Novartis>,
        <https://1145.am/db/2590887/Novartis>,
        <https://1145.am/db/2593780/Novartis>,
        <https://1145.am/db/2595924/Novartis_Ag>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_San_Francisco-Verge_Genomics_Inc_Slow_Ventures_Two_Sigma_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN FRANCISCO-Verge Genomics, Inc. (Verge) , a privately held biopharmaceutical company focused on neurodegenerative diseases, announced today that it has completed a seed financing totaling $ 4 million." ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2328288/San_Francisco-Verge_Genomics_Inc> ;
    ns1:targetDetails "seed" ;
    ns1:valueRaw "$ 4 million" ;
    ns1:whereGeoName "La Rose Verger" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3578301/about.rdf> ;
    ns1:whereRaw "Verge Genomics" .

<https://1145.am/db/2328288/Seed_Investment_Draper_Associates_Great_Oaks_Vc_Ia_Ventures_Karlin_Ventures_Slow_Ventures_Two_Sigma_Ventures_Verge_Genomics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-30T12:25:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN FRANCISCO-Verge Genomics, Inc. (Verge) , a privately held biopharmaceutical company focused on neurodegenerative diseases, announced today that it has completed a seed financing totaling $ 4 million.",
        "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data." ;
    ns1:documentTitle "Verge Genomics Completes Initial Financing to Discover and Develop Treatments for Neurodegenerative Diseases Using Genomic Data" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/verge-genomics-completes-initial-financing-to-discover-and-develop-treatments-for> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2328288/Verge_Genomics> ;
    ns1:targetDetails "seed" ;
    ns1:valueRaw "$ 4 million" ;
    ns1:when "2015-10-29T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 29, 2015" ;
    ns1:whereGeoName "La Rose Verger" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3578301/about.rdf> ;
    ns1:whereRaw "Verge Genomics" .

<https://1145.am/db/2368913/B_Investment_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-04T12:08:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "With an eye to jumping into the clinic with a lead drug for muscle wasting while building up a pipeline of drugs that target key growth factors, Scholar Rock is refueling for its next stage of development with a $ 36 million B round from a group of investors led by Fidelity Management and Research." ;
    ns1:documentTitle "Scholar Rock bags $36M to fuel muscle-wasting drug program, first clinical study" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/scholar-rock-bags-36m-to-fuel-muscle-wasting-drug-program-first-clinical-study> ;
    ns1:foundName "round" ;
    ns1:name "round" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2368913/Scholar_Rock> ;
    ns1:targetDetails "B" ;
    ns1:valueRaw "$ 36 million" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "Cambridge, MA" .

<https://1145.am/db/2370680/Series_B_Investment_Apitope_Lrm_Pmv_Vesalius_Biocapital_Wales_Life_Sciences_Fund_Wellcome_Trust_Wyvern_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-29T14:34:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The autoimmune biotech Apitope raised 12 million in a Series B financing." ;
    ns1:documentTitle "Apitope raises 12M for autoimmune work; Sanofi's new diabetes drug moves toward FDA nod;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/apitope-raises-%E2%82%AC12m-for-autoimmune-work-sanofi-s-new-diabetes-drug-moves-toward-fda-nod> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2370680/Apitope> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "12 million" ;
    ns1:whereGeoName "Wales" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2634895/about.rdf> ;
    ns1:whereRaw "Wales" .

<https://1145.am/db/2368333/Series_D_Investment_Anaptysbio_Bvf_Partners_Lp_Biomed_Ventures_Cormorant_Asset_Management_Frazier_Healthcare_Hbm_Healthcare_Investments_Longwood_Capital_Partners_Novo_A_S_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T15:28:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> San Diego - based AnaptysBio wrapped an oversubscribed $ 40M Series D financing round." ;
    ns1:documentTitle "AnaptysBio completes $40M Series D; Piqur raises $19M to back cancer drug R&D;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/anaptysbio-completes-40m-series-d-piqur-raises-19m-to-back-cancer-drug-r-d> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368333/Anaptysbio> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 40M" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "San Diego" .

<https://1145.am/db/2368912/Series_B_Investment_Arch_Venture_Partners_Cormorant_Asset_Management_Ecor1_Capital_Fidelity_Management_And_Research_Company_Polaris_Partners_Scholar_Rock_The_Kraft_Group_Timothy_Springer_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-04T12:36:05+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass.- (BUSINESS WIRE) -Scholar Rock, a biotechnology company focused on discovering and developing drugs that selectively target supracellular activation of growth factors in the disease microenvironment, today announced a $ 36 million Series B financing." ;
    ns1:documentTitle "Scholar Rock Announces $36 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/scholar-rock-announces-36-million-series-b-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368912/Scholar_Rock> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 36 million" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2369718/Series_B_Investment_Atlas_Venture_Ecor1_Capital_Fidelity_Management_And_Research_Company_Foresite_Capital_Sectoral_Asset_Management_Intellia_Therapeutics_Janus_Capital_Management_Novartis_Orbimed_Healthcare_Fund_Management_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-09-01T11:19:49+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass.- (BUSINESS WIRE) -Intellia Therapeutics, a leading gene-editing company focused on the development of curative medicines using CRISPR/Cas9 technology, has closed a Series B investment round with $ 70 million in additional financing led by OrbiMed HealthCare Fund Management.",
        "Intellia Therapeutics Secures $ 70 Million in Series B Financing." ;
    ns1:documentTitle "Intellia Therapeutics Secures $70 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intellia-therapeutics-secures-70-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing",
        "investment" ;
    ns1:name "Financing",
        "financing",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2369718/Intellia_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 70 Million",
        "$ 70 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2371169/Series_A_Investment_Caixa_Capital_Risc_Caixa_Capital_Risc_Chiesi_Ventures_Healthequity_Idinvest_Partners_Kurma_Partners_Minoryx_Therapeutics_Roche_Venture_Fund_Ysios_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-14T11:13:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Matar, Barcelona, Spain, October 14, 2015 - Minoryx Therapeutics, a drug development company specialized in the discovery of new drugs for orphan diseases, today announces it has completed a Series A funding round of 19.4M ($ 21.7M) .",
        "Minoryx Therapeutics completes Series A funding of 19.4M ($ 21.7M)" ;
    ns1:documentTitle "Minoryx Therapeutics completes Series A funding of 19.4M ($21.7M)" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/minoryx-therapeutics-completes-series-a-funding-of-%E2%82%AC19-4m-21-7m> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2371169/Minoryx_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 21.7M",
        "19.4M" ;
    ns1:whereGeoName "Kingdom of Spain" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2510769/about.rdf> ;
    ns1:whereRaw "Spain" .

<https://1145.am/db/2584561/Series_A_Investment_Casdin_Capital_Clarus_Ventures_Frazier_Healthcare_Partners_Gritstone_Oncology_Redmile_Group_The_Column_Group_Transformational_Healthcare_Opportunity_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-20T18:47:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Gritstone Oncology Announces $ 102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies.",
        "SAN FRANCISCO and CAMBRIDGE, Mass., Oct. 20, 2015 /PRNewswire/ - Gritstone Oncology, a cancer immunotherapy company developing next-generation, personalized cancer therapeutics, announced a Series A financing of $ 102 million." ;
    ns1:documentTitle "Gritstone Oncology Announces $102 Million Series A Financing to Support Discovery and Development of Personalized Cancer Immunotherapies" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/gritstone-oncology-announces-102-million-series-a-financing-to-support-discovery-and> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2584561/Gritstone_Oncology> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 102 Million",
        "$ 102 million" ;
    ns1:when "2015-10-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 20, 2015" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2367740/Series_C_Investment_Amgen_Ventures_Atlas_Venture_Boulder_Ventures_Brace_Pharma_Capital_Jafco_Co_Ltd_Mp_Healthcare_Venture_Management_Mrl_Ventures_Remeditex_Ventures_Miragen_Therapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-11-10T15:58:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOULDER, Colo.- (BUSINESS WIRE) -miRagen Therapeutics, a biopharmaceutical company developing innovative microRNA - based therapeutics, today announced a Series C Preferred Stock financing with gross proceeds of $ 41 million, including conversion of outstanding notes.",
        "MiRagen Therapeutics raises $ 41 mln. November 10, 2015 By Luisa Beltran.",
        "MiRagen Therapeutics said Tuesday it raised $ 41 million in Series C financing co - led by MRL Ventures and JAFCO Co. Ltd. New investors Brace Pharma Capital and MP Healthcare Venture Management took part in the round, which also included participation from existing investors Atlas Venture, Boulder Ventures, Remeditex Ventures, Amgen Ventures and others." ;
    ns1:documentTitle "MiRagen Therapeutics raises $41 mln" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/miragen-therapeutics-raises-41-mln> ;
    ns1:foundName "financing",
        "raises" ;
    ns1:name "financing",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2367740/Miragen_Therapeutics> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 41 million",
        "$ 41 mln" ;
    ns1:when "2015-11-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 10, 2015" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2368322/Series_C_Investment_Adage_Capital_Management_Canaan_Partners_Foresite_Capital_Johnson___Johnson_Innovation_Lilly_Ventures_Pharmstandard_International_Protagonist_Therapeutics_Ra_Capital_Management_Starfish_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-07-16T13:42:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MILPITAS, Calif., July 16, 2015 / - Protagonist Therapeutics, Inc., a company developing novel, orally stable peptide therapeutics for gastrointestinal diseases and disorders, today announced the closing of a $ 40 million Series C financing.",
        "Protagonist Therapeutics Raises $ 40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development." ;
    ns1:documentTitle "Protagonist Therapeutics Raises $40 Million Series C Financing to Advance Oral Peptide Drugs into Clinical Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/protagonist-therapeutics-raises-40-million-series-c-financing-to-advance-oral-peptide-drugs> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2368322/Protagonist_Therapeutics> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 40 Million",
        "$ 40 million" ;
    ns1:when "2015-07-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "July 16, 2015" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2369202/Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Third_Rock_Ventures_Wellington_Management_Company_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "In this round, new investors OrbiMed, Deerfield Management, Wellington Management Company, and an undisclosed public healthcare investment fund joined existing investors MPM Capital, New Enterprise Associates, Third Rock Ventures, Pfizer Ventures, and Ipsen." ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2371160/Investment_5am_Ventures_Deerfield_Management_Company_Foresite_Capital_Orbimed_Redmile_Group_Sofinnova_Ventures_Venrock_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The gene therapy biotech has raised a whopping $ 65 million in a big round that includes some classic biotech crossover investors." ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:whereRaw "San Francisco" .

<https://1145.am/db/2369202/Series_A_Investment_Deerfield_Management_Ipsen_Mpm_Capital_New_Enterprise_Associates_Orbimed_Pfizer_Ventures_Rhythm_Metabolic_Third_Rock_Ventures_Wellington_Management_Company_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-08-13T14:47:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "BOSTON, August 13, 2015- Rhythm announced today the completion of a $ 40 million Series A financing for its subsidiary, Rhythm Metabolic, Inc., which is developing setmelanotide (RM-493) , a novel peptide MC4 agonist for the treatment of obesity caused by genetic deficiencies in the MC4 pathway.",
        "Rhythm Subsidiary Raises $ 40 Million in Oversubscribed Financing." ;
    ns1:documentTitle "Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rhythm-subsidiary-raises-40-million-oversubscribed-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2369202/Rhythm_Metabolic> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 40 Million",
        "$ 40 million" ;
    ns1:when "2015-08-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "August 13, 2015" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2371160/Investment_Audentes_Therapeutics_Cormorant_Asset_Management_Cowen_Private_Investments_Foresite_Capital_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-13T15:43:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Is Audentes Therapeutics lining up an IPO ? The gene therapy biotech has raised a whopping $ 65 million in a big round that includes some classic biotech crossover investors." ;
    ns1:documentTitle "Audentes Therapeutics may be eyeing IPO after a $65M crossover round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-may-be-eyeing-ipo-after-a-65m-crossover-round> ;
    ns1:foundName "IPO",
        "raised" ;
    ns1:name "IPO",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2371160/Audentes_Therapeutics> ;
    ns1:valueRaw "$ 65 million" ;
    ns1:whereGeoName "San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:whereRaw "San Francisco" .

<https://1145.am/db/2369027/Kairos_Therapeutics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2016-01-08T01:19:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Vancouver - based Zymeworks has completed a long-awaited venture raise, bagging a $ 61.5 million mezzanine round with an eye to following up with an IPO-when the time is right." ;
    ns1:documentTitle "Zymeworks bags a $61.5M round, with a merger on tap and an IPO in view" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zymeworks-bags-a-61-5m-round-a-merger-on-tap-and-an-ipo-view> ;
    ns1:foundName "buy",
        "venture raise" ;
    ns1:name "buy",
        "venture raise" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2369027/Kairos_Therapeutics>,
        <https://1145.am/db/2369027/Zymeworks> ;
    ns1:targetName "Kairos Therapeutics" ;
    ns1:valueRaw "$ 61.5 million" ;
    ns1:vendor <https://1145.am/db/2369027/Zymeworks> ;
    ns1:whereGeoName "Vancouver" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6173331/about.rdf> ;
    ns1:whereRaw "Vancouver" .

<https://1145.am/db/2369000/Series_A_Investment_Arch_Venture_Partners_Abbvie_Accelerator_Corporation_Alexandria_Venture_Investments_Eli_Lilly_And_Company_Harris___Harris_Group_Innovate_Ny_Fund_Johnson___Johnson_Innovation_-_Jjdc_Inc_Petra_Pharma_Petra_Pharma_Pfizer_Venture_Investments_The_Partnership_Fund_For_New_York_City_Watson_Fund_Weill_Cornell_Medicine_Wuxi_Pharmatech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2016-01-06T05:00:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW YORK CITY - January 6, 2016 - Accelerator Corporation, a leading life science investment and management firm, today announced the Series A financing of Petra Pharma Corporation to develop small molecule inhibitors for the treatment of cancer and metabolic diseases in alliance with Weill Cornell Medicine.",
        "Petra Pharma Secures $ 48 Million Series A Financing to Develop Therapies for Cancer and Metabolic Diseases." ;
    ns1:documentTitle "Accelerator Corporation Launches First Startup in New York City Portfolio" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/accelerator-corporation-launches-first-startup-new-york-city-portfolio> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2369000/Petra_Pharma> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 48 Million",
        "$ 48 million" ;
    ns1:when "2016-01-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "January 6, 2016" ;
    ns1:whereGeoName "New York City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:whereRaw "New York" .

<https://1145.am/db/2371163/Series_C_Investment_5am_Ventures_Audentes_Therapeutics_Cormorant_Asset_Management_Llc_Cowen_Private_Investments_Deerfield_Management_Company_Foresite_Capital_Orbimed_Ra_Capital_Management_Redmile_Group_Rock_Springs_Capital_Management_Lp_Sofinnova_Ventures_T_Rowe_Price_Associates_Venrock_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2015-10-13T16:41:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Audentes Therapeutics Raises $ 65 Million in Series C Financing.",
        "SAN FRANCISCO- (BUSINESS WIRE) -Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, today announced the closing of an oversubscribed $ 65 million Series C financing." ;
    ns1:documentTitle "Audentes Therapeutics Raises $65 Million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/audentes-therapeutics-raises-65-million-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2371163/Audentes_Therapeutics> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 65 Million",
        "$ 65 million" ;
    ns1:when "2015-10-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 13, 2015" ;
    ns1:whereGeoName "Daylight",
        "Time" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3134627/about.rdf>,
        <https://sws.geonames.org/4617522/about.rdf> ;
    ns1:whereRaw "Eastern Daylight Time" .

